<PAGE>
Registration No. 33-57792
811-7466
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-6
FOR REGISTRATION UNDER THE SECURITIES ACT OF 1933 OF
SECURITIES OF UNIT INVESTMENT TRUSTS REGISTERED ON FORM
N-8B-2
Post-Effective Amendment No. 12
VEL II ACCOUNT
OF ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
(Exact Name of Registrant)
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
440 Lincoln Street
Worcester MA 01653
(Address of Principal Executive Office)
Abigail M. Armstrong, Esq.
440 Lincoln Street
Worcester MA 01653
(Name and Address of Agent for Service of Process)
It is proposed that this filing will become effective:
immediately upon filing pursuant to paragraph (b)
-----
X on May 1, 1998 pursuant to paragraph (b)
-----
60 days after filing pursuant to paragraph (a) (1)
-----
on (date) pursuant to paragraph (a) (1) of Rule 485
-----
this post-effective amendment designates a new effective date
----- for a previously filed post-effective amendment
FLEXIBLE PREMIUM VARIABLE LIFE
Pursuant to Reg. Section 270.24f-2 of the Investment Company Act of 1940 ("1940
Act"), Registrant hereby declares that an indefinite amount of its securities is
being registered under the Securities Act of 1933 ("1933 Act"). The 24f-2 Notice
for the issuer's fiscal year ended December 31, 1997 was filed on or before
March 30, 1998.
<PAGE>
RECONCILIATION AND TIE BETWEEN ITEMS
IN FORM N-8b-2 AND THE PROSPECTUS
ITEM NO. OF
FORM N-8b-2 CAPTION IN PROSPECTUS
1. . . . . . . . . . . . Cover Page
2 . . . . . . . . . . . Cover Page
3. . . . . . . . . . . . Not Applicable
4. . . . . . . . . . . . Distribution
5. . . . . . . . . . . . The Company, The VEL II Account
6. . . . . . . . . . . . The VEL II Account
7. . . . . . . . . . . . Not Applicable
8. . . . . . . . . . . . Not Applicable
9. . . . . . . . . . . . Legal Proceedings
10 . . . . . . . . . . . Summary; Description of the Company, The VEL II
Account and the Underlying Funds; The Policy; Policy
Termination and Reinstatement; Other Policy
Provisions
11 . . . . . . . . . . . Summary; Allmerica Investment Trust; Variable
Insurance Products Fund; Variable Insurance Products
Fund II; T. Rowe Price International Series, Inc.;
Delaware Group Premium Fund, Inc.; Investment
Objectives and Policy
12 . . . . . . . . . . . Summary; Allmerica Investment Trust; Variable
Insurance Products Fund; Variable Insurance Products
Fund II; T. Rowe Price International Series, Inc.;
Delaware Group Premium Fund, Inc.
13 . . . . . . . . . . . Summary; Allmerica Investment Trust; Variable
Insurance Products Fund; Variable
Insurance Products Fund II; T. Rowe Price
International Series, Inc.; Delaware Group Premium
Fund, Inc.; Investment Advisory Services to the
Trust; Investment Advisory Services to Variable
Insurance Products Fund; Investment Advisory Services
to Variable Insurance Products Fund II; Investment
Advisory Services to T. Rowe Price International
Series, Inc.; Investment Advisory Services to
Delaware Group Premium Fund, Inc.; Charges and
Deductions
14 . . . . . . . . . . . Summary; Applying for a Policy
15 . . . . . . . . . . . Summary; Applying for a Policy; Premium Payments;
Allocation of Net Premiums
16 . . . . . . . . . . . The VEL II Account; Allmerica Investment Trust;
Variable Insurance Products Fund; Variable Insurance
Products Fund II; T. Rowe Price International Series,
Inc.; Delaware Group Premium Fund, Inc.; Premium
Payments; Allocation of Net Premiums
17 . . . . . . . . . . . Summary; Policy Surrender; Partial Withdrawal;
Charges and Deductions; Policy Termination and
Reinstatement
18 . . . . . . . . . . . The VEL II Account; Allmerica Investment Trust;
Variable Insurance Products Fund; Variable Insurance
Products Fund II; T. Rowe Price International Series,
Inc.; Delaware Group Premium Fund, Inc.; Premium
Payments
19 . . . . . . . . . . . Reports; Voting Rights
20 . . . . . . . . . . . Not Applicable
21 . . . . . . . . . . . Summary; Policy Loans; Other Policy Provisions
22 . . . . . . . . . . . Other Policy Provisions
23 . . . . . . . . . . . Not Required
24 . . . . . . . . . . . Other Policy Provisions
25 . . . . . . . . . . . The Company
<PAGE>
26 . . . . . . . . . . . Not Applicable
27 . . . . . . . . . . . The Company
28 . . . . . . . . . . . Directors and Principal Officers of the Company
29 . . . . . . . . . . . The Company
30 . . . . . . . . . . . Not Applicable
31 . . . . . . . . . . . Not Applicable
32 . . . . . . . . . . . Not Applicable
33 . . . . . . . . . . . Not Applicable
34 . . . . . . . . . . . Not Applicable
35 . . . . . . . . . . . Distribution
36 . . . . . . . . . . . Not Applicable
37 . . . . . . . . . . . Not Applicable
38 . . . . . . . . . . . Summary; Distribution
39 . . . . . . . . . . . Summary; Distribution
40 . . . . . . . . . . . Not Applicable
41 . . . . . . . . . . . The Company, Distribution
42 . . . . . . . . . . . Not Applicable
43 . . . . . . . . . . . Not Applicable
44 . . . . . . . . . . . Premium Payments; Policy Value and Cash Surrender
Value
45 . . . . . . . . . . . Not Applicable
46 . . . . . . . . . . . Policy Value and Cash Surrender Value; Federal Tax
Considerations
47 . . . . . . . . . . . The Company
48 . . . . . . . . . . . Not Applicable
49 . . . . . . . . . . . Not Applicable
50 . . . . . . . . . . . The VEL II Account
51 . . . . . . . . . . . Cover Page; Summary; Charges and Deductions; The
Policy; Policy Termination and Reinstatement; Other
Policy Provisions
52 . . . . . . . . . . . Addition, Deletion or Substitution of Investment
53 . . . . . . . . . . . Federal Tax Considerations
54 . . . . . . . . . . . Not Applicable
55 . . . . . . . . . . . Not Applicable
56 . . . . . . . . . . . Not Applicable
57 . . . . . . . . . . . Not Applicable
58 . . . . . . . . . . . Not Applicable
59 . . . . . . . . . . . Not Applicable
<PAGE>
INDIVIDUAL FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE POLICY
This Prospectus describes an individual flexible premium variable life insurance
policy ("Policy") offered
by Allmerica Financial Life Insurance and Annuity Company ("Company") to
applicants Age 85 years
old and under.
The Policy permits you to allocate net premiums among up to 20 sub-accounts
("Sub-Accounts") of the Separate Account, a separate account of the Company, and
a fixed-interest account ("General Account") of the Company (collectively,
"Accounts"). Each Sub-Account invests its assets in a corresponding investment
portfolio of Allmerica Investment Trust ("Trust"), Fidelity Variable Insurance
Products Fund ("Fidelity VIP"), Fidelity Variable Insurance Products Fund II
("Fidelity VIP II"), T. Rowe Price International Series, Inc. ("T. Rowe Price")
or Delaware Group Premium Fund, Inc. ("DGPF"). The following Underlying Funds
are available under the Policy:
<TABLE>
<S> <C>
ALLMERICA INVESTMENT TRUST FIDELITY VIP
Select Aggressive Growth Fund Overseas Portfolio
Select Capital Appreciation Fund Equity-Income Portfolio
Select Value Opportunity Fund Growth Portfolio
Select Emerging Markets Fund High Income Portfolio
Select International Equity Fund
Select Growth Fund FIDELITY VIP II
Select Strategic Growth Fund Asset Manager Portfolio
Growth Fund
Equity Index Fund T. ROWE PRICE
Select Growth and Income Fund International Stock Portfolio
Investment Grade Income Fund
Government Bond Fund DGPF
Money Market Fund International Equity Series
</TABLE>
CERTAIN FUNDS MAY NOT BE AVAILABLE IN ALL STATES.
THIS PROSPECTUS IS VALID ONLY WHEN ACCOMPANIED BY CURRENT PROSPECTUSES OF THE
ALLMERICA INVESTMENT TRUST, FIDELITY VARIABLE INSURANCE PRODUCTS FUND, FIDELITY
VARIABLE INSURANCE PRODUCTS FUND II, T. ROWE PRICE INTERNATIONAL SERIES, INC.,
AND DELAWARE GROUP PREMIUM FUND, INC. THE FIDELITY VIP HIGH INCOME PORTFOLIO MAY
INVEST IN HIGHER YIELDING, HIGHER RISK, LOWER RATED DEBT SECURITIES (SEE
"INVESTMENT OBJECTIVES AND POLICIES" IN THIS PROSPECTUS). INVESTORS SHOULD
RETAIN A COPY OF THIS PROSPECTUS FOR FUTURE REFERENCE.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION, NOR HAS THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
THE POLICY IS AN OBLIGATION OF ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY
COMPANY, AND IS DISTRIBUTED BY ALLMERICA INVESTMENTS, INC. THE POLICY IS NOT A
DEPOSIT OR OBLIGATION OF, OR GUARANTEED OR ENDORSED BY, ANY BANK OR CREDIT
UNION. THE POLICY IS NOT INSURED BY THE U.S. GOVERNMENT, THE FEDERAL DEPOSIT
INSURANCE CORPORATION (FDIC), OR ANY OTHER FEDERAL AGENCY. INVESTMENTS IN THE
POLICY ARE SUBJECT TO VARIOUS RISKS, INCLUDING THE FLUCTUATION OF VALUE AND
POSSIBLE LOSS OF PRINCIPAL.
CORRESPONDENCE MAY BE MAILED TO:
ALLMERICA LIFE, P.O. BOX 8014,
BOSTON MA 02266-8014
PROSPECTUS DATED MAY 1, 1998
WORCESTER, MASSACHUSETTS 01653
(508) 855-1000
<PAGE>
(Continued from cover page)
Each Underlying Fund has its own investment objectives. The accompanying
prospectuses of the Trust, Fidelity VIP, Fidelity VIP II, T. Rowe Price and DGPF
describe the investment objectives and certain attendant risks of each
Underlying Fund.
There is no guaranteed minimum Policy Value. The value of a Policy will vary up
or down to reflect the investment experience of allocations to the Sub-Accounts
and the fixed rates of interest earned by allocations to the General Account.
The Policy Value also will be adjusted for other factors, including the amount
of charges imposed. A Policy will remain in effect so long as the Policy Value
less any surrender charges and less any outstanding Debt is sufficient to pay
certain monthly charges imposed in connection with the Policy. The Policy Value
may decrease to the point where the Policy will lapse and provide no further
death benefit without additional premium payments, unless the optional
Guaranteed Death Benefit rider is in effect.
If the Policy is in effect at the death of the Insured, the Company will pay a
death benefit (the "Death Proceeds") to the Beneficiary. Prior to the Final
Premium Payment Date, the Death Proceeds equal the Sum Insured, less any Debt,
partial withdrawals, and any due and unpaid charges. You may choose either Sum
Insured Option 1 (the Sum Insured is fixed in amount) or Sum Insured Option 2
(the Sum Insured includes the Policy Value in addition to a fixed insurance
amount). A Policyowner has the right to change the Sum Insured Option, subject
to certain conditions. A Guideline Minimum Sum Insured, equivalent to a
percentage of the Policy Value, will apply if greater than the Sum Insured
otherwise payable under Option 1 or Option 2.
In certain circumstances, the Policy may be considered a "modified endowment
contract." Under the Internal Revenue Code (the "Code"), any policy loan,
partial withdrawal or surrender from a modified endowment contract may be
subject to tax and tax penalties. See "FEDERAL TAX CONSIDERATIONS -- Modified
Endowment Contracts."
IT MAY NOT BE ADVANTAGEOUS TO PURCHASE FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE
AS A REPLACEMENT FOR YOUR CURRENT LIFE INSURANCE, OR IF YOU ALREADY OWN A
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE POLICY.
THE PURPOSE OF THE POLICY IS TO PROVIDE INSURANCE PROTECTION FOR THE
BENEFICIARY. NO CLAIM IS MADE THAT THE POLICY IS IN ANY WAY SIMILAR OR
COMPARABLE TO A SYSTEMATIC INVESTMENT PLAN OF A MUTUAL FUND. THE POLICY,
TOGETHER WITH ITS ATTACHED APPLICATION, CONSTITUTES THE ENTIRE AGREEMENT BETWEEN
YOU AND THE COMPANY.
2
<PAGE>
TABLE OF CONTENTS
<TABLE>
<S> <C>
SPECIAL TERMS......................................................................... 5
SUMMARY............................................................................... 8
PERFORMANCE INFORMATION............................................................... 18
DESCRIPTION OF THE COMPANY, THE SEPARATE ACCOUNT AND THE UNDERLYING FUNDS............. 24
INVESTMENT OBJECTIVES AND POLICIES.................................................... 26
INVESTMENT ADVISORY SERVICES.......................................................... 28
ADDITION, DELETION OR SUBSTITUTION OF INVESTMENTS..................................... 31
VOTING RIGHTS......................................................................... 31
THE POLICY............................................................................ 32
Applying For a Policy............................................................... 32
Free-Look Period.................................................................... 33
Conversion Privileges............................................................... 34
Premium Payments.................................................................... 34
Incentive Funding Discount.......................................................... 35
Guaranteed Death Benefit Rider...................................................... 35
Paid-Up Insurance Option............................................................ 36
Allocation of Net Premiums.......................................................... 37
Transfer Privilege.................................................................. 37
Death Proceeds...................................................................... 38
Sum Insured Options................................................................. 39
Change in Sum Insured Option........................................................ 41
Change in the Face Amount........................................................... 42
Policy Value and Surrender Value.................................................... 43
Death Proceeds Payment Options...................................................... 45
Optional Insurance Benefits......................................................... 45
Policy Surrender.................................................................... 45
Partial Withdrawals................................................................. 46
CHARGES AND DEDUCTIONS................................................................ 46
Tax Expense Charge.................................................................. 46
Monthly Deduction from the Policy Value............................................. 47
Charges Against Assets of the Separate Account...................................... 49
Surrender Charge.................................................................... 50
Possible Surrender Charge on a Face Amount Decease.................................. 51
Charges on Partial Withdrawal....................................................... 52
Transfer Charges.................................................................... 52
Charge For Increase in the Face Amount.............................................. 53
Other Administrative Charges........................................................ 53
POLICY LOANS.......................................................................... 53
Loan Interest....................................................................... 53
Repayment of Loans.................................................................. 54
Effect of Policy Loans.............................................................. 54
Policies Issued in Connection with TSA Plans........................................ 54
POLICY TERMINATION AND REINSTATEMENT.................................................. 55
Termination......................................................................... 55
Reinstatement....................................................................... 55
</TABLE>
3
<PAGE>
<TABLE>
<S> <C>
OTHER POLICY PROVISIONS............................................................... 56
Policyowner......................................................................... 56
Beneficiary......................................................................... 57
Incontestability.................................................................... 57
Suicide............................................................................. 57
Age And Sex......................................................................... 57
Assignment.......................................................................... 57
Postponement of Payments............................................................ 57
DIRECTORS AND PRINCIPAL OFFICERS OF THE COMPANY....................................... 59
DISTRIBUTION.......................................................................... 60
SERVICES.............................................................................. 60
REPORTS............................................................................... 60
LEGAL PROCEEDINGS..................................................................... 61
FURTHER INFORMATION................................................................... 61
INDEPENDENT ACCOUNTANTS............................................................... 61
FEDERAL TAX CONSIDERATIONS............................................................ 61
The Company and the Separate Account................................................ 61
Taxation of the Policy.............................................................. 62
Modified Endowment Contracts........................................................ 63
MORE INFORMATION ABOUT THE GENERAL ACCOUNT............................................ 63
General Description................................................................. 64
General Account Values.............................................................. 64
The Policy.......................................................................... 64
FINANCIAL STATEMENTS.................................................................. 65
APPENDIX A -- OPTIONAL BENEFITS....................................................... A-1
APPENDIX B -- DEATH PROCEEDS PAYMENT OPTIONS.......................................... B-1
APPENDIX C -- ILLUSTRATIONS OF SUM INSURED, POLICY VALUES AND
ACCUMULATED PREMIUMS................................................................. C-1
APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER CHARGES................................ D-1
</TABLE>
4
<PAGE>
SPECIAL TERMS
ACCUMULATION UNIT: a measure of your interest in a Sub-Account.
AGE: the Insured's age as of the nearest birthday measured from a Policy
anniversary.
BENEFICIARY: the person(s) designated by the Policyowner to receive the
insurance proceeds upon the death of the Insured.
COMPANY: Allmerica Financial Life Insurance and Annuity Company.
DATE OF ISSUE: the date set forth in the Policy used to determine the Monthly
Payment Date, Policy months, Policy years, and Policy anniversaries.
DEATH PROCEEDS: Prior to the Final Premium Payment Date, the Death Proceeds
equal the amount calculated under the applicable Sum Insured Option (Option 1 or
Option 2), less Debt outstanding at the time of the Insured's death, partial
withdrawals, if any, partial withdrawal charges, and any due and unpaid Monthly
Deductions. After the Final Premium Payment Date, the Death Proceeds equal the
Surrender Value of the Policy, unless the optional Guaranteed Death Benefit
Rider is in effect. If the rider is in effect, the Death Proceeds will be
greater of (a) the Face Amount as of the Final Premium Payment Date or (b) the
Policy Value as of the date due proof of death is received by the Company.
DEBT: all unpaid Policy loans plus interest due or accrued on such loans.
DELIVERY RECEIPT: an acknowledgment, signed by the Policyowner and returned to
the Company's Principal Office, that the Policyowner has received the Policy and
the Notice of Withdrawal Rights.
EVIDENCE OF INSURABILITY: information, including medical information
satisfactory to the Company, that is used to determine the Insured's Premium
Class.
FACE AMOUNT: the amount of insurance coverage applied for; the Face Amount of
each Policy is set forth in the specification pages of the Policy.
FINAL PREMIUM PAYMENT DATE: the Policy anniversary nearest the Insured's 95th
birthday. The Final Premium Payment Date is the latest date on which a premium
payment may be made. After this date, the Death Proceeds equal the Surrender
Value of the Policy, unless the optional Guaranteed Death Benefit Rider is in
effect.
GENERAL ACCOUNT: all the assets of the Company other than those held in a
separate account.
GUIDELINE ANNUAL PREMIUM: the annual amount of premium that would be payable
through the Final Premium Payment Date of a Policy for the specified Sum
Insured, if premiums were fixed by the Company as to both timing and amount, and
monthly cost of insurance charges were based on the 1980 Commissioners Standard
Ordinary Mortality Tables (Mortality Table B, Smoker or Non-Smoker, for unisex
Policies), net investment earnings at an annual effective rate of 5%, and fees
and charges as set forth in the Policy and any Policy riders. The Sum Insured
Option 1 Guideline Annual Premium is used when calculating the maximum surrender
charge.
GUIDELINE MINIMUM SUM INSURED: the minimum Sum Insured required to qualify the
Policy as "life insurance" under federal tax laws. The Guideline Minimum Sum
Insured varies by age; it is calculated by multiplying the Policy Value by a
percentage determined by the Insured's Age.
5
<PAGE>
INSURANCE AMOUNT AT RISK: the Sum Insured less the Policy Value.
LOAN VALUE: the maximum amount that may be borrowed under the Policy.
MINIMUM MONTHLY FACTOR: a monthly premium amount calculated by the Company and
specified in your Policy. If you pay this amount, the Company guarantees that
your Policy will not lapse prior to the 49th Monthly Deduction after the Date of
Issue or the effective date of an increase in the Face Amount. Making payments
at least equal to the Minimum Monthly Factors, however, will not prevent the
Policy from lapsing if (a) Debt exceeds Policy Value less surrender charges, or
(b) Debt, partial withdrawals and partial withdrawal charges have reduced
premium payments below an amount equal to the Minimum Monthly Factor multiplied
by the number of months since the Date of Issue or the effective date of an
increase.
MONTHLY DEDUCTION: charges deducted monthly from the Policy Value of a Policy
prior to the Final Premium Payment Date. The charges include the monthly cost of
insurance, the monthly cost of any benefits provided by riders, and the monthly
administrative charge.
MONTHLY PAYMENT DATE: the date on which the Monthly Deduction is deducted from
the Policy Value.
NET PREMIUM: an amount equal to the premium less a tax expense charge.
POLICY CHANGE: any change in the Face Amount, the addition or deletion of a
rider, or a change in the Sum Insured Option.
POLICY VALUE: the total amount available for investment under a Policy at any
time. It is equal to the sum of (a) the value of the Accumulation Units credited
to a Policy in the Sub-Accounts, and (b) the accumulation in the General Account
credited to that Policy.
POLICYOWNER: the person, persons or entity entitled to exercise the rights and
privileges under the Policy.
PREMIUM CLASS: the risk classification that the Company assigns the Insured
based on the information in the application and any other Evidence of
Insurability considered by the Company. The Insured's Premium Class will affect
the cost of insurance charge and the amount of premium required to keep the
Policy in force.
PRINCIPAL OFFICE: the Company's office, located at 440 Lincoln Street,
Worcester, Massachusetts 01653.
PRO-RATA ALLOCATION: In certain circumstances, you may specify from which
Sub-Account certain deductions will be made or to which Sub-Account the Policy
Value will be allocated. If you do not, the Company will allocate the deduction
or Policy Value among the General Account and the Sub-Accounts in the same
proportion that the Policy Value in the General Account (less Debt) and the
Policy Value in each Sub-Account bear to the total Policy Value on the date of
deduction or allocation.
SEPARATE ACCOUNT: A separate account consists of assets segregated from the
Company's other assets. The investment performance of the assets of each
separate account is determined separately from the other assets of the Company.
The assets of a separate account which are equal to the reserves and other
contract liabilities are not chargeable with liabilities arising out of any
other business which the Company may conduct.
SUB-ACCOUNT: a division of the VEL II Account. Each Sub-Account invests
exclusively in the shares of a corresponding Fund of the Allmerica Investment
Trust, a corresponding Portfolio of the Fidelity Variable Insurance Products
Fund ("Fidelity VIP") or the Fidelity Variable Insurance Products Fund II
("Fidelity VIP II"), the T. Rowe Price International Stock Portfolio of T. Rowe
Price International Series ("T. Rowe Price"), Inc. or the International Equity
Series of the Delaware Group Premium Fund, Inc. ("DGPF").
6
<PAGE>
SUM INSURED: the amount payable upon the death of the Insured, before the Final
Premium Payment Date, prior to deductions for Debt outstanding at the time of
the Insured's death, partial withdrawals and partial withdrawal charges, if any,
and any due and unpaid Monthly Deductions. The amount of the Sum Insured will
depend on the Sum Insured Option chosen, but always will be at least equal to
the Face Amount.
SURRENDER VALUE: the amount payable upon a full surrender of the Policy. It is
the Policy Value less any Debt and applicable surrender charges.
UNDERLYING FUNDS (FUNDS): the Funds of the Allmerica Investment Trust, the
Portfolios of the Fidelity Variable Insurance Products Fund and Fidelity
Variable Insurance Products Fund II, the Portfolio of T. Rowe Price
International Series, Inc., and the Series of the Delaware Group Premium Fund,
Inc. available under the Policy.
VALUATION DATE: a day on which the net asset value of the shares of any of the
Underlying Funds is determined and Accumulation Unit values of the Sub-Accounts
are determined. Valuation Dates currently occur on each day on which the New
York Stock Exchange is open for trading, and on such other days (other than a
day during which no payment, partial withdrawal, or surrender of a Policy is
received) when there is a sufficient degree of trading in an Underlying Fund's
securities such that the current net asset value of the Sub-Accounts may be
affected materially.
VEL II ACCOUNT: a separate account of the Company to which the Policyowner may
make Net Premium allocations.
WRITTEN REQUEST: a request in writing, by the Policyowner, satisfactory to the
Company.
YOU OR YOUR: the Policyowner, as shown in the application or the latest change
filed with the Company.
7
<PAGE>
SUMMARY
The following is a summary of the flexible premium variable life insurance
policy sold by Allmerica Financial Life Insurance and Annuity Company. It
highlights key points from the Prospectus which follows. If you are considering
the purchase of this product, you should read the Prospectus carefully before
making a decision. It offers a more complete presentation of the topics
presented here, and will help you better understand the product.
FREE-LOOK PERIOD -- The Policy provides for an initial Free-Look Period. You
may cancel the Policy by mailing or delivering it to the Principal Office or
to an agent of the Company on or before the latest of:
- 45 days after the application for the Policy is signed,
- 10 days after you receive the Policy (or, if required by state law, the
longer period indicated in your Policy), or
- 10 days after the Company mails or personally delivers a Notice of
Withdrawal Rights to you.
Upon returning the Policy, you will receive a refund equal to the sum of:
(1) the difference between the premium, including fees and charges paid,
and any amount allocated to the Separate Account, plus
(2) the value of the amounts allocated to the Separate Account, PLUS
(3) any fees or charges imposed on the amounts allocated to the Separate
Account.
The amount refunded in (1) above includes any premiums allocated to the
General Account. Where required by state law, however, the Company will refund
the entire amount of premiums paid.A free-look privilege also applies after a
requested increase in the Face Amount. See THE POLICY, Free-Look Period.
CONVERSION PRIVILEGES -- During the first 24 Policy months after the Date of
Issue, subject to certain restrictions, you may convert the Policy to a
non-variable flexible premium adjustable life insurance policy by
simultaneously transferring all accumulated value in the Sub-Accounts to the
General Account and instructing the Company to allocate all future premiums to
the General Account. A similar conversion privilege is in effect for 24 Policy
months after the date of an increase in the Face Amount. Where required by
state law, and at your request, the Company will issue a flexible premium
adjustable life insurance policy to you. The new policy will have the same
Face Amount, issue age, Date of Issue, and Premium Class as the original
Policy. See THE POLICY, Conversion Privileges.
ABOUT THE POLICY
The Policy allows you to make premium payments in any amount and frequency,
subject to certain limitations. As long as the Policy remains in force, it will
provide for:
- life insurance coverage on the named Insured,
- Policy Value,
- surrender rights and partial withdrawal rights,
- loan privileges, and
- in some cases, additional insurance benefits available by rider for an
additional charge.
8
<PAGE>
LIFE INSURANCE
The Policy is a life insurance contract with death benefits, Policy Value, and
other features traditionally associated with life insurance. The Policy is
"variable" because the Policy Value will increase or decrease depending on the
investment experience of the Sub-Accounts of the Separate Account. Under some
circumstances, the Death Benefit may vary with the investment experience of the
Sub-Accounts.
FLEXIBLE PREMIUM
The Policy is a "flexible premium" policy because, unlike traditional insurance
policies, there is no fixed schedule for premium payments. You may vary the
frequency and amount of future premium payments, subject to certain limits,
restrictions and conditions set by Company standards and federal tax laws.
Although you may establish a schedule of premium payments ("planned premium
payments"), failure to make the planned premium payments will not necessarily
cause the Policy to lapse. Because of the variable nature of the Policy, making
planned premium payments does not guarantee that the Policy will remain in
force. Thus, you may, but are not required to, pay additional premiums. However,
if the optional Guaranteed Death Benefit rider is in effect, certain minimum
premium payment tests must be met. This Rider may not be available in all
states.
The Policy will remain in force until the Surrender Value is insufficient to
cover the next Monthly Deduction and loan interest accrued, if any, and a grace
period of 62 days has expired without adequate payment being made by you. During
the first 48 Policy months after the Date of Issue or the effective date of an
increase in the Face Amount, the Policy will not lapse if the total premiums
paid less the Debt, partial withdrawals and withdrawal charges are equal to or
exceed the sum of the Minimum Monthly Factors for the number of months the
Policy, increase, or a Policy Change which causes a change in the Minimum
Monthly Factor has been in force. Even during these periods, however, making
payments at least equal to the Minimum Monthly Factor will not prevent the
Policy from lapsing if the Debt equals or exceeds the Policy Value less
surrender charges.
CONDITIONAL INSURANCE
If at the time of application you make a payment equal to at least one Minimum
Monthly Factor for the Policy as applied for, the Company will provide
conditional insurance, equal to the amount of insurance applied for but not to
exceed $500,000. If the application is approved, the Policy will be issued as of
the date the terms of the conditional insurance are met. If you do not wish to
make any payment at the time of application, insurance coverage will not be in
force until delivery of the Policy and payment of sufficient premium to place
the insurance in force.
If any premiums are paid prior to the issuance of the Policy, such premiums will
be held in the Company's General Account. If your application is approved and
the Policy is issued and accepted, the initial premiums held in the General
Account will be credited with interest at a specified rate beginning not later
than the date of receipt of the premiums at the Principal Office. IF A POLICY IS
NOT ISSUED AND ACCEPTED, THE INITIAL PREMIUMS WILL BE RETURNED TO YOU WITHOUT
INTEREST.
GUARANTEED DEATH BENEFIT RIDER
This rider, WHICH IS AVAILABLE ONLY AT DATE OF ISSUE:
- guarantees that your Policy will not lapse regardless of the investment
performance of the Variable Account; and
- provides a guaranteed death benefit.
In order to maintain the rider, certain minimum premium payment tests must be
met on each Policy anniversary and within 48 months following the Date of Issue
and/or the date of any increase in Face Amount. In addition, a one-time
administrative charge of $25 will be deducted from Policy Value when the Rider
is elected. Certain transactions, including policy loans, partial withdrawals,
and changes in Sum Insured Options, can result in the termination of the Rider.
If this Rider is terminated, it cannot be reinstated.
9
<PAGE>
POLICIES ISSUED IN CONNECTION WITH TSA PLANS
The Policies may be issued in connection with Code Section 403(b) tax-sheltered
annuity plans ("TSA Plans") of certain public school systems and organizations
that are tax exempt under Section 501(c)(3) of the Code. A Policy issued in
connection with a TSA Plan will be endorsed to reflect the restrictions imposed
on assignment, premium payments, withdrawals, and surrender under Code Section
403(b). The Policyowner may terminate the endorsement at any time. However, the
termination of the endorsement may cause the Policy to fail to qualify under
Code Section 403(b). See "FEDERAL TAX CONSIDERATIONS -- POLICIES ISSUED IN
CONNECTION WITH TSA PLANS" and "POLICY LOANS -- POLICIES ISSUED IN CONNECTION
WITH TSA PLANS."
MINIMUM MONTHLY FACTOR
The Minimum Monthly Factor is a monthly premium amount calculated by the Company
and specified in your Policy. If you pay this amount, the Company guarantees
that the Policy will not lapse prior to the 49th Monthly Deduction after the
Date of Issue or the effective date of an increase in the Face Amount. At all
other times, however, payments of such premiums do not guarantee that the Policy
will remain in force, unless the Guaranteed Death Benefit rider is in effect.
See "THE POLICY," "Premium Payments." Moreover, even during the 48-month period,
if Debt exceeds the Policy Value less surrender charges, then making payments at
least equal to the Minimum Monthly Factor will not prevent the Policy from
lapsing. However, if the optional Guaranteed Death Benefit rider is in effect,
the Company (a) guarantees that the Policy will not lapse, regardless of the
investment performance of the Separate Account, and (b) provides a guaranteed
death benefit. See "THE POLICY," "Guaranteed Death Benefit Rider."
ALLOCATION OF INITIAL PREMIUMS
Upon completion of issuance procedures, delivery of the Policy, and receipt of
any additional premiums, if you have paid less than $10,000 of initial Net
Premiums, such Net Premiums will be allocated to the Sub-Accounts according to
your instructions. If initial Net Premiums equal or exceed $10,000, or if the
Policy provides for planned premium payments during the first year equal to or
exceeding $10,000 annually, $5,000 semi-annually, $2,500 quarterly or $1,000
monthly, the entire Net Premium plus any interest earned will be allocated to
the Sub-Accounts upon return to the Company of a Delivery Receipt. See "THE
POLICY," "Applying For a Policy."
Net premiums may be allocated to one or more Sub-Accounts of the Separate
Account, to the General Account, or to any combination of accounts. You bear the
investment risks of amounts allocated to the Sub-Accounts. Allocations may be
made to no more than 20 Sub-Accounts at any one time. The minimum allocation is
1% of Net Premium. All allocations must be in whole numbers and must total 100%.
See "THE POLICY" -- "Allocation of Net Premiums." Premiums allocated to the
General Account will earn a fixed rate of interest. Net premiums and minimum
interest are guaranteed by the Company. For more information, see "MORE
INFORMATION ABOUT THE GENERAL ACCOUNT."
PARTIAL WITHDRAWALS
After the first Policy year, you may make partial withdrawals in a minimum
amount of $500 from the Policy Value. Under Option 1, the Face Amount is reduced
by the amount of the partial withdrawal. A partial withdrawal will not be
allowed under Option 1 if it would reduce the Face Amount below $40,000.
A partial withdrawal transaction charge, which is described in "CHARGES AND
DEDUCTIONS," "Charges On Partial Withdrawal," will be assessed to reimburse the
Company for the cost of processing each partial withdrawal. A withdrawal charge
also may be imposed upon a partial withdrawal. Generally, amounts withdrawn
during each Policy year in excess of 10% of the Policy Value ("excess
withdrawal") are subject to the withdrawal charge. The withdrawal charge is
equal to 5% of the excess withdrawal up to the surrender charge on the date of
withdrawal. If no surrender charge is applicable at the time of withdrawal, no
partial withdrawal charge will be deducted. The Policy's outstanding surrender
charge will be reduced by the amount of the partial withdrawal charge deducted.
See "THE POLICY," "Partial Withdrawal" and "CHARGES AND DEDUCTIONS," "Charges On
Partial Withdrawal."
10
<PAGE>
LOAN PRIVILEGE
You may borrow against the Policy Value. The total amount you may borrow is the
Loan Value. Loan Value in the first Policy year is 75% of an amount equal to the
Policy Value less surrender charge, Monthly Deductions, and interest on Debt to
the end of the Policy year. Thereafter, Loan Value is 90% of an amount equal to
the Policy Value less the surrender charge.
Policy loans will be allocated among the General Account and the Sub-Accounts in
accordance with your instructions. If no allocation is made by you, the Company
will make a Pro-Rata Allocation among the Accounts. In either case, Policy Value
equal to the Policy loan will be transferred from the appropriate Sub-Account(s)
to the General Account, and will earn monthly interest at an effective annual
rate of at least 6%. Therefore, a Policy loan may have a permanent impact on the
Policy Value even though it eventually is repaid. Although the loan amount is a
part of the Policy Value, the Death Proceeds will be reduced by the amount of
outstanding Debt at the time of death.
Policy loans will bear interest at a fixed rate of 8% per year, due and payable
in arrears at the end of each Policy year. If interest is not paid when due, it
will be added to the loan balance. Policy loans may be repaid at any time. You
must notify the Company if a payment is a loan repayment; otherwise, it will be
considered a premium payment. Any partial or full repayment of Debt by you will
be allocated to the General Account or Sub-Accounts in accordance with your
instructions. If you do not specify an allocation, the Company will allocate the
loan repayment in accordance with your most recent premium allocation
instructions. See "POLICY LOANS."
PREFERRED LOAN OPTION
A preferred loan option is available under the Policy. The preferred loan option
will be available upon written request. It may be revoked by you at any time. If
this option has been selected, after the tenth policy anniversary, the Policy
Value in the General Account equal to the loan amount will be credited with
interest at an effective annual yield of at least 7.5%. The Company's current
position is to credit a rate of interest equal to the rate being charged for the
preferred loan.
There is some uncertainty as to the tax treatment of preferred loans. Consult a
qualified tax adviser (and see "FEDERAL TAX CONSIDERATIONS"). THE PREFERRED LOAN
OPTION IS NOT AVAILABLE IN ALL STATES.
POLICIES ISSUED IN CONNECTION WITH TSA PLANS
Loans from Policies issued in connection with tax-sheltered annuity plans ("TSA
Plans") of certain public school systems and organizations that are tax exempt
under Section 501(c)(3) of the Code are subject to additional restrictions. See
"POLICY LOANS," "Policies Issued in Connection with TSA Plans."
11
<PAGE>
POLICY LAPSE AND REINSTATEMENT
Except as otherwise provided in the optional Guaranteed Death Benefit Rider, the
failure to make premium payments will not cause a Policy to lapse unless:
(a) the Surrender Value is insufficient to cover the next Monthly Deduction
plus loan interest accrued, if any; or
(b) Debt exceeds Policy Value less surrender charges.
A 62-day grace period applies to each situation.
Even if the situation described in (a) above exists, the Policy will not lapse
if you meet the so-called "Minimum Monthly Factor" test. The Minimum Monthly
Factor test is only used to determine whether the Policy will enter the grace
period during the first 48 months or within 48 months following an increase in
the Face Amount. Under the Minimum Monthly Factor test, the Company determines
two amounts:
- the sum of the payments your have made, minus any Policy loans,
withdrawals and withdrawal charges.
- the amount of the Minimum Monthly Factor (the amount is shown on page 5 of
the Policy) multiplied by the number of months the Policy has been in
force or the number of months which have elapsed since the last increase
in the Face Amount.
The Company then compares the first amount to the second amount. The Policy will
not enter the grace period if the first amount is greater than the second
amount. If the Policy lapses, it may be reinstated within three years of the
date of default (but not later that the Final Premium Payment Date). In order to
reinstate, you must pay the reinstatement premium and provide satisfactory
Evidence of Insurability. The Company reserves the right to increase the Minimum
Monthly Factor upon reinstatement. See "POLICY TERMINATION AND REINSTATEMENT."
In addition, if the Guaranteed Death Benefit rider is in effect, the Company
guarantees that your Policy will not lapse regardless of the investment
performance of the Variable Account. However, the Policy may lapse under certain
circumstance. See "THE POLICY," "Guaranteed Death Benefit Rider."
POLICY VALUE AND SURRENDER VALUE
The Policy Value is the total amount available for investment under the Policy
at any time. It is the sum of the value of all Accumulation Units in the
Sub-Accounts of the Separate Account and all accumulations in the General
Account credited to the Policy. The Policy Value reflects the amount and
frequency of Net Premiums paid, charges and deductions imposed under the Policy,
interest credited to accumulations in the General Account, investment
performance of the Sub-Account(s) to which Policy Value has been allocated, and
partial withdrawals. The Policy Value may be relevant to the computation of the
Death Proceeds. You bear the entire investment risk for amounts allocated to the
Separate Account. The Company does not guarantee a minimum Policy Value.
The Surrender Value will be the Policy Value less any Debt and applicable
surrender charges. The Surrender Value is relevant, for example, to the
continuation of the Policy and in the computation of the amounts available upon
partial withdrawals, Policy loans or surrender.
DEATH PROCEEDS
The Policy provides for the payment of certain Death Proceeds to the named
Beneficiary upon the death of the Insured. Prior to the Final Premium Payment
Date, the Death Proceeds will be equal to the Sum Insured, reduced by any
outstanding Debt, partial withdrawals, partial withdrawal charges, and any
Monthly Deductions due and not yet deducted through the Policy month in which
the Insured dies.
12
<PAGE>
Two Sum Insured Options are available. Under Option 1, the Sum Insured is the
greater of the Face Amount of the Policy or the Guideline Minimum Sum Insured.
Under Option 2, the Sum Insured is the greater of the Face Amount of the Policy
plus the Policy Value or the Guideline Minimum Sum Insured. The Guideline
Minimum Sum Insured is equivalent to a percentage (determined each month based
on the Insured's Age) of the Policy Value. On or after the Final Premium Payment
Date, the Death Proceeds will equal the Surrender Value, unless the optional
Guaranteed Death Benefit Rider is in effect. See "THE POLICY," "Death Proceeds,"
and "Guaranteed Death Benefit Rider."
The Death Proceeds under the Policy may be received in a lump sum or under one
of the Payment Options described in the Policy. See "APPENDIX B -- DEATH
PROCEEDS PAYMENT OPTIONS."
FLEXIBILITY TO ADJUST SUM INSURED
Subject to certain limitations, you may adjust the Sum Insured, and thus the
Death Proceeds, at any time prior to the Final Premium Payment Date, by
increasing or decreasing the Face Amount of the Policy. Any change in the Face
Amount will affect the monthly cost of insurance charges and the amount of the
surrender charge. If the Face Amount is decreased, a pro-rata surrender charge
may be imposed. The Policy Value is reduced by the amount of the charge. See
"THE POLICY," "Change In the Face Amount."
The minimum increase in Face Amount is $10,000 and any increase also may require
additional Evidence of Insurability satisfactory to the Company. The increase is
subject to a "free-look period" and, during the first 24 months after the
increase, to a conversion privilege. See "THE POLICY," "Free-Look Period" and
"Conversion Privileges."
ADDITIONAL INSURANCE BENEFITS
You have the flexibility to add additional insurance benefits by rider. These
include the Waiver of Premium Rider, Accidental Death Benefit Rider, Guaranteed
Insurability Rider, Other Insured Rider, Children's Insurance Rider, Exchange
Option Rider, Living Benefits Rider and Guaranteed Death Benefit Rider. See
"APPENDIX A -- OPTIONAL BENEFITS."
The cost of these optional insurance benefits will be deducted from the Policy
Value as part of the Monthly Deduction. See "CHARGES AND DEDUCTIONS -- Monthly
Deduction From the Policy Value."
POLICY FEES AND CHARGES
There are costs related to the insurance and investment features of the Policy.
Fees and charges to cover these costs are deducted in several ways.
DEDUCTIONS FROM EACH PREMIUM
A tax expense charge will be deducted from each premium payment to compensate
the Company for premium taxes imposed by various states and local jurisdictions
and for federal taxes imposed for deferred acquisition costs ("DAC taxes"). The
tax expense charge is currently 3 1/2% but may be increased or decreased to
reflect changing tax rates. See "CHARGES AND DEDUCTIONS," "Tax Expense Charge."
MONTHLY DEDUCTIONS FROM THE POLICY VALUE
On the Date of Issue and each Monthly Payment Date, certain charges ("Monthly
Deductions") will be deducted from the Policy Value. The Monthly Deduction
consists of a charge for cost of insurance, a charge for administrative
expenses, and a charge for the cost of any additional benefits provided by
rider. You may instruct the Company to deduct the Monthly Deduction from one
specific Sub-Account. If you do not, the Company will make a Pro-Rata Allocation
of the charge. No Monthly Deductions are made on or after the Final Premium
Payment Date. See "CHARGES AND DEDUCTIONS," "Monthly Deductions from the Policy
Value."
13
<PAGE>
The MONTHLY COST OF INSURANCE CHARGE is determined by multiplying the Insurance
Amount at Risk for each Policy month by the applicable cost of insurance rate or
rates. The Insurance Amount at Risk will be affected by any decreases or
increases in the Face Amount.
A MONTHLY ADMINISTRATIVE CHARGE of $5 per month is made for administrative
expenses. The charge is designed to reimburse the Company for the costs
associated with issuing and administering the Policies, such as processing
premium payments, Policy loans and loan repayments, changes in Sum Insured
Option, and death claims. These charges also help cover the cost of providing
annual statements and responding to Policyholder inquiries.
As noted above, certain additional insurance rider benefits are available under
the Policy for an additional monthly charge. See "APPENDIX A -- OPTIONAL
BENEFITS."
DEDUCTIONS FROM THE SEPARATE ACCOUNT
A daily charge currently equivalent to an effective annual rate of 0.80% of the
average daily net asset value of each Sub-Account of the Separate Account is
imposed to compensate the Company for its assumption of certain mortality and
expense risks and for administrative costs associated with the Separate Account.
The rate is 0.65% for the mortality and expense risk and 0.15% for the Separate
Account administrative charge. The administrative charge is eliminated after the
tenth Policy year. See "CHARGES AND DEDUCTIONS," "Charges Against Assets of the
Separate Account."
The Underlying Funds also incur certain expenses which are reflected in the net
asset value of the Sub-Accounts. See "INVESTMENT OPTIONS -- CHARGES OF THE
UNDERLYING FUNDS," below.
OTHER CHARGES (NON-PERIODIC)
TRANSACTION CHARGE ON PARTIAL WITHDRAWALS
A transaction charge is assessed at the time of each partial withdrawal to
reimburse the Company for the cost of processing the withdrawal. The transaction
charge is the smaller of 2% of the amount withdrawn or $25. In addition to the
partial withdrawal transaction charge, a withdrawal charge also may be made
under certain circumstances. See "CHARGES AND DEDUCTIONS," "Charges on Partial
Withdrawal."
CHARGE FOR INCREASE IN THE FACE AMOUNT
For each increase in the Face Amount, a charge of $40 will be deducted from the
Policy Value. This charge is designed to reimburse the Company for underwriting
and administrative costs associated with the increase. See "THE POLICY," "Change
In the Face Amount" and "CHARGES AND DEDUCTIONS," "Charge for Increase In the
Face Amount."
TRANSFER CHARGE
The first 12 transfers of Policy Value in a Policy year will be free of charge.
Thereafter, with certain exceptions, a transfer charge of $10 will be imposed
for each transfer request to reimburse the Company for the costs of processing
the transfer. See "THE POLICY," "Transfer Privilege" and "CHARGES AND
DEDUCTIONS," "Transfer Charges."
SURRENDER CHARGES
At any time that the Policy is in effect, a Policyowner may elect to surrender
the Policy and receive its Surrender Value. A surrender charge is calculated
upon issuance of the Policy and upon each increase in Face Amount. The duration
of the surrender charge is 15 years for issue Ages 0 through 50, grading down to
10 years for issue Ages 55 and above. The surrender charge is imposed only if,
during its duration, you request a full surrender or a decrease in the Face
Amount.
14
<PAGE>
SURRENDER CHARGE ON THE INITIAL FACE AMOUNT
The maximum surrender charge calculated upon issuance of the Policy is equal to
the sum of (a) plus (b), where (a) is a DEFERRED ADMINISTRATIVE CHARGE, and (b)
is a DEFERRED SALES CHARGE.
The DEFERRED ADMINISTRATIVE CHARGE is $8.50 per thousand dollars of the initial
Face Amount or of an increase in the Face Amount. The charge is designed to
reimburse the Company for administrative costs associated with product research
and development, underwriting, Policy administration, decreasing the Face
Amount, and surrendering a Policy. Because the maximum surrender charge reduces
by 0.5% or more per month (depending on issue Age) after the 40th Policy month
from the Date of Issue or the effective date of an increase in the Face Amount,
in certain situations some or all of the deferred administrative charge may not
be assessed upon surrender of the Policy. The deferred sales charge is equal to
49% of premiums received up to a maximum number of Guideline Annual Premiums
that vary by issue Age. This maximum number varies from 1.660714 (for Ages 0
through 55) to 0.948980 (for Age 85). See "THE POLICY," "Surrender" and "CHARGES
AND DEDUCTIONS," "Surrender Charge."
In accordance with state insurance regulations, the amount of the maximum
surrender charge will not exceed a specified amount per $1,000 of the initial
Face Amount, as indicated in "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER
CHARGES."
If you surrender the Policy during the first two Policy years following the Date
of Issue, before making premium payments associated with the initial Face Amount
which are at least equal to one Guideline Annual Premium, the deferred
administrative charge will be $8.50 per thousand dollars of the initial Face
Amount, as described above. The deferred sales charge, however, will not exceed
29% of premiums received, up to one Guideline Annual Premium, plus 9% of
premiums received that are in excess of one Guideline Annual Premium, but less
than the maximum number of Guideline Annual Premiums subject to the deferred
sales charge. See "THE POLICY," "Policy Surrender" and "CHARGES AND DEDUCTIONS,"
"Surrender Charge."
SURRENDER CHARGES FOR INCREASES IN THE FACE AMOUNT
A separate surrender charge will apply to, and is calculated for, each increase
in the Face Amount. The maximum surrender charge for the increase is equal to
the sum of (a) plus (b), where (a) is the deferred administrative charge, and
(b) is a deferred sales charge. The deferred administrative charge is equal to
$8.50 per thousand dollars of increase. The deferred sales charge is equal to
49% of premiums associated with the increase, up to a maximum number of
Guideline Annual Premiums that varies by issue Age. This maximum number varies
from 1.660714 (for Ages 0 through 55) to 0.948980 (for Age 85).
In accordance with state insurance regulations, the amount of the surrender
charge will not exceed a specified amount per $1,000 of increase, as indicated
in "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER CHARGES." This maximum
surrender charge remains level for the first 40 Policy months following the
increase, and reduces by 0.5% or more per month (depending on Age at increase)
thereafter. See "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER CHARGES." The
actual surrender charge with respect to the increase may be less than the
maximum. See "THE POLICY," "Policy Surrender" and "CHARGES AND DEDUCTIONS,"
"Surrender Charge."
SURRENDER CHARGES ON DECREASES IN THE FACE AMOUNT
In the event of a decrease in the Face Amount, the surrender charge imposed is
proportional to the charge that would apply to a full Policy surrender. See "THE
POLICY," "Policy Surrender" and "CHARGES AND DEDUCTIONS," "Surrender Charge."
OTHER CHARGES
The Company reserves the right to impose a charge for the administrative costs
associated with changing the Net Premium allocation instructions, for changing
the allocation of any Monthly Deductions among
15
<PAGE>
the various Sub-Accounts, or for a projection of values. No such charges
currently are imposed, and any such charge is guaranteed not to exceed $25. See
"CHARGES AND DEDUCTIONS," "Other Administrative Charges."
INVESTMENT OPTIONS
The Policy permits Net Premiums to be allocated either to the Company's General
Account or to the Separate Account. The Separate Account currently is comprised
of 20 Sub-Accounts ("Sub-Accounts"). Each Sub-Account invests exclusively in a
corresponding Underlying Fund of the Allmerica Investment Trust ("Trust")
managed by Allmerica Financial Investment Management Services, Inc., ("AFIMS")
Fidelity Variable Insurance Products Fund ("Fidelity VIP") and Fidelity Variable
Insurance Products Fund II ("Fidelity VIP II") managed by Fidelity Management,
T. Rowe Price International Series, Inc. ("T. Rowe Price") managed by Rowe
Price-Fleming International, Inc., with respect to the International Stock
Portfolio, or the Delaware Group Premium Fund, Inc. ("DGPF") managed by Delaware
International Advisers, Ltd. with respect to the International Equity Series.
The Policy permits you to transfer Policy Value among the available Sub-Accounts
and between the Sub-Accounts and the General Account, subject to certain
limitations described under "THE POLICY," "Transfer Privilege. The Trust,
Fidelity VIP, Fidelity VIP II, T. Rowe Price and DGPF are open-end, diversified
series management investment companies. The following Underlying Funds are
available under the Policy:
<TABLE>
<S> <C>
ALLMERICA INVESTMENT TRUST FIDELITY VIP
Select Aggressive Growth Fund Overseas Portfolio
Select Capital Appreciation Fund Equity-Income Portfolio
Select Value Opportunity Fund Growth Portfolio
Select Emerging Markets Fund High Income Portfolio
Select International Equity Fund
Select Growth Fund FIDELITY VIP II
Select Strategic Growth Fund Asset Manager Portfolio
Growth Fund
Equity Index Fund T. ROWE PRICE
Select Growth and Income Fund International Stock Portfolio
Investment Grade Income Fund
Government Bond Fund DGPF
Money Market Fund International Equity Series
</TABLE>
Certain Funds may not be available in all states.
Each of the Underlying Funds has its own investment objectives. Certain
Underlying Funds, however, have investment objectives similar to certain other
Underlying Funds. The value of each Sub-Account will vary daily depending upon
the performance of the Underlying Fund in which it invests. Each Sub-Account
reinvests dividends or capital gains distributions received from an Underlying
Fund in additional shares of that Underlying Fund. There can be no assurance
that the investment objectives of the Underlying Funds can be achieved.
CHARGES OF THE UNDERLYING INVESTMENT COMPANIES
In addition to the charges described above, certain fees and expenses are
deducted from the assets of the Underlying Funds. The levels of fees and
expenses vary among the Underlying Funds. The following table
16
<PAGE>
shows the expenses of the Underlying Funds for 1997. For more information
concerning fees and expenses, see the prospectuses of the Underlying Funds.
<TABLE>
<CAPTION>
MANAGEMENT FEE OTHER FUND
(AFTER ANY EXPENSES (AFTER ANY
VOLUNTARY APPLICABLE TOTAL FUND
UNDERLYING FUND WAIVER) REIMBURSEMENTS) EXPENSES
- --------------------------------------------------------------- ------------------ --------------------- ---------------
<S> <C> <C> <C>
Select Aggressive Growth Fund.................................. 0.89%* 0.09% 0.98%(1)(3)
Select Capital Appreciation Fund............................... 0.95% 0.15% 1.10%(1)
Select Value Opportunity Fund.................................. 0.90%** 0.14% 1.04%(1)(3)
Select Emerging Markets Fund @................................. 1.35% 0.65% 2.00%(1)
Select International Equity Fund............................... 0.92% 0.20% 1.12%(1)(3)
DGPF International Equity Series............................... 0.75%(4) 0.15% 0.90%(4)
Fidelity VIP Overseas Portfolio................................ 0.75% 0.17% 0.92%(2)
T. Rowe Price International Stock Portfolio.................... 1.05% 0.00% 1.05%
Select Growth Fund............................................. 0.85% 0.08% 0.93%(1)(3)
Select Strategic Growth Fund @................................. 0.85% 0.13% 0.98%(1)
Growth Fund.................................................... 0.46%* 0.06% 0.52%(1)(3)
Fidelity VIP Growth Portfolio.................................. 0.60% 0.09% 0.69%(2)
Equity Index Fund.............................................. 0.31% 0.13% 0.44%(1)
Select Growth and Income Fund.................................. 0.70%* 0.07% 0.77%(1)(3)
Fidelity VIP Equity-Income Portfolio........................... 0.50% 0.08% 0.58%(2)
Fidelity VIP II Asset Manager Portfolio........................ 0.55% 0.10% 0.65%(2)
Fidelity VIP High Income Portfolio............................. 0.59% 0.12% 0.71%
Investment Grade Income Fund................................... 0.44%* 0.10% 0.54%(1)
Government Bond Fund........................................... 0.50% 0.17% 0.67%(1)
Money Market Fund.............................................. 0.27% 0.08% 0.35%(1)
</TABLE>
* Effective September 1, 1997, the management fee rates for these funds were
revised. The management fee ratios shown in the table above have been adjusted
to assume that the revised rates took effect on January 1, 1997.
(@) Select Emerging Markets Fund and Select Strategic Growth Fund commenced
operations in February, 1998. Expenses shown are annualized and are based on
estimated amounts for the current fiscal year. Actual expense may be greater or
less than shown.
** The Select Value Opportunity Fund was formerly known as the "Small-Mid Cap
Value Fund." Effective April 1, 1997, the management fee rate of the former
Small-Mid Cap Value Fund was revised. In addition, effective April 1, 1997 and
until further notice, the management fee has been voluntarily limited to an
annual rate of 0.90% of average daily net assets, and total expenses are limited
to 1.25% of average daily net assets. The management fee ratio shown above for
the Select Value Opportunity Fund has been adjusted to assume that the revised
rate and the voluntary limitations that took effect on January 1, 1997. Without
these adjustments, the management fee ratio and the total fund expense ratio
would have been 0.95% and 1.09%, respectively. The management fee limitation may
be terminated at any time.
(1) Until further notice, AFIMS has declared a voluntary expense limitation of
1.35% of average net assets for the Select Aggressive Growth Fund and Select
Capital Appreciation Fund, 1.50% for the Select International Equity Fund, 1.25%
for the Select Value Opportunity Fund, 1.20% for the Growth Fund and Select
Growth Fund, 1.10% for the Select Growth and Income, 1.00% for the Investment
Grade Income Fund and Government Bond Fund, and 0.60% for the Money Market Fund
and Equity Index Fund. The total operating expenses of these Funds of the Trust
were less than their respective expense limitations throughout 1997.
Until further notice, AFIMS has declared a voluntary expense limitation of 1.20%
of average daily net assets for the Select Strategic Growth Fund. In addition,
AFIMS has agreed to voluntarily waive its management fee to the extent that
expenses of the Select Emerging Markets Fund exceed 2.00% of the Fund's average
daily net assets, except that such waiver shall not exceed the net amount of
management fees earned by the manager from the Fund after subtracting fees paid
by AFIMS to a sub-adviser.
17
<PAGE>
The declaration of a voluntary expense limitation in any year does not bind
AFIMS to declare future expense limitations with respect to these funds. These
limitations may be terminated at any time.
(2) A portion of the brokerage commissions that certain funds pay was used to
reduce funds expenses. In addition, certain funds have entered into arrangements
with their custodian and transfer agent whereby interest earned on uninvested
cash balances was used to reduce custodian and transfer agent expenses.
Including these reductions, the total operating expenses ratios presented in the
table would have been 0.57% for Fidelity VIP Equity Income Portfolio, 0.67% for
Fidelity VIP Growth Portfolio, 0.90% for Fidelity VIP Overseas Portfolio and
0.64% for Fidelity VIP II Asset Manager Portfolio.
(3) These funds have entered into agreements with brokers whereby brokers rebate
a portion of commissions. Had these amounts been treated as reductions of
expenses, the total operating expenses ratios would have been 0.93% for the
Select Aggressive Growth Fund, 0.98% for the Select Value Opportunity Fund,
1.10% for the Select International Equity Fund, 0.91% for the Select Growth
Fund, 0.50% for the Growth Fund, 0.98% for the Select Value Opportunity Fund,
and 0.74% for the Select Growth and Income Fund.
(4) Effective July 1, 1997, Delaware International Advisers Ltd., the investment
adviser for the International Equity Series, has agreed to limit total annual
expenses of the fund to 0.95%. This limitation replaces a prior limitation of
0.80% that expired on June 30, 1997. The new limitation will be in effect
through October 31, 1998. The fee ratios shown above have been adjusted to
assume that the new voluntarily limitation took effect on January 1, 1997. In
1997, the actual ratio of total annual expenses of the International Equity
Series was 0.85%, and the actual management fee ratio was 0.70%.
TAXATION OF THE POLICIES
The Policy generally is subject to the same federal income tax treatment as a
conventional fixed benefit life insurance Policy. Under current tax law, to the
extent there is no change in benefits and the policy is not a modified endowment
contract, the Policyowner will be taxed on Policy Value withdrawn from the
Policy only to the extent that the amount withdrawn exceeds the total premiums
paid. Withdrawals in excess of premiums paid will be treated as ordinary income.
During the first 15 Policy years, however, an "interest first" rule applies to
any distribution of cash that is required under Section 7702 of the Code because
of a reduction in benefits under the Policy. Death Proceeds under the Policy are
generally excludable from the gross income of the Beneficiary, but in some
circumstances the Death Proceeds or the Policy Value may be subject to federal
estate tax. See "FEDERAL TAX CONSIDERATIONS," "Taxation of the Policy."
A Policy may be considered a "modified endowment contract" if it fails a
"seven-pay " test at any time during the first seven Policy years or within
seven years of a material change in the Policy. The Policy fails to satisfy the
seven-pay test if the cumulative premiums paid under the Policy at any time
during the first seven Policy years or within seven years of a material change
in the Policy, exceed the sum of the net level premiums that would have been
paid had the Policy provided for paid-up future benefits after the payment of
seven level premiums. If the Policy is considered a modified endowment contract,
all distributions (including Policy loans, partial withdrawals, Policy
surrenders or assignments) will be taxed on an "income-first" basis. With
certain exceptions, an additional 10% penalty will be imposed on the portion of
any distribution that is includible in income. For more information, see FEDERAL
TAX CONSEQUENCES," "Modified Endowment Contracts."
18
<PAGE>
PERFORMANCE INFORMATION
The Policy first was offered to the public in 1993. The Company may advertise
"Total Return" and "Average Annual Total Return" performance information based
on the periods that the Sub-Accounts have been in existence (Tables I[A] and
I[B]) and based on the periods that the Underlying Funds have been in existence
(Tables II[A] and II[B]). The results for any period prior to the Policy being
offered will be calculated as if the Policy had been offered during that period
of time, with all charges assumed to be those applicable to the Sub-Accounts,
the Underlying Funds, and (in Table I[A]) under a "representative" Policy that
is surrendered at the end of the applicable period. FOR MORE INFORMATION ON
CHARGES UNDER THE POLICY, SEE "CHARGES AND DEDUCTIONS."
In each Table below, "One-Year Total Return" refers to the total of the income
generated by a Sub-Account, based on certain charges and assumptions as
described in the respective tables, for the one-year period ended December 31,
1997. "Average Annual Total Return" is based on the same charges and
assumptions, but reflects the hypothetical annually compounded return that would
have produced the same cumulative return if the Sub-Account's performance had
been constant over the entire period. Because average annual total returns tend
to smooth out variations in annual performance return, they are not the same as
actual year-by-year results.
Performance information may be compared, in reports and promotional literature,
to:
- Standard & Poor's 500 Composite Stock Price Index (S&P 500), Dow Jones
Industrial Average (DJIA), Shearson, Lehman Aggregate Bond Index, or other
unmanaged indices so that investors may compare results with those of a
group of unmanaged securities widely regarded by investors as
representative of the securities markets in general (unmanaged indices may
assume the reinvestment of dividends, but generally do not reflect
deductions for administrative and management costs and expenses); or
- other groups of variable life separate accounts or other investment
products tracked by Lipper Analytical Services, a widely used independent
research firm which ranks mutual funds and other investment products by
overall performance, investment objectives and assets, or tracked by other
services, companies, publications or persons, such as Morningstar, Inc.,
who rank such investment products on overall performance or other
criteria; or
- the Consumer Price Index (a measure for inflation) to assess the real rate
of return from an investment.
At times, the Company may also advertise the ratings and other information
assigned to it by independent rating organizations such as A.M. Best Company
("A.M. Best"), Moody's Investors Services, Inc. ("Moody's"), Standard & Poor's
Insurance Rating Services ("S&P") and Duff & Phelps. A.M. Best's and Moody's
ratings reflect their current opinion of the Company's relative financial
strength and operating performance in comparison to the norms of the life/health
insurance industry. S&P's and Duff & Phelps' ratings measure the ability of an
insurance company to meet its obligations under insurance policies it issues and
do not measure the ability of such companies to meet other non-policy
obligations. The ratings also do not relate to the performance of the Underlying
Portfolios.
The Company may provide information on various topics of interest to
Policyowners and prospective Policyowners in sales literature, periodic
publications or other materials. These topics may include the relationship
between sectors of the economy and the economy as a whole and its effect on
various securities markets, investment strategies and techniques (such as value
investing, market timing, dollar-cost averaging, asset allocation, constant
ratio transfer and account rebalancing), the advantages and disadvantages of
investing in tax-deferred and taxable investments, customer profiles and
hypothetical purchase and investment scenarios, financial management and tax and
retirement planning, and investment alternatives to certificates of deposit and
other financial instruments.
19
<PAGE>
TABLE I(A)
AVERAGE ANNUAL TOTAL RETURNS FOR PERIODS ENDING DECEMBER 31, 1997
SINCE INCEPTION OF SUB-ACCOUNT
NET OF ALL CHARGES AND ASSUMING SURRENDER OF THE POLICY
The following performance information is based on the periods that the Sub-
Accounts have been in existence. The data is net of expenses of the Underlying
Funds, all Sub-Account charges, and all Policy charges (including surrender
charges) for a representative Policy. It is assumed that the Insured is male,
Age 36, standard (nonsmoker) Premium Class, that the Face Amount of the Policy
is $250,000, that an annual premium payment of $3,000 (approximately one
Guideline Annual Premium) was made at the beginning of each Policy year, that
ALL premiums were allocated to EACH Sub-Account individually, and that there was
a full surrender of the Policy at the end of the applicable period.
<TABLE>
<CAPTION>
10 YEARS
OR LIFE
ONE-YEAR OF
TOTAL 5 SUB-ACCOUNT
UNDERLYING FUND RETURN YEARS (IF LESS)
<S> <C> <C> <C>
Select Emerging Markets Fund N/A N/A N/A
Select Aggressive Growth Fund -99.78% N/A 2.75%
Select Capital Appreciation Fund -100.00% N/A -18.44%
Select Value Opportunity Fund -94.33% N/A -2.19%
T. Rowe Price International Stock Portfolio -100.00% N/A -39.23%
Fidelity VIP Overseas Portfolio -100.00% N/A -10.72%
Select International Equity Fund -100.00% N/A -18.86%
DGPF International Equity Series -100.00% N/A -8.15%
Fidelity VIP Growth Portfolio -95.55% N/A -1.59%
Select Growth Fund -86.16% N/A -0.94%
Select Strategic Growth Fund N/A N/A N/A
Growth Fund -94.08% N/A -0.26%
Equity Index Fund -87.63% N/A 2.44%
Fidelity VIP Equity-Income Portfolio -91.45% N/A 1.58%
Select Growth and Income Fund -96.41% N/A -2.36%
Fidelity VIP II Asset Manager Portfolio -98.06% N/A -15.40%
Fidelity VIP High Income Portfolio -100.00% N/A -8.30%
Investment Grade Income Fund -100.00% N/A -16.76%
Government Bond Fund -100.00% N/A -18.05%
Money Market Fund -100.00% N/A -18.70%
</TABLE>
The inception dates for the Sub-Accounts are: 7/6/93 for Growth; 7/18/93 for
Money Market, Equity Index, Fidelity VIP Growth, Fidelity VIP Equity-Income,
Fidelity VIP High Income, Select Value Opportunity and DGPF International
Equity; 7/19/93 for Investment Grade Income; 7/20/93 for Select Aggressive
Growth, Select Growth, Fidelity VIP Overseas; 7/22/93 for Government Bond;
7/26/93 for Select Growth and Income; 5/3/94 for Select International Equity;
5/10/94 for Fidelity VIP II Asset Manager; 4/30/95 for Select Capital
Appreciation and 6/21/95 for the T. Rowe Price International Stock. The Select
Emerging Markets Fund and the Select Strategic Growth Fund commenced operations
in February 1998.
PERFORMANCE INFORMATION REFLECTS ONLY THE PERFORMANCE OF A HYPOTHETICAL
INVESTMENT DURING THE PARTICULAR TIME PERIOD ON WHICH THE CALCULATIONS ARE
BASED. ONE-YEAR TOTAL RETURN AND AVERAGE ANNUAL TOTAL RETURN FIGURES ARE BASED
ON HISTORICAL EARNINGS AND ARE NOT INTENDED TO INDICATE FUTURE PERFORMANCE.
PERFORMANCE INFORMATION SHOULD BE CONSIDERED IN LIGHT OF THE INVESTMENT
OBJECTIVES AND POLICIES, CHARACTERISTICS AND QUALITY OF THE PORTFOLIO OF THE
UNDERLYING FUND IN WHICH A SUB-ACCOUNT INVESTS AND THE MARKET CONDITIONS DURING
THE GIVEN TIME PERIOD, AND SHOULD NOT BE CONSIDERED AS A REPRESENTATION OF WHAT
MAY BE ACHIEVED IN THE FUTURE.
20
<PAGE>
TABLE I(B)
AVERAGE ANNUAL TOTAL RETURNS FOR PERIODS ENDING DECEMBER 31, 1997
SINCE INCEPTION OF SUB-ACCOUNTS
EXCLUDING MONTHLY POLICY CHARGES AND SURRENDER CHARGES
The following performance information is based on the periods that the Sub-
Accounts have been in existence. The performance information is net of total
Underlying Fund expenses, all Sub-Account charges, and premium tax and expense
charges. THE DATA DOES NOT REFLECT MONTHLY CHARGES UNDER THE POLICY OR SURRENDER
CHARGES. It is assumed that an annual premium payment of $3,000 (approximately
one Guideline Annual Premium) was made at the beginning of each Policy year and
that ALL premiums were allocated to EACH Sub-Account individually.
<TABLE>
<CAPTION>
10 YEARS
OR LIFE
ONE-YEAR OF
TOTAL 5 SUB-ACCOUNT
UNDERLYING FUND RETURN YEARS (IF LESS)
<S> <C> <C> <C>
Select Emerging Markets Fund N/A N/A N/A
Select Aggressive Growth Fund 17.76% N/A 15.80%
Select Capital Appreciation Fund 13.37% N/A 21.79%
Select Value Opportunity Fund 23.86% N/A 16.21%
T. Rowe Price International Stock Portfolio 2.27% N/A 8.44%
Fidelity VIP Overseas Portfolio 10.67% N/A 9.68%
Select International Equity Fund 3.81% N/A 10.08%
DGPF International Equity Series 5.76% N/A 11.59%
Fidelity VIP Growth Portfolio 22.50% N/A 16.68%
Select Growth Fund 33.00% N/A 17.23%
Select Strategic Growth Fund N/A N/A N/A
Growth Fund 24.15% N/A 17.55%
Equity Index Fund 31.36% N/A 19.91%
Fidelity VIP Equity-Income Portfolio 27.09% N/A 19.03%
Select Growth and Income Fund 21.54% N/A 16.20%
Fidelity VIP II Asset Manager Portolio 19.69% N/A 12.77%
Fidelity VIP High Income Portfolio 16.73% N/A 11.47%
Investment Grade Income Fund 8.58% N/A 5.26%
Government Bond Fund 6.26% N/A 4.39%
Money Market Fund 4.63% N/A 3.87%
</TABLE>
The inception dates for the Sub-Accounts are: 7/6/93 for Growth; 7/18/93 for
Money Market, Equity Index, Fidelity VIP Growth, Fidelity VIP Equity-Income,
Fidelity VIP High Income, Select Value Opportunity and DGPF International
Equity; 7/19/93 for Investment Grade Income; 7/20/93 for Select Aggressive
Growth, Select Growth, Fidelity VIP Overseas; 7/22/93 for Government Bond;
7/26/93 for Select Growth and Income; 5/3/94 for Select International Equity;
5/10/94 for Fidelity VIP II Asset Manager; 4/30/95 for Select Capital
Appreciation;; and 6/21/95 for the T. Rowe Price International Stock. The Select
Emerging Markets Fund and the Select Strategic Growth Fund commenced operations
in February 1998.
PERFORMANCE INFORMATION REFLECTS ONLY THE PERFORMANCE OF A HYPOTHETICAL
INVESTMENT DURING THE PARTICULAR TIME PERIOD ON WHICH THE CALCULATIONS ARE
BASED. ONE-YEAR TOTAL RETURN AND AVERAGE ANNUAL TOTAL RETURN FIGURES ARE BASED
ON HISTORICAL EARNINGS AND ARE NOT INTENDED TO INDICATE FUTURE PERFORMANCE.
PERFORMANCE INFORMATION SHOULD BE CONSIDERED IN LIGHT OF THE INVESTMENT
OBJECTIVES AND POLICIES, CHARACTERISTICS AND QUALITY OF THE PORTFOLIO OF THE
UNDERLYING FUND IN WHICH A SUB-ACCOUNT INVESTS AND THE MARKET CONDITIONS DURING
THE GIVEN TIME PERIOD, AND SHOULD NOT BE CONSIDERED AS A REPRESENTATION OF WHAT
MAY BE ACHIEVED IN THE FUTURE.
21
<PAGE>
TABLE II(A):
AVERAGE ANNUAL TOTAL RETURNS FOR PERIODS ENDING DECEMBER 31, 1997
SINCE INCEPTION OF THE UNDERLYING FUNDS
NET OF ALL CHARGES AND ASSUMING SURRENDER OF THE POLICY
The following performance information is based on the periods that the
Underlying Funds have been in existence. The data is net of expenses of the
Underlying Funds, all Sub-Account charges, and all Policy charges (including
surrender charges) for a representative Policy. It is assumed that the Insured
is male, Age 36, standard (nonsmoker) Premium Class, that the Face Amount of the
Policy is $250,000, that an annual premium payment of $3,000 (approximately one
Guideline Annual Premium) was made at the beginning of each Policy year, that
ALL premiums were allocated to EACH Sub-Account individually, and that there was
a full surrender of the Policy at the end of the applicable period.
<TABLE>
<CAPTION>
10 YEARS
OR LIFE
ONE-YEAR OF
TOTAL 5 SUB-ACCOUNT
UNDERLYING FUND RETURN YEARS (IF LESS)
<S> <C> <C> <C>
Select Emerging Markets Fund N/A N/A N/A
Select Aggressive Growth Fund -99.78% 1.04% 5.77%
Select Capital Appreciation Fund -100.00% N/A -18.41%
Select Value Opportunity Fund -94.33% N/A -1.14%
T. Rowe Price International Stock Portfolio -100.00% N/A -21.84%
Fidelity VIP Overseas Portfolio -100.00% -2.26% 3.02%
Select International Equity Fund -100.00% N/A -18.83%
DGPF International Equity Series -100.00% -5.38% -5.06%
Fidelity VIP Growth Portfolio -95.55% 2.49% 11.35%
Select Growth Fund -86.16% -1.00% 1.95%
Select Strategic Growth Fund N/A N/A N/A
Growth Fund -94.08% 0.51% 11.27%
Equity Index Fund -87.63% 4.34% 11.10%
Fidelity VIP Equity-Income Portfolio -91.45% 5.09% 10.94%
Select Growth and Income Fund -96.41% 0.75% 0.74%
Fidelity VIP II Asset Manager Portfolio -98.06% -3.69% 5.62%
Fidelity VIP High Income Portfolio -100.00% -2.52% 6.56%
Investment Grade Income Fund -100.00% -10.73% 2.53%
Government Bond Fund -100.00% -12.79% -5.92%
Money Market Fund -100.00% -14.48% -1.36%
</TABLE>
The inception dates for the Underlying Funds are: 4/29/85 for Growth, Investment
Grade and Money Market; 9/28/90 for Equity Index; 8/26/91 for Government Bond;
8/21/92 for Select Aggressive Growth, Select Growth, and Select Growth and
Income; 4/30/93 for Select Value Opportunity; 5/01/94 for Select International
Equity; 4/28/95 for the Select Capital Appreciation Fund; 10/09/86 for Fidelity
VIP Equity-Income and Fidelity VIP Growth; 9/19/85 for Fidelity VIP High Income;
1/28/87 for Fidelity VIP Overseas; 9/06/89 for Fidelity VIP II Asset Manager;
10/29/92 for DGPF International Equity; and 3/31/94 for the T. Rowe Price
International Stock. The Select Emerging Markets Fund and the Select Strategic
Growth Fund commenced operations in February 1998.
PERFORMANCE INFORMATION REFLECTS ONLY THE PERFORMANCE OF A HYPOTHETICAL
INVESTMENT DURING THE PARTICULAR TIME PERIOD ON WHICH THE CALCULATIONS ARE
BASED. ONE-YEAR TOTAL RETURN AND AVERAGE ANNUAL TOTAL RETURN FIGURES ARE BASED
ON HISTORICAL EARNINGS AND ARE NOT INTENDED TO INDICATE FUTURE PERFORMANCE.
PERFORMANCE INFORMATION SHOULD BE CONSIDERED IN LIGHT OF THE INVESTMENT
OBJECTIVES AND POLICIES, CHARACTERISTICS AND QUALITY OF THE PORTFOLIO OF THE
UNDERLYING FUND IN WHICH A SUB-ACCOUNT INVESTS AND THE MARKET CONDITIONS DURING
THE GIVEN TIME PERIOD, AND SHOULD NOT BE CONSIDERED AS A REPRESENTATION OF WHAT
MAY BE ACHIEVED IN THE FUTURE.
22
<PAGE>
TABLE II(B)
AVERAGE ANNUAL TOTAL RETURNS FOR PERIODS ENDING DECEMBER 31, 1997
SINCE INCEPTION OF THE UNDERLYING FUNDS
EXCLUDING MONTHLY POLICY CHARGES AND SURRENDER CHARGES
The following performance information is based on the periods that the
Underlying Funds have been in existence. The performance information is net of
total Underlying Fund expenses, all Sub-Account charges, and premium tax and
expense charges. THE DATA DOES NOT REFLECT MONTHLY CHARGES UNDER THE POLICY OR
SURRENDER CHARGES. It is assumed that an annual premium payment of $3,000
(approximately one Guideline Annual Premium) was made at the beginning of each
Policy year and that ALL premiums were allocated to EACH Sub-Account
individually.
<TABLE>
<CAPTION>
10 YEARS
OR LIFE
ONE-YEAR OF
TOTAL 5 SUB-ACCOUNT
UNDERLYING FUND RETURN YEARS (IF LESS)
<S> <C> <C> <C>
Select Emerging Markets Fund N/A N/A N/A
Select Aggressive Growth Fund 17.76% 15.62% 18.34%
Select Capital Appreciation Fund 13.37% N/A 21.74%
Select Value Opportunity Fund 23.86% N/A 15.79%
T. Rowe Price International Stock Portfolio 2.27% N/A 7.01%
Fidelity VIP Overseas Portfolio 10.67% 12.97% 8.45%
Select International Equity Fund 3.81% N/A 10.07%
DGPF International Equity Series 5.76% 10.51% 10.17%
Fidelity VIP Growth Portfolio 22.50% 16.81% 15.93%
Select Growth Fund 33.00% 13.98% 15.16%
Select Strategic Growth Fund N/A N/A N/A
Growth Fund 24.15% 15.19% 15.86%
Equity Index Fund 31.36% 18.33% 18.42%
Fidelity VIP Equity-Income Portfolio 27.09% 18.95% 15.56%
Select Growth and Income Fund 21.54% 15.39% 14.17%
Fidelity VIP II Asset Manager Portfolio 19.69% 11.84% 12.21%
Fidelity VIP High Income Portfolio 16.73% 12.76% 11.59%
Investment Grade Income Fund 8.58% 6.42% 8.02%
Government Bond Fund 6.26% 4.89% 5.84%
Money Market Fund 4.63% 3.65% 4.66%
</TABLE>
The inception dates for the Underlying Funds are: 4/29/85 for Growth, Investment
Grade and Money Market; 9/28/90 for Equity Index; 8/26/91 for Government Bond;
8/21/92 for Select Aggressive Growth, Select Growth, and Select Growth and
Income; 4/30/93 for Select Value Opportunity; 5/01/94 for Select International
Equity; 4/28/95 for the Select Capital Appreciation Fund; 10/09/86 for Fidelity
VIP Equity-Income and Fidelity VIP Growth; 9/19/85 for Fidelity VIP High Income;
1/28/87 for Fidelity VIP Overseas; 9/06/89 for Fidelity VIP II Asset Manager;
10/29/92 for DGPF International Equity; and 3/31/94 for the T. Rowe Price
International Stock. The Select Emerging Markets Fund and Select Strategic
Growth Fund commenced operations in February, 1998.
PERFORMANCE INFORMATION REFLECTS ONLY THE PERFORMANCE OF A HYPOTHETICAL
INVESTMENT DURING THE PARTICULAR TIME PERIOD ON WHICH THE CALCULATIONS ARE
BASED. ONE-YEAR TOTAL RETURN AND AVERAGE ANNUAL TOTAL RETURN FIGURES ARE BASED
ON HISTORICAL EARNINGS AND ARE NOT INTENDED TO INDICATE FUTURE PERFORMANCE.
PERFORMANCE INFORMATION SHOULD BE CONSIDERED IN LIGHT OF THE INVESTMENT
OBJECTIVES AND POLICIES, CHARACTERISTICS AND QUALITY OF THE PORTFOLIO OF THE
UNDERLYING FUND IN WHICH A SUB-ACCOUNT INVESTS AND THE MARKET CONDITIONS DURING
THE GIVEN TIME PERIOD, AND SHOULD NOT BE CONSIDERED AS A REPRESENTATION OF WHAT
MAY BE ACHIEVED IN THE FUTURE.
23
<PAGE>
DESCRIPTION OF THE COMPANY, THE SEPARATE ACCOUNT
AND THE UNDERLYING FUNDS
THE COMPANY
The Company is a life insurance company organized under the laws of Delaware in
July 1974. Its Principal Office is located at 440 Lincoln Street, Worcester,
Massachusetts 01653, Telephone 508-855-1000. As of December 31, 1997, the
Company had over $9.4 billion in assets. The Company is subject to the laws of
the state of Delaware governing insurance companies and to regulation by the
Commissioner of Insurance of Delaware. In addition, the Company is subject to
the insurance laws and regulations of other states and jurisdictions in which it
is licensed to operate.
Effective October 1, 1995, the Company changed its name from SMA Life Assurance
Company to Allmerica Financial Life Insurance and Annuity Company. The Company
is an indirect wholly owned subsidiary of First Allmerica Financial Life
Insurance Company ("First Allmerica") which, in turn, is a wholly owned
subsidiary of Allmerica Financial Corporation ("AFC"). First Allmerica,
originally organized under the laws of Massachusetts in 1844 as a mutual life
insurance company and known as State Mutual Life Assurance Company of America,
converted to a stock life insurance company and adopted its present name on
October 16, 1995. First Allmerica is the fifth oldest life insurance company in
America.
The Company is a charter member of the Insurance Marketplace Standard
Association ("IMSA"). Companies that belong to IMSA subscribe to a rigorous set
of standards that cover the various aspects of sales and service for
individually sold life insurance and annuities. IMSA members have adopted
policies and procedures that demonstrate a commitment to honesty, fairness and
integrity in all customer contacts involving sales and service of individual
life insurance and annuity products.
THE SEPARATE ACCOUNT
The Separate Account was authorized by vote of the Board of Directors of the
Company on January 21, 1993. The Separate Account is registered with the
Securities and Exchange Commission ("SEC") as a unit investment trust under the
Investment Company Act of 1940 ("1940 Act"). Such registration does not involve
the supervision of its management or investment practices or policies of the
Separate Account or the Company by the SEC.
The assets used to fund the variable portion of the Policy are set aside in the
Separate Account, and are kept separate from the general assets of the Company.
Under Delaware law, assets equal to the reserves and other liabilities of the
Separate Account may not be charged with any liabilities arising out of any
other business of the Company. The Separate Account currently has 20
Sub-Accounts. Each Sub-Account is administered and accounted for as part of the
general business of the Company, but the income, capital gains, or capital
losses of each Sub-Account are allocated to such Sub-Account, without regard to
other income, capital gains or capital losses of the Company, or the other
Sub-Accounts. Each Sub-Account invests exclusively in a corresponding Underlying
Fund of one of the following investment companies:
- Allmerica Investment Trust
- Fidelity Variable Insurance Products Fund
- Fidelity Variable Insurance Products Fund II
- T. Rowe Price International Series, Inc.
- Delaware Group Premium Fund, Inc.
24
<PAGE>
The assets of each Underlying Fund are held separate from the assets of the
other Underlying Funds. Each Underlying Fund operates as a separate investment
vehicle, and the income or losses of one Underlying Fund generally have no
effect on the investment performance of another Underlying Fund. Shares of each
Underlying Fund are not offered to the general public but solely to separate
accounts of life insurance companies, such as the Separate Account.
Each Sub-Account has two subdivisions. One subdivision applies to a Policy
during the first ten Policy years, which are subject to the Separate Account
administrative charge. See "CHARGES AND DEDUCTIONS," "Charges Against Assets of
the Separate Account." Thereafter, such a Policy automatically is allocated to
the second subdivision to account for the elimination of the Separate Account
administrative charge.
The Company reserves the right, subject to compliance with applicable law, to
change the names of the Sub-Accounts and Separate Account.
ALLMERICA INVESTMENT TRUST
Allmerica Investment Trust (the "Trust") is an open-end, diversified management
investment company registered with the SEC under the 1940 Act. Such registration
does not involve supervision by the SEC of the investments or investment Policy
of the Trust or its separate investment funds.
The Trust was established by the Company as a Massachusetts business trust on
October 11, 1984, for the purpose of providing a vehicle for the investment of
assets of various separate accounts established by the Company, or other
affiliated insurance companies. Thirteen investment portfolios of the Trust
("Funds") are available under the Policy, each issuing a series of shares:
Select Aggressive Growth Fund, Select Capital Appreciation Fund, Select Value
Opportunity Fund, the Select Emerging Markets Fund, Select International Equity
Fund, Select Growth Fund, Select Strategic Growth Fund, Growth Fund, Equity
Index Fund, Select Growth and Income Fund, Investment Grade Income Fund,
Government Bond Fund and Money Market Fund.
AFIMS serves as investment adviser of the Trust and has entered into
sub-advisory agreements with other investment managers ("Sub-Advisers") who
manage the investments of the Underlying Funds. See "INVESTMENT ADVISORY
SERVICES," "Investment Advisory Services to the Trust."
FIDELITY VARIABLE INSURANCE PRODUCTS FUND
Fidelity Variable Insurance Products Fund ("Fidelity VIP"), managed by Fidelity
Management & Research Company ("Fidelity Management"), is an open-end,
diversified, management investment company organized as a Massachusetts business
trust on November 13, 1981, and registered with the SEC under the 1940 Act. Four
of its investment portfolios are available under the Policy: Fidelity VIP High
Income Portfolio, Fidelity VIP Equity-Income Portfolio, Fidelity VIP Growth
Portfolio and Fidelity VIP Overseas Portfolio.
Various Fidelity companies perform certain activities required to operate
Fidelity VIP. Fidelity Management is one of America's largest investment
management organizations, and has its principal business address at 82
Devonshire Street, Boston, Massachusetts. It is composed of a number of
different companies which provide a variety of financial services and products.
Fidelity Management is the original Fidelity company, founded in 1946. It
provides a number of mutual funds and other clients with investment research and
portfolio management services.
FIDELITY VARIABLE INSURANCE PRODUCTS FUND II
Fidelity Variable Insurance Products Fund II ("Fidelity VIP II"), managed by
Fidelity Management (see discussion under "Variable Insurance Products Fund"),
is an open-end, diversified, management investment company organized as a
Massachusetts business trust on March 21, 1988 and is registered with the SEC
under
25
<PAGE>
the 1940 Act. One of its investment portfolios is available under the Policy:
the Fidelity VIP II Asset Manager Portfolio.
T. ROWE PRICE INTERNATIONAL SERIES, INC.
T. Rowe Price International Series, Inc. ("T. Rowe Price"), managed by Rowe
Price-Fleming International, Inc. ("Price-Fleming"), is an open-end,
diversified, management investment company organized as a Maryland corporation
in 1994 and is registered with the SEC under the 1940 Act. One of its investment
portfolios is available under the Policy: the T. Rowe Price International Stock
Portfolio. See "Investment Advisory Services to T. Rowe Price."
DELAWARE GROUP PREMIUM FUND, INC.
Delaware Group Premium Fund, Inc. ("DGPF") is an open-end, diversified
management investment company registered with the SEC under the 1940 Act. Such
registration does not involve supervision by the SEC of the investments or
investment policy of DGPF or its separate investment series. DGPF was
established to provide a vehicle for the investment of assets of various
separate accounts supporting variable insurance policies. One investment
portfolio ("Series") is available under the Policy: the International Equity
Series. The Investment adviser for the International Equity Series is Delaware
International Advisers Ltd. ("Delaware International"). See "Investment Advisory
Services to DGPF."
INVESTMENT OBJECTIVES AND POLICIES
A summary of investment objectives of each of the Underlying Funds is set forth
below. The Underlying Funds are listed by general investment risk
characteristics. MORE DETAILED INFORMATION REGARDING THE INVESTMENT OBJECTIVES,
RESTRICTIONS AND RISKS, EXPENSES PAID BY THE UNDERLYING FUNDS AND OTHER RELEVANT
INFORMATION REGARDING THE UNDERLYING INVESTMENT COMPANIES MAY BE FOUND IN THEIR
RESPECTIVE PROSPECTUSES, WHICH ACCOMPANY THIS PROSPECTUS AND SHOULD BE READ
CAREFULLY BEFORE INVESTING. The statements of additional information of the
Underlying Funds are available upon request. There can be no assurance that the
investment objectives of the Underlying Funds can be achieved.
SELECT AGGRESSIVE GROWTH FUND -- The Select Aggressive Growth Fund of the Trust
seeks above-average capital appreciation by investing primarily in common stocks
of companies which are believed to have significant potential for capital
appreciation.
SELECT CAPITAL APPRECIATION FUND -- The Select Capital Appreciation Fund of the
Trust seeks long-term growth of capital in a manner consistent with the
preservation of capital. Realization of income is not a significant investment
consideration and any income realized on the Fund's investments will be
incidental to its primary objective. The Fund invests primarily in common stock
of industries and companies which are believed to be experiencing favorable
demand for their products and services, and which operate in a favorable
competitive environment and regulatory climate.
SELECT VALUE OPPORTUNITY FUND -- The Select Value Opportunity Fund of the Trust
seeks long-term growth of capital by investing primarily in a diversified
portfolio of common stocks of small and mid-size companies, whose securities at
the time of purchase are considered by the Sub-Adviser to be undervalued.
SELECT EMERGING MARKETS FUND -- The Select Emerging Markets Fund of the Trust
seeks long-term growth of capital by investing in the world's emerging markets.
The Fund may invest in high yielding, lower-rated fixed-income securities
(commonly referred to as "junk bonds") which are subject to greater risk than
investments in higher-rated securities.
26
<PAGE>
SELECT INTERNATIONAL EQUITY FUND -- The Select International Equity Fund of the
Trust seeks maximum long-term total return (capital appreciation and income)
primarily by investing in common stocks of established non-U.S. companies.
DGPF INTERNATIONAL EQUITY SERIES -- The International Equity Series of DGPF
seeks long-term growth without undue risk to principal by investing primarily in
equity securities of foreign issuers providing the potential for capital
appreciation and income.
FIDELITY VIP OVERSEAS PORTFOLIO -- The Overseas Portfolio of Fidelity VIP seeks
long-term growth of capital primarily through investments in foreign securities
and provides a means for aggressive investors to diversify their own portfolios
by participating in companies and economies outside of the United States.
T. ROWE PRICE INTERNATIONAL STOCK PORTFOLIO -- The T. Rowe Price International
Stock Portfolio seeks long-term growth of capital through investments primarily
in common stocks of established, non-U.S. companies.
SELECT GROWTH FUND -- The Select Growth Fund of the Trust seeks to achieve
long-term growth of capital by investing in a diversified portfolio consisting
primarily of common stocks selected on the basis of their long-term growth
potential.
SELECT STRATEGIC GROWTH FUND -- The Select Strategic Growth Fund of the Trust
seeks long-term growth of capital by investing primarily in common stocks of
established companies.
GROWTH FUND -- The Growth Fund of the Trust is invested in common stocks and
securities convertible into common stocks that are believed to represent
significant underlying value in relation to current market prices. The objective
of the Growth Fund is to achieve long-term growth of capital. Realization of
current investment income, if any, is incidental to this objective.
FIDELITY VIP GROWTH PORTFOLIO -- The Growth Portfolio of Fidelity VIP seeks to
achieve capital appreciation. The Portfolio normally purchases common stocks,
although its investments are not restricted to any one type of security. Capital
appreciation also may be found in other types of securities, including bonds and
preferred stocks.
EQUITY INDEX FUND -- The Equity Index Fund of the Trust seeks to provide
investment results that correspond to the aggregate price and yield performance
of a representative selection of United States publicly traded common stocks.
The Equity Index Fund seeks to achieve its objective by attempting to replicate
the aggregate price and yield performance of the Standard & Poor's Composite
Index of 500 Stocks.
SELECT GROWTH AND INCOME FUND -- The Select Growth and Income Fund seeks a
combination of long-term growth of capital and current income. The Fund will
invest primarily in dividend-paying common stocks and securities convertible
into common stocks.
FIDELITY VIP EQUITY-INCOME PORTFOLIO -- The Equity-Income Portfolio of Fidelity
VIP seeks reasonable income by investing primarily in income-producing equity
securities. In choosing these securities, the Portfolio also will consider the
potential for capital appreciation. The Portfolio's goal is to achieve a yield
which exceeds the composite yield on the securities comprising the S&P 500. The
Portfolio may invest in high yielding, lower-rated fixed-income securities
(commonly referred to as "junk bonds") which are subject to greater risk than
investments in higher-rated securities. See the Fidelity VIP prospectus.
FIDELITY VIP II ASSET MANAGER PORTFOLIO -- The Asset Manager Portfolio of
Fidelity VIP II seeks high total return with reduced risk over the long term by
allocating its assets among domestic and foreign stocks, bonds and short-term
money market instruments.
27
<PAGE>
FIDELITY VIP HIGH INCOME PORTFOLIO -- The High Income Portfolio of Fidelity VIP
seeks to obtain a high level of current income by investing primarily in
high-yielding, lower-rated fixed-income securities (commonly referred to as
"junk bonds"), while also considering growth of capital. These securities often
are considered to be speculative, and involve greater risk of default or price
changes than securities assigned a high quality rating.
INVESTMENT GRADE INCOME FUND -- The Investment Grade Income Fund of the Trust is
invested in a diversified portfolio of fixed income securities with the
objective of seeking as high a level of total return (including both income and
capital appreciation) as is consistent with prudent investment management.
GOVERNMENT BOND FUND -- The Government Bond Fund of the Trust has the investment
objectives of seeking high income, preservation of capital and maintenance of
liquidity, primarily through investments in debt instruments issued or
guaranteed by the U.S. Government or its agencies or instrumentalities, and in
related options, futures and repurchase agreements.
MONEY MARKET FUND -- The Money Market Fund of the Trust is invested in a
diversified portfolio of high-quality, short-term money market instruments with
the objective of obtaining maximum current income consistent with the
preservation of capital and liquidity.
CERTAIN UNDERLYING FUNDS HAVE INVESTMENT OBJECTIVES AND/OR POLICIES SIMILAR TO
THOSE OF OTHER UNDERLYING FUNDS. THEREFORE, TO CHOOSE THE SUB-ACCOUNTS WHICH
BEST WILL MEET YOUR NEEDS AND OBJECTIVES, CAREFULLY READ THE PROSPECTUSES OF THE
TRUST, FIDELITY VIP, FIDELITY VIP II, T. ROWE PRICE AND DGPF, ALONG WITH THIS
PROSPECTUS. IN SOME STATES, INSURANCE REGULATIONS MAY RESTRICT THE AVAILABILITY
OF PARTICULAR SUB-ACCOUNTS.
If required in your state, in the event of a material change in the investment
policy of a Sub-Account or the Underlying Fund in which it invests, you will be
notified of the change. If you have Policy Value in that Sub-Account, the
Company will transfer it without charge on Written Request within sixty (60)
days of the later of (1) the effective date of such change in the investment
policy, or (2) your receipt of the notice of the right to transfer. You may then
change the percentages of your premium and deduction allocations.
INVESTMENT ADVISORY SERVICES
INVESTMENT ADVISORY SERVICES TO THE TRUST
The overall responsibility for the supervision of the affairs of the Trust vests
in the Trustees. The Trustees have entered into a Management Agreement with
AFIMS to handle the day-to-day affairs of the Trust. AFIMS, subject to review by
the Trustees, is responsible for the general management of the Funds. AFIMS also
performs certain administrative and management services for the Trust, furnishes
to the Trust all necessary office space, facilities and equipment, and pays the
compensation, if any, of officers and Trustees who are affiliated with AFIMS.
Allmerica Asset Management, Inc., an indirect wholly-owned subsidiary of
Allmerica Financial Corporation, is an affiliate of the Company.
Other than the expenses specifically assumed by AFIMS under the Management
Agreement, all expenses incurred in the operation of the Trust are borne by it,
including fees and expenses associated with the registration and qualification
of the Trust's shares under the Securities Act of 1933 ("1933 Act"), other fees
payable to the SEC, independent public accountant, legal and custodian fees,
association membership dues, taxes, interest, insurance premiums, brokerage
commissions, fees and expenses of the Trustees who are not affiliated with
AFIMS, expenses for proxies, prospectuses, reports to shareholders, and other
expenses.
28
<PAGE>
For providing its services under the Management Agreement, AFIMS will receive a
fee, computed daily at an annual rate based on the average daily net asset value
of each Fund as follows:
<TABLE>
<S> <C> <C>
Select Aggressive Growth Fund First $100 million 1.00%
Next $150 million 0.90%
Over $250 million 0.85%
Select Capital Appreciation First $100 million
Fund 1.00%
Next $150 million 0.90%
Over $250 million 0.85%
Select Value Opportunity Fund First $100 million 1.00%
Next $150 million 0.85%
Next $250 million 0.80%
Next $250 million 0.75%
Over $750 million 0.70%
Select Emerging Markets Fund * 1.35%
Select International Equity First $100 million
Fund 1.00%
Next $150 million 0.90%
Over $250 million 0.85%
Select Growth Fund * 0.85%
Select Strategic Growth Fund * 0.85%
Growth Fund First $250 million 0.60%
Next $250 million 0.40%
Over $500 million 0.35%
Equity Index Fund First $50 million 0.35%
Next $200 million 0.30%
Over $250 million 0.25%
Select Growth and Income Fund First $100 million 0.75%
Next $150 million 0.70%
Over $250 million 0.65%
Investment Grade Income Fund First $50 million 0.50%
Next $50 million 0.45%
Over $100 million 0.40%
Government Bond Fund * 0.50%
Money Market Fund First $50 million 0.35%
Next $200 million 0.25%
Over $250 million 0.20%
</TABLE>
* For the Government Bond Fund, Select Emerging Markets Fund, the Select Growth
Fund, and the Select Strategic Growth Fund, the investment management fee does
not vary according to the level of assets in the Fund. AFIMS' fee computed for
each Fund will be paid from the assets of such Fund.
Pursuant to the Management Agreement with the Trust, AFIMS has entered into
agreements ("Sub-Adviser Agreements") with other investment advisers
("Sub-Advisers") under which each Sub-Adviser manages the investments of one or
more of the Funds. Under the Sub-Adviser Agreements, the Sub-Advisers are
authorized to engage in portfolio transactions on behalf of the applicable Fund,
subject to such general or specific instructions as may be given by the
Trustees. The terms of a Sub-Adviser Agreement cannot be materially changed
without the approval of a majority in interest of the shareholders of the
affected Fund. AFIMS is
29
<PAGE>
solely responsible for the payment of all fees for investment management
services to the Sub-Advisers. AFIMS' fee, computed for each Fund, will be paid
from the assets of such Fund. Pursuant to the Management Agreement with the
Trust, AFIMS has entered into agreements ("Sub-Adviser Agreements") with other
investment advisers ("Sub-Advisers") under which each Sub-Adviser manages the
investments of one or more of the Funds. Under the Sub-Adviser Agreement, the
Sub-Adviser is authorized to engage in portfolio transactions on behalf of the
applicable Fund, subject to such general or specific instructions as may be
given by the Trustees. The terms of a Sub-Adviser Agreement cannot be materially
changed without the approval of a majority in interest of the shareholders of
the affected Fund. AFIMS is solely responsible for the payment of all fees for
investment management services to the Sub-Advisers.
The prospectus of the Trust contains additional information concerning the
Funds, including information about additional expenses paid by the Funds and
fees paid to the Sub-Advisors by AFIMS, and should be read in conjunction with
this Prospectus.
INVESTMENT ADVISORY SERVICES TO FIDELITY VIP AND FIDELITY VIP II FUNDS
For managing investments and business affairs, each Portfolio pays a monthly fee
to Fidelity Management. The prospectuses of Fidelity VIP and Fidelity VIP II
contain additional information concerning the Portfolios, including information
about additional expenses paid by the Portfolios, and should be read in
conjunction with this Prospectus.
The Fidelity VIP High Income Portfolio pays a monthly fee to Fidelity Management
at an annual fee rate made up of the sum of two components:
1. A group fee rate based on the monthly average net assets of all the mutual
funds advised by Fidelity Management. On an annual basis this rate cannot
rise above 0.37%, and drops as total assets in all these funds rise.
2. An individual fund fee rate of 0.45% of the Fidelity VIP High Income
Portfolio's average net assets throughout the month. One-twelfth of the
annual management fee rate is applied to net assets averaged over the most
recent month, resulting in a dollar amount which is the management fee for
that month.
The fee rates of the Fidelity VIP Equity-Income, Fidelity VIP Growth, Fidelity
VIP II Asset Manager and Fidelity VIP Overseas Portfolios each are made of two
components:
1. A group fee rate based on the monthly average net assets of all of the
mutual funds advised by Fidelity Management. On an annual basis, this rate
cannot rise above 0.52%, and drops as total assets in all these mutual funds
rise.
2. An individual Portfolio fee rate of 0.20% for the Fidelity VIP Equity-Income
Portfolio, 0.30% for the Fidelity VIP Growth Portfolio, 0.25% for the
Fidelity VIP II Asset Manager Portfolio and 0.45% for the Fidelity VIP
Overseas Portfolio.
One-twelfth of the sum of these two rates is applied to the respective
Portfolio's net assets averaged over the most recent month, giving a dollar
amount which is the fee for that month. Thus, the Fidelity VIP High Income
Portfolio may have a fee as high as 0.82% of its average net assets. The
Fidelity VIP Equity-Income Portfolio may have a fee as high as 0.72% of its
average net assets. The Fidelity VIP Growth Portfolio may have a fee as high as
0.82% of its average net assets. The Fidelity VIP II Asset Manager Portfolio may
have a fee as high as 0.77% of its average net assets. The Fidelity VIP Overseas
Portfolio may have a fee as high as 0.97% of its average net assets. The actual
fee rate may be less depending on the total assets in the funds advised by
Fidelity Management.
INVESTMENT ADVISORY SERVICES TO T. ROWE PRICE
The Investment Adviser for the International Stock Portfolio is Rowe
Price-Fleming International, Inc. ("Price-Fleming"). Price-Fleming, founded in
1979 as a joint venture between T. Rowe Price Associates, Inc. and Robert
Fleming Holdings, Limited, is one of America's largest international mutual fund
asset managers
30
<PAGE>
with approximately $30 billion under management in its offices in Baltimore,
London, Tokyo, Hong Kong, Singapore and Buenos Aires. To cover investment
management and operating expenses, the T. Rowe Price International Stock
Portfolio pays Price-Fleming a single, all-inclusive fee of 1.05% of its average
daily net assets.
INVESTMENT ADVISORY SERVICES TO DGPF
Each Series of DGPF pays an investment adviser an annual fee for managing the
portfolios and making the investment decisions for the Series. The investment
adviser for the International Equity Series is Delaware International Advisers
Ltd. ("Delaware International"). The annual fee paid by the International Equity
Series to Delaware International is equal to 0.75% of the average daily net
assets of the Series.
ADDITION, DELETION OR SUBSTITUTION OF INVESTMENTS
The Company reserves the right, subject to applicable law, to make additions to,
deletions from, or substitutions for the shares that are held in the
Sub-Accounts or that the Sub-Accounts may purchase. If the shares of any
Underlying Fund are no longer available for investment or if in the Company's
judgment further investment in any Underlying Fund should become inappropriate
in view of the purposes of the Separate Account or the affected Sub-Account, the
Company may redeem the shares of that Underlying Fund and substitute shares of
another registered open-end management company. The Company will not substitute
any shares attributable to a Policy interest in a Sub-Account without notice to
the Policyowner and prior approval of the SEC and state insurance authorities,
to the extent required by law. The Separate Account may, to the extent permitted
by law, purchase other securities for other policies or permit a conversion
between policies upon request by a Policyowner.
The Company also reserves the right to establish additional Sub-Accounts of the
Separate Account, each of which would invest in shares of a new Underlying Fund
or in shares of another investment company. Subject to applicable law and any
required SEC approval, the Company may, in its sole discretion, establish new
Sub-Accounts or eliminate one or more Sub-Accounts if marketing needs, tax
considerations or investment conditions warrant. Any new Sub-Accounts may be
made available to existing Policyowners on a basis to be determined by the
Company.
Shares of the Funds of the Trust also are issued to separate accounts of the
Company and its affiliates which issue variable annuity contracts ("mixed
funding"). Shares of the Portfolios of Fidelity VIP and Fidelity VIP II, the
Portfolio of T. Rowe Price and the Series of DGPF also are issued to other
unaffiliated insurance companies ("shared funding"). It is conceivable that in
the future such mixed funding or shared funding may be disadvantageous for
variable life Policyowners or variable annuity contract owners. Although the
Company and the Underlying Investment Companies currently do not foresee any
such disadvantages to either variable life insurance Policyowners or variable
annuity contract owners, the Company and the respective Trustees intend to
monitor events in order to identify any material conflicts and to determine what
action, if any, should be taken. If the Trustees were to conclude that separate
Funds should be established for variable life and variable annuity separate
accounts, the Company will bear the expenses.
If any of these substitutions or changes are made, the Company may endorse the
Policy to reflect the substitution or change, and will notify Policyowners of
all such changes. If the Company deems it to be in the best interest of
Policyowners, and subject to any approvals that may be required under applicable
law, the Separate Account or any Sub-Account(s) may be operated as a management
company under the 1940 Act, may be deregistered under the 1940 Act if
registration is no longer required, or may be combined with other Sub-Accounts
or other separate accounts of the Company.
VOTING RIGHTS
To the extent required by law, the Company will vote Underlying Fund shares held
by each Sub-Account in accordance with instructions received from Policyowners
with Policy Value in such Sub-Account. If the 1940
31
<PAGE>
Act or any rules thereunder should be amended, or if the present interpretation
of the 1940 Act or such rules should change and, as a result the Company
determines that it is permitted to vote shares in its own right, whether or not
such shares are attributable to the Policy, the Company reserves the right to do
so.
Each person having a voting interest will be provided with proxy materials of
the respective Underlying Fund, together with an appropriate form with which to
give voting instructions to the Company. Shares held in each Sub-Account for
which no timely instructions are received will be voted in proportion to the
instructions which have been received by the Company. The Company also will vote
shares held in the Separate Account that it owns and which are not attributable
to the Policy in the same proportion.
The number of votes which a Policyowner has the right to instruct will be
determined by the Company as of the record date established for the Underlying
Fund. This number is determined by dividing each Policyowner's Policy Value in
the Sub-Account, if any, by the net asset value of one share in the
corresponding Underlying Fund in which the assets of the Sub-Account are
invested.
The Company may, when required by state insurance regulatory authorities,
disregard voting instructions if the instructions require that the shares be
voted so as (1) to cause a change in the sub-classification or investment
objective of one or more of the Underlying Funds, or (2) to approve or
disapprove an investment advisory contract for the Underlying Funds. In
addition, the Company may disregard voting instructions in favor of any change
in the investment policies or in any investment adviser or principal underwriter
initiated by Policyowners or the Trustees. The Company's disapproval of any such
change must be reasonable and, in the case of a change in investment policies or
investment adviser, based on a good faith determination that such change would
be contrary to state law or otherwise is inappropriate in light of the
objectives and purposes of the Underlying Funds. In the event the Company does
disregard voting instructions, a summary of and the reasons for that action will
be included in the next periodic report to Policyowners.
THE POLICY
APPLYING FOR A POLICY
A Policy cannot be issued until the underwriting procedure has been completed.
Upon receipt at its Principal Office of a completed application from a
prospective Policyowner, the Company will follow certain insurance underwriting
procedures designed to determine whether the proposed Insured is insurable. This
process may involve medical examinations, and may require that further
information be provided by the proposed Policyowner before a determination of
insurability can be made. The Company reserves the right to reject an
application which does not meet its underwriting guidelines, but in underwriting
insurance, the Company complies with all applicable federal and state
prohibitions concerning unfair discrimination.
CONDITIONAL INSURANCE AGREEMENT
It is possible to obtain life insurance protection during the underwriting
process through a Conditional Insurance Agreement. If at the time of application
you make a payment equal to at least one "Minimum Monthly Factor" for the Policy
as applied for, the Company will provide fixed conditional insurance in the
amount of insurance applied for up to a maximum of $500,000, pending
underwriting approval. This coverage generally will continue for a maximum of 90
days from the date of the application or the completion of a medical exam,
should one be required. In no event will any insurance proceeds be paid under
the Conditional Insurance Agreement if death is by suicide.
If the application is approved, the Policy will be issued as of the date the
terms of the Conditional Insurance Agreement were met. If no Conditional
Insurance Agreement is in effect because the prospective Policyowner does not
wish to make any payment until the Policy is issued, or has paid an initial
premium that is not sufficient to place the Policy in force, upon delivery of
the Policy the Company will require payment of sufficient premium to place the
insurance in force.
32
<PAGE>
PREMIUMS HELD IN THE GENERAL ACCOUNT PENDING UNDERWRITING APPROVAL
Pending completion of insurance underwriting and Policy issuance procedures, the
initial premium will be held in the General Account. If the application is
approved and the Policy is issued and accepted by you, the initial premium held
in the General Account will be credited with interest at a specified rate,
beginning not later than the date of receipt of the premium at the Principal
Office. IF A POLICY IS NOT ISSUED, THE PREMIUMS WILL BE RETURNED TO YOU WITHOUT
INTEREST.
If the Policy is issued to the trustee of an employee benefit plan, the amounts
held in the General Account will be allocated to the Sub-Accounts according to
the Policyowner's instructions when the Delivery Receipt is returned to the
Principal Office. For all other Policyowners, the date the Company transfers the
initial net premium from the General Account to the selected Sub-Accounts
depends on the premium amount. If the initial net premiums are less than
$10,000, the amounts held in the General Account will be allocated to the
selected Sub-Accounts not later than three days after underwriting approval of
the Policy. If the initial net premiums equal or exceed $10,000, or if the
Policy provides for planned premium payments during the first year equal to or
exceeding $10,000 annually, $5,000 semi-annually, $2,500 quarterly or $1,000
monthly, the entire Net Premium, plus any interest earned, will remain in the
General Account until return of the Policy's Delivery Receipt to the Principal
Office. The entire amount held in the General Account for allocation to the
Separate Account then will be allocated to the Sub-Accounts according to your
instructions.
FREE-LOOK PERIOD
The Policy provides for an initial "Free-Look" period. You may cancel the Policy
by mailing or delivering the Policy to the Principal Office or an agent of the
Company on or before the latest of:
- 45 days after the application for the Policy is signed, or
- 10 days after you receive the Policy (or longer if required by state law),
or
- 10 days after the Company mails or personally delivers a notice of
withdrawal rights to you.
When you return the Policy, the Company will mail within seven days a refund
equal to the sum of:
(1) the difference between the premiums, including fees and charges paid, and
any amounts allocated to the Separate Account, plus
(2) the value of the amounts allocated to the Separate Account, plus
(3) any fees or charges imposed on the amounts allocated to the Separate
Account.
The amount refunded in (1) above includes any premiums allocated to the General
Account. Where required by state law, the refund will equal the premiums paid.
The refund of any premium paid by check, however, may be delayed until the check
has cleared your bank.
FREE LOOK WITH FACE AMOUNT INCREASES
After an increase in the Face Amount, the Company will mail or personally
deliver a notice of a "Free Look" with respect to the increase. You will have
the right to cancel the increase before the latest of:
- 45 days after the application for the increase is signed, or
- 10 days after you receive the new specifications pages issued for the
increase (or longer if required by state law), or
- 10 days after the Company mails or delivers a notice of withdrawal rights
to you.
33
<PAGE>
Upon canceling the increase, you will receive a credit to your Policy Value of
charges which would not have been deducted but for the increase. The amount to
be credited will be refunded if you so request. The Company also will waive any
surrender charge calculated for the increase.
CONVERSION PRIVILEGES
Once during the first 24 months after the Date of Issue or after the effective
date of an increase in Face Amount (assuming the Policy is in force), you may
convert your Policy without Evidence of Insurability to a flexible premium
adjustable life insurance policy with fixed and guaranteed minimum benefits.
Assuming that there have been no increases in the initial Face Amount, you can
accomplish this within 24 months after the Date of Issue by transferring,
without charge, the Policy Value in the Separate Account to the General Account
and by simultaneously changing your premium allocation instructions to allocate
future premium payments to the General Account. Within 24 months after the
effective date of each increase, you can transfer, without charge, all or part
of the Policy Value in the Separate Account to the General Account and
simultaneously change your premium allocation instructions to allocate all or
part of future premium payments to the General Account.
Where required by state law, at your request the Company will issue a flexible
premium adjustable life insurance Policy to you. The new Policy will have the
same Face Amount, Issue Age, Dates of Issue, and Premium Class as the original
Policy.
PREMIUM PAYMENTS
Premium payments are payable to the Company, and may be mailed to the Principal
Office or paid through one of the Company's authorized agents. All premium
payments after the initial premium payment are credited to the Separate Account
or the General Account as of date of receipt at the Principal Office.
PREMIUM FLEXIBILITY
Unlike conventional insurance policies, the Policy does not obligate you to pay
premiums in accordance with a rigid and inflexible premium schedule. You may
establish a schedule of planned premiums which will be billed by the Company at
regular intervals. Failure to pay planned premiums will not itself cause the
Policy to lapse. However, if the optional Guaranteed Death Benefit rider is in
effect, certain minimum premium payment tests must be met.
You also may make unscheduled premium payments at any time prior to the Final
Premium Payment Date or skip planned premium payments, subject to the maximum
and minimum premium limitations described below.
You also may elect to pay premiums by means of a monthly automatic payment
procedure. Under this procedure, amounts will be deducted each month from your
checking account, generally on the Monthly Payment Date, from your checking
account and applied as a premium under a Policy. The minimum payment permitted
under this procedure is $50.
Premiums are not limited as to frequency and number. No premium payment may be
less than $100, however, without the Company's consent. Moreover, premium
payments must be sufficient to provide a positive Surrender Value at the end of
each Policy month, or the Policy may lapse. See "POLICY TERMINATION AND
REINSTATEMENT."
MINIMUM MONTHLY FACTOR
If, in the first 48 Policy months following issue or an increase in the Face
Amount, you make premium payments, less Debt, partial withdrawals and partial
withdrawal charges, at least equal to the sum of the Minimum Monthly Factor for
the number of months the Policy, increase in Face Amount, or Policy Change which
causes a change in the Minimum Monthly Factor has been in force, the Policy is
guaranteed not to lapse
34
<PAGE>
during that period. EXCEPT FOR THE 48 POLICY MONTHS AFTER THE DATE OF ISSUE, OR
THE EFFECTIVE DATE OF AN INCREASE IN THE FACE AMOUNT, MAKING MONTHLY PAYMENTS AT
LEAST EQUAL TO THE MINIMUM MONTHLY FACTOR DOES NOT GUARANTEE THAT THE POLICY
WILL REMAIN IN FORCE.
In no event may the total of all premiums paid exceed the current maximum
premium limitations set forth in the Policy which are required by federal tax
laws. These maximum premium limitations will change whenever there is any change
in the Face Amount, the addition or deletion of a rider, or a change in the Sum
Insured Option. If a premium is paid which would result in total premiums
exceeding the current maximum premium limitations, the Company will accept only
that portion of the premiums which shall make total premiums equal the maximum.
Any part of the premiums in excess of that amount will be returned, and no
further premiums will be accepted until allowed by the current maximum premium
limitation prescribed by Internal Revenue Service ("IRS") rules. Notwithstanding
the current maximum premium limitations, however, the Company will accept a
premium which is needed in order to prevent a lapse of the Policy during a
Policy year. See "POLICY TERMINATION AND REINSTATEMENT."
INCENTIVE FUNDING DISCOUNT
The Company will lower the cost of insurance charges by 5% during any Policy
year for which you qualify for an incentive funding discount. To qualify, total
premiums paid under the Policy, less any debt, withdrawals and withdrawal
charges, and transfers from other policies issued by the Company, must exceed
90% of the guideline level premiums (as defined in Section 7702 of the Code)
accumulated from the Date of Issue to the date of qualification. The incentive
funding discount is not available in all states.
The amount needed to qualify for the incentive funding discount is determined on
the Date of Issue for the first Policy year and on each Policy anniversary for
each subsequent Policy year. If the Company receives the proceeds from a Policy
issued by an unaffiliated company to be exchanged for the Policy, however, the
qualification for the incentive funding discount for the first Policy year will
be determined on the date the proceeds are received by the Company, and only
insurance charges becoming due after the date such proceeds are received will be
eligible for the incentive funding discount.
GUARANTEED DEATH BENEFIT RIDER
An optional Guaranteed Death Benefit Rider is available only at issue of the
Policy. If this rider is in effect, the Company:
- guarantees that your Policy will not lapse regardless of the investment
performance of the Separate Account and
- provides a guaranteed death benefit.
In order to maintain the Guaranteed Death Benefit Rider, certain minimum premium
payment tests must be met on each Policy anniversary and within 48 months
following the Date of Issue and/or the date of any increase in Face Amount, as
described below. In addition, a one-time administrative charge of $25 will be
deducted from Policy Value when the Rider is elected. Certain transactions,
including Policy Loans, partial withdrawals, and changes in Sum Insured Options,
can result in the termination of the rider. If this rider is terminated, it
cannot be reinstated.
GUARANTEED DEATH BENEFIT TESTS
While the Guaranteed Death Benefit Rider is in effect, the Policy will not lapse
if the following two tests are met:
1. Within 48 months following the Date of Issue of the Policy or of any
increase in the Face Amount, the sum of the premiums paid, less any debt,
partial withdrawals and withdrawal charges, must be greater
35
<PAGE>
than the Minimum Monthly Factors (if any) multiplied by the number of months
which have elapsed since the Date of Issue or the effective date of
increase; and
2. On each Policy anniversary, (a) must exceed (b), where, since the Date of
Issue:
(a) is the sum of your premiums, less any withdrawals, partial withdrawal
charges and debt which is classified as a preferred loan; and
(b) is the sum of the minimum guaranteed death benefit premiums, as shown on
the specifications page of the Policy.
GUARANTEED DEATH BENEFIT
If the Guaranteed Death Benefit Rider is in effect on the Final Premium Payment
Date, guaranteed Death Proceeds will be provided as long as the rider is in
force. The Death Proceeds will be the greater of:
- the Face Amount as of the Final Premium Payment Date; or
- the Policy Value as of the date due proof of death is received by the
Company.
TERMINATION OF THE GUARANTEED DEATH BENEFIT RIDER
The Guaranteed Death Benefit Rider will end and may not be reinstated on the
first to occur of the following:
- foreclosure of a Policy Loan; or
- the date on which the sum of your payments does not meet or exceed the
applicable Guaranteed Death Benefit test (above); or
- any Policy change that results in a negative guideline level premium; or
- the effective date of a change from Sum Insured Option 2 to Sum Insured
Option I, if such change occurs within 5 Policy years of the Final Premium
Payment Date; or
- a request for a partial withdrawal or preferred loan is made after the
Final Premium Payment Date.
It is possible that the Policy Value will not be sufficient to keep the Policy
in force on the first Monthly Payment Date following the date the Rider
terminates. The net amount payable to keep the Policy in force will never exceed
the surrender charge plus three Monthly Deductions.
PAID-UP INSURANCE OPTION
Upon Written Request, a Policyowner may exercise a paid-up insurance option.
Paid-up life insurance is fixed insurance, usually having a reduced Face Amount,
for the lifetime of the Insured with no further premiums due. If the Policyowner
elects this option, certain Policyowner rights and benefits may be limited.
The paid-up fixed insurance will be in the amount that the Surrender Value of
the Policy can purchase for a net single premium at the Insured's Age and
Underwriting Class on the date this option is elected. The Company will transfer
any Policy Value in the Separate Account to the General Account on the date it
receives the Written Request to elect the option. If the Surrender Value exceeds
the net single premium necessary for the fixed insurance, the Company will pay
the excess to the Policyowner. The net single premium is based on the
Commissioners 1980 Standard Ordinary Mortality Tables, Smoker or Non-Smoker
(Table B for unisex Policies) with increases in the tables for non-standard
risks. Interest will not be less than 4.5%.
36
<PAGE>
IF THE PAID-UP INSURANCE OPTION IS ELECTED, THE FOLLOWING
POLICYOWNER RIGHTS AND BENEFITS WILL BE AFFECTED:
- As described above, the paid-up insurance benefit is computed differently
from the net death benefit, and the death benefit options will not apply.
- The Company will transfer the Policy Value in the Separate Account to the
General Account on the date it receives the written request to elect the
option. The Company will not allow transfers of Policy Value from the
General Account back to the Separate Account.
- The Policyowner may not make further premium payments.
- The Policyowner may not increase or decrease the Face Amount or make
partial withdrawals.
- Riders will continue only with the Company's consent.
After electing paid-up fixed insurance, the Policyowner may make Policy loans or
surrender the Policy for its net cash value. The cash value is equal to the net
single premium for paid-up insurance at the Insured's attained age. The net cash
value is the cash value less any outstanding loans.
ALLOCATION OF NET PREMIUMS
The Net Premium equals the premium paid less the 3 1/2% tax expense charge. In
the application for a Policy, you indicate the initial allocation of Net
Premiums among the General Account and the Sub-Accounts of the Separate Account.
You may allocate premiums to one or more Sub-Accounts, but may not have Policy
Value in more than 20 Sub-Accounts at any one time. The minimum amount which may
be allocated to a Sub-Account is 1% of Net Premium paid. Allocation percentages
must be in whole numbers (for example, 33 1/3% may not be chosen) and must total
100%.
FUTURE CHANGES ALLOWED
You may change the allocation of future Net Premiums at any time pursuant to
written or telephone request. An allocation change will be effective as of the
date of receipt of the notice at the Principal Office. If allocation changes by
telephone are elected by the Policyowner, a properly completed authorization
form must be on file before telephone requests will be honored. The Company and
its agents and affiliates will not be responsible for losses resulting from
acting upon telephone requests reasonably believed to be genuine. The Company
will employ reasonable procedures to confirm that instructions communicated by
telephone are genuine; otherwise, the Company may be liable for any losses due
to unauthorized or fraudulent instructions.
The procedures the Company follows for telephone transactions include requiring
callers to identify themselves by name, and to identify the Policyowner by name,
date of birth and social security number. All transfer instructions by telephone
are tape recorded.
INVESTMENT RISK
The Policy Value in the Sub-Accounts will vary with their investment experience;
you bear this investment risk. The investment performance may affect the Death
Proceeds as well. Policyowners periodically should review their allocations of
premiums and Policy Value in light of market conditions and overall financial
planning requirements.
TRANSFER PRIVILEGE
Subject to the Company's then current rules, you may at any time transfer the
Policy Value among the Sub-Accounts or between a Sub-Account and the General
Account. However, the Policy Value held in the General Account to secure a
Policy loan may not be transferred.
37
<PAGE>
All requests for transfers must be made to the Principal Office. The amount
transferred will be based on the Policy Value in the Account(s) next computed
after receipt of the transfer order. The Company will make transfers pursuant to
written or telephone request. As discussed in "THE POLICY -- Allocation of Net
Premiums," a properly completed authorization form must be on file at the
Principal Office before telephone requests will be honored.
Currently, transfers involving the General Account are permitted only if:
- there has been at least a 90-day period since the last transfer from the
General Account, and
- the amount transferred from the General Account in each transfer does not
exceed the lesser of $100,000 or 25% of the Accumulated Value under the
Policy.
These rules are subject to change by the Company.
DOLLAR-COST AVERAGING OPTION AND AUTOMATIC REBALANCING OPTION
You may have automatic transfers of at least $100 a month made on a periodic
basis:
- from the Sub-Accounts which invest in the Money Market Fund and Government
Bond Fund of the Trust, respectively, to one or more of the other
Sub-Accounts ("Dollar-Cost Averaging Option"), or
- to reallocate Policy Value among the Sub-Accounts ("Automatic Rebalancing
Option").
Automatic transfers may be made on a monthly, bi-monthly, quarterly, semi-annual
or annual schedule. Generally, all transfers will be processed on the 15th of
each scheduled month. If the 15th is not a business day, however, or is the
Monthly Payment Date, the automatic transfer will be processed on the next
business day. The Dollar-Cost Averaging Option and the Automatic Rebalancing
Option may not be in effect at the same time.
TRANSFER PRIVILEGE SUBJECT TO POSSIBLE LIMITS
The transfer privilege is subject to the Company's consent. The Company reserves
the right to impose limitations on transfers including, but not limited to:
- the minimum amount that may be transferred,
- the minimum amount that may remain in a Sub-Account following a transfer
from that Sub-Account,
- the minimum period of time between transfers involving the General
Account, and
- the maximum amount that may be transferred each time from the General
Account.
Currently, the first 12 transfers in a Policy year will be free of any charge.
Thereafter, a $10 transfer charge will be deducted from the amount transferred
for each transfer in that Policy year. The Company may increase or decrease this
charge, but it is guaranteed never to exceed $25. The first automatic transfer
counts as one transfer towards the 12 free transfers allowed in each Policy
year; each subsequent automatic transfer is without charge and does not reduce
the remaining number of transfers which may be made free of charge. Any
transfers made with respect to a conversion privilege, Policy loan or material
change in investment Policy will not count towards the 12 free transfers.
DEATH PROCEEDS
As long as the Policy remains in force (see "POLICY TERMINATION AND
REINSTATEMENT"), upon due proof of the Insured's death, the Company will pay the
Death Proceeds of the Policy to the named
38
<PAGE>
Beneficiary. The Company normally will pay the Death Proceeds within seven days
of receiving due proof of the Insured's death, but the Company may delay
payments under certain circumstances. See "OTHER POLICY PROVISIONS,"
"Postponement of Payments." The Death Proceeds may be received by the
Beneficiary in cash or under one or more of the payment options set forth in the
Policy. See "APPENDIX B -- DEATH PROCEEDS PAYMENT OPTIONS."
Prior to the Final Premium Payment Date, the Death Proceeds are equal to:
- the Sum Insured provided under Option 1 or Option 2, whichever is elected
and in effect on the date of death; plus
- any additional insurance on the Insured's life that is provided by rider;
minus
- any outstanding Debt, any partial withdrawals and partial withdrawal
charges, and any Monthly Deductions due and unpaid through the Policy
month in which the Insured dies.
After the Final Premium Payment Date, the Death Proceeds equal the Surrender
Value of the Policy, unless the Guaranteed Death Benefit Rider is in effect. If
the Guaranteed Death Benefit Rider is in effect, the Death Proceed equal the
greater of the Face Amount or Surrender Value. The amount of Death Proceeds
payable will be determined as of the date of the Company's receipt of due proof
of the Insured's death.
SUM INSURED OPTIONS
The Policy provides two Sum Insured Options: Option 1 and Option 2, as described
below. You designate the desired Sum Insured Option in the application. You may
change the Option once per Policy year by written request. There is no charge
for a change in Option.
Under Option 1, the Sum Insured is equal to the greater of the Face Amount of
insurance or the Guideline Minimum Sum Insured. Under Option 2, the Sum Insured
is equal to the greater of the Face Amount of insurance plus the Policy Value or
the Guideline Minimum Sum Insured.
GUIDELINE MINIMUM SUM INSURED
To remain qualified as "life insurance" for federal tax purposes, federal tax
law requires that policies have a minimum amount of pure life insurance
protection in relation to the size of the Policy Value. The Guideline Minimum
Sum Insured is used to determine compliance with this requirement. So long as
the Policy qualifies as a life insurance contract, the insurance proceeds will
be excluded from the gross income of the Beneficiary.
39
<PAGE>
GUIDELINE MINIMUM SUM INSURED TABLE
<TABLE>
<CAPTION>
Age of Insured Percentage of
on Date of Death Policy Value
- ------------------------------------------------------------- -----------------
<S> <C>
40 and under............................................. 250%
45....................................................... 215%
50....................................................... 185%
55....................................................... 150%
60....................................................... 130%
65....................................................... 120%
70....................................................... 115%
75....................................................... 105%
80....................................................... 105%
85....................................................... 105%
90....................................................... 105%
95 and above............................................. 100%
</TABLE>
For the Ages not listed, the progression between the listed Ages is linear.
Under both Option 1 and Option 2, the Sum Insured provides insurance protection.
Under Option 1, the Sum Insured remains level unless the applicable percentage
of Policy Value under the Guideline Minimum Sum Insured exceeds the Face Amount,
in which case the Sum Insured will vary as the Policy Value varies. Under Option
2, the Sum Insured varies as the Policy Value changes.
For any Face Amount, the amount of the Sum Insured (and the Death Proceeds) will
be greater under Option 2 than under Option 1. This is because the Policy Value
is added to the specified Face Amount and included in the Death Proceeds only
under Option 2. Under Option 2, however, the cost of insurance included in the
Monthly Deduction will be greater, and the rate at which Policy Value will
accumulate will be slower (assuming the same specified Face Amount and the same
actual premiums paid). See "CHARGES AND DEDUCTIONS," "Monthly Deduction From
Policy Value."
If you desire to have premium payments and investment performance reflected in
the amount of the Sum Insured, you should choose Option 2. If you desire premium
payments and investment performance reflected to the maximum extent in the
Policy Value, you should select Option 1.
ILLUSTRATIONS
For the purposes of the following illustrations, assume that the Insured is
under the Age of 40 and that there is no outstanding Debt.
ILLUSTRATION OF OPTION 1
Under Option 1, the Face Amount of the Policy generally will equal the Sum
Insured. If at any time, however, the Policy Value multiplied by the applicable
percentage is less than the Face Amount, the Sum Insured will equal the Face
Amount of the Policy.
For example, a Policy with a $50,000 Face Amount will generally have a Sum
Insured equal to $50,000. Because the Sum Insured must be equal to or greater
than 250% of Policy Value, however, if at any time the Policy Value exceeds
$20,000, the Sum Insured will exceed the $50,000 Face Amount. In this example,
each additional dollar of Policy Value above $20,000 will increase the Sum
Insured by $2.50. For example, a Policy with a Policy Value of $35,000 will have
a Guideline Minimum Sum Insured of $87,500 ($35,000 X 2.50); Policy Value of
$40,000 will produce a Guideline Minimum Sum Insured of $100,000 ($40,000 X
2.50); and Policy Value of $50,000 will produce a Guideline Minimum Sum Insured
of $125,000 ($50,000 X 2.50).
40
<PAGE>
Similarly, so long as Policy Value exceeds $20,000, each dollar taken out of
Policy Value will reduce the Sum Insured by $2.50. If, for example, the Policy
Value is reduced from $25,000 to $20,000 (because of partial withdrawals,
charges or negative investment performance), the Sum Insured will be reduced
from $62,500 to $50,000.
The applicable percentage becomes lower as the Insured's Age increases. If the
Insured's Age in the above example were, for example, 50 (rather than between 0
and 40), the applicable percentage would be 185%. The Sum Insured would not
exceed the $50,000 Face Amount unless the Policy Value exceeded $27,027 (rather
than $20,000), and each dollar then added to or taken from Policy Value would
change the Sum Insured by $1.85.
ILLUSTRATION OF OPTION 2
Under Option 2, the Sum Insured is generally equal to the Face Amount of the
Policy plus the Policy Value. The Sum Insured under Option 2, however, always
will be the greater of:
- the Face Amount plus Policy Value; or
- the Policy Value multiplied by the applicable percentage from the
Guideline Minimum Sum Insured Table.
For example, a Policy with a Face Amount of $50,000 and with Policy Value of
$5,000 will produce a Sum Insured of $55,000 ($50,000 + $5,000). Policy Value of
$10,000 will produce a Sum Insured of $60,000 ($50,000 + $10,000); Policy Value
of $25,000 will produce a Sum Insured of $75,000 ($50,000 + $25,000).
According to the Guideline Minimum Sum Insured Table, however, the Sum Insured
for the example must be at least 250% of the Policy Value. Therefore, if the
Policy Value is greater than $33,333, 250% of that amount will be the required
Sum Insured, which will be greater than the Face Amount plus Policy Value. In
this example, each additional dollar of Policy Value above $33,333 will increase
the Sum Insured by $2.50. For example, if the Policy Value is $35,000, the
Guideline Minimum Sum Insured will be $87,500 ($35,000 X 2.50); Policy Value of
$40,000 will produce a Guideline Minimum Sum Insured of $100,000 ($40,000 X
2.50); and Policy Value of $50,000 will produce a Guideline Minimum Sum Insured
of $125,000 ($50,000 X 2.50).
Similarly, if the Policy Value exceeds $33,333, each dollar taken out of the
Policy Value will reduce the Sum Insured by $2.50. If, for example, the Policy
Value is reduced from $45,000 to $40,000 because of partial withdrawals, charges
or negative investment performance, the Sum Insured will be reduced from
$112,500 to $100,000. If at any time, however, Policy Value multiplied by the
applicable percentage is less than the Face Amount plus Policy Value, then the
Sum Insured will be the current Face Amount plus the Policy Value.
The applicable percentage becomes lower as the Insured's Age increases. If the
Insured's Age in the above example were 50, the Sum Insured must be at least
1.85 times the Policy Value. The amount of the Sum Insured would be the sum of
the Policy Value plus $50,000 unless the Policy Value exceeded $58,824 (rather
than $33,000). Each dollar added to or subtracted from the Policy would change
the Sum Insured by $1.85.
CHANGE IN SUM INSURED OPTION
Generally, the Sum Insured Option in effect may be changed once each Policy year
by sending a Written Request for change to the Principal Office. Changing Sum
Insured Options will not require Evidence of Insurability. The effective date of
any such change will be the Monthly Payment Date on or following the date of
receipt of the request. No charges will be imposed on changes in Sum Insured
Options.
41
<PAGE>
CHANGE FROM OPTION 1 TO OPTION 2
If the Sum Insured Option is changed from Option 1 to Option 2, the Face Amount
will be decreased to equal the Sum Insured less the Policy Value on the
effective date of the change. This change may not be made if it would result in
a Face Amount of less than $40,000. A change from Option 1 to Option 2 will not
alter the amount of the Sum Insured at the time of the change, but will affect
the determination of the Sum Insured from that point on. Because the Policy
Value will be added to the new specified Face Amount, the Sum Insured will vary
with the Policy Value. Under Option 2, the Insurance Amount at Risk always will
equal the Face Amount unless the Guideline Minimum Sum Insured is in effect. The
cost of insurance also may be higher or lower than it otherwise would have been
without the change in Sum Insured Option. See "CHARGES AND DEDUCTIONS," "Monthly
Deduction from the Policy Value."
CHANGE FROM OPTION 2 TO OPTION 1
If the Sum Insured Option is changed from Option 2 to Option 1, the Face Amount
will be increased to equal the Sum Insured which would have been payable under
Option 2 on the effective date of the change (i.e., the Face Amount immediately
prior to the change plus the Policy Value on the date of the change). The amount
of the Sum Insured will not be altered at the time of the change. The change in
option, however, will affect the determination of the Sum Insured from that
point on, since the Policy Value no longer will be added to the Face Amount in
determining the Sum Insured; the Sum Insured will equal the new Face Amount (or,
if higher, the Guideline Minimum Sum Insured). The cost of insurance may be
higher or lower than it otherwise would have been since any increases or
decreases in Policy Value will reduce or increase, respectively, the Insurance
Amount at Risk under Option 1. Assuming a positive net investment return with
respect to any amounts in the Separate Account, changing the Sum Insured Option
from Option 2 to Option 1 will reduce the Insurance Amount at Risk and therefore
the cost of insurance charge for all subsequent Monthly Deductions, compared to
what such charge would have been if no such change were made.
A change in Sum Insured Option may result in total premiums paid exceeding the
then-current maximum premium limitation determined by IRS rules. In such event,
the Company will pay the excess to the Policyowner. See "THE POLICY," "Premium
Payments."
CHANGE IN THE FACE AMOUNT
Subject to certain limitations, you may increase or decrease the specified Face
Amount of a Policy at any time by submitting a Written Request to the Company.
Any increase or decrease in the specified Face Amount requested by you will
become effective on the Monthly Payment Date on or next following the date of
receipt of the request at the Principal Office or, if Evidence of Insurability
is required, the date of approval of the request.
INCREASES IN THE FACE AMOUNT
Along with the Written Request for an increase, you must submit satisfactory
Evidence of Insurability. The consent of the Insured also is required whenever
the Face Amount is increased. A request for an increase in the Face Amount may
not be less than $10,000. You may not increase the Face Amount after the Insured
reaches Age 85. An increase must be accompanied by an additional premium if the
Surrender Value is less than $50 plus an amount equal to the sum of two Minimum
Monthly Factors.
On the effective date of each increase in the Face Amount, a transaction charge
of $40 will be deducted from the Policy Value for administrative costs. The
effective date of the increase will be the first Monthly Payment Date on or
following the date all of the conditions for the increase are met.
An increase in the Face Amount generally will affect the Insurance Amount at
Risk, and may affect the portion of the Insurance Amount at Risk included in
various Premium Classes (if more than one Premium Class applies), both of which
may affect the monthly cost of insurance charges. A surrender charge also will
be calculated for the increase. See "CHARGES AND DEDUCTIONS," "Monthly
Deductions From the Policy Value" and "Surrender Charge."
42
<PAGE>
After increasing the Face Amount, you will have the right (1) during a Free-Look
Period, to have the increase canceled and the charges which would not have been
deducted but for the increase will be credited to the Policy, and (2) during the
first 24 months following the increase, to transfer any or all Policy Value to
the General Account free of charge. See "THE POLICY," "Free-Look Period" and
"Conversion Privileges." A refund of charges which would not have been deducted
but for the increase will be made at your request.
DECREASES IN THE FACE AMOUNT
The minimum amount for a decrease in the Face Amount is $10,000. The Face Amount
in force after any decrease may not be less than $50,000. If, following a
decrease in the Face Amount, the Policy would not comply with the maximum
premium limitation applicable under the IRS Rules, the decrease may be limited
or Policy Value may be returned to the Policyowner (at your election) to the
extent necessary to meet the requirements. A return of Policy Value may result
in tax liability to you.
A decrease in the Face Amount will affect the total Insurance Amount at Risk and
the portion of the Insurance Amount at Risk covered by various Premium Classes,
both of which may affect a Policyowner's monthly cost of insurance charges. See
"CHARGES AND DEDUCTIONS," "Monthly Deductions From the Policy Value." For
purposes of determining the cost of insurance charge, any decrease in the Face
Amount will reduce the Face Amount in the following order:
- the Face Amount provided by the most recent increase;
- the next most recent increases successively; and
- the initial Face Amount.
This order also will be used to determine whether a surrender charge will be
deducted and in what amount. If you request a decrease in the Face Amount, the
amount of any surrender charge deducted will reduce the current Policy Value.
You may specify one Sub-Account from which the surrender charge will be
deducted. If no specification is provided, the Company will make a Pro-Rata
Allocation. The current surrender charge will be reduced by the amount deducted.
See "CHARGES AND DEDUCTIONS," "Surrender Charge."
POLICY VALUE AND SURRENDER VALUE
The Policy Value is the total amount available for investment, and is equal to
the sum of:
- your accumulation in the General Account, plus
- the value of the Accumulation Units in the Sub-Accounts.
The Policy Value is used in determining the Surrender Value (the Policy Value
less any Debt and applicable surrender charges). See "THE POLICY," "Policy
Surrender." There is no guaranteed minimum Policy Value. Because the Policy
Value on any date depends upon a number of variables, it cannot be
predetermined.
The Policy Value and the Surrender Value will reflect the frequency and amount
of Net Premiums paid, interest credited to accumulations in the General Account,
the investment performance of the chosen Sub-Accounts, any partial withdrawals,
any loans, any loan repayments, any loan interest paid or credited, and any
charges assessed in connection with the Policy.
CALCULATION OF POLICY VALUE
The Policy Value is determined first on the Date of Issue and thereafter on each
Valuation Date. On the Date of Issue, the Policy Value will be the Net Premiums
received, plus any interest earned during the period when premiums are held in
the General Account (before being transferred to the Separate Account; see "THE
43
<PAGE>
POLICY," "Applying for a Policy") less any Monthly Deductions due. On each
Valuation Date after the Date of Issue the Policy Value will be:
- the aggregate of the values in each of the Sub-Accounts on the Valuation
Date, determined for each Sub-Account by multiplying the value of an
Accumulation Unit in that Sub-Account on that date by the number of such
Accumulations Units allocated to the Policy; PLUS
- the value in the General Account (including any amounts transferred to the
General Account with respect to a loan).
Thus, the Policy Value is determined by multiplying the number of Accumulation
Units in each Sub-Account by the value of the applicable Accumulation Units on
the particular Valuation Date, adding the products, and adding the amount of the
accumulations in the General Account, if any.
THE ACCUMULATION UNIT
Each Net Premium is allocated to the Sub-Account(s) selected by you. Allocations
to the Sub-Accounts are credited to the Policy in the form of Accumulation
Units. Accumulation Units are credited separately for each Sub-Account.
The number of Accumulation Units of each Sub-Account credited to the Policy is
equal to the portion of the Net Premium allocated to the Sub-Account, divided by
the dollar value of the applicable Accumulation Unit as of the Valuation Date
the payment is received at the Principal Office. The number of Accumulation
Units will remain fixed unless changed by a subsequent split of Accumulation
Unit value, transfer, partial withdrawal or Policy surrender. In addition, if
the Company is deducting the Monthly Deduction or other charges from a
Sub-Account, each such deduction will result in cancellation of a number of
Accumulation Units equal in value to the amount deducted.
The dollar value of an Accumulation Unit of each Sub-Account varies from
Valuation Date to Valuation Date based on the investment experience of that
Sub-Account. That experience, in turn, will reflect the investment performance,
expenses and charges of the respective Underlying Fund. The value of an
Accumulation Unit was set at $1.00 on the first Valuation Date for each
Sub-Account. The dollar value of an Accumulation Unit on a given Valuation Date
is determined by multiplying the dollar value of the corresponding Accumulation
Unit as of the immediately preceding Valuation Date by the appropriate net
investment factor.
NET INVESTMENT FACTOR
The net investment factor measures the investment performance of a Sub-Account
of the Separate Account during the Valuation Period just ended. The net
investment factor for each Sub-Account is equal to 1.0000 plus the number
arrived at by dividing (a) by (b) and subtracting (c) and (d) from the result,
where:
(a) is the investment income of that Sub-Account for the Valuation Period, plus
capital gains, realized or unrealized, credited during the Valuation Period;
minus capital losses, realized or unrealized, charged during the Valuation
Period; adjusted for provisions made for taxes, if any;
(b) is the value of that Sub-Account's assets at the beginning of the Valuation
Period;
(c) is a charge for each day in the Valuation Period equal, on an annual basis,
to 0.65% of the daily net asset value of that Sub-Account for mortality and
expense risks. This charge may be increased or decreased by the Company, but
may not exceed 0.90%; and
(d) is the Separate Account administrative charge for each day in the Valuation
Period equal, on an annual basis, to 0.15% of the daily net asset value of
that Sub-Account. The administrative charge may be increased or decreased by
the Company, but may not exceed 0.25%. This charge is applicable only during
the first ten Policy years.
44
<PAGE>
The net investment factor may be greater or less than one. Therefore, the value
of an Accumulation Unit may increase or decrease. You bear the investment risk.
Allocations to the General Account are not converted into Accumulation Units,
but are credited interest at a rate periodically set by the Company. See "MORE
INFORMATION ABOUT THE GENERAL ACCOUNT."
DEATH PROCEEDS PAYMENT OPTIONS
During the Insured's lifetime, you may arrange for the Death Proceeds to be paid
in a single sum or under one or more of the available payment options. The
payment options currently available are described in APPENDIX B, "DEATH PROCEEDS
PAYMENT OPTIONS." These choices also are available at the Final Premium Payment
Date and if the Policy is surrendered. The Company may make more payment options
available in the future.
If no election is made, the Company will pay the Death Proceeds in a single sum.
When the Death Proceeds are payable in a single sum, the Beneficiary may, within
one year of the Insured's death, select one or more of the payment options if no
payments have yet been made.
OPTIONAL INSURANCE BENEFITS
Subject to certain requirements, one or more of the optional insurance benefits
described in APPENDIX A, "OPTIONAL BENEFITS" may be added to a Policy by rider.
The cost of any optional insurance benefits will be deducted as part of the
Monthly Deductions. See "CHARGES AND DEDUCTIONS," "Monthly Deductions From the
Policy Value."
POLICY SURRENDER
You may surrender the Policy at any time and receive its Surrender Value. The
Surrender Value is equal to:
- the Policy Value, MINUS
- any Debt and applicable surrender charges.
The Surrender Value will be calculated as of the Valuation Date on which a
written request for surrender is received at the Principal Office. A surrender
charge is calculated upon issuance of the Policy and from the effective date of
any increase in the Face Amount. The duration of the surrender charge is 15
years for issue Ages 0 through 50, grading down to 10 years for issue Ages 55
and above. See "CHARGES AND DEDUCTIONS," "Surrender Charge."
The proceeds on surrender may be paid in a single lump sum or under one of the
payment options described in APPENDIX B, "DEATH PROCEEDS PAYMENT OPTIONS."
Normally, the Company will pay the Surrender Value within seven days following
the Company's receipt of the surrender request, but the Company may delay
payment under the circumstances described in "OTHER POLICY PROVISIONS,"
"Postponement Of Payments."
The surrender rights of Policyowners who are participants under Section 403(b)
plans or who are participants in the Texas Optional Retirement Program (Texas
ORP) are restricted; see "FEDERAL TAX CONSIDERATIONS," "POLICIES ISSUED IN
CONNECTION WITH TSA PLANS."
For important tax consequences which may result from surrender, see "FEDERAL TAX
CONSIDERATIONS."
45
<PAGE>
PARTIAL WITHDRAWALS
Any time after the first Policy year, you may withdraw a portion of the
Surrender Value of your Policy, subject to the limits stated below, upon written
request filed at the Principal Office. The written request must indicate the
dollar amount you wish to receive and the Accounts from which such amount is to
be withdrawn. You may allocate the amount withdrawn among the Sub-Accounts and
the General Account. If you do not provide allocation instructions, the Company
will make a Pro-Rata Allocation. Each partial withdrawal must be in a minimum
amount of $500.
Under Option 1, the Face Amount is reduced by the amount of the withdrawal, and
a withdrawal will not be allowed if it would reduce the Face Amount below
$40,000.
A withdrawal from a Sub-Account will result in the cancellation of the number of
Accumulation Units equivalent in value to the amount withdrawn. The amount
withdrawn equals the amount requested by you plus the transaction charge and any
applicable partial withdrawal charge as described under "CHARGES AND
DEDUCTIONS," "Charges On Partial Withdrawal." Normally, the Company will pay the
amount of the partial withdrawal within seven days following the Company's
receipt of the partial withdrawal request, but the Company may delay payment
under certain circumstances described in "OTHER POLICY PROVISIONS,"
"Postponement of Payments."
The withdrawal rights of Policyowners who are participants under Section 403(b)
plans or who are participants in the Texas Optional Retirement Program (Texas
ORP) are restricted; see "FEDERAL TAX CONSIDERATIONS -- POLICIES ISSUED IN
CONNECTION WITH TSA PLANS." For important tax consequences which may result from
partial withdrawals, see "FEDERAL TAX CONSIDERATIONS."
CHARGES AND DEDUCTIONS
Charges will be deducted in connection with the Policy to compensate the Company
for providing the insurance benefits set forth in the Policy and any additional
benefits added by rider, administering the Policy, incurring distribution
expenses, and assuming certain risks in connection with the Policy. Each of the
charges identified as an administrative charge is intended to reimburse the
Company for actual administrative costs incurred, and is not intended to result
in a profit to the Company.
The Company may waive or reduce the premium tax charge, administrative charges,
surrender charge, or 5% partial withdrawal charge, and will not pay commissions
on Policies, where the Insured is within the following class of individuals:
All employees of First Allmerica and its affiliates and subsidiaries located
at First Allmerica's home office (or at off-site locations if such employees
are on First Allmerica's home office payroll); all directors of First
Allmerica and its affiliates and subsidiaries; all retired employees of
First Allmerica and its affiliates and subsidiaries eligible under First
Allmerica Companies' Pension Plan or any successor plan; all General Agents,
agents and field staff of First Allmerica; and all spouses, children,
siblings, parents and grandparents of any individuals identified above, who
reside in the same household.
TAX EXPENSE CHARGE
Currently, a deduction of 3 1/2% of premiums for state and local premium taxes
and federal taxes imposed for deferred acquisition costs ("DAC taxes") is made
from each premium payment. The premium payment, less the tax expense charge,
equals the Net Premium. The total charge is a combined state and local premium
tax deduction of 2 1/2% of premiums and a DAC tax deduction of 1% of premiums.
46
<PAGE>
While the premium tax of 2 1/2% is deducted from each premium payment, some
jurisdictions may not impose premium taxes. Premium taxes vary from state to
state, ranging from zero to 4.0%, and the 2 1/2% rate attributable to premiums
for state and local premium taxes approximates the average expenses to the
Company associated with the premium taxes. The 2 1/2% charge may be higher or
lower than the actual premium tax imposed by the applicable jurisdiction. The
Company, however, does not expect to make a profit from this charge.
The 1% rate attributable to premiums for DAC taxes approximates the Company's
expenses in paying federal taxes for deferred acquisition costs associated with
the Policy. The Company reserves the right to increase or decrease the DAC tax
charge to reflect changes in the Company's expenses for premium taxes and DAC
taxes.
MONTHLY DEDUCTION FROM THE POLICY VALUE
Prior to the Final Premium Payment Date, a Monthly Deduction from the Policy
Value will be made to cover a charge for the cost of insurance, a charge for any
optional insurance benefits added by rider, and a monthly administrative charge.
The cost of insurance charge and the monthly administrative charge is discussed
below. The Monthly Deduction on or following the effective date of a requested
increase in the Face Amount also will include a $40 administrative charge for
the increase. See "THE POLICY," "Change In the Face Amount."
Prior to the Final Premium Payment Date, the Monthly Deduction will be deducted
as of each Monthly Payment Date commencing with the Date of Issue of the Policy.
It will be allocated to one Sub-Account according to your instructions or, if no
allocation is specified, the Company will make a Pro-Rata Allocation. If the
Sub-Account you specify does not have sufficient funds to cover the Monthly
Deduction, the Company will deduct the charge for that month as if no
specification were made. If, however, on subsequent Monthly Payment Dates there
is sufficient Policy Value in the Sub-Account you specified, the Monthly
Deduction will be deducted from that Sub-Account. No Monthly Deductions will be
made on or after the Final Premium Payment Date.
COST OF INSURANCE
This charge is designed to compensate the Company for the anticipated cost of
providing Death Proceeds to Beneficiaries of those Insureds who die prior to the
Final Premium Payment Date. The cost of insurance is determined on a monthly
basis, and is determined separately for the initial Face Amount, for each
subsequent increase in the Face Amount, and for riders. Because the cost of
insurance depends upon a number of variables, it can vary from month to month.
CALCULATION OF THE CHARGE
If you select Sum Insured Option 2, the monthly cost of insurance charge for the
initial Face Amount generally will equal the applicable cost of insurance rate
multiplied by the initial Face Amount. If you select Sum Insured Option 1,
however, the applicable cost of insurance rate will be multiplied by the initial
Face Amount less the Policy Value (minus charges for rider benefits) at the
beginning of the Policy month. Thus, the cost of insurance charge may be greater
for Policyowners who have selected Sum Insured Option 2 than for those who have
selected Sum Insured Option 1 ( assuming the same Face Amount in each case and
assuming that the Guideline Minimum Sum Insured is not in effect). In other
words, since the Sum Insured under Option 1 remains constant while the Sum
Insured under Option 2 varies with the Policy Value, any Policy Value increases
will reduce the insurance charge under Option 1 but not under Option 2.
If you select Sum Insured Option 2, the monthly insurance charge for each
increase in Face Amount (other than an increase caused by a change in Sum
Insured Option) will be equal to the cost of insurance rate applicable to that
increase multiplied by the increase in the Face Amount. If you select Sum
Insured Option 1, the applicable cost of insurance rate will be multiplied by
the increase in the Face Amount reduced by any Policy Value (minus rider
charges) in excess of the initial Face Amount at the beginning of the Policy
month.
47
<PAGE>
EFFECT OF THE GUIDELINE MINIMUM SUM INSURED
If the Guideline Minimum Sum Insured is in effect under either Option, a monthly
cost of insurance charge also will be calculated for that additional portion of
the Sum Insured which is required to comply with the Guideline rules. This
charge will be calculated by:
- multiplying the cost of insurance rate applicable to the initial Face
Amount times the Guideline Minimum Sum Insured (Policy Value times the
applicable percentage), MINUS
- the greater of the Face Amount or the Policy Value (if you selected Sum
Insured Option 1)
OR
- the Face Amount PLUS the Policy Value (if you selected Sum Insured
Option 2).
When the Guideline Minimum Sum Insured is in effect, the cost of insurance
charge for the initial Face Amount and for any increases will be calculated as
set forth above. The monthly cost of insurance charge also will be adjusted for
any decreases in the Face Amount. See "THE POLICY," "Change In the Face Amount."
COST OF INSURANCE RATES
Cost of insurance rates are based on male, female or a blended unisex rate
table, Age and Premium Class of the Insured, the effective date of an increase
or date of rider, as applicable, the amount of premiums paid less Debt, any
partial withdrawals and withdrawal charges, risk classification and the
Incentive Funding Discount, if applicable. For those Policies issued on a unisex
basis in certain states or in certain cases, sex-distinct rates do not apply.
The cost of insurance rates are determined at the beginning of each Policy year
for the initial Face Amount. The cost of insurance rates for an increase in the
Face Amount or rider are determined annually on the anniversary of the effective
date of each increase or rider. The cost of insurance rates generally increase
as the Insured's Age increases. The actual monthly cost of insurance rates will
be based on the Company's expectations as to future mortality experience. They
will not, however, be greater than the guaranteed cost of insurance rates set
forth in the Policy. These guaranteed rates are based on the 1980 Commissioners
Standard Ordinary Mortality Tables, Smoker or Non-Smoker (Mortality Table B for
unisex Policies) and the Insured's sex and Age. The Tables used for this purpose
set forth different mortality estimates for males and females and for smokers
and non-smokers. Any change in the cost of insurance rates will apply to all
persons of the same insuring Age, sex and Premium Class whose Policies have been
in force for the same length of time.
The Premium Class of an Insured will affect the cost of insurance rates. The
Company currently places Insureds into preferred Premium Classes, standard
Premium Classes and substandard Premium Classes. In an otherwise identical
Policy, an Insured in the preferred Premium Class will have a lower cost of
insurance than an Insured in a standard Premium Class who, in turn, will have a
lower cost of insurance than an Insured in a substandard Premium Class with a
higher mortality risk.
Premium Classes also are divided into two categories: smokers and non-smokers.
Non-smoking Insureds will incur lower cost of insurance rates than Insureds who
are classified as smokers but who are otherwise in the same Premium Class. Any
Insured with an Age at issuance under 18 will be classified initially as regular
or substandard. The Insured then will be classified as a smoker at Age 18 unless
the Insured provides satisfactory evidence that the Insured is a non-smoker. The
Company will provide notice to you of the opportunity for the Insured to be
classified as a non-smoker when the Insured reaches Age 18.
The cost of insurance rate is determined separately for the initial Face Amount
and for the amount of any increase in the Face Amount. For each increase in the
Face Amount you request, at a time when the Insured is in a less favorable
Premium Class than previously, a correspondingly higher cost of insurance rate
will apply only to that portion of the Insurance Amount at Risk for the
increase. For the initial Face Amount and any prior
48
<PAGE>
increases, the Company will use the Premium Class previously applicable. On the
other hand, if the Insured's Premium Class improves on an increase, the lower
cost of insurance rate generally will apply to the entire Insurance Amount at
Risk.
MONTHLY ADMINISTRATIVE CHARGES
Prior to the Final Premium Payment Date, a monthly administrative charge of $5
per month will be deducted from the Policy Value. This charge will be used to
compensate the Company for expenses incurred in the administration of the
Policy, and will compensate the Company for first-year underwriting and other
start-up expenses incurred in connection with the Policy. These expenses include
the cost of processing applications, conducting medical examinations,
determining insurability and the Insured's Premium Class, and establishing
Policy records. The Company does not expect to derive a profit from these
charges.
CHARGES AGAINST ASSETS OF THE SEPARATE ACCOUNT
The Company assesses each Sub-Account with a charge for mortality and expense
risks assumed by the Company, and a charge for administrative expenses of the
Separate Account.
MORTALITY AND EXPENSE RISK CHARGE
The Company currently makes a charge on an annual basis of 0.65% of the daily
net asset value in each Sub-Account. This charge is for the mortality risk and
expense risk which the Company assumes in relation to the variable portion of
the Policy. The total charges may be increased or decreased by the Board of
Directors of the Company once each year, subject to compliance with applicable
state and federal requirements, but it may not exceed 0.90% on an annual basis.
The mortality risk assumed by the Company is that Insureds may live for a
shorter time than anticipated, and that the Company therefore will pay an
aggregate amount of Death Proceeds greater than anticipated. The expense risk
assumed is that the expenses incurred in issuing and administering the Policy
will exceed the amounts realized from the administrative charges provided in the
Policy. If the charge for mortality and expense risks is not sufficient to cover
actual mortality experience and expenses, the Company will absorb the losses. If
costs are less than the amounts provided, the difference will be a profit to the
Company. To the extent this charge results in a current profit to the Company,
such profit will be available for use by the Company for, among other things,
the payment of distribution, sales and other expenses. Since mortality and
expense risks involve future contingencies which are not subject to precise
determination in advance, it is not feasible to identify specifically the
portion of the charge which is applicable to each.
ADMINISTRATIVE CHARGE
During the first ten Policy years, the Company assesses a charge on an annual
basis of 0.15% of the daily net asset value in each Sub-Account. The charge is
assessed to help defray administrative expenses actually incurred in the
administration of the Separate Account and the Sub-Accounts. The administrative
functions and expenses assumed by the Company in connection with the Separate
Account and the Sub-Accounts include, but are not limited to, clerical,
accounting, actuarial and legal services, rent, postage, telephone, office
equipment and supplies, expenses of preparing and printing registration
statements, expenses of preparing and typesetting prospectuses, and the cost of
printing prospectuses not allocable to sales expense, filing and other fees. No
Separate Account administrative charge is imposed after the tenth Policy year.
The charge may be increased or decreased by the Board of Directors of the
Company, subject to compliance with applicable state and federal requirements,
but it may not exceed 0.25% on an annual basis.
OTHER CHARGES AND EXPENSES
Because the Sub-Accounts purchase shares of the Underlying Funds, the value of
the Accumulation Units of the Sub-Accounts will reflect the investment advisory
fee and other expenses incurred by the Underlying Funds. The prospectuses and
statements of additional information of the Trust, Fidelity VIP, Fidelity VIP
II, T. Rowe Price and DGPF contain additional information concerning such fees
and expenses.
49
<PAGE>
Currently, no charges are made against the Sub-Accounts for federal or state
income taxes. Should the Company determine that taxes will be imposed, the
Company may make deductions from the Sub-Account to pay such taxes. See "FEDERAL
TAX CONSIDERATIONS." The imposition of such taxes would result in a reduction of
the Policy Value in the Sub-Accounts.
SURRENDER CHARGE
The Policy provides for a contingent surrender charge. A separate surrender
charge is calculated upon the issuance of the Policy and for each increase in
the Face Amount. A surrender charge may be deducted if you request a full
surrender of the Policy or a decrease in the Face Amount.
The surrender charge is comprised of a contingent deferred administrative charge
and a contingent deferred sales charge. The contingent deferred administrative
charge compensates the Company for expenses incurred in administering the
Policy. The contingent deferred sales charge compensates the Company for
expenses relating to the distribution of the Policy, including agents'
commissions, advertising and the printing of the prospectus and sales
literature.
The duration of the surrender charge is 15 years from the Date of Issue or from
the effective date of any increase in the Face Amount for issue Ages 0 through
50, grading down to 10 years for issue Ages 55 and above.
The maximum surrender charge calculated upon issuance of the Policy is equal to
the sum of (a) plus (b) where:
(a) is a deferred administrative charge equal to $8.50 per thousand dollars of
the initial Face Amount, and
(b) is a deferred sales charge of 49% of premiums received, up to a maximum
number of Guideline Annual Premiums subject to the deferred sales charge
that varies by issue Age from 1.660714 (for Ages 0 through 55) to 0.948980
(for Age 80).
In accordance with limitations under state insurance regulations, the amount of
the maximum surrender charge will not exceed a specified amount per $1,000
initial face Amount, as indicated in "APPENDIX D -- CALCULATION OF MAXIMUM
SURRENDER CHARGES." The maximum surrender charge continues in a level amount for
40 Policy months, and reduces by 0.5% or more per month (depending on issue Age)
thereafter, as described in "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER
CHARGES." This reduction in the maximum surrender charge will reduce the
deferred sales charge and the deferred administrative charge proportionately.
MAXIMUM SURRENDER CHARGE DURING FIRST TWO POLICY YEARS
If you surrender the Policy during the first two Policy years following the Date
of Issue before making premium payments associated with the initial Face Amount
which are at least equal to one Guideline Annual Premium, the deferred
administrative charge will be $8.50 per thousand dollars of the initial Face
Amount, as described above, but the deferred sales charge will not exceed 29% of
premiums received, up to one Guideline Annual Premium, plus 9% of premiums
received in excess of one Guideline Annual Premium, but less than the maximum
number of Guideline Annual Premiums subject to the deferred sales charge. See
"APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER CHARGES."
SEPARATE SURRENDER CHARGE FOR EACH FACE AMOUNT INCREASE
A separate surrender charge will apply to and is calculated for each increase in
the Face Amount. The surrender charge for the increase is in addition to that
for the initial Face Amount. The maximum surrender charge for the increase is
equal to the sum of (a) plus (b), where (a) is equal to $8.50 per thousand
dollars of increase, and (b) is a deferred sales charge of 49% of premiums
associated with the increase, up to a maximum number of Guideline Annual
Premiums (for the increase) subject to the deferred sales charge that varies by
Age (at the time of increase) from 1.660714 (for Ages 0 through 55) to 0.948980
(for Age 80).
50
<PAGE>
In accordance with limitations under state insurance regulations, the amount of
the Surrender charge will not exceed a specified amount per $1,000 of increase,
as indicated in "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER CHARGES." As is
true for the initial Face Amount, (a) is a deferred administrative charge, and
(b) is a deferred sales charge. The maximum surrender charge for the increase
continues in a level amount for 40 Policy months, and reduces by 0.5% or more
per month (depending on Age) thereafter, as provided in "APPENDIX D --
CALCULATION OF MAXIMUM SURRENDER CHARGES."
REDUCED CHARGE DURING FIRST TWO YEARS FOLLOWING INCREASE
During the first two Policy years following an increase in the Face Amount
before making premium payments associated with the increase in the Face Amount
which are at least equal to one Guideline Annual Premium, the deferred
administrative charge will be $8.50 per thousand dollars of the Face Amount
increase, as described above, but the deferred sales charge imposed will be less
than the maximum described above. Upon such a surrender, the deferred sales
charge will not exceed 29% of premiums associated with the increase, up to one
Guideline Annual Premium (for the increase), plus 9% of premiums associated with
the increase in excess of one Guideline Annual Premium, but less than the
maximum number of Guideline Annual Premiums (for the increase) subject to the
deferred sales charge. See "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER
CHARGES." The premiums associated with the increase are determined as described
below.
Additional premium payments may not be required to fund a requested increase in
the Face Amount. Therefore, a special rule, which is based on relative Guideline
Annual Premium payments, applies to allocate a portion of the existing Policy
Value to the increase, and to allocate subsequent premium payments between the
initial Policy and the increase. For example, suppose the Guideline Annual
Premium is equal to $1,500 before an increase, and is equal to $2,000 as a
result of the increase. The Policy Value on the effective date of the increase
would be allocated 75% ($1,500/$2,000) to the initial Face Amount and 25% to the
increase. All future premiums also would be allocated 75% to the initial Face
Amount and 25% to the increase. Thus, existing Policy Value associated with the
increase will equal the portion of the Policy Value allocated to the increase on
the effective date of the increase, before any deductions are made. Premiums
associated with the increase will equal the portion of the premium payments
actually made on or after the effective date of the increase which are allocated
to the increase.
See "APPENDIX D -- CALCULATION OF MAXIMUM SURRENDER CHARGES," for examples
illustrating the calculation of the maximum surrender charge for the initial
Face Amount and for any increases, as well as for the surrender charge based on
actual premiums paid or associated with any increases.
POSSIBLE SURRENDER CHARGE ON A FACE AMOUNT DECREASE
A surrender charge may be deducted on a decrease in the Face Amount. In the
event of a decrease, the surrender charge deducted is a fraction of the charge
that would apply to a full surrender of the Policy. The fraction will be
determined by dividing the amount of the decrease by the current Face Amount and
multiplying the result by the surrender charge. If more than one surrender
charge is in effect (i.e., pursuant to one or more increases in the Face Amount
of a Policy), the surrender charge will be applied in the following order:
- the most recent increase;
- the next most recent increases successively, and
- the initial Face Amount.
Where a decrease causes a partial reduction in an increase or in the initial
Face Amount, a proportionate share of the surrender charge for that increase or
for the initial Face Amount will be deducted.
51
<PAGE>
CHARGES ON PARTIAL WITHDRAWAL
Partial withdrawals of Surrender Value may be made after the first Policy year.
The minimum withdrawal is $500. Under Option 1, the Face Amount is reduced by
the amount of the partial withdrawal, and a partial withdrawal will not be
allowed if it would reduce the Face Amount below $40,000.
A transaction charge, which is the smaller of 2% of the amount withdrawn or $25,
will be assessed on each partial withdrawal to reimburse the Company for the
cost of processing the withdrawal. The Company does not expect to make a profit
on this charge.
A partial withdrawal charge also may be deducted from the Policy Value. For each
partial withdrawal you may withdraw an amount equal to 10% of the Policy Value
on the date the written withdrawal request is received by the Company less the
total of any prior withdrawals in that Policy year which were not subject to the
Partial Withdrawal charge, without incurring a partial withdrawal charge. Any
partial withdrawal in excess of this amount ("excess withdrawal") will be
subject to the partial withdrawal charge. The partial withdrawal charge is equal
to 5% of the excess withdrawal up to the amount of the surrender charge(s) on
the date of withdrawal. This right is not cumulative from Policy year to Policy
year. For example, if only 8% of Policy Value were withdrawn in Policy year two,
the amount you could withdraw in subsequent Policy years would not be increased
by the amount you did not withdraw in the second Policy year.
The Policy's outstanding surrender charge will be reduced by the amount of the
partial withdrawal charge deducted by proportionately reducing the deferred
sales charge component and the deferred administrative charge component. The
partial withdrawal charge deducted will decrease existing surrender charges in
the following order:
- first, the surrender charge for the most recent increase in the Face
Amount;
- second, the surrender charge for the next most recent increases
successively;
- last, the surrender charge for the initial Face Amount.
TRANSFER CHARGES
The first 12 transfers in a Policy year will be free of charge. Thereafter, a
transfer charge of $10 will be imposed for each transfer request to reimburse
the Company for the administrative costs incurred in processing the transfer
request. The Company reserves the right to increase the charge, but it never
will exceed $25. The Company also reserves the right to change the number of
free transfers allowed in a Policy year. See "THE POLICY," "Transfer Privilege."
You may have automatic transfers of at least $100 a month made on a periodic
basis:
- from the Sub-Accounts which invest in the Money Market Fund and Government
Bond Fund of the Trust to one or more of the other Sub-Accounts; or
- to reallocate Policy Value among the Sub-Accounts.
The first automatic transfer counts as one transfer towards the 12 free
transfers allowed in each Policy year. Each subsequent automatic transfer is
without charge and does not reduce the remaining number of transfers which may
be made without charge.
If you utilize the Conversion Privilege, Loan Privilege or reallocate Policy
Value within 20 days of the Date of Issue of the Policy, any resulting transfer
of Policy Value from the Sub-Accounts to the General Account will
52
<PAGE>
be free of charge, and in addition to the 12 free transfers in a Policy year.
See "THE POLICY," "Conversion Privileges," and "POLICY LOANS."
CHARGE FOR INCREASE IN THE FACE AMOUNT
For each increase in the Face Amount you request, a transaction charge of $40
will be deducted from Policy Value to reimburse the Company for administrative
costs associated with the increase. This charge is guaranteed not to increase
and the Company does not expect to make a profit on this charge.
OTHER ADMINISTRATIVE CHARGES
The Company reserves the right to impose a charge guaranteed not to exceed $25,
for the administrative costs incurred for changing the Net Premium allocation
instructions, for changing the allocation of any Monthly Deductions among the
various Sub-Accounts, or for a projection of values.
POLICY LOANS
You may borrow against the Policy Value. Policy loans may be obtained by request
to the Company on the sole security of the Policy. The total amount which may be
borrowed is the Loan Value.
In the first Policy year, the Loan Value is 75% of Policy Value reduced by
applicable surrender charges, as well as Monthly Deductions and interest on Debt
to the end of the Policy year. The Loan Value in the second Policy year and
thereafter is 90% of an amount equal to the Policy Value reduced by applicable
surrender charges. There is no minimum limit on the amount of the loan.
The loan amount normally will be paid within seven days after the Company
receives the loan request at the Principal Office, but the Company may delay
payments under certain circumstances. See "OTHER POLICY PROVISIONS,"
"Postponement of Payments."
A Policy loan may be allocated among the General Account and one or more
Sub-Accounts. If you do not make an allocation, the Company will make a Pro-Rata
Allocation based on the amounts in the Accounts on the date the Company receives
the loan request. The Policy Value in each Sub-Account equal to the Policy loan
allocated to such Sub-Account will be transferred to the General Account, and
the number of Accumulation Units equal to the Policy Value so transferred will
be canceled. This will reduce the Policy Value in these Sub-Accounts. These
transactions are not treated as transfers for purposes of the transfer charge.
The Policy loan rights of Policyowners who are participants under Section 403(b)
plans are restricted; see "FEDERAL TAX CONSIDERATIONS -- POLICIES ISSUED IN
CONNECTION WITH TSA PLANS.
LOAN INTEREST
LOAN AMOUNT EARNS INTEREST IN GENERAL ACCOUNT
As long as the Policy is in force, the Policy Value in the General Account equal
to the loan amount will be credited with interest at an effective annual yield
of at least 6.00% per year.
PREFERRED LOAN OPTION
A preferred loan option is available under the Policy. The preferred loan option
will be available upon written request. It may be revoked by you at any time. If
this option has been selected, after the tenth Policy anniversary the Policy
Value in the General Account that is equal to the loan amount will be credited
with interest at an effective annual yield of at least 7.5%. The Company's
current position is to credit a rate of interest equal to the rate being charged
for the preferred loan.
53
<PAGE>
There is some uncertainty as to the tax treatment of preferred loans. Consult a
qualified tax adviser (and see "FEDERAL TAX CONSIDERATIONS"). THE PREFERRED LOAN
OPTION IS NOT AVAILABLE IN ALL STATES.
LOAN INTEREST CHARGED
Outstanding Policy loans are charged interest. Interest accrues daily and is
payable in arrears at the annual rate of 8%. Interest is due and payable at the
end of each Policy year or on a pro-rata basis for such shorter period as the
loan may exist. Interest not paid when due will be added to the loan amount and
will bear interest at the same rate. If the new loan amount exceeds the Policy
Value in the General Account after the due and unpaid interest is added to the
loan amount, the Company will the transfer Policy Value equal to that excess
loan amount from the Policy Value in each Sub-Account to the General Account as
security for the excess loan amount. The Company will allocate the amount
transferred among the Sub-Accounts in the same proportion that the Policy Value
in each Sub-Account bears to the total Policy Value in all Sub-Accounts.
REPAYMENT OF LOANS
Loans may be repaid at any time prior to the lapse of the Policy. Upon repayment
of the Debt, the portion of the Policy Value that is in the General Account
securing the loan repaid will be allocated to the various Accounts and increase
the Policy Value in such accounts in accordance with your instructions. If you
do not make a repayment allocation, the Company will allocate Policy Value in
accordance with your most recent premium allocation instructions; provided,
however, that loan repayments allocated to the Separate Account cannot exceed
the Policy Value previously transferred from the Separate Account to secure the
Debt.
If Debt exceeds the Policy Value less the surrender charge, the Policy will
terminate. A notice of such pending termination will be mailed to the last known
address of you and any assignee. If you do not make sufficient payment within 62
days after this notice is mailed, the Policy will terminate with no value. See
"POLICY TERMINATION AND REINSTATEMENT."
EFFECT OF POLICY LOANS
Although Policy loans may be repaid at any time prior to the lapse of the
Policy, Policy loans will permanently affect the Policy Value and Surrender
Value, and may permanently affect the Death Proceeds. The effect could be
favorable or unfavorable, depending upon whether the investment performance of
the Sub-Account(s) is less than or greater than the interest credited to the
Policy Value in the General Account attributable to the loan. Moreover,
outstanding Policy loans and the accrued interest will be deducted from the
proceeds payable upon the death of the Insured or surrender.
POLICIES ISSUED IN CONNECTION WITH TSA PLANS
Policies loans are permitted in accordance with the terms of the Policy.
However, if a Policy loan does not comply with the requirements of Code Section
72(p), the Policyowner's TSA plan may become disqualified and Policy values may
be includible in current income. Policy loans must meet the following additional
requirements:
- Loans must be repaid within five (5) years, except when the loan is used
to acquire any dwelling unit which within a reasonable time is to be used
as the Policyowner's principal residence.
- All Policy loans must be amortized on a level basis with loan repayments
being made not less frequently than quarterly.
- The sum of all outstanding loan balances for all loans from all the
Policyowner's TSA plans may not exceed the lesser of:
- $50,000 reduced by the excess (if any) of
54
<PAGE>
- the highest outstanding balance of loans from all of the
Policyowner's TSA plans during the one-year period preceding the
date of the loan, minus
- the outstanding balance of loans from the Policyowner's TSA plans
on the date on which such loan was made
OR
- 50% of the Policyowner's non-forfeitable accrued benefit in all of
his/her TSA plans, but not less than $10,000.
See "FEDERAL TAX CONSIDERATIONS" -- POLICIES ISSUED IN CONNECTION WITH TSA
PLANS.
POLICY TERMINATION AND REINSTATEMENT
TERMINATION
The failure to make premium payments will not cause the Policy to lapse unless:
(a) the Surrender Value is insufficient to cover the next Monthly Deduction plus
loan interest accrued; or
(b) the Debt exceeds the Policy Value less surrender charges.
If one of these situations occurs, the Policy will be in default. You then will
have a grace period of 62 days, measured from the date of default, to make
sufficient payments to prevent termination. On the date of default, the Company
will send a notice to you and to any assignee of record. The notice will state
the amount of premium due and the date on which it is due.
Failure to make a sufficient payment within the grace period will result in
termination of the Policy. If the Insured dies during the grace period, the
Death Proceeds still will be payable, but any Monthly Deductions due and unpaid
through the Policy month in which the Insured dies, and any other overdue
charge, will be deducted from the Death Proceeds.
LIMITED 48-MONTH GUARANTEE
Except for the situation described in (b) above, the Policy is guaranteed not to
lapse during the first 48 months after the Date of Issue or the effective date
of an increase in the Face Amount if you make a minimum amount of premium
payments. The minimum amount paid, minus the Debt, partial withdrawals and
partial withdrawal charges, must be at least equal to the sum of the Minimum
Monthly Factors for the number of months the Policy, increase, or a Policy
Change which causes a change in the Minimum Monthly Factor has been in force. A
Policy Change which may cause a change in the amount of the Minimum Monthly
Factor is a change in the Face Amount or the addition or deletion of a rider.
Except for the first 48 months after the Date of Issue or the effective date of
an increase, payments equal to the Minimum Monthly Factor do not guarantee that
the Policy will remain in force. However, see "THE POLICY," "Guaranteed Death
Benefit Rider."
REINSTATEMENT
If the Policy has not been surrendered and the Insured is alive, the terminated
Policy may be reinstated any time within three years after the date of default
and before the Final Premium Payment Date. The reinstatement will be effective
on the Monthly Payment Date following the date you submit the following to the
Company:
- a written application for reinstatement,
55
<PAGE>
- Evidence of Insurability showing that the Insured is insurable according
to the Company's underwriting rules, and
- a premium that, after the deduction of the tax expense charge, is large
enough to cover the minimum amount payable, as described below.
MINIMUM AMOUNT PAYABLE
If reinstatement is requested when fewer than 48 Monthly Deductions have been
made since the Date of Issue or the effective date of an increase in the Face
Amount, you must pay the lesser of the amount shown in A or B. Under A, the
minimum amount payable is the Minimum Monthly Factor for the three-month period
beginning on the date of reinstatement. Under B, the minimum amount payable is
the sum of:
- the amount by which the surrender charge as of the date of reinstatement
exceeds the Policy Value on the date of default, PLUS
- Monthly Deductions for the three-month period beginning on the date of
reinstatement.
If reinstatement is requested after 48 Monthly Deductions have been made since
the Date of Issue of the Policy or any increase in the Face Amount, you must pay
the amount shown in B above. The Company reserves the right to increase the
Minimum Monthly Factor upon reinstatement.
SURRENDER CHARGE
The surrender charge on the date of reinstatement is the surrender charge which
would have been in effect had the Policy remained in force from the Date of
Issue. The Policy Value less Debt on the date of default will be restored to the
Policy to the extent it does not exceed the surrender charge on the date of
reinstatement. Any Policy Value less the Debt as of the date of default which
exceeds the surrender charge on the date of reinstatement will not be restored.
POLICY VALUE ON REINSTATEMENT
The Policy Value on the date of reinstatement is:
- the Net Premium paid to reinstate the Policy increased by interest from
the date the payment was received at the Principal Office, PLUS
- an amount equal to the Policy Value less Debt on the date of default to
the extent it does not exceed the surrender charge on the date of
reinstatement, MINUS
- the Monthly Deduction due on the date of reinstatement.
You may not reinstate any Debt outstanding on the date of default or
foreclosure.
OTHER POLICY PROVISIONS
The following Policy provisions may vary in certain states in order to comply
with requirements of the insurance laws, regulations and insurance regulatory
agencies in those states.
POLICYOWNER
The Policyowner is the Insured unless another Policyowner has been named in the
application for the Policy. The Policyowner generally is entitled to exercise
all rights under the Policy while the Insured is alive, subject to the consent
of any irrevocable Beneficiary (the consent of a revocable Beneficiary is not
required). The consent of the Insured is required whenever the Face Amount of
insurance is increased.
56
<PAGE>
BENEFICIARY
The Beneficiary is the person or persons to whom the insurance proceeds are
payable upon the Insured's death. Unless otherwise stated in the Policy, the
Beneficiary has no rights in the Policy before the death of the Insured. While
the Insured is alive, you may change any Beneficiary unless you have declared a
Beneficiary to be irrevocable. If no Beneficiary is alive when the Insured dies,
the Policyowner (or the Policyowner's estate) will be the Beneficiary. If more
than one Beneficiary is alive when the Insured dies, they will be paid in equal
shares, unless you have chosen otherwise. Where there is more than one
Beneficiary, the interest of a Beneficiary who dies before the Insured will pass
to surviving Beneficiaries proportionally, unless otherwise requested.
INCONTESTABILITY
The Company will not contest the validity of the Policy after it has been in
force during the Insured's lifetime for two years from the Date of Issue. The
Company will not contest the validity of any increase in the Face Amount after
such increase or rider has been in force during the Insured's lifetime for two
years from its effective date.
SUICIDE
The Death Proceeds will not be paid if the Insured commits suicide, while sane
or insane, within two years from the Date of Issue. Instead, the Company will
pay the Beneficiary an amount equal to all premiums paid for the Policy, without
interest, and less any outstanding Debt and any partial withdrawals. If the
Insured commits suicide, while sane or insane, generally within two years from
the effective date of any increase in the Sum Insured, the Company's liability
with respect to such increase will be limited to a refund of the cost thereof.
The Beneficiary will receive the administrative charges and insurance charges
paid for such increase.
AGE AND SEX
If the Insured's Age or sex as stated in the application for the Policy is not
correct, benefits under the Policy will be adjusted to reflect the correct Age
and sex, if death occurs prior to the Final Premium Payment Date. The adjusted
benefit will be that which the most recent cost of insurance charge would have
purchased for the correct Age and sex. In no event will the Sum Insured be
reduced to less than the Guideline Minimum Sum Insured. In the case of a Policy
issued on a unisex basis, this provision as it relates to misstatement of sex
does not apply.
ASSIGNMENT
The Policyowner may assign the Policy as collateral or make an absolute
assignment of the Policy. All rights under the Policy will be transferred to the
extent of the assignee's interest. The consent of the assignee may be required
in order to make changes in premium allocations, to make transfers, or to
exercise other rights under the Policy. The Company is not bound by an
assignment or release thereof, unless it is in writing and is recorded at the
Principal Office. When recorded, the assignment will take effect as of the date
the Written Request was signed. Any rights created by the assignment will be
subject to any payments made or actions taken by the Company before the
assignment is recorded. The Company is not responsible for determining the
validity of any assignment or release.
POSTPONEMENT OF PAYMENTS
Payments of any amount due from the Separate Account upon surrender, partial
withdrawals, or death of the Insured, as well as payments of a Policy loan and
transfers, may be postponed whenever: (I) the New York Stock Exchange is closed
other than customary weekend and holiday closings, or trading on the New York
Stock Exchange is restricted as determined by the SEC or (2i) an emergency
exists, as determined by the SEC,
57
<PAGE>
as a result of which disposal of securities is not reasonably practicable or it
is not reasonably practicable to determine the value of the Separate Account's
net assets. Payments under the Policy of any amounts derived from the premiums
paid by check may be delayed until such time as the check has cleared your bank.
The Company also reserves the right to defer payment of any amount due from the
General Account upon surrender, partial withdrawal or death of the Insured, as
well as payments of Policy loans and transfers from the General Account, for a
period not to exceed six months.
58
<PAGE>
DIRECTORS AND PRINCIPAL OFFICERS OF THE COMPANY
<TABLE>
<CAPTION>
NAME AND POSITION PRINCIPAL OCCUPATION(S) DURING PAST FIVE YEARS
- ---------------------------------- --------------------------------------------------------
<S> <C>
Bruce C. Anderson Director of First Allmerica since 1996; Vice President,
Director First Allmerica since 1984
Abigail M. Armstrong Secretary of First Allmerica since 1996; Counsel, First
Secretary and Counsel Allmerica since 1991
Robert E. Bruce Director and Chief Information Officer of First
Director, Vice President and Allmerica since 1997; Vice President of First Allmerica
Chief Information Officer since 1995; Corporate Manager, Digital Equipment
Corporation 1979 to 1995
John P. Kavanaugh
Director, Vice President and Director and Chief Investment Officer of First Allmerica
Chief Investment Officer since 1996; Vice President, First Allmerica since 1991
John F. Kelly Director (since 1996), General Counsel (since 1981),
Director, Vice President and Senior Vice President and Assistant Secretary (since
General Counsel 1986), of First Allmerica
J. Barry May Director of First Allmerica since 1996; Director and
Director President, The Hanover Insurance Company since 1996;
Vice President, The Hanover Insurance Company, 1993 to
1996; General Manager, The Hanover Insurance Company
1989 to 1993
James R. McAuliffe Director of First Allmerica since 1996; Director (since
Director 1992), President (since 1994), and CEO (since 1996), of
Citizens Insurance Company of America; Vice President
(1982 to 1994), and Chief Investment Officer (1986 to
1994), of First Allmerica
John F. O'Brien
Director and Chairman of the Director, Chairman of the Board, President and Chief
Board Executive Officer, First Allmerica since 1989
Edward J. Parry, III
Director, Vice President, Director and Chief Financial Officer of First Allmerica
Treasurer and Chief Financial since 1996; Vice President and Treasurer, First
Officer Allmerica since 1993
Richard M. Reilly Director of First Allmerica since 1996; Vice President,
Director, President and First Allmerica since 1990; Director, Allmerica
Chief Executive Officer Investments, Inc. since 1990; Director and President,
Allmerica Financial Investment Management Services, Inc.
since 1990
Eric A. Simonsen Director of First Allmerica since 1996; Vice President,
Director and Vice President First Allmerica since 1990; Chief Financial Officer,
First Allmerica 1990 to 1996
Phillip E. Soule Director of First Allmerica since 1996; Vice President,
Director First Allmerica since 1987
</TABLE>
59
<PAGE>
DISTRIBUTION
Allmerica Investments, Inc., a subsidiary of First Allmerica, acts as the
principal underwriter of the Policy pursuant to a Sales and Administrative
Services Agreement with the Company and the VEL II Account. Allmerica
Investments, Inc. is registered with the SEC as a broker-dealer, and is a member
of the National Association of Securities Dealers, Inc. ("NASD"). The Policy is
sold by agents of the Company who are registered representatives of Allmerica
Investments, Inc., or of certain independent broker-dealers which are members of
the NASD.
The Company pays commissions to registered representatives who sell the Policy
based on a commission schedule. After issue of the Policy or an increase in the
Face Amount, commissions generally will equal 50% of the first-year premiums up
to a basic premium amount established by the Company. Thereafter, commissions
generally will equal 4% of any additional premiums. Certain registered
representatives, including registered representatives enrolled in the Company's
training program for new agents, may receive additional first-year and renewal
commissions and training reimbursements. General Agents of the Company and
certain registered representatives also may be eligible to receive expense
reimbursements based on the amount of earned commissions. General Agents may
also receive overriding commissions, which will not exceed 10% of first-year, or
14% of renewal premiums.
The Company intends to recoup the commission and other sales expense through a
combination of the deferred sales charge component of the anticipated surrender
and partial withdrawal charges, and the investment earnings on amounts allocated
to accumulate on a fixed basis in excess of the interest credited on fixed
accumulations by the Company. There is no additional charge to Policyowners or
to the Separate Account. Any surrender charge assessed on a Policy will be
retained by the Company except for amounts it may pay to Allmerica Investments,
Inc. for services it performs and expenses it may incur as principal underwriter
and general distributor.
SERVICES
The Company receives fees from the investment advisers or other service
providers of certain Underlying Funds in return for providing certain services
to Policyowners. Currently, the Company receives service fees with respect to
the Fidelity VIP Overseas Portfolio, Fidelity VIP Equity-Income Portfolio,
Fideltiy VIP Growth Portfolio, Fidelity VIP High Income Portfolio, and Fidelity
VIP II Asset Manager Portfolio, at an annual rate of 0.10% of the aggregate net
asset value, respectively, of the shares of such Underlying Funds held by the
Separate Account. With respect to the T. Rowe Price International Stock
Portfolio, the Company receives service fees an annual rate of 0.15% per annum
of the aggregate net asset value of shares held by the VEL II Account. The
Company may in the future render services for which it will receive compensation
from the investment advisers or other service providers of other Underlying
Funds.
REPORTS
The Company will maintain the records relating to the Separate Account.
Statements of significant transactions such as premium payments, changes in
specified Face Amount, changes in Sum Insured Option, transfers among
Sub-Accounts and the General Account, partial withdrawals, increases in loan
amount by you, loan repayments, lapse, termination for any reason, and
reinstatement will be sent to you promptly. An annual statement also will be
sent to you within 30 days after a Policy anniversary. The annual statement will
summarize all of the above transactions and deductions of charges during the
Policy year. It also will set forth the status of the Death Proceeds, Policy
Value, Surrender Value, amounts in the Sub-Accounts and General Account, and any
Policy loan(s). In addition, you will be sent periodic reports containing
financial statements and other information for the Separate Account and the
Underlying Funds as required by the 1940 Act.
60
<PAGE>
LEGAL PROCEEDINGS
There are no legal proceedings pending to which the Separate Account is a party,
or to which the assets of the Separate Account are subject. The Company is not
involved in any litigation that is of material importance in relation to its
total assets or that relates to the Separate Account.
FURTHER INFORMATION
A Registration Statement under the 1933 Act relating to this offering has been
filed with the SEC. Certain portions of the Registration Statement and
amendments have been omitted from this Prospectus pursuant to the rules and
regulations of the SEC. Statements contained in this Prospectus concerning the
Policy and other legal documents are summaries. The complete documents and
omitted information may be obtained from the SEC's principal office in
Washington, D.C., upon payment of the SEC's prescribed fees.
INDEPENDENT ACCOUNTANTS
The financial statements of the Company as of December 31, 1997 and 1996 and for
each of the two years in the period ended December 31, 1997, and the financial
statements of the VEL II Account of the Company as of December 31, 1997 and for
the periods indicated, included in this Prospectus constituting part of the
Registration Statement, have been so included in reliance on the reports of
Price Waterhouse LLP, independent accountants, given on the authority of said
firm as experts in auditing and accounting.
The financial statements of the Company included herein should be considered
only as bearing on the ability of the Company to meet its obligations under the
Policies.
FEDERAL TAX CONSIDERATIONS
The effect of federal income taxes on the value of the Policy, on loans,
withdrawals, or surrenders, on death benefit payments, and on the economic
benefit to you or the Beneficiary depends upon a variety of factors. The
following discussion is based upon the Company's understanding of the present
federal income tax laws as they currently are interpreted. From time to time
legislation is proposed which, if passed, could significantly, adversely and
possibly retroactively affect the taxation of the Policy. No representation is
made regarding the likelihood of continuation of current federal income tax laws
or of current interpretations by the IRS. Moreover, no attempt has been made to
consider any applicable state or other tax laws. It should be recognized that
the following summary of federal income tax aspects of amounts received under
the Policy is not exhaustive, does not purport to cover all situations, and is
not intended as tax advice. Specifically, the discussion below does not address
certain tax provisions that may be applicable if the Policyowner is a
corporation or the Trustee of an employee benefit plan. A qualified tax adviser
always should be consulted with regard to the application of law to individual
circumstances.
THE COMPANY AND THE SEPARATE ACCOUNT
The Company is taxed as a life insurance company under Subchapter L of the Code
and files a consolidated tax return with its parent and affiliates. The Company
does not expect to incur any income tax upon the earnings or realized capital
gains attributable to the Separate Account. Based on this, no charge is made for
federal income taxes which may be attributable to the Separate Account.
Periodically, the Company will review the question of a charge to the Separate
Account for federal income taxes. Such a charge may be made in future years for
any federal income taxes incurred by the Company. This might become necessary if
the tax treatment of the Company ultimately is determined to be other than what
the Company believes it to be, if there are changes made in the federal income
tax treatment of variable life insurance at the Company level, or if there is a
change in the Company's tax status. Any such charge would be designed to cover
the federal income taxes attributable to the investment results of the Separate
Account.
61
<PAGE>
Under current laws the Company also may incur state and local taxes (in addition
to premium taxes) in several states. At present these taxes are not significant.
If there is a material change in applicable state or local tax laws, charges may
be made for such taxes paid, or reserves for such taxes, attributable to the
Separate Account.
TAXATION OF THE POLICY
The Company believes that the Policy described in this Prospectus will be
considered a life insurance contract under Section 7702 of the Code, which
generally provides for the taxation of life insurance policies and places
limitations on the relationship of the Policy Value to the Insurance Amount at
Risk. As a result, the Death Proceeds payable are excludable from the gross
income of the Beneficiary. Moreover, any increase in the Policy Value is not
taxable until received by the Policyowner or the Policyowner's designee. But see
"MODIFIED ENDOWMENT CONTRACTS."
The Code also requires that the investment of each Sub-Account be adequately
diversified in accordance with Treasury regulations in order to be treated as a
life insurance Policy for tax purposes. Although the Company does not have
control over the investments of the Underlying Funds, the Company believes that
the Underlying Funds currently meet the Treasury's diversification requirements,
and the Company will monitor continued compliance with these requirements. In
connection with the issuance of previous regulations relating to diversification
requirements, the Treasury Department announced that such regulations do not
provide guidance concerning the extent to which Policyowners may direct their
investments to particular divisions of a separate account. Regulations in this
regard may be issued in the future. It is possible that if and when regulations
are issued, the Policy may need to be modified to comply with such regulations.
For these reasons, the Policy or the Company's administrative rules may be
modified as necessary to prevent a Policyowner from being considered the owner
of the assets of the Separate Account.
Depending upon the circumstances, a surrender, partial withdrawal, change in the
Sum Insured Option, change in the Face Amount, lapse with Policy loan
outstanding or assignment of the Policy may have tax consequences. In
particular, under specified conditions, a distribution under the Policy during
the first 15 years from Date of Issue that reduces future benefits under the
Policy will be taxed to the Policyowner as ordinary income to the extent of any
investment earnings in the Policy. Federal, state and local income, estate,
inheritance, and other tax consequences of ownership or receipt of Policy
proceeds depend on the circumstances of each Insured, Policyowner or
Beneficiary.
POLICY LOANS
The Company believes that non-preferred loans received under the Policy will be
treated as an indebtedness of the Policyowner for federal income tax purposes.
Under current law, these loans will not constitute income for the Policyowner
while the Policy is in force (but see "Modified Endowment Policies"). There is a
risk, however, that a preferred loan may be characterized by the IRS as a
withdrawal and taxed accordingly. At the present time, the IRS has not issued
any guidance on whether loans with the attributes of a preferred loan should be
treated differently than a non-preferred loan. This lack of specific guidance
makes the tax treatment of preferred loans uncertain. In the event pertinent IRS
guidelines are issued in the future, you may revoke your request for a preferred
loan.
Section 264 of the Code restricts the deduction of interest on Policy loans.
Consumer interest paid on Policy loans under an individually owned Policy is not
tax deductible. No tax deduction for interest is allowed on Policy loans
exceeding $50,000 in aggregate, if the Insured is an officer or employee of, or
is financially interested in, any business carried on by the taxpayer.
POLICIES ISSUED IN CONNECTION WITH TSA PLANS
The Policies may be issued in connection with tax-sheltered annuity plans ("TSA
Plans") of certain public school systems and organizations that are tax exempt
under Section 501(c)(3) of the Code.
62
<PAGE>
Under the provisions of Section 403(b) of the Code, payments made for annuity
policies purchased for employees under TSA Plans are excludable from the gross
income of such employees, to the extent that the aggregate purchase payments in
any year do not exceed the maximum contribution permitted under the Code. The
Company has received a Private Letter Ruling with respect to the status of the
Policies as providing "incidental life insurance" when issued in connection with
TSA Plans. In the Private Letter Ruling, the IRS has taken the position that the
purchase of a life insurance Policy by the employer as part of a TSA Plan will
not violate the "incidental benefit" rules of Section 403(b) and the regulations
thereunder. The Private Letter Ruling also stated that the use of current or
accumulated contributions to purchase a life insurance Policy will not result in
current taxation of the premium payments for the life insurance Policy, except
for the current cost of the life insurance protection.
A Policy qualifying under Section 403(b) of the Code must provide that
withdrawals or other distributions attributable to salary reduction
contributions (including earnings) may not begin before the employee attains age
59 1/2, separates from service, dies, or becomes disabled. In the case of
hardship, a Policyowner may withdraw amounts contributed by salary reduction,
but not the earnings on such amounts. Even though a distribution may be
permitted under these rules (e.g., for hardship or after separation from
service), it may nonetheless be subject to a 10% penalty tax as a premature
distribution, in addition to income tax.
Policy loans are generally permitted in accordance with the terms of the Policy.
However, if a Policy loan does not comply with the requirements of Code Section
72(p), the Policyowner's TSA plan may become disqualified and Policy values may
be includible in current income.
MODIFIED ENDOWMENT CONTRACTS
The Technical and Miscellaneous Revenue Act of 1988 ("the 1988 Act") adversely
affects the tax treatment of distributions under so-called "modified endowment
contracts." Under the 1988 Act, any life insurance policy, including the Policy
offered by this Prospectus, that fails to satisfy a "seven-pay" test is
considered a modified endowment contract. The Policy would fail to satisfy the
seven-pay test if the cumulative premiums paid under the Policy at any time
during the first seven Policy years (or within seven years of a material change
in the Policy) exceed the sum of the net level premiums that would have been
paid, had the Policy provided for paid-up future benefits after the payment of
seven level premiums.
If the Policy is considered a modified endowment contract, all distributions
under the Policy will be taxed on an "income-first" basis. Most distributions
received by the Policyowner directly or indirectly (including loans,
withdrawals, surrenders, or the assignment or pledge of any portion of the
Policy Value) will be includible in gross income to the extent that the cash
Surrender Value of the Policy exceeds the Policyowner's investment in the
Policy. Any additional amounts will be treated as a return of capital to the
extent of the Policyowner's basis in the Policy. With certain exceptions, an
additional 10% tax will be imposed on the portion of any distribution that is
includible in income. All modified endowment contracts issued by the same
insurance company to the same Policyowner during any 12-month period will be
treated as a single modified endowment contract in determining taxable
distributions.
Currently, each Policy is reviewed when premiums are received to determine if it
satisfies the seven-pay test. If the Policy does not satisfy the seven-pay test,
the Company will notify the Policyowner of the option of requesting a refund of
the excess premium. The refund process must be completed within 60 days after
the Policy anniversary, or the Policy will be classified permanently as a
modified endowment contract.
MORE INFORMATION ABOUT THE GENERAL ACCOUNT
As discussed earlier, you may allocate Net Premiums and transfer Policy Value to
the General Account. Because of exemption and exclusionary provisions in the
securities law, any amount in the General Account generally is not subject to
regulation under the provisions of the 1933 Act or the 1940 Act. Accordingly,
the disclosures in this section have not been reviewed by the SEC. Disclosures
regarding the fixed portion of the
63
<PAGE>
Policy and the General Account may, however, be subject to certain generally
applicable provisions of the federal securities laws concerning the accuracy and
completeness of statements made in prospectuses.
GENERAL DESCRIPTION
The General Account of the Company is made up of all of the general assets of
the Company other than those allocated to any separate account. Allocations to
the General Account become part of the assets of the Company and are used to
support insurance and annuity obligations. Subject to applicable law, the
Company has sole discretion over the investment of assets of the General
Account.
A portion or all of Net Premiums may be allocated or transferred to accumulate
at a fixed rate of interest in the General Account. Such net amounts are
guaranteed by the Company as to principal and a minimum rate of interest. The
allocation or transfer of funds to the General Account does not entitle you to
share in the investment experience of the General Account.
GENERAL ACCOUNT VALUES
The Company bears the full investment risk for amounts allocated to the General
Account, and guarantees that interest credited to each Policyowner's Policy
Value in the General Account will not be less than an annual rate of 4%
("Guaranteed Minimum Rate").
The Company may, AT ITS SOLE DISCRETION, credit a higher rate of interest
("excess interest"), although it is not obligated to credit interest in excess
of 4%, and might not do so. The excess interest rate, if any, in effect on the
date a premium is received at the Principal Office, however, is guaranteed on
that premium for one year, unless the Policy Value associated with the premium
becomes security for a Policy loan. AFTER SUCH INITIAL ONE-YEAR GUARANTEE OF
INTEREST ON NET PREMIUM, ANY INTEREST CREDITED ON THE POLICY'S ACCUMULATED VALUE
IN THE GENERAL ACCOUNT IN EXCESS OF THE GUARANTEED MINIMUM RATE PER YEAR WILL BE
DETERMINED IN THE SOLE DISCRETION OF THE COMPANY. THE POLICYOWNER ASSUMES THE
RISK THAT INTEREST CREDITED MAY NOT EXCEED THE GUARANTEED MINIMUM RATE.
Even if excess interest is credited to accumulated value in the General Account,
no excess interest will be credited to that portion of the Policy Value which is
equal to the Debt. Such Policy Value, however, will be credited interest at an
effective annual yield of at least 6%.
The Company guarantees that, on each Monthly Payment Date, the Policy Value in
the General Account will be the amount of the Net Premiums allocated or the
Policy Value transferred to the General Account, plus interest at an annual rate
of 4%, plus any excess interest which the Company credits, less the sum of all
Policy charges allocable to the General Account and any amounts deducted from
the General Account in connection with loans, partial withdrawals, surrenders or
transfers.
THE POLICY
This Prospectus describes a flexible premium variable life insurance Policy and
is intended generally to serve as a disclosure document only for the aspects of
the Policy relating to the Separate Account. For complete details regarding the
General Account, see the Policy itself.
SURRENDERS AND PARTIAL WITHDRAWALS
If a Policy is surrendered or if a partial withdrawal is made, a surrender
charge or partial withdrawal charge, as applicable, may be imposed. In the event
of a decrease in the Face Amount, the surrender charge deducted is a fraction of
the charge that would apply to a full surrender of the Policy. Partial
withdrawals are made on a last-in/first-out basis from the Policy Value
allocated to the General Account.
64
<PAGE>
TRANSFERS
The first 12 transfers in a Policy year are free of charge. Thereafter, a $10
transfer charge will be deducted for each transfer in that Policy year. The
transfer privilege is subject to the consent of the Company and to the Company's
then current rules.
Policy loans also may be made from the Policy Value in the General Account.
DELAY OF PAYMENTS
Transfers, surrenders, partial withdrawals, Death Proceeds and Policy loans
payable from the General Account may be delayed up to six months. If payment is
delayed for 30 days or more, however, the Company will pay interest at least
equal to an effective annual yield of 3 1/2% per year for the period of
deferment. Amounts from the General Account used to pay premiums on policies
with the Company will not be delayed.
FINANCIAL STATEMENTS
Financial Statements for the Company and the Separate Account are included in
this Prospectus beginning immediately after this section. The financial
statements of the Company should be considered only as bearing on the ability of
the Company to meet its obligations under the Policy. They should not be
considered as bearing on the investment performance of the assets held in the
Separate Account.
65
<PAGE>
ALLMERICA FINANCIAL
LIFE INSURANCE AND
ANNUITY COMPANY
FINANCIAL STATEMENTS
DECEMBER 31, 1997
<PAGE>
REPORT OF INDEPENDENT ACCOUNTANTS
To the Board of Directors and Shareholder of
Allmerica Financial Life Insurance and Annuity Company
In our opinion, the accompanying consolidated balance sheets and the related
consolidated statements of income, of shareholder's equity, and of cash flows
present fairly, in all material respects, the financial position of Allmerica
Financial Life Insurance and Annuity Company at December 31, 1997 and 1996, and
the results of their operations and their cash flows for the years then ended in
conformity with generally accepted accounting principles. These financial
statements are the responsibility of the Company's management; our
responsibility is to express an opinion on these financial statements based on
our audits. We conducted our audits of these statements in accordance with
generally accepted auditing standards which require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, and evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for the opinion expressed
above.
/s/ Price Waterhouse LLP
PRICE WATERHOUSE LLP
Boston, Massachusetts
February 3, 1998
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
(AN INDIRECT WHOLLY OWNED SUBSIDIARY OF ALLMERICA FINANCIAL CORPORATION)
CONSOLIDATED STATEMENTS OF INCOME
<TABLE>
<CAPTION>
FOR THE YEARS ENDED DECEMBER 31,
(IN MILLIONS) 1997 1996
----------------------------------------------- --------- ---------
<S> <C> <C>
REVENUES
Premiums..................................... $ 22.8 $ 32.7
Universal life and investment product
policy fees.............................. 212.2 176.2
Net investment income...................... 164.2 171.7
Net realized investment gains (losses)..... 2.9 (3.6 )
Other income............................... 1.4 0.9
--------- ---------
Total revenues......................... 403.5 377.9
--------- ---------
BENEFITS, LOSSES AND EXPENSES
Policy benefits, claims, losses and loss
adjustment expenses...................... 187.8 192.6
Policy acquisition expenses................ 2.8 49.9
Loss from cession of disability income
business................................. 53.9 --
Other operating expenses................... 101.3 86.6
--------- ---------
Total benefits, losses and expenses.... 345.8 329.1
--------- ---------
Income before federal income taxes............. 57.7 48.8
--------- ---------
FEDERAL INCOME TAX EXPENSE (BENEFIT)
Current.................................... 13.9 26.9
Deferred................................... 7.1 (9.8 )
--------- ---------
Total federal income tax expense....... 21.0 17.1
--------- ---------
Net income..................................... $ 36.7 $ 31.7
--------- ---------
--------- ---------
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-1
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
(AN INDIRECT WHOLLY OWNED SUBSIDIARY OF ALLMERICA FINANCIAL CORPORATION)
CONSOLIDATED BALANCE SHEETS
<TABLE>
<CAPTION>
DECEMBER 31,
(IN MILLIONS) 1997 1996
-------------------------------------------------------- ---------- ----------
<S> <C> <C>
ASSETS
Investments:
Fixed maturities at fair value (amortized cost of
$1,340.5 and $1,660.2)............................ $1,402.5 $1,698.0
Equity securities at fair value (cost of $34.4 and
$33.0)............................................ 54.0 41.5
Mortgage loans...................................... 228.2 221.6
Real estate......................................... 12.0 26.1
Policy loans........................................ 140.1 131.7
Other long term investments......................... 20.3 7.9
---------- ----------
Total investments............................... 1,857.1 2,126.8
---------- ----------
Cash and cash equivalents............................. 31.1 18.8
Accrued investment income............................. 34.2 37.7
Deferred policy acquisition costs..................... 765.3 632.7
Reinsurance receivables on paid and unpaid losses,
benefits and unearned premiums...................... 251.1 81.5
Other assets.......................................... 10.7 8.2
Separate account assets............................... 7,567.3 4,524.0
---------- ----------
Total assets.................................... $10,516.8 $7,429.7
---------- ----------
---------- ----------
LIABILITIES
Policy liabilities and accruals:
Future policy benefits.............................. $2,097.3 $2,171.3
Outstanding claims, losses and loss adjustment
expenses.......................................... 18.5 16.1
Unearned premiums................................... 1.8 2.7
Contractholder deposit funds and other policy
liabilities....................................... 32.5 32.8
---------- ----------
Total policy liabilities and accruals........... 2,150.1 2,222.9
---------- ----------
Expenses and taxes payable............................ 77.6 77.3
Reinsurance premiums payable.......................... 4.9 --
Deferred federal income taxes......................... 75.9 60.2
Separate account liabilities.......................... 7,567.3 4,523.6
---------- ----------
Total liabilities............................... 9,875.8 6,884.0
---------- ----------
Commitments and contingencies (Note 13)
SHAREHOLDER'S EQUITY
Common stock, $1,000 par value, 10,000 shares
authorized, 2,521 and 2,518 shares issued and
outstanding......................................... 2.5 2.5
Additional paid in capital............................ 386.9 346.3
Unrealized appreciation on investments, net........... 38.5 20.5
Retained earnings..................................... 213.1 176.4
---------- ----------
Total shareholder's equity...................... 641.0 545.7
---------- ----------
Total liabilities and shareholder's equity...... $10,516.8 $7,429.7
---------- ----------
---------- ----------
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-2
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
(AN INDIRECT WHOLLY OWNED SUBSIDIARY OF ALLMERICA FINANCIAL CORPORATION)
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY
<TABLE>
<CAPTION>
FOR THE YEARS ENDED DECEMBER 31,
(IN MILLIONS) 1997 1996
----------------------------------------------- --------- ---------
<S> <C> <C>
COMMON STOCK
Balance at beginning of period............. $ 2.5 $ 2.5
Issued during year......................... -- --
--------- ---------
Balance at end of period................... 2.5 2.5
--------- ---------
ADDITIONAL PAID IN CAPITAL
Balance at beginning of period............. 346.3 324.3
Contribution from Parent................... 40.6 22.0
--------- ---------
Balance at end of period................... 386.9 346.3
--------- ---------
RETAINED EARNINGS
Balance at beginning of period............. 176.4 144.7
Net income................................. 36.7 31.7
--------- ---------
Balance at end of period................... 213.1 176.4
--------- ---------
NET UNREALIZED APPRECIATION ON INVESTMENTS
Balance at beginning of period............. 20.5 23.8
Net appreciation (depreciation) on
available for sale securities............ 27.0 (5.1 )
(Provision) benefit for deferred federal
income taxes............................. (9.0 ) 1.8
--------- ---------
Balance at end of period................... 38.5 20.5
--------- ---------
Total shareholder's equity............. $641.0 $545.7
--------- ---------
--------- ---------
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-3
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
(AN INDIRECT WHOLLY OWNED SUBSIDIARY OF ALLMERICA FINANCIAL CORPORATION)
CONSOLIDATED STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
FOR THE YEARS ENDED DECEMBER 31,
(IN MILLIONS) 1997 1996
-------------------------------------------- ---------- ----------
<S> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net income.............................. $ 36.7 $ 31.7
Adjustments to reconcile net income to
net cash used in operating activities:
Net realized gains.................. (2.9 ) 3.6
Net amortization and depreciation... -- 3.5
Loss from cession of disability
income business................... 53.9 --
Deferred federal income taxes....... 7.1 (9.8 )
Payment related to cession of
disability income business........ (207.0 ) --
Change in deferred acquisition
costs............................. (181.3 ) (66.8 )
Change in premiums and notes
receivable, net of reinsurance
payable........................... 3.9 (0.2 )
Change in accrued investment
income............................ 3.5 1.2
Change in policy liabilities and
accruals, net..................... (72.4 ) (39.9 )
Change in reinsurance receivable.... 22.1 (1.5 )
Change in expenses and taxes
payable........................... 0.2 32.3
Separate account activity, net...... 0.4 10.5
Other, net.......................... (7.5 ) (0.2 )
---------- ----------
Net used in operating
activities.................... (343.3 ) (35.6 )
---------- ----------
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from disposals and maturities
of available-for-sale fixed
maturities............................ 909.7 809.4
Proceeds from disposals of equity
securities............................ 2.4 1.5
Proceeds from disposals of other
investments........................... 23.7 17.4
Proceeds from mortgages matured or
collected............................. 62.9 34.0
Purchase of available-for-sale fixed
maturities............................ (579.7 ) (795.8 )
Purchase of equity securities........... (3.2 ) (13.2 )
Purchase of other investments........... (79.4 ) (36.2 )
Other investing activities, net......... -- (2.0 )
---------- ----------
Net cash provided by investing
activities........................ 336.4 15.1
---------- ----------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of stock and
capital paid in....................... 19.2 22.0
---------- ----------
Net cash provided by financing
activities........................ 19.2 22.0
---------- ----------
Net change in cash and cash equivalents..... 12.3 1.5
Cash and cash equivalents, beginning of
period..................................... 18.8 17.3
---------- ----------
Cash and cash equivalents, end of period.... $ 31.1 $ 18.8
---------- ----------
---------- ----------
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid........................... $ -- $ 3.4
Income taxes paid....................... $ 5.4 $ 16.5
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.
F-4
<PAGE>
NOTES TO FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
A. BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION
Allmerica Financial Life Insurance and Annuity Company ("AFLIAC" or the
"Company") is organized as a stock life insurance company, and is a wholly-owned
subsidiary of SMA Financial Corporation ("SMAFCO"), which is wholly owned by
First Allmerica Financial Life Insurance Company ("FAFLIC"). FAFLIC is a
wholly-owned subsidiary of Allmerica Financial Corporation ("AFC").
The consolidated financial statements of AFLIAC include the accounts of Somerset
Square, Inc., a wholly-owned non-insurance company and its results of operations
for the month of December, 1997. Somerset Square, Inc. was transferred from
SMAFCO effective November 30, 1997. (See Significant Transactions.)
The Statutory stockholder's equity of the Company is being maintained at a
minimum level of 5% of general account assets by FAFLIC in accordance with a
policy established by vote of FAFLIC's Board of Directors.
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amount of revenues and expenses during the reporting period. Actual
results could differ from those estimates. Certain reclassifications have been
made to the 1996 financial statements in order to conform to the 1997
presentation.
B. VALUATION OF INVESTMENTS
In accordance with the provisions of Statement of Financial Accounting Standards
No. 115 ("Statement No. 115"), "ACCOUNTING FOR CERTAIN INVESTMENTS IN DEBT AND
EQUITY SECURITIES", the Company is required to classify its investments into one
of three categories: held-to-maturity, available-for-sale or trading. The
Company determines the appropriate classification of debt securities at the time
of purchase and reevaluates such designation as of each balance sheet date.
Mortgage loans on real estate are stated at unpaid principal balances, net of
unamortized discounts and reserves. Reserves on mortgage loans are based on
losses expected by management to be realized on transfers of mortgage loans to
real estate (upon foreclosure), on the disposition or settlement of mortgage
loans and on mortgage loans which management believes may not be collectible in
full. In establishing reserves, management considers, among other things, the
estimated fair value of the underlying collateral.
Fixed maturities and mortgage loans that are delinquent are placed on
non-accrual status, and thereafter interest income is recognized only when cash
payments are received.
Policy loans are carried principally at unpaid principal balances.
During 1997, the Company committed to a plan to dispose of all real estate
assets by the end of 1998. As a result of this decision real estate held by the
Company and real estate joint ventures were written down to the estimated fair
value less cost to sell. Depreciation is not recorded on these assets while they
are held for disposal.
Realized investment gains and losses, other than those related to separate
accounts for which the Company does not bear the investment risk, are reported
as a component of revenues based upon specific identification of the investment
assets sold. When an other-than-temporary impairment of the value of a specific
investment
F-5
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
or a group of investments is determined, a realized investment loss is recorded.
Changes in the valuation allowance for mortgage loans and real estate are
included in realized investment gains or losses.
C. FINANCIAL INSTRUMENTS
In the normal course of business, the Company enters into transactions involving
various types of financial instruments, including debt, investments such as
fixed maturities, mortgage loans and equity securities, and investment and loan
commitments. These instruments involve credit risk and also may be subject to
risk of loss due to interest rate fluctuation. The Company evaluates and
monitors each financial instrument individually and, when appropriate, obtains
collateral or other security to minimize losses.
D. CASH AND CASH EQUIVALENTS
Cash and cash equivalents includes cash on hand, amounts due from banks and
highly liquid debt instruments purchased with an original maturity of three
months or less.
E. DEFERRED POLICY ACQUISITION COSTS
Acquisition costs consist of commissions, underwriting costs and other costs,
which vary with, and are primarily related to, the production of revenues.
Acquisition costs related to universal life products, variable annuities and
contractholder deposit funds are deferred and amortized in proportion to total
estimated gross profits from investment yields, mortality, surrender charges and
expense margins over the expected life of the contracts. This amortization is
reviewed annually and adjusted retrospectively when the Company revises its
estimate of current or future gross profits to be realized from this group of
products, including realized and unrealized gains and losses from investments.
Acquisition costs related to fixed annuities and other life insurance products
are deferred and amortized, generally in proportion to the ratio of annual
revenue to the estimated total revenues over the contract periods based upon the
same assumptions used in estimating the liability for future policy benefits.
Deferred acquisition costs for each product are reviewed to determine if they
are recoverable from future income, including investment income. If such costs
are determined to be unrecoverable, they are expensed at the time of
determination. Although realization of deferred policy acquisition costs is not
assured, management believes it is more likely than not that all of these costs
will be realized. The amount of deferred policy acquisition costs considered
realizable, however, could be reduced in the near term if the estimates of gross
profits or total revenues discussed above are reduced. The amount of
amortization of deferred policy acquisition costs could be revised in the near
term if any of the estimates discussed above are revised.
F. SEPARATE ACCOUNTS
Separate account assets and liabilities represent segregated funds administered
and invested by the Company for the benefit of certain pension, variable annuity
and variable life insurance contractholders. Assets consist principally of
bonds, common stocks, mutual funds, and short-term obligations at market value.
The investment income, gains, and losses of these accounts generally accrue to
the contractholders and, therefore, are not included in the Company's net
income. Appreciation and depreciation of the Company's interest in the separate
accounts, including undistributed net investment income, is reflected in
shareholder's equity or net investment income.
G. POLICY LIABILITIES AND ACCRUALS
Future policy benefits are liabilities for life, health and annuity products.
Such liabilities are established in amounts adequate to meet the estimated
future obligations of policies in force. The liabilities associated with
traditional life insurance products are computed using the net level premium
method for individual life and annuity policies, and are based upon estimates as
to future investment yield, mortality and withdrawals that include provisions
for adverse deviation. Future policy benefits for individual life insurance and
annuity policies are computed using interest rates ranging from 2 1/2% to 6% for
life insurance and 2% to 9 1/2% for
F-6
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
annuities. Mortality, morbidity and withdrawal assumptions for all policies are
based on the Company's own experience and industry standards. Liabilities for
universal life include deposits received from customers and investment earnings
on their fund balances, less administrative charges. Universal life fund
balances are also assessed mortality and surrender charges. Individual health
benefit liabilities for active lives are estimated using the net level premium
method, and assumptions as to future morbidity, withdrawals and interest which
provide a margin for adverse deviation. Benefit liabilities for disabled lives
are estimated using the present value of benefits method and experience
assumptions as to claim terminations, expenses and interest.
Liabilities for outstanding claims, losses and loss adjustment expenses are
estimates of payments to be made for reported claims and estimates of claims
incurred but not reported. These liabilities are determined using case basis
evaluations and statistical analyses and represent estimates of the ultimate
cost of all claims incurred but not paid. These estimates are continually
reviewed and adjusted as necessary; such adjustments are reflected in current
operations.
Premiums for individual accident and health insurance are reported as earned on
a pro-rata basis over the contract period.
The unexpired portion of these premiums is recorded as unearned premiums.
Contractholder deposit funds and other policy liabilities include
investment-related products and consist of deposits received from customers and
investment earnings on their fund balances.
All policy liabilities and accruals are based on the various estimates discussed
above. Although the adequacy of these amounts cannot be assured, management
believes that it is more likely than not that policy liabilities and accruals
will be sufficient to meet future obligations of policies in force. The amount
of liabilities and accruals, however, could be revised in the near term if the
estimates discussed above are revised.
H. PREMIUM AND FEE REVENUE AND RELATED EXPENSES
Premiums for individual life and health insurance and individual annuity
products, excluding universal life and investment-related products, are
considered revenue when due. Individual accident and health insurance premiums
are recognized as revenue over the related contract periods. Benefits, losses
and related expenses are matched with premiums, resulting in their recognition
over the lives of the contracts. This matching is accomplished through the
provision for future benefits, estimated and unpaid losses and amortization of
deferred policy acquisition costs. Revenues for investment-related products
consist of net investment income and contract charges assessed against the fund
values. Related benefit expenses primarily consist of net investment income
credited to the fund values after deduction for investment and risk charges.
Revenues for universal life and group variable universal life products consist
of net investment income, and mortality, administration and surrender charges
assessed against the fund values. Related benefit expenses include universal
life benefits in excess of fund values and net investment income credited to
universal life fund values. Certain policy charges that represent compensation
for services to be provided in future periods are deferred and amortized over
the period benefited using the same assumptions used to amortize capitalized
acquisition costs.
I. FEDERAL INCOME TAXES
AFC, its life insurance subsidiaries, FAFLIC and AFLIAC, and its non-life
insurance domestic subsidiaries file a life-nonlife consolidated United States
Federal income tax return. Entities included within the consolidated group are
segregated into either a life insurance or non-life insurance company subgroup.
The consolidation of these subgroups is subject to certain statutory
restrictions on the percentage of eligible non-life insurance company taxable
operating losses that can be applied to offset life insurance company taxable
income. Allmerica P&C and its subsidiaries will be included in the AFC
consolidated return as part of the
F-7
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
non-life insurance company subgroup for the period July 17, 1997 through
December 31, 1997. For the period January 1, 1997 through July 16, 1997,
Allmerica P&C and its subsidiaries will file a separate consolidated United
States Federal income tax return.
The Board of Directors has delegated to AFC management, the development and
maintenance of appropriate Federal Income Tax allocation policies and
procedures, which are subject to written agreement between the companies. The
Federal income tax for all subsidiaries in the consolidated return of AFC is
calculated on a separate return basis. Any current tax liability is paid to AFC.
Tax benefits resulting from taxable operating losses or credits of AFC's
subsidiaries are not reimbursed to the subsidiary until such losses or credits
can be utilized by the subsidiary on a separate return basis.
Deferred income taxes are generally recognized when assets and liabilities have
different values for financial statement and tax reporting purposes, and for
other temporary taxable and deductible differences as defined by Statement of
Financial Accounting Standards No. 109, "Accounting for Income Taxes" (SFAS No.
109). These differences result primarily from loss reserves, policy acquisition
expenses, and unrealized appreciation/depreciation on investments.
J. NEW ACCOUNTING PRONOUNCEMENTS
In June 1997, the FASB issued Statement No. 131, DISCLOSURES ABOUT SEGMENTS OF
AN ENTERPRISE AND RELATED INFORMATION. This statement establishes standards for
the way that public enterprises report information about operating segments in
annual financial statements and requires that selected information about those
operating segments be reported in interim financial statements. This statement
supersedes Statement No. 14, FINANCIAL REPORTING FOR SEGMENTS OF A BUSINESS
ENTERPRISE. Statement No. 131 requires that all public enterprises report
financial and descriptive information about their reportable operating segments.
Operating segments are defined as components of an enterprise about which
separate financial information is available that is evaluated regularly by the
chief operating decision maker in deciding how to allocate resources and in
assessing performance. This statement is effective for fiscal years beginning
after December 15, 1997. The Company anticipates no impact from the adoption of
Statement No. 131.
In June 1997, the FASB also issued Statement No. 130, REPORTING COMPREHENSIVE
INCOME, which established standards for the reporting and display of
comprehensive income and its components in a full set of general-purpose
financial statements. All items that are required to be recognized under
accounting standards as components of comprehensive income are to be reported in
a financial statement that is displayed with the same prominence as other
financial statements. This statement stipulates that comprehensive income
reflect the change in equity of an enterprise during a period from transactions
and other events and circumstances from non-owner sources. This statement is
effective for fiscal years beginning after December 15, 1997. The Company
anticipates that the adoption of Statement No. 130 will result primarily in
reporting the changes in unrealized gains and losses on investments in debt and
equity securities in comprehensive income.
2. SIGNIFICANT TRANSACTIONS
On April 14, 1997, the Company entered into an agreement in principle to
transfer the Company's individual disability income under a 100% coinsurance
agreement to Metropolitan Life Insurance Company. The coinsurance agreement
became effective October 1, 1997. The transaction has resulted in the
recognition of a $53.9 million pre-tax loss in the first quarter of 1997.
During the 4th quarter of 1997, SMAFCO contributed $40.6 million of additional
paid in capital to the Company. The nature of the contribution was $19.2 million
in cash and $21.4 million in other assets including Somerset Square, Inc.
F-8
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
Effective January 1, 1998, the Company entered into an agreement with
Reinsurance Group of America, Inc. to reinsure the mortality risk on the
universal life and variable universal life blocks of business. Management
believes that this agreement will not have a material effect on the results of
operations or financial position of the Company.
3. INVESTMENTS
A. SUMMARY OF INVESTMENTS
The Company accounts for its investments, all of which are classified as
available-for-sale, in accordance with the provisions of SFAS No. 115.
The amortized cost and fair value of available-for-sale fixed maturities and
equity securities were as follows:
<TABLE>
<CAPTION>
1997
--------------------------------------------
GROSS GROSS
DECEMBER 31, AMORTIZED UNREALIZED UNREALIZED FAIR
(IN MILLIONS) COST (1) GAINS LOSSES VALUE
- ---------------------------------------- ---------- -------- --------- --------
<S> <C> <C> <C> <C>
U.S. Treasury securities and U.S.
government and agency securities....... $ 6.3 $ .5 $-- $ 6.8
States and political subdivisions....... 2.8 .2 -- 3.0
Foreign governments..................... 50.1 2.0 -- 52.1
Corporate fixed maturities.............. 1,147.5 58.7 3.3 1,202.9
Mortgage-backed securities.............. 133.8 5.2 1.3 137.7
---------- -------- --------- --------
Total fixed maturities
available-for-sale..................... $1,340.5 $66.6 $ 4.6 $1,402.5
---------- -------- --------- --------
Equity securities....................... $ 34.4 $19.9 $ 0.3 $ 54.0
---------- -------- --------- --------
---------- -------- --------- --------
1996
--------------------------------------------
U.S. Treasury securities and U.S.
government and agency securities....... $ 15.7 $ 0.5 $ 0.2 $ 16.0
States and political subdivisions....... 8.9 1.6 -- 10.5
Foreign governments..................... 53.2 2.9 -- 56.1
Corporate fixed maturities.............. 1,437.2 38.6 6.1 1,469.7
Mortgage-backed securities.............. 145.2 2.2 1.7 145.7
---------- -------- --------- --------
Total fixed maturities
available-for-sale..................... $1,660.2 $45.8 $ 8.0 $1,698.0
---------- -------- --------- --------
Equity securities....................... $ 33.0 $10.2 $ 1.7 $ 41.5
---------- -------- --------- --------
---------- -------- --------- --------
</TABLE>
(1) Amortized cost for fixed maturities and cost for equity securities.
In connection with AFLIAC's voluntary withdrawal of its license in New York,
AFLIAC agreed with the New York Department of Insurance to maintain, through a
custodial account in New York, a security deposit, the market value of which
will at all times equal 102% of all outstanding liabilities of AFLIAC for New
York policyholders, claimants and creditors. At December 31, 1997, the amortized
cost and market value of these assets on deposit were $276.8 million and $291.7
million, respectively. At December 31, 1996, the amortized cost and market value
of these assets on deposit were $284.9 million and $292.2 million, respectively.
In addition, fixed maturities, excluding those securities on deposit in New
York, with an amortized cost of $4.2 million were on deposit with various state
and governmental authorities at December 31, 1997 and 1996.
There were no contractual fixed maturity investment commitments at December 31,
1997 and 1996, respectively.
F-9
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
The amortized cost and fair value by maturity periods for fixed maturities are
shown below. Actual maturities may differ from contractual maturities because
borrowers may have the right to call or prepay obligations with or without call
or prepayment penalties, or the Company may have the right to put or sell the
obligations back to the issuers. Mortgage backed securities are included in the
category representing their ultimate maturity.
<TABLE>
<CAPTION>
1997
--------------------
DECEMBER 31, AMORTIZED FAIR
(IN MILLIONS) COST VALUE
- ------------------------------------------------------------ --------- ---------
<S> <C> <C>
Due in one year or less..................................... $ 63.0 $ 63.5
Due after one year through five years....................... 328.8 343.9
Due after five years through ten years...................... 649.5 679.9
Due after ten years......................................... 299.2 315.2
--------- ---------
Total....................................................... $1,340.5 $1,402.5
--------- ---------
--------- ---------
</TABLE>
The proceeds from voluntary sales of available-for-sale securities and the gross
realized gains and gross realized losses on those sales were as follows:
<TABLE>
<CAPTION>
PROCEEDS
FROM
FOR THE YEARS ENDED DECEMBER 31, VOLUNTARY GROSS GROSS
(IN MILLIONS) SALES GAINS LOSSES
- ------------------------------------------------------------ ---------- ------ ------
<S> <C> <C> <C>
1997
Fixed maturities............................................ $702.9 $ 11.4 $ 5.0
Equity securities........................................... $ 1.3 $ 0.5 $ --
1996
Fixed maturities............................................ $496.6 $ 4.3 $ 8.3
Equity securities........................................... $ 1.5 $ 0.4 $ 0.1
</TABLE>
Unrealized gains and losses on available-for-sale and other securities, are
summarized as follows:
<TABLE>
<CAPTION>
EQUITY
FOR THE YEAR ENDED DECEMBER 31, FIXED SECURITIES
(IN MILLIONS) MATURITIES AND OTHER (1) TOTAL
- ------------------------------------------------------------ ---------- ------------- ------
<S> <C> <C> <C>
1997
Net appreciation, beginning of year......................... $ 12.7 $ 7.8 $ 20.5
Net appreciation on available-for-sale securities........... 24.3 12.5 36.8
Net depreciation from the effect on deferred policy
acquisition costs and on policy liabilities................ (9.8) -- (9.8)
Provision for deferred federal income taxes................. (5.1) (3.9) (9.0)
---------- ----- ------
9.4 8.6 18.0
---------- ----- ------
Net appreciation, end of year............................... $ 22.1 $ 16.4 $ 38.5
---------- ----- ------
---------- ----- ------
</TABLE>
(1) Includes net appreciation on other investments of $11.1 million in 1997, and
$2.2 million in 1996.
F-10
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
<TABLE>
<CAPTION>
EQUITY
FOR THE YEAR ENDED DECEMBER 31, 1996 FIXED SECURITIES
(IN MILLIONS) MATURITIES AND OTHER (1) TOTAL
- ------------------------------------------------------------ ---------- ------------- ------
<S> <C> <C> <C>
Net appreciation, beginning of year......................... $ 20.4 $ 3.4 $ 23.8
Net (depreciation) appreciation on available-for-sale
securities................................................. (20.8) 6.7 (14.1)
Net appreciation from the effect on deferred policy
acquisition costs and on policy liabilities................ 9.0 -- 9.0
Benefit (provision) for deferred federal income taxes....... 4.1 (2.3) 1.8
---------- ----- ------
(7.7) 4.4 (3.3)
---------- ----- ------
Net appreciation, end of year............................... $ 12.7 $ 7.8 $ 20.5
---------- ----- ------
---------- ----- ------
</TABLE>
(1) Includes net appreciation on other investments of $11.1 million in 1997, and
$2.2 million in 1996.
B. MORTGAGE LOANS AND REAL ESTATE
AFLIAC's mortgage loans and real estate are diversified by property type and
location. Real estate investments have been obtained primarily through
foreclosure. Mortgage loans are collateralized by the related properties and
generally are no more than 75% of the property's value at the time the original
loan is made.
The carrying values of mortgage loans and real estate investments net of
applicable reserves were as follows:
<TABLE>
<CAPTION>
DECEMBER 31
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Mortgage loans.............................................. $228.2 $221.6
Real estate:
Held for sale............................................. 12.0 26.1
Held for production of income............................. -- --
---------- ------
Total real estate....................................... $ 12.0 $ 26.1
---------- ------
Total mortgage loans and real estate........................ $240.2 $247.7
---------- ------
---------- ------
</TABLE>
Reserves for mortgage loans were $9.4 million and $9.5 million at December 31,
1997 and 1996, respectively.
During 1997, the Company committed to a plan to dispose of all real estate
assets by the end of 1998. As a result, real estate assets with a carrying
amount of $15.7 million were written down to the estimated fair value less cost
to sell of $12.0 million, and a net realized investment loss of $3.7 million was
recognized. Depreciation is not recorded on these assets while they are held for
disposal.
There were no non-cash investing activities, including real estate acquired
through foreclosure of mortgage loans, in 1997. During 1996, non-cash investing
activities included real estate acquired through foreclosure of mortgage loans,
which had a fair value of $0.9 million.
At December 31, 1997, contractual commitments to extend credit under commercial
mortgage loan agreements amounted to approximately $18.7 million. These
commitments generally expire within one year.
F-11
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
Mortgage loans and real estate investments comprised the following property
types and geographic regions:
<TABLE>
<CAPTION>
DECEMBER 31,
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Property type:
Office building........................................... $101.7 $ 86.1
Residential............................................... 19.3 39.0
Retail.................................................... 42.2 55.9
Industrial/warehouse...................................... 61.9 52.6
Other..................................................... 24.5 25.3
Valuation allowances...................................... (9.4) (11.2)
---------- ------
Total....................................................... $240.2 $247.7
---------- ------
---------- ------
Geographic region:
South Atlantic............................................ $ 68.7 $ 72.9
Pacific................................................... 56.6 37.0
East North Central........................................ 61.4 58.3
Middle Atlantic........................................... 29.8 35.0
West South Central........................................ 6.9 5.7
New England............................................... 12.4 21.9
Other..................................................... 13.8 28.1
Valuation allowances...................................... (9.4) (11.2)
---------- ------
Total....................................................... $240.2 $247.7
---------- ------
---------- ------
</TABLE>
At December 31, 1997, scheduled mortgage loan maturities were as follows: 1998
- -- $52.0 million; 1999 -- $17.1 million; 2000 -- $46.3 million; 2001 -- $7.0
million; 2002 -- $11.7 million; and $94.1 million thereafter. Actual maturities
could differ from contractual maturities because borrowers may have the right to
prepay obligations with or without prepayment penalties and loans may be
refinanced. During 1997, the Company did not refinance any mortgage loans based
on terms which differed from those granted to new borrowers.
C. INVESTMENT VALUATION ALLOWANCES
Investment valuation allowances which have been deducted in arriving at
investment carrying values as presented in the balance sheet and changes thereto
are shown below.
<TABLE>
<CAPTION>
FOR THE YEAR ENDED DECEMBER 31, BALANCE AT BALANCE AT
(IN MILLIONS) JANUARY 1 ADDITIONS DEDUCTIONS DECEMBER 31
- ------------------------------------------------------------ ---------- ------------- ------------- -------------
<S> <C> <C> <C> <C>
1997
Mortgage loans.............................................. $ 9.5 $ 1.1 $ 1.2 $ 9.4
Real estate................................................. 1.7 3.7 5.4 --
----- --- --- -----
Total................................................... $ 11.2 $ 4.8 $ 6.6 $ 9.4
----- --- --- -----
----- --- --- -----
1996
Mortgage loans.............................................. $ 12.5 $ 4.5 $ 7.5 $ 9.5
Real estate................................................. 2.1 -- 0.4 1.7
----- --- --- -----
Total................................................... $ 14.6 $ 4.5 $ 7.9 $ 11.2
----- --- --- -----
----- --- --- -----
</TABLE>
F-12
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
Deductions of $5.4 million to the investment valuation allowance related to real
estate in 1997 primarily reflect writedowns to the estimated fair value less
cost to sell pursuant to the aforementioned 1997 plan of disposal.
The carrying value of impaired loans was $20.6 million and $21.5 million, with
related reserves of $7.1 million and $7.3 million as of December 31, 1997 and
1996, respectively. All impaired loans were reserved as of December 31, 1997 and
1996.
The average carrying value of impaired loans was $19.8 million and $26.3
million, with related interest income while such loans were impaired of $2.2
million and $3.4 million as of December 31, 1997 and 1996, respectively.
D. OTHER
At December 31, 1997, AFLIAC had no concentration of investments in a single
investee exceeding 10% of shareholder's equity.
4. INVESTMENT INCOME AND GAINS AND LOSSES
A. NET INVESTMENT INCOME
The components of net investment income were as follows:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED DECEMBER 31
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Fixed maturities............................................ $130.0 $137.2
Mortgage loans.............................................. 20.4 22.0
Equity securities........................................... 1.3 0.7
Policy loans................................................ 10.8 10.2
Real estate................................................. 3.9 6.2
Other long-term investments................................. 1.0 0.8
Short-term investments...................................... 1.4 1.4
---------- ------
Gross investment income..................................... 168.8 178.5
Less investment expenses.................................... (4.6) (6.8)
---------- ------
Net investment income....................................... $164.2 $171.7
---------- ------
---------- ------
</TABLE>
At December 31, 1997, mortgage loans on non-accrual status were $2.8 million,
which were all restructured loans. There were no fixed maturities on non-accrual
status at December 31, 1997. The effect of non-accruals, compared with amounts
that would have been recognized in accordance with the original terms of the
investment, had no impact in 1997, and reduced net income by $0.1 million in
1996.
The payment terms of mortgage loans may from time to time be restructured or
modified. The investment in restructured mortgage loans, based on amortized
cost, amounted to $21.1 million and $25.4 million at December 31, 1997 and 1996,
respectively. Interest income on restructured mortgage loans that would have
been recorded in accordance with the original terms of such loans amounted to
$1.9 million and $3.6 million in 1997 and 1996, respectively. Actual interest
income on these loans included in net investment income aggregated $2.1 million
and $2.2 million in 1997 and 1996, respectively.
There were no fixed maturities or mortgage loans which were non-income producing
for the twelve months ended December 31, 1997.
F-13
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
B. REALIZED INVESTMENT GAINS AND LOSSES
Realized gains (losses) on investments were as follows:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED DECEMBER 31
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Fixed maturities............................................ $ 3.0 $ (3.3)
Mortgage loans.............................................. (1.1) (3.2)
Equity securities........................................... 0.5 0.3
Real estate................................................. (1.5) 2.5
Other....................................................... 2.0 0.1
---------- ------
Net realized investment losses.............................. $ 2.9 $ (3.6)
---------- ------
---------- ------
</TABLE>
5. FAIR VALUE DISCLOSURES OF FINANCIAL INSTRUMENTS
SFAS No. 107, "Disclosures about Fair Value of Financial Instruments", requires
disclosure of fair value information about certain financial instruments
(insurance contracts, real estate, goodwill and taxes are excluded) for which it
is practicable to estimate such values, whether or not these instruments are
included in the balance sheet. The fair values presented for certain financial
instruments are estimates which, in many cases, may differ significantly from
the amounts which could be realized upon immediate liquidation. In cases where
market prices are not available, estimates of fair value are based on discounted
cash flow analyses which utilize current interest rates for similar financial
instruments which have comparable terms and credit quality.
The following methods and assumptions were used to estimate the fair value of
each class of financial instruments:
CASH AND CASH EQUIVALENTS
For these short-term investments, the carrying amount approximates fair value.
FIXED MATURITIES
Fair values are based on quoted market prices, if available. If a quoted market
price is not available, fair values are estimated using independent pricing
sources or internally developed pricing models using discounted cash flow
analyses.
EQUITY SECURITIES
Fair values are based on quoted market prices, if available. If a quoted market
price is not available, fair values are estimated using independent pricing
sources or internally developed pricing models.
MORTGAGE LOANS
Fair values are estimated by discounting the future contractual cash flows using
the current rates at which similar loans would be made to borrowers with similar
credit ratings. The fair value of below investment grade mortgage loans are
limited to the lesser of the present value of the cash flows or book value.
F-14
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
REINSURANCE RECEIVABLES
The carrying amount of the reinsurance receivable for outstanding claims, losses
and loss adjustment expenses reported in the balance sheet approximates fair
value.
POLICY LOANS
The carrying amount reported in the balance sheet approximates fair value since
policy loans have no defined maturity dates and are inseparable from the
insurance contracts.
INVESTMENT CONTRACTS (WITHOUT MORTALITY FEATURES)
Fair values for the Company's liabilities under investment type contracts are
estimated based on current surrender values.
The estimated fair values of the financial instruments were as follows:
<TABLE>
<CAPTION>
1997 1996
-------------------------- -----------------------------
DECEMBER 31, CARRYING FAIR CARRYING FAIR
(IN MILLIONS) VALUE VALUE VALUE VALUE
- ------------------------------------------------------------ ---------- ------------- ------------- -------------
<S> <C> <C> <C> <C>
FINANCIAL ASSETS
Cash and cash equivalents................................. $ 31.1 $ 31.1 $ 18.8 $ 18.8
Fixed maturities.......................................... 1,402.5 1,402.5 1,698.0 1,698.0
Equity securities......................................... 54.0 54.0 41.5 41.5
Mortgage loans............................................ 228.2 239.8 221.6 229.3
Policy loans.............................................. 140.1 140.1 131.7 131.7
Reinsurance receivables................................... 251.1 251.1 72.5 72.5
---------- ------------- ------------- -------------
2$,107.0 2$,118.6 2$,184.1 2$,191.8
---------- ------------- ------------- -------------
---------- ------------- ------------- -------------
FINANCIAL LIABILITIES
Individual annuity contracts.............................. 876.0 850.6 910.2 885.9
Supplemental contracts without life contingencies......... 15.3 15.3 15.9 15.9
Other individual contract deposit funds................... 0.3 0.3 0.3 0.3
---------- ------------- ------------- -------------
$891.6 $866.2 $926.4 $902.1
---------- ------------- ------------- -------------
---------- ------------- ------------- -------------
</TABLE>
6. DEBT
In 1997 the Company incurred no debt. During 1996, the Company utilized
repurchase agreements to finance certain investments.
Interest expense was $3.4 million in 1996, relating to the repurchase
agreements, and is recorded in other operating expenses.
F-15
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
7. FEDERAL INCOME TAXES
Provisions for federal income taxes have been calculated in accordance with the
provisions of SFAS No. 109. A summary of the federal income tax expense
(benefit) in the statement of income is shown below:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED DECEMBER 31,
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- ------
<S> <C> <C>
Federal income tax expense (benefit)
Current................................................... $ 13.9 $ 26.9
Deferred.................................................. 7.1 (9.8)
----- -----
Total....................................................... $ 21.0 $ 17.1
----- -----
----- -----
</TABLE>
The provision for federal income taxes does not materially differ from the
amount of federal income tax determined by applying the appropriate U.S.
statutory income tax rate to income before federal income taxes. The deferred
tax (assets) liabilities are comprised of the following at December 31, 1997:
<TABLE>
<CAPTION>
DECEMBER 31,
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Deferred tax (assets) liabilitie
Loss reserves............................................. $(175.8) $(137.0)
Deferred acquisition costs................................ 226.4 186.9
Investments, net.......................................... 27.0 14.2
Bad debt reserve.......................................... (2.0) (1.1)
Other, net................................................ 0.3 (2.8)
---------- -------------
Deferred tax liability, net............................... $ 75.9 $ 60.2
---------- -------------
---------- -------------
</TABLE>
Gross deferred income tax liabilities totaled $253.7 million and $201.1 million
at December 31, 1997 and 1996. Gross deferred income tax assets totaled $177.8
million and $140.9 at December 31, 1997 and 1996.
Management believes, based on the Company's recent earnings history and its
future expectations, that the Company's taxable income in future years will be
sufficient to realize all deferred tax assets. In determining the adequacy of
future income, management considered the future reversal of its existing
temporary differences and available tax planning strategies that could be
implemented, if necessary.
The Company's federal income tax returns are routinely audited by the IRS, and
provisions are routinely made in the financial statements in anticipation of the
results of these audits. The IRS has examined the life-nonlife consolidated
group's federal income tax returns through 1991. The Company is currently
considering its response to certain adjustments proposed by the IRS with respect
to the life-nonlife consolidated group's federal income tax returns for 1989,
1990, and 1991. In management's opinion, adequate tax liabilities have been
established for all years. However, the amount of these tax liabilities could be
revised in the near term if estimates of the Company's ultimate liability are
revised.
8. RELATED PARTY TRANSACTIONS
The Company has no employees of its own, but has agreements under which FAFLIC
provides management, space and other services, including accounting, electronic
data processing, human resources, legal and other staff functions. Charges for
these services are based on full cost including all direct and indirect overhead
costs, and amounted to $124.1 million and $112.4 million in 1997 and 1996. The
net amounts payable to FAFLIC and affiliates for accrued expenses and various
other liabilities and receivables were $15.0 million and $13.3 million at
December 31, 1997 and 1996.
F-16
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
9. DIVIDEND RESTRICTIONS
Delaware has enacted laws governing the payment of dividends to stockholders by
insurers. These laws affect the dividend paying ability of the Company.
Pursuant to Delaware's statute, the maximum amount of dividends and other
distributions that an insurer may pay in any twelve month period, without the
prior approval of the Delaware Commissioner of Insurance, is limited to the
greater of (i) 10% of its policyholders' surplus as of the preceding December 31
or (ii) the individual company's statutory net gain from operations for the
preceding calendar year (if such insurer is a life company) or its net income
(not including realized capital gains) for the preceding calendar year (if such
insurer is not a life company). Any dividends to be paid by an insurer, whether
or not in excess of the aforementioned threshold, from a source other than
statutory earned surplus would also require the prior approval of the Delaware
Commissioner of Insurance.
At January 1, 1998, AFLIAC could pay dividends of $33.9 million to FAFLIC
without prior approval.
10. REINSURANCE
In the normal course of business, the Company seeks to reduce the loss that may
arise from events that cause unfavorable underwriting results by reinsuring
certain levels of risk in various areas of exposure with other insurance
enterprises or reinsurers. Reinsurance transactions are accounted for in
accordance with the provisions of SFAS No. 113.
Amounts recoverable from reinsurers are estimated in a manner consistent with
the claim liability associated with the reinsured policy. Reinsurance contracts
do not relieve the Company from its obligations to policyholders. Failure of
reinsurers to honor their obligations could result in losses to the Company;
consequently, allowances are established for amounts deemed uncollectible. The
Company determines the appropriate amount of reinsurance based on evaluation of
the risks accepted and analyses prepared by consultants and reinsurers and on
market conditions (including the availability and pricing of reinsurance). The
Company also believes that the terms of its reinsurance contracts are consistent
with industry practice in that they contain standard terms with respect to lines
of business covered, limit and retention, arbitration and occurrence. Based on
its review of its reinsurers' financial statements and reputations in the
reinsurance marketplace, the Company believes that its reinsurers are
financially sound.
The effects of reinsurance were as follows:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED DECEMBER 31
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Insurance premiums:
Direct.................................................... $ 48.8 $ 53.3
Assumed................................................... 2.6 3.1
Ceded..................................................... (28.6) (23.7)
---------- ------
Net premiums................................................ $ 22.8 $ 32.7
---------- ------
---------- ------
Insurance and other individual policy benefits, claims,
losses and loss adjustment expenses:
Direct.................................................... $226.0 $206.4
Assumed................................................... 4.2 4.5
Ceded..................................................... (42.4) (18.3)
---------- ------
Net policy benefits, claims, losses and loss adjustment
expenses................................................... $187.8 $192.6
---------- ------
---------- ------
</TABLE>
F-17
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
11. DEFERRED POLICY ACQUISITION EXPENSES
The following reflects the changes to the deferred policy acquisition asset:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED DECEMBER 31
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Balance at beginning of year................................ $632.7 $555.7
Acquisition expenses deferred............................. 184.1 116.6
Amortized to expense during the year...................... (53.0) (49.9)
Adjustment to equity during the year...................... (10.2) 10.3
Adjustment for cession of disability income insurance..... (38.6) --
Adjustment for revision of universal life and variable
universal life insurance mortality assumptions.......... 50.3 --
---------- ------
Balance at end of year...................................... $765.3 $632.7
---------- ------
---------- ------
</TABLE>
On October 1, 1997, the Company revised the mortality assumptions for universal
life and variable universal life product lines. These revisions resulted in a
$50.3 million recapitalization of deferred policy acquisition costs.
12. LIABILITIES FOR INDIVIDUAL ACCIDENT AND HEALTH BENEFITS
The Company regularly updates its estimates of liabilities for future policy
benefits and outstanding claims, losses and loss adjustment expenses as new
information becomes available and further events occur which may impact the
resolution of unsettled claims. Changes in prior estimates are reflected in
results of operations in the year such changes are determined to be needed and
recorded.
The liability for future policy benefits and outstanding claims, losses and loss
adjustment expenses related to the Company's accident and health business was
$219.9 million and $226.2 million at December 31, 1997 and 1996. Accident and
health claim liabilities have been re-estimated for all prior years and were
increased by $-0- million in 1997 and $3.2 million in 1996. Due to the
reinsurance agreement whereby the Company has ceded substantially all of its
accident and health business to the Metropolitan, management believes that no
material adverse development of losses will occur. However, the amount of the
liabilities could be revised in the near term if the estimates are revised.
13. CONTINGENCIES
REGULATORY AND INDUSTRY DEVELOPMENTS
Unfavorable economic conditions may contribute to an increase in the number of
insurance companies that are under regulatory supervision. This may result in an
increase in mandatory assessments by state guaranty funds, or voluntary payments
by solvent insurance companies to cover losses to policyholders of insolvent or
rehabilitated companies. Mandatory assessments, which are subject to statutory
limits, can be partially recovered through a reduction in future premium taxes
in some states. The Company is not able to reasonably estimate the potential
effect on it of any such future assessments or voluntary payments.
LITIGATION
In July 1997, a lawsuit was instituted in Louisiana against Allmerica Financial
Corp. and certain of its subsidiaries by individual plaintiffs alleging fraud,
unfair or deceptive acts, breach of contract, misrepresentation and related
claims in the sale of life insurance policies. In October 1997, plaintiffs
voluntarily dismissed the Louisiana suit and refiled the action in Federal
District Court in Worcester, Massachusetts. The plaintiffs
F-18
<PAGE>
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
seek to be certified as a class. The case is in the early stages of discovery
and the Company is evaluating the claims. Although the Company believes it has
meritorious defenses to plaintiffs' claims, there can be no assurance that the
claims will be resolved on a basis which is satisfactory to the Company.
The Company has been named a defendant in various legal proceedings arising in
the normal course of business. In the opinion of management, based on the advice
of legal counsel, the ultimate resolution of these proceedings will not have a
material effect on the Company's financial statements. However, liabilities
related to these proceedings could be established in the near term if estimates
of the ultimate resolution of these proceedings are revised.
YEAR 2000
The Year 2000 Issue is the result of computer programs being written using two
digits rather than four to define the applicable year. Any of the Company's
computer programs that have date-sensitive software may recognize a date using
"00" as the year 1900 rather than the year 2000. This could result in a system
failure or miscalculations causing disruptions of operations, including, among
other things, a temporary inability to process transactions, send invoices, or
engage in similar normal business activities. Although the Company does not
believe that there is a material contingency associated with the Year 2000
project, there can be no assurance that exposure for material contingencies will
not arise.
14. STATUTORY FINANCIAL INFORMATION
The Company is required to file annual statements with state regulatory
authorities prepared on an accounting basis prescribed or permitted by such
authorities (statutory basis). Statutory surplus differs from shareholder's
equity reported in accordance with generally accepted accounting principles for
stock life insurance companies primarily because policy acquisition costs are
expensed when incurred, investment reserves are based on different assumptions,
life insurance reserves are based on different assumptions and income tax
expense reflects only taxes paid or currently payable. Statutory net income and
surplus are as follows:
<TABLE>
<CAPTION>
(IN MILLIONS) 1997 1996
- ------------------------------------------------------------ ---------- -------------
<S> <C> <C>
Statutory net income........................................ $ 31.5 $ 5.4
Statutory Surplus........................................... $307.1 $234.0
---------- ------
---------- ------
</TABLE>
F-19
<PAGE>
REPORT OF INDEPENDENT ACCOUNTANTS
To the Board of Directors of Allmerica Financial Life Insurance and Annuity
Company and Policyowners of the VEL II Account of Allmerica Financial Life
Insurance and Annuity Company
In our opinion, the accompanying statements of assets and liabilities and the
related statements of operations and of changes in net assets present fairly, in
all material respects, the financial position of each of the Sub-Accounts
(Growth, Investment Grade Income, Money Market, Equity Index, Government Bond,
Select Aggressive Growth. Select Growth and Income, Select Value Opportunity,
Select International Equity, Select Capital Appreciation, Fidelity VIP High
Income, Fidelity VIP Equity-Income, Fidelity VIP Growth, Fidelity VIP Overseas,
Fidelity VIP II Asset Manager, T. Rowe Price International Stock, and DGPF
International Equity) constituting the VEL II Account of Allmerica Financial
Life Insurance and Annuity Company at December 31, 1997, the results of each of
their operations and the changes in each of their net assets for the periods
indicated, in conformity with generally accepted accounting principles. These
financial statements are the responsibility of Allmerica Financial Life
Insurance and Annuity Company's management; our responsibility is to express an
opinion on these financial statements based on our audits. We conducted our
audits of these financial statements in accordance with generally accepted
auditing standards which require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and
evaluating the overall financial statement presentation. We believe that our
audits, which included confirmation of investments at December 31, 1997 by
correspondence with the Funds, provide a reasonable basis for the opinion
expressed above.
/s/ Price Waterhouse LLP
PRICE WATERHOUSE LLP
Boston, Massachusetts
March 25, 1998
<PAGE>
VEL II ACCOUNT
STATEMENTS OF ASSETS AND LIABILITIES
DECEMBER 31, 1997
<TABLE>
<CAPTION>
INVESTMENT
GROWTH GRADE INCOME MONEY MARKET EQUITY INDEX GOVERNMENT BOND
----------- ------------ ------------ ------------ ---------------
<S> <C> <C> <C> <C> <C>
ASSETS (NOTES 3 AND 6):
Investments in shares of Allmerica
Investment Trust.......................... $24,185,289 $6,972,182 $7,522,775 $13,449,393 $1,918,563
Investments in shares of Fidelity Variable
Insurance Products Funds (VIP)............ -- -- -- -- --
Investment in shares of T. Rowe Price
International Series, Inc................. -- -- -- -- --
Investment in shares of Delaware Group
Premium Fund, Inc......................... -- -- -- -- --
----------- ------------ ------------ ------------ ---------------
Total assets.............................. 24,185,289 6,972,182 7,522,775 13,449,393 1,918,563
LIABILITIES: -- -- -- -- --
----------- ------------ ------------ ------------ ---------------
Net assets................................ $24,185,289 $6,972,182 $7,522,775 $13,449,393 $1,918,563
----------- ------------ ------------ ------------ ---------------
----------- ------------ ------------ ------------ ---------------
Net asset distribution by category:
Variable life policies.................... $24,185,289 $6,972,182 $7,522,775 $13,449,393 $1,918,563
----------- ------------ ------------ ------------ ---------------
----------- ------------ ------------ ------------ ---------------
Units outstanding,
December 31, 1997......................... 11,704,964 5,548,476 6,351,008 5,990,322 1,585,026
Net asset value per unit,
December 31, 1997......................... $ 2.066242 $ 1.256594 $ 1.184501 $ 2.245187 $ 1.210430
<CAPTION>
SELECT SELECT SELECT VALUE
AGGRESSIVE GROWTH SELECT GROWTH GROWTH AND INCOME OPPORTUNITY**
----------------- -------------- ------------------ ------------
<S> <C> <C> <C> <C>
ASSETS (NOTES 3 AND 6):
Investments in shares of Allmerica
Investment Trust.......................... $27,443,264 $13,875,988 $10,308,497 $14,048,150
Investments in shares of Fidelity Variable
Insurance Products Funds (VIP)............ -- -- -- --
Investment in shares of T. Rowe Price
International Series, Inc................. -- -- -- --
Investment in shares of Delaware Group
Premium Fund, Inc......................... -- -- -- --
----------------- -------------- ------------------ ------------
Total assets.............................. 27,443,264 13,875,988 10,308,497 14,048,150
LIABILITIES: -- -- -- --
----------------- -------------- ------------------ ------------
Net assets................................ $27,443,264 $13,875,988 $10,308,497 $14,048,150
----------------- -------------- ------------------ ------------
----------------- -------------- ------------------ ------------
Net asset distribution by category:
Variable life policies.................... $27,443,264 $13,875,988 $10,308,497 $14,048,150
----------------- -------------- ------------------ ------------
----------------- -------------- ------------------ ------------
Units outstanding,
December 31, 1997......................... 14,290,970 6,841,599 5,299,227 7,193,744
Net asset value per unit,
December 31, 1997......................... $ 1.920322 $ 2.028179 $ 1.945283 $ 1.952829
</TABLE>
** Name changed. See Note 1.
The accompanying notes are an integral part of these financial statements.
SA-1
<PAGE>
VEL II ACCOUNT
STATEMENTS OF ASSETS AND LIABILITIES (CONTINUED)
DECEMBER 31, 1997
<TABLE>
<CAPTION>
FIDELITY FIDELITY
SELECT SELECT FIDELITY VIP VIP VIP
INTERNATIONAL EQUITY CAPITAL APPRECIATION HIGH INCOME EQUITY-INCOME GROWTH
--------------------- --------------------- ------------ ------------- ------------
<S> <C> <C> <C> <C> <C>
ASSETS (NOTES 3 AND 6):
Investments in shares of Allmerica
Investment Trust.......................... $12,244,949 $ 9,106,746 $ -- $ -- $ --
Investments in shares of Fidelity Variable
Insurance Products Funds (VIP)............ -- -- 12,529,100 42,253,743 37,994,280
Investment in shares of T. Rowe Price
International Series, Inc................. -- -- -- -- --
Investment in shares of Delaware Group
Premium Fund, Inc......................... -- -- -- -- --
--------------------- ----------- ------------ ------------- ------------
Total assets.............................. 12,244,949 9,106,746 12,529,100 42,253,743 37,994,280
LIABILITIES: -- -- -- -- --
--------------------- ----------- ------------ ------------- ------------
Net assets................................ $12,244,949 $ 9,106,746 $12,529,100 $42,253,743 $37,994,280
--------------------- ----------- ------------ ------------- ------------
--------------------- ----------- ------------ ------------- ------------
Net asset distribution by category:
Variable life policies.................... $12,244,949 $ 9,106,746 $12,529,100 $42,253,743 $37,994,280
--------------------- ----------- ------------ ------------- ------------
--------------------- ----------- ------------ ------------- ------------
Units outstanding,
December 31, 1997......................... 8,612,426 5,377,150 7,725,005 19,334,371 19,110,533
Net asset value per unit,
December 31, 1997......................... $ 1.421777 $ 1.693601 $ 1.621889 $ 2.185421 $ 1.988133
<CAPTION>
FIDELITY FIDELITY
VIP VIP II T. ROWE PRICE DGPF
OVERSEAS ASSET MANAGER INTERNATIONAL STOCK INTERNATIONAL EQUITY
------------ ------------- ------------------- --------------------
<S> <C> <C> <C> <C>
ASSETS (NOTES 3 AND 6):
Investments in shares of Allmerica
Investment Trust.......................... $ -- $ -- $ -- $ --
Investments in shares of Fidelity Variable
Insurance Products Funds (VIP)............ 10,388,531 3,652,492 -- --
Investment in shares of T. Rowe Price
International Series, Inc................. -- -- 4,113,549 --
Investment in shares of Delaware Group
Premium Fund, Inc......................... -- -- -- 7,956,053
------------ ------------- ------------------- -----------
Total assets.............................. 10,388,531 3,652,492 4,113,549 7,956,053
LIABILITIES: -- -- -- --
------------ ------------- ------------------- -----------
Net assets................................ $10,388,531 $3,652,492 $4,113,549 $7,956,053
------------ ------------- ------------------- -----------
------------ ------------- ------------------- -----------
Net asset distribution by category:
Variable life policies.................... $10,388,531 $3,652,492 $4,113,549 $7,956,053
------------ ------------- ------------------- -----------
------------ ------------- ------------------- -----------
Units outstanding,
December 31, 1997......................... 6,886,585 2,356,886 3,351,190 4,881,305
Net asset value per unit,
December 31, 1997......................... $ 1.508517 $ 1.549711 $ 1.227489 $ 1.629903
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-2
<PAGE>
VEL II ACCOUNT
STATEMENTS OF OPERATIONS
<TABLE>
<CAPTION>
GROWTH INVESTMENT GRADE INCOME
FOR THE YEAR ENDED DECEMBER 31, FOR THE YEAR ENDED DECEMBER 31,
------------------------------------- -------------------------------
1997 1996 1995 1997 1996 1995
----------- ----------- ----------- --------- --------- ---------
<S> <C> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 283,355 $ 206,184 $ 129,684 $ 407,722 $ 326,845 $ 241,196
----------- ----------- ----------- --------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 116,436 65,259 47,437 38,709 33,445 31,269
Administrative expense
fees.................... 32,345 18,128 13,177 10,754 9,291 8,686
----------- ----------- ----------- --------- --------- ---------
Total expenses.......... 148,781 83,387 60,614 49,463 42,736 39,955
----------- ----------- ----------- --------- --------- ---------
Net investment income
(loss).................. 134,574 122,797 69,070 358,259 284,109 201,241
----------- ----------- ----------- --------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON
INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 3,803,334 1,122,802 536,820 -- -- --
Net realized gain (loss)
from sales of
investments............. 13,705 16,012 5,655 4,905 3,288 (901)
----------- ----------- ----------- --------- --------- ---------
Net realized gain
(loss)................ 3,817,039 1,138,814 542,475 4,905 3,288 (901)
Net unrealized gain
(loss).................. (302,672) 475,209 787,522 157,561 (130,047) 324,379
----------- ----------- ----------- --------- --------- ---------
Net realized and
unrealized gain
(loss)................ 3,514,367 1,614,023 1,329,997 162,466 (126,759) 323,478
----------- ----------- ----------- --------- --------- ---------
Net increase in net
assets from
operations............ $ 3,648,941 $ 1,736,820 $ 1,399,067 $ 520,725 $ 157,350 $ 524,719
----------- ----------- ----------- --------- --------- ---------
----------- ----------- ----------- --------- --------- ---------
<CAPTION>
MONEY MARKET EQUITY INDEX
FOR THE YEAR ENDED DECEMBER 31, FOR THE YEAR ENDED DECEMBER 31,
------------------------------- ---------------------------------
1997 1996 1995 1997 1996 1995
--------- --------- --------- ----------- --------- ---------
<S> <C> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 380,873 $ 258,693 $ 242,819 $ 120,956 $ 58,986 $ 12,705
--------- --------- --------- ----------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 44,692 33,783 38,093 54,835 21,545 14,209
Administrative expense
fees.................... 12,415 9,385 10,581 15,233 5,985 3,947
--------- --------- --------- ----------- --------- ---------
Total expenses.......... 57,107 43,168 48,674 70,068 27,530 18,156
--------- --------- --------- ----------- --------- ---------
Net investment income
(loss).................. 323,766 215,525 194,145 50,888 31,456 (5,451)
--------- --------- --------- ----------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON
INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... -- -- -- 358,920 70,001 120,730
Net realized gain (loss)
from sales of
investments............. -- -- -- 18,631 13,660 9,558
--------- --------- --------- ----------- --------- ---------
Net realized gain
(loss)................ -- -- -- 377,551 83,661 130,288
Net unrealized gain
(loss).................. -- -- -- 1,740,965 523,125 330,836
--------- --------- --------- ----------- --------- ---------
Net realized and
unrealized gain
(loss)................ -- -- -- 2,118,516 606,786 461,124
--------- --------- --------- ----------- --------- ---------
Net increase in net
assets from
operations............ $ 323,766 $ 215,525 $ 194,145 $ 2,169,404 $ 638,242 $ 455,673
--------- --------- --------- ----------- --------- ---------
--------- --------- --------- ----------- --------- ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-3
<PAGE>
VEL II ACCOUNT
STATEMENTS OF OPERATIONS (CONTINUED)
<TABLE>
<CAPTION>
GOVERNMENT BOND SELECT AGGRESSIVE GROWTH
FOR THE YEAR FOR THE YEAR
ENDED ENDED
DECEMBER 31, DECEMBER 31,
----------------------------------- -------------------------------------
1997 1996 1995 1997 1996 1995
--------- ----------- ----------- ----------- ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 104,946 $ 86,148 $ 74,840 $ -- $ -- $ --
--------- ----------- ----------- ----------- ----------- -----------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 11,118 9,827 11,239 143,062 92,527 67,216
Administrative expense
fees.................... 3,088 2,730 3,122 39,742 25,703 18,671
--------- ----------- ----------- ----------- ----------- -----------
Total expenses.......... 14,206 12,557 14,361 182,804 118,230 85,887
--------- ----------- ----------- ----------- ----------- -----------
Net investment income
(loss).................. 90,740 73,591 60,479 (182,804) (118,230) (85,887)
--------- ----------- ----------- ----------- ----------- -----------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... -- -- -- 2,145,475 1,196,236 --
Net realized gain (loss)
from sales of
investments............. (3,012) (2,403) (13,206) 85,955 52,019 9,893
--------- ----------- ----------- ----------- ----------- -----------
Net realized gain
(loss)................ (3,012) (2,403) (13,206) 2,231,430 1,248,255 9,893
Net unrealized gain
(loss).................. 21,888 (32,151) 94,918 1,740,371 983,776 2,062,137
--------- ----------- ----------- ----------- ----------- -----------
Net realized and
unrealized gain
(loss)................ 18,876 (34,554) 81,712 3,971,801 2,232,031 2,072,030
--------- ----------- ----------- ----------- ----------- -----------
Net increase in net
assets from
operations............ $ 109,616 $ 39,037 $ 142,191 $ 3,788,997 $ 2,113,801 $ 1,986,143
--------- ----------- ----------- ----------- ----------- -----------
--------- ----------- ----------- ----------- ----------- -----------
<CAPTION>
SELECT GROWTH SELECT GROWTH AND INCOME
FOR THE YEAR FOR THE YEAR
ENDED ENDED
DECEMBER 31, DECEMBER 31,
--------------------------------- ---------------------------------
1997 1996 1995 1997 1996 1995
----------- --------- --------- ----------- --------- ---------
<S> <C> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 39,996 $ 17,349 $ 432 $ 110,140 $ 65,013 $ 43,005
----------- --------- --------- ----------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 61,074 27,144 20,827 51,419 29,966 22,472
Administrative expense
fees.................... 16,966 7,540 5,786 14,284 8,324 6,242
----------- --------- --------- ----------- --------- ---------
Total expenses.......... 78,040 34,684 26,613 65,703 38,290 28,714
----------- --------- --------- ----------- --------- ---------
Net investment income
(loss).................. (38,044) (17,335) (26,181) 44,437 26,723 14,291
----------- --------- --------- ----------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 704,995 830,250 -- 875,928 411,607 126,190
Net realized gain (loss)
from sales of
investments............. 15,462 35,539 13,636 25,787 30,955 6,805
----------- --------- --------- ----------- --------- ---------
Net realized gain
(loss)................ 720,457 865,789 13,636 901,715 442,562 132,995
Net unrealized gain
(loss).................. 1,960,237 (97,967) 447,503 593,928 357,212 488,877
----------- --------- --------- ----------- --------- ---------
Net realized and
unrealized gain
(loss)................ 2,680,694 767,822 461,139 1,495,643 799,774 621,872
----------- --------- --------- ----------- --------- ---------
Net increase in net
assets from
operations............ $ 2,642,650 $ 750,487 $ 434,958 $ 1,540,080 $ 826,497 $ 636,163
----------- --------- --------- ----------- --------- ---------
----------- --------- --------- ----------- --------- ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-4
<PAGE>
VEL II ACCOUNT
STATEMENTS OF OPERATIONS (CONTINUED)
<TABLE>
<CAPTION>
SELECT INTERNATIONAL
SELECT VALUE OPPORTUNITY** EQUITY
FOR THE YEAR FOR THE YEAR
ENDED ENDED
DECEMBER 31, DECEMBER 31,
----------------------------------- --------------------
1997 1996 1995 1997 1996
----------- ----------- --------- --------- ---------
<S> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 76,994 $ 53,312 $ 29,297 $ 276,917 $ 119,061
----------- ----------- --------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 66,512 38,196 29,314 60,368 25,452
Administrative expense
fees.................... 18,476 10,611 8,142 16,769 7,070
----------- ----------- --------- --------- ---------
Total expenses.......... 84,988 48,807 37,456 77,137 32,522
----------- ----------- --------- --------- ---------
Net investment income
(loss).................. (7,994) 4,505 (8,159) 199,780 86,539
----------- ----------- --------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 1,853,239 338,499 109,702 385,980 14,019
Net realized gain (loss)
from sales of
investments............. 31,580 19,554 10,514 21,396 3,792
----------- ----------- --------- --------- ---------
Net realized gain
(loss)................ 1,884,819 358,053 120,216 407,376 17,811
Net unrealized gain
(loss).................. 400,302 994,751 385,149 (359,194) 719,795
----------- ----------- --------- --------- ---------
Net realized and
unrealized gain
(loss)................ 2,285,121 1,352,804 505,365 48,182 737,606
----------- ----------- --------- --------- ---------
Net increase in net
assets from
operations............ $ 2,277,127 $ 1,357,309 $ 497,206 $ 247,962 $ 824,145
----------- ----------- --------- --------- ---------
----------- ----------- --------- --------- ---------
<CAPTION>
SELECT CAPITAL APPRECIATION FIDELITY VIP HIGH INCOME
FOR THE YEAR FOR THE YEAR
ENDED ENDED
DECEMBER 31, FOR THE PERIOD DECEMBER 31,
---------------------- 4/28/95* TO ---------------------------------
1995 1997 1996 12/31/95 1997 1996 1995
--------- ----------- --------- -------------------- ----------- --------- ---------
<S> <C> <C> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 20,203 $ -- $ -- $17,885 $ 559,997 $ 350,078 $ 177,656
--------- ----------- --------- ------- ----------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 10,284 44,096 17,100 1,885 62,697 39,682 30,208
Administrative expense
fees.................... 2,857 12,249 4,750 524 17,417 11,023 8,391
--------- ----------- --------- ------- ----------- --------- ---------
Total expenses.......... 13,141 56,345 21,850 2,409 80,114 50,705 38,599
--------- ----------- --------- ------- ----------- --------- ---------
Net investment income
(loss).................. 7,062 (56,345) (21,850) 15,476 479,883 299,373 139,057
--------- ----------- --------- ------- ----------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 7,587 -- 7,014 -- 69,213 68,494 --
Net realized gain (loss)
from sales of
investments............. 7,234 29,423 7,676 94 13,499 20,404 1,925
--------- ----------- --------- ------- ----------- --------- ---------
Net realized gain
(loss)................ 14,821 29,423 14,690 94 82,712 88,898 1,925
Net unrealized gain
(loss).................. 170,527 1,139,908 64,919 64,003 990,433 319,076 422,411
--------- ----------- --------- ------- ----------- --------- ---------
Net realized and
unrealized gain
(loss)................ 185,348 1,169,331 79,609 64,097 1,073,145 407,974 424,336
--------- ----------- --------- ------- ----------- --------- ---------
Net increase in net
assets from
operations............ $ 192,410 $ 1,112,986 $ 57,759 $79,573 $ 1,553,028 $ 707,347 $ 563,393
--------- ----------- --------- ------- ----------- --------- ---------
--------- ----------- --------- ------- ----------- --------- ---------
</TABLE>
* Date of initial investment.
** Name changed. See Note 1.
The accompanying notes are an integral part of these financial statements.
SA-5
<PAGE>
VEL II ACCOUNT
STATEMENTS OF OPERATIONS (CONTINUED)
<TABLE>
<CAPTION>
FIDELITY VIP EQUITY-INCOME FIDELITY VIP GROWTH
FOR THE YEAR ENDED DECEMBER 31, FOR THE YEAR ENDED DECEMBER 31,
------------------------------------- -------------------------------------
1997 1996 1995 1997 1996 1995
----------- ----------- ----------- ----------- ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 471,623 $ 27,058 $ 301,374 $ 179,959 $ 45,598 $ 46,838
----------- ----------- ----------- ----------- ----------- -----------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 215,740 144,230 110,955 202,868 142,781 111,534
Administrative expense
fees.................... 59,931 40,066 30,821 56,355 39,664 30,982
----------- ----------- ----------- ----------- ----------- -----------
Total expenses.......... 275,671 184,296 141,776 259,223 182,445 142,516
----------- ----------- ----------- ----------- ----------- -----------
Net investment income
(loss).................. 195,952 (157,238) 159,598 (79,264) (136,847) (95,678)
----------- ----------- ----------- ----------- ----------- -----------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 2,371,217 775,651 441,909 805,529 1,151,351 --
Net realized gain (loss)
from sales of
investments............. 89,970 43,028 7,785 102,342 38,097 9,207
----------- ----------- ----------- ----------- ----------- -----------
Net realized gain
(loss)................ 2,461,187 818,679 449,694 907,871 1,189,448 9,207
Net unrealized gain
(loss).................. 5,395,541 2,101,563 2,929,112 5,592,661 1,555,911 3,349,417
----------- ----------- ----------- ----------- ----------- -----------
Net realized and
unrealized gain
(loss)................ 7,856,728 2,920,242 3,378,806 6,500,532 2,745,359 3,358,624
----------- ----------- ----------- ----------- ----------- -----------
Net increase in net
assets from
operations............ $ 8,052,680 $ 2,763,004 $ 3,538,404 $ 6,421,268 $ 2,608,512 $ 3,262,946
----------- ----------- ----------- ----------- ----------- -----------
----------- ----------- ----------- ----------- ----------- -----------
<CAPTION>
FIDELITY VIP OVERSEAS
FOR THE YEAR ENDED DECEMBER 31,
-------------------------------
1997 1996 1995
--------- --------- ---------
<S> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 164,581 $ 85,914 $ 19,971
--------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 63,163 57,395 56,407
Administrative expense
fees.................... 17,547 15,944 15,669
--------- --------- ---------
Total expenses.......... 80,710 73,339 72,076
--------- --------- ---------
Net investment income
(loss).................. 83,871 12,575 (52,105)
--------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 653,336 94,506 19,972
Net realized gain (loss)
from sales of
investments............. 137,675 66,545 16,418
--------- --------- ---------
Net realized gain
(loss)................ 791,011 161,051 36,390
Net unrealized gain
(loss).................. 100,802 804,672 573,790
--------- --------- ---------
Net realized and
unrealized gain
(loss)................ 891,813 965,723 610,180
--------- --------- ---------
Net increase in net
assets from
operations............ $ 975,684 $ 978,298 $ 558,075
--------- --------- ---------
--------- --------- ---------
<CAPTION>
FIDELITY VIP II
ASSET MANAGER
FOR THE YEAR ENDED DECEMBER 31,
-------------------------------
1997 1996 1995
--------- --------- ---------
INVESTMENT INCOME:
Dividends................. $ 74,088 $ 57,493 $ 20,108
--------- --------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 17,355 12,103 11,899
Administrative expense
fees.................... 4,822 3,362 3,305
--------- --------- ---------
Total expenses.......... 22,177 15,465 15,204
--------- --------- ---------
Net investment income
(loss).................. 51,911 42,028 4,904
--------- --------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 185,848 47,406 --
Net realized gain (loss)
from sales of
investments............. 18,276 25,651 11,836
--------- --------- ---------
Net realized gain
(loss)................ 204,124 73,057 11,836
Net unrealized gain
(loss).................. 230,651 117,171 184,941
--------- --------- ---------
Net realized and
unrealized gain
(loss)................ 434,775 190,228 196,777
--------- --------- ---------
Net increase in net
assets from
operations............ $ 486,686 $ 232,256 $ 201,681
--------- --------- ---------
--------- --------- ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-6
<PAGE>
VEL II ACCOUNT
STATEMENTS OF OPERATIONS (CONTINUED)
<TABLE>
<CAPTION>
DGPF
INTERNATIONAL
EQUITY
FOR THE
T. ROWE PRICE INTERNATIONAL STOCK YEAR
FOR THE YEAR ENDED
ENDED DECEMBER
DECEMBER 31, FOR THE PERIOD 31,
-------------------- 6/21/95* TO ---------
1997 1996 12/31/95 1997
--------- --------- ----------------------- ---------
<S> <C> <C> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 37,234 $ 17,766 $ -- $ 197,248
--------- --------- ------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 19,910 6,461 882 43,126
Administrative expense
fees.................... 5,530 1,795 245 11,980
--------- --------- ------- ---------
Total expenses.......... 25,440 8,256 1,127 55,106
--------- --------- ------- ---------
Net investment income
(loss).................. 11,794 9,510 (1,127) 142,142
--------- --------- ------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON
INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 52,748 10,233 -- --
Net realized gain (loss)
from sales of
investments............. 7,824 6,686 (76) 38,749
--------- --------- ------- ---------
Net realized gain
(loss)................. 60,572 16,919 (76) 38,749
Net unrealized gain
(loss).................. (67,400) 106,328 13,064 102,792
--------- --------- ------- ---------
Net realized and
unrealized gain
(loss)................. (6,828) 123,247 12,988 141,541
--------- --------- ------- ---------
Net increase in net
assets from
operations............. $ 4,966 $ 132,757 $11,861 $ 283,683
--------- --------- ------- ---------
--------- --------- ------- ---------
<CAPTION>
1996 1995
--------- ---------
<S> <C> <C>
INVESTMENT INCOME:
Dividends................. $ 105,224 $ 32,943
--------- ---------
EXPENSES (NOTE 4):
Mortality and expense risk
fees.................... 27,458 21,047
Administrative expense
fees.................... 7,627 5,846
--------- ---------
Total expenses.......... 35,085 26,893
--------- ---------
Net investment income
(loss).................. 70,139 6,050
--------- ---------
REALIZED AND UNREALIZED GAIN
(LOSS) ON
INVESTMENTS:
Realized gain
distributions from
portfolio sponsors...... 28,310 12,354
Net realized gain (loss)
from sales of
investments............. 27,242 2,810
--------- ---------
Net realized gain
(loss)................. 55,552 15,164
Net unrealized gain
(loss).................. 593,576 266,755
--------- ---------
Net realized and
unrealized gain
(loss)................. 649,128 281,919
--------- ---------
Net increase in net
assets from
operations............. $ 719,267 $ 287,969
--------- ---------
--------- ---------
</TABLE>
* Date of initial investment.
The accompanying notes are an integral part of these financial statements.
SA-7
<PAGE>
VEL II ACCOUNT
STATEMENTS OF CHANGES IN NET ASSETS
<TABLE>
<CAPTION>
GROWTH INVESTMENT GRADE INCOME
YEAR ENDED YEAR ENDED
DECEMBER 31, DECEMBER 31,
--------------------------------------- -------------------------------------
1997 1996 1995 1997 1996 1995
------------ ------------ ----------- ----------- ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ 134,574 $ 122,797 $ 69,070 $ 358,259 $ 284,109 $ 201,241
Net realized gain
(loss)................ 3,817,039 1,138,814 542,475 4,905 3,288 (901)
Net unrealized gain
(loss)................ (302,672) 475,209 787,522 157,561 (130,047) 324,379
------------ ------------ ----------- ----------- ----------- -----------
Net increase in net
assets from
operations............ 3,648,941 1,736,820 1,399,067 520,725 157,350 524,719
------------ ------------ ----------- ----------- ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 5,187,881 3,576,337 2,087,620 1,556,516 1,593,863 1,270,897
Terminations............ (288,326) (163,133) (71,002) (144,261) (160,699) (63,109)
Insurance and other
charges............... (1,328,256) (794,780) (529,201) (479,054) (443,364) (387,658)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... 4,045,176 1,335,293 788,786 (195,265) 283,487 164,011
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- -- --
------------ ------------ ----------- ----------- ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions.......... 7,616,475 3,953,717 2,276,203 737,936 1,273,287 984,141
------------ ------------ ----------- ----------- ----------- -----------
Net increase (decrease)
in net assets......... 11,265,416 5,690,537 3,675,270 1,258,661 1,430,637 1,508,860
NET ASSETS:
Beginning of period....... 12,919,873 7,229,336 3,554,066 5,713,521 4,282,884 2,774,024
------------ ------------ ----------- ----------- ----------- -----------
End of period............. $ 24,185,289 $ 12,919,873 $ 7,229,336 $ 6,972,182 $ 5,713,521 $ 4,282,884
------------ ------------ ----------- ----------- ----------- -----------
------------ ------------ ----------- ----------- ----------- -----------
<CAPTION>
MONEY MARKET EQUITY INDEX
YEAR ENDED YEAR ENDED
DECEMBER 31, DECEMBER 31,
------------------------------------- --------------------------------------
1997 1996 1995 1997 1996 1995
----------- ----------- ----------- ------------ ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ 323,766 $ 215,525 $ 194,145 $ 50,888 $ 31,456 $ (5,451)
Net realized gain
(loss)................ -- -- -- 377,551 83,661 130,288
Net unrealized gain
(loss)................ -- -- -- 1,740,965 523,125 330,836
----------- ----------- ----------- ------------ ----------- -----------
Net increase in net
assets from
operations............ 323,766 215,525 194,145 2,169,404 638,242 455,673
----------- ----------- ----------- ------------ ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 8,532,423 6,749,544 4,953,921 3,434,564 1,507,147 690,804
Terminations............ (394,510) (77,221) (56,249) (133,574) (62,433) (36,353)
Insurance and other
charges............... (1,155,011) (965,654) (718,149) (732,490) (292,375) (152,104)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... (6,865,628) (3,500,485) (3,196,213) 3,869,568 823,638 238,989
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- -- --
----------- ----------- ----------- ------------ ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions.......... 117,274 2,206,184 983,310 6,438,068 1,975,977 741,336
----------- ----------- ----------- ------------ ----------- -----------
Net increase (decrease)
in net assets......... 441,040 2,421,709 1,177,455 8,607,472 2,614,219 1,197,009
NET ASSETS:
Beginning of period....... 7,081,735 4,660,026 3,482,571 4,841,921 2,227,702 1,030,693
----------- ----------- ----------- ------------ ----------- -----------
End of period............. $ 7,522,775 $ 7,081,735 $ 4,660,026 $ 13,449,393 $ 4,841,921 $ 2,227,702
----------- ----------- ----------- ------------ ----------- -----------
----------- ----------- ----------- ------------ ----------- -----------
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-8
<PAGE>
VEL II ACCOUNT
STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)
<TABLE>
<CAPTION>
GOVERNMENT BOND SELECT AGGRESSIVE GROWTH
YEAR YEAR
ENDED ENDED
DECEMBER 31, DECEMBER 31,
------------------------------------- ----------------------------------------
1997 1996 1995 1997 1996 1995
----------- ----------- ----------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ 90,740 $ 73,591 $ 60,479 $ (182,804) $ (118,230) $ (85,887)
Net realized gain
(loss)................ (3,012) (2,403) (13,206) 2,231,430 1,248,255 9,893
Net unrealized gain
(loss)................ 21,888 (32,151) 94,918 1,740,371 983,776 2,062,137
----------- ----------- ----------- ------------ ------------ ------------
Net increase in net
assets from
operations............ 109,616 39,037 142,191 3,788,997 2,113,801 1,986,143
----------- ----------- ----------- ------------ ------------ ------------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 653,635 755,854 643,512 6,131,806 4,891,290 3,199,437
Terminations............ (45,711) (21,159) (21,022) (473,349) (324,067) (158,752)
Insurance and other
charges............... (254,593) (284,369) (273,667) (1,625,760) (1,136,275) (780,631)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... (157,204) (210,735) (565,064) 1,956,809 2,022,570 886,738
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- -- --
----------- ----------- ----------- ------------ ------------ ------------
Net increase (decrease)
in net assets from
capital
transactions.......... 196,127 239,591 (216,241) 5,989,506 5,453,518 3,146,792
----------- ----------- ----------- ------------ ------------ ------------
Net increase (decrease)
in net assets......... 305,743 278,628 (74,050) 9,778,503 7,567,319 5,132,935
NET ASSETS:
Beginning of period....... 1,612,820 1,334,192 1,408,242 17,664,761 10,097,442 4,964,507
----------- ----------- ----------- ------------ ------------ ------------
End of period............. $ 1,918,563 $ 1,612,820 $ 1,334,192 $ 27,443,264 $ 17,664,761 $ 10,097,442
----------- ----------- ----------- ------------ ------------ ------------
----------- ----------- ----------- ------------ ------------ ------------
<CAPTION>
SELECT GROWTH SELECT GROWTH AND INCOME
YEAR YEAR
ENDED ENDED
DECEMBER 31, DECEMBER 31,
-------------------------------------- --------------------------------------
1997 1996 1995 1997 1996 1995
------------ ----------- ----------- ------------ ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ (38,044) $ (17,335) $ (26,181) $ 44,437 $ 26,723 $ 14,291
Net realized gain
(loss)................ 720,457 865,789 13,636 901,715 442,562 132,995
Net unrealized gain
(loss)................ 1,960,237 (97,967) 447,503 593,928 357,212 488,877
------------ ----------- ----------- ------------ ----------- -----------
Net increase in net
assets from
operations............ 2,642,650 750,487 434,958 1,540,080 826,497 636,163
------------ ----------- ----------- ------------ ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 3,046,076 1,471,312 855,190 2,186,957 1,458,393 1,013,420
Terminations............ (99,899) (133,417) (46,595) (144,681) (115,094) (58,542)
Insurance and other
charges............... (658,772) (305,175) (216,864) (596,095) (371,473) (257,771)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... 3,001,708 1,207,033 400,438 1,393,412 756,071 321,955
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- -- --
------------ ----------- ----------- ------------ ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions.......... 5,289,113 2,239,753 992,169 2,839,593 1,727,897 1,019,062
------------ ----------- ----------- ------------ ----------- -----------
Net increase (decrease)
in net assets......... 7,931,763 2,990,240 1,427,127 4,379,673 2,554,394 1,655,225
NET ASSETS:
Beginning of period....... 5,944,225 2,953,985 1,526,858 5,928,824 3,374,430 1,719,205
------------ ----------- ----------- ------------ ----------- -----------
End of period............. $ 13,875,988 $ 5,944,225 $ 2,953,985 $ 10,308,497 $ 5,928,824 $ 3,374,430
------------ ----------- ----------- ------------ ----------- -----------
------------ ----------- ----------- ------------ ----------- -----------
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-9
<PAGE>
VEL II ACCOUNT
STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)
<TABLE>
<CAPTION>
SELECT VALUE OPPORTUNITY** SELECT INTERNATIONAL EQUITY
YEAR YEAR
ENDED ENDED
DECEMBER 31, DECEMBER 31,
-------------------------------------- --------------------------------------
1997 1996 1995 1997 1996 1995
------------ ----------- ----------- ------------ ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ (7,994) $ 4,505 $ (8,159) $ 199,780 $ 86,539 $ 7,062
Net realized gain
(loss)................ 1,884,819 358,053 120,216 407,376 17,811 14,821
Net unrealized gain
(loss)................ 400,302 994,751 385,149 (359,194) 719,795 170,527
------------ ----------- ----------- ------------ ----------- -----------
Net increase in net
assets from
operations............ 2,277,127 1,357,309 497,206 247,962 824,145 192,410
------------ ----------- ----------- ------------ ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 3,004,320 1,861,028 1,411,066 3,615,659 2,183,184 841,681
Terminations............ (191,453) (140,220) (60,789) (123,443) (48,303) (13,798)
Insurance and other
charges............... (704,362) (422,764) (324,932) (736,991) (367,224) (136,659)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... 1,860,980 979,101 416,643 2,767,585 1,767,463 781,868
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- (132) --
------------ ----------- ----------- ------------ ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions.......... 3,969,485 2,277,145 1,441,988 5,522,810 3,534,988 1,473,092
------------ ----------- ----------- ------------ ----------- -----------
Net increase (decrease)
in net assets......... 6,246,612 3,634,454 1,939,194 5,770,772 4,359,133 1,665,502
NET ASSETS:
Beginning of period....... 7,801,538 4,167,084 2,227,890 6,474,177 2,115,044 449,542
------------ ----------- ----------- ------------ ----------- -----------
End of period............. $ 14,048,150 $ 7,801,538 $ 4,167,084 $ 12,244,949 $ 6,474,177 $ 2,115,044
------------ ----------- ----------- ------------ ----------- -----------
------------ ----------- ----------- ------------ ----------- -----------
<CAPTION>
SELECT CAPITAL APPRECIATION FIDELITY VIP HIGH INCOME
YEAR YEAR
ENDED ENDED
DECEMBER 31, PERIOD DECEMBER 31,
------------------------ FROM 4/28/95* --------------------------------------
1997 1996 TO 12/31/95 1997 1996 1995
----------- ----------- -------------------- ------------ ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ (56,345) $ (21,850) $ 15,476 $ 479,883 $ 299,373 $ 139,057
Net realized gain
(loss)................ 29,423 14,690 94 82,712 88,898 1,925
Net unrealized gain
(loss)................ 1,139,908 64,919 64,003 990,433 319,076 422,411
----------- ----------- -------- ------------ ----------- -----------
Net increase in net
assets from
operations............ 1,112,986 57,759 79,573 1,553,028 707,347 563,393
----------- ----------- -------- ------------ ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 2,762,349 2,286,232 319,705 3,060,740 2,471,469 1,664,839
Terminations............ (81,117) (33,966) (792) (250,657) (168,885) (75,296)
Insurance and other
charges............... (661,875) (321,105) (30,152) (869,264) (620,511) (440,883)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... 986,974 2,057,646 572,624 1,518,033 704,375 448,890
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- (295) 200 -- -- --
----------- ----------- -------- ------------ ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions.......... 3,006,331 3,988,512 861,585 3,458,852 2,386,448 1,597,550
----------- ----------- -------- ------------ ----------- -----------
Net increase (decrease)
in net assets......... 4,119,317 4,046,271 941,158 5,011,880 3,093,795 2,160,943
NET ASSETS:
Beginning of period....... 4,987,429 941,158 -- 7,517,220 4,423,425 2,262,482
----------- ----------- -------- ------------ ----------- -----------
End of period............. $ 9,106,746 $ 4,987,429 $941,158 $ 12,529,100 $ 7,517,220 $ 4,423,425
----------- ----------- -------- ------------ ----------- -----------
----------- ----------- -------- ------------ ----------- -----------
</TABLE>
* Date of initial investment.
** Name changed. See Note 1.
The accompanying notes are an integral part of these financial statements.
SA-10
<PAGE>
VEL II ACCOUNT
STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)
<TABLE>
<CAPTION>
FIDELITY VIP EQUITY-INCOME FIDELITY VIP GROWTH
YEAR ENDED YEAR ENDED
DECEMBER 31, DECEMBER 31,
---------------------------------------- ----------------------------------------
1997 1996 1995 1997 1996 1995
------------ ------------ ------------ ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ 195,952 $ (157,238) $ 159,598 $ (79,264) $ (136,847) $ (95,678)
Net realized gain
(loss)................ 2,461,187 818,679 449,694 907,871 1,189,448 9,207
Net unrealized gain
(loss)................ 5,395,541 2,101,563 2,929,112 5,592,661 1,555,911 3,349,417
------------ ------------ ------------ ------------ ------------ ------------
Net increase in net
assets from
operations............ 8,052,680 2,763,004 3,538,404 6,421,268 2,608,512 3,262,946
------------ ------------ ------------ ------------ ------------ ------------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 8,345,475 7,421,307 5,056,248 7,970,339 7,554,363 5,026,577
Terminations............ (691,960) (502,308) (255,845) (729,359) (557,319) (266,538)
Insurance and other
charges............... (2,509,855) (1,823,775) (1,255,073) (2,417,623) (1,878,817) (1,332,572)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... 2,156,972 2,043,151 1,827,310 516,623 2,271,269 1,560,078
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- -- --
------------ ------------ ------------ ------------ ------------ ------------
Net increase (decrease)
in net assets from
capital
transactions.......... 7,300,632 7,138,375 5,372,640 5,339,980 7,389,496 4,987,545
------------ ------------ ------------ ------------ ------------ ------------
Net increase (decrease)
in net assets......... 15,353,312 9,901,379 8,911,044 11,761,248 9,998,008 8,250,491
NET ASSETS:
Beginning of period....... 26,900,431 16,999,052 8,088,008 26,233,032 16,235,024 7,984,533
------------ ------------ ------------ ------------ ------------ ------------
End of period............. $ 42,253,743 $ 26,900,431 $ 16,999,052 $ 37,994,280 $ 26,233,032 $ 16,235,024
------------ ------------ ------------ ------------ ------------ ------------
------------ ------------ ------------ ------------ ------------ ------------
<CAPTION>
FIDELITY VIP OVERSEAS FIDELITY VIP II ASSET MANAGER
YEAR ENDED YEAR ENDED
DECEMBER 31, DECEMBER 31,
-------------------------------------- -------------------------------------
1997 1996 1995 1997 1996 1995
------------ ----------- ----------- ----------- ----------- -----------
<S> <C> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................ $ 83,871 $ 12,575 $ (52,105) $ 51,911 $ 42,028 $ 4,904
Net realized gain
(loss)................ 791,011 161,051 36,390 204,124 73,057 11,836
Net unrealized gain
(loss)................ 100,802 804,672 573,790 230,651 117,171 184,941
------------ ----------- ----------- ----------- ----------- -----------
Net increase in net
assets from
operations............ 975,684 978,298 558,075 486,686 232,256 201,681
------------ ----------- ----------- ----------- ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 2,046,534 2,367,301 2,625,716 834,108 599,994 780,563
Terminations............ (274,848) (264,283) (131,576) (59,008) (82,153) (13,402)
Insurance and other
charges............... (641,234) (651,790) (670,203) (221,398) (167,378) (157,180)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)..... (1,118,668) (363,267) 41,172 520,341 (70,110) (132,024)
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor)............. -- -- -- -- -- --
------------ ----------- ----------- ----------- ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions.......... 11,784 1,087,961 1,865,109 1,074,043 280,353 477,957
------------ ----------- ----------- ----------- ----------- -----------
Net increase (decrease)
in net assets......... 987,468 2,066,259 2,423,184 1,560,729 512,609 679,638
NET ASSETS:
Beginning of period....... 9,401,063 7,334,804 4,911,620 2,091,763 1,579,154 899,516
------------ ----------- ----------- ----------- ----------- -----------
End of period............. $ 10,388,531 $ 9,401,063 $ 7,334,804 $ 3,652,492 $ 2,091,763 $ 1,579,154
------------ ----------- ----------- ----------- ----------- -----------
------------ ----------- ----------- ----------- ----------- -----------
</TABLE>
The accompanying notes are an integral part of these financial statements.
SA-11
<PAGE>
VEL II ACCOUNT
STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)
<TABLE>
<CAPTION>
DGPF INTERNATIONAL
T. ROWE PRICE INTERNATIONAL STOCK EQUITY
YEAR YEAR
ENDED ENDED
DECEMBER 31, PERIOD DECEMBER 31,
------------------------ FROM 6/21/95* ------------------------
1997 1996 TO 12/31/95 1997 1996
----------- ----------- -------------------- ----------- -----------
<S> <C> <C> <C> <C> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................. $ 11,794 $ 9,510 $ (1,127) $ 142,142 $ 70,139
Net realized gain
(loss)................. 60,572 16,919 (76) 38,749 55,552
Net unrealized gain
(loss)................. (67,400) 106,328 13,064 102,792 593,576
----------- ----------- -------- ----------- -----------
Net increase in net
assets from
operations............. 4,966 132,757 11,861 283,683 719,267
----------- ----------- -------- ----------- -----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 1,202,548 710,635 138,207 2,108,363 1,509,158
Terminations............ (46,171) (15,845) -- (125,515) (87,745)
Insurance and other
charges................ (255,771) (103,524) (11,617) (478,785) (343,477)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)...... 1,293,366 763,779 288,358 908,374 329,618
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor).............. -- -- -- -- --
----------- ----------- -------- ----------- -----------
Net increase (decrease)
in net assets from
capital
transactions........... 2,193,972 1,355,045 414,948 2,412,437 1,407,554
----------- ----------- -------- ----------- -----------
Net increase (decrease)
in net assets.......... 2,198,938 1,487,802 426,809 2,696,120 2,126,821
NET ASSETS:
Beginning of period....... 1,914,611 426,809 -- 5,259,933 3,133,112
----------- ----------- -------- ----------- -----------
End of period............. $ 4,113,549 $ 1,914,611 $426,809 $ 7,956,053 $ 5,259,933
----------- ----------- -------- ----------- -----------
----------- ----------- -------- ----------- -----------
<CAPTION>
1995
-----------
<S> <C>
INCREASE (DECREASE) IN NET
ASSETS:
FROM OPERATIONS:
Net investment income
(loss)................. $ 6,050
Net realized gain
(loss)................. 15,164
Net unrealized gain
(loss)................. 266,755
-----------
Net increase in net
assets from
operations............. 287,969
-----------
FROM CAPITAL TRANSACTIONS:
Net premiums............ 1,148,621
Terminations............ (36,634)
Insurance and other
charges................ (263,542)
Other transfers from
(to) the General
Account of Allmerica
Financial Life
Insurance and Annuity
Company (Sponsor)...... 462,270
Net increase (decrease)
in investment by
Allmerica Financial
Life Insurance and
Annuity Company
(Sponsor).............. --
-----------
Net increase (decrease)
in net assets from
capital
transactions........... 1,310,715
-----------
Net increase (decrease)
in net assets.......... 1,598,684
NET ASSETS:
Beginning of period....... 1,534,428
-----------
End of period............. $ 3,133,112
-----------
-----------
</TABLE>
* Date of initial investment.
The accompanying notes are an integral part of these financial statements.
SA-12
<PAGE>
VEL II ACCOUNT
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 1997
NOTE 1 -- ORGANIZATION
The VEL II Account (VEL II) is a separate investment account of Allmerica
Financial Life Insurance and Annuity Company (the Company), established on June
10, 1993, for the purpose of separating from the general assets of the Company
those assets used to fund the variable portion of certain flexible premium
variable life policies issued by the Company. The Company is a wholly-owned
subsidiary of First Allmerica Financial Life Insurance Company (First
Allmerica). First Allmerica is a wholly-owned subsidiary of Allmerica Financial
Corporation (AFC). Under applicable insurance law, the assets and liabilities of
VEL II are clearly identified and distinguished from the other assets and
liabilities of the Company. VEL II cannot be charged with liabilities arising
out of any other business of the Company.
VEL II is registered as a unit investment trust under the Investment Company Act
of 1940, as amended (the 1940 Act). VEL II currently offers eighteen
Sub-Accounts. Each Sub-Account invests exclusively in a corresponding investment
portfolio of the Allmerica Investment Trust (the Trust) managed by Allmerica
Investment Management Company, Inc., a wholly-owned subsidiary of First
Allmerica, or of the Variable Insurance Products Fund (Fidelity VIP) or the
Variable Insurance Products Fund II (Fidelity VIP II) managed by Fidelity
Management & Research Company (FMR), or of T. Rowe Price International Series,
Inc. (T. Rowe Price) managed by Rowe Price-Fleming International, Inc., or of
the Delaware Group Premium Fund, Inc. (DGPF) managed by Delaware International
Advisers, Ltd. The Trust, Fidelity VIP, Fidelity VIP II, T. Rowe Price, and DGPF
(the Funds) are open-end, diversified management investment companies registered
under the 1940 Act.
Effective April 1, 1997, the investment portfolio of the Trust, which was
formerly known as Small Cap Value Fund, changed its name to Small-Mid Cap Value
Fund. At the Meeting of Shareholders of the Small Cap Value Fund, held on March
18, 1997, shareholders approved the name change and the revisions in the
investment objective of the Fund from investing primarily in small cap value
stocks to investing primarily in small and mid-cap value stocks. Effective
January 9, 1998, this portfolio changed its name to Select Value Opportunity
Fund.
Certain prior year balances have been reclassified to conform with current year
presentation.
NOTE 2 -- SIGNIFICANT ACCOUNTING POLICIES
INVESTMENTS -- Security transactions are recorded on the trade date. Investments
held by the Sub-Accounts are stated at the net asset value per share of the
respective investment portfolio of the Trust, Fidelity VIP, Fidelity VIP II, T.
Rowe Price, or DGPF. Net realized gains and losses on securities sold are
determined using the average cost method. Dividends and capital gain
distributions are recorded on the ex-dividend date and are reinvested in
additional shares of the respective investment portfolio of the Trust, Fidelity
VIP, Fidelity VIP II, T. Rowe Price, or DGPF at net asset value.
FEDERAL INCOME TAXES -- The Company is taxed as a "life insurance company" under
Subchapter L of the Internal Revenue Code (the Code) and files a consolidated
federal income tax return with First Allmerica. The Company anticipates no tax
liability resulting from the operations of VEL II. Therefore, no provision for
income taxes has been charged against VEL II.
SA-13
<PAGE>
VEL II ACCOUNT
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 1997
NOTE 3 -- INVESTMENTS
The number of shares owned, aggregate cost, and net asset value per share of
each Sub-Account's investment in the Trust, Fidelity VIP, Fidelity VIP II, T.
Rowe Price, and DGPF at December 31, 1997 were as follows:
<TABLE>
<CAPTION>
PORTFOLIO INFORMATION
---------------------------------------
NET ASSET
NUMBER OF AGGREGATE VALUE
INVESTMENT PORTFOLIO SHARES COST PER SHARE
- ------------------------------------------------------- ------------ ------------ ---------
<S> <C> <C> <C>
ALLMERICA INVESTMENT TRUST:
Growth............................................... 10,010,468 $ 23,506,511 $ 2.416
Investment Grade Income.............................. 6,269,947 6,809,489 1.112
Money Market......................................... 7,522,775 7,522,775 1.000
Equity Index......................................... 4,885,359 10,872,925 2.753
Government Bond...................................... 1,832,438 1,916,370 1.047
Select Aggressive Growth............................. 12,334,051 22,699,734 2.225
Select Growth........................................ 7,662,058 11,580,806 1.811
Select Growth and Income............................. 6,642,073 8,936,463 1.552
Select Value Opportunity*............................ 8,639,699 12,349,304 1.626
Select International Equity.......................... 9,131,207 11,726,885 1.341
Select Capital Appreciation.......................... 5,366,379 7,837,916 1.697
FIDELITY VARIABLE INSURANCE PRODUCTS FUND:
High Income.......................................... 922,614 10,868,335 13.580
Equity-Income........................................ 1,740,269 31,778,315 24.280
Growth............................................... 1,024,105 27,443,678 37.100
Overseas............................................. 541,069 8,960,683 19.200
FIDELITY VARIABLE INSURANCE PRODUCTS FUND II:
Asset Manager........................................ 202,804 3,142,767 18.010
T. ROWE PRICE INTERNATIONAL SERIES, INC.:
International Stock.................................. 322,885 4,061,556 12.740
DELAWARE GROUP PREMIUM FUND, INC.:
DGPF International Equity............................ 512,632 6,994,666 15.520
</TABLE>
* Name changed. See Note 1.
NOTE 4 -- RELATED PARTY TRANSACTIONS
On the date of issue and each monthly payment date thereafter, a monthly charge
is deducted from the policy value to compensate the Company for the cost of
insurance, which varies by policy, the cost of any additional benefits provided
by rider, and a monthly administrative charge of $5. The policyowner may
instruct the Company to deduct this monthly charge from a specific Sub-Account,
but if not so specified, it will be deducted on a pro-rata basis of allocation
which is the same proportion that the policy value in the General Account of the
Company and in each Sub-Account bear to the total policy value. For the years
ended December 31, 1997, 1996, and 1995, these monthly deductions from
Sub-Account policy values amounted to $16,327,180, $11,293,811, and $7,938,857,
respectively. These amounts are included on the statements of changes in net
assets in Insurance and other charges.
SA-14
<PAGE>
VEL II ACCOUNT
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 1997
NOTE 4 -- RELATED PARTY TRANSACTIONS (CONTINUED)
Effective March 21, 1996, the Company makes a charge of .65% (previously .90%)
per annum based on the average daily net assets of each Sub-Account at each
valuation date for mortality and expense risks. The total mortality and expense
risks charge may be increased or decreased by the Board of Directors of the
Company once each year, subject to compliance with applicable state and federal
requirements, but the total charge may not exceed 1.275% per annum. Effective
May 21, 1996, the Company also charges each Sub-Account .15% (previously .25%)
per annum based on the average daily net assets of each Sub-Account for
administrative expenses. These charges are deducted in the daily computation of
unit values and paid to the Company on a daily basis.
Allmerica Investments, Inc., (Allmerica Investments), a wholly-owned subsidiary
of First Allmerica, is principal underwriter and general distributor of VEL II,
and does not receive any compensation for sales of VEL II policies. Commissions
are paid to registered representatives of Allmerica Investments and certain
independent broker-dealers by the Company. As the current series of policies
have a surrender charge, no deduction is made for sales charges at the time of
the sale. For the years ended December 31, 1997, 1996, and 1995, the Company
received $1,478,536, $1,697,182, and $692,673, respectively, for surrender
charges applicable to VEL II.
NOTE 5 -- DIVERSIFICATION REQUIREMENTS
Under the provisions of Section 817(h) of the Code, a variable life insurance
contract, other than a contract issued in connection with certain types of
employee benefit plans, will not be treated as a variable life insurance
contract for federal income tax purposes for any period for which the
investments of the segregated asset account on which the contract is based are
not adequately diversified. The Code provides that the "adequately diversified"
requirement may be met if the underlying investments satisfy either a statutory
safe harbor test or diversification requirements set forth in regulations issued
by the Secretary of The Treasury.
The Internal Revenue Service has issued regulations under Section 817(h) of the
Code. The Company believes that VEL II satisfies the current requirements of the
regulations, and it intends that VEL II will continue to meet such requirements.
SA-15
<PAGE>
VEL II ACCOUNT
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 1997
NOTE 6 -- PURCHASES AND SALES OF SECURITIES
Cost of purchases and proceeds from sales of the Trust, Fidelity VIP, Fidelity
VIP II, T. Rowe Price, and DGPF shares by VEL II during the year ended December
31, 1997 were as follows:
<TABLE>
<CAPTION>
INVESTMENT PORTFOLIO PURCHASES SALES
- ------------------------------------------------------------------ ----------- -----------
<S> <C> <C>
ALLMERICA INVESTMENT TRUST:
Growth.......................................................... $11,643,736 $ 89,353
Investment Grade Income......................................... 1,561,144 464,947
Money Market.................................................... 10,215,192 9,774,152
Equity Index.................................................... 6,944,085 96,209
Government Bond................................................. 936,999 650,133
Select Aggressive Growth........................................ 8,286,191 334,014
Select Growth................................................... 6,048,453 92,390
Select Growth and Income........................................ 3,910,253 150,295
Select Value Opportunity*....................................... 5,968,833 154,104
Select International Equity..................................... 6,344,893 236,324
Select Capital Appreciation..................................... 3,372,536 422,550
FIDELITY VARIABLE INSURANCE PRODUCTS FUND:
High Income..................................................... 4,171,646 163,698
Equity-Income................................................... 10,324,654 456,852
Growth.......................................................... 6,495,494 429,249
Overseas........................................................ 1,845,693 1,096,702
FIDELITY VARIABLE INSURANCE PRODUCTS FUND II:
Asset Manager................................................... 1,517,230 205,429
T. ROWE PRICE INTERNATIONAL SERIES, INC.:
International Stock............................................. 2,385,322 126,809
DELAWARE GROUP PREMIUM FUND, INC.:
DGPF International Equity....................................... 2,773,949 219,370
----------- -----------
Totals............................................................ $94,746,303 $15,162,580
----------- -----------
----------- -----------
</TABLE>
* Name changed. See Note 1.
SA-16
<PAGE>
APPENDIX A
OPTIONAL BENEFITS
This Appendix is intended to provide only a very brief overview of additional
insurance benefits available by rider. For more information, contact your agent.
Certain riders may not be available in all states.
The following supplemental benefits are available for issue under the Policy for
an additional charge.
WAIVER OF PREMIUM RIDER
This rider provides that during periods of total disability, continuing more
than four months, the Company will add to the Policy Value each month an
amount selected by you or the amount needed to pay the Policy charges. This
value will be used to keep the Policy in force. This benefit is subject to
the Company's maximum issue benefits. Its cost will change yearly.
GUARANTEED INSURABILITY RIDER
This rider guarantees that insurance may be added at various option dates
without Evidence of Insurability. This benefit may be exercised on the
option dates even if the Insured is disabled.
OTHER INSURED RIDER
This rider provides a term insurance benefit for up to five Insureds. At
present this benefit is only available for the spouse and children of the
primary Insured. The rider includes a feature that allows the "other
Insured" to convert the coverage to a flexible premium adjustable life
insurance Policy.
CHILDREN'S INSURANCE RIDER
This rider provides coverage for eligible minor children. It also covers
future children, including adopted children and stepchildren.
ACCIDENTAL DEATH BENEFIT RIDER
This rider pays an additional benefit for death resulting from a covered
accident prior to the Policy anniversary nearest the Insured's Age 70.
EXCHANGE OPTION RIDER
This rider allows you to use the Policy to insure a different person,
subject to Company guidelines.
LIVING BENEFITS RIDER
This rider permits part of the proceeds of the Policy to be available before
death if the Insured becomes terminally ill or is permanently confined to a
nursing home.
GUARANTEED DEATH BENEFIT RIDER
This rider, WHICH IS AVAILABLE ONLY AT ISSUE, (a) guarantees that your
policy will not lapse regardless of the Performance of the Separate Account
and (b) provides a guaranteed net death benefit. See "THE POLICY,"
"Guaranteed Death Benefit Rider."
A-1
<PAGE>
APPENDIX B
DEATH PROCEEDS PAYMENT OPTIONS
PAYMENT OPTIONS
Upon written request, the Surrender Value or all or part of the Death Proceeds
may be placed under one or more of the payment options below or any other option
offered by the Company. If you do not make an election, the Company will pay the
benefits in a single sum. A certificate will be provided to the payee describing
the payment option selected. If a payment option is selected, the Beneficiary
may pay to the Company any amount that otherwise would be deducted from the Sum
Insured.
The amounts payable under a payment option for each $1,000 value applied will be
the greater of:
- the rate per $1,000 of value applied based on the Company's non-guaranteed
current payment option rates for the Policy, or
- the rate in the Policy for the applicable payment option.
The following payment options currently are available. The amounts payable under
these options are paid from the General Account. None is based on the investment
experience of the Separate Account.
<TABLE>
<C> <S>
Option A: PAYMENTS FOR A SPECIFIED NUMBER OF YEARS. The Company will make equal
payments for any selected number of years (not greater than 30). Payments
may be made annually, semi- annually, quarterly or monthly.
Option B: LIFETIME MONTHLY PAYMENTS. Payments are based on the payee's age on the date
the first payment will be made. One of three variations may be chosen.
Depending upon this choice, payments will end:
(1) upon the death of the payee, with no further payments due (Life Annuity), or
(2) upon the death of the payee, but not before the sum of the payments made
first equals or exceeds the amount applied under this option (Life Annuity
with Installment Refund),
(3) upon the death of the payee, but not before a selected period (5, 10 or 20
years) has elapsed (Life Annuity with Period Certain).
Option C: INTEREST PAYMENTS. The Company will pay interest at a rate determined by the
Company each year, but which will not be less than 3 1/2%. Payments may be
made annually, semi-annually, quarterly or monthly. Payments will end when
the amount left with the Company has been withdrawn. Payments will not
continue, however, after the death of the payee. Any unpaid balance plus
accrued interest will be paid in a lump sum.
Option D: PAYMENTS FOR A SPECIFIED AMOUNT. Payments will be made until the unpaid
balance is exhausted. Interest will be credited to the unpaid balance. The
rate of interest will be determined by the Company each year, but will not
be less than 3 1/2%. Payments may be made annually, semi-annually, quarterly
or monthly. The payment level selected must provide for the payment each
year of at least 8% of the amount applied.
Option E: LIFETIME MONTHLY PAYMENTS FOR TWO PAYEES. One of three variations may be
chosen. After the death of one payee, payments will continue to the
survivor:
(1) in the same amount as the original amount;
(2) in an amount equal to 2/3 of the original amount; or
(3) in an amount equal to 1/2 of the original amount.
</TABLE>
B-1
<PAGE>
Payments are based on the payees' ages on the date the first payment is due.
Payments will end upon the death of the surviving payee.
SELECTION OF PAYMENT OPTIONS
The amount applied under any one option for any one payee must be at least
$5,000. The periodic payment for any one payee must be at least $50. Subject to
your and/or the Beneficiary's provision, any option selection may be changed
before the Death Proceeds become payable. If you make no selection, the
Beneficiary may select an option when the Death Proceeds becomes payable.
If the amount of monthly income payments under Option B(3) for the attained age
of the payee are the same for different periods certain, the Company will deem
an election to have been made for the longest period certain which could have
been elected for such age and amount.
You may give the Beneficiary the right to change from Option C or D to any other
option at any time. If the payee selects Option C or D when the Policy becomes a
claim, the right may be reserved to change to any other option. The payee who
elects to change options must be a payee under the option selected.
ADDITIONAL DEPOSITS
An additional deposit may be made to any proceeds when they are applied under
Option B or E. A charge not to exceed 3% will be made. The Company may limit the
amount of this deposit.
RIGHTS AND LIMITATIONS
A payee does not have the right to assign any amount payable under any option. A
payee does not have the right to commute any amount payable under Option B or E.
A payee will have the right to commute any amount payable under Option A only if
the right is reserved in the written request selecting the option. If the right
to commute is exercised, the commuted values will be computed at the interest
rates used to calculate the benefits. The amount left under Option C, and any
unpaid balance under Option D, may be withdrawn by the payee only as set forth
in the written request selecting the option.
A corporation or fiduciary payee may select only option A, C or D. Such
selection will be subject to the consent of the Company.
PAYMENT DATES
The first payment under any option, except Option C, will be due on the date the
Policy matures by death or otherwise, unless another date is designated.
Payments under Option C begin at the end of the first payment period.
The last payment under any option will be made as stated in the description of
that option. Should a payee under Option B or E die prior to the due date of the
second monthly payment, however, the amount applied less the first monthly
payment will be paid in a lump sum or under any option other than Option E. A
lump sum payment will be made to the surviving payee under Option E or the
succeeding payee under Option B.
B-2
<PAGE>
APPENDIX C
ILLUSTRATIONS OF SUM INSURED, POLICY VALUES AND
ACCUMULATED PREMIUMS
The following tables illustrate the way in which the Policy's Sum Insured and
Policy Value could vary over an extended period of time.
ASSUMPTIONS
The tables illustrate a Policy issued to a male, Age 30, under a standard
Premium Class and qualifying for the non-smoker discount, and a Policy issued to
a male, Age 45, under a standard Premium Class and qualifying for the non-smoker
discount. In each case, one table illustrate the guaranteed cost of insurance
rates and the other table illustrates the current cost of insurance rates as
presently in effect.
The tables assume that no Policy loans have been made, that you have not
requested an increase or decrease in the initial Face Amount, that no partial
withdrawals have been made, and that no transfers above 12 have been made in any
Policy year (so that no transaction or transfer charges have been incurred).
The tables assume that all premiums are allocated to and remain in the Separate
Account for the entire period shown. The tables are based on hypothetical gross
investment rates of return for the Underlying Fund (i.e., investment income and
capital gains and losses, realized or unrealized) equivalent to constant gross
(after tax) annual rates of 0%, 6%, and 12%. The second column of the tables
show the amount which would accumulate if an amount equal to the Guideline
Annual Premium were invested to earn interest (after taxes) at 5%, compounded
annually.
The Policy Values and Death Proceeds would be different from those shown if the
gross annual investment rates of return averaged 0%, 6%, and 12% over a period
of years, but fluctuated above or below such averages for individual Policy
years. The values also would be different depending on the allocation of the
Policy's total Policy Value among the Sub-Accounts of the Separate Account, if
the actual rates of return averaged 0%, 6% or 12%, but the rates of each
Underlying Fund varied above and below such averages.
DEDUCTIONS FOR CHARGES
The amounts shown for the Death Proceeds and the Policy Values take into account
the deduction from premium for the tax expense charge, the Monthly Deduction
from Policy Value, and the daily charge against the Separate Account for
mortality and expense risks and the Separate Account administrative charge for
the first ten Policy years. In the Current Cost of Insurance tables, the
Separate Account charges are equivalent to an effective annual rate of 0.80% of
the average daily value of the assets in the Separate Account in the first ten
Policy Years, and 0.65% thereafter. In the Guaranteed Cost of Insurance Charges
tables, the Separate Account charges are equivalent to an effective annual rate
of 1.15% of the average daily value of the assets in the Separate Account in the
first ten Policy Years, and 0.90% thereafter.
EXPENSES OF THE UNDERLYING FUNDS
The amounts shown in the tables also take into account the Underlying Fund
advisory fees and operating expenses, which are assumed to be at an annual rate
of 0.85% of the average daily net assets of the Underlying Fund. The actual fees
and expenses of each Underlying Fund vary, and, in 1997, ranged from an annual
rate of 0.35% to an annual rate of 2.00% of average daily net assets. The fees
and expenses associated with the Policy may be more or less than 0.85% in the
aggregate, depending upon how you make allocations of the Policy Value among the
Sub-Accounts.
AFIMS has declared a voluntary expense limitation of 1.35% of average net assets
for the Select Aggressive Growth Fund and Select Capital Appreciation Fund,
1.50% for the Select International Equity Fund, 1.25% for the Select Value
Opportunity Fund, 1.20% for the Growth Fund and Select Growth Fund, 1.10% for
the
C-1
<PAGE>
Select Growth and Income, 1.00% for the Investment Grade Income Fund and
Government Bond Fund, and 0.60% for the Money Market Fund and Equity Index Fund.
The total operating expenses of these Funds of the Trust were less than their
respective expense limitations throughout 1997. These limitations may be
terminated at any time.
Until further notice, AFIMS has declared a voluntary expense limitation of 1.20%
of average daily net assets for the Select Strategic Growth Fund. In addition,
AFIMS has agreed to voluntarily waive its management fee to the extent that
expenses of the Select Emerging Markets Fund exceed 2.00% of the Fund's average
daily net assets, except that such waiver shall not exceed the net amount of
management fees earned by AFIMS from the Fund after subtracting fees paid by
AFIMS to a sub-adviser. These limitations may be terminated at any time.
Effective July 1, 1997, Delaware International Advisers Ltd., the investment
adviser for the International Equity Series, has agreed to limit total annual
expenses of the fund to 0.95%. This limitation replaces a prior limitation of
0.80% that expired on June 30, 1997. The new limitation will be in effect
through October 31, 1998. In 1997, the actual ratio of total annual expenses of
the International Equity Series was 0.85%.
NET ANNUAL RATES OF INVESTMENT
In the Current Cost of Insurance Tables, taking into account the mortality and
expense risk charge (0.65% and the Separate Account administrative charge (0.15%
in the first ten policy years) and the assumed charge for Underlying Fund
advisory fees and operating expenses (0.85%), the gross annual rates of
investment return of 0%, 6% and 12% correspond to net annual rates of (-1.65%),
4.35%, 10.35%, respectively, during the first ten Policy years and (-1.50%),
4.50% and 10.50%, respectively, thereafter.
In the Guaranteed Cost of Insurance Tables, taking into account the guaranteed
mortality and expense risk charge (0.90%), the guaranteed VEL II Account
administrative charge (0.25% in the first ten policy years) and the assumed
charge for Underlying Fund advisory fees and operating expenses (0.85%), the
gross annual rates of investment return of 0%, 6% and 12% correspond to net
annual rates of (-2.00%), 4.00%, 10.00%, respectively, during the first ten
Policy years and (-1.75%), 4.25% and 10.25%, respectively, thereafter.
The hypothetical returns shown in the table do not reflect any charges for
income taxes against the Separate Account since no charges are currently made.
If in the future, however, such charges are made in order to produce illustrated
death benefits and cash values, the gross annual investment rate of return would
have to exceed 0%, 6% or 12% by a sufficient amount to cover the tax charges.
UPON REQUEST, THE COMPANY WILL PROVIDE A COMPARABLE ILLUSTRATION BASED UPON THE
PROPOSED INSURED'S AGE, SEX, AND UNDERWRITING CLASSIFICATION, AND THE REQUESTED
FACE AMOUNT, SUM INSURED OPTION, AND RIDERS.
TO CHOOSE THE SUB-ACCOUNTS WHICH BEST WILL MEET YOUR NEEDS AND OBJECTIVES,
CAREFULLY READ THE PROSPECTUSES OF THE UNDERLYING FUNDS ALONG WITH THIS
PROSPECTUS.
C-2
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
VARI-EXCEPTIONAL LIFE POLICY
MALE NON-SMOKER AGE 45
SPECIFIED FACE AMOUNT = $250,000
SUM INSURED OPTION 1
CURRENT COST OF INSURANCE CHARGES
<TABLE>
<CAPTION>
PREMIUMS HYPOTHETICAL 0% HYPOTHETICAL 6%
PAID PLUS GROSS INVESTMENT RETURN GROSS INVESTMENT RETURN HYPOTHETICAL 12%
INTEREST ---------------------------- ----------------------------- GROSS INVESTMENT RETURN
AT 5% POLICY POLICY -------------------------------
POLICY PER YEAR SURRENDER VALUE DEATH SURRENDER VALUE DEATH SURRENDER POLICY DEATH
YEAR (1) VALUE (2) BENEFIT VALUE (2) BENEFIT VALUE VALUE (2) BENEFIT
------ --------- --------- ------- ------- --------- -------- ------- --------- --------- ---------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
1 4,410 0 3,200 250,000 75 3,418 250,000 293 3,636 250,000
2 9,041 2,566 6,301 250,000 3,203 6,937 250,000 3,866 7,601 250,000
3 13,903 3,688 9,287 250,000 4,948 10,546 250,000 6,315 11,913 250,000
4 19,008 6,786 12,161 250,000 8,876 14,251 250,000 11,237 16,612 250,000
5 24,368 9,883 14,921 250,000 13,014 18,052 250,000 16,698 21,736 250,000
6 29,996 12,849 17,552 250,000 17,236 21,939 250,000 22,614 27,317 250,000
7 35,906 15,701 20,068 250,000 21,562 25,929 250,000 29,052 33,419 250,000
8 42,112 18,435 22,466 250,000 25,994 30,024 250,000 36,067 40,098 250,000
9 48,627 21,052 24,747 250,000 30,536 34,231 250,000 43,725 47,420 250,000
10 55,469 23,537 26,897 250,000 35,182 38,542 250,000 52,087 55,446 250,000
11 62,652 26,397 29,084 250,000 40,458 43,145 250,000 61,773 64,460 250,000
12 70,195 29,131 31,146 250,000 45,868 47,883 250,000 72,373 74,389 250,000
13 78,114 31,721 33,064 250,000 51,404 52,748 250,000 83,984 85,328 250,000
14 86,430 34,156 34,828 250,000 57,067 57,739 250,000 96,723 97,395 250,000
15 95,161 36,422 36,422 250,000 62,852 62,852 250,000 110,720 110,720 250,000
16 104,330 37,861 37,861 250,000 68,112 68,112 250,000 125,477 125,477 250,000
17 113,956 39,125 39,125 250,000 73,515 73,515 250,000 141,838 141,838 250,000
18 124,064 40,195 40,195 250,000 79,058 79,058 250,000 160,007 160,007 250,000
19 134,677 41,027 41,027 250,000 84,722 84,722 250,000 180,212 180,212 250,000
20 145,821 41,647 41,647 250,000 90,544 90,544 250,000 202,749 202,749 250,000
Age 60 95,161 36,422 36,422 250,000 62,852 62,852 250,000 110,720 110,720 250,000
Age 65 145,821 41,647 41,647 250,000 90,544 90,544 250,000 202,749 202,749 250,000
Age 70 210,477 40,696 40,696 250,000 122,197 122,197 250,000 355,914 355,914 412,861
Age 75 292,995 30,366 30,366 250,000 159,685 159,685 250,000 605,316 605,316 647,688
</TABLE>
(1) Assumes a $4,200 premium is paid at the beginning of each Policy year.
Values will be different if premiums are paid with a different frequency or
in different amounts.
(2) Assumes that no Policy loan has been made. Excessive loans or withdrawals
may cause the Policy to lapse because of insufficient Policy Value
THE HYPOTHETICAL INVESTMENT RATES OF RETURN ARE ILLUSTRATIVE ONLY, AND SHOULD
NOT BE DEEMED A REPRESENTATION OF PAST OR FUTURE INVESTMENT RATES OF RETURN.
ACTUAL INVESTMENT RESULTS MAY BE MORE OR LESS THAN THOSE SHOWN, AND WILL DEPEND
ON A NUMBER OF FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS BY A POLICYOWNER
AND THE DIFFERENT INVESTMENT RATES OF RETURN FOR THE UNDERLYING FUNDS. THE VALUE
OF UNITS, POLICY VALUE, AND DEATH BENEFIT FOR A POLICY WOULD BE DIFFERENT FROM
THOSE SHOWN IF THE ACTUAL RATES OF INVESTMENT RETURN AVERAGED 0%, 6%, AND 12%
OVER A PERIOD OF YEARS, BUT FLUCTUATED ABOVE AND BELOW THOSE AVERAGES FOR
INDIVIDUAL POLICY YEARS, OR IF ANY PREMIUMS WERE ALLOCATED OR POLICY VALUE
TRANSFERRED TO THE GENERAL ACCOUNT. NO REPRESENTATIONS CAN BE MADE THAT THESE
HYPOTHETICAL INVESTMENT RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE YEAR OR
SUSTAINED OVER ANY PERIOD OF TIME.
C-3
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
VARI-EXCEPTIONAL LIFE POLICY
MALE NON-SMOKER AGE 45
SPECIFIED FACE AMOUNT = $250,000
SUM INSURED OPTION 1
GUARANTEED COST OF INSURANCE CHARGES
<TABLE>
<CAPTION>
PREMIUMS HYPOTHETICAL 0% HYPOTHETICAL 6%
PAID PLUS GROSS INVESTMENT RETURN GROSS INVESTMENT RETURN HYPOTHETICAL 12%
INTEREST ------------------------------ ---------------------------- GROSS INVESTMENT RETURN
AT 5% POLICY POLICY -------------------------------
POLICY PER YEAR SURRENDER VALUE DEATH SURRENDER VALUE DEATH SURRENDER POLICY DEATH
YEAR (1) VALUE (2) BENEFIT VALUE (2) BENEFIT VALUE VALUE (2) BENEFIT
------ --------- --------- -------- -------- --------- ------- ------- --------- --------- ---------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
1 4,410 0 3,089 250,000 0 3,304 250,000 176 3,519 250,000
2 9,041 2,314 6,049 250,000 2,936 6,671 250,000 3,586 7,321 250,000
3 13,903 3,281 8,880 250,000 4,504 10,102 250,000 5,831 11,430 250,000
4 19,008 6,206 11,581 250,000 8,222 13,596 250,000 10,501 15,875 250,000
5 24,368 9,109 14,147 250,000 12,110 17,149 250,000 15,645 20,684 250,000
6 29,996 11,876 16,579 250,000 16,057 20,759 250,000 21,189 25,891 250,000
7 35,906 14,497 18,863 250,000 20,051 24,418 250,000 27,159 31,526 250,000
8 42,112 16,959 20,990 250,000 24,082 28,113 250,000 33,590 37,620 250,000
9 48,627 19,255 22,950 250,000 28,142 31,837 250,000 40,521 44,216 250,000
10 55,469 21,369 24,728 250,000 32,216 35,575 250,000 47,993 51,352 250,000
11 62,652 23,697 26,385 250,000 36,728 39,415 250,000 56,531 59,218 250,000
12 70,195 25,824 27,839 250,000 41,247 43,262 250,000 65,754 67,770 250,000
13 78,114 27,743 29,087 250,000 45,769 47,113 250,000 75,743 77,086 250,000
14 86,430 29,444 30,115 250,000 50,287 50,959 250,000 86,584 87,255 250,000
15 95,161 30,903 30,903 250,000 54,783 54,783 250,000 98,372 98,372 250,000
16 104,330 31,428 31,428 250,000 58,570 58,570 250,000 110,547 110,547 250,000
17 113,956 31,665 31,665 250,000 62,299 62,299 250,000 123,912 123,912 250,000
18 124,064 31,577 31,577 250,000 65,944 65,944 250,000 138,617 138,617 250,000
19 134,677 31,118 31,118 250,000 69,470 69,470 250,000 154,842 154,842 250,000
20 145,821 30,241 30,241 250,000 72,842 72,842 250,000 172,804 172,804 250,000
Age 60 95,161 30,903 30,903 250,000 54,783 54,783 250,000 98,372 98,372 250,000
Age 65 142,821 30,241 30,241 250,000 72,842 72,842 250,000 172,804 172,804 250,000
Age 70 210,477 17,834 17,834 250,000 86,272 86,272 250,000 295,454 295,454 342,726
Age 75 292,995 0 (17,264 ) 250,000 88,139 88,139 250,000 488,521 488,521 522,717
</TABLE>
(1) Assumes a $4,200 premium is paid at the beginning of each Policy year.
Values will be different if premiums are paid with a different frequency or
in different amounts.
(2) Assumes that no Policy loan has been made. Excessive loans or withdrawals
may cause the Policy to lapse because of insufficient Policy Value
THE HYPOTHETICAL INVESTMENT RATES OF RETURN ARE ILLUSTRATIVE ONLY, AND SHOULD
NOT BE DEEMED A REPRESENTATION OF PAST OR FUTURE INVESTMENT RATES OF RETURN.
ACTUAL INVESTMENT RESULTS MAY BE MORE OR LESS THAN THOSE SHOWN, AND WILL DEPEND
ON A NUMBER OF FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS BY A POLICYOWNER
AND THE DIFFERENT INVESTMENT RATES OF RETURN FOR THE UNDERLYING FUNDS. THE VALUE
OF UNITS, POLICY VALUE, AND DEATH BENEFIT FOR A POLICY WOULD BE DIFFERENT FROM
THOSE SHOWN IF THE ACTUAL RATES OF INVESTMENT RETURN AVERAGEE 0%, 6%, AND 12%
OVER A PERIOD OF YEARS, BUT FLUCTUATED ABOVE AND BELOW THOSE AVERAGES FOR
INDIVIDUAL POLICY YEARS, OR IF ANY PREMIUMS WERE ALLOCATED OR POLICY VALUE
TRANSFERRED TO THE GENERAL ACCOUNT. NO REPRESENTATIONS CAN BE MADE THAT THESE
HYPOTHETICAL INVESTMENT RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE YEAR OR
SUSTAINED OVER ANY PERIOD OF TIME.
C-4
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
VARI-EXCEPTIONAL LIFE POLICY
MALE NON-SMOKER AGE 30
SPECIFIED FACE AMOUNT = $75,000
SUM INSURED OPTION 2
CURRENT COST OF INSURANCE CHARGES
<TABLE>
<CAPTION>
PREMIUMS HYPOTHETICAL 0% HYPOTHETICAL 6%
PAID PLUS GROSS INVESTMENT RETURN GROSS INVESTMENT RETURN HYPOTHETICAL 12%
INTEREST ------------------------------ ------------------------------- GROSS INVESTMENT RETURN
AT 5% POLICY POLICY --------------------------------------
POLICY PER YEAR SURRENDER VALUE DEATH SURRENDER VALUE DEATH SURRENDER POLICY DEATH
YEAR (1) VALUE (2) BENEFIT VALUE (2) BENEFIT VALUE VALUE (2) BENEFIT
------ --------- --------- ------- ------- --------- -------- ------- ---------- --------- ----------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
1 1,470 283 1,178 76,178 359 1,254 76,254 435 1,331 76,331
2 3,014 1,312 2,333 77,333 1,538 2,559 77,559 1,774 2,795 77,795
3 4,634 2,398 3,465 78,465 2,850 3,917 78,917 3,339 4,407 79,407
4 6,336 3,549 4,574 79,574 4,305 5,329 80,329 5,156 6,180 81,180
5 8,123 4,699 5,659 80,659 5,837 6,797 81,797 7,171 8,132 83,132
6 9,999 5,825 6,721 81,721 7,427 8,324 83,324 9,383 10,280 85,280
7 11,969 6,927 7,759 82,759 9,077 9,910 84,910 11,810 12,643 87,643
8 14,037 8,000 8,768 83,768 10,784 11,553 86,553 14,470 15,238 90,238
9 16,209 9,049 9,753 84,753 12,555 13,260 88,260 17,390 18,094 93,094
10 18,490 10,062 10,703 85,703 14,381 15,021 90,021 20,585 21,226 96,226
11 20,884 11,161 11,673 86,673 16,390 16,903 91,903 24,222 24,735 99,735
12 23,398 12,237 12,621 87,621 18,476 18,860 93,860 28,219 28,603 103,603
13 26,038 13,287 13,544 88,544 20,638 20,895 95,895 32,610 32,866 107,866
14 28,810 14,312 14,440 89,440 22,880 23,008 98,008 37,436 37,564 112,564
15 31,720 15,309 15,309 90,309 25,201 25,201 100,201 42,740 42,740 117,740
16 34,777 16,147 16,147 91,147 27,476 27,476 102,476 48,441 48,441 123,441
17 37,985 16,950 16,950 91,950 29,829 29,829 104,829 54,715 54,715 129,715
18 41,355 17,714 17,714 92,714 32,261 32,261 107,261 61,621 61,621 136,621
19 44,892 18,440 18,440 93,440 34,775 34,775 109,775 69,223 69,223 144,223
20 48,607 19,126 19,126 94,126 37,371 37,371 112,371 77,592 77,592 152,592
Age 60 97,665 23,624 23,624 98,624 68,489 68,489 143,489 225,810 225,810 302,586
Age 65 132,771 23,633 23,633 98,633 87,621 87,621 162,621 374,826 374,826 457,288
Age 70 177,576 21,275 21,275 96,275 108,731 108,731 183,731 615,951 615,951 714,503
Age 75 234,759 15,583 15,583 90,583 131,003 131,003 206,003 1,007,907 1,007,907 1,082,907
</TABLE>
(1) Assumes a $1,400 premium is paid at the beginning of each Policy year.
Values will be different if premiums are paid with a different frequency or
in different amounts.
(2) Assumes that no Policy loan has been made. Excessive loans or withdrawals
may cause the Policy to lapse because of insufficient Policy Value
THE HYPOTHETICAL INVESTMENT RATES OF RETURN ARE ILLUSTRATIVE ONLY, AND SHOULD
NOT BE DEEMED A REPRESENTATION OF PAST OR FUTURE INVESTMENT RATES OF RETURN.
ACTUAL INVESTMENT RESULTS MAY BE MORE OR LESS THAN THOSE SHOWN, AND WILL DEPEND
ON A NUMBER OF FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS BY A POLICYOWNER
AND THE DIFFERENT INVESTMENT RATES OF RETURN FOR THE UNDERLYING FUNDS. THE VALUE
OF UNITS, POLICY VALUE, AND DEATH BENEFIT FOR A POLICY WOULD BE DIFFERENT FROM
THOSE SHOWN IF THE ACTUAL RATES OF INVESTMENT RETURN AVERAGED 0%, 6%, AND 12%
OVER A PERIOD OF YEARS, BUT FLUCTUATED ABOVE AND BELOW THOSE AVERAGES FOR
INDIVIDUAL POLICY YEARS, OR IF ANY PREMIUMS WERE ALLOCATED OR POLICY VALUE
TRANSFERRED TO THE GENERAL ACCOUNT. NO REPRESENTATIONS CAN BE MADE THAT THESE
HYPOTHETICAL INVESTMENT RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE YEAR OR
SUSTAINED OVER ANY PERIOD OF TIME.
C-5
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
VARI-EXCEPTIONAL LIFE POLICY
MALE NON-SMOKER AGE 30
SPECIFIED FACE AMOUNT = $75,000
SUM INSURED OPTION 2
GUARANTEED COST OF INSURANCE CHARGES
<TABLE>
<CAPTION>
PREMIUMS HYPOTHETICAL 0% HYPOTHETICAL 6% HYPOTHETICAL 12%
PAID PLUS GROSS INVESTMENT RETURN GROSS INVESTMENT RETURN GROSS INVESTMENT RETURN
INTEREST ---------------------------- ---------------------------- -----------------------------
AT 5% POLICY POLICY POLICY
POLICY PER YEAR SURRENDER VALUE DEATH SURRENDER VALUE DEATH SURRENDER VALUE DEATH
YEAR (1) VALUE (2) BENEFIT VALUE (2) BENEFIT VALUE (2) BENEFIT
------ --------- --------- ------- ------- --------- ------- ------- --------- -------- -------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
1 1,470 258 1,153 76,153 333 1,229 76,229 409 1,304 76,304
2 3,014 1,255 2,276 77,276 1,478 2,499 77,499 1,710 2,732 77,732
3 4,634 2,304 3,371 78,371 2,747 3,814 78,814 3,227 4,294 79,294
4 6,336 3,411 4,436 79,436 4,148 5,173 80,173 4,979 6,003 81,003
5 8,123 4,510 5,471 80,471 5,615 6,576 81,576 6,911 7,872 82,872
6 9,999 5,579 6,475 81,475 7,127 8,023 83,023 9,018 9,914 84,914
7 11,969 6,618 7,450 82,450 8,685 9,518 84,518 11,314 12,147 87,147
8 14,037 7,625 8,393 83,393 10,289 11,058 86,058 13,817 14,585 89,585
9 16,209 8,601 9,306 84,306 11,940 12,644 87,644 16,545 17,249 92,249
10 18,490 9,545 10,186 85,186 13,637 14,277 89,277 19,518 20,158 95,158
11 20,884 10,550 11,062 86,062 15,485 15,997 90,997 22,877 23,389 98,389
12 23,398 11,523 11,907 86,907 17,386 17,770 92,770 26,541 26,925 101,925
13 26,038 12,464 12,720 87,720 19,341 19,597 94,597 30,539 30,796 105,796
14 28,810 13,372 13,500 88,500 21,351 21,479 96,479 34,904 35,032 110,032
15 31,720 14,248 14,248 89,248 23,418 23,418 98,418 39,670 39,670 114,670
16 34,777 14,962 14,962 89,962 25,413 25,413 100,413 44,746 44,746 119,746
17 37,985 15,640 15,640 90,640 27,465 27,465 102,465 50,301 50,301 125,301
18 41,355 16,283 16,283 91,283 29,573 29,573 104,573 56,383 56,383 131,383
19 44,892 16,888 16,888 91,888 31,740 31,740 106,740 63,040 63,040 138,040
20 48,607 17,455 17,455 92,455 33,964 33,964 108,964 70,328 70,328 145,328
Age 60 97,665 20,234 20,234 95,234 58,790 58,790 133,790 193,823 193,823 268,823
Age 65 132,771 18,601 18,601 93,601 71,880 71,880 146,880 311,606 311,606 386,606
Age 70 177,576 13,328 13,328 88,328 83,326 83,326 158,326 495,140 495,140 574,362
Age 75 234,759 2,191 2,191 77,191 89,820 89,820 164,820 780,502 780,502 855,502
</TABLE>
(1) Assumes a $1,400 premium is paid at the beginning of each Policy year.
Values will be different if premiums are paid with a different frequency or
in different amounts.
(2) Assumes that no Policy loan has been made. Excessive loans or withdrawals
may cause the Policy to lapse because of insufficient Policy Value
THE HYPOTHETICAL INVESTMENT RATES OF RETURN ARE ILLUSTRATIVE ONLY, AND SHOULD
NOT BE DEEMED A REPRESENTATION OF PAST OR FUTURE INVESTMENT RATES OF RETURN.
ACTUAL INVESTMENT RESULTS MAY BE MORE OR LESS THAN THOSE SHOWN, AND WILL DEPEND
ON A NUMBER OF FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS BY A POLICYOWNER
AND THE DIFFERENT INVESTMENT RATES OF RETURN FOR THE UNDERLYING FUNDS. THE VALUE
OF UNITS, POLICY VALUE, AND DEATH BENEFIT FOR A POLICY WOULD BE DIFFERENT FROM
THOSE SHOWN IF THE ACTUAL RATES OF INVESTMENT RETURN AVERAGED 0%, 6%, AND 12%
OVER A PERIOD OF YEARS, BUT FLUCTUATED ABOVE AND BELOW THOSE AVERAGES FOR
INDIVIDUAL POLICY YEARS, OR IF ANY PREMIUMS WERE ALLOCATED OR POLICY VALUE
TRANSFERRED TO THE GENERAL ACCOUNT. NO REPRESENTATIONS CAN BE MADE THAT THESE
HYPOTHETICAL INVESTMENT RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE YEAR OR
SUSTAINED OVER ANY PERIOD OF TIME.
C-6
<PAGE>
APPENDIX D
CALCULATION OF MAXIMUM SURRENDER CHARGES
A separate surrender charge is calculated upon issuance of the Policy and upon
each increase in the Face Amount. The maximum surrender charge is equal to the
sum of (a) plus (b), where (a) is a deferred administrative charge equal to
$8.50 per $1,000 of the initial Face Amount (or Face Amount increase), and (b)
is a deferred sales charge of 49% of premiums received up to a maximum number of
Guideline Annual Premiums (GAPs) subject to the deferred sales charge that
varies by issue Age or Age at time of increase
as applicable:
<TABLE>
<CAPTION>
APPLICABLE AGE MAXIMUM GAPS APPLICABLE AGE MAXIMUM GAPS
- -------------- --------------- -------------- ---------------
<S> <C> <C> <C>
0-55 1.660714 68 1.290612
56 1.632245 69 1.262143
57 1.603776 70 1.233673
58 1.575306 71 1.205204
59 1.546837 72 1.176735
60 1.518367 73 1.148265
61 1.489898 74 1.119796
62 1.461429 75 1.091327
63 1.432959 76 1.062857
64 1.404490 77 1.034388
65 1.376020 78 1.005918
66 1.347551 79 0.977449
67 1.319082 80 0.948980
</TABLE>
A further limitation is imposed based on the Standard Nonforfeiture Law of each
state. The maximum surrender charges upon issuance of the Policy and upon each
increase in the Face Amount are shown in the table below. During the first two
Policy years following issue or an increase in the Face Amount, the actual
surrender charge may be less than the maximum. See "CHARGES AND DEDUCTIONS,"
"Surrender Charge."
The maximum surrender charge initially remains level and then grades down
according to the following schedule:
<TABLE>
<CAPTION>
AGES
- ---------
<S> <C>
0-50 The maximum surrender charge remains level for the first 40 Policy months, reduces by 0.5% for the next
80 Policy months, then decreases by 1% per month to zero at the end of 180 Policy months (15 Policy
years).
51 and The maximum surrender charge remains level for 40 Policy months and decreases per month by the
above percentages below:
age 51 - 0.78% per month for 128 months
age 52 - 0.86% per month for 116 months
age 53 - 0.96% per month for 104 months
age 54 - 1.09% per month for 92 months
age 55 and over - 1.25% per month for 80 months
</TABLE>
D-1
<PAGE>
The Factors used in calculating the maximum surrender charges vary with the
issue Age, sex and Premium Class (Smoker) as indicated in the table below.
MAXIMUM SURRENDER CHARGE PER $1,000 FACE AMOUNT
<TABLE>
<CAPTION>
Age at
issue or Male Male Female Female
increase Nonsmoker Smoker Nonsmoker Smoker
- --------- ------------- ----------- ------------- -----------
<S> <C> <C> <C> <C>
0 8.63 7.68
1 8.63 7.70
2 8.78 7.81
3 8.94 7.93
4 9.10 8.05
5 9.27 8.18
6 9.46 8.32
7 9.65 8.47
8 9.86 8.62
9 10.08 8.78
10 10.31 8.95
11 10.55 9.13
12 10.81 9.32
13 11.07 9.51
14 11.34 9.71
15 11.62 9.92
16 11.89 10.14
17 12.16 10.36
18 10.65 12.44 9.73 10.59
19 10.87 12.73 9.93 10.83
20 11.10 13.02 10.15 11.09
21 11.34 13.33 10.37 11.35
22 11.59 13.66 10.60 11.63
23 11.85 14.01 10.85 11.92
24 12.14 14.38 11.10 12.22
25 12.44 14.77 11.37 12.54
26 12.75 15.19 11.66 12.88
27 13.09 15.64 11.95 13.23
28 13.45 16.11 12.26 13.60
29 13.83 16.62 12.59 13.99
30 14.23 17.15 12.93 14.40
31 14.66 17.72 13.29 14.83
32 15.10 18.32 13.67 15.28
33 15.58 18.96 14.07 15.75
34 16.08 19.63 14.49 16.25
35 16.60 20.35 14.93 16.77
36 17.16 21.10 15.39 17.33
37 17.75 21.89 15.88 17.91
38 18.37 22.73 16.39 18.51
39 19.02 23.55 16.93 19.15
40 19.71 24.28 17.50 19.81
41 20.44 25.04 18.09 20.51
42 21.20 25.85 18.71 21.23
43 22.02 26.71 19.36 21.98
</TABLE>
D-2
<PAGE>
<TABLE>
<CAPTION>
Age at
issue or Male Male Female Female
increase Nonsmoker Smoker Nonsmoker Smoker
- --------- ------------- ----------- ------------- -----------
<S> <C> <C> <C> <C>
44 22.87 27.61 20.04 22.77
45 23.61 28.56 20.76 23.56
46 24.36 29.57 21.52 24.23
47 25.15 30.63 22.33 24.94
48 26.00 31.16 23.14 24.69
49 26.90 32.95 23.83 26.47
50 27.85 34.21 24.57 27.31
51 28.87 35.56 25.35 28.18
52 29.96 36.99 26.17 29.11
53 31.12 38.25 27.05 30.09
54 32.56 38.25 27.95 31.12
55 33.67 38.25 28.97 32.21
56 34.62 38.25 29.65 32.94
57 35.61 38.25 30.36 33.70
58 36.65 38.25 31.11 34.49
59 37.73 38.25 32.74 36.23
60 38.25 38.25 32.74 36.23
61 38.25 38.25 33.63 37.18
62 38.25 38.25 34.57 38.18
63 38.25 38.25 35.56 38.25
64 38.25 38.25 36.60 38.25
65 38.25 38.25 37.68 38.25
66 38.25 38.25 38.25 38.25
67 38.25 38.25 38.25 38.25
68 38.25 38.25 38.25 38.25
69 38.25 38.25 38.25 38.25
70 38.25 38.25 38.25 38.25
71 38.25 38.25 38.25 38.25
72 38.25 38.25 38.25 38.25
73 38.25 38.25 38.25 38.25
74 38.25 38.25 38.25 38.25
75 38.25 38.25 38.25 38.25
76 38.25 38.25 38.25 38.25
77 38.25 38.25 38.25 38.25
78 38.25 38.25 38.25 38.25
79 38.25 38.25 38.25 38.25
80 38.25 38.25 38.25 38.25
</TABLE>
D-3
<PAGE>
EXAMPLES
For the purposes of these examples, assume that a male, Age 35, non-smoker,
purchases a $100,000 Policy. In this example the Guideline Annual Premium
("GAP") equals $1,118.22. His maximum surrender charge is calculated as follows:
(a) Deferred administrative charge $850.00
($8.50/$1,000 of Face Amount)
(b) Deferred sales charge $909.95
(49% X 1.660714 GAPs)
-----------
TOTAL $1,759.95
Maximum surrender charge per table on page 84 (16.60 X 100) $1,660.00
During the first two Policy years after the Date of Issue, the actual surrender
charge is the smaller of the maximum surrender charge and the following sum:
(a) Deferred administrative charge $850.00
($8.50/$1,000 of Face Amount)
(b) Deferred sales charge Varies
(not to exceed 29% of Premiums received,
up to one GAP, plus 9% of premiums
received in excess of one GAP, but
less than the maximum number of GAPs
subject to the deferred sales charge)
--------------------
Sum of (a) and (b)
The maximum surrender charge is $1,660. All premiums are associated with the
initial Face Amount unless the Face Amount is increased.
EXAMPLE 1:
Assume the Policyowner surrenders the Policy in the tenth Policy month, having
paid total premiums of $900. The actual surrender charge would be $1,111.
EXAMPLE 2:
Assume the Policyowner surrenders the Policy in the 120th month. After the 40th
Policy month, the maximum surrender charge decreases by 0.5% per month ($8.30
per month in this example). In this example, the maximum surrender charge would
be $996.
D-4
<PAGE>
PART II
UNDERTAKINGS AND REPRESENTATIONS
UNDERTAKING TO FILE REPORTS
Subject to the terms and conditions of Section 15(d) of the Securities Exchange
Act of 1934, the undersigned Registrant hereby undertakes to file with the
Securities and Exchange Commission ("SEC") such supplementary and periodic
information, documents, and reports as may be prescribed by any rule or
regulation of the SEC heretofore or hereafter duly adopted pursuant to authority
conferred in that section.
RULE 484 UNDERTAKING
Article VIII of Registrant's Bylaws provides: Each Director and each Officer of
the Corporation, whether or not in office, (and his executors or
administrators), shall be indemnified or reimbursed by the Corporation against
all expenses actually and necessarily incurred by him in the defense or
reasonable settlement of any action, suit, or proceeding in which he is made a
party by reason of his being or having been a Director or Officer of the
Corporation, including any sums paid in settlement or to discharge judgment,
except in relation to matters as to which he shall be finally adjudged in such
action, suit, or proceeding to be liable for negligence or misconduct in the
performance of his duties as such Director or Officer; and the foregoing right
of indemnification or reimbursement shall not affect any other rights to which
he may be entitled under the Articles of Incorporation, any statute, bylaw,
agreement, vote of stockholders, or otherwise.
Insofar as indemnification for liability arising under the 1933 Act may be
permitted to Directors, Officers and controlling persons of the Registrant
pursuant to the foregoing provisions, or otherwise, the Registrant has been
advised that in the opinion of the SEC such indemnification is against public
Policy as expressed in the 1933 Act and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than the
payment by the Registrant of expenses incurred or paid by a Director, Officer or
controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such Director, Officer or controlling person
in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public Policy as expressed in the 1933 Act
and will be governed by the final adjudication of such issue.
REPRESENTATIONS PURSUANT TO SECTION 26(e) OF THE INVESTMENT COMPANY ACT OF 1940
The Company hereby represents that the aggregate fees and charges under the
Policy are reasonable in relation to the services rendered, the expenses
expected to be incurred, and the risks assumed by the Company.
REPRESENTATIONS CONCERNING WITHDRAWAL RESTRICTIONS ON SECTION 403(b) PLANS AND
UNDER THE TEXAS OPTIONAL RETIREMENT PROGRAM.
The Company and its registered separate accounts which fund annuity contracts
issued in connection with Section 403(b) plans have relied (a) on Rule 6c-7
under the 1940 Act with respect to withdrawal restrictions under the Texas
Optional Retirement Program ("Program") and (b) on the "no-action" letter (Ref.
No. IP-6-88) issued on November 28, 1988 to the American Council of Life
Insurance, in applying the withdrawal restrictions of Internal Revenue Code
Section 403(b)(11). The variable life insurance Policies issued by the
Registrant may be issued in
<PAGE>
connection with Section 403(b) plans ("plans"), and would be subject to the same
restrictions on redeemability which are applicable to annuity contracts issued
to such Plans. While the Company and the Registrant are relying on the
exemptions provided by Rule 6e-3(T) in connection with the issuance of the
Policies in connection with the Plans, the Company and the Registrant represent
that they will take the following steps in connection with the issuance of the
Policies to Section 403(b) plans:
1. Appropriate disclosures regarding the redemption restrictions imposed by
the Program and by Section 403(b)(11) have been included in the prospectus
of each registration statement used in connection with the offer of the
Company's variable contracts.
2. Appropriate disclosures regarding the redemption restrictions imposed by
the Program and by Section 403(b)(11) have been included in sales
literature used in connection with the offer of the Company's variable
contracts.
3. Sales Representatives who solicit participants to purchase the variable
contracts have been instructed to specifically bring the redemption
restrictions imposed by the Program and by Section 403(b)(11) to the
attention of potential participants.
4. A signed statement acknowledging the participant's understanding of (I) the
restrictions on redemption imposed by the Program and by Section 403(b)(11)
and (ii) the investment alternatives available under the employer's
arrangement will be obtained from each participant who purchases a variable
annuity contract prior to or at the time of purchase.
Registrant hereby represents that it will not act to deny or limit a transfer
request except to the extent that a Service-Ruling or written opinion of
counsel, specifically addressing the fact pattern involved and taking into
account the terms of the applicable employer plan, determines that denial or
limitation is necessary for the variable annuity contracts to meet the
requirements of the Program or of Section 403(b). Any transfer request not so
denied or limited will be effected as expeditiously as possible.
<PAGE>
CONTENTS OF THE REGISTRATION STATEMENT
This registration statement amendment comprises the following papers and
documents:
The facing sheet
Cross-reference to items required by Form N-8B-2
The prospectus consisting of ____ pages
The undertaking to file reports
The undertaking pursuant to Rule 484 under the 1933 Act
Representations pursuant to Section 26(e) of the 1940 Act
Representations Concerning Withdrawal Restrictions on Section 403(b) Plans and
under the Texas Optional Retirement Program
The signatures
Written consents of the following persons:
1. Actuarial Consent
2. Opinion of Counsel
3. Consent of Independent Accountants
The following exhibits:
1. Exhibit 1 (Exhibits required by paragraph A of the instructions to
Form N-8B-2)
(1) Certified copy of Resolutions of the Board of Directors of the
Company of January 21, 1993 establishing the VEL II Account was
previously filed on February 13, 1998 in Post-Effective Amendment
No. 10 and is incorporated by reference herein.
(2) Not Applicable.
(3) (a) Underwriting and Administrative Services Agreement between
the Company and Allmerica Investments, Inc. is filed herewith.
(b) Registered Representatives/Agents Agreement is filed
herewith.
(c) Sales Agreements with broker-dealers are filed herewith.
(d) Commission Schedule is filed herewith.
(e) General Agents Agreement
(f) Career Agents Agreement
(4) Not Applicable.
(5) Policy and initial Policy endorsements are filed herewith. The
following endorsements were previously filed in Post-Effective
Amendment No. 8 on February 27, 1997 and are incorporated by
reference herein:
- Paid up Life Insurance Option Endorsement
- Preferred Loan Endorsement
- 403(b) Life Insurance Policy Endorsement
The Guaranteed Death Benefit Rider is filed herewith.
<PAGE>
(6) Articles of Incorporation and Bylaws, as amended of the Company,
effective as of October 1, 1995 were previously filed on
September 29, 1995 in Post-Effective Amendment No. 5 and are
incorporated by reference herein.
(7) Not Applicable.
(8) (a) Participation Agreement with Allmerica Investment
Trust is filed herewith.
(b) Participation Agreement with Variable Insurance
Products Fund, as amended, is filed herewith.
(c) Participation Agreement with Variable Insurance
Products Fund II, as amended, is filed herewith.
(d) Participation Agreement with Delaware Group
Premium Fund, Inc. is filed herewith.
(e) Participation Agreement with T. Rowe Price
International Series, Inc. is filed herewith
(f) Fidelity Service Agreement, effective as of
November 1, 1995, was previously filed on April 30, 1996 in
Post-Effective Amendment No. 6, and is incorporated by
reference herein.
(g) An Amendment to the Fidelity Service Agreement,
effective as of January 1, 1997, was previously filed on
April 30, 1997 in Post-Effective Amendment No. 9 and is
incorporated by reference herein.
(h) Fidelity Service Contract, effective as of
January 1, 1997, was previously filed in Post-Effective
Amendment No. 9 and is incorporated by reference herein.
(i) Service Agreement with Rowe Price-Fleming
International, Inc. is filed herewith.
(j) BFDS Agreements for lockbox and mailroom services
are filed herewith.
(9) Not Applicable.
(10) Applications are filed herewith.
2. Policy and Policy riders are included in Exhibit 1(5) above.
3. Opinion of Counsel is filed herewith.
4. Not Applicable.
5. Not Applicable.
6. Actuarial Consent is filed herewith.
<PAGE>
7. Procedures Memorandum dated May, 1993 pursuant to Rule
6e-3(T)(b)(12)(iii) under the 1940 Act, which includes conversion
procedures pursuant to Rule 6e-3(T)(b)(13)(v)(B), is filed herewith.
8. Consent of Independent Accountants is filed herewith.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment
Company Act of 1940 the Registrant certifies that it meets all the requirements
for effectiveness of this Registration Statement pursuant to Rule 485(b) under
the Securities Act of 1933 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized, in the City of
Worcester, and Commonwealth of Massachusetts, on the 15th day of April, 1998.
VEL II ACCOUNT OF
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
By: /s/ Abigail M. Armstrong
----------------------------
Abigail M. Armstrong, Secretary
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed below by the following persons in the capacities and
on the dates indicated.
Signatures Title Date
/s/ John F. O'Brien Director and Chairman of April 15, 1998
- ---------------------------- the Board
John F. O'Brien
/s/ Bruce C. Anderson Director
- ----------------------------
Bruce C. Anderson
/s/ Robert E. Bruce Director and Chief
- ---------------------------- Information Officer
Robert E. Bruce
/s/ John P. Kavanaugh Director, Vice President and
- ---------------------------- Chief Investment Officer
John P. Kavanaugh
/s/ John F. Kelly Director, Vice President and
- ---------------------------- General Counsel
John F. Kelly
/s/ J. Barry May Director
- ----------------------------
J. Barry May
/s/ James R. McAuliffe Director
- ----------------------------
James R. McAuliffe
/s/ Edward J. Parry III Director, Vice President,
- ---------------------------- Chief Financial
Edward J. Parry III Officer and Treasurer
/s/ Richard M. Reilly Director, President and
- ---------------------------- Chief Executive Officer
Richard M. Reilly
/s/ Eric A. Simonsen Director and Vice President
- ----------------------------
Eric A. Simonsen
/s/ Phillip E. Soule Director
- ----------------------------
Phillip E. Soule
<PAGE>
FORM S-6 EXHIBIT TABLE
Exhibit 1(3)(a) Underwriting and Administrative Services Agreement
Exhibit 1(3)(b) Registered Representatives/Agents Agreement
Exhibit 1(3)(c) Sales Agreement
Exhibit 1(3)(d) Commission Schedule
Exhibit 1(3)(e) General Agents Agreement
Exhibit 1(3)(f) Career Agents Agreement
Exhibit 1(5) Policy, initial Policy Riders and Guaranteed Death Benefit
Rider
Exhibit 1(8)(a) Participation Agreement with Allmerica Investment Trust
Exhibit 1(8)(b) Participation Agreement with Variable Insurance Products
Fund
Exhibit 1(8)(c) Participation Agreement with Variable Insurance Products
Fund II
Exhibit 1(8)(d) Participation Agreement with Delaware Group Premium Fund,
Inc.
Exhibit 1(8)(e) Participation Agreement with T. Rowe Price International
Series, Inc.
Exhibit 1(8)(i) Service Agreement with Rowe Price-Fleming International,
Inc.
Exhibit 1(8)(j) BFDS Agreements
Exhibit 1(10) Applications
Exhibit 3 Consent of Counsel
Exhibit 6 Actuarial Consent
Exhibit 7 Procedures Memorandum
Exhibit 8 Consent of Independent Accountants
<PAGE>
UNDERWRITING AND
ADMINISTRATIVE SERVICES AGREEMENT
AGREEMENT made this 26th day of November, 1997 between and among Allmerica
Financial Life Insurance and Annuity Company, a Delaware corporation (the
"Company"), each of its separate investment accounts (the "Accounts") which is a
registered investment company under the Investment Company Act of 1940 (the
"1940 Act"), as may be established by the Company from time-to-time, and
Allmerica Investments, Inc., a Massachusetts corporation (the "Distributor").
WITNESSETH:
WHEREAS, the Company and the respective Accounts issue certain variable annuity
contracts or variable insurance policies (the "contracts") which may be deemed
to be securities under the Securities Act of 1933 (the "1933 Act"), and the laws
of some states;
WHEREAS, the Distributor, an affiliate of the Company, is registered as a
broker-dealer with the Securities and Exchange Commission ("SEC") under the
Securities Exchange Act of 1934 (the "1934 Act") and is a member of the National
Association of Securities Dealers, Inc. ("NASD");
WHEREAS, the parties desire to have the Distributor act as principal underwriter
for the Accounts set forth in Exhibit A, as may be amended from time-to-time by
mutual consent of the parties, and to assume full responsibility for the
securities activities of all "persons associated" (as that term is defined in
Section 3(a)(18) of the 1934 Act) with the Distributor and engaged directly or
indirectly in the variable contract operation (the "associated persons");
WHEREAS, the parties desire to have the Company perform certain administrative
services in connection with the sale and servicing of the contracts.
NOW, THEREFORE, in consideration of the covenants and mutual promises of the
parties made to each other, it is hereby covenanted and agreed as follows:
1. The Distributor will act as the exclusive principal underwriter for the
Accounts and as such will assume full responsibility for the securities
activities of all the associated persons in connection with the sale of the
contracts. The Distributor will train the associated persons, use its best
efforts to prepare them to complete satisfactorily the applicable NASD and
state examinations so that they may be qualified, register the associated
persons as its registered representatives before they engage in the sale of
the contracts, and supervise and control them in the performance of such
activities. Notwithstanding anything in this Agreement to the contrary,
the Distributor may enter into sales agreements with independent
broker-dealers for the sale of the contracts. All such sales agreements
entered into by the Distributor with independent broker-dealers shall
provide that each independent broker-dealer will assume full responsibility
for continued compliance by itself and its associated persons with the NASD
Rules of Fair Practice and Federal and state securities laws.
2. The Distributor will assume full responsibility for the continued
compliance by itself and its associated persons with the NASD Rules of Fair
Practice and Federal and state securities laws, to the extent applicable in
connection with the sale of the contracts. The Distributor, directly or
through the Company as its agent, will make timely filings with the SEC,
NASD, and any other securities regulatory authorities of all reports and
any sales literature relating to the Accounts required by law to be filed
by the Distributor.
3. The Company will prepare and submit to the Accounts (a) all registration
statements and prospectuses (including amendments) and all reports required
by law to be filed by the Accounts with Federal and state securities
regulatory authorities, and (b) all notices, proxies, proxy statements, and
periodic reports that are to be transmitted to persons having voting rights
with respect to the Accounts.
- 1 -
<PAGE>
4. The Company will, except as otherwise provided in this Agreement, bear the
cost of all services and expenses, including legal services and expenses,
filing fees, and other fees incurred in connection with (a) registering and
qualifying the Accounts and the contracts, and (b) preparing, printing, and
distributing all registration statements and prospectuses (including
amendments), contracts, notices, periodic reports, proxy solicitation
material, sales literature, and advertising filed or distributed in
connection with the sale of the contracts.
All cost associated with the variable contract compliance function
including, but not limited to, fees and expenses associated with qualifying
and licensing associated persons with Federal and state regulatory
authorities and the NASD and with performing compliance-related
administrative services, shall be allocated to the Company. To the extent
that the Distributor incurs out-of-pocket expenses in connection with the
variable contracts compliance function, the Company shall reimburse the
Distributor for such expenses. To the extent that such costs are in
connection with services provided by employees of the Company, they shall
be charged to the Company. The determination and allocation of all such
costs shall be pursuant to the Cost Distribution Policy as stated in the
Consolidated Service Agreement (effective January 1, 1993) among the
Allmerica Financial group of affiliated companies, as may be amended from
time.
5. All purchase payments made under the contracts will be forwarded by or on
behalf of Contract Owners directly to the Company and shall become the
exclusive property of the Company. The Company agrees to pay on behalf of
Distributor all sales commissions and any other remuneration due in
connection with the sale of the contracts by associated persons of the
Distributor and any independent broker-dealers having a sales agreement
with the Distributor. The Distributor or the Company as agent for the
Distributor shall pay all other remuneration due any other person for
activities relating to the sale of the contracts. The Company shall
reimburse the Distributor fully and completely for all amounts paid by the
Distributor to any person pursuant to this Section.
6. The Company will, as the Distributor's agent, (a) maintain and preserve in
accordance with Rules 17a-3 and 17a-4 under the 1934 Act all books and
records required to be maintained by the Distributor in connection with the
offer and sale of the contracts being offered for sale pursuant to this
Agreement, which books and records shall remain the property of the
Distributor, and shall at all times be subject to inspection by the SEC in
accordance with Section 17(a) of the 1934 Act, and all other regulatory
bodies having jurisdiction, and (b) send a written confirmation for each
such transaction reflecting the facts of the transaction and showing that
it is being sent on behalf of the Distributor acting in the capacity of
agent for the Accounts, in conformance with the requirements of Rule 10b-10
of the 1934 Act.
7. Each party hereto shall advise the others promptly of (a) any action of the
SEC or any authorities of any state or territory of which it has knowledge,
affecting registration or qualification of the Accounts or the contracts,
or the right to offer the contracts for sale, and (b) the happening of any
event which makes untrue any statement, or which requires the making of any
change in the registration statement or prospectus in order to make the
statements therein not misleading.
8. The Company agrees to be responsible to the Accounts for all sales and
administrative expenses incurred in connection with the administration of
the contracts and the Accounts other than applicable taxes arising from
income and capital gains of the Accounts and any other taxes arising from
the existence and operation of the Accounts.
9. As compensation for services performed and expenses incurred under this
Agreement, the Company will receive the charges and deductions as provided
in each outstanding series of the Company's contracts. Distributor will
receive the compensation provided for in Section 4, and may receive such
additional compensation, if any, as may be agreed upon by the parties from
time-to-time.
- 2 -
<PAGE>
10. Each party hereto agrees to furnish any other state insurance commissioner
or regulatory authority with jurisdiction over the contracts with any
information or reports in connection with services provided under this
Agreement which may be requested in order to ascertain whether the variable
insurance product operations of the Company are being conducted in a manner
consistent with applicable statutes, rules and regulations.
11. This Agreement shall upon execution become effective as of the date first
above written, and
(a) Unless otherwise terminated, this Agreement shall continue in effect
from year-to-year;
(b) This Agreement may be terminated by any party at any time upon giving
60 days' written notice to the other parties hereto; and
(c) This Agreement shall automatically terminate in the event of its
assignment.
12. The initial Accounts covered by this Agreement are set forth in Appendix A.
This Agreement, including Appendix A, may be amended at any time by mutual
consent of the parties.
13. This Agreement shall be governed by and construed in accordance with the
laws of Massachusetts.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the day
and year first above written.
ALLMERICA FINANCIAL LIFE INSURANCE
AND ANNUITY COMPANY
By: /s/ David J. Mueller
-------------------------------------
Title: Vice President
ALLMERICA INVESTMENTS, INC.
By: /s/ Thomas P. Cunningham
-------------------------------------
Title: Vice President
- 3 -
<PAGE>
Appendix A
SEPARATE ACCOUNTS OF ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
AS OF SEPTEMBER 1, 1997
VEL Account
VEL II Account
Inheiritage Account
Allmerica Select Separate Account II
Group VEL Account
Fulcrum Variable Life Separate Account
Separate Account VA-K
Separate Account VA-P
Allmerica Select Separate Account
Separate Account KG
Separate Account KGC
Fulcrum Separate Account
- 4 -
<PAGE>
Registered
[LOGO] ALLMERICA Allmerica 440 Lincoln Street Representative's
FINANCIAL(R) Investments, Inc. Worcester, MA 01653 Agreement
- --------------------------------------------------------------------------------
Allmerica Investments, Inc. ("Company") hereby appoints ________________________
("Registered Representative") for the purpose of selling and servicing variable
contracts offered by Allmerica Financial Life Insurance and Annuity Company,
mutual funds, limited partnerships and other investment products and services
(collectively "Investment Products and Services") offered and distributed by
Company. Registered Representative will submit Investment Products and Services
business through the office of _________________________________________________
("General Agent") or successor at ______________________________________________
("Agency") or successor. This appointment is effective as of the date accepted
by Registered Representative and acknowledged by General Agent.
1. DUTY OF COMPLIANCE/SUPERVISION: Registered Representative is assigned to
the above named Agency and General Agent for the purposes of training,
supervision and recordkeeping. Registered Representative agrees to comply
with all of the applicable laws, rules and regulations of the Securities
and Exchange Commission (SEC), National Association of Securities Dealers,
Inc. (NASD) and all other applicable federal and state insurance and
securities laws and regulations.
Registered Representative agrees to comply with all procedures and
requirements outlined in Company manuals, memoranda and other publications
as may be amended from time-to-time.
Registered Representative agrees to abide by Company's Compliance Program
including his/her mandatory attendance, on at least an annual basis, at
Agency's Compliance Meeting(s) and/or Interview(s). Failure to attend
Compliance Meeting and/or Interview is grounds for immediate termination
for cause.
2. LIMITATIONS OF AUTHORITY: Registered Representative may not delegate any
authority granted under this Agreement and shall not appoint any
solicitors or subagents to act on his/her behalf. Registered
Representative may not sign and/or submit any customer applications or
orders on behalf of any individual who is not fully qualified as a
Registered Representative of Company.
Registered Representative will only offer for sale those Investment
Products and Services for which he/she is properly NASD registered,
securities-licensed through Company and, if required by state law, state
insurance-licensed through Allmerica Financial Life Insurance and Annuity
Company, and for which Company has fully executed sales agreements with
the sponsor or issuer. To participate in the sale of Investment Products
and Services for which no agreement has been executed is to "sell-away"
from Company and is grounds for immediate termination of this Agreement
upon written notice to Registered Representative.
Registered Representative will maintain his/her NASD registration solely
through Company and will provide full disclosure to Company of his/her
background. Registered Representative agrees to notify Company immediately
of any matter requiring disclosure on the NASD Form U-4, Uniform
Application for Securities Industry Registration, including but not
limited to any income generating business activity, other than personal,
passive investment, which is outside the scope of Registered
Representative's Agreement with Company.
Customer accounts or applications may only be accepted on behalf of
Company based on approval by a Home Office principal. Registered
Representative has no authority to accept any risk on Company's behalf, to
incur any indebtedness or liability on behalf of Company and understands
and agrees to Company's prohibition against assuming discretionary
authority over client investments.
3. ASSIGNABILITY: No assignment, sale or transfer of this Agreement or any of
the rights, claims or interests under it may be made by Registered
Representative without the prior written consent of Company. Such
assignment, sale or transfer by Registered Representative without written
consent of Company will immediately make this Agreement void, and will be
a release in full to Company of any and all of its obligations hereunder.
4. SUBMISSION OF APPLICATIONS/ACCOUNTING FOR FUNDS COLLECTED: All
applications and/or payments collected by Registered Representative on
behalf of Company or any issuer or sponsor are to be delivered immediately
to Registered Representative's Agency no later than noon of the business
day following receipt by Registered Representative.
Investment Product and Services purchase checks are to be client personal
checks, cashier's checks or money orders made payable to either the
Company, appropriate issuer, sponsor or other designated agent. Such
checks may not be made payable to Registered Representative, General Agent
or any personal or Agency account.
5. SUITABILITY/RESPONSIBILITY TO EXPLAIN INVESTMENT PRODUCTS: Registered
Representative agrees to make Investment Product and Services
recommendations to clients only after obtaining sufficient information
regarding a client's financial background, goals and objectives so as to
make a reasonable determination that the proposed Investment Product
and/or Service is suitable based on such background, goals and
objectives. Registered Representative agrees to fully explain the risks,
terms and conditions of the purchase of an Investment Product or Service
and that he/she will not make untrue statements, interpretations,
misrepresentations nor omit or evade material facts concerning such
Investment Product or Service.
6. DISTRIBUTION AND USE OF ADVERTISING MATERIAL, CORRESPONDENCE: Registered
Representative agrees not to directly or indirectly use or distribute
any advertising or sales literature material (including but not limited
to prospectuses, illustrations, circulars, form letters or postal cards,
business cards, stationery, booklets, schedules, broadcasting and other
sales material of any kind) concerning Company and/or the offering of
Investment Products and Services of any kind until the material has been
approved by Company in writing.
Registered Representative also agrees to provide to General Agent copies
of all correspondence pertaining to the solicitation of execution of any
Investment Products and Services transaction, and to any other aspect of
his/her Investment Products and Services business in order to allow for
the review and endorsement of the correspondence in writing, on an
official internal record of Company by a registered principal located at
Home Office.
SMAE-050NS (11/95)
<PAGE>
7. RECORDKEEPING: Registered Representative agrees, in accordance with
Company guidelines and requirements, to cooperate in the maintenance of
complete customer account files and other records at the assigned Agency
which pertain to the conduct of Investment Products and Services business
through Company. Customer account files of Registered Representative are
to be considered the property of Company and are not to be taken from the
immediate Agency premises for any purpose.
8. COMMISSIONS: Commissions for the sale of Investment Products and Services
offered or effected by Registered Representative will be paid after
compensation for those sales is paid to Company. Commissions for
Investment Products and Services will be paid at the rates established and
published by Company.
Commissions may be changed by Company at any time without advance notice.
However, this policy shall not be applied retroactively to divest any
Registered Representative of specific commission amounts already due
him/her.
Registered Representative agrees not to share commissions with
non-qualified representatives or with clients.
Under certain circumstances, i.e., termination of agents subject to
variable contract commission vesting, retirement or death, Registered
Representative or his/her estate may be entitled to receive continuing
commissions from Company for transactions conducted prior to the cessation
of his/her service with Company. Continuing commissions will be paid based
on vesting schedules established and published by Company, as may be
amended from time-to-time.
If Company or any issuer or sponsor returns or waives payments on any
application or order, commissions will not be due or payable on the
payments. Registered Representative shall repay to Company on demand any
commissions already received by Registered Representative with respect to
such returned or waived payments.
Where cancellation of any Investment Products and Services order results
in expense or loss to Company, Registered Representative is liable for
reimbursement to Company of the expense or loss including but not limited
to any sales charge levied by an issuer and any decline in the price of an
Investment Product, as of the time of cancellation.
In the event Registered Representative becomes party to a Career Builder
Supplemental Agreement (Supplemental Agreement) with First Allmerica
Financial Life Insurance Company ("First Allmerica"), and its affiliate,
Allmerica Financial Life Insurance and Annuity Company, commissions
payable under this Registered Representative's Agreement will be credited
to the Reserve Account described in such Supplemental Agreement during the
period such Supplemental Agreement is in effect and will be paid to
Registered Representative only as provided therein.
Company reserves the right to pay commissions to the Registered
Representative for Investment Products and Services sold or performed by
utilizing one check issued by Allmerica Financial or one of its
wholly-owned subsidiaries. Such check may also contain compensation for
traditional life, health and disability policies as well as other products
and services sold by Registered Representatives through Allmerica
Financial.
9. RIGHT OF OFF-SET: Company, for its own benefit and/or the benefit of its
affiliates, will have a lien on any commissions and other compensation
payable under this Agreement, and may deduct any monies owed Company or
affiliates from such commissions or other compensation to the extent
permitted by law.
10. TERMINATION FOR CAUSE: If Registered Representative withholds or
misappropriates monies, securities, certificates, payments, receipts,
"sells-away," commits any willful or dishonest act which, in the sole
discretion of Company, is detrimental to Company, or fails to comply with
any of the conditions, duties or obligations of this Agreement, this
Agreement will immediately terminate without notice.
11. TERMINATIONS WITHOUT CAUSE: Registered Representative or company may
terminate this Agreement without cause during the first twelve (12) months
following the date this Agreement is executed by providing ten (10) days'
notice in writing to the other party of the intention to terminate. After
the first twelve (12) months, Registered Representative or Company may
terminate this Agreement without cause upon thirty (30) days' notice in
writing of the intention to terminate.
In the event Registered Representative terminates his/her Career Agent
Agreement with First Allmerica Financial Life Insurance Company, this
Agreement will be terminated upon written notice as described herein.
12. RELATIONSHIP OF PARTIES: Nothing contained in this Agreement is to be
construed to create the relationship of employer and employee between
Company and Registered Representative or between Company's General Agent
and Registered Representative. Registered Representative shall exercise
his/her own judgment concerning the individual(s) to whom he/she will
solicit Investment Products and Services as well as the time, place and
manner of the solicitations. Registered Representative, however, shall
comply with all applicable laws, rules and regulations of the SEC, NASD,
federal and state authorities as well as Company's rules, regulations
and procedures concerning the conduct of Investment Products and
Services business, as may be amended from time-to-time.
13. EFFECTIVENESS OF CONTRACT: This Agreement constitutes the entire contract
between Registered Representative and Company.
Registered Representative accepts the appointment, subject to all of the
conditions and provisions set forth in this Agreement. This Agreement
supersedes all previous agreements, whether oral or written between the
parties, and no modification, except to attached Compensation Schedules
(if any), will be valid unless made in writing and signed by both parties.
IN WITNESS WHEREOF, this Agreement has been executed by the undersigned on the
____________________________________ day of
_________________________ ,19 _______. Allmerica Investments, Inc.
By__________________________
__________________________________ ____________________________
Registered Representative General Agent
<PAGE>
SALES
AGREEMENT ALLMERICA INVESTMENTS, INC.
440 Lincoln Street
Worcester, Massachusetts 01653
- ------------------------------------------------------------------------------
Agreement, effective as of _________________, 19___, by and between Allmerica
Investments, Inc., a Massachusetts corporation (herein "Allmerica"), ________
__________________________________________________________________________, a
_____________________________ corporation (herein the "Broker-Dealer") and the
affiliates of Broker-Dealer listed on Exhibit "A" attached hereto, each
affiliate being referred to herein as a "General Agent".
Allmerica, subject to the terms and conditions set forth in this Agreement,
authorizes and appoints each General Agent to solicit applications for the
sale of Contracts. Each General Agent accepts this appointment and each
General Agent and the Broker-Dealer agree to the terms and conditions set
forth below.
DEFINITIONS
INSURANCE COMPANIES - All Contracts will be issued by First Allmerica
Financial Life Insurance Company (herein "First Allmerica") or by Allmerica
Financial Life Insurance and Annuity Company (herein "Allmerica Financial
Life"), a subsidiary of First Allmerica. The Principal Office of First
Allmerica and Allmerica Financial Life (herein collectively referred to as
"the Insurance Companies") is located at 440 Lincoln Street, Worcester,
Massachusetts 01653.
CONTRACTS - The variable annuity and variable life insurance contracts of the
Insurance Companies listed on the attached Commission Schedule(s), for which
Allmerica Investments, Inc., an affiliate of First Allmerica, has been
appointed the exclusive distributor and principal underwriter.
REGISTERED REPRESENTATIVES - Individuals affiliated with each General Agent
and the Broker-Dealer who are licensed as life insurance agents in those
jurisdictions in which applications for the sale of Contracts are to be
solicited and who are also duly registered with the National Association of
Securities Dealers, Inc. (herein "NASD") in compliance with the '34 Act.
'33 ACT - The Securities Act of 1933, as amended.
'34 ACT - The Securities Exchange Act of 1934, as amended.
RELATIONSHIP OF PARTIES
SECTION 1. Nothing in this Agreement will be construed to create the
relationship of employer and employee between Allmerica or either Insurance
Company and any General Agent, the Broker-Dealer or any Registered
Representative. General Agents and Registered Representatives will be free
to exercise their independent judgment as to the time, place and manner of
solicitation and servicing of business underwritten by the Insurance
Companies. However, General Agents, the Broker-Dealer and Registered
Representatives shall have no authority to act on behalf of Allmerica or the
1
<PAGE>
Insurance Companies in a manner which does not conform to applicable
statutes, ordinances, or governmental regulations or to reasonable rules
adopted from time to time by Allmerica or the Insurance Companies.
LIMITATIONS ON AUTHORITY
SECTION 2. General Agents, the Broker-Dealer and Registered Representatives
will have no authority to accept risks of any kind; to make, alter or
discharge Contracts; to waive forfeitures or exclusions; to alter or amend
any papers received from either Insurance Company; to deliver any life
insurance Contract or any document, agreement or endorsement changing the
amount of insurance coverage if the General Agent, the Broker-Dealer or the
soliciting Registered Representative know or have reason to believe that the
insured is uninsurable; or to accept any payment unless the payment meets the
minimum payment requirement for the Contract established by the Insurance
Company.
LICENSING AND REGISTRATION
SECTION 3. Each General Agent is hereby authorized to recommend Registered
Representatives for appointment by the Insurance Companies and only
individuals so recommended by a General Agent shall become Registered
Representatives hereunder. Allmerica shall arrange for the Insurance
Companies to apply for life insurance agent appointments in the appropriate
jurisdictions for such recommended Registered Representatives. Until
Contracts of First Allmerica are offered for sale, applications for
appointments shall only be made on behalf of Allmerica Financial Life.
Notwithstanding the foregoing, the Insurance Companies and Allmerica reserve
the right to refuse to appoint any proposed Registered Representative and/or
to terminate any Registered Representative who has been appointed by the
Insurance Companies.
AGREEMENTS BY GENERAL AGENT AND BROKER-DEALER
SECTION 4. The Broker-Dealer agrees that at all times when performing its
duties under this Agreement it shall be duly registered as a securities
broker-dealer under the '34 Act, be a member in good standing of the NASD,
and be duly licensed or registered as a securities broker-dealer in each
jurisdiction where such licensing or registration is required in connection
with the sale of the Contracts or the supervision of Registered
Representatives who solicit applications for the Contracts.
Each General Agent agrees that at all times when performing its duties under
this Agreement it shall be duly licensed to sell Contracts in each
jurisdiction in which General Agent intends to perform hereunder.
Each General Agent and the Broker-Dealer shall be responsible for carrying
out their sales and administrative obligations under this Agreement in
continued compliance with the NASD Rules of Fair Practice, federal and state
securities laws and regulations, and state insurance laws and regulations.
Each General Agent and the Broker-Dealer agree to offer the Contracts for
sale through their Registered Representatives and to offer such Contracts
only in accordance with the prospectus. General Agents, the Broker-Dealer
and Registered Representatives are not authorized to give any information or
make any representations concerning such Contracts other
2
<PAGE>
than those contained in the prospectus or in such sales literature or
advertising as may be authorized by Allmerica.
Each General Agent and the Broker-Dealer agree that they shall be fully
responsible for ensuring that no person shall offer or sell Contracts on
their behalf until such person is appropriately licensed, registered or
otherwise qualified to offer and sell such Contracts under the state and
federal securities laws and the insurance laws of each jurisdiction in which
such person intends to solicit.
Each General Agent and the Broker-Dealer agree to train, supervise and be
solely responsible for the conduct of their Registered Representatives in the
solicitation and sale of the Contracts and for the supervision as to their
strict compliance with Allmerica's rules and procedures, the NASD rules of
Fair Practice, and applicable rules and regulations of any other governmental
or other agency that has jurisdiction over the offering for sale of the
Contracts.
Each General Agent and the Broker-Dealer shall take reasonable steps to
ensure that their Registered Representatives shall not make recommendations
to an applicant to purchase a Contract in the absence of reasonable grounds
to believe that the purchase of such Contract is suitable for such applicant.
Such determination will be based upon, but will not be limited to,
information furnished to a Registered Representative after reasonable inquiry
of such applicant concerning the applicant's insurance and investment
objectives, financial situation and needs.
Each General Agent and the Broker-Dealer agree that Registered
Representatives shall conduct their business with respect to the Contracts at
all times in compliance with all applicable federal and state laws and
regulations and shall be subject to a standard of conduct including, but not
limited to, the following:
(a) A Registered Representative shall not solicit or participate in the sale
of the Contracts in any jurisdiction until such Registered Representative
is trained and licensed.
(b) A Registered Representative shall not solicit for the sale of Contracts
without delivering the then currently effective prospectus for such
Contracts and any then applicable amendments or supplements thereto,
including the current prospectus(es) for any fund(s) in which Contract
separate account(s) invest.
(c) A Registered Representative shall have no authority to advertise for or
on behalf of the Insurance Companies or Allmerica without express written
authorization from Allmerica.
AGREEMENTS BY ALLMERICA
SECTION 5. Allmerica agrees that at all times while this Agreement remains
in force that it shall be a registered broker-dealer under the '34 Act and be
a member in good standing of the NASD.
3
<PAGE>
During the term of this Agreement, Allmerica will provide to, or cause to be
provided to, each General Agent and the Broker-Dealer, without charge, as
many copies of the prospectus(es) for the Contracts (and any amendments, or
supplements thereto), the current prospectus(es) for any underlying fund(s)
and applications for the Contracts as each General Agent and the
Broker-Dealer may reasonably request. Upon termination of the Agreement, any
prospectuses, applications, and other materials and supplies furnished by
Allmerica to General Agents and the Broker-Dealer shall be promptly returned
to Allmerica.
Allmerica agrees to promptly notify each General Agent and the Broker-Dealer
of newly declared effective prospectus(es) for the Contracts and any
amendments or supplements thereto.
Allmerica agrees to keep each General Agent and the Broker-Dealer informed of
all jurisdictions in which the Insurance Companies are licensed to sell the
Contracts and in which the Contracts may be offered for sale.
SUBMISSION OF APPLICATIONS; DELIVERY OF CONTRACTS; REJECTED BUSINESS
SECTION 6. Each General Agent or the Broker-Dealer will submit, or cause to
be submitted, directly to the Principal Office of the Insurance Companies all
Contract applications solicited by their Registered Representatives. Each
General Agent or the Broker-Dealer will deliver, or cause to be delivered,
within 10 days of the date of issue all Contracts issued on applications
submitted by the General Agent, the Broker-Dealer or their Registered
Representatives. Each General Agent or the Broker-Dealer will promptly
return, or cause to be returned, to the Insurance Companies any Contract
which is declined by the applicant or which cannot be delivered within the
time permitted by the Insurance Company's rules.
ILLUSTRATIONS AND PROPOSALS
SECTION 7. General Agents, the Broker-Dealer and Registered Representatives
will not furnish any prospective Contract owner with an illustration of the
financial or other aspects of a Contract or a proposal for a Contract unless
the same has been either furnished by the Insurance Companies or prepared
from computer software or other material furnished or approved by the
Insurance Companies. Any illustration or proposal will conform to standards
of completeness and accuracy established by the Insurance Companies. If the
proposal or illustration was not furnished by the Insurance Companies, each
General Agent or the Broker-Dealer will retain in its records for
availability to the Insurance Companies a copy thereof or the means to
duplicate the same. Any computer software or materials furnished by either
Insurance Company will be and remain its property.
ACCOUNTING FOR FUNDS COLLECTED
SECTION 8. In accordance with the rules of the Insurance Companies, each
General Agent and the Broker-Dealer will account for and remit immediately to
the Principal Office of the Insurance Companies all funds received or
collected for or on behalf of either Insurance Company without deduction for
any commissions, or other claim the General Agent, the Broker-Dealer or any
Registered Representative may have against either Insurance Company or
Allmerica and will make such reports and file such
4
<PAGE>
substantiating documents and records as the Insurance Companies may
reasonably require.
INDEMNIFICATION
SECTION 9. Each General Agent and the Broker-Dealer, jointly and severally,
shall indemnify and hold Allmerica and the Insurance Companies and their
officers, directors and employees harmless from any liability arising from
any act or omission of the General Agent, the Broker-Dealer or of any
affiliate of the Broker-Dealer, or any officer, director, employee of the
General Agent or the Broker-Dealer or of their Registered Representatives,
including but not limited to, any fines, penalties, attorney's fees, costs of
settlement, damages or financial loss. Each General Agent and the
Broker-Dealer expressly authorize Allmerica and the Insurance Companies,
without precluding them from exercising any other remedy they may have, to
charge against all compensation due or to become due to the General Agent or
the Broker-Dealer under this Agreement, any monies paid on any liability
incurred by Allmerica or the Insurance Companies by reason of any such act or
omission of any General Agent, the Broker-Dealer, any affiliate of the
Broker-Dealer, or of any officer, director, employee of a General Agent or
the Broker-Dealer or of their Registered Representatives.
Allmerica shall indemnify and hold each General Agent and the Broker-Dealer
and their officers, directors, employees and registered representatives
harmless from any liability arising from any act or omission of Allmerica,
the Insurance Companies or any affiliate of Allmerica or any of the Insurance
Companies (collectively the "Allmerica Companies"), or any officer, director
or employee of the Allmerica Companies, including but not limited to, any
fines, penalties, reasonable attorney's fees, costs of settlement, damages or
financial loss.
The indemnifications provided by this Section shall survive termination of
this Agreement.
If a Contract is not delivered to the Contract owner within 10 days of the
date of issue of the Contract and if after delivery the owner returns the
Contract to the Insurance Company and receives a full refund of all payments
made, in any situation where the failure to deliver in a timely manner was
due to the inaction or negligence of a General Agent, the Broker-Dealer or a
Registered Representative, the difference between the payments refunded and
the cash value of the Contract on the date the Contract is received by the
Insurance Company at its Principal Office shall be reimbursed to the
Insurance Company by the offending General Agent or the Broker-Dealer in any
case where the cash value is less than the payments refunded. Any such
reimbursement shall be paid to the affected Insurance Company within 30 days
of receipt of a written request for payment.
COMMISSION REFUNDS
SECTION 10. If a Contract owner rescinds a Contract or exercises a right to
surrender a Contract for return of all payments made, the soliciting General
Agent or the Broker-Dealer will repay the appropriate Insurance Company the
amount of any
5
<PAGE>
commissions received on the payments returned within 10 days of receipt of a
written request for repayment.
BASIS OF COMPENSATION
SECTION 11. While this Agreement remains in force, the Insurance Companies
agree to pay each General Agent commissions in accordance with the Commission
Schedule(s) attached hereto and incorporated herein, from which amounts the
General Agent agrees to pay its Registered Representatives. Commission
payments will be made for each Contract issued pursuant to an application
solicited by duly appointed Registered Representatives.
TIME OF PAYMENT OF COMMISSIONS
SECTION 12. A payment will not be considered made until it has been received
by the Insurance Company at its Principal Office. On payments made,
commissions will be paid at regular intervals in accordance with the rules of
the Insurance Companies.
TERMINATION
SECTION 13. This Agreement shall automatically terminate immediately and
without notice upon any General Agent's or the Broker-Dealer's ceasing to
comply with any of the terms and conditions of this Agreement or upon the
dissolution, bankruptcy or insolvency of a General Agent or the Broker-Dealer.
Whether or not there is a breach of this Agreement, the Broker-Dealer or
Allmerica may terminate this Agreement by giving ten (10) days' written
notice to the other party at any time during the first year hereof, and by
giving thirty (30) days' written notice after the expiration of the first
year hereof.
Upon termination of this Agreement all authorizations, rights and obligations
shall cease except the obligation to pay commissions due on payments received
prior to termination for Contracts in effect on the date of termination, or
for Contracts to be issued pursuant to applications received by the Insurance
Companies prior to termination. Except as provided in the preceding
sentence, no further commissions shall be paid after termination of this
Agreement.
RIGHT OF SET-OFF
SECTION 14. Allmerica and the Insurance Companies will have a lien on any
commissions payable under this Agreement, whether or not such payments are
now due or hereafter become due, and may apply any such monies to the
satisfaction of indebtedness to Allmerica or to either Insurance Company to
the extent permitted by law.
NON-WAIVER OF BREACH
SECTION 15. Waiver of any breach of any provision of this Agreement will not
be construed as a waiver of the provision or of the right of Allmerica to
enforce said provision thereafter.
ASSIGNABILITY
SECTION 16. This Agreement is not transferable. Without the written consent
of Allmerica and the Insurance Companies, no rights or interest in or to
commissions will be subject to assignment, and any attempted assignment, sale
or transfer of any commissions without such written consents will immediately
make this Agreement
6
<PAGE>
void and be a release to Allmerica and to the Insurance Companies in full of
any and all of their obligations hereunder.
RESERVATION OF RIGHT TO CHANGE
SECTION 17. Allmerica reserves the right at any time, and from time to time,
to change prospectively the terms and conditions of this Agreement, including
but not limited to, the rates of commissions. Any change will become
effective on the date specified in a notice or, if later, 10 days after the
notice is given to each General Agent and the Broker-Dealer. However, the
requirement to give advance notice shall not apply if the change becomes
necessary or expedient by reason of legislation or the requirements of any
governmental body and, in the opinion of Allmerica, it is not reasonably
possible to meet the 10 day requirement. Changes will not be retroactive and
will apply only to life insurance coverage solicited or annuity payments made
on or after the effective date of the change.
COMPLAINTS AND INVESTIGATIONS
SECTION 18. Each General Agent, the Broker-Dealer and Allmerica agree to
cooperate fully in any customer complaint, insurance or securities regulatory
proceeding or judicial proceeding with respect to the General Agent, the
Broker-Dealer, Allmerica, the Insurance Companies, their affiliates or their
Registered Representatives to the extent that such customer complaint or
proceeding is in connection with Contracts marketed under this Agreement. To
the extent required, Allmerica will arrange for the Insurance Companies to
cooperate in any such complaint or proceeding. Without limiting the
foregoing:
(a) General Agents and the Broker-Dealer will be notified promptly by
Allmerica or the Insurance Companies of any written customer complaint or
notice of any regulatory proceeding or judicial proceeding of which they
become aware including the General Agent, the Broker-Dealer or any
Registered Representative which may be related to the issuance of any
Contract marketed under this Agreement. Each General Agent or the
Broker-Dealer will promptly notify Allmerica of any written customer
complaint or notice of any regulatory proceeding or judicial proceeding
received by the General Agent or the Broker-Dealer including the General
Agent, the Broker-Dealer or any of their Registered Representatives which
may be related to the issuance of any Contract marketed under this
Agreement or any activity in connection with any such Contract(s).
(b) In the case of a customer complaint, each General Agent, the
Broker-Dealer, Allmerica and the Insurance Companies will cooperate in
investigating such complaint and any proposed response to such complaint
will be sent to the other parties to this Agreement for approval not less
than five business days prior to its being sent to the customer or
regulatory authority, except that if a more prompt response is required,
the proposed response shall be communicated by telephone or facsimile
transmission.
7
<PAGE>
CONFIDENTIALITY
SECTION 19. Allmerica agrees that the names and addresses of all customers
and prospective customers of each General Agent and the Broker-Dealer and of
any company or person affiliated with a General Agent or the Broker-Dealer,
and the names and addresses of any Registered Representatives of the
Broker-Dealer which may come to the attention of Allmerica exclusively as a
result of its relationship with a General Agent and the Broker-Dealer or any
affiliated company and not from any independent source, are confidential and
shall not be used by Allmerica, the Insurance Companies, or any company or
person affiliated with Allmerica or the Insurance Companies, nor divulged to
any party for any purpose whatsoever, except as may be necessary in
connection with the administration and marketing of the Contracts sold by or
through General Agents, including responses to specified requests to the
Insurance Companies for service by Contract owners or efforts to prevent the
replacement of such Contracts or to encourage the exercise of options under
the terms of the Contracts. In no event shall the names and addresses of
such customers, prospective customers and Registered Representatives be
furnished by Allmerica to any other company or person, including but not
limited to, any of their managers, registered representatives, or brokers who
are not Registered Representatives of the Broker-Dealer, any company
affiliated with Allmerica or any manager, agency, or broker of such company,
or any securities broker-dealer or any insurance agent affiliated with such
broker-dealer. The intent of this section is that Allmerica, the Insurance
Companies or companies or persons affiliated with them shall not utilize, or
permit to be utilized, their knowledge of each General Agent, the
Broker-Dealer or of any affiliated companies which is derived exclusively as
a result of the relationships created through the sale of the Contracts.
Notwithstanding the foregoing provisions of this Section 19, nothing herein
shall prohibit Allmerica, the Insurance Companies or any company or person
affiliated with Allmerica or the Insurance Companies from (i) seeking
business relationships and entering into separate sales agreements with
Registered Representatives of the Broker-Dealer if the names of said
Registered Representatives were obtained from independent sources and not
exclusively as a result of Allmerica's relationship with a General Agent and
the Broker-Dealer; (ii) from entering into separate sales agreements with
Registered Representatives of the Broker-Dealer upon the request and at the
initiation of said Registered Representatives; or (iii) divulging the names
and addresses of any such customers, prospective customers, Registered
Representatives, or other companies or persons described in the preceding
paragraph in connection with any customer complaint or insurance or
securities regulatory proceeding described in Section 18.
BONDING
SECTION 20. Each General Agent and the Broker-Dealer agree to furnish such
bond or bonds as Allmerica may require. Upon failure or inability of a
General Agent or the Broker-Dealer to obtain or renew any such bonds, this
Agreement shall terminate at Allmerica's discretion upon notice by Allmerica.
8
<PAGE>
NOTICE
SECTION 21. Whenever this Agreement requires a notice to be given, the
requirement will be considered to have been met, in the case of notice to the
Insurance Companies or to Allmerica, if delivered or mailed postage prepaid
to the address specified on page 1 of this Agreement and, in the case of
notice to a General Agent or the Broker-Dealer, if delivered or mailed
postage prepaid to the intended recipient's principal place of business.
CAPTIONS
SECTION 22. Captions are used for informational purposes only and no caption
shall be construed to affect the substance of any provision of this Agreement.
EFFECTIVENESS; ENTIRE CONTRACT; PRIOR AGREEMENTS
SECTION 23. This Agreement contains the entire contract between the parties.
Upon execution it will replace all previous agreements between each General
Agent or the Broker-Dealer and Allmerica and the Insurance Companies, or any
of them, relating to the solicitation of Contracts. It is hereby understood
and agreed that any other agreement or representation, commitment, promise or
statement of any nature, whether oral or written, relating to or purporting
to relate to the relationship of the parties is hereby rendered null and
void.
IN WITNESS WHEREOF, the parties have executed this Agreement in duplicate to
take effect on its effective date.
*For: _________________________________ For: Allmerica Investments, Inc.
Name of General Agent
By:__________________________________ By:________________________________
Name:________________________________ Name:______________________________
Title:_______________________________ Title:_____________________________
Date:________________________________ Date:______________________________
For: __________________________________
Name of Broker-Dealer
By:__________________________________
Name:________________________________
Title:_______________________________
Date:________________________________
* A separate signature line is required for each General Agent affiliate of the
Broker-Dealer.
9
<PAGE>
SALES
AGREEMENT ALLMERICA INVESTMENTS, INC.
440 Lincoln Street
Worcester, Massachusetts 01653
- ------------------------------------------------------------------------------
Agreement, effective as of _________________, 19___, by and between Allmerica
Investments, Inc., a Massachusetts corporation (herein "Allmerica") and
_________________________________________________________________, a
________________________ corporation (herein "Broker-Dealer").
Allmerica, subject to the terms and conditions set forth in this Agreement,
authorizes and appoints Broker-Dealer to solicit applications for the sale of
Contracts. Broker-Dealer accepts this appointment and agrees to the terms
and conditions set forth below.
DEFINITIONS
INSURANCE COMPANIES - All Contracts will be issued by First Allmerica
Financial Life Insurance Company (herein "First Allmerica") or by Allmerica
Financial Life Insurance and Annuity Company (herein "Allmerica Financial
Life"), a subsidiary of First Allmerica. The Principal Office of First
Allmerica and Allmerica Financial Life (herein collectively referred to as
"the Insurance Companies") is located at 440 Lincoln Street, Worcester,
Massachusetts 01653.
CONTRACTS - The variable annuity and variable life insurance contracts of the
Insurance Companies listed on the attached Commission Schedule(s), for which
Allmerica Investments, Inc., an affiliate of First Allmerica, has been
appointed the exclusive distributor and principal underwriter.
REGISTERED REPRESENTATIVES - Individuals affiliated with Broker-Dealer who
are licensed as life insurance agents in those jurisdictions in which
applications for the sale of Contracts are to be solicited and who are also
duly registered with the National Association of Securities Dealers, Inc.
(herein "NASD") in compliance with the '34 Act.
'33 ACT - The Securities Act of 1933, as amended.
'34 ACT - The Securities Exchange Act of 1934, as amended.
RELATIONSHIP OF PARTIES
SECTION 1. Nothing in this Agreement will be construed to create the
relationship of employer and employee between Allmerica or either Insurance
Company and any Broker-Dealer or Registered Representative. Broker-Dealer
and each Registered Representative will be free to exercise their independent
judgment as to the time, place and manner of solicitation and servicing of
business underwritten by the Insurance Companies. However, neither
Broker-Dealer nor any Registered Representative shall have authority to act
on behalf of Allmerica or the Insurance
1
<PAGE>
Companies in a manner which does not conform to applicable statutes,
ordinances, or governmental regulations or to reasonable rules adopted from
time to time by Allmerica or the Insurance Companies.
LIMITATIONS OF AUTHORITY
SECTION 2. Neither Broker-Dealer nor any Registered Representative will have
authority to accept risks of any kind; to make, alter or discharge Contracts;
to waive forfeitures or exclusions; to alter or amend any papers received
from either Insurance Company; to deliver any life insurance Contract or any
document, agreement or endorsement changing the amount of insurance coverage
if Broker-Dealer or the soliciting Registered Representative knows or has
reason to believe that the insured is uninsurable; or to accept any payment
unless the payment meets the minimum payment requirement for the Contract
established by the Insurance Company.
LICENSING AND REGISTRATION
SECTION 3. Broker-Dealer is hereby authorized to recommend Registered
Representatives for appointment by the Insurance Companies and only
individuals so recommended by Broker-Dealer shall become Registered
Representatives hereunder. Allmerica shall arrange for the Insurance
Companies to apply for life insurance agent appointments in the appropriate
jurisdictions for such recommended Registered Representatives of
Broker-Dealer.
Notwithstanding the foregoing, the Insurance Companies and Allmerica reserve
the right to refuse to appoint any proposed Registered Representative and/or
to terminate any Registered Representative or firm who has been appointed by
the Insurance Companies.
AGREEMENTS BY BROKER-DEALER
SECTION 4. Broker-Dealer agrees that at all times when performing its duties
under this Agreement it shall be duly registered as a securities
broker-dealer under the '34 Act, be a member in good standing of the NASD,
and be duly licensed or registered as a securities broker-dealer in each
jurisdiction where such licensing or registration is required in connection
with the sale of the Contracts or the supervision of Registered
Representatives who solicit applications for the Contracts.
Broker-Dealer agrees that at all times when performing its duties under this
Agreement it shall be duly licensed to sell Contracts in each jurisdiction in
which Broker-Dealer intends to perform hereunder.
Broker-Dealer shall be responsible for carrying out its sales and
administrative obligations under this Agreement in continued compliance with
the NASD Rules of Fair Practice, federal and state securities laws and
regulations, and state insurance laws and regulations. Broker-Dealer agrees
to offer the Contracts for sale through its Registered Representatives and to
offer such Contracts only in accordance with the prospectus. Broker-Dealer
and Registered Representative(s) are not authorized to give any information
or make any representations concerning such Contracts other than
2
<PAGE>
those contained in the prospectus or in such sales literature or advertising
as may be authorized by Allmerica.
Broker-Dealer agrees that it shall take reasonable steps to ensure that no
person shall offer or sell Contracts on its behalf until such person is
appropriately licensed, registered or otherwise qualified to offer and sell
such Contracts under the state and federal securities laws and the insurance
laws of each jurisdiction in which such person intends to solicit.
Broker-Dealer agrees to train, supervise and be solely responsible for the
conduct of its Registered Representatives in the solicitation and sale of the
Contracts and for the supervision as to their strict compliance with
Allmerica's rules and procedures, the NASD rules of Fair Practice, and
applicable rules and regulations of any other governmental or other agency
that has jurisdiction over the offering for sale of the Contracts.
Broker-Dealer shall take reasonable steps to ensure that its Registered
Representatives shall not make recommendations to an applicant to purchase a
Contract in the absence of reasonable grounds to believe that the purchase of
such Contract is suitable for such applicant. Such determination will be
based upon, but will not be limited to, information furnished to a Registered
Representative after reasonable inquiry of such applicant concerning the
applicant's insurance and investment objectives, financial situation and
needs.
Broker-Dealer shall take reasonable steps to ensure that Registered
Representatives of Broker-Dealer shall conduct their business with respect to
the Contracts at all times in compliance with all applicable federal and
state laws and regulations and shall be subject to a standard of conduct
including, but not limited to, the following:
(a) A Registered Representative shall not solicit or participate in the sale
of the Contracts in any jurisdiction until such Registered Representative
is trained and licensed.
(b) A Registered Representative shall not solicit applications for the sale of
the Contracts without delivering the then currently effective prospectus
for such Contracts and any then applicable amendments or supplements
thereto, including the current prospectus(es) for any fund(s) in which
Contract separate account(s) invest.
(c) A Registered Representative shall have no authority to advertise for or
on behalf of the Insurance Companies or Allmerica without express written
authorization from Allmerica.
3
<PAGE>
AGREEMENTS BY ALLMERICA
SECTION 5. Allmerica agrees that at all times while this Agreement remains
in force that it shall be a registered Broker-Dealer under the '34 Act and be
a member in good standing of the NASD.
During the term of this Agreement, Allmerica will provide Broker-Dealer,
without charge, with as many copies of the prospectus(es) for the Contracts
(and any amendments, or supplements thereto), the current prospectus(es) for
any underlying fund(s) and applications for the Contracts as Broker-Dealer
may reasonably request. Upon termination of the Agreement, any prospectuses,
applications, and other materials and supplies furnished by Allmerica to
Broker-Dealer shall be promptly returned to Allmerica by Broker-Dealer.
Allmerica agrees to promptly notify Broker-Dealer of newly declared effective
prospectus(es) for the Contracts and any amendments or supplements thereto.
Allmerica agrees to keep Broker-Dealer informed of all jurisdictions in which
the Insurance Companies are licensed to sell the Contracts and in which the
Contracts may be offered for sale.
SUBMISSION OF APPLICATIONS; DELIVERY OF CONTRACTS; REJECTED BUSINESS
SECTION 6. Broker-Dealer will submit, or cause to be submitted, directly to
the Principal Office of the Insurance Companies all Contract applications
solicited by Registered Representatives of the Broker-Dealer. Broker-Dealer
will deliver, or cause to be delivered, within 10 days of its receipt by
Broker-Dealer all Contracts issued on applications submitted by Broker-Dealer
or its Registered Representatives and will ensure that any Contract
endorsement, amendment or other agreement is properly executed by the
Contract owner at the time of Contract delivery. Broker-Dealer will promptly
return, or cause to be returned, to the Insurance Companies any Contract
which is declined by the applicant or which cannot be delivered within the
time permitted by the Insurance Company's rules.
ILLUSTRATIONS AND PROPOSALS
SECTION 7. Neither Broker-Dealer nor any Registered Representative of
Broker-Dealer will furnish any prospective Contract owner with an
illustration of the financial or other aspects of a Contract or a proposal
for a Contract unless the same has been either furnished by the Insurance
Companies or prepared from computer software or other material furnished or
approved by the Insurance Companies. Any illustration or proposal will
conform to standards of completeness and accuracy established by the
Insurance Companies. If the proposal or illustration was not furnished by
the Insurance Companies, Broker-Dealer will retain in its records for
availability to the Insurance Companies a copy thereof or the means to
duplicate the same. Any computer software or materials furnished by either
Insurance Company will be and remain its property.
4
<PAGE>
ACCOUNTING FOR FUNDS COLLECTED
SECTION 8. In accordance with the rules of the Insurance Companies,
Broker-Dealer will account for and remit immediately to the Principal Office
of the Insurance Companies all funds received or collected by Broker-Dealer
or by Registered Representatives of Broker-Dealer for or on behalf of either
Insurance Company without deduction for any commissions, or other claim
Broker-Dealer or the Registered Representative may have against either
Insurance Company or Allmerica and will make such reports and file such
substantiating documents and records as the Insurance Companies may
reasonably require.
INDEMNIFICATION
SECTION 9. Broker-Dealer shall indemnify and hold Allmerica and the
Insurance Companies and their officers, directors and employees harmless from
any liability arising from any act or omission of Broker-Dealer or of any
affiliate of Broker-Dealer, or any officer, director, employee of
Broker-Dealer or of its Registered Representatives, including but not limited
to, any fines, penalties, attorney's fees, costs of settlement, damages or
financial loss. Broker-Dealer expressly authorizes Allmerica and the
Insurance Companies, without precluding them from exercising any other remedy
they may have, to charge against all compensation due or to become due to
Broker-Dealer under this Agreement, any monies paid on any liability incurred
by Allmerica or the Insurance Companies by reason of any such act or omission
of Broker-Dealer, or any affiliate of Broker-Dealer, or of any officer,
director, employee of Broker-Dealer or of its Registered Representatives.
Allmerica shall indemnify and hold Broker-Dealer, its affiliates and their
officers, directors and employees harmless from any liability arising from
any act or omission of Allmerica, the Insurance Companies or any affiliate of
Allmerica or any of the Insurance Companies (collectively the "Allmerica
Companies"), or any officer, director or employee of the Allmerica Companies,
including but not limited to, any fines, penalties, reasonable attorney's
fees, costs of settlement damages or financial loss.
The indemnifications provided by this Section shall survive termination of this
Agreement.
If a Contract is not delivered to the Contract owner within 10 days of its
receipt by the Broker-Dealer and if after delivery the owner returns the
Contract to the Insurance Company and receives a full refund of all payments
made, in any situation where the failure to deliver in a timely manner was due
to the inaction or negligence of the Broker-Dealer or a Registered
Representative of Broker-Dealer, the difference between the payments refunded
and the cash value of the Contract on the date the Contract is received by the
Insurance Company at its Principal Office shall be reimbursed to the Insurance
Company by the Broker-Dealer in any case where the cash value is less than the
payments refunded. Any such reimbursement shall be paid by the Broker-Dealer to
the affected Insurance Company within 30 days of Broker-Dealer's receipt of a
written request for payment.
5
<PAGE>
If Broker-Dealer utilizes delivery receipts as part of its Contract delivery
rules and procedures, the date of execution of the delivery receipt by the
Contract owner shall be deemed to be the date of Contract delivery for
purposes of this Agreement.
COMMISSION REFUNDS
SECTION 10. If a Contract owner rescinds a Contract or exercises the
Contract's Right to Examine privilege (i.e., free-look), then Broker-Dealer
will repay the appropriate Insurance Company the amount of any commissions
received on the payments returned within 10 days of Broker-Dealer's receipt
of a written request for repayment.
BASIS OF COMPENSATION
SECTION 11. While this Agreement remains in force, the Insurance Companies
agree to pay Broker-Dealer commissions in accordance with the Commission
Schedule(s) attached hereto and incorporated herein, from which amounts
Broker-Dealer agrees to pay its Registered Representatives. Commission
payments will be made to Broker-Dealer for each Contract issued pursuant to
an application solicited by duly appointed Registered Representatives of
Broker-Dealer.
TIME OF PAYMENT OF COMMISSIONS
SECTION 12. A payment will not be considered made until it has been received
by the Insurance Company at its Principal Office. On payments made,
commissions will be paid at regular intervals in accordance with the rules of
the Insurance Companies.
TERMINATION
SECTION 13. This Agreement shall automatically terminate immediately and
without notice upon Broker-Dealer's or Allmerica's ceasing to comply with any
of the terms and conditions of this Agreement or upon the dissolution,
bankruptcy or insolvency of Broker-Dealer or Allmerica.
Whether or not there is a breach of this Agreement, Broker-Dealer or
Allmerica may terminate this Agreement by giving ten (10) days' written
notice to the other party at any time during the first year hereof, and by
giving thirty (30) days' written notice after the expiration of the first
year hereof.
Upon termination of this Agreement all authorizations, rights and obligations
shall cease except the obligation to pay commissions due on payments received
prior to termination for Contracts in effect on the date of termination, or
for Contracts to be issued pursuant to applications received by the Insurance
Companies prior to termination. Except as provided in the preceding
sentence, no further commissions shall be paid after termination of this
Agreement.
RIGHT TO SET-OFF
SECTION 14. Allmerica and the Insurance Companies will have a lien on any
commissions payable under this Agreement, whether or not such payments are
now due or hereafter become due, and may apply any such monies to the
satisfaction of indebtedness to Allmerica or to either Insurance Company to
the extent permitted by law.
6
<PAGE>
NON-WAIVER OF BREACH
SECTION 15. Waiver of any breach of any provision of this Agreement will not
be construed as a waiver of the provision or of the right of Allmerica or
Broker-Dealer to enforce said provision thereafter.
ASSIGNABILITY
SECTION 16. This Agreement is not transferable. Without the written consent
of Allmerica and the Insurance Companies, no rights or interest in or to
commissions will be subject to assignment, and any attempted assignment, sale
or transfer of any commissions without such written consents will be void and
of no effect hereunder.
RESERVATION OF RIGHT TO CHANGE
SECTION 17. Allmerica reserves the right at any time, and from time to time,
to change prospectively the terms and conditions of this Agreement, including
but not limited to, the rates of commissions. Any change will become
effective on the date specified in a notice or, if later, 30 days after the
notice is given to Broker-Dealer. However, the requirement to give advance
notice shall not apply if the change becomes necessary or expedient by reason
of legislation or the requirements of any governmental body and, in the
opinion of Allmerica, it is not reasonably possible to meet the 30 day
requirement. Changes will not be retroactive and will apply only to life
insurance coverage solicited or annuity payments made on or after the
effective date of the change.
COMPLAINTS AND INVESTIGATIONS
SECTION 18. Broker-Dealer and Allmerica agree to cooperate fully in any
customer complaint, insurance or securities regulatory proceeding or judicial
proceeding with respect to Broker-Dealer, Allmerica, the Insurance Companies,
their affiliates or their Registered Representatives to the extent that such
customer complaint or proceeding is in connection with Contracts marketed
under this Agreement. To the extent required, Allmerica will arrange for the
Insurance Companies to cooperate in any such complaint or proceeding.
Without limiting the foregoing:
(a) Broker-Dealer will be notified promptly by Allmerica or the Insurance
Companies of any written customer complaint or notice of any regulatory
proceeding or judicial proceeding of which they become aware including
Broker-Dealer or any Registered Representative of Broker-Dealer which may
be related to the issuance of any Contract marketed under this Agreement.
Broker-Dealer will promptly notify Allmerica of any written customer
complaint, or notice of any regulatory proceeding or judicial proceeding
received by Broker-Dealer, with respect to Broker-Dealer or any of its
Registered Representatives in connection with any Contract marketed under
this Agreement or any activity in connection with any such Contract(s).
(b) In the case of a customer complaint specified above, Broker-Dealer,
Allmerica and the Insurance Companies will cooperate in investigating
such complaint and any proposed response to such complaint will be sent
to the other party of this Agreement for approval not less than five
business days prior to its being sent to the customer or regulatory
authority, except that if a more prompt
7
<PAGE>
response is required, the proposed response shall be communicated by
telephone or facsimile transmission.
CONFIDENTIALITY
SECTION 19. Allmerica agrees that the names and addresses of all customers
and prospective customers of Broker-Dealer and of any company or person
affiliated with Broker-Dealer, and the names and addresses of any Registered
Representatives of Broker-Dealer which may come to the attention of Allmerica
exclusively as a result of its relationship with Broker-Dealer or any
affiliated company and not from any independent source, are confidential and
shall not be used by Allmerica, the Insurance Companies, or any company or
person affiliated with Allmerica or the Insurance Companies, nor divulged to
any party for any purpose whatsoever, except as may be necessary in
connection with the administration and marketing of the Contracts sold by or
through Broker-Dealer, including responses to specified requests to the
Insurance Companies for service by Contract owners or efforts to prevent the
replacement of such Contracts or to encourage the exercise of options under
the terms of the Contracts. In no event shall the names and addresses of
such customers, prospective customers and Registered Representatives be
furnished by Allmerica to any other company or person, including but not
limited to, any of their managers, registered representatives, or brokers who
are not Registered Representatives of Broker-Dealer, any company affiliated
with Allmerica or any manager, agency, or broker of such company, or any
securities broker-dealer or any insurance agent affiliated with such
broker-dealer. The intent of this section is that Allmerica, the Insurance
Companies or companies or persons affiliated with them shall not utilize, or
permit to be utilized, their knowledge of Broker-Dealer or of any affiliated
companies which is derived exclusively as a result of the relationships
created through the sale of the Contracts.
Notwithstanding the foregoing provisions of this Section 19, nothing herein
shall prohibit Allmerica, the Insurance Companies or any company or person
affiliated with Allmerica or the Insurance Companies from (i) seeking
business relationships and entering into separate sales agreements with
Registered Representatives of Broker-Dealer if the names of said Registered
Representatives were obtained from independent sources and not exclusively as
a result of Allmerica's relationship with Broker-Dealer; (ii) from entering
into separate sales agreements with Registered Representatives of
Broker-Dealer upon the request and at the initiation of said Registered
Representatives; or (iii) divulging the names and addresses of any such
customers, prospective customers, Registered Representatives, or other
companies or persons described in the preceding paragraph in connection with
any customer complaint or insurance or securities regulatory proceeding
described in Section 18. PROVIDED, HOWEVER, that Allmerica shall not enter
into separate sales agreements with Registered Representatives of
Broker-Dealer while such Registered Representatives are affiliated with
Broker-Dealer.
8
<PAGE>
BONDING
SECTION 20. Broker-Dealer represents that it shall maintain bonding in the
form, type, and amount required under the NASD Rules of Fair Practice.
NOTICE
SECTION 21. Whenever this Agreement requires a notice to be given, the
requirement will be considered to have been met, in the case of notice to the
Insurance Companies or to Allmerica, if delivered or mailed postage prepaid
to the address specified on page 1 of this Agreement and, in the case of
notice to Broker-Dealer, if delivered or mailed postage prepaid to the
intended recipient's principal place of business.
CAPTIONS
SECTION 22. Captions are used for informational purposes only and no caption
shall be construed to affect the substance of any provision of this Agreement.
EFFECTIVENESS; ENTIRE CONTRACT; PRIOR AGREEMENTS
SECTION 23. This Agreement contains the entire contract between the parties.
Upon execution it will replace all previous agreements between Broker-Dealer
and Allmerica and the Insurance Companies, or any of them, relating to the
solicitation of Contracts. It is hereby understood and agreed that any other
agreement or representation, commitment, promise or statement of any nature,
whether oral or written, relating to or purporting to relate to the
relationship of the parties is hereby rendered null and void.
IN WITNESS WHEREOF, the parties have executed this Agreement in duplicate to
take effect on its effective date.
*For: _________________________________ For: Allmerica Investments, Inc.
Name of Broker-Dealer
By:__________________________________ By:________________________________
Name:________________________________ Name:______________________________
Title:_______________________________ Title:_____________________________
Date:________________________________ Date:______________________________
9
<PAGE>
Allmerica 440 Lincoln Street Commission Schedule
Investments, Inc. Worcester, MA 01653 (Percent of Contract Payments)
- --------------------------------------------------------------------------------
First Allmerica Financial Life Insurance Company
Allmerica Financial Life Insurance and Annuity
Company
Principal Underwriter and Exclusive Distributor -
Allmerica Investments, Inc.
- --------------------------------------------------------------------------------
FLEXIBLE PREMIUM ANNUITY CONTRACTS
----------------------------------
COMMISSION SCHEDULE AM-2 (Rev. 1/1/98) (Applicable to contracts issued on
or after January 1, 1998.)
Allmerica Select Resource II Flexible Premium Variable Annuity Contracts
- ------------------------------------------------------------------------
Issued by Allmerica Financial Life Insurance and Annuity Company (First
Allmerica Financial Life Insurance Company in New York and Hawaii).
Commission Percentage
- ---------------------
(1) All contracts except contracts issued to 401(k) plans or contracts
where the owner or annuitant is beyond age 85 1/2 at date of contract
issue.
The following choices are available:
(a) 6.00% of each premium paid, no trail commission
(b) 5.25% of each premium paid, .25% annual trail commission
(c) 1.75% of each premium paid, 1.00% annual trail commission
(2) Contracts issued to 401(k) plans.
The following choices are available:
(a) 5.00% of each premium paid, no trail commission
(b) 4.25% of each premium paid, .25% annual trail commission
(c) 0.75% of each premium paid, 1.00% annual trail commission
(3) Contracts issued where the owner or annuitant is beyond age 85 1/2 at
date of issue.
No choice available
1.75% of each premium paid, 1.00% annual trail commission.
Rules for Trail Commission Payments
- -----------------------------------
o Commission options, where available, can be chosen on a contract by contract
basis by the individual registered representative.
o The commission option chosen must be indicated on the back of the
application.
o If no selection is made, the default will be option (a), 6.0% of each
premium paid, 5% for contracts issued to 401(k) plans.
Trail commissions will be paid quarterly in January, April, July and October.
The first trail commission for a contract will be paid on the first quarterly
payment date following the first anniversary of the date of issue (e.g., if a
contract is issued on July 5, 1998, the first trail commission will be payable
in October, 1999). Trail commissions will continue to be paid while the Sales
Agreement remains in force and will be paid on a particular contract until the
contract is surrendered or annuity benefits begin to be paid under an annuity
option.
Quarterly trail commissions will be a percentage of the unloaned account value
of each eligible contract. For purposes of trail commission calculations,
"unloaned account value" means the cash value of the contract on the last day of
the calendar quarter immediately preceding the payment date less the principal
of any contract loan and accrued interest thereon. The quarterly trail
commission percentage will be 25% of the applicable annual rate (e.g., .0625% if
the annual rate is .25%, .25% if the annual rate is 1.00%).
If a First Allmerica Financial or Allmerica Financial Life annuity is exchanged
for another First Allmerica Financial or Allmerica Financial Life annuity, the
commission rate applicable to the old contract, including any applicable trail
commission rate, will be applicable to new premium payments (other than the
rollover amount) made to the new contract. No commissions other than continuing
trail commissions are payable on the rollover amount allocated to the new
contract. Trails will be paid as described above based on the issue date of the
new contract.
NOTE: NO TRAIL COMMISSIONS WILL BE PAYABLE AFTER THE DATE THE SALES AGREEMENT
IS TERMINATED FOR ANY REASON.
- --------------------------------------------------------------------------------
j4-042
<PAGE>
Allmerica 440 Lincoln Street Commission Schedule
Investments, Inc. Worcester, MA 01653 (Percent of Premium Payments)
- --------------------------------------------------------------------------------
First Allmerica Financial Life Insurance Company
Allmerica Financial Life Insurance and Annuity Company
Principal Underwriter and Exclusive Distributor -
Allmerica Investments, Inc.
- --------------------------------------------------------------------------------
COMMISSION SCHEDULE AM-2*
(Effective March 15, 1995)
Allmerica Select
Variable Universal Life Policies
A. Issued by Allmerica Financial Life Insurance and Annuity Company
Year One: 90% of payments up to target payment (See attached)
4% of payments on excess above target
Renewal: 2% of Payments
Trail: .25% annual trail commission of unloaned account value.
Payable each calendar quarter at 25% the annual rate (.0625%)
on policies in the second and subsequent years.
B. Issued by First Allmerica Life Insurance Company
Year One: 50% of payments plus 40% expense reimbursement up to target
payment
4% of payments on excess above target
Renewal: 4% of Payments
Trail: None
*This schedule sets forth the commissions applicable to Allmerica Select Life
policies issued on or after March 15, 1995 which do not replace existing
Allmerica policies. Commissions applicable to replacements, increases in the
face amount, conversions and exchanges will be in accordance with Allmerica
rules.
- --------------------------------------------------------------------------------
<PAGE>
Allmerica 440 Lincoln Street Commission Schedule
Investments, Inc. Worcester, MA 01653 (Percent of Premium Payments)
- --------------------------------------------------------------------------------
First Allmerica Financial Life Insurance Company
Allmerica Financial Life Insurance and Annuity Company
Principal Underwriter and Exclusive Distributor -
Allmerica Investments, Inc.
- --------------------------------------------------------------------------------
COMMISSION SCHEDULE AM-3*
(Effective May 1, 1996)
Allmerica Select
Variable Survivorship Universal Life Policies
A. Issued by Allmerica Financial Life Insurance and Annuity Company
Year One: 90% of payments up to target payment
4% of payments on excess above target
Renewal: 2% of Payments
Trail: .25% annual trail commission of unloaned account value.
Payable each calendar quarter at 25% the annual rate (.0625%)
on policies in the second and subsequent years.
B. Issued by First Allmerica Life Insurance Company
Year One: 50% of payments plus 40% expense reimbursement up to target
payment
4% of payments on excess above target
Renewal: 4% of Payments
Trail: None
*This schedule sets forth the commissions applicable to Allmerica Select Life
policies issued on or after May 1, 1996 which do not replace existing Allmerica
policies. Commissions applicable to replacements, increases in the face amount,
conversions and exchanges will be in accordance with rules of the issuing
insurer.
- --------------------------------------------------------------------------------
<PAGE>
ALLMERICA ALLMERICA 440 Lincoln Street GENERAL AGENT'S
FINANCIAL INVESTMENTS, INC. Worcester, MA 01653 AGREEMENT
- --------------------------------------------------------------------------------
Allmerica Investments, Inc. ("Company") hereby appoints
__________________________________________________
("General Agent") as local supervisor for the purpose of training and
supervising all associated persons and registered representatives of Company
assigned to _________________________________________________________
("Agency") engaged in the solicitation, sale or service of variable life
insurance and variable annuity contracts offered by Allmerica Financial Life
Insurance and Annuity Company and/or First Allmerica Financial Life Insurance
Company, mutual funds, limited partnerships and general securities (collectively
"Investment Products and Services") offered and/or distributed by Company. This
appointment is effective as of the date accepted by General Agent and
acknowledged by Company.
1. SUPERVISION: General Agent agrees to supervise all registered
representatives assigned to Agency, both those operating from Agency and
those operating from detached locations, consistent with the standards of
conduct outlined in Company's Business Conduct Guide, Company's Statement
of Compliance for the Office of Supervisory Jurisdiction and Branch
Offices, the Program for Allmerica Financial Life/Allmerica Investments
Office Examinations, and the procedures and requirements outlined in other
Company manuals, memoranda and other publications, as may be amended from
time to time.
General Agent agrees to be responsible for Investment Products and Services
activity conducted through Agency by monitoring Investment Products and
Services activity in order to ensure that the business is processed in
accordance with regulatory and Company standards and to notify Company of
any irregularities and/or deficiencies.
General Agent agrees to be responsible for the maintenance and periodic
review of the books and records of Agency, as required by Company.
On at least an annual basis, General Agent agrees to conduct and/or
participate, in coordination with Company's compliance personnel, an agency
compliance meeting which all registered representatives assigned to Agency
shall attend. If for any reason a registered representative does not
attend agency compliance meeting, General Agent will schedule a personal
interview, on at least an annual basis, for the purpose of reviewing
activity of registered representative with respect to Investment Products
and Services and to discuss the compliance topics reviewed at agency
compliance meeting.
General Agent agrees to acquire and/or comply with all of the applicable
laws, rules and regulations (General Securities Principal Registration) of
the Securities and Exchange Commission (SEC), National Association of
Securities Dealers, Inc. (NASD) and all other federal and state laws and
regulations.
General Agent agrees to maintain all NASD registrations required to
supervise the solicitation and sale of Investment Products and Services
offered through Agency. General Agent will maintain all state securities
licenses and state insurance licenses as may be required to offer and
solicit Investment Products and Services.
2. LIMITATIONS OF AUTHORITY: General Agent has no authority to accept any
risk on Company's behalf, to issue, make, alter or discharge any contract,
to extend the time of payments, to waive or extend any contract obligation
or condition, or to alter or amend any communication sent by Company
without express authority in writing from an officer of Company.
3. ASSIGNABILITY: No assignment, sale or transfer of this Agreement or any
of the rights, claims or interests under it may be made by General Agent
without the prior written consent of Company. An assignment, sale or
transfer by General Agent without written consent of Company will
immediately make this Agreement void and shall be a release in full to
Company of any and all of its obligations under this Agreement.
4. AGENCY STAFFING: General Agent agrees to recruit, train and supervise
registered representatives to solicit Investment Products and Services
offered through Company. General Agent agrees to develop a sales force of
sufficient size and quality to adequately penetrate the market with
Investment Products and Services of Company.
<PAGE>
5. BUSINESS AUTHORIZED: General Agent agrees to act for Company in the
solicitation of orders only for those Investment Products and Services for
which Company has executed sales agreements. General Agent shall monitor
his/her registered representatives on a continuing basis to prevent the
offering or the selling of Investment Products and Services not offered by
Company and to prevent registered representatives of Company from
exercising discretionary authority on behalf of any of their clients.
6. SUBMISSION OF APPLICATIONS/ACCOUNTING FOR FUNDS COLLECTED: General Agent
agrees to establish and maintain at Agency procedures, as outlined in
Company manuals, concerning the collection, recording and transmittal of
all applications and/or payments collected on behalf of Company, any
issuer, or any sponsor.
General Agent agrees to be responsible to Company for monies collected by
registered representatives and for any securities, certificates, payments,
receipts and other Company papers in the possession of registered
representatives and employees of Agency.
Purchase checks for Investment Products and Services are to be client
personal checks, cashier's checks or money orders made payable to either
the Company, appropriate issuer, sponsor or other designated agent.
Purchase checks may not be made payable to registered representative,
General Agent or any personal or Agency Accounts.
7. REVIEW OF INVESTMENT PRODUCT BUSINESS: General Agent agrees, in accordance
with Company procedures, to conduct periodic reviews of Investment Product
and Services business of each registered representative. Such review of
Investment Product and Services business shall include, but not be limited
to, reviews for adequate NASD registrations and state securities and/or
insurance licensing of registered representative, prompt transmittal of
applications, checks and other pertinent items to Agency and subsequently
to Home Office, the correct use of applications and proper mode of payment
and the suitability of Investment Products and Service based on client's
financial profile and objectives.
8. BOOKS AND RECORDS: General Agent agrees to maintain a regular and
accurate record of all Investment Products and Services transactions of
Agency, including any journal, account books, records, papers, customer
account files or any other material, as required by Company. General Agent
agrees, at such times that Company may request, to make detailed report to
Company, on forms furnished for that purpose, showing an accurate
accounting of all monies and other items received for, or on behalf of
Company.
General Agent agrees that all records, files and papers are, and remain,
property of Company and will at all times be freely exhibited for the
purpose of examinations and inspection by duly authorized personnel of
Company.
Upon termination, all records revert to Company and should be turned over
to a Company representative.
9. DISTRIBUTION AND USE OF ADVERTISING MATERIAL, CORRESPONDENCE: General
Agent agrees not to directly or indirectly recommend or distribute any
advertising and/or sales literature to registered representatives
(including but not limited to prospectuses, illustrations, circulars, form
letters or postal cards, business cards, stationary, booklets, schedules,
broadcasting and other sales material of any kind) concerning Company
and/or the offering of Investment Products and Services until the material
has been approved in writing by a registered principal in the Company's
Compliance Department.
General Agent also agrees to obtain from his/her registered
representatives, at the time of development, copies of all correspondence
pertaining to the solicitations and/or sale of any Investment Products and
Services or to any other aspect of their Investment Products and Services
business, and to forward the correspondence to Home Office to allow for the
review and endorsement of correspondence in writing, on an official record
of Company, by a registered principal in the Company's Compliance
Department. General Agent shall periodically inspect Registered
Representatives' materials, sales literature and correspondence to ensure
compliance with Company requirements.
10. COMPENSATION: General Agent, subject to the provisions of this Agreement,
will be allowed expense reimbursement or allowances and overriding
commissions on payments collected on all Investment Product sales solicited
by Registered Representatives assigned to General Agent and effected
through Agency at rates established and published by Company, as may be
amended from time to time.
<PAGE>
11. COMMISSIONS: Company will pay commissions to General Agent, after
concession payments are made to Company by an issuer or sponsor, in
connection with sales of Investment Products and Services effected through
General Agent's personal solicitation. Such commissions will be paid on
the same basis and terms as specified in Company's Registered
Representative Agreement, which is incorporated herein by reference and as
may be amended from time to time.
12. TERMINATION WITHOUT CAUSE: General Agent and Company may terminate this
Agreement at any time without cause.
13. RELATIONSHIP OF PARTIES: Nothing contained in this Agreement is to be
construed to create the relationship of employer and employee between
Company and General Agent. General Agent, however, is to always comply
with all of the applicable laws, rules and regulations of the SEC, NASD,
federal and state authorities as well as Company's rules, regulations and
procedures concerning methods of conducting Investment Products and
Services business, as may be amended from time to time.
14. EFFECTIVENESS OF CONTRACT: This Agreement between General Agent and
Company is not binding until Agreement has been duly executed by both
parties. This Agreement supersedes all previous agreements, whether oral
or written. This Agreement shall not cancel or affect any right, claim or
interest General Agent may have concerning commissions now due or hereafter
to become due under preceding agreements between General Agent and Company.
Neither shall Agreement cancel, terminate or affect in any way any lien,
right or interest which Company may have, or may hereafter acquire, with
respect to commissions or equities to General Agent under any other
agreement with Company, any provision of any such agreement which, by its
terms or by implications, continues beyond termination of such agreement.
IN WITNESS THEREOF, this Agreement has been executed by the undersigned on the
dates indicated below.
Allmerica Investments, Inc.
By: By:
---------------------------------- ----------------------------------
General Agent Signature Home Office Principal
Date: Date:
-------------------------------- --------------------------------
<PAGE>
ALLMERICA FINANCIAL LIFE 440 Lincoln Street
INSURANCE AND ANNUITY COMPANY Worcester, MA 01653 CAREER AGENT AGREEMENT
- --------------------------------------------------------------------------------
Allmerica Financial Life Insurance and Annuity Company (the "Company") does
hereby appoint_____________________________ of _________________________________
("Career Agent") its Agent to solicit applications for insurance and annuities
and to submit such applications through the office of
__________________________________________ ("General Agent"), this appointment
to be effective on _____________________________.
Career Agent accepts this appointment, subject to the terms and provisions set
forth in this Agreement.
WITNESSETH:
Career Agent will solicit applications for coverages offered by the Company and
for which he/she is duly licensed. Career Agent is authorized to collect and
pay over to General Agent premiums on coverages solicited by him/her. Career
Agent shall not delegate any authority granted under this Agreement and shall
not appoint any solicitors or subagents to act on his/her behalf.
TERRITORY AND CLASSES OF BUSINESS
Territory SECTION 1. The district within which Career Agent may
solicit insurance and annuity applications for the Company
is the district assigned to General Agent.
Permissible SECTION 2. Career Agent agrees that in the sale and service
Activity of insurance and annuities he/she will act only on behalf of
the Company and such of its affiliates as he/she is
authorized to represent; and he/she will not engage in any
other activity for remuneration or profit which requires
his/her personal services without first obtaining the
consent of the Company. If the Company makes arrangements
with another business entity to make any of its products
available to Career Agents, this will constitute consent to
Career Agent to enter into an arrangement with such entity
to sell and service such products on its behalf. If, with
the consent of the Company, Career Agent engages in any
personal service activities for remuneration or profit,
he/she will, upon request of the Company, disclose the
amount of time expended and the amount of income derived
from such other activities.
STATUS, DUTIES AND AUTHORITY
Relationship SECTION 3. Nothing in this Agreement will be construed to
of Parties create the relationship of employer and employee between the
Company and Career Agent. Within the scope of his/her
authority, Career Agent will be free to exercise his/her
independent judgment as to the time, place and manner of
solicitation and servicing of business underwritten by the
Company. However, he/she will have no authority to act in a
manner which does not conform to applicable statutes,
ordinances or governmental regulations pertaining to the
conduct of the business or to reasonable rules adopted, from
time to time, by the Company.
-1-
<PAGE>
Limitations SECTION 4. Career Agent will have no authority to accept
on Authority risks of any kind; to make, alter or discharge contracts of
insurance or annuities; to waive forfeitures or exclusions;
to fix any premium for hazardous or substandard risks; to
alter or amend any papers received by him/her from the
Company; to deliver any policy of insurance or any document,
agreement or endorsement changing the amount of insurance
coverage if Career Agent knows or has reason to believe that
the insured is uninsurable; to collect any premium after the
expiration of the policy grace period except in connection
with a policy reinstatement; to accept payment of any
premium unless the premium meets the minimum premium
requirement for the policy established by the Company; or to
contract any debt rendering or purporting to render the
Company liable therefor, without express authority in
writing from an authorized officer of the Company.
Implied SECTION 5. Career Agent will have no power or authority
Authority other than as expressly provided in this Agreement and no
other power or authority shall be implied from the grant or
denial of power specifically mentioned in this Agreement.
Duty of SECTION 6. Career Agent agrees that he/she will not
Compliance; intentionally violate any applicable state or Federal law,
Negative ruling or regulation pertaining to the insurance business or
Obligations any rule or regulation of the Company. Career Agent will
not knowingly engage in any activity which is detrimental to
the best interests of the Company or any of its affiliates.
Neither while this Career Agent Agreement is in force nor
for a period of two years following the termination of this
Agreement will Career Agent directly or indirectly interfere
with the relationship of the Company or any of its
affiliates with any agent or broker.
Policy While this Agreement remains in force, Career Agent agrees
Termination that he/she will not, directly or indirectly, replace or
and Replacement induce or attempt to induce any policyholder to terminate or
replace any policy issued by the Company or any of its
affiliates except when permitted by the rules of the issuing
insurer. For a period of two years following termination of
this Agreement, Career Agent agrees that he/she will not,
directly or indirectly, replace or induce or attempt to
induce any policyholder serviced through the office of the
General Agent to terminate or replace any policy issued by
the Company or any of its affiliates.
SOLICITATION OF INSURANCE AND ANNUITIES
Submission of SECTION 7. Career Agent will submit through General Agent
Applications; all Company policy applications solicited by him/her,
Delivery of whether or not it appears the proposed insured is an
Policies; acceptable risk under the rules of the Company. Career
Rejected Agent will deliver, or cause to be delivered, in accordance
Business with the rules of the Company all policies issued on
applications submitted by him/her and will return to General
Agent any policy which is declined by the applicant or which
cannot be delivered within the time permitted by the
Company's rules. If an application is declined by the
Company or is accepted at a rate higher than standard which
is not acceptable to the applicant, with the Company's
permission Career Agent may place the coverage with another
insurance company.
-2-
<PAGE>
Limitation on SECTION 8. Career Agent will not solicit any insurance or
Solicitation annuities in any jurisdiction in which he/she is not
licensed nor will he/she solicit by mail or otherwise any
insurance or annuities outside the district assigned to
General Agent without first receiving consent of the Company
and ascertaining that he/she is properly licensed to solicit
such insurance or annuities.
Advertising SECTION 9. The Company, through General Agent, will make
Material, Rate available to Career Agent a supply of canvassing and
Books, Forms, advertising materials, stationery, books, records and forms
etc. necessary or suitable to properly solicit insurance and
annuities. Career Agent will not print, publish or
distribute any advertisement, circular, statement or
document relating to the business of the Company or any of
its affiliates or use any title or language descriptive of
his/her status without the prior approval of the Company.
Policyowner Solely to assist Career Agent in rendering service to
Service Aids policyowners, Career Agent may use whatever aids, such as
data cards, computer printouts, etc. as may be available.
All such aids, whether furnished by the Company or otherwise
- including any copies thereof - shall be the property of
the Company.
Illustrations Career Agent will not furnish any prospective insured or
and Proposals policyowner an illustration of the financial or other
aspects of a policy or a proposal for a policy of the
Company unless the same has been either furnished by the
Company or prepared from computer software or other material
furnished or approved by the Company. Any illustration or
proposal delivered by Career Agent will conform to standards
of completeness and accuracy established by the Company. If
the proposal or illustration was not furnished by the
Company, Career Agent will retain in his/her records for
availability to the Company a copy thereof or the means to
duplicate the same. Any computer software or materials
furnished by the Company will be and remain its property.
Return of Upon termination of this Agreement, Career Agent will return
Materials, etc. to the Company all manuals, computer software, policyholder
data cards, policyholder files, stationery and business
cards and other material which, by the terms of this Section
or otherwise, is the property of the Company.
Accounting for SECTION 10. In accordance with the rules of the Company,
Funds Collected Career Agent will account for and remit immediately through
General Agent all funds received or collected by him/her for
or on behalf of the Company without deduction for any
commissions, fees, or other claim he/she may have against
the Company and will make such reports and file such
substantiating documents and records as the Company or
General Agent may require.
Liability for SECTION 11. If the Company pays Career Agent commissions or
Refund of fees in advance of receipt of the premium on which the
Commissions payment is based, the amount by which the payment to Career
and Fees Agent exceeds, at any time, the amount attributable to the
premiums paid will constitute a personal debt of Career
Agent payable on demand. If the Company returns premiums on
a policy for any reason whatsoever (other than as a part of
claim settlement) or rescinds or cancels a policy for any
reason whatsoever or if a policyholder exercises a right to
surrender
-3-
<PAGE>
the policy for return of all premiums paid, Career Agent
will pay on demand the amount of any commissions received on
the premiums returned.
Notwithstanding the foregoing, after this Agreement has been
in force for 10 complete years and prior to the date the
Agreement is terminated for cause, unearned commissions paid
in advance on policies the premiums for which are being paid
under the Company's Monthly Automatic Premium (MAP) Plan or
other annualized commission arrangement that are repayable
because of a lapse or surrender of the policy may only be
recovered by set-off from first year and renewal commissions
and fees otherwise payable by the Company or its affiliates
to Career Agents.
COMPENSATION
Basis of SECTION 12. Career Agent's compensation will be a
Compensation combination of commissions and fees payable on premiums for
individual and group life, health and annuity policies
placed with the Company. The amount of commissions and fees
payable for individual insurance and annuity policies will
be determined by the further provisions of this Agreement
and the published rules of the Company. The amount of
commissions and fees payable on group life and health
insurance and group annuity policies solicited by Career
Agent will be specified in separate agreements related
solely to that class of business.
Commissions payable on premiums on a policy resulting from
conversion, exchange, replacement or the exercise of an
option to purchase additional insurance will be determined
by Company rules in effect at the time of the conversion,
exchange, replacement or exercise of the option.
Published Rules The Company may, by published rule, limit the amount of
Affecting premium on which commissions or fees are payable and limit,
Compensation defer, or exclude commissions or fees because of the nature
of the transaction, discretionary nature of the premium or
other circumstances.
Payor All compensation due Career Agent under this Agreement will
be paid by First Allmerica Financial Life Insurance Company
(First Allmerica), an affiliate of the Company, as the
common paymaster.
Time of Payment SECTION 13. A premium will not be considered paid until it
of Commissions has been received by the Company at its Principal Office.
On premiums paid or allocated prior to the 15th day of the
month, commissions and fees will be paid on the last
business day of the month. On premiums paid or allocated
subsequent to the 15th day of the month, commissions and
fees will be paid on the 15th day of the following month, or
on the last business day preceding such pay date, if such
pay date is not a business day.
-4-
<PAGE>
TERMINATION AND ITS EFFECT ON COMMISSIONS AND FEES
Termination SECTION 14. This Agreement may be terminated for cause and
for Cause without notice if Career Agent:
(a) misappropriates any funds belonging to or received on
behalf of the Company or any of its affiliates; or
(b) withholds any funds or other property belonging to the
Company or any of its affiliates after the same should
have been reported and transmitted to the Company or
its affiliate or after a demand has been made for the
same; or
(c) commits any willful or dishonest act which injures the
Company or any of its affiliates; or
(d) commits any intentional act which violates any
applicable Fair Trade Practices Act and thereby injures
the Company or any of its affiliates; or
(e) intentionally performs any act prohibited by law or
intentionally omits any act required by law with the
result that the Company or any of its affiliates is
subject to disciplinary action; or
(f) willfully violates any of the provisions of this
Agreement.
Forfeiture of SECTION 15. No commissions or fees will be paid following
Commissions termination of this Agreement, if it is terminated for
and Fees cause, nor will commissions or fees continue to be paid
after termination of this Agreement if Career Agent breaches
any of its terms or conditions by the commission of an act
prohibited by its terms.
Termination SECTION 16. Notwithstanding the foregoing, and whether or
Without Cause not there is a breach of this Agreement, either party may
terminate this Agreement during its first year by giving 10
days' notice in writing to the other party of the intention
to do so and thereafter by giving 30 days' notice in writing
to the other party of the intention to do so.
Effect of Certain SECTION 17. If this Agreement terminates without breach of
Terminations any of its provisions by Career Agent:
(a) by reason of the death of Career Agent; or
(b) by reason of the permanent Total Disability of Career
Agent; or
(c) by reason of retirement of Career Agent under the
Career Agents' Retirement Plan established and
maintained by the Company; or
(d) by reason of employment of Career Agent by the Company
or any of its affiliates in some capacity other than as
a Career Agent;
-5-
<PAGE>
commissions will continue to be paid to Career Agent only as
provided in the Exhibits attached hereto.
After termination of this Agreement by reason of the
permanent Total Disability of Career Agent, if Career Agent
recovers from said disability, this Agreement may be
reinstated. If Career Agent recovers from disability and
this Agreement is not reinstated, commissions will be
payable on premiums paid thereafter only if they would have
been payable if Section 18 had applied on termination.
Effect of Other SECTION 18. If this Agreement terminates without breach of
Terminations any of its provisions by Career Agent for any reason other
Without Cause than asset forth in Section 17, commissions will continue to
be paid to Career Agent only as provided in the Exhibits
attached hereto.
GENERAL PROVISIONS
Right of SECTION 19. The Company, for its own benefit, for the
Set-Off benefit of its affiliates and for the benefit of the General
Agent, will have a lien on any commissions and fees payable
under this Agreement, whether or not the commissions are now
due or hereafter become due, and may apply any such monies
to the satisfaction of indebtedness to any of said persons
to the extent permitted by law.
Non-waiver SECTION 20. Waiver of any breach of any provision of this
of Breach Agreement will not be construed as a waiver of the provision
or of the right of the Company to enforce said provision
thereafter.
Assignability SECTION 21. This Agreement is not transferable. Without
the consent of the Company, no rights or interest in or to
commissions or fees will be subject to assignment, other
than a collateral assignment of commissions and fees, and
any attempted absolute assignment, sale or transfer of this
Agreement or of any commissions or fees without the written
consent of the Company will immediately make this Agreement
void and be a release to the Company in full of any and all
of its obligations hereunder.
Errors and SECTION 22. Career Agent agrees to maintain errors and
Omissions omissions insurance coverage meeting the Company's minimum
Coverage coverage requirements and to furnish the Company proof of
such coverage upon request. If any lawsuit is brought
against the Company as a result of any alleged action, error
or omission of Career Agent and if (1) Career Agent has
maintained errors and omissions coverage which complies with
the Company's minimum requirements, and (2) the alleged
action, error or omission of Career Agent was not committed
intentionally or with dishonest, fraudulent or criminal
intent, Career Agent agrees to reimburse the Company and its
affiliates for all costs of the lawsuit, including
attorney's fees, and all damages resulting therefrom up to
the Company's Career Agent liability limit. The minimum
coverage requirements and Career Agent liability limit will
be set forth in a bulletin or announcement published by the
Company and are subject to change at any time. Distribution
of the bulletin or announcement in the usual manner will
constitute notice to Career Agent. If any lawsuit is
brought against the Company as a result of any alleged
Career Agent action, error or omission and if Career Agent
(1) did not maintain at least the
-6-
<PAGE>
required minimum errors and omissions coverage, or (2) did
maintain such coverage but Career Agent's action, error or
omission was committed intentionally or with dishonest,
fraudulent or criminal intent, Career Agent agrees to
reimburse the Company and its affiliates for all costs of
the lawsuit, including attorney's fees, and all damages
resulting therefrom unless the court determines the suit to
be groundless and without merit.
Reservation of SECTION 23. The Company reserves the right at any time to
Right to Change change the terms and conditions of this Agreement,
including but not limited to, the rates of commissions and
fees, or to discontinue the payment of any commissions and
fees described in the Exhibits attached hereto.
Effective Date SECTION 24. Any change will become effective on the date
of Change specified in a notice or, if later, 30 days after the notice
is given to Career Agent. However, the requirement to give
advance notice shall not apply if the change becomes
necessary or expedient by reason of legislation or the
requirements of any governmental body and, in the opinion of
the Company, it is not reasonably possible to meet the 30
day requirement. Changes will not be retroactive and will
apply only to units of coverage solicited on or after the
effective date of the change. Notice of any change may be
given by a Company bulletin or announcement and distribution
of the bulletin or announcement in the usual manner will
constitute notice to Career Agent.
Arbitration SECTION 25. By his/her execution of this Agreement, Career
Agent agrees to settle any dispute, claim or controversy
arising between Career Agent and the Company by arbitration
pursuant to the then current rules of the American
Arbitration Association. Judgment upon any award rendered
in the arbitration may be entered in any court of competent
jurisdiction.
All applicable disputes shall be referred to three
arbitrators, one to be chosen by each party, and the third
by the two so chosen. If either party refuses or neglects
to appoint an arbitrator within thirty days after the
receipt of written notice from the other party requesting it
to do so, the requesting party may nominate two arbitrators
who shall choose the third. In the event the two
arbitrators do not agree on the selection of the third
arbitrator within thirty days after both arbitrators have
been named, then the third arbitrator shall be selected
pursuant to the then current rules of the American
Arbitration Association. The decision of the majority of
the arbitrators shall be final and binding upon all parties.
The expenses of the arbitrators and of the arbitration shall
be equally divided between all parties. Arbitration is the
sole remedy for disputes arising under this Career Agent
Agreement.
General Agent SECTION 26. General Agent means the General Agent
identified on the face page or any other General Agent in
charge from time to time of a general agency office to which
Career Agent is assigned.
Definitions SECTION 27. As used in this Agreement, including the
Exhibits attached hereto:
"Replacement" means a transaction in which a new life or
disability insurance policy or a new annuity contract is to
be purchased, and by reason of the transaction, all or a
portion of
-7-
<PAGE>
any existing life or disability insurance policy or any
existing annuity contract has been or is to be lapsed,
forfeited, reduced in face amount, surrendered, assigned to
the replacing insurer, placed on a reduced paid-up basis or
under another nonforfeiture provision or terminated, or
subjected to borrowing or withdrawals, whether in a single
sum or under a schedule of borrowing or withdrawals over a
period of time.
"Total Disability" means the inability of the Career Agent,
because of injury or sickness, to perform the duties of any
occupation for which he/she is reasonably fitted by
training, education or experience. During the first 24
months of total disability, Career Agent will be considered
to have met the foregoing requirement if he/she is unable to
perform the duties of his/her regular occupation and is not
performing the duties of any other occupation. Total
disability will be considered permanent after it has existed
6 months and thereafter while it continues.
"Flexible premium policy" means an individual insurance or
annuity policy under which the policyowner may unilaterally
vary the amount and timing of premium payments.
"Unit of Coverage" means all benefits of a policy which have
the same date of issue, except as modified by Company
published rules. Usually all the benefits specified in the
policy Schedule of Benefits and in each Supplementary
Schedule of Benefits constitute a unit of coverage.
"Policy Year," as to each unit of coverage, means a period
of 1 year commencing on its date of issue and each
anniversary thereof.
"Monthaversary," as to each unit of coverage, means its date
of issue and the corresponding day of each month thereafter.
"Basic premium," for each unit of coverage, means the sum of
the basic or target premiums for each benefit in the unit,
as determined from the Company's Rate Manual.
"Excess premium" means premium paid in any policy year in
excess of basic or target premium.
"Agreement" means this entire agreement, including all
Exhibits and commission and fee schedules attached thereto.
Other Exhibits issued hereafter will become a part of this
Agreement on their effective date.
Notice SECTION 28. Whenever this Agreement requires a notice to be
given, the requirement will be considered to have been met,
in the case of notice to the Company, if delivered or mailed
postage prepaid to General Agent at the agency office or to
a Vice President in the Company's Allmerica Financial
Services Operation and, in the case of notice to Career
Agent, if left at the usual place for him/her to pick up
mail within the agency office, or by mailing postage
prepaid, to Career Agent's last home address known to the
Company or to such other address as may be designated by
Career Agent.
-8-
<PAGE>
Captions SECTION 29. Captions are used for informational purposes
only and no caption shall be construed to affect the
substance of any provision of this Agreement.
Effectiveness; SECTION 30. This Agreement contains the entire contract
Entire Contract; between the parties. Upon execution it will replace all
Prior Agreements previous agreements between Career Agent and the Company
relating to the solicitation of insurance and annuity
policies except as the previous agreement relates to the
payment of commissions and fees on policies solicited prior
to the effective date of this Agreement. For purposes of
determining vestings on termination, the date of the
earliest prior Career Agent Agreement executed by Career
Agent during his current period of continuous service with
the Company and First Allmerica will be considered the date
of this Agreement. It is hereby understood and agreed that
any other agreement or representation, commitment, promise
or statement of any nature, whether oral or written,
relating to or purporting to relate to the relationship of
the parties is hereby rendered null and void.
IT IS UNDERSTOOD THAT THIS IS AN "AT WILL" RELATIONSHIP WHICH MAY BE TERMINATED
BY EITHER PARTY WITHOUT CAUSE OR REASON AS PROVIDED FOR IN SECTION 16.
IN WITNESS WHEREOF, the parties have executed this Agreement in triplicate to
take effect on its effective date.
Allmerica Financial Life Insurance and Annuity Company
By:
--------------------------------------------------
Vice President
--------------------------------------------------
Career Agent
Approved:
--------------------------------------------------
General Agent
-9-
<PAGE>
CAREER AGENT COMMISSION |
SCHEDULE |
|
CAREER AGENT | Allmerica Financial Life Insurance
(Per Cent of Premium) | and Annuity Company Worcester, MA 01653
- -------------------------------------------------------------------------------
INDIVIDUAL LIFE INSURANCE
COMMISSION SCHEDULE - CA1
<TABLE>
<CAPTION>
POLICY YEAR
Policy Form 1 2-10 11 & Over
- -------------------------------------------------------------------------------
UNIVERSAL LIFE POLICIES % % %
- -------------------------------------------------------------------------------
<S> <C> <C> <C>
Variable Inheiritage
Up to Basic Premium 50 3.5 2.0
On Excess 4 3.5 2.0
- -------------------------------------------------------------------------------
Exceptional Life Plus
Vari Exceptional Life
Up to Basic Premium 50 4 2
On Excess 4 4 2
- -------------------------------------------------------------------------------
Vari Exceptional Life Plus
Up to Basic Premium 15 4 2
On Excess 4 4 2
- -------------------------------------------------------------------------------
</TABLE>
INDIVIDUAL ANNUITIES
COMMISSION SCHEDULE - CA2
EXEC ANNUITY PLUS
5% of each payment
FORM 03443
<PAGE>
================================= Definitions ==================================
Age means the insured's age as of the nearest birthday measured from a policy
anniversary.
Amount at risk is the sum insured less the policy value.
Company means Allmerica Financial Life Insurance and Annuity Company.
Date of issue is stated on page 3. Policy months, years and anniversaries are
measured from this date.
Debt means all unpaid policy loans plus interest due or accrued on such loans.
Evidence of insurability is information, including medical information
satisfactory to the Company that is used to determine the insured's class of
risk.
Final premium payment date is the policy anniversary nearest the insured's 95th
birthday. No premiums may be paid after this date. The death proceeds after the
final premium payment date will be the policy value less debt.
Monthly payment date is the date on which the insurance charge and
administrative charge are deducted from the policy value. This date is shown on
page 3.
Policy change means any change in the face amount, the addition or deletion of a
rider or a change in the sum insured option.
Principal Office means the Company's office located at 440 Lincoln Street,
Worcester, Massachusetts 01653 (1-800-533-7881).
Written request is a request in writing satisfactory to the Company and filed at
its Principal Office.
You or your means the owner as shown in the application or the latest change
filed with the Company.
Form 1018-93 7
<PAGE>
============================== General Provisions ==============================
Entire Contract -- This policy is a contract between the owner and the Company.
This policy, with a copy of the application attached to it, is the entire
contract. The entire contract also includes a copy of any application for an
increase in the face amount and supplemental pages issued as provided in the
Benefit Change Provision.
All statements in the application are considered representations and not
warranties. The Company will not use any statement to contest this policy or
defend a claim unless the statement is in an application. Agents are not
permitted to change this contract or extend the time for paying premiums. Only
the President, a Vice President or the Secretary of the Company may modify the
provisions of this policy, and then only in writing.
Incontestability -- Except for failure to pay premiums, the initial sum insured
under this policy cannot be contested after the policy has been in force during
the insured's lifetime for two years from the date of issue.
An increase in the face amount as a result of a request by the owner which
includes evidence of insurability cannot be contested after the increased amount
has been in force during the insured's lifetime for two years from its effective
date, except for failure to pay premiums.
Non-Participating -- This policy is non-participating.
Adjustment of Cost Factors -- Monthly insurance charges and interest rates used
to calculate the policy value are set by the Company, subject to the guarantees
set forth in this policy. Any changes in these factors will be by class of risk
and will be based on changes in future expectations for such elements as:
investment earnings, mortality, persistency and expenses.
Suicide Exclusion -- The risk of suicide of the insured, while sane or insane,
within two years of the date of issue of this policy is not assumed. Instead of
the death benefit, the beneficiary will receive the sum of the premiums paid,
less the sum of any outstanding debt and partial withdrawal amounts.
The risk of suicide of the insured, while sane or insane, within two years of
the effective date of any increase in the face amount as a result of a request
by the owner which includes evidence of insurability is also not assumed to the
extent of such increase. Instead of the death benefit, the beneficiary will
receive the administrative charge and insurance charges paid for such increase.
Misstatement of Age or Sex -- If the insured's age or sex or both is misstated,
the death proceeds will be adjusted if death occurs before the final premium
payment date. The adjusted death proceeds will be equal to the policy value plus
the benefit which the insurance charges for the amount at risk on the monthly
payment date immediately prior to the date of death would have purchased at the
correct age and sex. In no event will the sum insured be reduced to less than
the guideline minimum sum insured. This provision as it relates to a
misstatement of sex does not apply if this policy is issued in a unisex premium
class as indicated on page 3.
Ownership of Assets -- The Company shall have exclusive and absolute ownership
and control of its assets, including the assets of the Variable Account.
Protection of Proceeds -- To the extent allowed by law, the proceeds of this
policy and any payments made under it will be exempt from attachment by the
claims of creditors of the payee. No beneficiary can assign, transfer,
anticipate or encumber the proceeds or payments unless you give them this right.
Annual Report -- An annual report will be mailed to you at your last known
address. This report will show the following information as of the policy
anniversary:
o the sum insured;
o the policy value in the General Account and in each sub-account of the
Variable Account;
o the surrender value;
o premiums paid and monthly deductions made during the policy year;
o existing debt;
o changes in the guideline premiums; and
o any information required by law.
Form 1018-93 8
<PAGE>
============================ Owner and Beneficiary =============================
Owner -- The insured is the owner of this policy unless another is named as
owner in the application. The owner may change the ownership of this policy
without the consent of any beneficiary. The consent of the insured is required
whenever the face amount of insurance is increased. You may exercise all other
rights and options granted by this policy, subject to the consent of any
irrevocable beneficiary. The consent of any revocable beneficiary is not
required.
Assignment -- This policy may be assigned by written request. An absolute
assignment will transfer ownership of the policy from you to the assignee. The
policy may also be collaterally assigned as security. The limitations on your
ownership rights while a collateral assignment is in force are set forth in the
assignment. An assignment will take place only when recorded at the Principal
Office. When recorded, the assignment will take effect as of the date the
written request was signed. Any rights created by the assignment will be subject
to any payments made or actions taken by the Company before the change is
recorded.
The Company will not be responsible for the validity of any assignment or the
extent of any assignee's interest. If you assign this policy as collateral, any
excess of the amount due the assignee will accrue to those otherwise entitled to
it.
Beneficiary -- The beneficiary is named by you to receive the death proceeds.
The interest of any beneficiary will be subject to any assignment. You may
declare your choice of any beneficiary to be revocable or irrevocable. A
revocable beneficiary may be changed by you at a later time. An irrevocable
beneficiary must consent in writing to any change. Unless otherwise indicated,
the beneficiary will be revocable.
A change of beneficiary may be made by written request while the insured is
living. The change will take place as of the date the request is signed even if
the insured is not living on the day the request is received. Any rights created
by the change will be subject to any payments made or actions taken by the
Company before the written request is received.
The interest of a beneficiary who dies before the insured will pass to the
surviving beneficiaries in proportion to their share in the proceeds unless
otherwise provided. If all beneficiaries die before the insured, the death
proceeds will pass to the owner.
Form 1018-93 9
<PAGE>
=================================== Premiums ===================================
Premiums -- Premiums are payable to the Company. Premiums may be paid at any
time prior to the final premium payment date to the Principal Office or to an
agent of the Company. On written request a premium receipt signed by a Company
officer will be given after payment. This policy will not be in force until the
first premium is paid. No premium payment may be less than $100 without the
Company's consent.
Incentive Funding Discount -- The Company will lower the insurance charges by 5%
if you qualify for the incentive funding discount. To qualify, your total
premiums paid less any withdrawals, withdrawal charges, debt and transfers from
other policies issued by the Company must exceed 90% of the guideline level
premiums accumulated from the date of issue to the date of determination.
The Company will determine on the date of issue whether the policy qualifies for
the incentive funding discount. If the policy qualifies, the insurance charges
will be reduced until the next policy anniversary. The policy will be
reevaluated at the end of each policy year to determine if it qualifies for the
incentive funding discount for the next policy year.
Maximum Premium -- The Company may limit the maximum premium received in any
policy year to an amount not less than the guideline level premium. In addition,
the sum of the premiums paid less any partial withdrawals may not exceed the
greater of:
o the guideline single premium; or
o the sum of the guideline level premiums to the date of payment.
The amounts of the guideline premiums are shown on page 4. The guideline
premiums will change whenever there is a policy change. The new guideline
premiums will be shown in the new specification pages. These premium limitations
do not apply to the extent necessary to prevent lapse of the policy during the
policy year.
The guideline premiums are determined according to the rules set forth in the
federal tax law. The guideline premiums will be adjusted to conform to any
changes in the federal tax law.
In the event the maximum premium limit applies, the Company will return the
excess premium payment.
Net Premium and Allocation of Net Premiums -- The net premium is equal to the
premium less the tax expense charge. The current tax expense charge is shown on
page 4. The tax expense charge approximates the expense to the Company
associated with state and local premium taxes and the federal deferred
acquisition charge. The Company reserves the right to change the tax expense
charge to reflect changes in the Company's tax expenses.
You may allocate the net premiums to one or more of the sub-accounts of the
Variable Account, to the General Account, or to any combination of these
accounts. You may not allocate net premiums to more than seven sub-accounts of
the Variable Account at any one time without the consent of the Company. The
minimum percentage that you may allocate to any one of these accounts is 1% of
the net premium paid. All percentage allocations must be in whole numbers. The
total allocation to all selected accounts must equal 100%.
The sub-accounts that you chose for your initial allocations are shown on the
application for this policy, a copy of which is attached to this policy. You may
change the allocation of future net premiums at any time on written request.
Insurance Charge -- Beginning on the date of issue and monthly thereafter, prior
to the final premium payment date, an insurance charge will be deducted from the
policy value. You may specify from which sub-account of the Variable Account
this charge will be deducted. If you do not, the Company will allocate the
charge among the General Account and the sub-accounts of the Variable Account in
the same proportion that the policy value in the General Account, less debt, and
the policy value in each sub-account bear to the total policy value, less debt.
To the extent this charge is allocated to the General Account, it will be
deducted on a last-in, first-out basis. If the sub-account you specify does not
have funds sufficient to cover the charge, the Company will deduct the charge as
if no specification were made.
The charge equals the sum of the insurance charges applicable to the following:
o the initial face amount; plus
o each increase in the face amount; plus
o any rider benefits.
Form 1018-93 10 (Continued on page 11)
<PAGE>
Premiums (Continued from page 10)
The insurance charge will be determined each month by the Company. Any change in
the insurance charge will be uniform by premium class. The monthly insurance
charge will be adjusted for any decreases in the face amount according to the
Benefit Change Provision.
The monthly insurance charge for the initial face amount will not exceed (1)
multiplied by (2) where:
(1) is the cost of insurance rate shown in the Insurance Charge Table
for the insured's age;
(2) is the initial face amount divided by 1,000. For the purpose of this
calculation, the initial face amount will be reduced by the policy
value minus charges for rider benefits at the beginning of the month
if Sum Insured Option 1 is in effect to the extent such policy value
does not exceed the initial face amount; however, if the policy
value exceeds the initial face amount while Sum Insured Option 1 is
in effect, the excess policy value will be applied to reduce any
increases in the face amount in the order in which the increases
were issued.
The monthly insurance charge for each increase in the face amount issued at the
owner's request will not exceed (1) multiplied by (2) where:
(1) is the cost of insurance rate shown in the Supplemental Insurance
Charge Table for the insured's age; and
(2) is the amount of the increase in the face amount divided by 1,000.
For the purpose of this calculation, the increase in the face amount
will be reduced by the excess policy value minus charges for rider
benefits (as described in the monthly insurance charge for the
initial face amount, above) at the beginning of the month if Sum
Insured Option 1 is in effect.
If the sum insured is the guideline minimum sum insured as defined on page 13,
the monthly insurance charge for that portion of the sum insured which exceeds
the face amount will not exceed (1) multiplied by the quotient of (2) divided by
1,000 where:
(1) is the cost of insurance rate applicable to the initial face amount;
and
(2) is the sum insured less
(a) the greater of the face amount or the policy value if Sum
Insured Option 1 is in effect; or
(b) the face amount plus the policy value if Sum Insured Option 2
is in effect.
The maximum rates shown in the Supplemental Insurance Charge Table will be the
same as the rates shown on page 5 if the insured's premium class remains the
same.
Cost of Insurance Rate -- The cost of insurance is based on the insured's age,
sex (unless this policy is issued in a unisex premium class as indicated on page
3) amount of premiums paid less debt, partial withdrawals and withdrawal charge
and risk classification. The guaranteed rates are based on the Commissioner's
1980 Standard Ordinary Mortality Table, Smoker or Non-Smoker, Male, Female or
Table B for unisex risks (or appropriate increases in such tables for rated
risks). The non-guaranteed monthly cost of insurance rate will be reviewed by
the Company when rates for new flexible premium variable life insurance policies
change. Rates will be reviewed not more than once each year nor less than once
in a five-year period. The cost will not exceed the guaranteed amounts shown in
the Insurance Charge Table and any supplements to it.
Grace Period and Policy Lapse -- Beginning on the date of issue of this policy
and the effective date of any increase in the face amount, and continuing for
the next 47 monthly payment dates on which monthly deductions are made, the
grace period will begin if both of the following conditions are met:
o the surrender value is less than the amount needed to pay the next monthly
insurance charge; the $5 monthly administrative charge, if applicable; and
any loan interest accrued; and
o the sum of the premiums paid less any debt, partial withdrawals and
withdrawal charges since the later of:
the date of issue of this policy;
the effective date of any increase in the face amount; or
the date of a policy change which causes a change in the minimum
monthly factor;
is less than the minimum monthly factor multiplied by the number of months
which have elapsed since that date.
Form 1018-93 11 (Continued on page 12)
<PAGE>
Premiums (Continued from page 11)
After 48 monthly deductions have been made since the date of issue of this
policy and the effective date of any increase, the grace period will begin if
the surrender value is less than the amount needed to pay the next monthly
deduction plus any loan interest accrued.
The minimum monthly factor as of the date of issue is shown on page 5. The
factor will change if there is a policy change. The new factor will be shown in
the new specification pages.
The first day of the grace period is called the date of default. The Company
will send a notice to your last known address, or to the person named by you to
receive this notice, on the date the grace period begins. The notice will state
the due date and the amount of premium payable to keep the policy in force. The
grace period continues for 62 days. The policy is in force during the grace
period. The death benefit payable during the grace period will be reduced by any
overdue charges. A lapse occurs if the amount shown in the notice remains unpaid
at the end of the grace period. The policy terminates on the date of lapse.
Reinstatement -- This policy may be reinstated during the insured's lifetime if
this policy has lapsed or foreclosed and has not been surrendered. You may not
reinstate more than three years after the date of default or foreclosure. The
policy will be reinstated effective on the monthly payment date following the
date you provide the Company with the following:
o a written application for reinstatement;
o evidence of insurability showing the insured is insurable according to the
Company's underwriting rules; and
o payment of the reinstatement premium.
If fewer than 48 monthly deductions have been made since the date of issue of
the policy and an increase in the face amount, the reinstatement premium is the
lesser of the amount shown in A or B:
Under A, the minimum amount payable is the minimum monthly factor for the
three-month period beginning on the date of reinstatement.
Under B, the minimum amount payable is the sum of:
o the amount by which the surrender charge, as of the date of reinstatement,
exceeds the policy value on the date of default; plus
o three monthly administrative fees; and
o insurance charges for the three-month period beginning on the date of
reinstatement.
If 48 monthly deductions have been made since the date of issue of this policy
and the effective date of any increase in the face amount, the reinstatement
premium is the amount shown in B above.
You may not repay or reinstate any debt outstanding on the date of default or
foreclosure.
The premium paid on reinstatement will be allocated to the General Account and
the sub-accounts of the Variable Account in accordance with your most recent
premium allocation notice.
The policy value on the date of reinstatement is:
o the net premium paid to reinstate the policy increased by interest from
the date the payment was received at the Principal Office; plus
o an amount equal to the policy value less debt on the date of default to
the extent it does not exceed the surrender charge on the date of
reinstatement; minus
o the monthly deduction due on the date of reinstatement.
The surrender charge on the date of reinstatement is the surrender charge which
would have been in effect had the policy remained in force from the date of
issue. The policy value less debt on the date of default will be restored to the
policy to the extent it does not exceed the surrender charge on the date of
reinstatement. Any policy value less debt as of the date of default which
exceeds the surrender charge on the date of reinstatement will be forfeited to
the Company.
Form 1018-93 12
<PAGE>
==================================== Benefit ===================================
Death Proceeds -- The amount payable on death of the insured prior to the final
premium payment date will be the sum insured under either Option 1 or Option 2.
Options 1 and 2 are described later. Any debt, rider charges, administrative
charges and insurance charges due and unpaid through the policy month in which
the insured dies will be deducted from the death proceeds. Partial withdrawals
and withdrawal charges also will be deducted from the death proceeds. The amount
payable on the death of the insured after the final premium payment date will be
the policy value less debt.
Interest will be paid on lump sum death proceeds at a rate not less than 3 1/2%
per year or the minimum rate set by law, if greater. Interest will be paid from
the date of death to the payment date except, when Sum Insured Option 2 is
elected, interest will be calculated on the policy value portion of the death
proceeds from the date the Company receives due proof of death to the payment
date.
Guideline Minimum Sum Insured -- This policy must provide a minimum amount at
risk to qualify as "life insurance" under the federal tax law. It does so by
providing a minimum sum insured which is obtained by multiplying the policy
value by the percentage shown in the Minimum Sum Insured Table for the insured's
attained age. The guideline minimum sum insured varies by age.
- -----------------------------------------------
Minimum Sum Insured Table
- -----------------------------------------------
Age Percentage Age Percentage
- -----------------------------------------------
thru 40 250% 60 130%
41 243% 61 128%
42 236% 62 126%
43 229% 63 124%
44 222% 64 122%
45 215% 65 120%
46 209% 66 119%
47 203% 67 118%
48 197% 68 117%
49 191% 69 116%
50 185% 70 115%
51 178% 71 113%
52 171% 72 111%
53 164% 73 109%
54 157% 74 107%
55 150% 75 thru 90 105%
56 146% 91 104%
57 142% 92 103%
58 138% 93 102%
59 134% 94 101%
95 100%
- -----------------------------------------------
The guideline minimum sum insured is determined according to the rules set forth
in the federal tax law. The guideline minimum sum insured will be adjusted to
conform to any changes in the law.
Sum Insured Options -- There are two options in this policy. The option is
elected in the application. The options are:
Option 1 -- The sum insured is the greater of:
o the face amount; or
o the guideline minimum sum insured.
Option 2 -- The sum insured is the greater of:
o the face amount plus the policy value on the date due proof of death is
received by the Company increased by any monthly deductions made by the
Company after the date of death; or
o the guideline minimum sum insured.
The option may be changed on written request. The effective date of the change
is the monthly payment date following the date the request is received at the
Principal Office. If the change is from Option 1 to Option 2, the face amount
under Option 2 will be equal to the sum insured less the policy value under
Option 1 on the effective date of the change. If the change is from Option 2 to
Option 1, the face amount will be equal to the sum insured under Option 2 on the
effective date of the change. The sum insured option may not be changed more
than once in any policy year. You may not change the option if it reduces the
face amount to less than $40,000.
Change Provision -- You may change the face amount of insurance according to the
Increase or Decrease provisions if such request is made:
o during the lifetime of the insured; and
o on written request while this policy is in force.
No change in the face amount may be made which disqualifies the policy as "life
insurance" under the federal tax law.
Increase -- All of the following must occur before the effective date of any
increase in the face amount:
o evidence of insurability must be provided to the Company;
o the insured must be under the Company's maximum issue age for new
insurance and be insurable according to its underwriting rules; and
Form 1018-93 13 (Continued on page 14)
<PAGE>
Benefit (Continued from page 13)
o payment to the Company of a $50 transaction charge plus two times the new
minimum monthly factor if the surrender value is less than this sum.
The Company will deduct the $50 transaction charge from the surrender value on
the effective date of the increase.
The effective date of the increased face amount will be the first monthly
payment date on or following the date all the conditions are met. New
specification pages, including a Supplemental Insurance Charge Table, will be
issued. These pages will include the following information for the additional
face amount of insurance:
o the effective date of the increase;
o the amount of the increase; and
o the premium class.
These pages also will show the new minimum monthly factor, the new guideline
premiums and surrender charges applicable to the entire policy. No increase
shall be less than the Company's minimum limit in effect on the date of the
request.
You may return the new specification pages by mailing or delivering them to the
Principal Office or to an agent of the Company within ten days after receiving
them, 45 days after you complete the Part 1 of the application for the increase,
or ten days after the Company mails you the Notice of Withdrawal Right. If the
specification pages are returned, the increase will be considered void from the
beginning, and the Company will refund the charges deducted from the policy
value which would not have been deducted but for the increase. The refunded
amount will be added to your policy value unless you otherwise request. The
Company also will waive any surrender charge for the increase.
Decrease -- A request to decrease the face amount will be effective on the
monthly payment date following the date of the written request. Existing
insurance will be decreased or eliminated in the following order:
o first, the most recent increase;
o second, the next most recent increases successively; and
o last, the initial face amount.
A surrender charge will be deducted from the policy value on the date of the
decrease. Such charge will be:
o the surrender charge for any increased amount which is eliminated in the
order set forth above; plus
o a pro rata share of the surrender charge for a partial reduction in an
increase or in the initial face amount.
You may specify from which sub-account this charge will be deducted. If you do
not, the Company will allocate the charge among the General Account and the
sub-accounts of the Variable Account in the same proportion that the policy
value in the General Account, less debt, and the policy value in each
sub-account bear to the total policy value, less debt.
New specification pages will be issued. These pages will include the following
information:
o the effective date of the decrease;
o the amount of the decrease and the benefit remaining in force;
o the revised minimum monthly factor, if any;
o the revised surrender charge as of the effective date of the decrease; and
o the new guideline premiums.
The face amount of this policy may not be reduced to less than the Company's
minimum issue limits for this type of policy.
The Company reserves the right to establish a minimum limit on the amount of any
decrease.
Form 1018-93 14
<PAGE>
================================= Policy Value =================================
Monthly Deduction -- The monthly deduction is:
o the monthly insurance charge; plus
o a $5 monthly administrative charge.
Monthly deductions are made on the date of issue and on each monthly payment
date unless the premium is in default. Monthly deductions are not made during
the grace period (unless the insured's death occurs during the grace period) or
after the policy has lapsed.
You may specify from which sub-account of the Variable Account this deduction
will be taken. If you do not, the Company will allocate the charge among the
General Account and the sub-accounts of the Variable Account in the same
proportion that the policy value in the General Account, less debt, and the
policy value in each sub-account bear to the total policy value, less debt.
General Account -- The General Account consists of all assets owned by the
Company other than those in the Variable Account and other separate accounts.
Subject to applicable law, the Company has sole discretion over the investment
of the assets in the General Account. The allocation or transfer of funds to the
General Account does not entitle the owner to share in the investment experience
of the General Account. The guaranteed minimum interest rate used to calculate
the policy value in the General Account is 4% annually. The actual interest rate
will be determined by the Company at least annually; however, the interest rate
applicable to that portion of the policy value equal to existing debt will be
not less than 6% annually.
The interest rate in effect on the date a premium is received at the Principal
Office is guaranteed for one year unless the policy value associated with the
premium becomes subject to a policy loan. The interest rate on policy value
transferred from a sub-account of the Variable Account to the General Account is
not guaranteed. Policy value which is within the first-year guarantee period
will be used for payment of fees, charges, loans and partial withdrawals on a
last-in, first-out basis.
Basis of Value of General Account -- Minimum policy value in the General Account
is based on the Commissioner's 1980 Standard Ordinary Mortality Table, Smoker
or Non-Smoker, Male, Female or Table B for unisex risks (or appropriate
increases in such tables for rated risks) with interest at 4% per year,
compounded annually. Policy values are based on interest rates and mortality
rates set by the Company. A detailed statement of the way this value is
determined has been filed with the State Insurance Department. All value is not
less than the minimums required by the law in the state in which this policy is
delivered.
General Account Policy Value -- If premium is paid with the application or at
any time prior to the delivery of the policy, that premium will be placed in the
General Account on the date it is received at the Principal Office. Policy value
in the General Account will be allocated to the sub-accounts of the Variable
Account in accordance with your premium allocation no later than the expiration
of the period during which you may exercise your right to examine this policy.
On each monthly payment date, the policy value in the General Account is:
o the policy value in the General Account on the preceding monthly payment
date increased by one month's interest; plus
o net premiums received since the last monthly payment date which are
allocated to the General Account increased by interest from the date the
payment is received by the Company; plus
o Variable Account policy value transferred to the General Account from any
sub-account of the Variable Account since the preceding monthly payment
day increased by interest from the date the policy value is transferred;
less
o policy value transferred from the General Account to a sub-account of the
Variable Account since the preceding monthly payment date and interest on
said transfers from the date of transfer to the monthly payment date; less
o partial withdrawals from the General Account, partial withdrawal charges
and partial withdrawal transaction charges since the last monthly payment
date and interest on such
Form 1018-93 15 (Continued on page 16)
<PAGE>
Policy Value (Continued from page 15)
withdrawals and charges from the date of withdrawal to the monthly payment
date; less
o any transaction charges for any increases in face amount since the last
monthly payment date and interest on such charges to the monthly payment
date; less
o any surrender charges incurred since the last monthly payment date and
interest on such charges to the monthly payment date; and less
o the portion of the monthly deduction allocated to the policy value in the
General Account.
During any policy month the policy value will be calculated on a consistent
basis.
Variable Account -- The policy value may vary if funded through investments in
the sub-accounts of the Variable Account. The Variable Account is separate from
the Company's General Account. That portion of the assets of the Variable
Account equal to the reserves and other liabilities of the policies which are
supported by the Variable Account will not be charged with liabilities that
arise from any other business the Company conducts.
The Company established the Variable Account to support variable life insurance
contracts. The Variable Account is registered with the Securities and Exchange
Commission (SEC) as a unit investment trust under the Investment Company Act of
1940. It also is governed by the laws of the State of Delaware.
The Variable Account has several sub-accounts. The Company reserves the right,
subject to compliance with applicable law, to change the names of the Variable
Account or its sub-accounts. The sub-accounts in which you initially chose to
invest are shown in your application for this policy, a copy of which is
attached to this policy.
Each sub-account invests its assets in a separate registered investment company
or a separate series of a registered investment company ("Fund").
Income and realized and unrealized gains or losses from the assets of each
sub-account of the Variable Account are credited to or charged against that
sub-account without regard to income, gains, or losses in the other sub-accounts
of the Variable Account, the General Account or any other separate accounts.
Variable Account Policy Value -- On each valuation date the Company will value
the assets of each sub-account of the Variable Account in which there has been
activity. The policy value in a sub-account of the Variable Account at any time
is equal to the number of units this policy then has in that sub-account
multiplied by the sub-account's unit value.
The value of a unit for any sub-account of the Variable Account for any
valuation period is determined by multiplying that sub-account's unit value for
the immediately preceding valuation period by the net investment factor for the
valuation period for which the unit value is being calculated.
Net Investment Factor -- The net investment factor measures the investment
performance of a sub-account of the Variable Account during the valuation period
just ended. The net investment factor for each sub-account is equal to 1.0000
plus the number arrived at by dividing (a) by (b) and subtracting (c) and (d)
from the result, where:
(a) is the investment income of that sub-account for the valuation
period, plus capital gains, realized or unrealized, credited during
the valuation period; minus capital losses, realized or unrealized,
charged during the valuation period; adjusted for provisions made
for taxes, if any;
(b) is the value of that sub-account's assets at the beginning of the
valuation period; and
(c) is a charge for mortality and expense risks in the valuation period
equal to .90%, on an annual basis, of the sub-account's assets. This
charge may be increased or decreased by the Company, but may not
exceed 1.275%; and
(d) is an administrative charge equal to .25% on an annual basis, of the
sub-accounts' assets. This charge is applicable only during the
first ten policy years.
The net investment factor may be greater or less than one; therefore, the unit
value may increase or decrease. You bear the investment risk. Subject to any
required regulatory approvals, the Company reserves the right to change the
method for determining the net investment factor.
Valuation Dates and Periods -- A valuation date is each day that the New York
Stock Exchange is open for business and any other day in which there is a
sufficient degree of trading in the Variable Account's portfolio securities to
materially affect the value of the Variable Account. A valuation period is the
period between valuation dates.
Form 1018-93 16 (Continued on page 17)
<PAGE>
Policy Value (Continued from page 16)
Addition, Deletion, or Substitution of Investments -- The investment policy of
the Variable Account shall not be changed without the approval of the Insurance
Commissioner of Delaware. The approval process is on file with the Commissioner
of the state in which this policy is issued.
The Company reserves the right, subject to compliance with applicable law, to
make additions to, deletions from, or substitutions for the shares of a Fund
that are held by the Variable Account or that the Variable Account may purchase.
The Company reserves the right to eliminate the shares of any Fund if the shares
of a Fund are no longer available for investment or if, in the Company's
judgment, further investment in any eligible Fund should become inappropriate in
view of the purposes of the Variable Account.
The Company will not substitute any shares attributable to your interest in a
sub-account of the Variable Account without notice to you and any prior approval
of the SEC required by the Investment Company Act of 1940. This shall not
prevent the Variable Account from purchasing other securities for other series
or classes of policies, or from permitting a conversion between series or
classes of policies or contracts on the basis of requests made by owners.
The Company reserves the right to establish additional sub-accounts of the
Variable Account, and to make such sub-accounts available to any class or series
of policies as the Company deems appropriate. Each new sub-account would invest
in a new investment company or in shares of another open-end investment company.
Subject to obtaining any required approvals or any consents required by
applicable law, the Company also reserves the right to eliminate or combine
existing sub-accounts of the Variable Account and to transfer the assets of one
or more sub-accounts to any other sub-accounts.
In the event of any substitution or change, the Company may, by appropriate
endorsement, make such changes in this and other policies as may be necessary or
appropriate to reflect the substitution or change. If the Company considers it
to be in the best interests of policyholders, the Variable Account may be
operated as a management company under the Investment Company Act of 1940, or
it may be deregistered under that Act in the event registration is no longer
required, or it may be combined with other separate accounts.
Federal Tax Considerations -- The Company intends to make a charge for any
effect which the income, assets or existence of the Variable Account may have
upon its tax. The Variable Account presently is not subject to tax, but the
Company reserves the right to assess a charge for taxes if the Variable Account
at any time becomes subject to tax.
Form 1018-93 17
<PAGE>
============================== Transfers of Value ==============================
You may transfer amounts between the General Account and the sub-accounts of the
Variable Account or among the sub-accounts of the Variable Account by sending
the Company a written request. Once during the first 24 months after the date of
issue and during the first 24 months after an increase in the face amount, you
may transfer, without charge, all or part of the policy value in the Variable
Account to the General Account of this policy. If you do so, future payments
will be allocated to the General Account unless you specify otherwise. All other
transfers are subject to the following rules and will be permitted only with the
consent of the Company.
If the Company consents to a transfer, the minimum and maximum amounts that may
be transferred shall be determined by the Company according to its then current
rules. In addition, the Company reserves the right to limit the number of
transfers which may be made in each policy year and to establish other
reasonable rules restricting transfers.
If a transfer would reduce the policy value in the sub-account from which the
transfer is to be made to less than the then current minimum balance required by
the Company for such sub-account, the Company reserves the right to include such
remaining value in the amount transferred.
There will be no charge for the first six transfers per policy year. A transfer
charge of up to $25 will be imposed on each additional transfer and deducted
from the amount that is transferred. Transfers as a result of a policy loan or
repayment thereof are not subject to these rules.
================== Surrender and Partial Withdrawal of Value ===================
Surrender -- Upon written request while the insured is living you may surrender
this policy for its surrender value as of the date your request is received in
the Principal Office. The policy will terminate on that date. You may elect to
receive the surrender value paid in a lump sum or under a settlement option.
Surrender Value -- The surrender value is the policy value less the sum of the
debt and the applicable surrender charge.
Surrender Charge -- There is a separate surrender charge for the initial face
amount and each increase in the face amount. Surrender charges begin on the date
of issue of the policy and on the effective date of each increase in the face
amount.
The maximum surrender charge for the initial face amount is shown on page 4. The
changes in the surrender charge when the face amount is increased or decreased
are shown in the new specification pages.
Partial Withdrawals -- You may withdraw a portion of the surrender value on
written request. Partial withdrawals may not be made during the first policy
year. The amount of a partial withdrawal shall not be less than $500. A partial
withdrawal transaction charge of 2%, not to exceed $25, will always be deducted
from the policy value with each partial withdrawal. A withdrawal charge may also
be deducted from the policy value.
A portion of the partial withdrawal will not be subject to the withdrawal
charge. This amount is (a) less (b) where:
(a) is 10% of the policy value on the date the written request is
received at the Principal Office; and
(b) is the sum of the withdrawals (or portions thereof) made in the same
policy year which were not subject to the withdrawal charge.
A charge will be made on the balance of the withdrawal (called "excess
withdrawal"). The charge is obtained by multiplying the excess withdrawal by 5%;
however, in no event will the withdrawal charge exceed the surrender charge in
effect on the date of the withdrawal.
The policy's surrender charge will be reduced by the withdrawal charge, if any.
There will be no withdrawal charge if there is no surrender charge
Form 1018-93 18 (Continued on page 19)
<PAGE>
Surrender and Partial Withdrawal of Value (Continued from page 18)
applicable to the policy on the date of the withdrawal. The partial withdrawal
charge made will decrease existing surrender charges in the following order:
o first, the most recent increase's surrender charge;
o second, the next most recent increases' surrender charges successively;
and
o last, the initial face amount's surrender charge.
Under Sum Insured Option 1, the face amount and policy value will be reduced by
the amount of the partial withdrawal and the policy value will be reduced
further by the partial withdrawal transaction charge and withdrawal charge. The
face amount will be decreased in the following order:
o first, the most recent increase;
o second, the next most recent increases successively; and
o last, the initial face amount.
Under Sum Insured Option 2, the policy value will be reduced by the amount of
the partial withdrawal, the partial withdrawal transaction charge and the
withdrawal charge. No partial withdrawal may reduce the face amount to less than
$40,000.
You may allocate a partial withdrawal and the associated charges among the
General Account and each sub-account of the Variable Account. If you do not, the
Company will allocate the partial withdrawal and the charges among those
accounts in the same proportion that the policy value in the General Account,
less debt, and the policy value in each sub-account bear to the total policy
value, less debt, on the date the Company receives your request.
Postponement of Payment -- The Company may defer any transfer from the Variable
Account or payment of any amount payable on surrender, partial withdrawal,
transfer, policy loan, or death of the insured allocated to the Variable Account
during any period when (a) trading on the New York Stock Exchange is restricted
as determined by the SEC or such Exchange is closed for other than weekends and
holidays, (b) the SEC by order has permitted such suspension, or (c) an
emergency exists, as determined by the SEC, such that disposal of portfolio
securities or valuation of assets of the Variable Account is not reasonably
practicable.
The Company may defer the portion of any transfer from the General Account or
payment of any portion of the amount payable on surrender, partial withdrawal or
policy loan allocated to the General Account for not more than six months from
the day the written request and the policy, if required, are received by the
Company. If such payments are deferred for 30 days or more, the amount deferred
will earn interest during the period of deferment at a rate not less than 3 1/2%
per year. No payment to pay premiums on policies with the Company will be
deferred.
Form 1018-93 19
<PAGE>
================================= Policy Loans =================================
Policy Loans -- Loans may be obtained by request to the Company on the sole
security of this policy.
Amount Available -- The total amount you may borrow is an amount equal to the
loan value. The maximum loan value in the first policy year is 75% of (a) less
(b) where:
(a) is the policy value reduced by the surrender charge; and
(b) is the monthly deductions and interest on debt to the end of the
policy year.
The loan value in the second policy year and thereafter is 90% of the result
obtained when the policy value is reduced by the surrender charge.
You may allocate a policy loan among the General Account and the sub-accounts of
the Variable Account. If you do not, the Company will allocate the loan among
those accounts in the same proportion that the policy value in the General
Account, less debt, and the policy value in each sub-account bear to the total
policy value, less debt, on the date the Company receives your request. Policy
value in each sub-account of the Variable Account equal to the policy loan
allocated to each sub-account will be transferred to the General Account to
secure the debt.
Loan Interest -- Interest accrues daily and is payable in arrears at the annual
rate of 8%. Interest is payable at the end of each policy year or on a pro-rata
basis for such shorter period as the loan may exist. Interest not paid when due
will be added to the loan principal and bear interest at the same rate of
interest. If the resulting loan principal exceeds the policy value in the
General Account, the Company will transfer policy value equal to that excess
debt from the policy value in each sub-account of the Variable Account to the
General Account as security for the excess debt. The Company will allocate the
amount transferred among the sub-accounts in the same proportion that the policy
value in each sub-account bears to the total policy value in all sub-accounts.
Repayment of Debt -- Loans may be repaid at any time prior to the lapse of this
policy. Upon repayment of debt, the portion of the policy value that is in the
General Account securing debt will be transferred to the various accounts and
increase the policy value in these accounts. You may tell the Company how to
allocate repayments to the policy value among the General Account and the
sub-accounts of the Variable Account. If you do not, the Company will allocate
the loan repayment in accordance with the most recent premium allocation notice.
Loan repayments allocated to the Variable Account cannot exceed policy value
previously transferred from the Variable Account to secure the debt.
Foreclosure -- If the debt exceeds the policy value less the surrender charge,
the policy will terminate. A notice of such pending termination will be mailed
to the last known address of you and any assignee. If the excess debt is not
paid within 62 days after this notice is mailed, the policy will terminate with
no value. You may reinstate this policy according to the Reinstatement
provision.
Form 1018-93 20
<PAGE>
============================== Payment of Proceeds =============================
Payment Options -- Upon written request, the surrender value or all or part of
the death proceeds may be placed under one or more of the payment options below
or any other option offered by the Company. If you make no election, the Company
will pay the benefits in a single sum. A certificate will be provided to the
payee describing the payment option selected.
If a payment option is selected, the beneficiary, when filing proof of claim,
may pay to the Company any amount that otherwise would be deducted from the
proceeds.
You may choose one of the following payment options. The amounts payable under
these options are paid from the General Account. None is based on the investment
experience of the Variable Account.
The amounts payable under a payment option for each $1,000 of value applied will
be the greater of:
(a) the rate per $1,000 of value applied based on the Company's
non-guaranteed current payment option rates for this class of
policies; or
(b) the rate in this policy for the applicable payment option.
Option A: Payments for a Specified Number of Years (Table A). The Company will
make equal payments for any selected number of years (not greater
than 30). Payments may be made annually, semi-annually, quarterly or
monthly.
Option B: Lifetime Monthly Payments (Table B). Payments are based on the
payee's age on the date the first payment will be made. One of three
variations may be chosen. Depending upon this choice, payments will
end:
(1) upon the death of the payee, with no further payments due
(Life Annuity); or
(2) upon the death of the payee, but not before the sum of the
payments made first equals or exceeds the amount applied under
this option (Life Annuity with Installment Refund); or
(3) upon the death of the payee, but not before a selected period
(5, 10 or 20 years) has elapsed (Life Annuity with Period
Certain).
Option C: Interest Payments. The Company will pay interest at a rate
determined by the Company each year. The rate will not be less than
3 1/2%. Payments may be made annually, semiannually, quarterly or
monthly. Payments will end when the amount left with the Company has
been withdrawn; however, payments will not continue after the death
of the payee. Any unpaid balance plus accrued interest will be paid
in a lump sum.
Option D: Payments for a Specified Amount. Payments will be made until the
unpaid balance is exhausted. Interest will be credited to the unpaid
balance. The rate of interest will be determined by the Company each
year but will not be less than 3 1/2%. Payments may be made
annually, semi-annually, quarterly or monthly. The payment level
selected must provide for the payment each year of at least 8% of
the amount applied.
Option E: Lifetime Monthly Payments for Two Payees (Table E). One of three
variations may be chosen. After the death of one payee, payments
will continue to the survivor:
(1) in the same amount as the original amount; or
(2) in an amount equal to 2/3 of the original amount; or
(3) in an amount equal to 1/2 of the original amount.
Payments are based on the payees' ages on the date the first payment
is due. Payments will end upon the death of the surviving payee.
Form 1018-93 21 (Continued on page 22)
<PAGE>
Payment of Proceeds (Continued from page 21)
Selection of Payment Options -- The amount applied under any one option for any
one payee must be at least $5,000. The periodic payment for any one payee must
be at least $50.
Subject to the Owner and Beneficiary provision, you may change any option
selection before the proceeds become payable. If you make no selection, the
beneficiary may select an option when the proceeds become payable.
If the amount of monthly income payments under Option B(3) for the attained age
of the payee is the same for different periods certain, the Company will deem an
election to have been made for the longest period certain which could have been
elected for such age and amount.
You may give the beneficiary the right to change from Option C or D to any other
option at any time. If the payee selects Option C or D when this policy becomes
a claim, the right may be reserved to change to any other option. The payee who
elects to change options must be a payee under the option selected.
Additional Deposits -- An additional deposit may be added to any proceeds when
they are applied under Option B or E. A charge not to exceed 3% will be made.
The Company may limit the amount of this deposit.
Rights and Limitations -- A payee does not have the right to assign any amount
payable under any option. A payee does not have the right to commute any amount
payable under Option B or E. A payee will have the right to commute any amount
payable under Option A only if the right is reserved in the written request
selecting the option.
If the right to commute is exercised, the commuted values will be computed at
the interest rates used to calculate the benefits. The amount left under Option
C, and any unpaid balance under Option D, may be withdrawn by the payee only as
set forth in the written request selecting the option.
A corporate or fiduciary payee may select only Option A, C or D. Such selection
will be subject to the consent of the Company.
Payment Dates -- The first payment under any option, except Option C, will be
due on the date this policy matures by death or otherwise, unless another date
is designated. Payments under Option C begin at the end of the first payment
period.
The last payment under any option will be made as stated in the description of
that option. However, should a payee under Option B or E die prior to the due
date of the second monthly payment, the amount applied less the first monthly
payment will be paid in a lump sum or under any option other than Option E. Such
payment will be made to the surviving payee under Option E or the succeeding
payee under Option B.
Payment Rates -- The Payment Options Tables show payment rates for Options A, B
and E. For policy proceeds placed under these options within five years of the
date of surrender or the date the proceeds are otherwise payable, the more
favorable of the rates contained in this policy or the rates in use by the
Company as of the date the proceeds are applied will be the basis for the
periodic payments. Payments which commence more than five years after such date
or as a result of additional deposits will be based on the rates in use by the
Company as of the date the first payment is due.
Form 1018-93 22
<PAGE>
=============================== Payment Options ================================
TABLE A
Payments for Specified Number of Years
Payments Per $1,000 Applied
Based on Interest at 3 1/2% Per Year.
- ------------------------------------------------
SEMI- QUAR-
YEARS ANNUAL ANNUAL TERLY MONTHLY
- ------------------------------------------------
1 1000.00 504.30 253.23 84.65
2 508.60 256.49 128.79 43.05
3 344.86 173.91 87.33 29.19
4 263.04 132.65 66.61 22.27
5 213.99 107.92 54.19 18.12
6 181.32 91.44 45.92 15.35
7 158.01 79.69 40.01 13.38
8 140.56 70.88 35.59 11.90
9 127.00 64.05 32.16 10.75
10 116.18 58.59 29.42 9.83
11 107.34 54.13 27.18 9.09
12 99.98 50.42 25.32 8.46
13 93.78 47.29 23.75 7.94
14 88.47 44.62 22.40 7.49
15 83.89 42.31 21.24 7.10
16 79.89 40.29 20.23 6.76
17 76.37 38.51 19.34 6.47
18 73.25 36.94 18.55 6.20
19 70.47 35.54 17.85 5.97
20 67.98 34.28 17.22 5.75
21 65.74 33.15 16.65 5.56
22 63.70 32.13 16.13 5.39
23 61.85 31.19 15.66 5.24
24 60.17 30.34 15.24 5.09
25 58.62 29.56 14.85 4.96
26 57.20 28.85 14.49 4.84
27 55.90 28.19 14.15 4.73
28 54.69 27.58 13.85 4.63
29 53.57 27.02 13.57 4.53
30 52.53 26.49 13.30 4.45
- ------------------------------------------------
Form 1018-93 23
<PAGE>
=============================== Payment Options ================================
TABLE B
Monthly Payments Per $1,000 Applied
Based on Interest at 3 1/2% Per Year
- --------------------------------------------------------------
OPTION B OPTION B OPTION B
(1) (2) (3)
- --------------------------------------------------------------
Life Annuity With
------------------------------------
Instal.
Age Life Refund 5 Years 10 Years 20 Years
Annuity Annuity Certain Certain Certain
- --------------------------------------------------------------
0-5 3.09 3.09 3.09 3.09 3.09
6 3.10 3.10 3.10 3.10 3.10
7 3.11 3.11 3.11 3.11 3.11
8 3.12 3.11 3.12 3.12 3.12
9 3.13 3.12 3.13 3.13 3.13
10 3.14 3.13 3.14 3.14 3.14
11 3.15 3.14 3.15 3.15 3.15
12 3.16 3.15 3.16 3.16 3.16
13 3.17 3.16 3.17 3.17 3.17
14 3.18 3.17 3.18 3.18 3.18
15 3.19 3.19 3.19 3.19 3.19
16 3.21 3.20 3.21 3.20 3.20
17 3.22 3.21 3.22 3.22 3.21
18 3.23 3.22 3.23 3.23 3.23
19 3.25 3.24 3.25 3.24 3.24
20 3.26 3.25 3.26 3.26 3.25
21 3.27 3.26 3.27 3.27 3.27
22 3.29 3.28 3.29 3.29 3.28
23 3.31 3.29 3.31 3.30 3.30
24 3.32 3.31 3.32 3.32 3.32
25 3.34 3.33 3.34 3.34 3.33
26 3.36 3.35 3.36 3.36 3.35
27 3.38 3.36 3.38 3.38 3.37
28 3.40 3.38 3.40 3.40 3.39
29 3.42 3.40 3.42 3.42 3.41
30 3.44 3.42 3.44 3.44 3.43
31 3.46 3.44 3.46 3.46 3.45
32 3.49 3.47 3.49 3.48 3.47
33 3.51 3.49 3.51 3.51 3.50
34 3.54 3.52 3.54 3.54 3.52
35 3.57 3.54 3.57 3.56 3.55
36 3.60 3.57 3.59 3.59 3.58
37 3.63 3.60 3.63 3.62 3.60
38 3.66 3.62 3.66 3.65 3.63
39 3.69 3.65 3.69 3.69 3.66
40 3.73 3.69 3.73 3.72 3.70
41 3.76 3.72 3.76 3.76 3.73
42 3.80 3.75 3.80 3.79 3.76
43 3.84 3.79 3.84 3.83 3.80
44 3.89 3.83 3.88 3.88 3.84
45 3.93 3.87 3.93 3.92 3.88
46 3.98 3.91 3.98 3.97 3.92
47 4.03 3.95 4.03 4.01 3.96
48 4.08 4.00 4.08 4.06 4.00
49 4.14 4.05 4.13 4.11 4.05
50 4.19 4.10 4.19 4.17 4.10
51 4.25 4.15 4.25 4.23 4.14
52 4.32 4.20 4.31 4.29 4.20
53 4.38 4.26 4.38 4.35 4.25
54 4.46 4.32 4.45 4.42 4.30
55 4.53 4.38 4.52 4.49 4.36
56 4.61 4.45 4.60 4.56 4.42
57 4.69 4.52 4.68 4.64 4.48
58 4.78 4.59 4.77 4.72 4.54
59 4.88 4.67 4.86 4.81 4.60
60 4.98 4.75 4.96 4.90 4.66
61 5.09 4.83 5.07 5.00 4.73
62 5.20 4.92 5.18 5.10 4.79
63 5.32 5.02 5.30 5.21 4.86
64 5.46 5.12 5.42 5.33 4.93
65 5.60 5.22 5.56 5.44 4.99
66 5.74 5.33 5.70 5.57 5.06
67 5.90 5.45 5.85 5.70 5.12
68 6.07 5.57 6.02 5.84 5.18
69 6.26 5.70 6.19 5.98 5.24
70 6.45 5.84 6.37 6.13 5.30
71 6.66 5.98 6.57 6.29 5.35
72 6.89 6.14 6.78 6.45 5.41
73 7.13 6.30 7.00 6.62 5.45
74 7.39 6.47 7.23 6.79 5.49
75 7.68 6.65 7.48 6.97 5.53
76 7.98 6.84 7.75 7.14 5.57
77 8.30 7.04 8.03 7.33 5.60
78 8.65 7.25 8.32 7.51 5.62
79 9.02 7.47 8.64 7.69 5.65
80 9.43 7.71 8.96 7.87 5.67
- --------------------------------------------------------------
Rates for ages 81 and over are
the same as those for age 80
- --------------------------------------------------------------
Form 1018-93 24
<PAGE>
=============================== Payment Options ================================
TABLE E(1)
Monthly Payments Per $1,000 Applied
Joint & Survivor
Based on Interest at 3 1/2% Per Year
OLDER AGE
- --------------------------------------------------------------------------------
50 55 60 65 70 75 80
--------------------------------------------------------------------------
50 3.70 3.77 3.82 3.86 3.89 3.91 3.93
Y
O 55 3.92 4.01 4.08 4.14 4.17 4.20
U
N 60 4.22 4.34 4.43 4.50 4.54
G
E 65 4.61 4.77 4.90 4.98
R
70 5.16 5.38 5.54
A
G 75 5.92 6.23
E
80 7.00
--------------------------------------------------------------------------
- --------------------------------------------------------------------------------
TABLE E(2)
Initial Monthly Payments Per $1,000 Applied
Joint & 2/3 Survivor
Based on Interest at 3 1/2% Per Year
OLDER AGE
- --------------------------------------------------------------------------------
50 55 60 65 70 75 80
--------------------------------------------------------------------------
50 4.03 4.16 4.31 4.47 4.65 4.83 5.02
Y
O 55 4.33 4.50 4.69 4.89 5.10 5.32
U
N 60 4.72 4.95 5.19 5.44 5.69
G
E 65 5.25 5.55 5.87 6.18
R
70 5.99 6.39 6.79
A
G 75 7.03 7.57
E
80 8.50
--------------------------------------------------------------------------
- --------------------------------------------------------------------------------
TABLE E(3)
Initial Monthly Payments Per $1,000 Applied
Joint & 1/2 Survivor
Based on Interest at 3 1/2% Per Year
OLDER AGE
- --------------------------------------------------------------------------------
50 55 60 65 70 75 80
--------------------------------------------------------------------------
50 4.22 4.39 4.60 4.85 5.14 5.47 5.83
Y
O 55 4.56 4.79 5.06 5.38 5.74 6.13
U
N 60 5.02 5.32 5.68 6.08 6.52
G
E 65 5.65 6.05 6.51 7.02
R
70 6.52 7.05 7.65
A
G 75 7.75 8.48
E
80 9.52
--------------------------------------------------------------------------
- --------------------------------------------------------------------------------
Payment rates for combinations of ages not shown may be obtained
from the Company upon request.
Joint life rates are based on the 1983a Individual Mortality Table
using a proportional blend of 50% male and 50% female.
Form 1018-93 25
<PAGE>
======================== Paid Up Life Insurance Option =========================
Benefit: Paid up life insurance is insurance, usually having a reduced face
amount, which continues for the lifetime of the insured with no further premiums
due. The amount of paid-up insurance is the amount the policy's surrender value
can purchase for a net single premium at the insured's age and class of risk on
the date this option is exercised. In the event the face amount of the policy
has been increased, the class of risk for the paid-up life insurance will be the
class of risk assigned to the last increase.
The paid-up insurance death benefit may not be less than $10,000 or exceed the
policy's sum insured in effect on the date this option is exercised. In the
event that the surrender value exceeds the net single premium for the policy's
sum insured on the date this option is exercised, the excess surrender value
will be paid to you.
Basis of Value: The policy value and net single premium of the paid-up insurance
meet the minimum standards which are set by state law. The net single premium is
based on the Commissioners 1980 Standard Ordinary Mortality Table, Smoker or
Non-Smoker; Male, Female or Table B for unisex risks (or appropriate increases
in such tables for non-standard risks). Interest will not be less than 4 1/2%
per annum nor higher than the maximum rate allowed by law.
Exercise of Option: The paid-up insurance option may be exercised by you on
written request. The Company will issue supplemental specifications pages that
show the policy as paid-up effective as of the monthly payment date following
receipt of the written request.
The supplemental specifications pages will show:
o the effective date of paid-up insurance;
o the paid-up death benefit;
o the interest rate used to calculate the cash values and paid-up insurance
benefit; and
o riders.
Effect on the Policy: After the policy becomes paid-up, no further premiums may
be paid by you. You may not increase or decrease the death benefit; the death
benefit remains level. You may not make partial withdrawals or transfer funds to
the Variable Account. You may make policy loans or surrender the policy for its
net cash value. Riders will continue only with the consent of the Company.
The guaranteed cash value of the paid-up insurance equals the net single premium
for the paid-up insurance at the insured's attained age. The net single premium
is determined on the same basis as is used for the purchase price of the paid-up
insurance. The net cash value is the cash value less debt. The policy loan
interest rate will be 6%. The loan value of paid-up insurance is the amount
that, with interest at 6% per year, equals the cash value of the paid-up policy
as of the next policy anniversary.
Misstatement of Age or Sex: If the insured's age or sex is misstated, the amount
of paid-up insurance will be that which the net single premium would have
purchased at the correct age or sex.
Flexible Premium Variable Life Insurance Policy. Adjustable Sum Insured. Death
Proceeds Payable at Death of Insured. Flexible Premiums Payable to the Final
Premium Payment Date. Coverage to the Final Premium Payment Date and Amount of
Policy Value Not Guaranteed. Some Benefits Reflect Investment Results.
Non-Participating.
Form 1018-93 26
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
======================== Accidental Death Benefit Rider ========================
This rider is a part of the policy to which it is attached if it is shown in the
schedule of benefits and premiums. The insured under the policy is the insured
under this rider.
Benefit--The Company will pay the accidental death benefit when the principal
office receives due proof that:
o the insured's death resulted directly and solely from accidental drowning
or accidental bodily injury evidenced by a visible contusion or wound on
the exterior of the body or by internal injuries shown by an autopsy; and
o the insured's death occurred within 90 days after such injury; and
o the insured's injury and death occurred while this rider was in force.
If the accidental injury occurred while the insured was a fare paying passenger
in or on a public conveyance operated by a common carrier for passenger service,
the accidental death benefit will be doubled.
Unless requested otherwise, the benefit will be paid to the beneficiary entitled
to the proceeds under the policy and will be paid in the same manner.
Exclusions--This rider does not cover death which results directly or indirectly
from:
o suicide or attempted suicide, while sane or insane; or
o the commission of a felony by the insured; or
o war, declared or undeclared, or any act of war; or
o travel or flight in or descent from any aircraft if the insured:
o is a pilot, officer or member of the crew; or
o is traveling or flying for the purpose of descent from such
aircraft while in flight; or
o is giving or receiving any kind of training or instructions; or
o has duties aboard such aircraft.
o any physical or mental infirmity, illness or disease; or
o the entry into the body by any means, whether voluntary or involuntary,
of:
o any excitant or hallucinogen; or
o any narcotic, hypnotic or sedative, unless use is as prescribed by
a physician acting within the scope of his license; or
o any poison or poisonous substance; or
o any gas or fumes, other than involuntarily in the course of
employment.
Claim--Written notice of claim must be sent to the principal office within 91
days after the insured's death. Failure to furnish notice within such time will
not void a claim if it is shown that notice was given as soon as was reasonably
possible.
If a claim under this rider is denied, any other death benefits may be paid
under the policy without prejudice to the claim for, or the defense to, the
accidental death benefit.
Incontestability--Except for failure to pay the monthy mortality charge, this
rider cannot be contested after it has been in force during the insured's
lifetime for two years from its date of issue.
Termination--This rider will terminate on the first to occur of:
o the end of the grace period of a premium in default; or
o the termination or maturity of the policy while the insured is alive; or
o the day before the policy anniversary nearest age 70; or
Form 1063-83
<PAGE>
o the end of the policy month following a request for termination.
General--The schedule of benefits and premiums (page 3 or 3.1 of the policy)
will show for this rider:
o the date of issue; and
o the accidental death benefit amount.
Charges for this rider are payable as a part of the monthly mortality charges
due under this policy. The monthly mortality charge for this rider is shown on
page 5 or 5.1.
Except as otherwise provided, all conditions and provisions of the policy apply
to this rider.
Signed for the Company at Dover, Delaware.
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
Form 1063-83
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
============================ Waiver Of Premium Rider ===========================
This rider is a part of the policy to which it is attached if it is shown in the
schedule of benefits and premiums. The insured under the policy is the insured
under this rider.
Benefit--While the insured is totally disabled, the company will add to the
policy value the waiver of premium benefit. This benefit is the larger of:
o the amount shown in the schedule of benefits and premiums; or
o the minimum monthly factor applicable to the face amount covered by this
rider; or
o the monthly mortality charges applicable to the face amounts and other
riders covered by this rider.
The waiver of premium benefit is subject to:
o the company's receipt of due proof of such total disability; and
o evidence the total disability:
o began while this rider was in force; and
o began before the policy anniversary nearest age 65; and
o has continued for at least 4 months; and
o the other terms and conditions of this rider.
The benefit will begin with the policy month following the date total disability
begins or the policy anniversary nearest age 5, if later. The benefit will not
be provided for any period more than one year prior to the date the company
receives written notice of claim. The company will credit the policy value with
any benefit which applies to the time during which benefits are payable.
If the insured's total disability occurs before the policy anniversary nearest
age 60, the benefit will end when total disability ends. If the total disability
occurs on or after the policy anniversary nearest age 60, the benefit will
continue during such total disability but not beyond the policy anniversary
nearest age 65 or two years, whichever is longer.
Benefits will cease on the next monthly payment date following the end of a
period of total disability.
Definitions of Total Disability--Total disability means the insured is unable to
engage in an occupation as a result of disease or bodily injury. "Occupation"
means to attend school if the insured is not old enough to legally end his or
her formal education. Otherwise "occupation" means:
o during the first 60 months of disability, the occupation of the insured
when such disability began; and
o thereafter, any occupation for which the insured is or becomes reasonably
fitted by training, education or experience.
Total loss of the following as a result of disease or bodily injury shall be
deemed total disability:
o speech;
o hearing in both ears; or
o the sight of both eyes; or
o the use of both hands; or
o the use of both feet; or
o the use of one hand and one foot.
Risks Not Covered--No benefit will be provided if total disability results,
directly or indirectly, from:
o an act of war, whether such war is declared or undeclared, and the
insured is a member of the armed forces of a country or combination of
countries; or
o any bodily injury occurring or disease first manifesting itself prior to
the date of issue of this rider. However, no claim for total disability
commencing after two years from the date of issue will be denied on the
ground that the disease or impairment not excluded from coverage by name
or specific description existed prior to the date of issue of this rider.
Form 1074-86 (over)
<PAGE>
Notice and Proof of Claim--Written notice of claim must be sent to the principal
office:
o during the lifetime of the insured; and
o while the insured is totally disabled; and
o not later than 12 months after this rider terminates.
Proof of claim must be sent to the principal office within 6 months of the
notice of claim. Failure to give notice and proof within the time required will
not void or reduce any claim if it can be shown that notice and proof were given
as soon as was reasonably possible.
Proof of continued total disability must be furnished upon request by the
company. Failure to do so will end the benefit. Such proof will include an
authorization to disclose facts concerning the insured's health and may include
medical exams of the insured conducted by physicians chosen by the company. Such
medical exam will be at the company's expense. After total disability has
continued for 24 months, proof will not be required more than once a year nor
after the policy anniversary nearest age 65.
Benefit Changes--The benefit may be changed on written request. Any increase is
subject to:
o evidence of insurability;
o the insured must be under age 60 and insurable according to the
company's underwriting rules; and
o payment to the company of the amount needed to keep the policy in force if
the surrender value is less than all charges due on the policy.
No increases when added to the existing benefit, shall exceed the following
limits:
- ------------------------------------------
Maximum Benefit Table
- ------------------------------------------
Monthly Benefit
Attained Per $1,000
Age Face Amount
- ------------------------------------------
0-19 $1.00
20-29 1.25
30-39 2.00
40-49 3.00
50-54 4.00
55 and above 5.50
- ------------------------------------------
The waiver of premium benefit will be reduced if it exceeds the maximum benefit
after the face amount of the policy is reduced. The monthly benefit may not
exceed the amount shown in the Maximum Benefit Table.
The effective date of the changed benefit will be the first monthly payment date
on or after the date all conditions are met. The changed benefit will be shown
in a supplementary schedule of benefits and premiums. The charges for an
increased benefit will be shown in a Supplementary Mortality Rate Table if the
insured's class of risk changes.
Incontestability--Except for failure to pay the monthly charges, this rider
cannot be contested after the end of the following time periods:
o the initial benefit cannot be contested after the rider has been in force
during the insured's lifetime and without the occurrence of the total
disability of the insured for two years from the date of issue; and
o an increase in the benefit cannot be contested after the increased benefit
has been in force during the insured's lifetime and without the occurrence
of the total disability of the insured for two years from its effective
date.
Termination--This rider will terminate on the first to occur of:
o the end of the grace period of a premium in default; or
o the termination or maturity of the policy; or
o the day before the policy anniversary nearest age 65, except as provided
in the benefit provision; or
o the end of the policy month following a request for termination.
Rider Charge--Charges for this rider are paid as a part of the monthly mortality
charges due under this policy.
The monthly charge is the waiver charge shown in the Mortality Rate Table
multiplied by the greater of:
o the monthly mortality charges applicable to the face amount and other
riders covered by this rider; or
o one-half of the waiver of premium benefit shown in the schedule of
benefits and premiums.
Form 1074-86
<PAGE>
General--The schedule of benefits and premiums (page 3 or 3.1 of the policy)
will show the date of issue of this rider.
When an increase in face amount or an additional rider is applied for, waiver of
premium coverage must also be requested. The company reserves the right to
decline issuance of the waiver of premium coverage for the increased face amount
or additional rider benefit.
If total disability begins during the grace period of a past due premium, such
premium will be payable.
The waiver of premium benefit will not reduce any amount payable under the
policy.
Except as otherwise provided, all conditions and provisions of the policy apply
to this rider.
Signed for the company at Dover, Delaware.
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
Form 1074-86
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
========================= Guaranteed Insurability Rider ========================
This rider is a part of the policy to which it is attached if it is shown in the
schedule of benefits and premiums. The insured under the policy is the insured
under this rider.
Benefit--On each option date the owner may increase the face amount of insurance
without evidence of insurability if written request is made:
o during the lifetime of the insured;
o while this rider and policy are in force; and
o subject to the terms of this rider.
Option Dates--The first option date for this rider is shown in the schedule of
benefits and premiums. Subsequent option dates occur on every second anniversary
of the first option date until the policy anniversary nearest age 40 or until
the fifth option date, whichever is later.
Exercise of Increase Option--Options may be exercised on the life of the insured
not earlier than 60 days prior to, nor later than 31 days after an option date.
The increased face amount will be:
o not less than $10,000; and
o not greater than the option amount or the total option amount remaining,
if less.
The mortality charges for the increased face amount will be calculated in the
same manner as mortality charges for other increases in the face amount. The
guaranteed mortality charges for such increases will not exceed the guaranteed
mortality charges in effect on the date of issue of this rider.
A supplemental schedule of benefits and premiums will be issued. This schedule
will include the following information:
o the effective date of the increased face amount;
o the amount of the increase; and
o the surrender charge.
The supplemental schedule of benefits and premiums will also show the new
minimum monthly factor and the new guideline premiums applicable to the entire
policy. There is no administrative charge for the exercise of this option.
If the surrender value on the date of issue of an increase is less than the
mortality charges due on the policy you must pay to the Company the grace period
premium.
The effective date of the increased face amount will be the monthly payment date
following the date of the written request. If the insured dies after the date of
the written request and before the increased face amount takes effect, the
Company will refund any premium paid to exercise this option.
The time periods in the suicide and incontestable clauses for the increased face
amount will be measured from the date of issue of this rider.
Waiver of Premium--If this policy contains a waiver of premium benefit rider on
the increase date, the benefit may be increased without evidence of
insurability. If waiver of premium benefits are being paid on the increase date,
the increased benefit will become payable on the increase date.
If the waiver of premium benefit on an increase date is designated in the
schedule of benefits and premiums as the mortality charges, this benefit will be
increased by the mortality charges for the increased face amount.
If the waiver of premium benefit on an increase date is a dollar amount shown in
the schedule of benefits and premiums, this benefit will be increased by the
smaller of:
o the excess, if any, of the monthly equivalent of the periodic premium for
the policy on the increase date over the waiver of premium benefit
immediately prior to the increase; and
o the amount shown in the waiver of premium benefit table.
- -----------------------------------------------
Waiver of Premium Benefit Table
- -----------------------------------------------
Monthly Benefit
Attained Increase Per $1,000
Ages Face Amount Increased:*
- -----------------------------------------------
18-19 $.50
20-29 .63
30-39 1.00
40-49 1.50
50-54 2.00
55-59 2.75
- -----------------------------------------------
* In no event may the waiver of premium benefit
be increased to exceed the monthly equivalent
of the periodic premium.
- -----------------------------------------------
Form 1066-86 (Over)
<PAGE>
Incontestability--Except for failure to pay the monthly mortality charge, this
rider cannot be contested after it has been in force during the insured's
lifetime for two years from its date of issue.
Termination--This rider will terminate on the first to occur of:
o the end of the grace period of a premium in default; or
o the end of the policy month following a request for termination; or
o the last option date; or
o the date of issue of an increase which, when added to the sum of all prior
increases under this rider, reduces the total option amount remaining to
less than $10,000.
General--The schedule of benefits and premiums (page 3 or 3.1 of the policy)
will show for this rider:
o the date of issue;
o the first option date;
o the option amount; and
o the total option amount.
Except as otherwise provided, any additional benefits or riders will not be
added or increased without the Company's prior consent.
Reinstatement of this rider will not revive any option date which occurred
during the period of lapse.
Charges for this rider are payable as a part of the monthly mortality charges
due under this policy. The monthly mortality charge for this rider is shown on
page 5 or 5.1.
Except as otherwise provided, all conditions and provisions of the policy apply
to this rider.
Signed for the Company at Dover, Delaware.
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
Form 1066-86
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
========================== Children's Insurance Rider ==========================
This rider is a part of the policy to which it is attached if it is shown in the
schedule of benefits and premiums. The insured under the policy is the insured
under this rider. "Insured child" is defined below.
==================================== Benefit ===================================
Benefit--The Company will pay the children's insurance benefit upon receipt of
due proof that an insured child died while this rider was in force. The amount
of the children's insurance benefit is shown in the schedule of benefits and
premiums. Unless requested otherwise, the beneficiary under this rider is the
owner.
Insured Child Description--"Acquired" means born, legally adopted or attained
the status of stepchild.
"Insured Child" means an acquired child of the insured who:
o is named in the application for this rider and on the date of the
application has not reached his or her 18th birthday; or
o is acquired during the insured's lifetime after the date of the
application but before such child's 18th birthday.
No child can be an insured child while under the age of 14 days. A person will
cease to be an insured child on the policy anniversary nearest the earlier of
the insured child's 25th birthday and or the insured's 65th birthday.
Period of Term Insurance--The term insurance on each insured child will begin on
the date of issue of this rider if the child is an insured child on such date;
otherwise the term insurance will begin on the date the insured child is
acquired and is 14 days old. The term insurance will expire on the date the
child ceases to be an insured child.
Paid-Up Term Insurance--If the insured dies while this rider is in force, the
term insurance in force on each insured child will be converted to paid-up term
insurance. The paid-up term insurance on each child will terminate on the date
the child ceases to be an insured child. This rider may be surrendered any time
while the paid-up term insurance is in force for its net reserve on the date of
surrender. However, if this rider is surrendered within 30 days after a policy
anniversary, the value will not be less than the net reserve on such
anniversary. We will furnish a statement of the values for this rider upon
request.
================================== Conversion ==================================
Conversion--You may convert the insurance on the life of an insured child if
such request is made:
o within 60 days before the term insurance on the life of an insured child
expires;
o during the insured child's lifetime; and
o while the rider is in force.
You may convert to a new policy issued either by the Company or by First
Allmerica Financial Life Insurance Company. Evidence of insurability will not be
required.
New Policy Description--The new policy will be issued:
o on any form of life insurance other than term being issued on the date
of issue of the new policy;
o on the life of the insured child only; and
o at the insured child's age and for the premium rates in use on the date
of issue of the new policy.
Form 1068-84 (Over)
<PAGE>
============================ Conversion (continued) ============================
The sum insured may not be less than the minimum issue limit of the company
issuing the new policy. The sum insured may not be more than 5 times the amount
of insurance under this rider on the insured child.
The new policy will not become binding unless the first premium is paid during
the lifetime of the insured child and within 31 days after the expiration of the
term insurance under this rider.
The date of issue of the new policy will be the day after the expiration of the
term insurance under this rider.
The new policy will be subject to any assignments outstanding against this
rider. Riders will be available on the new policy subject to evidence of
insurability and consent of the company. The time periods of the suicide and
incontestability provisions of the new policy will expire on the same date as
such provisions in this rider would have expired.
First Allmerica Financial Life Insurance Company agrees that, on written request
and payment of the premium for the new policy, it will issue a policy of
insurance in accordance with the terms and conditions of the Conversion
Provision of this policy.
Signed for the Company at Worcester, Massachusetts on the date of issue.
/s/ Richard J. Baker /s/ John J. O'Brien
Secretary President
==================================== General ===================================
Incontestability--Except for failure to pay the charges, this rider cannot be
contested after it has been in force, during the insured's lifetime, for two
years from its date of issue. The insurance on any insured child named in the
application cannot be contested after it has been in force, during the insured
child's lifetime, for two years from the date of issue of this rider.
Misstatement of Age--If the age of a child has been misstated and if the child
would not have been an insured child upon his or her death if the age had been
correctly stated, no benefit will be payable if the child dies. Any benefit paid
to the beneficiary because of the death of such child shall be repaid to the
company. If the age of the insured has been misstated, the termination date of
the insured child's coverage will be based upon the insured's correct age.
Termination--This rider will terminate on the first to occur of:
o the end of the grace period of a premium in default; or
o the termination or maturity of the policy except as provided in the
Paid-Up Term Insurance provision; or
o the day before the policy anniversary nearest the insured's age 65; or
o the end of the policy month following a request for termination.
General--The schedule of benefits and premiums (page 3 or 3.1 of the policy)
will show the date of issue of this rider.
Charges for this rider are payable as a part of the monthly mortality charges
due under this policy. The monthly charge is shown on page 5 or 5.1.
Except as otherwise provided, all conditions and provisions of the policy apply
to this rider.
Signed for the Company at Dover, Delaware
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
Form 1068-84
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
============================== Other Insured Rider =============================
This rider is a part of the policy to which it is attached if it is shown in the
schedule of benefits and premiums. The insured under the policy is the insured
under this rider. "Other insured" is each person other than the insured who is
insured under this rider.
==================================== Benefit ===================================
Benefit--The company will pay the term insurance benefit upon receipt of due
proof that an "other insured" died prior to his or her term expiry date while
this rider is in force. Unless otherwise requested, the term insurance benefit
will be paid to the owner.
An Other Insured Schedule Page shows for each "other insured":
o the name and age;
o the adminstrative charge, if any;
o the term insurance benefit;
o the effective date of the term insurance; and
o the term expiry date.
=========================== Benefit Change Provisions ==========================
Change Provisions--The owner may change the amount of term insurance with
respect to each "other insured" if such request is made:
o during the lifetime of the "other insured"; and
o on written request while this policy is in force.
Increase--Any increase in the amount of term insurance is subject to:
o evidence of insurability;
o the "other insured" must be under age 81 and insurable according to the
Company's underwriting rules;
o payment of an administrative charge not greater than $50; and
o payment to the Company of the amount needed to keep the policy in force if
the surrender value of the policy is less than all charges due on the
policy.
The effective date of the increased amount of term insurance will be the first
monthly payment date on or following the date all the conditions are met. A
supplemental Other Insured Schedule will be issued. This schedule will include
the following information for the additional amount of term insurance:
o the name of the "other insured";
o the effective date of the increased term insurance;
o the amount of the increase in the term insurance; and
o minimum monthly factor, guideline premiums and charges.
No increase may be less than the Company's minimum limit in effect on the date
of the request.
Decrease--A request to decrease the amount of term insurance on an "other
insured" will be effective on the monthly payment date following the date of the
written request. Such term insurance will be decreased or eliminated in the
following order:
o first, the most recent increase;
Form 1067-86 (Over)
<PAGE>
o second, the next most recent increase successively; and
o finally, the original amount of term insurance.
A supplemental Other Insured Schedule will be issued. This schedule will include
the following information:
o the name of the "other insured";
o the effective date of the decrease in the amount of term insurance; and
o the amount of the decrease in the term insurance and the benefit
remaining in force.
Term insurance on an "other insured" may not be reduced to less than the
Company's minimum issue limit.
The Company reserves the right to establish a minimum limit for the amount of
any decrease.
================================== Conversion ==================================
Conversion--You may convert the insurance on the life of an "other insured" if
such request is made:
o prior to the "other insured's" age 71;
o during the "other insured's" lifetime; and
o while this rider is in force.
Evidence of insurability will not be required.
New Policy Description--The new policy will be a flexible premium adjustable
life insurance policy. The new policy will be issued:
o on the life of the "other insured" only;
o for the same risk class which applies to the "other insured" under this
rider; and
o at the "other insured's" age and for the rates in use on the date of
issue of the new policy.
The date of issue of the new policy will be the monthly payment date following
the date conversion is requested and the first premium is paid. Term insurance
for the "other insured" ends when coverage under the new policy begins.
The sum insured may not be less than the minimum issue limit of the Company. The
sum insured may not exceed the sum insured in effect on the date conversion is
requested.
The owner will pay an amount equal to the premium on the new policy. Riders will
be available on the new policy subject to evidence of insurability and consent
of the Company. The time periods of the suicide and incontestability provisions
of the new policy will expire on the same date as such provisions in this rider
would have expired. The new policy will be subject to any assignments
outstanding against this rider.
==================================== General ===================================
Owner--The owner of the policy is the owner of this rider. However, if the
insured is the owner of the policy and at the time of the insured's death there
is no contingent owner named, each "other insured" will become the owner of the
term insurance on his or her life.
Conversion Following Insured's Death--If the insured dies while the policy and
rider are in force, the owner may convert any "other insured" insurance within
90 days after the insured's death.
Conversion is subject to the conversion provisions. Term insurance will continue
on the life of each covered "other insured" during the conversion period. This
term insurance will begin on the date of the insured's death and will end on the
first to occur of:
o the expiration of the conversion period; or
o the date of issue of the conversion policy.
Form 1067-86
<PAGE>
Incontestability--Except for failure to pay premiums, term insurance with
respect to each "other insured" cannot be contested after the expiration of the
following time periods:
o the initial term insurance benefit cannot be contested after the term
insurance has been in force during the "other insured's" lifetime for two
years from the effective date; and
o an increase in the term insurance as a result of a request by the owner
which includes evidence of insurability cannot be contested after the
increased amount has been in force during the "other insured's" lifetime
for two years from its effective date.
Suicide Exclusion--The risk of suicide of an "other insured", while sane or
insane, within two years of the effective date of the initial term insurance is
not assumed. The beneficiary will receive the sum of the mortality charges paid.
The risk of suicide of an "other insured", while sane or insane, within two
years of the effective date of any increase in the term insurance amount as a
result of a request by the owner which includes evidence of insurability is also
not assumed to the extent of such increase. The beneficiary will receive the
mortality charges paid for such increase.
Misstatement of Age--If the age of an "other insured" has been misstated, the
amount payable under this rider will be such as the charges paid on the last
monthly payment date would have purchased at the "other insured's" correct age.
Charges--Charges for this rider are payable as a part of the monthly mortality
charges due under this policy.
The maximum charges for each year for each "other insured" are shown in the
Other Insured Schedule or Schedules. There may be no more than five "other
insureds" under this rider.
Termination--This rider will terminate on the first to occur of:
o the end of the grace period of a premium in default; or
o the termination or maturity of the policy; or
o the monthly payment date following a request for termination.
Term insurance will terminate with respect to an "other insured" on such "other
insured's" term expiry date.
General--The schedule of benefits and premiums (page 3 or 3.1 of the policy)
will show the date of issue of this rider.
Except as otherwise provided, all conditions and provisions of the policy apply
to this rider.
Signed for the Company at Dover, Delaware
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
Form 1067-86
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
OPTION TO ACCELERATE DEATH BENEFITS ENDORSEMENT
This endorsement is a part of the policy to which it is attached. The insured
under this endorsement is the insured under the policy. This endorsement does
not apply to any benefits provided by rider.
Benefit--While this endorsement is in force, the owner may elect to receive a
portion of the death proceeds, called the "living benefit," prior to the
insured's death under either the terminal illness option or the nursing home
option, subject to the definitions, conditions and limitations in this
endorsement.
Definitions--"Option amount" means that portion of the sum insured which the
owner elects to apply under this option. The option amount must be at least
$25,000 and may not exceed the lesser of:
o one-half of the sum insured on the date the option is elected; or
o the amount that would reduce the face amount to the Company's minimum
issue limit for this policy; or
o $250,000.
"Option percentage" is the option amount divided by the sum insured.
"Living benefit" is the option amount which has been reduced for interest and
other factors. It is equal to the lump sum benefit under this endorsement, and
is the amount used to determine the monthly benefit. The living benefit will not
be less than the surrender value of the policy multiplied by the option
percentage. The following factors will be used to calculate the living benefit:
o age;
o sex, unless the policy is issued on a unisex basis;
o life expectancy;
o policy value;
o debt;
o rate of interest currently being credited to the policy value including
those values which are subject to debt;
o face amount;
o death benefit option;
o current insurance charges;
o administrative charges; and
o an expense charge of $150.
An amount equal to the debt multiplied by the option percentage will be deducted
from the living benefit. The remaining debt will continue in force.
The assumptions used by the Company to calculate the living benefit may change
from time to time. The factors used to compute the living benefit will be set
and changed only prospectively; that is, based on changes in future
expectations. The Company will not change these factors to recoup any prior
losses or distribute past gains under the endorsement.
"Eligible nursing home" means an institution or special nursing unit of a
hospital which meets at least one of the following requirements:
1. it is Medicare - approved as a provider of skilled nursing care
services; or
2. it is licensed as a skilled nursing home or as an intermediate care
facility by the state in which it is located; or
3. it meets all the requirements listed below:
o it is licensed as a nursing home by the state in which it is
located;
o its main function is to provide skilled, intermediate or custodial
nursing care;
o it is engaged in providing continuous room and board
accommodations to 3 or more persons;
o it is under the supervision of a registered nurse (RN) or licensed
practical nurse (LPN);
o it maintains a daily medical record of each patient; and
o it maintains control and records for all medications dispensed.
Institutions which primarily provide residential facilities are not eligible
nursing homes.
"Proof of claim satisfactory to the Company" shall include:
o a request signed by the insured to disclose all facts concerning the
insured's health;
END 239-91 1
<PAGE>
o records of the attending physician, including a prognosis of the
insured; and
o if requested by the Company, and at its expense, a medical examination of
the insured, conducted by a physician of the Company's choice.
Conditions--Upon written request you may elect to receive payment under one of
the accelerated death benefit options subject to the following conditions:
o the policy is in force;
o a written consent has been given by any collateral assignee, irrevocable
beneficiary and the insured if other than the owner; and
o the insured qualifies for the option you elect.
Terminal Illness Option--If you provide proof of claim satisfactory to the
Company that the insured's life expectancy is 12 months or less, you may elect
to receive equal monthly payments for 12 months. For each $1,000 of living
benefit, each payment will be at least $85.21. This assumes an annual interest
rate of 5%.
If the insured dies before all the payments have been made, the Company will pay
the beneficiary in one sum the present value of the remaining payments due under
this endorsement calculated at the interest rate used by the Company to
determine those payments.
If you do not wish to receive monthly payments, you may elect to receive an
amount equal to the living benefit in a lump sum.
Nursing Home Option--If (1) the insured is confined to an eligible nursing home
and has been confined there continuously for the preceding six months; and (2)
you provide proof of claim satisfactory to the Company that the insured is
expected to remain in the nursing home until death, you may elect level monthly
payments for the number of years shown in the table that follows. For each
$1,000 of living benefit, each payment will be at least the minimum amount shown
in that table. The table assumes an annual interest rate of 5%.
If the insured dies before all the payments have been made, the Company will pay
the beneficiary in one sum the present value of the remaining payments due under
this endorsement calculated at the interest rate used by the Company to
determine those payments.
You may elect a longer payment period than that shown in the table. If you do,
monthly payments will be reduced so that the present value of the monthly
payments for the longer payment period is equal to the present value of the
payments for the period shown in the table, calculated at an interest rate of at
least 5%.
MINIMUM MONTHLY
PAYMENT PAYMENT FOR
PERIOD EACH $1,000
IN YEARS OF LIVING BENEFIT
1 $85.21
2 $43.64
3 $29.80
4 $22.89
5 $18.74
6 $15.99
7 $14.02
8 $12.56
9 $11.42
10 $10.51
11 $9.77
12 $9.16
13 $8.64
14 $8.20
15 $7.82
16 $7.49
17 $7.20
18 $6.94
19 $6.71
20 $6.51
21 $6.33
22 $6.17
23 $6.02
24 $5.88
25 $5.76
26 $5.65
27 $5.54
28 $5.45
29 $5.36
30 $5.28
The Company reserves the right to set a maximum monthly benefit, which will not
be less than $5,000.
If you do not wish to receive monthly payments, you may elect to receive a
single sum equal to the living benefit.
END 239-91 2 (Continued on page 3)
<PAGE>
Effect on Policy--The sum insured of the policy will be decreased by the option
amount. Such decrease will be effective on the monthly payment date following
the date of the written request. Existing insurance will be decreased or
eliminated in the following order:
o first, the most recent increase;
o second, the next most recent increases successively; and
o last, the initial face amount.
A surrender charge applicable to the decrease in the face amount will be waived.
The amount of the charge which is waived will be:
o the surrender charge applicable to any increased face amount which is
eliminated in the order set forth above; plus
o a pro rata share of the surrender charge applicable to a partial reduction
in an increase or in the original face amount.
New specification pages will be issued. These pages will include the following
information:
o the effective date of the decrease;
o the amount of the decrease and the benefit remaining in force;
o the revised surrender charge;
o the revised minimum monthly factor, if any; and
o the new guideline premiums.
The policy value will be reduced in the same proportion as the reduction in the
sum insured. Riders will continue in force.
If the policy definition of "sum insured" provides that the sum insured may
equal "$25,000 plus the cash value," this portion of the definition hereby is
amended to read:
"$25,000 times the option percentage plus the cash value."
First to Die Policy--The following provisions apply if this endorsement is
attached to a First to Die Flexible Premium Adjustable Life Insurance Policy:
The "insured" shall mean the first insured to qualify for benefits under this
endorsement. No additional living benefits will be provided if other insureds
qualify prior to the death of the first insured to die. If the first to die
under the policy is not the insured under this endorsement, the death proceeds
as adjusted by this endorsement will be paid to the beneficiary of the policy,
and payment of the living benefit will continue as provided in this endorsement.
Exclusion--No benefit will be paid under this endorsement if a claim results,
directly or indirectly, from a suicide attempt or a self-inflicted injury (while
sane or insane) for any period during which a suicide exclusion is applicable.
Termination--This endorsement will terminate on the first to occur of:
o the end of the grace period of a premium in default; or
o the termination or maturity of the policy while the insured is alive; or
o at any time on your written request.
General--The schedule of benefits and premiums (page 3 or 3.1 of the policy)
will show the date of issue of this endorsement.
The living benefit will be made available to you on a voluntary basis only.
Accordingly:
(a) If you are required by law to exercise this option to satisfy the claim of
creditors, whether in bankruptcy or otherwise, you are not eligible for
this benefit.
(b) If you are required by a government agency to exercise this option in
order to apply for, obtain, or retain a government benefit or entitlement,
you are not eligible for this benefit.
Except as otherwise provided, all conditions and provisions of the policy apply
to this endorsement.
Signed for the Company by its President and Secretary at Worcester,
Massachusetts.
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
END 239-91 3
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
GUARANTEED DEATH BENEFIT RIDER
This rider is a part of the policy to which it is attached if it is listed in
the specifications page. The rider is issued is consideration of the payment of
the premium. The amount of the premium for this rider is shown in the
specifications page.
While this rider is in effect, the policy will not lapse if the following tests
are met:
1. Within 48 months following the date of issue of the policy and the date of
issue of any increase in the face amount, the sum of the premiums paid
less any debt, partial withdrawals and withdrawal charges must be greater
than the minimum monthly factor (if any) multiplied by the number of
months which have elapsed since the date; and
2. On each policy anniversary, (a) must exceed (b) where, since the date this
policy was issued:
(a) is the sum of your premiums less any partial withdrawals, partial
withdrawal charges and debt which is classified as a preferred loan;
and
(b) is the sum of the minimum guaranteed death benefit premiums. The
minimum guaranteed death benefit premium amount is shown on the
specifications page or on a new specifications page in the event of
a policy change. The minimum guaranteed death benefit premium will
be prorated in any year in which there is a policy change.
If the policy value is less than the surrender charge on a monthly payment date,
the monthly deduction will be made from the policy value. If the policy value is
less than the monthly deduction, the entire policy value will be applied to the
monthly deduction.
If this rider is in effect on the final premium payment date, a death benefit
will be provided while this rider remains in force. The death benefit will be
the face amount as of the final premium payment date or the policy value as of
the date due proof of death is received by the Company, whichever is greater.
Monthly insurance charges will not be deducted after the final premium payment
date if the policy qualifies for the Guaranteed Death Benefit.
The Guaranteed Death Benefit will end and may not be reinstated on the first to
occur of the following:
1. Foreclosure of a policy loan; or
2. The date on which the sum of your payments does not meet or exceed
the applicable Guaranteed Death Benefit test; or
3. Any policy change that results in a negative guideline level
premium; or
4. The effective date of a change from Sum Insured Option 2 to Sum
Insured Option 1 if such change occurs within 5 policy years of the
final premium payment date; or
5. A request for a partial withdrawal or preferred loan is made after
the final premium payment date.
Form 1091-97
<PAGE>
It is possible that the policy value will not be sufficient to keep the policy
in force on the first monthly payment date following the date this rider
terminates. The net amount payble to keep the policy in force will never exceed
the surrender charge plus three monthly deductions.
IN WITNESS WHEREOF, the Company has, by its President and Secretary, execeuted
this rider at Worcester, Massachusetts on the date of issue of this rider.
/s/ Richard M. Reilly /s/ [Illegible]
President Secretary
Form 1091-97
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
===================== Life Insurance Exchange Option Rider =====================
This rider is a part of the policy to which it is attached if it is listed in
the schedule of benefits and premiums. The rider is issued in consideration of
the payment of the premium. The amount of the premium for this rider is shown in
the schedule. The insured under this policy is the insured under this agreement.
The successor insured will be the person named in the application when the
exchange option is exercised.
Exchange Option Benefit--While this rider is in force, the owner may exchange
the existing policy for a new policy of life insurance on the life of the
successor insured subject to the provisions and conditions of this rider.
Definitions--"Existing policy" means the policy to which this rider is attached
insuring the life of the insured.
"New policy" means the policy insuring the life of the successor insured.
Exercise of the Option--The owner must provide the following to the Company
while the rider is in force:
o a written application for an eligible policy of life insurance,
o evidence of insurability showing the successor insured is under age 76
and insurable,
o proof the owner has an insurable interest in the successor insured,
o written consent to the exchange by all assignees and irrevocable
beneficiaries, if any, of this policy,
o payment of any amounts required by this rider, and
o surrender of the existing policy.
If the successor insured is not insurable, the Company will return to the owner
any amounts paid. In such event the existing policy and this rider will remain
in force.
Exchange Date--The exchange date will be the monthly payment date next following
the later of:
(a) the date the Company receives payment of any amount due for the
exchange; and
(b) the date the Company approves the issuance of the new policy.
Insurance provided by the existing policy shall terminate at the end of the day
preceding the exchange date. Insurance on the life of the successor insured will
begin on the exchange date. No death benefit will be paid if the successor
insured dies on or after the date of the application for the new policy and
before the exchange date. Instead, the Company will refund the amount paid on
the new policy, if any.
Required Payment or Adjustment--If the exchange date is within one year of the
date of issue of the existing policy or any increase in the face amount, a
premium adjustment may be made. If the minimum monthly factor for the new policy
exceeds such factor for the existing policy, there will be paid to the Company
an amount equal to the excess.
A premium equal to two month's charges will be due if the surrender value is not
large enough to pay such charges on the exchange date for the successor insured.
After the first anniversary the surrender value of the new policy may not exceed
the surrender value of this policy on the date of exchange.
Any debt under the existing policy will be transferred to the new policy;
however, if the debt is greater than the loan value of the new policy, the
excess must be repaid to the Company before the exchange date.
New Policy Description--The date of issue of the new policy will be the later of
the date of issue of the existing policy and the policy anniversary following
the successor insured's date of birth. The time periods in the suicide and
incontestability provisions will be measured from the exchange date.
Form 1069-87 (Over)
<PAGE>
The new policy will be a flexible premium adjustable life insurance policy. The
mortality charges will be based on the rates in use on the date of issue of the
new policy for the successor insured's class of risk on the exchange date.
The face amount of the new policy may not be less than the Company's published
minimum issue limits nor greater than the face amount of the existing policy.
The Company, at its discretion, may decline to include in the new policy any
riders. Charges for riders included in the new policy will be at the rates in
use on the exchange date for the successor insured's class of risk.
Termination--This rider will terminate on the first to occur of:
o the expiration of the grace period of any premium in default under the
existing policy, or
o termination or maturity of this policy during the lifetime of the
insured, or
o upon written request by the owner, or
o the date preceding the policy anniversary nearest the insured's 70th
birthday, or
o exercise of this exchange option.
General--Except as otherwise provided herein, all of the provisions and
conditions of the existing policy apply to this rider.
IN WITNESS WHEREOF, the Company has, by its President and Secretary, executed
this rider at Worcester, Massachusetts on the date of issue of this rider.
/s/ [Illegible] /s/ Richard M. Reilly
Secretary President
Form 1069-87
<PAGE>
PARTICIPATION AGREEMENT
AMONG
ALLMERICA INVESTMENT TRUST
ALLMERICA INVESTMENT MANAGEMENT COMPANY, INC.
AND
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
DATED AS OF
FEBRUARY 25, 1998
<PAGE>
TABLE OF CONTENTS
PAGE
ARTICLE I Purchase of Fund Shares 4
ARTICLE II Representations and Warranties 5
ARTICLE III Prospectuses, Reports to Shareholders
and Proxy Statements, Voting 6
ARTICLE IV Sales Material and Information 8
ARTICLE V Fees and Expenses 9
ARTICLE VI Diversification 9
ARTICLE VII Potential Conflicts 10
ARTICLE VIII Indemnification 11
ARTICLE IX Applicable Law 15
ARTICLE X Termination 15
ARTICLE XI Notices 17
ARTICLE XII Miscellaneous 17
SCHEDULE A Separate Accounts and Variable Products A-1
SCHEDULE B Portfolios of Allmerica Investment Trust B-1
SCHEDULE C Proxy Voting Procedures C-1
2
<PAGE>
THIS AGREEMENT, made and entered into as of the 25th day of February, 1998 by
and among: ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
(hereinafter the "Company"), a Delaware corporation, on its own behalf and on
behalf of each separate account of the Company set forth on Schedule A
hereto, as may be amended from time to time (each such account hereinafter
referred to as the "Account"); ALLMERICA INVESTMENT TRUST, an unincorporated
Massachusetts business trust (hereinafter the "Fund"), and ALLMERICA
INVESTMENT MANAGEMENT COMPANY, INC. (hereinafter the "Adviser"), a
Massachusetts corporation
WHEREAS, the Fund engages in business as an open-end management
investment company and is available to act as (i) the investment vehicle for
separate accounts established by insurance companies for individual and group
life insurance policies and annuity contracts with variable accumulation
and/or pay-out provisions (hereinafter referred to individually and/or
collectively as "Variable Products") and (ii) the investment vehicle for
certain qualified pension and retirement plans (hereinafter "Qualified
Plans"); and
WHEREAS, insurance companies desiring to utilize the Fund as an
investment vehicle under their Variable Products enter into participation
agreements with the Fund and the Adviser (the "Participating Insurance
Companies");
WHEREAS, shares of the Fund are divided into several series of shares,
each representing the interest in a particular managed portfolio of
securities and other assets (each such series hereinafter referred to as a
"Portfolio"), any one or more of which may be made available under this
Agreement, as may be amended from time to time by mutual agreement of the
parties hereto; and
WHEREAS, the Fund has applied for an order from the Securities and
Exchange Commission, granting Participating Insurance Companies and Variable
Insurance Product separate accounts exemptions from the provisions of
Sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940,
as amended (hereinafter the "1940 Act"), and Rules 6e-2(b)(15) and
6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the
Fund to be sold to and held by separate accounts of both affiliated and
unaffiliated life insurance companies and Qualified Plans (hereinafter the
"Shared Funding Exemptive Order"); and
WHEREAS, the Fund is registered as an open-end management investment
company under the 1940 Act and its shares are registered under the Securities
Act of 1933, as amended (hereinafter the "1933 Act"); and
WHEREAS, the Adviser is duly registered as an investment adviser under
the Investment Advisers Act of 1940, as amended, and any applicable state
securities laws and manages each of the certain portfolios of the Fund and
retains Sub-Advisers for the daily investment and reinvestment of the assets
of each portfolio; and
WHEREAS, Allmerica Investments, Inc. (the "Distributor") is registered
as a broker/dealer under the Securities Exchange Act of 1934, as amended
(hereinafter the "1934 Act"), is a member in good standing of the National
Association of Securities Dealers, Inc. (hereinafter "NASD"); and
WHEREAS, the Company has registered or will register certain Variable
Products under the 1933 Act; and
3
<PAGE>
WHEREAS, each Account is a duly organized, validly existing segregated
asset account, established by resolution or under authority of the Board of
Directors of the Company, to set aside and invest assets attributable to the
aforesaid Variable Products, and the Company has registered or will register
each Account as a unit investment trust under the 1940 Act; and
WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase, on behalf of each Account,
shares in the Portfolios set forth in Schedule B attached to this Agreement,
to fund certain of the aforesaid Variable Insurance Products and the Fund is
authorized to sell such shares to each such Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the parties
hereto agree as follows:
ARTICLE I. PURCHASE OF FUND SHARES
1.1. The Fund agrees to make available for purchase by the Company
shares of the Fund and shall execute orders placed for each Account on a
daily basis at the net asset value next computed after receipt by the Fund or
its designee of such order. For purposes of this Section 1.1, the Company
shall be the designee of the Fund for receipt of such orders from each
Account and receipt by such designee of an order prior to the close of
regular trading on the New York Stock Exchange ("NYSE") shall constitute
receipt by the Fund; provided that the Fund receives notice of such order by
10:00 a.m. Eastern time on the next following Business Day. "Business Day"
shall mean any day on which the New York Stock Exchange is open for trading
and on which the Fund calculates its net asset value pursuant to the rules of
the Securities and Exchange Commission.
1.2. The Fund, so long as this Agreement is in effect, agrees to make
its shares available indefinitely for purchase at the applicable net asset
value per share by the Company and its Accounts on those days on which the
Fund calculates its net asset value pursuant to rules of the Securities and
Exchange Commission and the Fund shall use reasonable efforts to calculate
such net asset value on each day which the New York Stock Exchange is open
for trading. Notwithstanding the foregoing, the Board of Trustees of the
Fund (hereinafter the "Board") may refuse to permit the Fund to sell shares
of any Portfolio to any person, or suspend or terminate the offering of
shares of any Portfolio if such action is required by law or by regulatory
authorities having jurisdiction or is, in the sole discretion of the Board
acting in good faith and in light of their fiduciary duties under federal and
any applicable state laws, necessary in the best interests of the
shareholders of such Portfolio.
1.3. The Fund agrees that shares of the Fund will be sold only to
Participating Insurance Companies and their separate accounts and to certain
Qualified Plans. No shares of any Portfolio will be sold to the general
public.
1.4. The Fund agrees to redeem for cash, on the Company's request, any
full or fractional shares of the Fund held by the Company, executing such
requests on a daily basis at the net asset value next computed after receipt
by the Fund or its designee of the request for redemption. For purposes of
this Section 1.4, the Company shall be the designee of the Fund for receipt
of requests for redemption from each Account and receipt by such designee of
a request prior to the close of regular trading on the NYSE shall constitute
receipt by the Fund, provided that the Fund receives notice of such request
for redemption on the next following Business Day.
4
<PAGE>
1.5. The Company agrees that purchases and redemptions of Portfolio
shares offered by the then current prospectus of the Fund shall be made in
accordance with the provisions of such prospectus.
1.6. The Company shall pay for Fund shares no later than the next
Business Day after an order to purchase Fund shares is made in accordance
with the provisions of Section 1.1 hereof. Payment shall be in federal funds
transmitted by wire.
1.7. Issuance and transfer of the Fund's shares will be by book entry
only. Stock certificates will not be issued to the Company or any Account.
Shares ordered from the Fund will be recorded in an appropriate title for
each Account or the appropriate subaccount of each Account.
1.9. The Fund shall furnish same day notice (by wire or telephone,
followed by written confirmation) to the Company of any income, dividends or
capital gain distributions payable on the Fund's shares. The Company hereby
elects to receive all such income dividends and capital gain distributions as
are payable on the Portfolio shares in additional shares of that Portfolio.
The Company reserves the right to revoke this election and to receive all
such income dividends and capital gain distributions in cash. The Fund shall
notify the Company of the number of shares so issued as payment of such
dividends and distributions.
1.10. The Fund shall make the net asset value per share for each
Portfolio available to the Company on a daily basis as soon as reasonably
practical after the net asset value per share is calculated (normally by 6:30
p.m. Eastern time) and shall use its best efforts to make such net asset
value per share available by 7:00 p.m. Eastern time.
ARTICLE II. REPRESENTATIONS AND WARRANTIES
2.1. The Company represents and warrants that the Variable Products are
or will be registered under the 1933 Act; that the Variable Products will be
issued and sold in compliance in all material respects with all applicable
federal and state laws, and that the sale of the Variable Products shall
comply in all material respects with state insurance suitability
requirements. The Company further represents and warrants that it is an
insurance company duly organized and in good standing under applicable law,
that it has legally and validly established each Account as a segregated
asset account under Section 2932 of the Delaware Insurance Code, and that it
has registered or, prior to any issuance or sale of the Variable Products,
will register each Account as a unit investment trust in accordance with the
provisions of the 1940 Act to serve as a segregated investment account for
the Variable Products.
2.2. The Fund represents and warrants that Fund shares sold pursuant to
this Agreement shall be registered under the 1933 Act, duly authorized for
issuance and sold in compliance with the laws of the Commonwealth of
Massachusetts and all applicable federal and state securities laws, and that
the Fund is and shall make every effort to remain registered under the 1940
Act. The Fund shall amend the registration statement for its shares under the
1933 Act and the 1940 Act from time to time as required in order to effect
the continuous offering of its shares. The Fund shall register and qualify
the shares for sale in accordance with the laws of the various states only if
and to the extent deemed advisable by the Fund.
2.3. The Fund represents that it is currently qualified as a Regulated
Investment Company under Subchapter M of the Internal Revenue Code of 1986,
as amended (the "Code"), and that it will make every effort to maintain such
qualification (under Subchapter M or any successor or similar provision)
5
<PAGE>
and that it will notify the Company promptly upon having a reasonable basis
for believing that it has ceased to so qualify or that it might not so
qualify in the future.
2.4. The Company represents that the Variable Products are currently
treated as life insurance policies or annuity contracts under applicable
provisions of the Code, that it will make every effort to maintain such
treatment, and that it will notify the Fund immediately upon having a
reasonable basis for believing that the Variable Products have ceased to be
so treated or that they might not be so treated in the future.
2.5. The Fund represents that to the extent that it decides to finance
distribution expenses pursuant to Rule 12b-1 under the 1940 Act, the Fund
undertakes to have its board of Trustees, a majority of whom are not
interested persons of the Fund, formulate and approve any plan under Rule
12b-1 to finance distribution expenses.
2.6. The Fund makes no representation as to whether any aspect of its
operations (including, but not limited to, fees and expenses and investment
policies) complies with the insurance laws or regulations of the various
states.
2.7. The Fund represents that it is lawfully organized and validly
existing under the laws of the Commonwealth of Massachusetts and that it does
and will comply in all material respects with the 1940 Act.
2.8. The Adviser represents and warrants that it is and shall remain
duly registered in all material respects under all applicable federal and
state securities laws and that it will perform its obligations for the Fund
in compliance in all material respects with the laws of its state of domicile
and any applicable state and federal securities laws.
2.9. The Fund represents and warrants that its Trustees, officers,
employees, and other individuals/entities dealing with the money and/or
securities of the Fund are and shall continue to be at all times covered by a
blanket fidelity bond or similar coverage for the benefit of the Fund in an
amount not less than the minimal coverage as required currently by Rule
17g-(1) of the 1940 Act or related provisions as may be promulgated from time
to time. The aforesaid blanket fidelity bond shall include coverage for
larceny and embezzlement and shall be issued by a reputable bonding company.
2.10. The Company represents and warrants that all of its directors,
officers, employees, investment advisers, and other individuals/entities
dealing with the money and/or securities of the Fund are covered by a blanket
fidelity bond or similar coverage, in an amount not less $5 million. The
aforesaid, which includes coverage for larceny and embezzlement, shall be
issued by a reputable bonding company. The Company agrees to make all
reasonable efforts to see that this bond or another bond containing these
provisions is always in effect, and agrees to notify the Fund and the
Distributor promptly in writing in the event that such coverage no longer
applies.
ARTICLE III. PROSPECTUSES, REPORTS TO SHAREHOLDERS AND PROXY STATEMENTS;
VOTING
3.1. The Fund or its designee shall provide the Company with as many
printed copies of the Fund's current prospectus and statement of additional
information as the Company may reasonably request. If requested by the
Company, in lieu of providing printed copies, the Fund shall provide
camera-ready film or computer diskettes containing the Fund's prospectus and
statement of additional
6
<PAGE>
information, and such other assistance as is reasonably necessary in order
for the Company once each year (or more frequently if the prospectus and/or
statement of additional information for the Fund is amended during the year)
to have the prospectus for the Variable Products and the Fund's prospectus
printed together in one document, and to have the statement of additional
information for the Fund and the statement of additional information for the
Variable Products printed together in one document. Alternatively, the
Company may print the Fund's prospectus and/or its statement of additional
information in combination with other fund companies' prospectuses and
statements of additional information.
3.2. Except as provided in this Section 3.2., all expenses of printing
and distributing Fund prospectuses and statements of additional information
shall be the expense of the Company. For any prospectuses and statements of
additional information provided by the Company to the existing owners of
Variable Products who currently own shares of one or more of the Fund's
Portfolios, in order to update disclosure as required by the 1933 Act and/or
the 1940 Act, the cost of printing shall be borne by the Fund. If the
Company chooses to receive camera-ready film or computer diskettes in lieu of
receiving printed copies of the Fund's prospectus, the Fund will reimburse
the Company in an amount equal to the product of x and y where x is the
number of such prospectuses distributed to owners of the Variable Products
who currently own shares of one or more of the Fund's Portfolios, and y is
the Fund's per unit cost of typesetting and printing the Fund's prospectus.
The same procedures shall be followed with respect to the Fund's statement of
additional information. The Company agrees to provide the Fund or its
designee with such information as may be reasonably requested by the Fund to
assure that the Fund's expenses do not include the cost of printing any
prospectuses or statements of additional information other than those
actually distributed to existing owners of the Variable Products.
3.3. The Fund's statement of additional information shall be obtainable
from the Fund, the Company or such other person as the Fund may designate, as
agreed upon by the parties.
3.4. The Fund, at its expense, shall provide the Company with copies of
its proxy statements, reports to shareholders, and other communications
(except for prospectuses and statements of additional information, which are
covered in section 3.1) to shareholders in such quantity as the Company shall
reasonably require for distribution to contract owners. The Fund or its
designee shall bear the cost of printing, duplicating, and mailing of these
documents to current contract owners, and the Company shall bear the cost for
such documents used for purposes other than distribution to current contract
owners.
3.5. If and to the extent required by law the Company shall:
(i) solicit voting instructions from contract owners;
(ii) vote the Fund shares in accordance with instructions received
from contract owners; and
(iii) vote Fund shares for which no instructions have been received
in the same proportion as Fund shares of such Portfolio for
which instructions have been received,
so long as and to the extent that the Securities and Exchange Commission
continues to interpret the 1940 Act to require pass-through voting privileges
for variable contract owners. The Company reserves the right to vote Fund
shares held in any segregated asset account in its own right, to the extent
permitted by law. The Fund and the Company shall follow the procedures, and
shall have the corresponding
7
<PAGE>
responsibilities, for the handling of proxy and voting instruction
solicitations, as set forth in Schedule C attached hereto and incorporated
herein by reference. Participating Insurance Companies shall be responsible
for ensuring that each of their separate accounts participating in the Fund
calculates voting privileges in a manner consistent with the standards set
forth on Schedule C, which standards will also be provided to the other
Participating Insurance Companies, if any.
3.6. The Fund will comply with all provisions of the 1940 Act requiring
voting by shareholders, including Sections 16(a) and, if and when applicable,
16(b). Further, the Fund will act in accordance with the Securities and
Exchange Commission's interpretation of the requirements of Section 16(a)
with respect to periodic elections of trustees and with whatever rules the
Commission may promulgate with respect thereto.
3.7. The Fund shall use reasonable efforts to provide Fund prospectuses,
reports to shareholders, proxy materials and other Fund communications (or
camera-ready equivalents) to the Company sufficiently in advance of the
Company's mailing dates to enable the Company to complete, at reasonable
cost, the printing, assembling and/or distribution of the communications in
accordance with applicable laws and regulations.
ARTICLE IV. SALES MATERIAL AND INFORMATION
4.1. The Company shall furnish, or shall cause to be furnished, to the
Fund or its designee, each piece of sales literature or other promotional
material in which the Fund or the Adviser(s) is named, at least fifteen
Business Days prior to its use. No such material shall be used if the Fund
or its designee reasonably objects to such use within fifteen Business Days
after receipt of such material.
4.2. The Company shall not give any information or make any
representations or statements on behalf of the Fund or concerning the Fund in
connection with the sale of the Variable Products other than the information
or representations contained in the registration statement or prospectus for
the Fund shares, as such registration statement and prospectus may be amended
or supplemented from time to time, or in reports or proxy statements for the
Fund, or in sales literature or other promotional material approved by the
Fund or its designee, except with the permission of the Fund.
4.3. The Fund or its designee shall furnish, or shall cause to be
furnished, to the Company or its designee, each piece of sales literature or
other promotional material in which the Company and/or its separate
account(s) is named at least fifteen Business Days prior to its use. No such
material shall be used if the Company or its designee reasonably objects to
such use within fifteen Business Days after receipt of such material.
4.4. The Fund and the Adviser shall not give any information or make
any representations on behalf of the Company or concerning the Company, each
Account, or the Variable Products, other than the information or
representations contained in a registration statement or prospectus for the
Variable Products, as such registration statement and prospectus may be
amended or supplemented from time to time, or in published reports for each
Account which are in the public domain or approved by the Company for
distribution to contract owners, or in sales literature or other promotional
material approved by the Company or its designee, except with the permission
of the Company.
4.5. The Fund will provide to the Company at least one complete copy of
all registration statements, prospectuses, statements of additional
information, reports, proxy statements, sales literature
8
<PAGE>
and other promotional materials, applications for exemptions, requests for
no-action letters, and all amendments to any of the above, that relate to the
Fund or its shares, which are relevant to the Company or the Variable
Products.
4.6. The Company will provide to the Fund at least one complete copy of
all registration statements, prospectuses, statements of additional
information, reports, solicitations for voting instructions, sales literature
and other promotional materials, applications for exemptions, requests for no
action letters, and all amendments to any of the above, that relate to the
investment in the Fund under the Variable Products.
4.7. For purposes of this Article IV, the phrase "sales literature or
other promotional material" includes, but is not limited to, any of the
following that refer to the Fund or any affiliate of the Fund: advertisements
(such as material published, or designed for use in, a newspaper, magazine,
or other periodical, radio, television, telephone or tape recording,
videotape display, signs or billboards, motion pictures, or other public
media), sales literature (I.E., any written communication distributed or made
generally available to customers or the public, including brochures,
circulars, research reports, market letters, form letters, seminar texts,
reprints or excerpts of any other advertisement, sales literature, or
published article), educational or training materials or other communications
distributed or made generally available to some or all agents or employees,
and registration statements, prospectuses, statements of additional
information, shareholder reports, and proxy materials.
ARTICLE V. FEES AND EXPENSES
5.1. The Fund shall pay no fee or other compensation to the Company
under this Agreement, except that if the Fund or any Portfolio adopts and
implements a plan pursuant to Rule 12b-1 to finance distribution expenses,
then the Distributor may make payments to the Company or to the distributor
for the Variable Products if and in amounts agreed to by the Distributor in
writing.
5.2. All expenses incident to performance by the Fund under this
Agreement shall be paid by the Fund, other than expenses assumed by the
Adviser under the Management Agreement between the Fund and the Adviser or by
another party. The Fund shall see to it that all its shares are registered
and authorized for issuance in accordance with applicable federal law and, if
and to the extent deemed advisable by the Fund, in accordance with applicable
state laws prior to their sale. The Fund shall bear the expenses for the
cost of registration and qualification of the Fund's shares, preparation and
filing of the Fund's prospectus and registration statement, proxy materials
and reports, setting the prospectus in type, setting in type and printing the
proxy materials and reports to shareholders (including the costs of printing
a prospectus that constitutes an annual report), the preparation of all
statements and notices required by any federal or state law, and all taxes on
the issuance or transfer of the Fund's shares.
ARTICLE VI. DIVERSIFICATION
6.1. The Fund will at all times invest money from the Variable Products
in such a manner as to ensure that the Variable Products will be treated as
variable contracts under the Code and the regulations issued thereunder.
Without limiting the scope of the foregoing, the Fund will at all times
comply with Section 817(h) of the Code and Treasury Regulation 1.817-5,
relating to the diversification requirements for variable annuity, endowment,
or life insurance contracts and any amendments or other modifications to such
Section or Regulations. In the event of a breach of this Article VI by the
Fund, it will take all reasonable steps (a) to notify Company of such breach
and (b) to adequately diversify the Fund so as to achieve compliance within
the grace period afforded by Regulation 1.817-5.
9
<PAGE>
ARTICLE VII. POTENTIAL CONFLICTS
7.1. The Board will monitor the Fund for the existence of any material
irreconcilable conflict between the interests of the contract owners of all
separate accounts investing in the Fund. An irreconcilable material conflict
may arise for a variety of reasons, including: (a) an action by any state
insurance regulatory authority; (b) a change in applicable federal or state
insurance, tax, or securities laws or regulations, or a public ruling,
private letter ruling, no-action or interpretative letter, or any similar
action by insurance, tax, or securities regulatory authorities; (c) an
administrative or judicial decision in any relevant proceeding; (d) the
manner in which the investments of any Portfolio are being managed; (e) a
difference in voting instructions given by Variable Insurance Product owners;
or (f) a decision by a Participating Insurance Company to disregard the
voting instructions of contract owners. The Board shall promptly inform the
Company if it determines that an irreconcilable material conflict exists and
the implications thereof.
7.2. Each of the Company and the Adviser will report any potential or
existing conflicts of which it is aware to the Board. Each of the Company
and the Adviser will assist the Board in carrying out its responsibilities
under SEC rules and regulations. The Adviser, and the participating
insurance companies and participating qualified plans will at least annually
submit to the Board such reports, materials, or data as the Board may
reasonably request so that the Board may fully carry out the obligations
imposed upon by the conditions contained in the Shared Funding Exemptive
Order, and said reports, materials, and data will be submitted more
frequently if deemed appropriate by the Board.
7.3. If it is determined by a majority of the Board, or a majority of
its members who are not "interested persons" of the Fund, the Adviser or the
Company as that term is defined in the 1940 Act (hereinafter "disinterested
members"), that a material irreconcilable conflict exists, the Company and
other Participating Insurance Companies shall, at their expense and to the
extent reasonably practicable (as determined by a majority of the
disinterested directors), take whatever steps are necessary to remedy or
eliminate the irreconcilable material conflict, up to and including: (1)
withdrawing the assets allocable to some or all of the separate accounts from
the Fund or any Portfolio and reinvesting such assets in a different
investment medium, including (but not limited to) another Portfolio of the
Fund, or submitting the question whether such segregation should be
implemented to a vote of all affected contract owners and, as appropriate,
segregating the assets of any appropriate group (I.E., annuity contract
owners, life insurance policy owners, or variable contract owners of one or
more Participating Insurance Companies) that votes in favor of such
segregation, or offering to the affected contract owners the option of making
such a change; and (2) establishing a new registered management investment
company or managed separate account.
7.4. If a material irreconcilable conflict arises because of a decision
by the Company to disregard contract owner voting instructions and that
decision represents a minority position or would preclude a majority vote,
the Company may be required, at the Fund's election, to withdraw the affected
Account's investment in the Fund and terminate this Agreement with respect to
such Account (at the Company's expense); provided, however that such
withdrawal and termination shall be limited to the extent required by the
foregoing material irreconcilable conflict as determined by a majority of the
disinterested members of the Board.
7.5. If a material irreconcilable conflict arises because a particular
state insurance regulator's decision applicable to the Company conflicts with
the majority of other state regulators, then the
10
<PAGE>
Company will withdraw the affected Account's investment in the Fund and
terminate this Agreement with respect to such Account within six months after
the Board informs the Company in writing that it has determined that such
decision has created an irreconcilable material conflict; provided, however,
that such withdrawal and termination shall be limited to the extent required
by the foregoing material irreconcilable conflict as determined by a majority
of the disinterested members of the Board. Until the end of the foregoing
six month period, the Distributor and Fund shall continue to accept and
implement orders by the Company for the purchase (and redemption) of shares
of the Fund.
7.6. For purposes of Sections 7.3 through 7.5 of this Agreement, a
majority of the disinterested members of the Board shall determine whether
any proposed action adequately remedies any irreconcilable material conflict,
but in no event will the Fund be required to establish a new funding medium
for the Variable Products. The Company shall not be required by Section 7.3
to establish a new funding medium for the Variable Products if an offer to do
so has been declined by vote of a majority of contract owners materially
adversely affected by the irreconcilable material conflict.
7.7. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended,
or Rule 6e-3 is adopted, to provide exemptive relief from any provision of
the 1940 Act or the rules promulgated thereunder with respect to mixed or
shared funding, or if the Fund obtains a Shared Exemptive Order which
requires provisions that are materially different from the provisions of this
Agreement, then (a) the Fund and/or the Participating Insurance Companies, as
appropriate, shall take such steps as may be necessary to comply with Rules
6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, or to the terms of
the Shared Exemptive Order, to the extent applicable; and (b) Sections 3.4,
3.5, 7.1, 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect
only to the extent that terms and conditions substantially identical to such
Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. INDEMNIFICATION
8.1. INDEMNIFICATION BY THE COMPANY
8.1(a) The Company agrees to indemnify and hold harmless the Fund and
the Adviser, each of their respective officers, employees, and Trustees or
Directors, and each person, if any, who controls the Fund or the Adviser
within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" and individually, "Indemnified Party," for purposes of
this Section 8.1) against any and all losses, claims, damages, liabilities
(including amounts paid in settlement with the written consent of the
Company) or litigation (including legal and other expenses), to which the
Indemnified Parties may become subject under any statute, regulation, at
common law or otherwise, insofar as such losses, claims, damages, liabilities
or expenses (or actions in respect thereof) or settlements are related to the
sale or acquisition of the Fund's shares or the Variable Products and:
(i) arise out of or are based upon any untrue statements or
alleged untrue statements of any material fact contained in
the registration statement or prospectus for the Variable
Products or contained in the Variable Products or sales
literature for the Variable Products (or any amendment or
supplement to any of the foregoing), or arise out of or are
based upon the omission or the alleged omission to state
therein a material fact required to be stated therein or
necessary to make the statements therein not misleading,
provided that this agreement to indemnify shall not apply as
to any Indemnified Party if such statement or omission or such
alleged statement or omission was made in reliance upon and in
conformity with information furnished to the Company by or on
behalf of the Fund for use in the registration statement or
prospectus for the Variable Products or in the Variable
Products or sales literature (or any amendment or
11
<PAGE>
supplement) or otherwise for use in connection with the sale of the
Variable Products or Fund shares; or
(ii) arise out of or as a result of statements or
representations (other than statements or representations
contained in the registration statement, prospectus or sales
literature of the Fund not supplied by the Company, or persons
under its control and other than statements or representations
authorized by the Fund or an Adviser) or unlawful conduct of
the Company or persons under its control, with respect to the
sale or distribution of the Variable Products or Fund shares;
or
(iii) arise out of or as a result of any untrue statement or
alleged untrue statement of a material fact contained in a
registration statement, prospectus, or sales literature of the
Fund or any amendment thereof or supplement thereto or the
omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the
statements therein not misleading, if such a statement or
omission was made in reliance upon and in conformity with
information furnished to the Fund by or on behalf of the
Company; or
(iv) arise as a result of any failure by the Company to
provide the services and furnish the materials under the terms
of this Agreement; or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Company in this
Agreement or arise out of or result from any other material
breach of this Agreement by the Company, as limited by and in
accordance with the provisions of Sections 8.1(b) and 8.1(c)
hereof.
8.1(b). The Company shall not be liable under this indemnification
provision with respect to any losses, claims, damages, liabilities or
litigation incurred or assessed against an Indemnified Party as such may
arise from such Indemnified Party's willful misfeasance, bad faith, or gross
negligence in the performance of such Indemnified Party's duties or by reason
of such Indemnified Party's reckless disregard of obligations or duties under
this Agreement.
8.1(c). The Company shall not be liable under this indemnification
provision with respect to any claim made against an Indemnified Party unless
such Indemnified Party shall have notified the Company in writing within a
reasonable time after the summons or other first legal process giving
information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice
of such service on any designated agent), but failure to notify the Company
of any such claim shall not relieve the Company from any liability which it
may have to the Indemnified Party against whom such action is brought
otherwise than on account of this indemnification provision. In case any
such action is brought against the Indemnified Parties, the Company shall be
entitled to participate, at its own expense, in the defense of such action.
The Company also shall be entitled to assume the defense thereof, with
counsel satisfactory to the party named in the action. After notice from the
Company to such party of the Company's election to assume the defense
thereof, the Indemnified Party shall bear the fees and expenses of any
additional counsel retained by it, and the Company will not be liable to such
party under this Agreement for any legal or other expenses subsequently
incurred by such party independently in connection with the defense thereof
other than reasonable costs of investigation.
12
<PAGE>
8.1(d). The Indemnified Parties will promptly notify the Company of the
commencement of any litigation or proceedings against them in connection with
the issuance or sale of the Fund shares or the Variable Products or the
operation of the Fund.
8.2. INDEMNIFICATION BY THE ADVISER
8.2(a). The Adviser agrees, with respect to each Portfolio that it
manages, to indemnify and hold harmless the Company, each of its directors,
officers, and employees, and each person, if any, who controls the Company
within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" and individually, "Indemnified Party," for purposes of
this Section 8.2) against any and all losses, claims, damages, liabilities
(including amounts paid in settlement with the written consent of the
Adviser) or litigation (including legal and other expenses) to which the
Indemnified Parties may become subject under any statute, regulation, at
common law or otherwise, insofar as such losses, claims, damages, liabilities
or expenses (or actions in respect thereof) or settlements are related to the
sale or acquisition of shares of the Portfolio that it manages or the
Variable Products and:
(i) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in the registration
statement or prospectus or sales literature of the Fund (or any
amendment or supplement to any of the foregoing), or arise out of
or are based upon the omission or the alleged omission to state
therein a material fact required to be stated therein or necessary
to make the statements therein not misleading, provided that this
agreement to indemnify shall not apply as to any Indemnified Party
if such statement or omission or such alleged statement or omission
was made in reliance upon and in conformity with information
furnished to the Fund by or on behalf of the Company for use in the
registration statement or prospectus for the Fund or in sales
literature (or any amendment or supplement) or otherwise for use in
connection with the sale of the Variable Products or Portfolio
shares; or
(ii) arise out of or as a result of statements or representations
(other than statements or representations contained in the
registration statement, prospectus or sales literature for the
Variable Products not supplied by the Fund or persons under its
control and other than statements or representations authorized by
the Company) or unlawful conduct of the Fund, Adviser(s) or
Distributor or persons under their control, with respect to the
sale or distribution of the Variable Products or Portfolio shares;
or
(iii) arise out of or as a result of any untrue statement or
alleged untrue statement of a material fact contained in a
registration statement, prospectus, or sales literature covering
the Variable Products, or any amendment thereof or supplement
thereto, or the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make
the statement or statements therein not misleading, if such
statement or omission was made in reliance upon information
furnished to the Company by or on behalf of the Fund; or
(iv) arise as a result of any failure by the Fund to provide the
services and furnish the materials under the terms of this
Agreement; or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Adviser in this
Agreement or arise out of or result from any other material breach
of this Agreement by the Adviser; as limited by and in accordance
with the provisions of Sections 8.2(b) and 8.2(c) hereof.
13
<PAGE>
8.2(b). The Adviser shall not be liable under this
indemnification provision with respect to any losses, claims,
damages, liabilities or litigation incurred or assessed against an
Indemnified Party as such may arise from such Indemnified Party's
willful misfeasance, bad faith, or gross negligence in the
performance of such Indemnified Party's duties or by reason of such
Indemnified Party's reckless disregard of obligations and duties
under this Agreement.
8.2(c). The Adviser shall not be liable under this
indemnification provision with respect to any claim made against an
Indemnified Party unless such Indemnified Party shall have notified
the Adviser in writing within a reasonable time after the summons
or other first legal process giving information of the nature of
the claim shall have been served upon such Indemnified Party (or
after such Indemnified Party shall have received notice of such
service on any designated agent), but failure to notify the Adviser
of any such claim shall not relieve the Adviser from any liability
which it may have to the Indemnified Party against whom such action
is brought otherwise than on account of this indemnification
provision. In case any such action is brought against the
Indemnified Parties, the Adviser will be entitled to participate,
at its own expense, in the defense thereof. The Adviser also shall
be entitled to assume the defense thereof, with counsel
satisfactory to the party named in the action. After notice from
the Adviser to such party of the Adviser's election to assume the
defense thereof, the Indemnified Party shall bear the fees and
expenses of any additional counsel retained by it, and the Adviser
will not be liable to such party under this Agreement for any legal
or other expenses subsequently incurred by such party independently
in connection with the defense thereof other than reasonable costs
of investigation.
8.2(d). The Company agrees promptly to notify the Adviser of
the commencement of any litigation or proceedings against it or any
of its officers or directors in connection with the issuance or
sale of the Variable Products or the operation of each Account.
8.3. INDEMNIFICATION BY THE FUND
8.3(a). The Fund agrees to indemnify and hold harmless the
Company, and each of its directors and officers and each person, if
any, who controls the Company within the meaning of Section 15 of
the 1933 Act (hereinafter collectively, the "Indemnified Parties"
and individually, "Indemnified Party," for purposes of this Section
8.3) against any and all losses, claims, damages, liabilities
(including amounts paid in settlement with the written consent of
the Fund) or litigation (including legal and other expenses) to
which the Indemnified Parties may become subject under any statute,
regulation, at common law or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions in respect
thereof), litigation or settlements result from the gross
negligence, bad faith or willful misconduct of the Board or any
member thereof, are related to the operations of the Fund and:
(i) arise as a result of any failure by the Fund to provide the services
and furnish the materials under the terms of this Agreement; or
(ii) arise out of or result from any material breach of any
representation and/or warranty made by the Fund in this Agreement
or arise out of or result from any other material breach of this
Agreement by the Fund, as limited and in accordance with the
provisions of Sections 8.3(b) and 8.3(a);
8.3(b). The Fund shall not be liable under this
indemnification provision with respect to any losses, claims,
damages, liabilities or litigation incurred or assessed against an
Indemnified Party as may arise from such Indemnified Party's gross
negligence, bad faith, or willful misconduct the performance of
14
<PAGE>
such Indemnified Party's duties or by reason of such Indemnified Party's
reckless disregard of obligations and duties under this Agreement.
8.3(c). The Fund shall not be liable under this
indemnification provision with respect to any claim made against an
Indemnified Party unless such Indemnified Party shall have notified
the Fund in writing within a reasonable time after the summons or
other first legal process giving information of the nature of the
claim shall have been served upon such Indemnified Party (or after
such Indemnified Party shall have received notice of such service
on any designated agent), but failure to notify the Fund of any
such claim shall not relieve the Fund from any liability which it
may have to the Indemnified Party against whom such action is
brought otherwise than on account of this indemnification
provision. In case any such action is brought against the
Indemnified Parties, the Fund will be entitled to participate, at
its own expense, in the defense thereof. The Fund also shall be
entitled to assume the defense thereof, with counsel satisfactory
to the party named in the action. After notice from the Fund to
such party of the Fund's election to assume the defense thereof,
the Indemnified Party shall bear the fees and expenses of any
additional counsel retained by it, and the Fund will not be liable
to such party under this Agreement for any legal or other expenses
subsequently incurred by such party independently in connection
with the defense thereof other than reasonable costs of
investigation.
8.3(d). The Company agrees promptly to notify the Fund of the
commencement of any litigation or proceedings against it or any of
its respective officers or directors in connection with this
Agreement, the issuance or sale of the Variable Products, with
respect to the operation of either Account, or the sale or
acquisition of shares of the Fund.
ARTICLE IX. APPLICABLE LAW
9.1. This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of the Commonwealth of
Massachusetts.
9.2. This Agreement shall be subject to the provisions of the 1933,
1934 and 1940 Acts, and the rules and regulations and rulings thereunder,
including such exemptions from those statutes, rules and regulations as the
Securities and Exchange Commission may grant (including, but not limited to,
the Shared Funding Exemptive Order) and the terms hereof shall be interpreted
and construed in accordance therewith.
ARTICLE X. TERMINATION
10.1. This Agreement shall continue in full force and effect until the
first to occur of:
10.1(a) termination by any party for any reason by at least sixty (60)
days advance written notice delivered to the other parties; or
10.1(b) termination by the Company by written notice to the Fund and
the Adviser with respect to any Portfolio based upon the Company's
determination that shares of such Portfolio are not reasonably available to
meet the requirements of the Variable Products; or
10.1(c) termination by the Company by written notice to the Fund and
the Adviser with respect to any Portfolio in the event any of the Portfolio's
shares are not registered, issued or sold in accordance with applicable state
and/or federal law or such law precludes the use of such shares as the
underlying investment media of the Variable Products issued or to be issued
by the Company; or
15
<PAGE>
10.1(d) termination by the Company by written notice to the Fund and the
Adviser with respect to any Portfolio in the event that such Portfolio ceases to
qualify as a Regulated Investment Company under Subchapter M of the Code or
under any successor or similar provision, or if the Company reasonably believes
that the Fund may fail to so qualify; or
10.1(e) termination by the Company by written notice to the Fund and the
Adviser with respect to any Portfolio in the event that such Portfolio fails to
meet the diversification requirements specified in Article VI hereof; or
10.1(f) termination by the Fund by written notice to the Company if the
Fund shall determine, in its sole judgment exercised in good faith, that the
Company and/or its affiliated companies has suffered a material adverse change
in its business, operations, financial condition or prospects since the date of
this Agreement or is the subject of material adverse publicity, or
10.1(g) termination by the Company by written notice to the Fund and the
Adviser, if the Company shall determine, in its sole judgment exercised in good
faith, that either the Fund or the Adviser has suffered a material adverse
change in its business, operations, financial condition or prospects since the
date of this Agreement or is the subject of material adverse publicity; or
10.2. Notwithstanding any termination of this Agreement, the Fund shall,
at the option of the Company, continue to make available additional shares of
the Fund pursuant to the terms and conditions of this Agreement, for all
Variable Products in effect on the effective date of termination of this
Agreement (hereinafter referred to as "Existing Variable Products").
Specifically, without limitation, the owners of the Existing Variable Products
shall be permitted to direct reallocation of investments in the Portfolios of
the Fund, redemption of investments in the Portfolios of the Fund and/or
investment in the Portfolios of the Fund upon the making of additional purchase
payments under the Existing Variable Products. The parties agree that this
Section 10.2 shall not apply to any termination under Article VII and the effect
of such Article VII termination shall be governed by Article VII of this
Agreement.
10.3. The provisions of Article VIII Indemnification shall survive any
termination of this Agreement pursuant to this Article X Termination.
10.4. The Company shall not redeem Fund shares attributable to the
Variable Products (as distinct from Fund shares attributable to the Company's
assets held in the Account) except (i) as necessary to implement contract owner
initiated or approved transactions, or (ii) as required by state and/or federal
laws or regulations or judicial or other legal precedent of general application
(hereinafter referred to as a "Legally Required Redemption") or (iii) as
permitted by an order of the Securities and Exchange Commission pursuant to
Section 26(b) of the 1940 Act. Upon request, the Company will promptly furnish
to the Fund the opinion of counsel for the Company (which counsel shall be
reasonably satisfactory to the Fund) to the effect that any redemption pursuant
to clause (ii) above is a Legally Required Redemption. Furthermore, except in
cases where permitted under the terms of the Variable Products, the Company
shall not prevent contract owners from allocating payments to a Portfolio that
was otherwise available under the Variable Products without first giving the
Fund 90 days prior written notice of its intention to do so.
16
<PAGE>
ARTICLE XI. NOTICES
Any notice shall be sufficiently given when hand delivered or sent by
registered or certified mail to the other party at the address of such party set
forth below or at such other address as such party may from time to time specify
in writing to the other party.
If to the Fund:
Allmerica Investment Trust
440 Lincoln Street
Worcester, MA 01653
Attention: George M. Boyd, Esq.
If to Adviser:
Allmerica Investment Management Company, Inc.
440 Lincoln Street
Worcester, MA 01653
Attention: Abigail M. Armstrong, Esq.
If to the Company:
Allmerica Financial Life Insurance and Annuity Company
440 Lincoln Street
Worcester, Massachusetts 01653
Attention: Richard M. Reilly, President
ARTICLE XII. MISCELLANEOUS
12.1. A copy of the Fund's Agreement and Declaration of Trust, as may be
amended from time to time, is on file with the Secretary of the Commonwealth of
Massachusetts. Notice is hereby given that this instrument is executed by the
Fund's Trustees as Trustees and not individually, and the Fund's obligations
under this Agreement are not binding upon any of the Trustees or Shareholders of
the Fund, but are binding only upon the assets and property of the Fund.
12.2. Subject to the requirements of legal process and regulatory
authority, each party hereto shall treat as confidential the names and addresses
of the owners of the Variable Products and all information reasonably identified
as confidential in writing by any other party hereto and, except as permitted by
this Agreement, shall not disclose, disseminate or utilize such names and
addresses and other confidential information until such time as it may come into
the public domain without the express written consent of the affected party.
12.3. The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
12.4. This Agreement may be executed simultaneously in two or more
counterparts, each of which taken together shall constitute one and the same
instrument.
12.5. If any provision of this Agreement shall be held or made invalid by
a court decision, statute, rule or otherwise, the remainder of the Agreement
shall not be affected thereby.
17
<PAGE>
12.6. Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the
Securities and Exchange Commission, the National Association of Securities
Dealers and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation
or inquiry relating to this Agreement or the transactions contemplated hereby.
Notwithstanding the generality of the foregoing, each party hereto further
agrees to furnish the California Insurance Commissioner with any information or
reports in connection with services provided under this Agreement which such
Commissioner may request in order to ascertain whether the insurance operations
of the Company are being conducted in a manner consistent with the California
Insurance Regulations and any other applicable law or regulations.
12.7. The rights, remedies and obligations contained in this Agreement are
cumulative and are in addition to any and all rights, remedies and obligations
at law or in equity, which the parties hereto are entitled to under state and
federal laws.
12.8. This Agreement or any of the rights and obligations hereunder may
not be assigned by any party without the prior written consent of all parties
hereto; provided, however, that the Adviser may assign this Agreement or any
rights or obligations hereunder to any affiliate of or company controlled by or
under common control with the Adviser, if such assignee is duly licensed and
registered to perform the obligations of the Adviser under this Agreement.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be
executed in its name and on its behalf by its duly authorized representative and
its seal to be hereunder affixed hereto as of the date specified above.
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
By: /s/ Joseph W. MacDougall, Jr.
--------------------------------------
NAME: Joseph W. MacDougall, Jr.
TITLE: Vice President
ALLMERICA INVESTMENT TRUST
By: /s/ Thomas P. Cunningham
--------------------------------------
NAME: Thomas P. Cunningham
TITLE: Vice President & Treasurer
ALLMERICA INVESTMENT MANAGEMENT COMPANY, INC.
By: /s/ Richard F. Betzler, Jr.
--------------------------------------
NAME: Richard F. Betzler, Jr.
TITLE: Vice President
18
<PAGE>
SCHEDULE A
SEPARATE ACCOUNTS AND VARIABLE PRODUCTS
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------------------
VARIABLE LIFE PRODUCTS
SEPARATE ACCOUNT PRODUCT NAME 1933 ACT # 1940 ACT #
- ---------------- ------------ ---------- ----------
<S> <C> <C> <C>
- --------------------------------------------------------------------------------------------------------------
VEL VEL ('87) 33-14672 811-5183
VEL VEL ('91) 33-90320 811-5183
VEL II VEL ('93) 33-57792 811-7466
VEL VEL (Plus) 33-42687 811-5183
Inheiritage Inheiritage 33-70948 811-8120
Select Inheiritage
Allmerica Select Separate Account II Select Life 33-83604 811-8746
Group VEL Group VEL 33-82658 811-08704
- --------------------------------------------------------------------------------------------------------------
<CAPTION>
- --------------------------------------------------------------------------------------------------------------
VARIABLE ANNUITY PRODUCTS
SEPARATE ACCOUNT PRODUCT NAME 1933 ACT # 1940 ACT #
- ---------------- ------------ ---------- ----------
<S> <C> <C> <C>
- --------------------------------------------------------------------------------------------------------------
VA-K ExecAnnuity Plus 91 33-39702 811-6293
ExecAnnuity Plus 93
Allmerica Advantage
Allmerica Select Separate Account Allmerica Select Resource I 33-47216 811-6632
Allmerica Select Resource II
Separate Accounts VA-A, VA-B, VA-C, Variable Annuities (discontinued)
VA-G, VA-H
- --------------------------------------------------------------------------------------------------------------
</TABLE>
A-1
<PAGE>
SCHEDULE B
PORTFOLIOS OF
ALLMERICA INVESTMENT TRUST
Select Emerging Markets Fund
Select International Equity Fund
Select Aggressive Growth Fund
Select Capital Appreciation Fund
Select Value Opportunity Fund
Select Strategic Growth Fund
Select Growth Fund
Growth Fund
Equity Index Fund
Select Growth and Income Fund
Select Income Fund
Investment Grade Income Fund
Government Bond Fund
Money Market Fund
B-1
<PAGE>
SCHEDULE C
PROXY VOTING PROCEDURES
The following is a list of procedures and corresponding responsibilities for the
handling of proxies and voting instructions relating to the Fund. The defined
terms herein shall have the meanings assigned in the Participation Agreement
except that the term "Company" shall also include the department or third party
assigned by the Company to perform the steps delineated below.
- - The proxy proposals are given to the Company by the Fund as early as
possible before the date set by the Fund for the shareholder meeting to
enable the Company to consider and prepare for the solicitation of voting
instructions from owners of the Variable Products and to facilitate the
establishment of tabulation procedures. At this time the Fund will inform
the Company of the Record, Mailing and Meeting dates. This will be done
verbally approximately two months before meeting.
- - Promptly after the Record Date, the Company will perform a "tape run," or
other activity, which will generate the names, addresses and number of
units which are attributed to each contract owner/policyholder (the
"Customer") as of the Record Date. Allowance should be made for account
adjustments made after this date that could affect the status of the
Customers' accounts as of the Record Date.
- - Note: The number of proxy statements is determined by the activities
described above. The Company will use its best efforts to call in the
number of Customers to the Fund, as soon as possible, but no later than
two weeks after the Record Date.
- - The Fund's Annual Report must be sent to each Customer by the Company
either before or together with the Customers' receipt of voting instruction
solicitation material. The Fund will provide the last Annual Report to the
Company pursuant to the terms of Section 3.43 of the Agreement to which
this Schedule relates.
- - The text and format for the Voting Instruction Cards ("Cards" or "Card") is
provided to the Company by the Fund. The Company, at its expense, shall
produce and personalize the Voting Instruction Cards. The Fund or its
affiliate must approve the Card before it is printed. Allow approximately
2-4 business days for printing information on the Cards. Information
commonly found on the Cards includes:
- name (legal name as found on account registration)
address
- fund or account number
- coding to state number of units
- individual Card number for use in tracking and verification of votes
(already on Cards as printed by the Fund).
(This and related steps may occur later in the chronological process due to
possible uncertainties relating to the proposals.)
C-1
<PAGE>
- - During this time, the Fund will develop, produce and pay for the Notice of
Proxy and the Proxy Statement (one document). Printed and folded notices
and statements will be sent to Company for insertion into envelopes
(envelopes and return envelopes are provided and paid for by the Company).
Contents of envelope sent to Customers by the Company will include:
- Voting Instruction Card(s)
- One proxy notice and statement (one document)
- return envelope (postage pre-paid by Company) addressed to the Company
or its tabulation agent
- "urge buckslip" - optional, but recommended. (This is a small, single
sheet of paper that requests Customers to vote as quickly as possible
and that their vote is important. One copy will be supplied by the
Fund.)
- cover letter - optional, supplied by Company and reviewed and approved
in advance by the Fund.
- - The above contents should be received by the Company approximately 3-5
business days before mail date. Individual in charge at Company reviews
and approves the contents of the mailing package to ensure correctness and
completeness. Copy of this approval sent to the Fund.
- - Package mailed by the Company.
* The Fund must allow at least a 15-day solicitation time to the Company
as the shareowner. (A 5-week period is recommended.) Solicitation
time is calculated as calendar days from (but NOT including,) the
meeting, counting backwards.
- - Collection and tabulation of Cards begins. Tabulation usually takes place
in another department or another vendor depending on process used. An
often used procedure is to sort Cards on arrival by proposal into vote
categories of all yes, no, or mixed replies, and to begin data entry.
Note: Postmarks are not generally needed. A need for postmark information
would be due to an insurance company's internal procedure and has not been
required by the Fund in the past.
- - Signatures on Card checked against legal name on account registration which
was printed on the Card.
Note: For Example, if the account registration is under "John A. Smith,
Trustee," then that is the exact legal name to be printed on the Card and
is the signature needed on the Card.
- - If Cards are mutilated, or for any reason are illegible or are not signed
properly, they are sent back to Customer with an explanatory letter and a
new Card and return envelope. The mutilated or illegible Card is
disregarded and considered to be NOT RECEIVED for purposes of vote
tabulation. Any Cards that have been "kicked out" (e.g. mutilated,
illegible) of the procedure are "hand verified," i.e., examined as to why
they did not complete the system. Any questions on those Cards are usually
remedied individually.
- - There are various control procedures used to ensure proper tabulation of
votes and accuracy of that tabulation. The most prevalent is to sort the
Cards as they first arrive into categories depending upon their vote; an
estimate of how the vote is progressing may then be calculated. If the
initial estimates and the actual vote do not coincide, then an internal
audit of that vote should occur. This may entail a recount.
C-2
<PAGE>
- - The actual tabulation of votes is done in units which is then converted to
shares. (It is very important that the Fund receives the tabulations stated
in terms of a percentage and the number of SHARES.) The Fund must review
and approve tabulation format.
- - Final tabulation in shares is verbally given by the Company to the Fund on
the morning of the meeting not later than 10:00 a.m. Eastern time. The
Fund may request an earlier deadline if reasonable and if required to
calculate the vote in time for the meeting.
- - A Certification of Mailing and Authorization to Vote Shares will be
required from the Company as well as an original copy of the final vote.
The Fund will provide a standard form for each Certification.
- - The Company will be required to box and archive the Cards received from the
Customers. In the event that any vote is challenged or if otherwise
necessary for legal, regulatory, or accounting purposes, the Fund will be
permitted reasonable access to such Cards.
- - All approvals and "signing-off" may be done orally, but must always be
followed up in writing.
C-3
<PAGE>
PARTICIPATION AGREEMENT
Among
VARIABLE INSURANCE PRODUCTS FUND,
FIDELITY DISTRIBUTORS CORPORATION
and
SMA LIFE ASSURANCE COMPANY
THIS AGREEMENT, made and entered into this 1st day of May, 1991 by
and among SMA LIFE ASSURANCE COMPANY, (hereinafter the "Company"), a Delaware
corporation, on its own behalf and on behalf of each segregated asset account
of the Company set forth on Schedule A hereto as may be amended from time to
time (each such account hereinafter referred to as the "Account"), and the
VARIABLE INSURANCE PRODUCTS FUND, an unincorporated business trust organized
under the laws of the Commonwealth of Massachusetts (hereinafter the "Fund") and
FIDELITY DISTRIBUTORS CORPORATION (hereinafter the "Underwriter"), a
Massachusetts corporation.
WHEREAS, the Fund engages in business as an open-end management
investment company and is available to act as the investment vehicle for
separate accounts established for variable life insurance policies and variable
annuity contracts (collectively, the "Variable Insurance Products") to be
offered by insurance companies which have entered into participation agreements
with the Fund and the Underwriter (hereinafter "Participating Insurance
Companies"); and
WHEREAS, the beneficial interest in the Fund is divided into several
series of shares, each designated a "Portfolio" and representing the interest in
a particular managed portfolio of securities and other assets; and
WHEREAS, the Fund has obtained an order from the Securities and
Exchange Commission, dated October 15, 1985 (File No. 812-6102), granting
Participating Insurance Companies and variable annuity and variable life
insurance separate accounts exemptions from the provisions of sections 9(a),
13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended,
(hereinafter the "1940 Act") and Rules 6e-2(b) (15) and 6e-3(T) (b) (15)
thereunder, to the extent necessary to permit shares of the Fund to be sold to
and held by variable annuity and variable life insurance separate accounts of
both affiliated and unaffiliated life insurance companies (hereinafter the
"Shared Funding Exemptive Order"); and
WHEREAS, the Fund is registered as an open-end management investment
company under the 1940 Act and its shares are registered under the Securities
Act of 1933, as amended (hereinafter the "1933 Act"); and
-1-
<PAGE>
WHEREAS, Fidelity Management & Research Company (the "Adviser") is
duly registered as an investment adviser under the federal Investment Advisers
Act of 1940 and any applicable state securities law; and
WHEREAS, the Company has registered or will register certain
variable life and variable annuity contracts under the 1933 Act; and
WHEREAS, each Account is a duly organized, validly existing
segregated asset account, established by resolution of the Board of Directors
of the Company, on the date shown for such Account on Schedule A hereto, to set
aside and invest assets attributable to one or more variable life and annuity
contracts; and
WHEREAS, the Company has registered or will register each Account as
a unit investment trust under the 1940 Act; and
WHEREAS, the Underwriter is registered as a broker dealer with the
Securities and Exchange Commission under the Securities Exchange Act of 1934, as
amended, (hereinafter the "1934 Act"), and is a member in good standing of the
National Association of Securities Dealers, Inc. (hereinafter "NASD"); and
WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase shares in the Portfolios on behalf
of each Account to fund certain of the aforesaid variable life and variable
annuity contracts and the Underwriter is authorized to sell such shares to unit
investment trusts such as each Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the
Company, the Fund and the Underwriter agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. The Underwriter agrees to sell to the Company those shares of
the Fund which each Account orders, executing such orders on a daily basis at
the net asset value next computed after receipt by the Fund or its designee of
the order for the shares of the Fund. For purposes of this Section 1.1, the
Company shall be the designee of the Fund for receipt of such orders from each
Account and receipt by such designee shall constitute receipt by the Fund;
provided that the Fund receives notice of such order by 9:30 a.m. Boston time on
the next following Business Day. "Business Day" shall mean any day on which the
New York Stock Exchange is open for trading and on which the Fund calculates its
net asset value pursuant to the rules of the Securities and Exchange Commission.
1.2. The Fund agrees to make its shares available indefinitely for
purchase at the applicable net asset value per share by the Company and its
Accounts on those days on which the Fund calculates its net asset value pursuant
to rules of the Securities and Exchange Commission and the Fund shall use
reasonable efforts to
-2-
<PAGE>
calculate such net asset value on each day which the New York Stock Exchange is
open for trading. Notwithstanding the foregoing, the Board of Trustees of the
Fund (hereinafter the "Board") may refuse to sell shares of any Portfolio to any
person, or suspend or terminate the offering of shares of any Portfolio if such
action is required by law or by regulatory authorities having jurisdiction or
is, in the sole discretion of the Board acting in good faith and in light of
their fiduciary duties under federal and any applicable state laws, necessary in
the best interests of the shareholders of such Portfolio.
1.3. The Fund and the Underwriter agree that shares of the Fund will
be sold only to Participating Insurance Companies and their separate accounts.
No shares of any Portfolio will be sold to the general public.
1.4. The Fund and the Underwriter will not sell Fund shares to any
insurance company or separate account unless an agreement containing provisions
substantially the same as Articles I, III, V, VII and Sections 2.5 and 2.12 of
Article II of this Agreement is in effect to govern such sales.
1.5. The Fund agrees to redeem for cash, on the Company's request,
any full or fractional shares of the Fund held by the Company, executing such
requests on a daily basis at the net asset value next computed after receipt by
the Fund or its designee of the request for redemption. For purposes of this
Section 1.5, the Company shall be the designee of the Fund for receipt of
requests for redemption from each Account and receipt by such designee shall
constitute receipt by the Fund; provided that the Fund receives notice of such
request for redemption on the next following Business Day.
1.6. The Company agrees to purchase and redeem the shares of each
Portfolio offered by the then current prospectus of the Fund and in accordance
with the provisions of such prospectus. The Company agrees that all net amounts
available under the variable life and variable annuity contracts with the form
number(s) which are listed on Schedule B attached hereto and incorporated herein
by this reference, as such Schedule B may be amended from time to time hereafter
by mutual written agreement of all the parties hereto, (the "Contracts") shall
be invested in the Fund, in such other Funds advised by the Adviser as may be
mutually agreed to in writing by the parties hereto, or in the Company's general
account, provided that such amounts may also be invested in an investment
company other than the Fund if (a) such other investment company, or series
thereof, has investment objectives or policies that are substantially different
from the investment objectives and policies of all the Portfolios of the Fund;
or (b) the Company gives the Fund and the Underwriter 45 days written notice of
its intention to make such other investment company available as a funding
vehicle for the Contracts; or (c) such other investment company was available as
a funding vehicle for the Contracts prior to the date of this Agreement and the
Company so informs the Fund and Underwriter prior to their signing this
Agreement; or (d) the Fund or Underwriter consents to the use of such other
investment company.
-3-
<PAGE>
1.7. The Company shall pay for Fund shares on the next Business Day
after an order to purchase Fund shares is made in accordance with the provisions
of Section 1.1 hereof. Payment shall be in federal funds transmitted by wire.
For purpose of Section 2.10 and 2.11, upon receipt by the Fund of the federal
funds so wired, such funds shall cease to be the responsibility of the Company
and shall become the responsibility of the Fund.
1.8. Issuance and transfer of the Fund's shares will be by book
entry only. Stock certificates will not be issued to the Company or any
Account. Shares ordered from the Fund will be recorded in an appropriate title
for each Account or the appropriate subaccount of each Account.
1.9. The Fund shall furnish same day notice (by wire or telephone,
followed by written confirmation) to the Company of any income, dividends or
capital gain distributions payable on the Fund's shares. The Company hereby
elects to receive all such income dividends and capital gain distributions as
are payable on the Portfolio shares in additional shares of that Portfolio. The
Company reserves the right to revoke this election and to receive all such
income dividends and capital gain distributions in cash. The Fund shall notify
the Company of the number of shares so issued as payment of such dividends and
distributions.
1.10. The Fund shall make the net asset value per share for each
Portfolio available to the Company on a daily basis as soon as reasonably
practical after the net asset value per share is calculated and shall use its
best efforts to make such net asset value per share available by 7 p.m. Boston
time.
ARTICLE II. Representations and Warranties
2.1. The Company represents and warrants that the Contracts are or
will be registered under the 1933 Act; that the Contracts will be issued and
sold in compliance in all material respects with all applicable Federal and
State laws and that the sale of the Contracts shall comply in all material
respects with state insurance suitability requirements. The Company further
represents and warrants that it is an insurance company duly organized and in
good standing under applicable law and that it has legally and validly
established each Account prior to any issuance or sale thereof as a segregated
asset account under Section 2932 of the Delaware Insurance Code and has
registered or, prior to any issuance or sale of the Contracts, will register
each Account as a unit investment trust in accordance with the provisions of the
1940 Act to serve as a segregated investment account for the Contracts.
2.2. The Fund represents and warrants that Fund shares sold pursuant
to this Agreement shall be registered under the 1933 Act, duly authorized for
issuance and sold in compliance with the laws of the State of Delaware and all
applicable federal and state securities laws and that the Fund is and shall
remain registered under the 1940 Act. The Fund shall amend the Registration
Statement for its shares
-4-
<PAGE>
under the 1933 Act and the 1940 Act from time to time as required in order to
effect the continuous offering of its shares. The Fund shall register and
qualify the shares for sale in accordance with the laws of the various states
only if and to the extent deemed advisable by the Fund or the Underwriter.
2.3. The Fund represents that it is currently qualified as a
Regulated Investment Company under Subchapter M of the Internal Revenue Code of
1986, as amended, (the "Code") and that it will make every effort to maintain
such qualification (under Subchapter M or any successor or similar provision)
and that it will notify the Company immediately upon having a reasonable basis
for believing that it has ceased to so qualify or that it might not so qualify
in the future.
2.4. The Company represents that the Contracts are currently treated
as endowment, annuity or life insurance contracts, under applicable provisions
of the Code and that it will make every effort to maintain such treatment and
that it will notify the Fund and the Underwriter immediately upon having a
reasonable basis for believing that the Contracts have ceased to be so treated
or that they might not be so treated in the future.
2.5. The Fund currently does not intend to make any payments to
finance distribution expenses pursuant to Rule 12b-l under the 1940 Act or
otherwise, although it may make such payments in the future. The Fund has
adopted a "no fee" or "defensive" Rule 12b-l Plan under which it makes no
payments for distribution expenses. To the extent that it decides to finance
distribution expenses pursuant to Rule 12b-l, the Fund undertakes to have a
board of trustees, a majority of whom are not interested persons of the Fund,
formulate and approve any plan under Rule 12b-l to finance distribution
expenses.
2.6. The Fund makes no representation as to whether any aspect of
its operations (including, but not limited to, fees and expenses and investment
policies) complies with the insurance laws or regulations of the various states
except that the Fund represents that the Fund's investment policies, fees and
expenses are and shall at all times remain in compliance with the laws of the
State of Delaware and the Fund and the Underwriter represent that their
respective operations are and shall at all times remain in material compliance
with the laws of the State of Delaware to the extent required to perform this
Agreement.
2.7. The Underwriter represents and warrants that it is a member in
good standing of the NASD and is registered as a broker-dealer with the SEC. The
Underwriter further represents that it will sell and distribute the Fund shares
in accordance with the laws of the State of Delaware and all applicable state
and federal securities laws, including without limitation the 1933 Act, the 1934
Act, and the 1940 Act.
2.8. The Fund represents that it is lawfully organized and validly
existing under the laws of the State of Delaware and that it does and will
comply in all material respects with the 1940 Act.
-5-
<PAGE>
2.9. The Underwriter represents and warrants that the Adviser is and
shall remain duly registered in all material respects under all applicable
federal and state securities laws and that the Adviser shall perform its
obligations for the Fund in compliance in all material respects with the laws of
the State of Delaware and any applicable state and federal securities laws.
2.10. The Fund and Underwriter represent and warrant that all of
their directors, officers, employees, investment advisers, and other
individuals/entities dealing with the money and/or securities of the Fund are
and shall continue to be at all times covered by a blanket fidelity bond or
similar coverage for the benefit of the Fund in an amount not less than the
minimal coverage as required currently by Rule 17g-(l) of the 1940 Act or
related provisions as may be promulgated from time to time. The aforesaid Bond
shall include coverage for larceny and embezzlement and shall be issued by a
reputable bonding company.
2.11. The Company represents and warrants that all of its directors,
officers, employees, investment advisers, and other individuals/entities dealing
with the money and/or securities of the Fund are and shall continue to be at all
times covered by a blanket fidelity bond or similar coverage for the benefit of
the Fund, in an amount not less than the minimal coverage as required currently
by entities subject to the requirements of Rule 17g-1 of the 1940 Act or related
provisions as may be promulgated from time to time. The aforesaid Bond shall
include coverage for larceny and embezzlement and shall be issued by a reputable
bonding company.
2.12. The Company represents and warrants that it will not purchase
Fund shares with Account assets derived from the sale of Contracts to deferred
compensation plans with respect to service for state and local governments which
qualify under Section 457 of the federal Internal Revenue Code, as may be
amended. The Company may purchase Fund shares with Account assets derived from
any sale of a Contract to any other type of tax-advantaged employee benefit
plan; provided however that such plan has no more than 500 employees who are
eligible to participate at the time of the first such purchase hereunder by the
Company of Fund shares derived from the sale of such Contract.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1. The Underwriter shall provide the Company (at the Company's
expense) with as many copies of the Fund's current prospectus as the Company may
reasonably request. If requested by the Company in lieu thereof, the Fund shall
provide such documentation (including a final copy of the new prospectus as set
in type at the Fund's expense) and other assistance as is reasonably necessary
in order for the Company once each year (or more frequently if the prospectus
for the Fund is amended) to have the prospectus for the Contracts and the Fund's
prospectus printed together in one document (such printing to be at the
Company's expense).
-6-
<PAGE>
3.2. The Fund's prospectus shall state that the Statement of
Additional Information for the Fund is available from the Underwriter (or in the
Fund's discretion, the Prospectus shall state that such Statement is available
from the Fund), and the Underwriter (or the Fund), at its expense, shall print
and provide such Statement free of charge to the Company and to any owner of a
Contract or prospective owner who requests such Statement.
3.3. The Fund, at its expense, shall provide the Company with copies
of its proxy material, reports to stockholders and other communications to
stockholders in such quantity as the Company shall reasonably require for
distributing to Contract owners.
3.4. If and to the extent required by law the Company shall:
(i) solicit voting instructions from Contract Owners;
(ii) vote the Fund shares in accordance with instructions
received from Contract owners; and
(iii) vote Fund shares for which no instructions have been
received in the same proportion as Fund shares of such
portfolio for which instructions have been received:
so long as and to the extent that the Securities and Exchange Commission
continues to interpret the 1940 Act to require pass-through voting privileges
for variable contract owners. The Company reserves the right to vote Fund shares
held in any segregated asset account in its own right, to the extent permitted
by law. Participating Insurance Companies shall be responsible for assuring that
each of their separate accounts participating in the Fund calculates voting
privileges in a manner consistent with the standards set forth on Schedule C
attached hereto and incorporated herein by this reference, which standards will
also be provided to the other Participating Insurance Companies.
3.5. The Fund will comply with all provisions of the 1940 Act
requiring voting by shareholders, and in particular the Fund will either provide
for annual meetings or comply with Section 16(c) of the 1940 Act (although the
Fund is not one of the trusts described in Section 16(c) of that Act) as well as
with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will
act in accordance with the Securities and Exchange Commission's interpretation
of the requirements of Section 16(a) with respect to periodic elections of
trustees and with whatever rules the Commission may promulgate with respect
thereto.
ARTICLE IV. Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to
the Fund or its designee, each piece of sales literature or other promotional
material in which the Fund or its investment adviser or the Underwriter is
named, at least fifteen Business Days prior to its use. No such material shall
be used if the Fund or its designee object to such use within fifteen Business
Days after receipt of such material.
-7-
<PAGE>
4.2. The Company shall not give any information or make any
representations or statements on behalf of the Fund or concerning the Fund in
connection with the sale of the Contracts other than the information or
representations contained in the registration statement or prospectus for the
Fund shares, as such registration statement and prospectus may be amended or
supplemented from time to time, or in reports or proxy statements for the Fund,
or in sales literature or other promotional material approved by the Fund or its
designee or by the Underwriter, except with the permission of the Fund or the
Underwriter or the designee of either.
4.3. The Fund, Underwriter, or its designee shall furnish, or shall
cause to be furnished, to the Company or its designee, each piece of sales
literature or other promotional material in which the Company and/or its
separate account(s), is named at least fifteen Business Days prior to its use.
No such material shall be used if the Company or its designee object to such use
within fifteen Business Days after receipt of such material.
4.4. The Fund and the Underwriter shall not give any information or
make any representations on behalf of the Company or concerning the Company,
each Account, or the Contracts other than the information or representations
contained in a registration statement or prospectus for the Contracts, as such
registration statement and prospectus may be amended or supplemented from time
to time, or in published reports for each Account which are in the public domain
or approved by the Company for distribution to Contract owners, or in sales
literature or other promotional material approved by the Company or its
designee, except with the permission of the Company.
4.5. The Fund will provide to the Company at least one complete copy
of all registration statements, prospectuses, Statements of Additional
Information, reports, proxy statements, sales literature and other promotional
materials, applications for exemptions, requests for no-action letters, and all
amendments to any of the above, that relate to the Fund or its shares,
contemporaneously with the filing of such document with the Securities and
Exchange Commission or other regulatory authorities.
4.6. The Company will provide to the Fund at least one complete copy
of all registration statements, prospectuses, Statements of Additional
Information, reports, solicitations for voting instructions, sales literature
and other promotional materials, applications for exemptions, requests for no
action letters, and all amendments to any of the above, that relate to the
Contracts or each Account, contemporaneously with the filing of such document
with the Securities and Exchange Commission.
4.7. For purposes of this Article IV, the phrase "sales literature
or other promotional material" includes, but is not limited to, advertisements
(such as material published, or designed for use in, a newspaper, magazine, or
other periodical, radio, television, telephone or tape recording, videotape
display, signs or billboards, motion pictures, or other public media), sales
literature (i.e., any written communication distributed or made generally
-8-
<PAGE>
available to customers or the public, including brochures, circulars, research
reports, market letters, form letters, seminar texts, reprints or excerpts of
any other advertisement, sales literature, or published article), educational or
training materials or other communications distributed or made generally
available to some or all agents or employees, and registration statements,
prospectuses, Statements of Additional Information, shareholder reports, and
proxy materials.
ARTICLE V. Fees and Expenses
5.1. The Fund and Underwriter shall pay no fee or other compensation
to the Company under this agreement, except that if the Fund or any Portfolio
adopts and implements a plan pursuant to Rule 12b-1 to finance distribution
expenses, then the Underwriter may make payments to the Company or to the
underwriter for the Contracts if and in amounts agreed to by the Underwriter in
writing and such payments will be made out of existing fees otherwise payable to
the Underwriter, past profits of the Underwriter or other resources available to
the Underwriter. No such payments shall be made directly by the Fund. Currently,
no such payments are contemplated.
5.2. All expenses incident to performance by the Fund under this
Agreement shall be paid by the Fund. The Fund shall see to it that all its
shares are registered and authorized for issuance in accordance with applicable
federal law and, if and to the extent deemed advisable by the Fund, in
accordance with applicable state laws prior to their sale. The Fund shall bear
the expenses for the cost of registration and qualification of the Fund's
shares, preparation and filing of the Fund's prospectus and registration
statement, proxy materials and reports, setting the prospectus in type, setting
in type and printing the proxy materials and reports to shareholders (including
the costs of printing a prospectus that constitutes an annual report), the
preparation of all statements and notices required by any federal or state law,
all taxes on the issuance or transfer of the Fund's shares.
5.3. The Company shall bear the expenses of printing and
distributing the Fund's prospectus to owners of Contracts issued by the Company
and of distributing the Fund's proxy materials and reports to such Contract
owners.
ARTICLE VI. Diversification
6.1. The Fund will at all times invest money from the Contracts in
such a manner as to ensure that the Contracts will be treated as variable
contracts under the Code and the regulations issued thereunder. Without limiting
the scope of the foregoing, the Fund will at all times comply with Section
817(h) of the Code and Treasury Regulation ss.1.817-5, relating to the
diversification requirements for variable annuity, endowment, or life insurance
contracts and any amendments or other modifications to such Section or
Regulations.
-9-
<PAGE>
ARTICLE VII. Potential Conflicts
7.1. The Board will monitor the Fund for the existence of any
material irreconcilable conflict between the interests of the contract owners of
all separate accounts investing in the Fund. An irreconcilable material conflict
may arise for a variety of reasons, including: (a) an action by any state
insurance regulatory authority; (b) a change in applicable federal or state
insurance, tax, or securities laws or regulations, or a public ruling, private
letter ruling, no-action or interpretative letter, or any similar action by
insurance, tax, or securities regulatory authorities; (c) an administrative or
judicial decision in any relevant proceeding; (d) the manner in which the
investments of any Portfolio are being managed; (e) a difference in voting
instructions given by variable annuity contract and variable life insurance
contract owners; or (f) a decision by an insurer to disregard the voting
instructions of contract owners. The Board shall promptly inform the Company if
it determines that an irreconcilable material conflict exists and the
implications thereof.
7.2. The Company will report any potential or existing conflicts of
which it is aware to the Board. The Company will assist the Board in carrying
out its responsibilities under the Shared Funding Exemptive Order, by providing
the Board with all information reasonably necessary for the Board to consider
any issues raised. This includes, but is not limited to, an obligation by the
Company to inform the Board whenever contract owner voting instructions are
disregarded.
7.3. If it is determined by a majority of the Board, or a majority
of its disinterested trustees, that a material irreconcilable conflict exists,
the Company and other Participating Insurance Companies shall, at their expense
and to the extent reasonably practicable (as determined by a majority of the
disinterested trustees), take whatever steps are necessary to remedy or
eliminate the irreconcilable material conflict, up to and including: (1),
withdrawing the assets allocable to some or all of the separate accounts from
the Fund or any Portfolio and reinvesting such assets in a different investment
medium, including (but not limited to) another Portfolio of the Fund, or
submitting the question whether such segregation should be implemented to a vote
of all affected Contract owners and, as appropriate, segregating the assets of
any appropriate group (i.e., annuity contract owners, life insurance contract
owners, or variable contract owners of one or more Participating Insurance
Companies) that votes in favor of such segregation, or offering to the affected
contract owners the option of making such a change; and (2), establishing a new
registered management investment company or managed separate account.
-10-
<PAGE>
7.4. If a material irreconcilable conflict arises because of a
decision by the Company to disregard contract owner voting instructions and that
decision represents a minority position or would preclude a majority vote, the
Company may be required, at the Fund's election, to withdraw the affected
Account's investment in the Fund and terminate this Agreement with respect to
such Account; provided, however that such withdrawal and termination shall be
limited to the extent required by the foregoing material irreconcilable conflict
as determined by a majority of the disinterested members of the Board. Any such
withdrawal and termination must take place within six (6) months after the Fund
gives written notice that this provision is being implemented, and until the end
of that six month period the Underwriter and Fund shall continue to accept and
implement orders by the Company for the purchase (and redemption) of shares of
the Fund.
7.5. If a material irreconcilable conflict arises because a
particular state insurance regulator's decision applicable to the Company
conflicts with the majority of other state regulators, then the Company will
withdraw the affected Account's investment in the Fund and terminate this
Agreement with respect to such Account within six months after the Board informs
the Company in writing that it has determined that such decision has created an
irreconcilable material conflict; provided, however, that such withdrawal and
termination shall be limited to the extent required by the foregoing material
irreconcilable conflict as determined by a majority of the disinterested members
of the Board. Until the end of the foregoing six month period, the Underwriter
and Fund shall continue to accept and implement orders by the Company for the
purchase (and redemption) of shares of the Fund.
7.6. For purposes of Sections 7.3 through 7.6 of this Agreement, a
majority of the disinterested members of the Board shall determine whether any
proposed action adequately remedies any irreconcilable material conflict, but in
no event will the Fund be required to establish a new funding medium for the
Contracts. The Company shall not be required by Section 7.3 to establish a new
funding medium for the Contracts if an offer to do so has been declined by vote
of a majority of Contract owners materially adversely affected by the
irreconcilable material conflict. In the event that the Board determines that
any proposed action does not adequately remedy any irreconcilable material
conflict, then the Company will withdraw the Account's investment in the Fund
and terminate this Agreement within six (6) months after the Board informs the
Company in writing of the foregoing determination, provided, however, that such
withdrawal and termination shall be limited to the extent required by any such
material irreconcilable conflict as determined by a majority of the
disinterested members of the Board.
-11-
<PAGE>
7.7. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are
amended, or Rule 6e-3 is adopted, to provide exemptive relief from any
provision of the Act or the rules promulgated thereunder with respect to mixed
or shared funding (as defined in the Shared Funding Exemptive Order) on terms
and conditions materially different from those contained in the Shared Funding
Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies,
as appropriate, shall take such steps as may be necessary to comply with Rules
6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such
rules are applicable; and (b) Sections 3.4, 3.5, 7.1, 7.2, 7.3, 7.4, and 7.5 of
this Agreement shall continue in effect only to the extent that terms and
conditions substantially identical to such Sections are contained in such
Rule(s) as so amended or adopted.
ARTICLE VIII. Indemnification
8.1. Indemnification By The Company
8.1(a). The Company agrees to indemnify and hold harmless the Fund
and each trustee of the Board and officers and each person, if any, who controls
the Fund within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" for purposes of this Section 8.1) against any and all
losses, claims, damages, liabilities (including amounts paid in settlement with
the written consent of the Company) or litigation (including legal and other
expenses), to which the Indemnified Parties may become subject under any
statute, regulation, at common law or otherwise, insofar as such losses, claims,
damages, liabilities or expenses (or actions in respect thereof) or settlements
are related to the sale or acquisition of the Fund's shares or the Contracts
and:
(i) arise out of or are based upon any untrue statements or
alleged untrue statements of any material fact contained in
the Registration Statement or prospectus for the Contracts or
contained in the Contracts or sales literature for the
Contracts (or any amendment or supplement to any of the
foregoing), or arise out of or are based upon the omission or
the alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements
therein not misleading, provided that this agreement to
indemnify shall not apply as to any Indemnified Party if such
statement or omission or such alleged statement or omission
was made in reliance upon and in conformity with information
furnished to the Company by or on behalf of the Fund for use
in the Registration Statement or prospectus for the Contracts
or in the Contracts or sales literature (or any amendment or
supplement) or otherwise for use in connection with the sale
of the Contracts or Fund shares; or
-12-
<PAGE>
(ii) arise out of or as a result of statements or
representations (other than statements or representations
contained in the Registration Statement, prospectus or sales
literature of the Fund not supplied by the Company, or persons
under its control) or wrongful conduct of the Company or
persons under its control, with respect to the sale or
distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue
statement of a material fact contained in a Registration
Statement, prospectus, or sales literature of the Fund or any
amendment thereof or supplement thereto or the omission or
alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein
not misleading if such a statement or omission was made in
reliance upon information furnished to the Fund by or on
behalf of the Company: or
(iv) arise as a result of any failure by the Company to
provide the services and furnish the materials under the terms
of this Agreement; or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Company in this
Agreement or arise out of or result from any other material
breach of this Agreement by the Company, as limited by and in
accordance with the provisions of Sections 8.1(b) and 8.1(c)
hereof.
8.1(b). The Company shall not be liable under this
indemnification provision with respect to any losses, claims,
damages, liabilities or litigation incurred or assessed
against an Indemnified Party as such may arise from such
Indemnified Party's willful misfeasance, bad faith, or gross
negligence in the performance of such Indemnified Party's
duties or by reason of such Indemnified Party's reckless
disregard of obligations or duties under this Agreement or to
the Fund, whichever is applicable.
8.1(c). The Company shall not be liable under this
indemnification provision with respect to any claim made
against an Indemnified Party unless such Indemnified Party
shall have notified the Company in writing within a reasonable
time after the summons or other first legal process giving
information of the nature of the claim shall have been served
upon such Indemnified Party (or after such Indemnified Party
shall have received notice of such service on any designated
agent), but failure to notify the Company of any such claim
shall not relieve the Company from any liability which it may
have to the Indemnified Party against whom such action is
brought otherwise than on account of this indemnification
provision. In case any such action is brought against the
Indemnified Parties, the Company shall be entitled to
-13-
<PAGE>
participate, at its own expense, in the defense of such
action. The Company also shall be entitled to assume the
defense thereof, with counsel satisfactory to the party named
in the action. After notice from the Company to such party of
the Company's election to assume the defense thereof, the
Indemnified Party shall bear the fees and expenses of any
additional counsel retained by it, and the Company will not be
liable to such party under this Agreement for any legal or
other expenses subsequently incurred by such party
independently in connection with the defense thereof other
than reasonable costs of investigation.
8.l(d). The Indemnified Parties will promptly notify the
Company of the commencement of any litigation or proceedings
against them in connection with the issuance or sale of the
Fund Shares or the Contracts or the operation of the Fund.
8.2. Indemnification by the Underwriter
8.2(a). The Underwriter agrees to indemnify and hold harmless the
Company and each of its directors and officers and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act
(collectively, the "Indemnified Parties" for purposes of this Section 8.2)
against any and all losses, claims, damages, liabilities (including amounts paid
in settlement with the written consent of the Underwriter) or litigation
(including legal and other expenses) to which the Indemnified Parties may become
subject under any statute, at common law or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions in respect thereof) or
settlements are related to the sale or acquisition of the Fund's shares or the
Contracts and:
(i) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the
Registration Statement or prospectus or sales literature of
the Fund (or any amendment or supplement to any of the
foregoing), or arise out of or are based upon the omission or
the alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements
therein not misleading, provided that this agreement to
indemnify shall not apply as to any Indemnified Party if such
statement or omission or such alleged statement or omission
was made in reliance upon and in conformity with information
furnished to the Underwriter or Fund by or on behalf of the
Company for use in the Registration Statement or prospectus
for the Fund or in sales literature (or any amendment or
supplement) or otherwise for use in connection with the sale
of the Contracts or Fund shares: or
(ii) arise out of or as a result of statements or
representations (other than statements or representations
contained in the Registration Statement, prospectus or
-14-
<PAGE>
sales literature for the Contracts not supplied by the
Underwriter or persons under its control) or wrongful conduct
of the Fund, Adviser or Underwriter or persons under their
control, with respect to the sale or distribution of the
Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue
statement of a material fact contained in a Registration
Statement, prospectus, or sales literature covering the
Contracts, or any amendment thereof or supplement thereto, or
the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the
statement or statements therein not misleading, if such
statement or omission was made in reliance upon information
furnished to the Company by or on behalf of the Fund; or
(iv) arise as a result of any failure by the Fund to provide
the services and furnish the materials under the terms of this
Agreement (including a failure, whether unintentional or in
good faith or otherwise, to comply with the diversification
requirements specified in Article VI of this Agreement); or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Underwriter in this
Agreement or arise out of or result from any other material
breach of this Agreement by the Underwriter; as limited by and
in accordance with the provisions of Sections 8.2(b) and
8.2(c) hereof.
8.2(b). The Underwriter shall not be liable under this
indemnification provision with respect to any losses, claims, damages,
liabilities or litigation to which an Indemnified Party would otherwise be
subject by reason of such Indemnified Party's willful misfeasance, bad faith, or
gross negligence in the performance of such Indemnified Party's duties or by
reason of such Indemnified Party's reckless disregard of obligations and duties
under this Agreement or to each Company or the Account, whichever is
applicable.
8.2(c). The Underwriter shall not be liable under this
indemnification provision with respect to any claim made against an Indemnified
Party unless such Indemnified Party shall have notified the Underwriter in
writing within a reasonable time after the summons or other first legal process
giving information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Underwriter of
any such claim shall not relieve the Underwriter from any liability which it may
have to the Indemnified Party against whom such action is brought otherwise than
on account of this indemnification provision. In case any such action is brought
against the Indemnified Parties, the Underwriter will be entitled to
participate, at its own expense, in the defense thereof. The Underwriter also
shall be entitled to
-15-
<PAGE>
assume the defense thereof, with counsel satisfactory to the party named in the
action. After notice from the Underwriter to such party of the Underwriter's
election to assume the defense thereof, the Indemnified Party shall bear the
fees and expenses of any additional counsel retained by it, and the Underwriter
will not be liable to such party under this Agreement for any legal or other
expenses subsequently incurred by such party independently in connection with
the defense thereof other than reasonable costs of investigation.
8.2(d). The Company agrees promptly to notify the Underwriter of the
commencement of any litigation or proceedings against it or any of its officers
or directors in connection with the issuance or sale of the Contracts or the
operation of each Account.
8.3. Indemnification By the Fund
8.3(a). The Fund agrees to indemnify and hold harmless the Company,
and each of its directors and officers and each person, if any, who controls the
Company within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" for purposes of this Section 8.3) against any and all
losses, claims, damages, liabilities (including amounts paid in settlement with
the written consent of the Fund) or litigation (including legal and other
expenses) to which the Indemnified Parties may become subject under any statute,
at common law or otherwise, insofar as such losses, claims, damages, liabilities
or expenses (or actions in respect thereof) or settlements result from the gross
negligence, bad faith or willful misconduct of the Board or any member thereof,
are related to the operations of the Fund and:
(i) arise as a result of any failure by the Fund to provide the
services and furnish the materials under the terms of this
Agreement (including a failure to comply with the diversification
requirements specified in Article VI of this Agreement); or
(ii) arise out of or result from any material breach of any
representation and/or warranty made by the Fund in this Agreement
or arise out of or result from any other material breach of this
Agreement by the Fund;
as limited by and in accordance with the provisions of Sections 8.3(b) and
8.3(c) hereof.
8.3(b). The Fund shall not be liable under this indemnification
provision with respect to any losses, claims, damages, liabilities or litigation
incurred or assessed against an Indemnified Party as such may arise from such
Indemnified Party's willful misfeasance, bad faith, or gross negligence in the
performance of such Indemnified Party's duties or by reason of such Indemnified
Party's reckless disregard of obligations and duties under this Agreement or to
the Company, the Fund, the Underwriter or each Account, whichever is applicable.
-16-
<PAGE>
8.3(c). The Fund shall not be liable under this indemnification
provision with respect to any claim made against an Indemnified Party unless
such Indemnified Party shall have notified the Fund in writing within a
reasonable time after the summons or other first legal process giving
information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Fund of any
such claim shall not relieve the Fund from any liability which it may have to
the Indemnified Party against whom such action is brought otherwise than on
account of this indemnification provision. In case any such action is brought
against the Indemnified Parties, the Fund will be entitled to participate, at
its own expense, in the defense thereof. The Fund also shall be entitled to
assume the defense thereof, with counsel satisfactory to the party named in the
action. After notice from the Fund to such party of the Fund's election to
assume the defense thereof, the Indemnified Party shall bear the fees and
expenses of any additional counsel retained by it, and the Fund will not be
liable to such party under this Agreement for any legal or other expenses
subsequently incurred by such party independently in connection with the defense
thereof other than reasonable costs of investigation.
8.3(d). The Company and the Underwriter agree promptly to notify the
Fund of the commencement of any litigation or proceedings against it or any of
its respective officers or directors in connection with this Agreement, the
issuance or sale of the Contracts, with respect to the operation of either
Account, or the sale or acquisition of shares of the Fund.
ARTICLE IX. Applicable Law
9.1. This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of the Commonwealth of
Massachusetts.
9.2. This Agreement shall be subject to the provisions of the 1933,
1934 and 1940 acts, and the rules and regulations and rulings thereunder,
including such exemptions from those statutes, rules and regulations as the
Securities and Exchange Commission may grant (including, but not limited to, the
Shared Funding Exemptive Order) and the terms hereof shall be interpreted and
construed in accordance therewith.
ARTICLE X. Termination
10.1. This Agreement shall terminate:
(a) at the option of any party upon one year advance written
notice to the other parties; or
-17-
<PAGE>
(b) at the option of the Company to the extent that shares of
Portfolios are not reasonably available to meet the
requirements of the Contracts as determined by the Company,
provided however, that such termination shall apply only to
the Portfolio(s) not reasonably available. Prompt notice of
the election to terminate for such cause shall be furnished by
the Company; or
(c) at the option of the Fund in the event that formal
administrative proceedings are instituted against the Company
by the NASD, the Securities and Exchange Commission, the
Insurance Commissioner or any other regulatory body regarding
the Company's duties under this Agreement or related to the
sale of the Contracts, with respect to the operation of any
Account, or the purchase of the Fund shares, provided,
however, that the Fund determines in its sole judgment
exercised in good faith, that any such administrative
proceedings will have a material adverse effect upon the
ability of the Company to perform its obligations under this
Agreement; or
(d) at the option of the Company in the event that formal
administrative proceedings are instituted against the Fund or
Underwriter by the NASD, the Securities and Exchange
Commission, or any state securities or insurance department or
any other regulatory body, provided, however, that the Company
determines in its sole judgment exercised in good faith, that
any such administrative proceedings will have a material
adverse effect upon the ability of the Fund or Underwriter to
perform its obligations under this Agreement; or
(e) with respect to any Account, upon requisite vote of the
Contract owners having an interest in such Account (or any
subaccount) to substitute the shares of another investment
company for the corresponding Portfolio shares of the Fund in
accordance with the terms of the Contracts for which those
Portfolio shares had been selected to serve as the underlying
investment media. The Company will give 30 days' prior written
notice to the Fund of the date of any proposed vote to replace
the Fund's shares; or
(f) at the option of the Company, in the event any of the
Fund's shares are not registered, issued or sold in accordance
with applicable state and/or federal law or such law precludes
the use of such shares as the underlying investment media of
the Contracts issued or to be issued by the Company; or
(g) at the option of the Company, if the Fund ceases to
qualify as a Regulated Investment Company under Subchapter M
of the Code or under any successor or similar provision, or if
the Company reasonably believes that the Fund may fail to so
qualify; or
-18-
<PAGE>
(h) at the option of the Company, if the Fund fails to meet
the diversification requirements specified in Article VI
hereof; or
(i) at the option of either the Fund or the Underwriter, if
(1) the Fund or the Underwriter, respectively, shall
determine, in their sole judgment reasonably exercised in good
faith, that the Company has suffered a material adverse change
in its business or financial condition or is the subject of
material adverse publicity and such material adverse change or
material adverse publicity will have a material adverse impact
upon the business and operations of either the Fund or the
Underwriter, (2) the Fund or the Underwriter shall notify the
Company in writing of such determination and its intent to
terminate this Agreement, and (3) after considering the
actions taken by the Company and any other changes in
circumstances since the giving of such notice, such
determination of the Fund or the Underwriter shall continue to
apply on the sixtieth (60th) day following the giving of such
notice, which sixtieth day shall be the effective date of
termination; or
(j) at the option of the Company, if (1) the Company shall
determine, in its sole judgment reasonably exercised in good
faith, that either the Fund or the Underwriter has suffered a
material adverse change in its business or financial condition
or is the subject of material adverse publicity and such
material adverse change or material adverse publicity will
have a material adverse impact upon the business and
operations of the Company, (2) the Company shall notify the
Fund and the Underwriter in writing of such determination and
its intent to terminate the Agreement, and (3) after
considering the actions taken by the Fund and/or the
Underwriter and any other changes in circumstances since the
giving of such notice, such determination shall continue to
apply on the sixtieth (60th) day following the giving of such
notice, which sixtieth day shall be the effective date of
termination; or
(k) at the option of either the Fund or the Underwriter, if
the Company gives the Fund and the Underwriter the written
notice specified in Section 1.6(b) hereof and at the time such
notice was given there was no notice of termination
outstanding under any other provision of this Agreement;
provided, however any termination under this Section 10.1(k)
shall be effective forty five (45) days after the notice
specified in Section 1.6(b) was given.
10.2. It is understood and agreed that the right of any party hereto
to terminate this Agreement pursuant to Section 10.1(a) may be exercised for any
reason or for no reason.
-19-
<PAGE>
10.3. Notice Requirement. No termination of this Agreement shall be
effective unless and until the party terminating this Agreement gives prior
written notice to all other parties to this Agreement of its intent to terminate
which notice shall set forth the basis for such termination. Furthermore,
(a) In the event that any termination is based upon the
provisions of Article VII, or the provision of Section 10.1(a),
10.1(i), 10.1(j) or 10.1(k) of this Agreement, such prior written
notice shall be given in advance of the effective date of
termination as required by such provisions; and
(b) in the event that any termination is based upon the
provisions of Section 10.1(c) or 10.1(d) of this Agreement, such
prior written notice shall be given at least ninety (90) days
before the effective date of termination.
10.4. Effect of Termination. Notwithstanding any termination of this
Agreement, the Fund and the Underwriter shall, at the option of the Company,
continue to make available additional shares of the Fund pursuant to the terms
and conditions of this Agreement, for all Contracts in effect on the effective
date of termination of this Agreement (hereinafter referred to as "Existing
Contracts"). Specifically, without limitation, the owners of the Existing
Contracts shall be permitted to reallocate investments in the Fund, redeem
investments in the Fund and/or invest in the Fund upon the making of additional
purchase payments under the Existing Contracts. The parties agree that this
Section 10.4 shall not apply to any terminations under Article VII and the
effect of such Article VII terminations shall be governed by Article VII of this
Agreement.
10.5. The Company shall not redeem Fund shares attributable to the
Contracts (as opposed to Fund shares attributable to the Company's assets held
in either Account) except (i) as necessary to implement Contract Owner initiated
transactions, or (ii) as required by state and/or federal laws or regulations or
judicial or other legal precedent of general application (hereinafter referred
to as a "Legally Required Redemption"). Upon request, the Company will promptly
furnish to the Fund and the Underwriter the opinion of counsel for the Company
(which counsel shall be reasonably satisfactory to the Fund and the Underwriter)
to the effect that any redemption pursuant to clause (ii) above is a Legally
Required Redemption. Furthermore, except in cases where permitted under the
terms of the Contracts, the Company shall not prevent Contract Owners from
allocating payments to a Portfolio that was otherwise available under the
Contracts without first giving the Fund or the Underwriter 90 days notice of its
intention to do so.
-20-
<PAGE>
ARTICLE XI. Notices
Any notice shall be sufficiently given when sent by registered or
certified mail to the other party at the address of such party set forth below
or at such other address as such party may from time to time specify in writing
to the other party.
If to the Fund:
82 Devonshire Street
Boston, Massachusetts 02109
Attention: Treasurer
If to the Company:
SMA Life Assurance
440 Lincoln Street
Worcester, Massachusetts 01605
Attention: Sheila B. St. Hilaire
If to the Underwriter:
82 Devonshire Street
Boston, Massachusetts 02109
Attention: Treasurer
ARTICLE XII. Miscellaneous
12.1 All persons dealing with the Fund must look solely to the
property of the Fund for the enforcement of any claims against the Fund as
neither the Board, officers, agents or shareholders assume any personal
liability for obligations entered into on behalf of the Fund.
12.2 Subject to the requirements of legal process and regulatory
authority, each party hereto shall treat as confidential the names and addresses
of the owners of the Contracts and all information reasonably identified as
confidential in writing by any other party hereto and, except as permitted by
this Agreement, shall not disclose, disseminate or utilize such names and
addresses and other confidential information until such time as it may come into
the public domain without the express written consent of the affected party.
12.3 The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
12.4 This Agreement may be executed simultaneously in two or more
counterparts, each of which taken together shall constitute one and the same
instrument.
-21-
<PAGE>
12.5 If any provision of this Agreement shall be held or made
invalid by a court decision, statute, rule or otherwise, the remainder of the
Agreement shall not be affected thereby.
12.6 Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the
Securities and Exchange Commission, the NASD and state insurance regulators) and
shall permit such authorities reasonable access to its books and records in
connection with any investigation or inquiry relating to this Agreement or the
transactions contemplated hereby. Notwithstanding the generality of the
foregoing, each party hereto further agrees to furnish the California Insurance
Commissioner with any information or reports in connection with services
provided under this Agreement which such Commissioner may request in order to
ascertain whether the variable life insurance operations of the Company are
being conducted in a manner consistent with the California Variable Life
Insurance Regulations and any other applicable law or regulations.
12.7 The Fund and Underwriter agree that to the extent any advisory
or other fees received by the Fund, the Underwriter or the Adviser are
determined to be unlawful in legal or administrative proceedings under the 1973
NAIC model variable life insurance regulation in the states of California,
Colorado, Maryland or Michigan, the Underwriter shall indemnify and reimburse
the Company for any out of pocket expenses and actual damages the Company has
incurred as a result of any such proceeding; provided however that the
provisions of Section 8.2(b) of this and 8.2(c) shall apply to such
indemnification and reimbursement obligation. Such indemnification and
reimbursement obligation shall be in addition to any other indemnification and
reimbursement obligations of the Fund and/or the Underwriter under this
Agreement.
12.8. The rights, remedies and obligations contained in this
Agreement are cumulative and are in addition to any and all rights, remedies and
obligations, at law or in equity, which the parties hereto are entitled to under
state and federal laws.
-22-
<PAGE>
IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed in its name and on its behalf by its duly authorized
representative and its seal to be hereunder affixed hereto as of the date
specified below.
Company:
SMA LIFE ASSURANCE COMPANY
By its authorized officer,
SEAL By: /s/ Bradford K. Gallagher
--------------------------------------
Title: President
--------------------------------------
Date: 7/11/91
--------------------------------------
Fund:
VARIABLE INSURANCE PRODUCTS FUND
By its authorized officer,
SEAL By: /s/ J. Gary Burkhead
--------------------------------------
Title: Senior Vice President
--------------------------------------
Date:
--------------------------------------
Underwriter:
FIDELITY DISTRIBUTORS CORPORATION
By its authorized officer,
SEAL By: /s/ [Illegible] B. Kincaid
--------------------------------------
Title: President
--------------------------------------
Date: 9/5/91
--------------------------------------
-23-
<PAGE>
Schedule A
----------
Accounts
--------
Name of Account Date of Resolution of Company's Board
which Established the Account
Separate Account VA-K November 1, 1990
-24-
<PAGE>
Schedule B
----------
Contracts
---------
1. Contract Form A3018-91
---------------
-25-
<PAGE>
SCHEDULE C
PROXY VOTING PROCEDURE
The following is a list of procedures and corresponding responsibilities for the
handling of proxies relating to the Fund by the Underwriter, the Fund and the
Company. The defined terms herein shall have the meanings assigned in the
Participation Agreement except that the term "Company" shall also include the
department or third party assigned by the Insurance Company to perform the steps
delineated below.
1. The number of proxy proposals is given to the Company by the Underwriter
as early as possible before the date set by the Fund for the shareholder
meeting to facilitate the establishment of tabulation procedures. At this
time the Underwriter will inform the Company of the Record, Mailing and
Meeting dates. This will be done verbally approximately two months before
meeting.
2. Promptly after the Record Date, the Company will perform a "tape run", or
other activity, which will generate the names, addresses and number of
units which are attributed to each contractowner/policyholder (the
"Customer") as of the Record Date. Allowance should be made for account
adjustments made after this date that could affect the status of the
Customers' accounts as of the Record Date.
Note: The number of proxy statements is determined by the activities
described in Step #2. The Company will use its best efforts to call
in the number of Customers to Fidelity, as soon as possible, but no
later than two weeks after the Record Date.
3. The Fund's Annual Report must be sent to each Customer by the Company
either before or together with the Customers' receipt of a proxy
statement. Underwriter will provide at least one copy of the last Annual
Report to the Company.
4. The text and format for the Voting Instruction Cards ("Cards" or "Card")
is provided to the Company by the Fund. The Company, at its expense, shall
produce and personalize the Voting Instruction Cards. The Legal
Department of the Underwriter or its affiliate ("Fidelity Legal") must
approve the Card before it is printed. Allow approximately 2-4 business
days for printing information on the Cards. Information commonly found on
the Cards includes:
a. name (legal name as found on account registration)
b. address
c. Fund or account number
d. coding to state number of units
e. individual Card number for use in tracking and verification of
votes (already on Cards as printed by the Fund)
(This and related steps may occur later in the chronological process due to
possible uncertainties relating to the proposals.)
-26-
<PAGE>
5. During this time, Fidelity Legal will develop, produce, and the Fund will
pay for the Notice of Proxy and the Proxy Statement (one document).
Printed and folded notices and statements will be sent to Company for
insertion into envelopes (envelopes and return envelopes are provided and
paid for by the Insurance Company). Contents of envelope sent to Customers
by Company will include:
a. Voting Instruction Card(s)
b. One proxy notice and statement (one document)
c. return envelope (postage pre-paid by Company) addressed to the
Company or its tabulation agent
d. "urge buckslip" - optional, but recommended. (This is a small,
single sheet of paper that requests Customers to vote as
quickly as possible and that their vote is important. One copy
will be supplied by the Fund.)
e. cover letter - optional, supplied by Company and reviewed and
approved in advance by Fidelity Legal.
6. The above contents should be received by the Company approximately 3-5
business days before mail date. Individual in charge at Company reviews
and approves the contents of the mailing package to ensure correctness and
completeness. Copy of this approval sent to Fidelity Legal.
7. Package mailed by the Company.
* The Fund must allow at least a 15-day solicitation time to the
Company as the shareowner. (A 5-week period is recommended.)
Solicitation time is calculated as calendar days from (but not
including) the meeting, counting backwards.
8. Collection and tabulation of Cards begins. Tabulation usually takes place
in another department or another vendor depending on process used. An
often used procedure is to sort Cards on arrival by proposal into vote
categories of all yes, no, or mixed replies, and to begin data entry.
Note: Postmarks are not generally needed. A need for postmark information
would be due to an insurance company's internal procedure and has
not been required by Fidelity in the past.
9. Signatures on Card checked against legal name on account registration
which was printed on the Card.
Note: For Example, If the account registration is under "Bertram C. Jones,
Trustee," then that is the exact legal name to be printed on the Card and
is the signature needed on the Card.
-27-
<PAGE>
10. If Cards are mutilated, or for any reason are illegible or are not signed
properly, they are sent back to Customer with an explanatory letter, a new
Card and return envelope. The mutilated or illegible Card is disregarded
and considered to be not received for purposes of vote tabulation. Any
Cards that have "kicked out" (e.g. mutilated, illegible) of the procedure
are "hand verified," i.e., examined as to why they did not complete the
system. Any questions on those Cards are usually remedied individually.
11. There are various control procedures used to ensure proper tabulation of
votes and accuracy of that tabulation. The most prevalent is to sort the
Cards as they first arrive into categories depending upon their vote; an
estimate of how the vote is progressing may then be calculated. If the
initial estimates and the actual vote do not coincide, then an internal
audit of that vote should occur. This may entail a recount.
12. The actual tabulation of votes is done in units which is then converted to
shares. (It is very important that the Fund receives the tabulations
stated in terms of a percentage and the number of shares.) Fidelity Legal
must review and approve tabulation format.
13. Final tabulation in shares is verbally given by the Company to Fidelity
Legal on the morning of the meeting not later than 10:00 a.m. Boston time.
Fidelity Legal may request an earlier deadline if required to calculate
the vote in time for the meeting.
14. A Certification of Mailing and Authorization to Vote Shares will be
required from the Company as well as an original copy of the final vote.
Fidelity Legal will provided a standard from for each Certification.
15. The Company will be required to box and archive the Cards received from
the Customers. In the event that any vote is challenged or if otherwise
necessary for legal, regulatory, or accounting purposes, Fidelity Legal
will be permitted reasonable access to such Cards.
16. All approvals and "signing-off" may be done orally, but must always be
followed up in writing.
-28-
<PAGE>
AMENDMENT NO. 1
Amendment to the Participation Agreement among SMA Life Assurance Company
(the "Company"), Variable Insurance Products Fund (the "Fund") and Fidelity
Distributors Corporation (the "Underwriter") dated May 1, 1991 (the Agreement").
WHEREAS, each of the parties is desirous of expanding the ability of
Company to participate in the qualified markets, the Company, the Underwriter
and the Fund hereby agree to amend the Agreement by deleting from Section 1.4
the reference to Section 2.12 and by deleting Section 2.12 in its entirety.
In witness whereof, each of the parties has caused this Amendment to be
executed in its name and on its behalf by its duly authorized representative as
of November 1, 1991.
SMA LIFE ASSURANCE COMPANY FIDELITY DISTRIBUTORS CORPORATION
By: /s/ Bradford K. Gallagher By: /s/ Roger T. Servison
------------------------- -------------------------
Name: Bradford K. Gallagher Name: Roger T. Servison
------------------------- -------------------------
Title: President, SMA Life Assurance Co. Title: President
------------------------- -------------------------
VARIABLE INSURANCE PRODUCTS FUND
By: /s/ J. Gary Burkhead
-------------------------
Name: J. Gary Burkhead
-------------------------
Title: Senior V.P.
-------------------------
<PAGE>
Amendment to Schedules A and B to the Participation Agreement
among
Variable Insurance Products Fund
Fidelity Distributors Corporation
and
Allmerica Financial Life Insurance and Annuity Company
WHEREAS, Allmerica Financial Life Insurance and Annuity Company (the "Company";
formerly SMA Life Assurance Company), Variable Insurance Products Fund, and
Fidelity Distributors Corporation have previously entered into a Participation
Agreement dated May 1, 1991 ("Participation Agreement"); and
WHEREAS, the Participation Agreement provides for the amendment of Schedules A
and B thereto by mutual written consent, the parties from time-to-time have so
amended Schedules A and B, and the parties now wish to consolidate said prior
amendments to Schedules A and B into a single document and to update Schedules A
and B;
NOW, THEREFORE, the parties do hereby agree:
1. To amend and update Schedule A and Schedule B to the Participation Agreement
by adopting the attached Schedule A/B, dated July 15, 1997, and by substituting
the attached Schedule A/B for any and all prior amendments to Schedule A and to
Schedule B, as may have been adopted from time-to-time.
In witness whereof, each of the parties has caused this agreement to be executed
in its name and on its behalf by its duly authorized representative as of the
date specified below.
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
By: /s/ Richard M. Reilly
-------------------------
Name: Richard M. Reilly
-------------------------
Title: President
-------------------------
Date: July 16, 1997
-------------------------
VARIABLE INSURANCE PRODUCTS FUND II FIDELITY DISTRIBUTORS CORPORATION
By: /s/ By: /s/
------------------------- -------------------------
Name: Name:
------------------------- -------------------------
Title: Title:
------------------------- -------------------------
Date: Date:
------------------------- -------------------------
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
Schedule A/B to Participation Agreement dated May 1, 1991
(Dated 7/15/97)
Separate Account* Product Name Registration
- ----------------- ------------ ------------
VEL (Variable Life) VEL '87 33-14672
Policy Form 1018-87 811-5183
VEL '91 33-90320
Policy Form 1018-91 811-5183
VEL PLUS 33-42687
Policy Forms 1023-91; 811-5183
1023-93
VEL II VEL '93 33-57792
(Variable Life) Policy Form 1018-93 811-7466
Inheiritage Inheiritage 33-70948
(Variable Life) Policy Form 1026-94 811-8120
Allmerica Select Select Life 33-83604
Separate Account II Policy Form 1027-95 811-8746
(Variable Life)
Group VEL Group VEL 33-82658
(Variable Life) Policy Form 1029-94 811-8704
VA-K ExecAnnuity 33-39702
(Annuity) ExecAnnuity Plus 811-6293
Advantage
Policy Forms 3018-91;
3021-93;3025-96; 8025-96
Allmerica Select Select Resource I 33-47216
(Annuity) Select Resource II 811-6632
Policy Forms A3020-92;
A3020-95; 3025-96;
8025-96
*The Separate Accounts were authorized by vote of the Board of Directors on the
following dates: VEL - April 2, 1987; VEL II - January 21, 1993; Inheiritage -
September 15, 1993; Allmerica Select Separate Account II - October 12, 1993;
Group VEL - November 22, 1993; VA-K - November 1, 1990; Allmerica Select - March
5, 1992.
<PAGE>
PARTICIPATION AGREEMENT
Among
VARIABLE INSURANCE PRODUCTS FUND II,
FIDELITY DISTRIBUTORS CORPORATION
and
SMA LIFE ASSURANCE COMPANY
THIS AGREEMENT, made and entered into as of the 1st day of March,
1994 by and among SMA LIFE ASSURANCE COMPANY, (hereinafter the "Company"), a
Delaware corporation, on its own behalf and on behalf of each segregated asset
account of the Company set forth on Schedule A hereto as may be amended from
time to time (each such account hereinafter referred to as the "Account"), and
the VARIABLE INSURANCE PRODUCTS FUND II, an unincorporated business trust
organized under the laws of the Commonwealth of Massachusetts (hereinafter the
"Fund") and FIDELITY DISTRIBUTORS CORPORATION (hereinafter the "Underwriter"), a
Massachusetts corporation.
WHEREAS, the Fund engages in business as an open-end management
investment company and is available to act as the investment vehicle for
separate accounts established for variable life insurance policies and variable
annuity contracts (collectively, the "Variable Insurance Products") to be
offered by insurance companies which have entered into participation agreements
with the Fund and the Underwriter (hereinafter "Participating Insurance
Companies"); and
WHEREAS, the beneficial interest in the Fund is divided into several
series of shares, each designated a "Portfolio" and representing the interest in
a particular managed portfolio of securities and other assets; and
WHEREAS, the Fund has obtained an order from the Securities and
Exchange Commission, dated September 17, 1986 (File No. 812-6422), granting
Participating Insurance Companies and variable annuity and variable life
insurance separate accounts exemptions from the provisions of sections 9(a),
13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended,
(hereinafter the "1940 Act") and Rules 6e-2(b) (15) and 6e-3(T) (b) (15)
thereunder, to the extent necessary to permit shares of the Fund to be sold to
and held by variable annuity and variable life insurance separate accounts of
both affiliated and unaffiliated life insurance companies (hereinafter the
"Shared Funding Exemptive Order"); and
1
<PAGE>
WHEREAS, the Fund is registered as an open-end management investment
company under the 1940 Act and its shares are registered under the Securities
Act of 1933, as amended (hereinafter the "1933 Act"); and
WHEREAS, Fidelity Management & Research Company (the "Adviser") is
duly registered as an investment adviser under the federal Investment Advisers
Act of 1940 and any applicable state securities law; and
WHEREAS, the Company has registered or will register certain
variable life insurance and variable annuity contracts under the 1933 Act; and
WHEREAS, each Account is a duly organized, validly existing
segregated asset account, established by resolution of the Board of Directors of
the Company, on the date shown for such Account on Schedule A hereto, to set
aside and invest assets attributable to the aforesaid variable annuity
contracts; and
WHEREAS, the Company has registered or will register each Account as
a unit investment trust under the 1940 Act; and
WHEREAS, the Underwriter is registered as a broker dealer with the
Securities and Exchange Commission ("SEC") under the Securities Exchange Act of
1934, as amended, (hereinafter the "1934 Act"), and is a member in good standing
of the National Association of Securities Dealers, Inc. (hereinafter "NASD");
and
WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase shares in the Portfolios on behalf
of each Account to fund certain of the aforesaid variable life and variable
annuity contracts and the Underwriter is authorized to sell such shares to unit
investment trusts such as each Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the
Company, the Fund and the Underwriter agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. The Underwriter agrees to sell to the Company those shares of
the Fund which each Account orders, executing such orders on a daily basis at
the net asset value next computed after receipt by the Fund or its designee of
the order for the shares of the Fund. For purposes of this Section 1.1, the
Company shall be the designee of the Fund for receipt of such orders from each
Account and receipt by such designee shall constitute receipt by the Fund;
provided that the Fund receives notice of such order by 9:30 a.m. Boston time on
the next following Business Day. "Business Day" shall mean any day on which the
New York Stock Exchange is open for trading and on which the Fund calculates its
net asset value pursuant to the rules of the Securities and Exchange Commission.
2
<PAGE>
1.2. The Fund agrees to make its shares available indefinitely for
purchase at the applicable net asset value per share by the Company and its
Accounts on those days on which the Fund calculates its net asset value pursuant
to rules of the Securities and Exchange Commission and the Fund shall use
reasonable efforts to calculate such net asset value on each day which the New
York Stock Exchange is open for trading. Notwithstanding the foregoing, the
Board of Trustees of the Fund (hereinafter the "Board") may refuse to sell
shares of any Portfolio to any person, or suspend or terminate the offering of
shares of any Portfolio if such action is required by law or by regulatory
authorities having jurisdiction or is, in the sole discretion of the Board
acting in good faith and in light of their fiduciary duties under federal and
any applicable state laws, necessary in the best interests of the shareholders
of such Portfolio.
1.3. The Fund and the Underwriter agree that shares of the Fund will
be sold only to Participating Insurance Companies and their separate accounts.
No shares of any Portfolio will be sold to the general public.
1.4. The Fund and the Underwriter will not sell Fund shares to any
insurance company or separate account unless an agreement containing provisions
substantially the same as Articles I, III, V, VII and Section 2.5 of Article II
of this Agreement is in effect to govern such sales.
1.5. The Fund agrees to redeem for cash, on the Company's request,
any full or fractional shares of the Fund held by the Company, executing such
requests on a daily basis at the net asset value next computed after receipt by
the Fund or its designee of the request for redemption. For purposes of this
Section 1.5, the Company shall be the designee of the Fund for receipt of
requests for redemption from each Account and receipt by such designee shall
constitute receipt by the Fund; provided that the Fund receives notice of such
request for redemption on the next following Business Day.
1.6. The Company agrees to purchase and redeem the shares of each
Portfolio offered by the then current prospectus of the Fund and in accordance
with the provisions of such prospectus. The Company agrees that all net amounts
available under the variable annuity contracts with the form number(s) which are
listed on Schedule A attached hereto and incorporated herein by this reference,
as such Schedule A may be amended from time to time hereafter by mutual written
agreement of all the parties hereto, (the "Contracts") shall be invested in the
Fund, in such other Funds advised by the Adviser as may be mutually agreed to in
writing by the parties hereto, or in the Company's general account, provided
that such amounts may also be invested in an investment company other than the
Fund if (a) such other investment company, or series thereof, has investment
objectives or policies that are substantially different from the investment
objectives and policies of all the Portfolios of the Fund; or (b) the Company
gives the Fund and the Underwriter 45 days written notice of its intention to
make such other investment company available as a funding vehicle for the
Contracts; or (c) such other investment company was available as a funding
vehicle for the Contracts prior to the date of this Agreement and the Company so
informs the Fund and Underwriter prior to their signing this Agreement (a list
of such funds appearing on Schedule C to this Agreement); or (d) the Fund or
Underwriter consents to the use of such other investment company.
3
<PAGE>
1.7. The Company shall pay for Fund shares on the next Business Day
after an order to purchase Fund shares is made in accordance with the provisions
of Section 1.1 hereof. Payment shall be in federal funds transmitted by wire.
For purpose of Section 2.10 and 2.11, upon receipt by the Fund of the federal
funds so wired, such funds shall cease to be the responsibility of the Company
and shall become the responsibility of the Fund.
1.8. Issuance and transfer of the Fund's shares will be by book
entry only. Stock certificates will not be issued to the Company or any Account.
Shares ordered from the Fund will be recorded in an appropriate title for each
Account or the appropriate subaccount of each Account.
1.9. The Fund shall furnish same day notice (by wire or telephone,
followed by written confirmation) to the Company of any income, dividends or
capital gain distributions payable on the Fund's shares. The Company hereby
elects to receive all such income dividends and capital gain distributions as
are payable on the Portfolio shares in additional shares of that Portfolio. The
Company reserves the right to revoke this election and to receive all such
income dividends and capital gain distributions in cash. The Fund shall notify
the Company of the number of shares so issued as payment of such dividends and
distributions.
1.10. The Fund shall make the net asset value per share for each
Portfolio available to the Company on a daily basis as soon as reasonably
practical after the net asset value per share is calculated and shall use its
best efforts to make such net asset value per share available by 7 p.m. Boston
time.
ARTICLE II. Representations and Warranties
2.1. The Company represents and warrants that the Contracts are or
will be registered under the 1933 Act; that the Contracts will be issued and
sold in compliance in all material respects with all applicable Federal and
State laws and that the sale of the Contracts shall comply in all material
respects with state insurance suitability requirements. The Company further
represents and warrants that it is an insurance company duly organized and in
good standing under applicable law and that it has legally and validly
established each Account prior to any issuance or sale thereof as a segregated
asset account under Section 2932 of the Delaware Insurance Code and has
registered or, prior to any issuance or sale of the Contracts, will register
each Account as a unit investment trust in accordance with the provisions of the
1940 Act to serve as a segregated investment account for the Contracts.
2.2. The Fund represents and warrants that Fund shares sold pursuant
to this Agreement shall be registered under the 1933 Act, duly authorized for
issuance and sold in compliance with the laws of the Commonwealth of
Massachusetts and all applicable federal and state securities laws and that the
Fund is and shall remain registered under the 1940 Act. The Fund shall amend the
Registration Statement for its shares under the 1933 Act and the 1940 Act from
time to time as required in order to effect the continuous offering of its
shares. The Fund
4
<PAGE>
shall register and qualify the shares for sale in accordance with the laws of
the various states only if and to the extent deemed advisable by the Fund or the
Underwriter.
2.3. The Fund represents that it is currently qualified as a
Regulated Investment Company under Subchapter M of the Internal Revenue Code of
1986, as amended, (the "Code") and that it will make every effort to maintain
such qualification (under Subchapter M or any successor or similar provision)
and that it will notify the Company immediately upon having a reasonable basis
for believing that it has ceased to so qualify or that it might not so qualify
in the future.
2.4. The Company represents that the Contracts are currently treated
as life insurance or annuity contracts, under applicable provisions of the Code
and that it will make every effort to maintain such treatment and that it will
notify the Fund and the Underwriter immediately upon having a reasonable basis
for believing that the Contracts have ceased to be so treated or that they might
not be so treated in the future.
2.5. The Fund currently does not intend to make any payments to
finance distribution expenses pursuant to Rule 12b-l under the 1940 Act or
otherwise, although it may make such payments in the future. The Fund has
adopted a "no fee" or "defensive" Rule 12b-l Plan under which it makes no
payments for distribution expenses. To the extent that it decides to finance
distribution expenses pursuant to Rule 12b-l, the Fund undertakes to have a
board of trustees, a majority of whom are not interested persons of the Fund,
formulate and approve any plan under Rule 12b-l to finance distribution
expenses.
2.6. The Fund makes no representation as to whether any aspect of
its operations (including, but not limited to, fees and expenses and investment
policies) complies with the insurance laws or regulations of the various states
except that the Fund represents that the Fund's investment policies, fees and
expenses are and shall at all times remain in compliance with the laws of the
State of Delaware and the Fund and the Underwriter represent that their
respective operations are and shall at all times remain in material compliance
with the laws of the State of Delaware to the extent required to perform this
Agreement.
2.7. The Underwriter represents and warrants that it is a member in
good standing of the NASD and is registered as a broker-dealer with the SEC. The
Underwriter further represents that it will sell and distribute the Fund shares
in accordance with the laws of the State of Delaware and all applicable state
and federal securities laws, including without limitation the 1933 Act, the 1934
Act, and the 1940 Act.
2.8. The Fund represents that it is lawfully organized and validly
existing under the laws of the Commonwealth of Massachusetts and that it does
and will comply in all material respects with the 1940 Act.
2.9. The Underwriter represents and warrants that the Adviser is and
shall remain duly registered in all material respects under all applicable
federal and state securities laws and
5
<PAGE>
that the Adviser shall perform its obligations for the Fund in compliance in all
material respects with the laws of the State of Delaware and any applicable
state and federal securities laws.
2.10. The Fund and Underwriter represent and warrant that all of
their directors, officers, employees, investment advisers, and other
individuals/entities dealing with the money and/or securities of the Fund are
and shall continue to be at all times covered by a blanket fidelity bond or
similar coverage for the benefit of the Fund in an amount not less than the
minimal coverage as required currently by Rule 17g-(1) of the 1940 Act or
related provisions as may be promulgated from time to time. The aforesaid Bond
shall include coverage for larceny and embezzlement and shall be issued by a
reputable bonding company.
2.11. The Company represents and warrants that all of its directors,
officers, employees, investment advisers, and other individuals/entities dealing
with the money and/or securities of the Fund are covered by a blanket fidelity
bond or similar coverage for the benefit of the Fund, in an amount not less $5
million. The aforesaid includes coverage for larceny and embezzlement is issued
by a reputable bonding company. The Company agrees to make all reasonable
efforts to see that this bond or another bond containing these provisions is
always in effect, and agrees to notify the Fund and the Underwriter in the event
that such coverage no longer applies.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1. The Underwriter shall provide the Company (at the Company's
expense) with as many copies of the Fund's current prospectus as the Company may
reasonably request. If requested by the Company in lieu thereof, the Fund shall
provide such documentation (including a final copy of the new prospectus as set
in type at the Fund's expense) and other assistance as is reasonably necessary
in order for the Company once each year (or more frequently if the prospectus
for the Fund is amended) to have the prospectus for the Contracts and the Fund's
prospectus printed together in one document (such printing to be at the
Company's expense).
3.2. The Fund's prospectus shall state that the Statement of
Additional Information for the Fund is available from the Underwriter (or in the
Fund's discretion, the Prospectus shall state that such Statement is available
from the Fund), and the Underwriter (or the Fund), at its expense, shall print
and provide such Statement free of charge to the Company and to any owner of a
Contract or prospective owner who requests such Statement.
3.3. The Fund, at its expense, shall provide the Company with copies
of its proxy material, reports to shareholders, and other communications to
shareholders in such quantity as the Company shall reasonably require for
distributing to Contract owners.
3.4. If and to the extent required by law the Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the Fund shares in accordance with instructions
received from Contract owners; and
6
<PAGE>
(iii) vote Fund shares for which no instructions have been
received in the same proportion as Fund shares of such
portfolio for which instructions have been received,
so long as and to the extent that the Securities and Exchange Commission
continues to interpret the 1940 Act to require pass-through voting privileges
for variable contract owners. The Company reserves the right to vote Fund shares
held in any segregated asset account in its own right, to the extent permitted
by law. Participating Insurance Companies shall be responsible for assuring that
each of their separate accounts participating in the Fund calculates voting
privileges in a manner consistent with the standards set forth on Schedule B
attached hereto and incorporated herein by this reference, which standards will
also be provided to the other Participating Insurance Companies.
3.5. The Fund will comply with all provisions of the 1940 Act
requiring voting by shareholders, and in particular the Fund will either provide
for annual meetings or comply with Section 16(c) of the 1940 Act (although the
Fund is not one of the trusts described in Section l6(c) of that Act) as well as
with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will
act in accordance with the Securities and Exchange Commission's interpretation
of the requirements of Section 16(a) with respect to periodic elections of
trustees and with whatever rules the Commission may promulgate with respect
thereto.
ARTICLE IV. Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to
the Fund or its designee, each piece of sales literature or other promotional
material in which the Fund or its investment adviser or the Underwriter is
named, at least fifteen Business Days prior to its use. No such material shall
be used if the Fund or its designee reasonably objects to such use within
fifteen Business Days after receipt of such material.
4.2. The Company shall not give any information or make any
representations or statements on behalf of the Fund or concerning the Fund in
connection with the sale of the Contracts other than the information or
representations contained in the registration statement or prospectus for the
Fund shares, as such registration statement and prospectus may be amended or
supplemented from time to time, or in reports or proxy statements for the Fund,
or in sales literature or other promotional material approved by the Fund or its
designee or by the Underwriter, except with the permission of the Fund or the
Underwriter or the designee of either.
4.3. The Fund, Underwriter, or its designee shall furnish, or shall
cause to be furnished, to the Company or its designee, each piece of sales
literature or other promotional material in which the Company and/or its
separate account(s), is named at least fifteen Business Days prior to its use.
No such material shall be used if the Company or its designee reasonably objects
to such use within fifteen Business Days after receipt of such material.
7
<PAGE>
4.4. The Fund and the Underwriter shall not give any information or
make any representations on behalf of the Company or concerning the Company,
each Account, or the Contracts other than the information or representations
contained in a registration statement or prospectus for the Contracts, as such
registration statement and prospectus may be amended or supplemented from time
to time, or in published reports for each Account which are in the public domain
or approved by the Company for distribution to Contract owners, or in sales
literature or other promotional material approved by the Company or its
designee, except with the permission of the Company.
4.5. The Fund will provide to the Company at least one complete copy
of all registration statements, prospectuses, Statements of Additional
Information, reports, proxy statements, sales literature and other promotional
materials, applications for exemptions, requests for no-action letters, and all
amendments to any of the above, that relate to the Fund or its shares,
contemporaneously with the filing of such document with the Securities and
Exchange Commission or other regulatory authorities.
4.6. The Company will provide to the Fund at least one complete copy
of all registration statements, prospectuses, Statements of Additional
Information, reports, solicitations for voting instructions, sales literature
and other promotional materials, applications for exemptions, requests for no
action letters, and all amendments to any of the above, that relate to the
Contracts or each Account, contemporaneously with the filing of such document
with the SEC or other regulatory authorities.
4.7. For purposes of this Article IV, the phrase "sales literature
or other promotional material" includes, but is not limited to, advertisements
(such as material published, or designed for use in, a newspaper, magazine, or
other periodical, radio, television, telephone or tape recording, videotape
display, signs or billboards, motion pictures, or other public media), sales
literature (i.e., any written communication distributed or made generally
available to customers or the public, including brochures, circulars, research
reports, market letters, form letters, seminar texts, reprints or excerpts of
any other advertisement, sales literature, or published article), educational or
training materials or other communications distributed or made generally
available to some or all agents or employees, and registration statements,
prospectuses, Statements of Additional Information, shareholder reports, and
proxy materials.
ARTICLE V. Fees and Expenses
5.1. The Fund and Underwriter shall pay no fee or other compensation
to the Company under this agreement, except that if the Fund or any Portfolio
adopts and implements a plan pursuant to Rule 12b-l to finance distribution
expenses, then the Underwriter may make payments to the Company or to the
underwriter for the Contracts if and in amounts agreed to by the Underwriter in
writing and such payments will be made out of existing fees otherwise payable to
the Underwriter, past profits of the Underwriter or other resources available to
the Underwriter. No such payments shall be made directly by the Fund. Currently,
no such payments are contemplated.
8
<PAGE>
5.2. All expenses incident to performance by the Fund under this
Agreement shall be paid by the Fund. The Fund shall see to it that all its
shares are registered and authorized for issuance in accordance with applicable
federal law and, if and to the extent deemed advisable by the Fund, in
accordance with applicable state laws prior to their sale. The Fund shall bear
the expenses for the cost of registration and qualification of the Fund's
shares, preparation and filing of the Fund's prospectus and registration
statement, proxy materials and reports, setting the prospectus in type, setting
in type and printing the proxy materials and reports to shareholders (including
the costs of printing a prospectus that constitutes an annual report) and, the
preparation of all statements and notices required by any federal or state law,
all taxes on the issuance or transfer of the Fund's shares.
5.3. The Company shall bear the expenses of printing and
distributing the Fund's prospectus to owners of Contracts issued by the Company
and of distributing the Fund's proxy materials and reports to such Contract
owners.
ARTICLE VI. Diversification
6.1. The Fund will at all times invest money from the Contracts in
such a manner as to ensure that the Contracts will be treated as variable
contracts under the Code and the regulations issued thereunder. Without limiting
the scope of the foregoing, the Fund will at all times comply with Section
817(h) of the Code and Treasury Regulation 1.817-5, relating to the
diversification requirements for variable annuity, endowment, or life insurance
contracts and any amendments or other modifications to such Section or
Regulations. In the event of a breach of this Article VI by the Fund, it will
take all reasonable steps (a) to notify Company of such breach and (b) to
adequately diversify the Fund so as to achieve compliance with the grace period
afforded by Regulation 817-5.
ARTICLE VII. Potential Conflicts
7.1. The Board will monitor the Fund for the existence of any
material irreconcilable conflict between the interests of the contract owners of
all separate accounts investing in the Fund. An irreconcilable material conflict
may arise for a variety of reasons, including: (a) an action by any state
insurance regulatory authority; (b) a change in applicable federal or state
insurance, tax, or securities laws or regulations, or a public ruling, private
letter ruling, no-action or interpretative letter, or any similar action by
insurance, tax, or securities regulatory authorities; (c) an administrative or
judicial decision in any relevant proceeding; (d) the manner in which the
investments of any Portfolio are being managed; (e) a difference in voting
instructions given by variable annuity contract and variable life insurance
contract owners; or (f) a decision by an insurer to disregard the voting
instructions of contract owners. The Board shall promptly inform the Company if
it determines that an irreconcilable material conflict exists and the
implications thereof.
9
<PAGE>
7.2. The Company will report any potential or existing conflicts of
which it is aware to the Board. The Company will assist the Board in carrying
out its responsibilities under the Shared Funding Exemptive Order, by providing
the Board with all information reasonably necessary for the Board to consider
any issues raised. This includes, but is not limited to, an obligation by the
Company to inform the Board whenever contract owner voting instructions are
disregarded.
7.3. If it is determined by a majority of the Board, or a majority
of its disinterested trustees, that a material irreconcilable conflict exists,
the Company and other Participating Insurance Companies shall, at their expense
and to the extent reasonably practicable (as determined by a majority of the
disinterested trustees), take whatever steps are necessary to remedy or
eliminate the irreconcilable material conflict, up to and including: (1),
withdrawing the assets allocable to some or all of the separate accounts from
the Fund or any Portfolio and reinvesting such assets in a different investment
medium, including (but not limited to) another Portfolio of the Fund, or
submitting the question whether such segregation should be implemented to a vote
of all affected Contract owners and, as appropriate, segregating the assets of
any appropriate group (i.e., annuity contract owners, life insurance contract
owners, or variable contract owners of one or more Participating Insurance
Companies) that votes in favor of such segregation, or offering to the affected
contract owners the option of making such a change; and (2), establishing a new
registered management investment company or managed separate account.
7.4. If a material irreconcilable conflict arises because of a
decision by the Company to disregard contract owner voting instructions and that
decision represents a minority position or would preclude a majority vote, the
Company may be required, at the Fund's election, to withdraw the affected
Account's investment in the Fund and terminate this Agreement with respect to
such Account; provided, however that such withdrawal and termination shall be
limited to the extent required by the foregoing material irreconcilable conflict
as determined by a majority of the disinterested members of the Board. Any such
withdrawal and termination must take place within six (6) months after the Fund
gives written notice that this provision is being implemented, and until the end
of that six month period the Underwriter and Fund shall continue to accept and
implement orders by the Company for the purchase (and redemption) of shares of
the Fund.
7.5. If a material irreconcilable conflict arises because a
particular state insurance regulator's decision applicable to the Company
conflicts with the majority of other state regulators, then the Company will
withdraw the affected Account's investment in the Fund and terminate this
Agreement with respect to such Account within six months after the Board informs
the Company in writing that it has determined that such decision has created an
irreconcilable material conflict; provided, however, that such withdrawal and
termination shall be limited to the extent required by the foregoing material
irreconcilable conflict as determined by a majority of the disinterested members
of the Board. Until the end of the foregoing six month period, the Underwriter
and Fund shall continue to accept and implement orders by the Company for the
purchase (and redemption) of shares of the Fund.
7.6. For purposes of Sections 7.3 through 7.6 of this Agreement, a
majority of the disinterested members of the Board shall determine whether any
proposed action adequately
10
<PAGE>
remedies any irreconcilable material conflict, but in no event will the Fund be
required to establish a new funding medium for the Contracts. The Company shall
not be required by Section 7.3 to establish a new funding medium for the
Contracts if an offer to do so has been declined by vote of a majority of
Contract owners materially adversely affected by the irreconcilable material
conflict. In the event that the Board determines that any proposed action does
not adequately remedy any irreconcilable material conflict, then the Company
will withdraw the Account's investment in the Fund and terminate this Agreement
within six (6) months after the Board informs the Company in writing of the
foregoing determination, provided, however, that such withdrawal and termination
shall be limited to the extent required by any such material irreconcilable
conflict as determined by a majority of the disinterested members of the Board.
7.7. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are
amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision
of the Act or the rules promulgated thereunder with respect to mixed or shared
funding (as defined in the Shared Funding Exemptive Order) on terms and
conditions materially different from those contained in the Shared Funding
Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies,
as appropriate, shall take such steps as may be necessary to comply with Rules
6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such
rules are applicable; and (b) Sections 3.4, 3.5, 7.1, 7.2, 7.3, 7.4, and 7.5 of
this Agreement shall continue in effect only to the extent that terms and
conditions substantially identical to such Sections are contained in such
Rule(s) as so amended or adopted.
ARTICLE VIII. Indemnification
8.1. Indemnification By The Company
8.1(a). The Company agrees to indemnify and hold harmless the Fund
and each trustee of the Board and officers and each person, if any, who controls
the Fund within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" for purposes of this Section 8.1) against any and all
losses, claims, damages, liabilities (including amounts paid in settlement with
the written consent of the Company) or litigation (including legal and other
expenses), to which the Indemnified Parties may become subject under any
statute, regulation, at common law or otherwise, insofar as such losses, claims,
damages, liabilities or expenses (or actions in respect thereof) or settlements
are related to the sale or acquisition of the Fund's shares or the Contracts
and:
(i) arise out of or are based upon any untrue statements or
alleged untrue statements of any material fact contained in the
Registration Statement or prospectus for the Contracts or contained
in the Contracts or sales literature for the Contracts (or any
amendment or supplement to any of the foregoing), or arise out of or
are based upon the omission or the alleged omission to state therein
a material fact required to be stated therein or necessary to make
the statements therein not misleading, provided that this agreement
to indemnify shall not apply as to any Indemnified Party if such
statement or omission or such alleged statement or
11
<PAGE>
omission was made in reliance upon and in conformity with
information furnished to the Company by or on behalf of the Fund for
use in the Registration Statement or prospectus for the Contracts or
in the Contracts or sales literature (or any amendment or
supplement) or otherwise for use in connection with the sale of the
Contracts or Fund shares; or
(ii) arise out of or as a result of statements or
representations (other than statements or representations contained
in the Registration Statement, prospectus or sales literature of the
Fund not supplied by the Company, or persons under its control) or
wrongful conduct of the Company or persons under its control, with
respect to the sale or distribution of the Contracts or Fund Shares;
or
(iii) arise out of any untrue statement or alleged untrue
statement of a material fact contained in a Registration Statement,
prospectus, or sales literature of the Fund or any amendment thereof
or supplement thereto or the omission or alleged omission to state
therein a material fact required to be stated therein or necessary
to make the statements therein not misleading if such a statement or
omission was made in reliance upon information furnished to the Fund
by or on behalf of the Company; or
(iv) arise as a result of any failure by the Company to
provide the services and furnish the materials under the terms of
this Agreement; or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Company in this Agreement
or arise out of or result from any other material breach of this
Agreement by the Company, as limited by and in accordance with the
provisions of Sections 8.1(b) and 8.1(c) hereof.
8.1(b). The Company shall not be liable under this
indemnification provision with respect to any losses, claims,
damages, liabilities or litigation incurred or assessed against an
Indemnified Party as such may arise from such Indemnified Party's
willful misfeasance, bad faith, or gross negligence in the
performance of such Indemnified Party's duties or by reason of such
Indemnified Party's reckless disregard of obligations or duties
under this Agreement or to the Fund, whichever is applicable.
8.1(c). The Company shall not be liable under this
indemnification provision with respect to any claim made against an
Indemnified Party unless such Indemnified Party shall have notified
the Company in writing within a reasonable time after the summons or
other first legal process giving information of the nature of the
claim shall have been served upon such Indemnified Party (or after
such Indemnified Party shall have received notice of such service on
any designated agent), but failure to notify the Company of any such
claim shall not relieve the Company from any liability which it may
have to the Indemnified Party against whom such action is brought
otherwise than on account of this indemnification provision. In case
any
12
<PAGE>
such action is brought against the Indemnified Parties, the Company
shall be entitled to participate, at its own expense, in the defense
of such action. The Company also shall be entitled to assume the
defense thereof, with counsel satisfactory to the party named in the
action. After notice from the Company to such party of the Company's
election to assume the defense thereof, the Indemnified Party shall
bear the fees and expenses of any additional counsel retained by it,
and the Company will not be liable to such party under this
Agreement for any legal or other expenses subsequently incurred by
such party independently in connection with the defense thereof
other than reasonable costs of investigation.
8.1(d). The Indemnified Parties will promptly notify the
Company of the commencement of any litigation or proceedings against
them in connection with the issuance or sale of the Fund Shares or
the Contracts or the operation of the Fund.
8.2. Indemnification by the Underwriter
8.2(a). The Underwriter agrees to indemnify and hold harmless the
Company and each of its directors and officers and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act
(collectively, the "Indemnified Parties" for purposes of this Section 8.2)
against any and all losses, claims, damages, liabilities (including amounts paid
in settlement with the written consent of the Underwriter) or litigation
(including legal and other expenses) to which the Indemnified Parties may become
subject under any statute, at common law or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions in respect thereof) or
settlements are related to the sale or acquisition of the Fund's shares or the
Contracts and:
(i) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained
in the Registration Statement or prospectus or sales
literature of the Fund (or any amendment or supplement
to any of the foregoing), or arise out of or are based
upon the omission or the alleged omission to state
therein a material fact required to be stated therein or
necessary to make the statements therein not misleading,
provided that this agreement to indemnify shall not
apply as to any Indemnified Party if such statement or
omission or such alleged statement or omission was made
in reliance upon and in conformity with information
furnished to the Underwriter or Fund by or on behalf of
the Company for use in the Registration Statement or
prospectus for the Fund or in sales literature (or any
amendment or supplement) or otherwise for use in
connection with the sale of the Contracts or Fund
shares; or
(ii) arise out of or as a result of statements or
representations (other than statements or
representations contained in the Registration Statement,
prospectus or sales literature for the Contracts not
supplied by the Underwriter or persons under its
control) or wrongful conduct of the Fund,
13
<PAGE>
Adviser or Underwriter or persons under their control,
with respect to the sale or distribution of the
Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue
statement of a material fact contained in a Registration
Statement, prospectus, or sales literature covering the
Contracts, or any amendment thereof or supplement
thereto, or the omission or alleged omission to state
therein a material fact required to be stated therein or
necessary to make the statement or statements therein
not misleading, if such statement or omission was made
in reliance upon information furnished to the Company by
or on behalf of the Fund; or
(iv) arise as a result of any failure by the Fund to provide
the services and furnish the materials under the terms
of this Agreement (including a failure, whether
unintentional or in good faith or otherwise, to comply
with the diversification requirements specified in
Article VI of this Agreement); or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Underwriter
in this Agreement or arise out of or result from any
other material breach of this Agreement by the
Underwriter; as limited by and in accordance with the
provisions of Sections 8.2(b) and 8.2(c) hereof.
8.2(b). The Underwriter shall not be liable under this
indemnification provision with respect to any losses, claims, damages,
liabilities or litigation to which an Indemnified Party would otherwise be
subject by reason of such Indemnified Party's willful misfeasance, bad faith, or
gross negligence in the performance of such Indemnified Party's duties or by
reason of such Indemnified Party's reckless disregard of obligations and duties
under this Agreement or to each Company or the Account, whichever is applicable.
8.2(c). The Underwriter shall not be liable under this
indemnification provision with respect to any claim made against an Indemnified
Party unless such Indemnified Party shall have notified the Underwriter in
writing within a reasonable time after the summons or other first legal process
giving information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Underwriter of
any such claim shall not relieve the Underwriter from any liability which it may
have to the Indemnified Party against whom such action is brought otherwise than
on account of this indemnification provision. In case any such action is brought
against the Indemnified Parties, the Underwriter will be entitled to
participate, at its own expense, in the defense thereof. The Underwriter also
shall be entitled to assume the defense thereof, with counsel satisfactory to
the party named in the action. After notice from the Underwriter to such party
of the Underwriter's election to assume the defense thereof, the Indemnified
Party shall bear the fees and expenses of any additional counsel retained by it,
and the Underwriter will not be liable to such party under this Agreement for
any legal or other expenses subsequently incurred by such party independently in
connection with the defense thereof other than reasonable costs of
investigation.
14
<PAGE>
8.2(d). The Company agrees promptly to notify the Underwriter of the
commencement of any litigation or proceedings against it or any of its officers
or directors in connection with the issuance or sale of the Contracts or the
operation of each Account.
8.3. Indemnification By the Fund
8.3(a). The Fund agrees to indemnify and hold harmless the Company,
and each of its directors and officers and each person, if any, who controls the
Company within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" for purposes of this Section 8.3) against any and all
losses, claims, damages, liabilities (including amounts paid in settlement with
the written consent of the Fund) or litigation (including legal and other
expenses) to which the Indemnified Parties may become subject under any statute,
at common law or otherwise, insofar as such losses, claims, damages, liabilities
or expenses (or actions in respect thereof) or settlements result from the gross
negligence, bad faith or willful misconduct of the Board or any member thereof,
are related to the operations of the Fund and:
(i) arise as a result of any failure by the Fund to provide
the services and furnish the materials under the terms
of this Agreement (including a failure to comply with
the diversification requirements specified in Article VI
of this Agreement); or
(ii) arise out of or result from any material breach of any
representation and/or warranty made by the Fund in this
Agreement or arise out of or result from any other
material breach of this Agreement by the Fund;
as limited by and in accordance with the provisions of Sections 8.3(b) and
8.3(c) hereof.
8.3(b). The Fund shall not be liable under this indemnification
provision with respect to any losses, claims, damages, liabilities or litigation
incurred or assessed against an Indemnified Party as such may arise from such
Indemnified Party's willful misfeasance, bad faith, or gross negligence in the
performance of such Indemnified Party's duties or by reason of such Indemnified
Party's reckless disregard of obligations and duties under this Agreement or to
the Company, the Fund, the Underwriter or each Account, whichever is applicable.
8.3(c). The Fund shall not be liable under this indemnification
provision with respect to any claim made against an Indemnified Party unless
such Indemnified Party shall have notified the Fund in writing within a
reasonable time after the summons or other first legal process giving
information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Fund of any
such claim shall not relieve the Fund from any liability which it may have to
the Indemnified Party against whom such action is brought otherwise than on
account of this indemnification provision. In case any such action is brought
against the Indemnified Parties, the Fund will be entitled to participate, at
its own expense, in the defense thereof. The Fund also shall be entitled to
assume the defense thereof, with counsel satisfactory
15
<PAGE>
to the party named in the action. After notice from the Fund to such party of
the Fund's election to assume the defense thereof, the Indemnified Party shall
bear the fees and expenses of any additional counsel retained by it, and the
Fund will not be liable to such party under this Agreement for any legal or
other expenses subsequently incurred by such party independently in connection
with the defense thereof other than reasonable costs of investigation.
8.3(d). The Company and the Underwriter agree promptly to notify the
Fund of the commencement of any litigation or proceedings against it or any of
its respective officers or directors in connection with this Agreement, the
issuance or sale of the Contracts, with respect to the operation of either
Account, or the sale or acquisition of shares of the Fund.
ARTICLE IX. Applicable Law
9.1. This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of the Commonwealth of
Massachusetts.
9.2. This Agreement shall be subject to the provisions of the 1933,
1934 and 1940 acts, and the rules and regulations and rulings thereunder,
including such exemptions from those statutes, rules and regulations as the
Securities and Exchange Commission may grant (including, but not limited to, the
Shared Funding Exemptive Order) and the terms hereof shall be interpreted and
construed in accordance therewith.
ARTICLE X. Termination
10.1. This Agreement shall continue in full force and effect until
the first to occur of:
(a) termination by any party for any reason by 180 (six months)
days advance written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Portfolio based upon the
Company's determination that shares of such Portfolio are not
reasonably available to meet the requirements of the
Contracts; or
(c) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Portfolio in the event any
of the Portfolio's shares are not registered, issued or sold
in accordance with applicable state and/or federal law or such
law precludes the use of such shares as the underlying
investment media of the Contracts issued or to be issued by
the Company; or
(d) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Portfolio in the event
that such Portfolio ceases to qualify as a Regulated
Investment Company under Subchapter M of the Code or under
16
<PAGE>
any successor or similar provision, or if the Company
reasonably believes that the Fund may fail to so qualify; or
(e) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Portfolio in the event
that such Portfolio fails to meet the diversification
requirements specified in Article VI hereof; or
(f) termination by either the Fund or the Underwriter by written
notice to the Company, if either one or both of the Fund or
the Underwriter respectively, shall determine, in their sole
judgment exercised in good faith, that the Company and/or its
affiliated companies has suffered a material adverse change in
its business, operations, financial condition or prospects
since the date of this Agreement or is the subject of material
adverse publicity; or
(g) termination by the Company by written notice to the Fund and
the Underwriter, if the Company shall determine, in its sole
judgment exercised in good faith, that either the Fund or the
Underwriter has suffered a material adverse change in its
business, operations, financial condition or prospects since
the date of this Agreement or is the subject of material
adverse publicity; or
(h) termination by the Fund or the Underwriter by written notice
to the Company, if the Company gives the Fund and the
Underwriter the written notice specified in Section 1.6(b)
hereof and at the time such notice was given there was no
notice of termination outstanding under any other provision of
this Agreement; provided, however any termination under this
Section 10.1(h) shall be effective forty five (45) days after
the notice specified in Section 1.6(b) was given.
10.2. Effect of Termination. Notwithstanding any termination of this
Agreement, the Fund and the Underwriter shall at the option of the Company,
continue to make available additional shares of the Fund pursuant to the terms
and conditions of this Agreement, for all Contracts in effect on the effective
date of termination of this Agreement (hereinafter referred to as "Existing
Contracts"). Specifically, without limitation, the owners of the Existing
Contracts shall be permitted to reallocate investments in the Fund, redeem
investments in the Fund and/or invest in the Fund upon the making of additional
purchase payments under the Existing Contracts. The parties agree that this
Section 10.2 shall not apply to any terminations under Article VII and the
effect of such Article VII terminations shall be governed by Article VII of this
Agreement.
10.3 The Company shall not redeem Fund shares attributable to the
Contracts (as opposed to Fund shares attributable to the Company's assets held
in the Account) except (i) as necessary to implement Contract Owner initiated or
approved transactions, or (ii) as required by state and/or federal laws or
regulations or judicial or other legal precedent of general application
(hereinafter referred to as a "Legally Required Redemption"). Upon request, the
Company will promptly furnish to the Fund and the Underwriter the opinion of
counsel for the Company (which counsel shall be reasonably satisfactory to the
Fund and the Underwriter) to the effect that any redemption pursuant to clause
(ii) above is a Legally Required Redemption. Furthermore, except in cases where
permitted under the terms of the Contracts,
17
<PAGE>
the Company shall not prevent Contract Owners from allocating payments to a
Portfolio that was otherwise available under the Contracts without first giving
the Fund or the Underwriter 90 days notice of its intention to do so.
ARTICLE XI. Notices
Any notice shall be sufficiently given when sent by registered or
certified mail to the other party at the address of such party set forth below
or at such other address as such party may from time to time specify in writing
to the other party.
If to the Fund:
82 Devonshire Street
Boston, Massachusetts 02109
Attention: Treasurer
If to the Company:
SMA Life Assurance Company
440 Lincoln Street
Worcester, MA 01653
Attention: Rod Vessels
If to the Underwriter:
82 Devonshire Street
Boston, Massachusetts 02109
Attention: Treasurer
ARTICLE XII. Miscellaneous
12.1 All persons dealing with the Fund must look solely to the
property of the Fund for the enforcement of any claims against the Fund as
neither the Board, officers, agents or shareholders assume any personal
liability for obligations entered into on behalf of the Fund.
12.2 Subject to the requirements of legal process and regulatory
authority, each party hereto shall treat as confidential the names and addresses
of the owners of the Contracts and all information reasonably identified as
confidential in writing by any other party hereto and, except as permitted by
this Agreement, shall not disclose, disseminate or utilize such names and
addresses and other confidential information until such time as it may come into
the public domain without the express written consent of the affected party.
12.3 The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
18
<PAGE>
12.4 This Agreement may be executed simultaneously in two or more
counterparts, each of which taken together shall constitute one and the same
instrument.
12.5 If any provision of this Agreement shall be held or made
invalid by a court decision, statute, rule or otherwise, the remainder of the
Agreement shall not be affected thereby.
12.6 Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the SEC, the
NASD and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation
or inquiry relating to this Agreement or the transactions contemplated hereby.
Notwithstanding the generality of the foregoing, each party hereto further
agrees to furnish the California Insurance Commissioner with any information or
reports in connection with services provided under this Agreement which such
Commissioner may request in order to ascertain whether the insurance operations
of the Company are being conducted in a manner consistent with the California
Insurance Regulations and any other applicable law or regulations.
12.7 The rights, remedies and obligations contained in this
Agreement are cumulative and are in addition to any and all rights, remedies and
obligations, at law or in equity, which the parties hereto are entitled to under
state and federal laws.
12.8. This Agreement or any of the rights and obligations hereunder
may not be assigned by any party without the prior written consent of all
parties hereto; provided, however, that the Underwriter may assign this
Agreement or any rights or obligations hereunder to any affiliate of or company
under common control with the Underwriter, if such assignee is duly licensed and
registered to perform the obligations of the Underwriter under this Agreement.
12.9. The Company shall furnish, or shall cause to be furnished, to
the Fund or its designee copies of the following reports:
(a) the Company's annual statement prepared under statutory
accounting principles) and annual report (prepared under
generally accepted accounting principles ("GAAP")), as
soon as practical and in any event within 90 days after
the end of each fiscal year;
(b) the Company's quarterly statements (statutory and GAAP),
as soon as practical and in any event within 45 days
after the end of each quarterly period:
(c) any financial statement, proxy statement, notice or
report of the Company sent to stockholders and/or
policyholders, as soon as practical after the delivery
thereof to stockholders;
19
<PAGE>
(d) any registration statement (without exhibits) and
financial reports of the Company filed with the
Securities and Exchange Commission or any state
insurance regulator, as soon as practical after the
filing thereof;
(e) any other report submitted to the Company by independent
accountants in connection with any annual, interim or
special audit made by them of the books of the Company,
as soon as practical after the receipt thereof.
IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed in its name and on its behalf by its duly authorized
representative and its seal to be hereunder affixed hereto as of the date
specified below.
SMA LIFE ASSURANCE COMPANY
By its authorized officer,
By: /s/ Richard M. Reilly
-----------------------------
Title: Vice President
--------------------------
Date: 3/14/94
---------------------------
VARIABLE INSURANCE PRODUCTS FUND II
By its authorized officer,
By: /s/ J. Gary Burkhead
-----------------------------
Title: Senior Vice President
--------------------------
Date: 3/18/94
---------------------------
FIDELITY DISTRIBUTORS CORPORATION
By its authorized officer,
By: /s/ [Illegible]
-----------------------------
Title: President
--------------------------
Date: 3/22/94
---------------------------
20
<PAGE>
Schedule A
Separate Accounts and Associated Contracts
Name of Separate Account and
Date Established by Board of Directors
Inheiritage Account, August 20, 1991
VEL II - August 20, 1991
VA-K - August 20, 1991
Contracts Funded
By Separate Account
Variable Inheiritage Form Number 1026.1-94
VEL '94 - Form Number 1018.1-94
Exec-Annuity Plus - Form Number A3018.44-94
21
<PAGE>
SCHEDULE B
PROXY VOTING PROCEDURE
The following is a list of procedures and corresponding responsibilities for the
handling of proxies relating to the Fund by the Underwriter, the Fund and the
Company. The defined terms herein shall have the meanings assigned in the
Participation Agreement except that the term "Company" shall also include the
department or third party assigned by the Insurance Company to perform the steps
delineated below.
1. The number of proxy proposals is given to the Company by the Underwriter
as early as possible before the date set by the Fund for the shareholder
meeting to facilitate the establishment of tabulation procedures. At this
time the Underwriter will inform the Company of the Record, Mailing and
Meeting dates. This will be done verbally approximately two months before
meeting.
2. Promptly after the Record Date, the Company will perform a "tape run", or
other activity, which will generate the names, addresses and number of
units which are attributed to each contractowner/policyholder (the
"Customer") as of the Record Date. Allowance should be made for account
adjustments made after this date that could affect the status of the
Customers' accounts as of the Record Date.
Note: The number of proxy statements is determined by the activities
described in Step #2. The Company will use its best efforts to call in the
number of Customers to Fidelity, as soon as possible, but no later than
two weeks after the Record Date.
3. The Fund's Annual Report must be sent to each Customer by the Company
either before or together with the Customers' receipt of a proxy
statement. Underwriter will provide at least one copy of the last Annual
Report to the Company.
4. The text and format for the Voting Instruction Cards ("Cards" or "Card")
is provided to the Company by the Fund. The Company, at its expense, shall
produce and personalize the Voting Instruction Cards. The Legal Department
of the Underwriter or its affiliate ("Fidelity Legal") must approve the
Card before it is printed. Allow approximately 2-4 business days for
printing information on the Cards. Information commonly found on the Cards
includes:
a. name (legal name as found on account registration)
b. address
c. Fund or account number
d. coding to state number of units
e. individual Card number for use in tracking and verification of
votes (already on Cards as printed by the Fund)
(This and related steps may occur later in the chronological process due to
possible uncertainties relating to the proposals.)
22
<PAGE>
5. During this time, Fidelity Legal will develop, produce, and the Fund will
pay for the Notice of Proxy and the Proxy Statement (one document).
Printed and folded notices and statements will be sent to Company for
insertion into envelopes (envelopes and return envelopes are provided and
paid for by the Insurance Company). Contents of envelope sent to Customers
by Company will include:
a. Voting Instruction Card(s)
b. One proxy notice and statement (one document)
c. return envelope (postage pre-paid by Company) addressed
to the Company or its tabulation agent
d. "urge buckslip" - optional, but recommended. (This is a
small, single sheet of paper that requests Customers to vote as
quickly as possible and that their vote is important. One copy
will be supplied by the Fund.)
e. cover letter - optional, supplied by Company and
reviewed and approved in advance by Fidelity Legal.
6. The above contents should be received by the Company approximately 3-5
business days before mail date. Individual in charge at Company reviews
and approves the contents of the mailing package to ensure correctness and
completeness. Copy of this approval sent to Fidelity Legal.
7. Package mailed by the Company.
* The Fund must allow at least a 15-day solicitation time to the
Company as the shareowner. (A 5-week period is recommended.)
Solicitation time is calculated as calendar days from (but not
including) the meeting, counting backwards.
8. Collection and tabulation of Cards begins. Tabulation usually takes place
in another department or another vendor depending on process used. An
often used procedure is to sort Cards on arrival by proposal into vote
categories of all yes, no, or mixed replies, and to begin data entry.
Note: Postmarks are not generally needed. A need for postmark information
would be due to an insurance company's internal procedure and has not been
required by Fidelity in the past.
9. Signatures on Card checked against legal name on account registration
which was printed on the Card.
Note: For Example, If the account registration is under "Bertram C. Jones,
Trustee," then that is the exact legal name to be printed on the Card and
is the signature needed on the Card.
23
<PAGE>
10. If Cards are mutilated, or for any reason are illegible or are not signed
properly, they are sent back to Customer with an explanatory letter, a new
Card and return envelope. The mutilated or illegible Card is disregarded
and considered to be not received for purposes of vote tabulation. Any
Cards that have "kicked out" (e.g. mutilated, illegible) of the procedure
are "hand verified," i.e., examined as to why they did not complete the
system. Any questions on those Cards are usually remedied individually.
11. There are various control procedures used to ensure proper tabulation of
votes and accuracy of that tabulation. The most prevalent is to sort the
Cards as they first arrive into categories depending upon their vote; an
estimate of how the vote is progressing may then be calculated. If the
initial estimates and the actual vote do not coincide, then an internal
audit of that vote should occur. This may entail a recount.
12. The actual tabulation of votes is done in units which is then converted to
shares. (It is very important that the Fund receives the tabulations
stated in terms of a percentage and the number of shares.) Fidelity Legal
must review and approve tabulation format.
13. Final tabulation in shares is verbally given by the Company to Fidelity
Legal on the morning of the meeting not later than 10:00 a.m. Boston time.
Fidelity Legal may request an earlier deadline if required to calculate
the vote in time for the meeting.
14. A Certification of Mailing and Authorization to Vote Shares will be
required from the Company as well as an original copy of the final vote.
Fidelity Legal will provide a standard form for each Certification.
15. The Company will be required to box and archive the Cards received from
the Customers. In the event that any vote is challenged or if otherwise
necessary for legal, regulatory, or accounting purposes, Fidelity Legal
will be permitted reasonable access to such Cards.
16. All approvals and "signing-off" may be done orally, but must always be
followed up in writing.
24
<PAGE>
SCHEDULE C
Other investment companies currently available under variable annuities or
variable life insurance issued by the Company:
Allmerica Investment Trust
Delaware Group Premium Fund, Inc.
25
<PAGE>
Amendment to Schedule A to Participation Agreement
among
Variable Insurance Products Fund II
Fidelity Distributors Corporation
and
Allmerica Financial Life Insurance and Annuity Company
Whereas, Allmerica Financial Life Insurance and Annuity Company (the "Company";
formerly SMA Life Assurance Company), Variable Insurance Products Fund II, and
Fidelity Distributors Corporation have previously entered into a Participation
Agreement dated March 1, 1994 ("Participation Agreement"); and
Whereas, the Participation Agreement provides for the amendment of Schedule A
thereto by mutual written consent, the parties from time-to-time have so amended
Schedule A, and the parties now wish to consolidate said prior amendments to
Schedule A into a single document and to update Schedule A;
Now, therefore, the parties do hereby agree:
1. To amend and update Schedule A to the Participation Agreement by adopting the
attached Schedule A, dated July 15, 1997, and by substituting the attached
Schedule A for and any all prior amendments to Schedule A, as may have been
adopted from time-to-time.
In witness whereof, each of the parties has caused this agreement to be executed
in its name and on its behalf by its duly authorized representative as of the
date specified below.
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
By: /s/ Richard M. Reilly
-------------------------------
Name: Richard M. Reilly
-----------------------------
Title: President
----------------------------
Date: July 16, 1997
------------------------------
VARIABLE INSURANCE PRODUCTS FUND II FIDELITY DISTRIBUTORS CORPORATION
By: /s/ By: /s/
------------------------------ ------------------------------
Name: Name:
--------------------------- ---------------------------
Title: Title:
--------------------------- ---------------------------
Date: Date
--------------------------- ---------------------------
<PAGE>
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
Schedule A, as amended, to Participation Agreement Dated March 1, 1994
(Dated 7/15/97)
Separate Account* Product Name Registration
- ----------------- ------------ ------------
VEL VEL '87 33-14672
(Variable Life) Policy Form 1018-87 811-5183
VEL '91 33-90320
Policy Form 1018-91 811-5183
VEL PLUS 33-42687
Policy Forms 1023-91; 811-5183
1023-93
VEL II VEL '93 33-57792
(Variable Life) Policy Form 1018-93 811-7466
Inheiritage Inheiritage 33-70948
(Variable Life) Policy Form 1026-94 811-8120
Group VEL Group VEL 33-82658
(Variable Life) Policy Form 1029-94 811-8704
VA-K ExecAnnuity 33-39702
(Annuity) ExecAnnuity Plus 811-6293
Advantage
Policy Forms 3018-91;
3021-93;3025-96; 8025-96
*The Separate Accounts were authorized by vote of the Board of Directors on the
following dates: VEL - April 2, 1987; VEL II - January 21, 1993; Inheiritage -
September 15, 1993; Group VEL - November 22, 1993; VA-K - November 1, 1990.
<PAGE>
PARTICIPATION AGREEMENT
Among
DELAWARE GROUP PREMIUM FUND, INC.
And
SMA LIFE ASSURANCE COMPANY
And
DELAWARE DISTRIBUTORS, INC.
THIS AGREEMENT, made and entered into this 23 day of December, 1991
by and among DELAWARE GROUP PREMIUM FUND, INC., a corporation organized under
the laws of Maryland (the "Fund"), SMA LIFE ASSURANCE COMPANY, a Delaware
corporation (the "Company"), on its own behalf and on behalf of each separate
account of the Company named in Schedule 1 to this Agreement as in effect at the
time this Agreement is executed and such other separate accounts that may be
added to Schedule 1 from time to time in accordance with the provisions of
Article XI of this Agreement (each such account referred to as the "Account"),
and DELAWARE DISTRIBUTORS, INC., a Delaware corporation (the "Distributor").
WHEREAS, the Fund is engaged in business as an open-end management
investment company and was established for the purpose of serving as the
investment vehicle for separate accounts established for variable life insurance
policies and variable annuity contracts (collectively referred to as "Variable
Insurance Products," the owners of such products being referred
<PAGE>
to as "Product owners") to be offered by insurance companies which have entered
into participation agreements with the Fund ("Participating Insurance
Companies"); and
WHEREAS, the common stock of the Fund (the "Fund shares") consists
of separate series ("Series") issuing separate classes of shares ("Series
shares"), each such class representing an interest in a particular managed
portfolio of securities and other assets; and
WHEREAS, the Fund filed with the Securities and Exchange Commission
(the "SEC") and the SEC has declared effective a registration statement
(referred to herein as the "Fund Registration Statement" and the prospectus
contained therein, or filed pursuant to Rule 497 under the 1933 Act, referred to
herein as the "Fund Prospectus") on Form N-1A to register itself as an open-end
management investment company (File No. 811-5162) under the Investment Company
Act of 1940, as amended (the "1940 Act"), and the Fund shares (File No.
33-14363) under the Securities Act of 1933, as amended (the "1933 Act"); and
WHEREAS, the Company has filed or will file a registration statement
with the SEC to register under the 1933 Act certain variable annuity contracts
described in Schedule 2 to this Agreement as in effect at the time this
Agreement is executed and such other variable annuity contracts and variable
life insurance policies which may be added to Schedule 2 from time to time in
accordance with Article XI of this Agreement
- 2 -
<PAGE>
(such policies and contracts shall be referred to herein collectively as the
"contracts," each such registration statement for a class or classes of
contracts listed on Schedule 2 being referred to as the "Contracts Registration
Statement" and the prospectus for each such class or classes being referred to
herein as the "Contracts Prospectus," and the owners of the such contracts, as
distinguished from all Product Owners, being referred to as "Contract Owners");
and
WHEREAS, the Account, a validly existing separate account, duly
authorized by resolution of the Board of Directors of the Company on the date
set forth on Schedule 1, sets aside and invests assets attributable to the
Contracts; and
WHEREAS, the Company has registered or will have registered the
Account with the SEC as a unit investment trust under the 1940 Act before any
Contracts are issued by the Account; and
WHEREAS, the Distributor is registered as a broker-dealer with the
SEC under the Securities Exchange Act of 1934, as amended (the "1934 Act"), and
is a member in good standing of the National Association of Securities Dealers,
Inc. (the "NASD"); and
WHEREAS, the Distributor and the Fund have entered into an agreement
(the "Fund Distribution Agreement") pursuant to which the Distributor will
distribute Fund shares; and
WHEREAS, Delaware Management Company, Inc. (the "Investment
Manager") is registered as an investment adviser
- 3 -
<PAGE>
under the 1940 Act and any applicable state securities laws and serves as an
investment manager to the Fund pursuant to an agreement; and
WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase Series shares on behalf of the
Account to fund the Contracts and the Distributor is authorized to sell such
Series shares to unit investment trusts such as the Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the
Company, the Fund and the Distributor agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. The Distributor agrees to sell to the Company those Series
shares which the Company orders on behalf of the Account, executing such orders
on a daily basis in accordance with Section 1.4 of this Agreement.
1.2. The Fund agrees to make the shares of its Series available for
purchase by the Company on behalf of the Account at the then applicable net
asset value per share on Business Days as defined in Section 1.4 of this
Agreement, and the Fund shall use reasonable efforts to calculate such net asset
value on each such Business Day. Notwithstanding any other provision in this
Agreement to the contrary, the Board of Directors of the Fund (the "Fund Board")
may suspend or terminate the offering of Fund shares of any Series, if such
action is required by law or by
- 4 -
<PAGE>
regulatory authorities having jurisdiction or if, in the sole discretion of the
Fund Board acting in good faith and in light of its fiduciary duties under
Federal and any applicable state laws, suspension or termination is necessary
and in the best interests of the shareholders of any Series (it being understood
that "shareholders" for this purpose shall mean Product owners).
1.3. The Fund agrees to redeem, at the Company's request, any full
or fractional shares of the Fund held by the Account or the Company, executing
such requests at the net asset value on a daily basis in accordance with Section
1.4 of this Agreement, the applicable provisions of the 1940 Act and the then
currently effective Fund Prospectus. Notwithstanding the foregoing, the Fund may
delay redemption of Fund shares of any Series to the extent permitted by the
1940 Act, any rules, regulations or orders thereunder, or the then currently
effective Fund Prospectus.
1.4.
(a) For purposes of Sections 1.1, 1.2 and 1.3, the Company
shall be the agent of the Fund for the limited purpose of receiving redemption
and purchase requests from the Account (but not from the general account of the
Company), and receipt on any Business Day by the Company as such limited agent
of the Fund prior to the time prescribed in the current Fund Prospectus (which
as of the date of execution of this Agreement is 4 p.m.) shall constitute
receipt by the Fund on that same Business Day, provided that the Fund receives
notice of such
- 5 -
<PAGE>
redemption or purchase request by 11:00 a.m. Eastern Time on the next following
Business Day. For purposes of this Agreement, "Business Day" shall mean any day
on which the New York Stock exchange is open for trading or as otherwise
provided in the Fund's then currently effective Fund Prospectus.
(b) The Company shall pay for shares of each Series on the
same day that it places an order with the Fund to purchase those Series shares.
Payment for Series shares will be made by the Account or the Company in Federal
Funds transmitted to the Fund by wire to be received by 11:00 a.m. on the day
the Fund is properly notified of the purchase order for Series shares (unless
sufficient proceeds are available from redemption of shares of other Series). If
Federal Funds are not received on time, such funds will be invested, and Series
shares purchased thereby will be issued, as soon as practicable.
(c) Payment for Series shares redeemed by the Account or the
Company will be made in Federal Funds transmitted to the Company by wire on the
day the Fund is notified of the redemption order of Series shares (unless
redemption proceeds are applied to the purchase of shares of other Series),
except that the Fund reserves the right to delay payment of redemption proceeds,
but in no event may such payment be delayed longer than the period permitted
under Section 22(e) of the 1940 Act. Neither the Fund nor the Distributor shall
bear any responsibility whatsoever for the proper disbursement or
- 6 -
<PAGE>
crediting of redemption proceeds; the Company alone shall be responsible for
such action.
1.5. Issuance and transfer of Fund shares will be by book entry
only. Stock certificates will not be issued to the Company or the Account.
Purchase and redemption orders for Fund shares will be recorded in an
appropriate ledger for the Account or the appropriate subaccount of the Account.
1.6. The Fund shall furnish notice as soon as reasonably practicable
to the Company of any income dividends or capital gain distributions payable on
any Series shares. The Company, on its behalf and on behalf of the Account,
hereby elects to receive all such dividends and distributions as are payable on
any Series shares in the form of additional shares of that Series. The Company
reserves the right, on its behalf and on behalf of the Account, to revoke this
election and to receive all such dividends in cash. The Fund shall notify the
Company of the number of Series shares so issued as payment of such dividends
and distributions.
1.7. The Fund shall use its best efforts to make the net asset value
per share for each Series available to the Company by 7 p.m. Eastern Time each
Business Day, and in any event, as soon as reasonably practicable after the net
asset value per share for such Series is calculated, and shall calculate such
net asset value in accordance with the then currently effective Fund Prospectus.
Neither the Fund, any Series, the Distributor, nor the Investment Manager nor
any of
- 7 -
<PAGE>
their affiliates shall be liable for any information provided to the Company
pursuant to this Agreement which information is based on incorrect information
supplied by the Company to the Fund, the Distributor or the Investment Manager.
1.8. While this Agreement is in effect, the Company agrees that all
amounts available for investment under the Contracts (other than those listed on
Schedule 3) shall be invested only in the Fund and/or allocated to the Company's
general account, provided that such amounts may also be invested in an
investment company other than the Fund if: (a) such other investment company is
advised by the Fund's investment adviser; (b) the Fund and/or the Distributor,
in their sole discretion, consents to the use of such other investment company;
(c) there is a substitution of the Fund made in accordance with Section 10.1(e)
of this Agreement; or (d) this Agreement is terminated pursuant to Article X of
this Agreement. The Company also agrees that it will not take any action to
operate the Account as a management investment company under the 1940 Act
without the Fund's and Distributor's prior written consent.
1.9. The Fund and the Distributor agree that Fund shares will be
sold only to Participating Insurance Companies and their separate accounts. The
Fund and the Distributor will not sell Fund shares to any insurance company or
separate account unless an agreement complying with Article VII of this
Agreement is in effect to govern such sales. No Fund shares of any Series will
be sold to the general public.
- 8 -
<PAGE>
ARTICLE II. Representations and Warranties
2.1. The Company represents and warrants (a) that the Contracts are
registered under the 1933 Act or will be so registered before the issuance
thereof, (b) that the Contracts will be issued in compliance in all material
respects with all applicable Federal and state laws and (c) that the Company
will require of every person distributing the Contracts (i) that the Contracts
be offered and sold in compliance in all material respects with all applicable
Federal and state laws and (ii) that at the time it is issued each Contract is a
suitable purchase for the applicant therefor under applicable state insurance
laws. The Company further represents and warrants that it is an insurance
company duly organized and in good standing under applicable law and that it has
legally and validly authorized the Account as a separate account under Title 18,
Section 2932 of the Delaware Insurance Code, and has registered or, prior to the
issuance of any Contracts, will register the Account as a unit investment trust
in accordance with the provisions of the 1940 Act to serve as a separate account
for the Contracts, and that it will maintain such registration for so long as
any Contracts are outstanding.
2.2. The Fund represents and warrants that Fund shares sold
pursuant to this Agreement shall be registered under the 1933 Act and duly
authorized for issuance in accordance with applicable law and that the Fund is
and shall remain registered under the 1940 Act for so long as the Fund shares
are sold. The
- 9 -
<PAGE>
Fund further represents and warrants that it is a corporation duly organized and
in good standing under the laws of Maryland.
2.3. The Fund represents that it currently qualifies and will make
every effort to continue to qualify as a Regulated Investment Company under
Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code") and
to maintain such qualification (under Subchapter M or any successor or similar
provision), and that it will notify the Company immediately upon having a
reasonable basis for believing that it has ceased to so qualify or that it might
not so qualify in the future.
2.4. The Fund represents that it will comply with Section 817(h) of
the Code, and all regulations issued thereunder.
2.5. The Company represents that the Contracts are currently and at
the time of issuance will be treated as annuity contracts or life insurance
policies, whichever is appropriate, under applicable provisions of the Code. The
Company shall make every effort to maintain such treatment and shall notify the
Fund and the Distributor immediately upon having a reasonable basis for
believing that the Contracts have ceased to be so treated or that they might not
be so treated in the future.
2.6. The Fund represents that the Fund's investment policies, fees
and expenses, and operations are and shall at all times remain in material
compliance with the laws of the state of Delaware, to the extent required to
perform this Agreement and with any investment restrictions set forth on
Schedule 4, as
- 10 -
<PAGE>
amended from time to time by the Company in accordance with Section 6.6. The
Fund, however, makes no representation as to whether any aspect of its
operations (including, but not limited to, fees and expenses and investment
policies) otherwise complies with the insurance laws or regulations of any
state. The Company alone shall be responsible for informing the Fund of any
investment restrictions imposed by state insurance law and applicable to the
Fund.
2.7. The Distributor represents and warrants that the Distributor is
duly registered as a broker-dealer under the 1934 Act, a member in good standing
with the NASD, and duly registered as a broker-dealer under applicable state
securities laws; its operations are in compliance with applicable law, and it
will distribute the Fund shares according to applicable law.
2.8. The Distributor, on behalf of the Investment Manager,
represents and warrants that the Investment Manager is registered as an
investment adviser under the Investment Advisers Act of 1940 and is in
compliance with applicable federal and state securities laws.
2.9. The Fund represents and warrants that it has and maintains a
fidelity bond in accordance with Rule 17g-l under the 1940 Act.
-11-
<PAGE>
ARTICLE III. Prospectuses and Proxy Statements; Sales Material and Other
Information
3.1. The Distributor shall provide the Company (at its expense) with
as many copies of the current Fund Prospectus as the Company may reasonably
request. If requested by the Company in lieu thereof, the Fund shall provide the
Fund Prospectus (including a final copy of the new prospectus as set in type at
the Distributor's expense) and other assistance as is reasonably necessary in
order for the Company to have a new Contracts Prospectus printed together with
the Fund Prospectus in one document (the cost of such printing to be shared
equally by the Company and the Distributor).
3.2. The Fund Prospectus shall state that the Statement of
Additional Information for the Fund is available from the Distributor (or, in
the Fund's discretion, the Fund Prospectus shall state that such Statement is
available from the Fund), and the Distributor (or the Fund) shall provide such
Statement free of charge to the Company and to any outstanding or prospective
Contract owner who requests such Statement.
3.3. The Fund (at its cost) shall provide the Company with copies of
its proxy material, shareholder reports and other communications to the Company.
3.4. The Company shall not, without the prior written consent of the
Distributor (unless otherwise required by applicable law), solicit, induce or
encourage Contract owners to (a) change the Fund's investment adviser or
contract with any
- 12 -
<PAGE>
sub-investment adviser, or (b) change, modify, substitute, add or delete the
Fund or other investment media.
3.5. The Company shall furnish each piece of sales literature or
other promotional material in which the Fund or the Investment Manager or the
Distributor is named to the Fund or the Distributor prior to its use. No such
material shall be used, except with the prior written permission of the Fund or
the Distributor. The Fund and the Distributor agree to respond to any request
for approval on a prompt and timely basis. Failure to respond shall not relieve
the Company of the obligation to obtain the prior written permission of the Fund
or the Distributor.
3.6. The Company shall not give any information or make any
representations or statements on behalf of the Fund or concerning the Fund other
than the information or representations contained in the Fund Registration
Statement or Fund Prospectus, as such Registration Statement and Prospectus may
be amended or supplemented from time to time, or in reports or proxy statements
for the Fund, or in sales literature or other promotional material approved by
the Fund or by the Distributor, except with the prior written permission of the
Fund or the Distributor. The Fund and the Distributor agree to respond to any
request for permission on a prompt and timely basis. Failure to respond shall
not relieve the Company of the obligation to obtain the prior written permission
of the Fund or the Distributor.
- 13 -
<PAGE>
3.7. The Fund and the Distributor shall not give any information or
make any representations on behalf of the Company or concerning the Company, the
Account or the Contracts other than the information or representations contained
in the Contracts Registration Statement or Contracts Prospectus, as such
Registration Statement and Prospectus may be amended or supplemented from time
to time, or in published reports of the Account which are in the public domain
or approved in writing by the Company for distribution to Contract owners, or in
sales literature or other promotional material approved in writing by the
Company, except with the prior written permission of the Company. The Company
agrees to respond to any request for permission on a prompt and timely basis.
Failure to respond shall not relieve the Fund or the Distributor of the
obligation to obtain the prior written permission of the Company.
3.8. The Fund will provide to the Company at least one complete copy
of all Fund Registration Statements, Fund Prospectuses, Statements of Additional
Information, annual and semi-annual reports and other reports, proxy statements,
sales literature and other promotional materials, applications for exemptions,
requests for no-action letters, and all amendments or supplements to any of the
above, that relate to the Fund or Fund shares, promptly after the filing of such
document with the SEC or other regulatory authorities.
3.9. The Company will provide to the Fund at least one complete
copy of all Contracts Registration Statements, Contracts
- 14 -
<PAGE>
Prospectuses, Statements of Additional Information, reports, solicitations for
voting instructions, sales literature and other promotional materials,
applications for exemptions, requests for no-action letters, and all amendments
or supplements to any of the above, that relate to the Contracts or those
Sub-Accounts of the Account to which Contract purchase payments and value are
allocable, promptly after the filing of such document with the SEC or other
regulatory authorities.
3.10. Each party will provide to the other party copies of draft
versions of any registration statements, prospectuses, statements of additional
information, reports, proxy statements, solicitations for voting instructions,
sales literature and other promotional materials, applications for exemptions,
requests for no-action letters, and all amendments or supplements to any of the
above, to the extent that the other party reasonably needs such information for
purposes of preparing a report or other filing to be filed with or submitted to
a regulatory agency. If a party requests any such information before it has been
filed, the other party will provide the requested information if then available
and in the version then available at the time of such request.
3.11. For purposes of this Article IV, the phrase "sales literature
or other promotional material" includes, but is not limited to, advertisements
(such as material published, or designed for use, in a newspaper, magazine or
other periodical, radio, television, telephone or tape recording, videotape dis-
- 15 -
<PAGE>
play, signs or billboards, motion pictures or other public media), sales
literature (i.e., any written communication distributed or made generally
available to customers or the public, including brochures, circulars, research
reports, market letters, form letters, seminar texts, or reprints or excerpts of
any other advertisement, sales literature, or published article), educational or
training materials or other communications distributed or made generally
available to some or all agents or employees, registration statements,
prospectuses, Statements of Additional Information, shareholder reports and
proxy materials, and any other material constituting sales literature or
advertising under NASD rules, the 1940 Act or the 1933 Act.
ARTICLE IV. Voting
Subject to applicable law, the Company shall:
(a) solicit voting instructions from Contract owners;
(b) vote Fund shares of each Series attributable to Contract
owners in accordance with instructions or proxies timely
received from such Contract owners;
(c) vote Fund shares of each Series attributable to Contract
owners for which no instructions have been received in
the same proportion as Fund shares of such Series for
which instructions have been timely received; and
(d) vote Fund shares of each Series held by the Company on
its own behalf or on behalf of the Account that are not
attributable to Contract owners in the same proportion
as Fund shares of such Series for which instructions
have been timely received.
- 16 -
<PAGE>
The Company shall be responsible for assuring that voting privileges for the
Account are calculated in a manner consistent with the provisions set forth
above and with other Participating Insurance Companies.
ARTICLE V. Fees and Expenses
5.1. The Fund and Distributor shall pay no fee or other compensation
to the Company under this Agreement, except that if the Fund or any Series
adopts and implements a plan pursuant to Rule 12b-1 under the 1940 Act to
finance distribution expenses, then the Distributor may make payments to the
Company in amounts agreed to by the Company and the Distributor in writing.
Currently, no such payments are contemplated. The Fund currently does not intend
to make any payments to finance distribution expenses pursuant to Rule 12b-l
under the 1940 Act or in contravention of such rule, although it may make
payments pursuant to Rule 12b-1 in the future.
5.2. All expenses incident to performance by the Fund under this
Agreement (including expenses expressly assumed by the Fund pursuant to this
Agreement) shall be paid by the Fund to the extent permitted by law. Except as
may otherwise be provided in Sections 1.4 and 3.1 of this Agreement (or Article
VII, as it may be amended), the Company shall not bear any of the expenses for
the cost of registration and qualification of the Fund shares under Federal and
any state securities law, preparation and filing of the Fund Prospectus and Fund
Registration Statement,
- 17 -
<PAGE>
Fund proxy materials and reports, setting the Prospectus in type, setting in
type and printing and distributing the Fund proxy materials and reports to
shareholders (including the costs of printing a prospectus that constitutes an
annual report), the preparation of all statements and notices required by any
Federal or state securities law, all taxes on the issuance or transfer of Fund
shares, and any expenses permitted to be paid or assumed by the Fund pursuant to
a plan, if any, under Rule 12b-1 under the 1940 Act.
ARTICLE VI. Compliance Undertakings
6.1. The Fund undertakes to comply with Subchapter M and Section
817(h) of the Code, and all regulations issued thereunder.
6.2. The Company shall amend the Contracts Registration Statement
under the 1933 Act and the Account's Registration Statement under the 1940 Act
from time to time as required in order to effect the continuous offering of the
Contracts or as may otherwise be required by applicable law. The Company shall
register and qualify the Contracts for sale to the extent required by applicable
securities laws of the various states.
6.3. The Fund shall amend the Fund Registration Statement under the
1933 Act and the 1940 Act from time to time as required in order to effect for
so long as Fund shares are sold the continuous offering of Fund shares as
described in the
- 18 -
<PAGE>
then currently effective Fund Prospectus. The Fund shall register and qualify
Fund shares for sale to the extent required by applicable securities laws of the
various states.
6.4. The Company shall be responsible for assuring that any
prospectus offering a Contract that is a life insurance contract where it is
reasonably probable that such Contract would be a "modified endowment contract,"
as that term is defined in Section 7702A of the Code, will identify such
Contract as a modified endowment contract (or policy).
6.5. To the extent that it decides to finance distribution expenses
pursuant to Rule 12b-1, the Fund undertakes to have a Fund Board of Directors, a
majority of whom are not interested persons of the Fund, formulate and approve
any plan under Rule 12b-1 to finance distribution expenses.
6.6. The Company shall amend Schedule 4 when appropriate in order to
inform the Fund of any applicable investment restrictions with which the Fund
must comply.
ARTICLE VII. Potential Conflicts
The parties to this Agreement acknowledge that the Fund intends to
file an application with the SEC to request an order granting relief from
various provisions of the 1940 Act and the rules thereunder to the extent
necessary to permit Fund shares to be sold to and held by variable annuity and
variable life insurance separate accounts of both affiliated and unaffiliated
Participating Insurance Companies. The parties to this Agreement
- 19 -
<PAGE>
agree that any conditions or undertakings that may be imposed on the Company,
the Fund and/or the Distributor by virtue of such order shall be incorporated
herein by this reference, as of the date such order is granted, as though set
forth herein in full, and such parties agree to comply with such conditions and
undertakings to the extent applicable to each such party. The Fund and the
Distributor will not enter into a participation agreement with any other
Participating Insurance Company unless it imposes the same conditions and
undertakings incorporated by reference herein on the parties to such agreement.
ARTICLE VIII. Indemnification
8.1. Indemnification by the Company
The Company agrees to indemnify and hold harmless the Fund, the
Distributor and each person who controls or is associated with the Fund or the
Distributor within the meaning of such terms under the federal securities laws
and any officer, trustee, director, employee or agent of the foregoing, against
any and all losses, claims, damages or liabilities, joint or several (including
any investigative, legal and other expenses reasonably incurred in connection
with, and any amounts paid in settlement of, any action, suit or proceeding or
any claim asserted), to which they or any of them may become subject under any
statute or regulation, at common law or otherwise, insofar as such losses,
claims, damages or liabilities:
(a) arise out of or are based upon any untrue statement or alleged
untrue statement of any
- 20 -
<PAGE>
material fact contained in the Contracts Registration
Statement, Contracts Prospectus, sales literature or other
promotional material for the Contracts or the Contracts
themselves (or any amendment or supplement to any of the
foregoing), or arise out of or are based upon the omission or
the alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances in which
they were made; provided that this obligation to indemnify
shall not apply if such statement or omission or such alleged
statement or alleged omission was made in reliance upon and in
conformity with information furnished in writing to the
Company by the Fund or the Distributor (or a person authorized
in writing to do so on behalf of the Fund or the Distributor)
for use in the Contracts Registration Statement, Contracts
Prospectus or in the Contracts or sales literature (or any
amendment or supplement) or otherwise for use in connection
with the sale of the Contracts or Fund shares; or
(b) arise out of or are based upon any untrue statement or alleged
untrue statement of a material fact by or on behalf of the
Company (other than statements or representations contained in
the Fund Registration Statement, Fund Prospectus or sales
literature or other promotional material of the Fund not
supplied by the Company or persons under its control) or
wrongful conduct of the Company or persons under its control
with respect to the sale or distribution of the Contracts or
Fund shares; or
(c) arise out of any untrue statement or alleged untrue statement
of a material fact contained in the Fund Registration
Statement, Fund Prospectus or sales literature or other
promotional material of the Fund or any amendment thereof or
supplement thereto, or the omission or alleged omission to
state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading in
light of the circumstances in which they were made, if such
statement or omission was made in reliance upon and in
conformity with information furnished to the Fund by or on
behalf of the Company; or
(d) arise as a result of any failure by the Company to provide the
services and furnish the materials or
- 21 -
<PAGE>
to make any payments under the terms of this Agreement; or
(e) arise out of any material breach by the Company of this
Agreement, including but not limited to any failure to
transmit a request for redemption or purchase of Fund shares
on a timely basis in accordance with the procedures set forth
in Article I.
This indemnification will be in addition to any liability which the Company may
otherwise have; provided, however, that no party shall be entitled to
indemnification if such loss, claim, damage or liability is due to the wilful
misfeasance, bad faith, gross negligence or reckless disregard of duty by the
party seeking indemnification.
8.2. Indemnification by the Distributor
The Distributor agrees to indemnify and hold harmless the Company
and each person who controls or is associated with the Company within the
meaning of such terms under the federal securities laws and any officer,
director, employee or agent of the foregoing, against any and all losses,
claims, damages or liabilities, joint or several (including any investigative,
legal and other expenses reasonably incurred in connection with, and any amounts
paid in settlement of, any action, suit or proceeding or any claim asserted), to
which they or any of them may become subject under any statute or regulation, at
common law or otherwise, insofar as such losses, claims, damages or liabilities:
(a) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in the Fund
Registration Statement, Fund Prospectus (or any amendment or
- 22 -
<PAGE>
supplement thereto) or sales literature or other promotional
material of the Fund, or arise out of or are based upon the
omission or the alleged omission to state therein a material
fact required to be stated therein or necessary to make the
statements therein not misleading in light of the
circumstances in which they were made; provided that this
obligation to indemnify shall not apply if such statement or
omission or alleged statement or alleged omission was made in
reliance upon and in conformity with information furnished in
writing by the Company to the Fund or the Distributor for use
in the Fund Registration Statement, Fund Prospectus (or any
amendment or supplement thereto) or sales literature for the
Fund or otherwise for use in connection with the sale of the
Contracts or Fund shares; or
(b) arise out of or are based upon any untrue statement or alleged
untrue statement of a material fact by the Distributor or the
Fund (other than statements or representations contained in
the Fund Registration Statement, Fund Prospectus or sales
literature or other promotional material of the Fund not
supplied by the Distributor or the Fund or persons under their
control) or wrongful conduct of the Distributor or persons
under its control with respect to the sale or distribution of
the Contracts or Fund shares; or
(c) arise out of any untrue statement or alleged untrue statement
of a material fact contained in the Contract's Registration
Statement, Contracts Prospectus or sales literature or other
promotional material for the Contracts (or any amendment or
supplement thereto), or the omission or alleged omission to
state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading in
light of the circumstances in which they were made, if such
statement or omission was made in reliance upon information
furnished in writing by the Distributor or the Fund to the
Company (or a person authorized in writing to do so on behalf
of the Fund or the Distributor); or
(d) arise as a result of any failure by the Fund to provide the
services and furnish the materials under the terms of this
Agreement (including a failure, whether unintentional or in
good faith or otherwise, to comply with the diversification
- 23 -
<PAGE>
requirements specified in Article VI of this Agreement); or
(e) arise out of any material breach by the Distributor or the
Fund of this Agreement.
This indemnification will be in addition to any liability which the Distributor
may otherwise have; provided, however, that no party shall be entitled to
indemnification if such loss, claim, damage or liability is due to the wilful
misfeasance, bad faith, gross negligence or reckless disregard of duty by the
party seeking indemnification.
8.3. Indemnification Procedures
After receipt by a party entitled to indemnification ("indemnified
party") under this Article VIII of notice of the commencement of any action, if
a claim in respect thereof is to be made by the indemnified party against any
person obligated to provide indemnification under this Article VIII
("indemnifying party"), such indemnified party will notify the indemnifying
party in writing of the commencement thereof as soon as practicable thereafter,
provided that the omission to so notify the indemnifying party will not relieve
it from any liability under this Article VIII, except to the extent that the
omission results in a failure of actual notice to the indemnifying party and
such indemnifying party is damaged solely as a result of the failure to give
such notice. The indemnifying party, upon the request of the indemnified party,
shall retain counsel reasonably satisfactory to the indemnified party to
represent the indemnified party and any others the indemnifying party may
- 24 -
<PAGE>
designate in such proceeding and shall pay the fees and disbursements of such
counsel related to such proceeding. In any such proceeding, any indemnified
party shall have the right to retain its own counsel, but the fees and expenses
of such counsel shall be at the expense of such indemnified party unless (i) the
indemnifying party and the indemnified party shall have mutually agreed to the
retention of such counsel or (ii) the named parties to any such proceeding
(including any impleaded parties) include both the indemnifying party and the
indemnified party and representation of both parties by the same counsel would
be inappropriate due to actual or potential differing interests between them.
The indemnifying party shall not be liable for any settlement of any proceeding
effected without its written consent but if settled with such consent or if
there be a final judgment for the plaintiff, the indemnifying party agrees to
indemnify the indemnified party from and against any loss or liability by reason
of such settlement or judgment.
A successor by law of the parties to this Agreement shall be
entitled to the benefits of the indemnification contained in this Article VIII.
The indemnification provisions contained in this Article VIII shall survive any
termination of this Agreement.
ARTICLE IX. Applicable Law
9.1. This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of
- 25 -
<PAGE>
the state of Delaware, without giving effect to the principles of conflicts of
laws.
9.2. This Agreement shall be subject to the provisions of the 1933,
1934 and 1940 Acts, and the rules and regulations and rulings thereunder,
including such exemptions from those statutes, rules and regulations as the SEC
may grant, and the terms hereof shall be limited, interpreted and construed in
accordance therewith.
ARTICLE X. Termination
10.1. This Agreement shall terminate:
(a) at the option of any party upon six months advance written
notice to the other parties, such termination to be effective no earlier than
one year following the date on which the first Contract is issued to the public;
or
(b) at the option of the Company if shares of any Series are
not reasonably available to meet the requirements of the Contracts as determined
by the Company. Prompt notice of the election to terminate for such cause shall
be furnished by the Company, said termination to be effective ten days after
receipt of notice unless the Fund makes available a sufficient number of Fund
shares to meet the requirements of the Contracts within said ten-day period; or
(c) at the option of the Fund upon institution of formal
proceedings against the Company by the NASD, the SEC, the insurance commission
of any state or any other regulatory body
- 26 -
<PAGE>
regarding the Company's duties under this Agreement or related to the sale of
the Contracts, the operation of the Account, the administration of the Contracts
or the purchase of Fund shares, or an expected or anticipated ruling, judgment
or outcome which would, in the Fund's reasonable judgment, materially impair the
Company's ability to meet and perform the Company's obligations and duties
hereunder; or
(d) at the option of the Company upon institution of formal
proceedings against the Fund by the NASD, the SEC, or any state securities or
insurance commission or any other regulatory body; or
(e) upon requisite vote of the Contract owners having an
interest in the affected Series and the written approval of the Distributor
(unless otherwise required by applicable law), to substitute the shares of
another investment company for the corresponding Series shares of the Fund in
accordance with the terms of the Contracts; or
(f) at the option of the Fund in the event any of the
Contracts are not registered, issued or sold in accordance with applicable
Federal and/or state law; or
(g) by either the Company or the Fund upon a determination by
a majority of the Fund Board, or a majority of disinterested Fund Board members,
that an irreconcilable material conflict exists among the interests of (i) all
Product owners or (ii) the interests of the Participating Insurance Companies
investing in the Fund; or
- 27 -
<PAGE>
(h) at the option of the Company if the Fund ceases to qualify
as a Regulated Investment Company under Subchapter M of the Code, or under any
successor or similar provision, or if the Company reasonably believes based on
an opinion of counsel satisfactory to the Fund that the Fund may fail to so
qualify; or
(i) at the option of the Company if the Fund fails to meet the
diversification requirements specified in Section 817(h) of the Code and any
regulations thereunder; or
(j) at the option of the Fund if the Contracts cease to
qualify as annuity contracts or life insurance policies, as applicable, under
the Code, or if the Fund reasonably believes that the Contracts may fail to so
qualify; or
(k) at the option of either the Fund or the Distributor if the
Fund or the Distributor, respectively, shall determine, in their sole judgment
exercised in good faith, that either (1) the Company shall have suffered a
material adverse change in its business or financial condition or (2) the
Company shall have been the subject of material adverse publicity which is
likely to have a material adverse impact upon the business and operations of
either the Fund or the Distributor; or
(l) at the option of the Company, if the Company shall
determine, in its sole judgment exercised in good faith, that the Fund or the
Distributor shall have been the subject of material adverse publicity which is
likely to have a material
- 28 -
<PAGE>
adverse impact upon the business and operations of the Company; or
(m) upon the assignment of this Agreement (including, without
limitation, any transfer of the Contracts or the Account to another insurance
company pursuant to an assumption reinsurance agreement) unless the
non-assigning party consents thereto or unless this Agreement is assigned to an
affiliate of the Distributor.
10.2. Notice Requirement. Except as otherwise provided in Section
10.1, no termination of this Agreement shall be effective unless and until the
party terminating this Agreement gives prior written notice to all other parties
to this Agreement of its intent to terminate which notice shall set forth the
basis for such termination. Furthermore:
(a) In the event that any termination is based upon the
provisions of Article VII or the provisions of Section 10.1(a) of this
Agreement, such prior written notice shall be given in advance of the effective
date of termination as required by such provisions; and
(b) in the event that any termination is based upon the
provisions of Section 10.1(c) or 10.1(d) of this Agreement, such prior written
notice shall be given at least ninety (90) days before the effective date of
termination.
(c) in the event that any termination is based upon the
provisions of Section 10.1(e) of this Agreement, such prior written notice shall
be given at least sixty (60) days
- 29 -
<PAGE>
before the date of any proposed vote to replace the Fund's shares.
10.3. Except as necessary to implement Contract owner initiated
transactions, or as required by state insurance laws or regulations, the Company
shall not redeem Fund shares attributable to the Contracts (as opposed to Fund
shares attributable to the Company's assets held in the Account).
10.4. Effect of Termination
(a) Notwithstanding any termination of this Agreement pursuant
to Section 10.1 of this Agreement, the Fund and the Distributor may, at the
option of the Fund, continue to make available additional Fund shares for so
long after the termination of this Agreement as the Fund desires pursuant to the
terms and conditions of this Agreement as provided in paragraph (b) below, for
all Contracts in effect on the effective date of termination of this Agreement
(hereinafter referred to as "Existing Contracts"). Specifically, without
limitation, if the Fund or Distributor so elects to make additional Fund shares
available, the owners of the Existing Contracts or the Company, whichever shall
have legal authority to do so, shall be permitted to reallocate investments in
the Fund, redeem investments in the Fund and/or invest in the Fund upon the
making of additional purchase payments under the Existing Contracts.
(b) In the event of a termination of this Agreement pursuant
to Section 10.1 of this Agreement, the Fund and the Distributor shall promptly
notify the Company whether the
- 30 -
<PAGE>
Distributor and the Fund will continue to make Fund shares available after such
termination. If Fund shares continue to be made available after such
termination, the provisions of this Agreement shall remain in effect except for
Section 10.1(a) and thereafter either the Fund or the Company may terminate the
Agreement, as so continued pursuant to this Section 10.4, upon prior written
notice to the other party, such notice to be for a period that is reasonable
under the circumstances but, if given by the Fund, need not be for more than six
months.
(c) The parties agree that this Section 10.4 shall not apply
to any termination made pursuant to Article VII or any conditions or
undertakings incorporated by reference in Article VII, and the effect of such
Article VII termination shall be governed by the provisions set forth or
incorporated by reference therein.
ARTICLE XI. Applicability to New Accounts and New Contacts
The parties to this Agreement may amend the schedules to this
Agreement from time to time to reflect changes in or relating to the Contracts
and to add new classes of variable annuity contracts and variable life insurance
policies to be issued by the Company through a Separate Account investing in the
Fund. The provisions of this Agreement shall be equally applicable to each such
class of contracts or policies, unless the context otherwise requires.
- 31 -
<PAGE>
ARTICLE XII. Notices
Any notice shall be sufficiently given when sent by registered or
certified mail to the other party at the address of such party set forth below
or at such other address as such party may from time to time specify in writing
to the other party.
If to the Fund:
Delaware Group Premium Fund, Inc.
Ten Penn Center Plaza
Philadelphia, PA 19103
Attn: Daniel J. O'Brien
If to the Company:
Charles W. Grover II
Vice President, Individual Insurance Marketing
SMA Life Assurance Company
440 Lincoln Street
Worcester, MA 01605
If to the Distributor:
Mr. Michael P. Drennan
Vice President
Delaware Distributors, Inc.
Ten Penn Center Plaza
Philadelphia, PA 19103
ARTICLE XIII. Miscellaneous
13.1. The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
13.2. This Agreement may be executed simultaneously in two or more
counterparts, each of which together shall constitute one and the same
instrument.
- 32 -
<PAGE>
13.3. If any provision of this Agreement shall be held or made
invalid by a court decision, statute, rule or otherwise, the remainder of the
Agreement shall not be affected thereby.
13.4. Each party hereto shall cooperate with each other party and
all appropriate governmental authorities (including without limitation the SEC,
the NASD and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation
or inquiry relating to this Agreement or the transactions contemplated hereby.
13.5. Each party represents that the execution and delivery of this
Agreement and the consummation of the transactions contemplated herein have been
duly authorized by all necessary corporate or trust action, as applicable, by
such party, and when so executed and delivered this Agreement will be the valid
and binding obligation of such party enforceable in accordance with its terms.
- 33 -
<PAGE>
IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed in its name and behalf by its duly authorized officer
on the date specified below.
SMA LIFE ASSURANCE COMPANY
(Company)
Date: 12/23/, 1991 By: /s/ Charles W. Grover, II
-----------------------------
Name: Charles W. Grover, II
Title: Vice President, Ind. Ins.
Marketing
DELAWARE GROUP PREMIUM FUND, INC.
(Fund)
Date: 12/23, 1991 By: /s/ Michael P. Drennan
-----------------------------
Name: Michael P. Drennan
Title: Vice President
DELAWARE DISTRIBUTORS, INC.
(Distributor)
Date: 12/23, 1991 By: /s/ Michael P. Drennan
-----------------------------
Name: Michael P. Drennan
Title: Vice President
<PAGE>
Schedule 1
Separate Accounts of SMA Life Assurance Company
Investing in the Fund
As of December 23, 1991
Name of Account Date Established
- --------------- ----------------
Separate Account VA-K
of SMA Life Assurance Company November 1, 1990
<PAGE>
Schedule 2
Variable Annuity Contracts
and Variable Life Insurance Policies
Supported by Separate Accounts
Listed on Schedule 1
As of December 23, 1991
Individual Variable Annuity Policies
funded by sub-accounts of Separate Account VA-K
and investing in shares of
Delaware Group Premium Fund, Inc.
<PAGE>
Schedule 3
Variable Contracts
Excluded from Section 1.8
As of December 23, 1991
Individual Variable Annuity Policies Marketed
under the name "ExecAnnuity Plus"
<PAGE>
Schedule 4
Investment Restrictions
Applicable to the Fund
As of December 23, 1991
None
<PAGE>
FIRST AMENDMENT TO
PARTICIPATION AGREEMENT
THIS FIRST AMENDMENT (the "Amendment Agreement") to the Participation
Agreement dated December 23, 1991 (the "Participation Agreement") by and among
DELAWARE GROUP PREMIUM FUND, INC. (the "FUND"), SMA LIFE ASSURANCE COMPANY
("SMA"), on its own behalf and on behalf of each separate account of SMA, and
DELAWARE DISTRIBUTORS, INC. (the "DISTRIBUTOR") is made as of the first day of
April, 1994 by and among the FUND, the DISTRIBUTOR, SMA, on its own behalf and
on behalf of each separate account of SMA named in Schedule 1 to this Amendment
Agreement as in effect as of the time this Amendment Agreement is executed and
such other separate accounts of SMA that may be added to Schedule 1 from time to
time in accordance with the provisions of Article XI of the Participation
Agreement (each such account referred to as the "SMA Account"), and STATE MUTUAL
LIFE ASSURANCE COMPANY OF AMERICA ("STATE MUTUAL"), on its own behalf and on
behalf of each separate account of STATE MUTUAL named in Schedule 1 to this
Amendment Agreement as in effect as of the time this Amendment Agreement is
executed and such other separate accounts of STATE MUTUAL that may be added to
Schedule 1 from time to time in accordance with the provisions of Article XI of
the Participation Agreement (each such account referred to as the "STATE MUTUAL
Account").
WHEREAS, the FUND, SMA, and the DISTRIBUTOR previously entered into the
Participation Agreement; and
<PAGE>
WHEREAS, the FUND, SMA, and the DISTRIBUTOR wish to add STATE MUTUAL as a
party to the Participation Agreement to enable STATE MUTUAL to purchase shares
of common stock issued by the various series of the FUND on behalf of the STATE
MUTUAL Account;
NOW THEREFORE, for consideration, the receipt and sufficiency of which are
hereby acknowledged, and intending to be legally bound, the FUND, the
DISTRIBUTOR, SMA, and STATE MUTUAL agree as follows:
1. Effective as of the date hereof, STATE MUTUAL shall be a party to the
Participation Agreement and shall independently be entitled to the same rights
and subject to the same obligations, covenants, conditions, undertakings and
liabilities under the Participation Agreement as SMA.
2. Effective as of the date hereof, STATE MUTUAL hereby makes, on its own
behalf and in respect of the STATE MUTUAL Account and Contracts (as defined in
the Participation Agreement) issued by STATE MUTUAL and not on behalf of SMA nor
in respect of the SMA Account or Contracts issued by SMA, the representations
and warranties set forth in Sections 2.1 and 2.5 of the Participation Agreement.
3. Effective as of the date hereof, all references in the Participation
Agreement to "the Company" shall hereafter be references to "SMA and/or STATE
MUTUAL, as the case may be."
2
<PAGE>
4. Effective as of the date hereof, the term "the Account" in the
Participation Agreement shall hereafter be read to include the SMA Account
and/or the STATE MUTUAL Account, as the case may be.
5. Effective as of the date hereof, except as otherwise set forth herein,
the term "Contracts" in the Participation Agreement shall hereafter be read to
include Contracts issued by SMA and/or Contracts issued by STATE MUTUAL, as the
case may be.
6. Schedules 1, 2, and 3 to the Participation Agreement are hereby amended
and restated in their entirety as set forth on Schedules 1, 2, and 3,
respectively, to this Amendment Agreement.
7. All references in the Participation Agreement to the "Investment
Manager" shall hereafter be references to Delaware Management Company, Inc. or
Delaware International Advisers Ltd., as appropriate.
8. With respect to the termination provisions set forth in Article X of
the Participation Agreement, (i) any notice provided by or option exercised by
SMA shall be operative solely with respect to SMA, and (ii) any notice provided
by or option exercised by STATE MUTUAL shall be operative solely with respect to
STATE MUTUAL.
9. All notices to be provided to any party to the Participation Agreement,
as amended, shall be sent in accordance with Article XII of the Participation
Agreement at the address of such party set forth below or at such other address
as such party may from time to time specify in writing to the other parties:
3
<PAGE>
If to the FUND:
Delaware Group Premium Fund, Inc.
1818 Market Street
Philadelphia, PA 19103
Attn: Daniel J. O'Brien
If to SMA:
Lila M. Weihs
Director, Annuity Products
SMA Life Assurance Company
440 Lincoln Street
Worcester, MA 01653
If to the DISTRIBUTOR:
Delaware Distributors, Inc.
1818 Market Street
Philadelphia, PA 19103
Attn: Michael P. Drennan, Vice President
If to STATE MUTUAL:
Lila M. Weihs
Director, Annuity Products
State Mutual Life Assurance Company of the America
440 Lincoln Street
Worcester, MA 01653
10. All other provisions of the Participation Agreement not amended by
this Amendment Agreement shall remain in full force and effect as set forth in
the Participation Agreement.
4
<PAGE>
IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment
Agreement to be executed in its name and on its behalf by its duly authorized
officer as of the date first set forth above.
STATE MUTUAL LIFE ASSURANCE SMA LIFE ASSURANCE COMPANY
COMPANY OF AMERICA
By: /s/ Richard M. Reilly By: /s/ Richard M. Reilly
--------------------------- ---------------------------
Name: Richard M. Reilly Name: Richard M. Reilly
Title: Vice President Title: Vice President
DELAWARE GROUP PREMIUM DELAWARE DISTRIBUTORS, INC.
FUND, INC.
By: /s/ By: /s/
--------------------------- ---------------------------
Name: Name:
Title: Title:
5
<PAGE>
SCHEDULE 1
Separate Accounts of SMA Life Assurance Company
and State Mutual Life Assurance Company of America
Investing in the Fund
As of April 1, 1994
Name of Account Date Established
- --------------- ----------------
Separate Account VA-K November 1, 1990
of SMA Life Assurance Company
Separate Account VEL June 3, 1987
of SMA Life Assurance Company
Separate Account VEL II January 21, 1993
of SMA Life Assurance Company
Separate Account Inheiritage* September 15, 1993
of SMA Life Assurance Company
Separate Account VA-K of August 20, 1991
State Mutual Life Assurance
Company of America
Separate Account VEL-II August 20, 1991
of State Mutual Life Assurance
Company of America
Separate Account Inheiritage* August 20, 1991
of State Mutual Life Assurance
Company of America
* Regulatory approvals are pending for the Inheiritage products.
<PAGE>
SCHEDULE 2
(continued)
Variable Annuity Contracts
and Variable Life Insurance Policies
Supported by Separate Accounts
Listed on Schedule 1
As of April 1, 1994
State Mutual Life Assurance Company of America
Individual Delaware Medallion Variable Annuity Contracts funded by sub-accounts
of Separate Account VA-K and investing in shares of Delaware Group Premium Fund,
Inc.
Individual ExecAnnuity Plus Variable Annuity Contracts funded by sub-accounts of
Separate Account VA-K and investing in shares of the International Equity Series
of Delaware Group Premium Fund, Inc.
Individual VEL II Variable Life Insurance Policies funded by sub-accounts of
Separate Account VEL II and investing in shares of the International Equity.
Series of Delaware Group Premium Fund, Inc.
Individual Inheiritage* Variable Life Insurance Policies funded by sub-accounts
of Separate Account Inheiritage and investing in shares of the International
Equity Series of Delaware Group Premium Fund, Inc.
* Regulatory approvals are currently pending for the Inheiritage product.
<PAGE>
SCHEDULE 3
Variable Contracts
Excluded from Section 1.8
As of April 1, 1994
SMA Life Assurance Company
Individual Variable Annuity Policies Marketed under the name "ExecAnnuity Plus"
Individual Variable Life Insurance Policies Marketed under the name "VEL"
Individual Variable Life Insurance Policies Marketed under the name "VEL Plus"
Individual Variable Life Insurance Policies Marketed under the name "VEL II"
Individual Variable Life Insurance Policies to be Marketed under the name
"Inheiritage" *
State Mutual Life Assurance Company of America
Individual Variable Annuity Policies Marketed under the name "ExecAnnuity Plus"
Individual Variable Life Insurance Policies Marketed under the name "VEL II"
Individual Variable Life Insurance Policies to be Marketed under the name
"Inheiritage"*
*Regulatory approvals are currently pending for the Inheiritage product.
<PAGE>
PARTICIPATION AGREEMENT
Among
T. ROWE PRICE INTERNATIONAL SERIES, INC.,
T. ROWE PRICE INVESTMENT SERVICES, INC.
and
SMA LIFE ASSURANCE COMPANY
THIS AGREEMENT, made and entered into as of this 1st day of May, 1995 by
and among SMA LIFE ASSURANCE COMPANY (hereinafter, the "Company"), a Delaware
insurance company, on its own behalf and on behalf of each segregated asset
account of the Company set forth on Schedule A hereto as may be amended from
time to time (each account hereinafter referred to as the "Account"), and the T.
ROWE PRICE INTERNATIONAL SERIES, INC., a corporation organized under the laws of
Maryland (hereinafter referred to as the "Fund") and T. ROWE PRICE INVESTMENT
SERVICES, INC. (hereinafter the "Underwriter"), a Maryland corporation.
WHEREAS, the Fund engages in business as an open-end management investment
company and is or will be available to act as the investment vehicle for
separate accounts established for variable life insurance and variable annuity
contracts (the "Variable Insurance Products") to be offered by insurance
companies which have entered into participation agreements with the Fund and
Underwriter (hereinafter "Participating Insurance Companies"); and
WHEREAS, the beneficial interest in the Fund is divided into several
series of shares, each designated a "Portfolio" and representing the interest in
a particular managed portfolio of securities and other assets; and
WHEREAS, the Fund has filed an application to obtain an order from the
Securities and Exchange Commission ("SEC") granting Participating Insurance
Companies and variable annuity and variable life insurance separate accounts
exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the
Investment Company Act of 1940, as amended, (hereinafter the "1940 Act") and
Rules 6e-2(b)(15) and 6e-3(T) (b)(15) thereunder, if and to the extent necessary
to permit shares of the Fund to be sold to and held by variable annuity and
variable life insurance separate accounts of both affiliated and unaffiliated
life insurance companies (hereinafter the "Shared Funding Exemptive Order"); and
WHEREAS, the Fund is registered as an open-end management investment
company under the 1940 Act and shares of the Portfolios are registered under the
Securities Act of 1933, as amended (hereinafter the "1933 Act"); and
<PAGE>
- 2 -
WHEREAS, Rowe Price-Fleming International, Inc. (hereinafter referred to
as the "Adviser") is duly registered as an investment adviser under the federal
Investment Advisers Act of 1940, as amended, and any applicable state securities
laws; and
WHEREAS, the Company has registered or will register certain variable life
insurance and variable annuity contracts supported wholly or partially by the
Account (the "Contracts") under the 1933 Act, and said Contracts are listed in
Schedule A hereto, as it may be amended from time to time by mutual written
agreement; and
WHEREAS, the Account is duly established and maintained as a segregated
asset account, established by resolution of the Board of Directors of the
Company, on the date shown for such Account on Schedule A hereto, to set aside
and invest assets attributable to the aforesaid Contracts; and
WHEREAS, the Company has registered or will register the Account as a unit
investment trust under the 1940 Act; and
WHEREAS, the Underwriter is registered as a broker dealer with the SEC
under the Securities Exchange Act of 1934, as amended (hereinafter the "1934
Act"), and is a member in good standing of the National Association of
Securities Dealers, Inc. (hereinafter "NASD"); and
WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase shares in the Portfolios listed in
Schedule A hereto, as it may be amended from time to time by mutual written
agreement (the "Designated Portfolios") on behalf of the Account to fund the
aforesaid Contracts, and the Underwriter is authorized to sell such shares to
unit investment trusts such as the Account at net asset value;
NOW, THEREFORE, in consideration of their mutual promises, the Company,
the Fund and the Underwriter agree as follows:
ARTICLE I. Sale of Fund Shares
1.1 The Underwriter agrees to sell to the Company those shares of the
Designated Portfolios which the Account orders, executing such orders on a daily
basis at the net asset value next computed after receipt by the Fund or its
designee of the order for the shares of the Designated Portfolios.
1.2 The Fund agrees to make shares of the Designated Portfolios available
for purchase at the applicable net asset value per share by the Company and the
Account on those days on which the Fund calculates its net asset value pursuant
to rules of the SEC, and the Fund shall use reasonable efforts to calculate such
net asset value on each day which the New York Stock Exchange is open for
trading. Notwithstanding the foregoing, the Board of Directors of the Fund
(hereinafter the "Board") may refuse to sell shares of any Designated Portfolio
to any person, or suspend or terminate the offering of shares of any Designated
Portfolio if such action is required by law or by regulatory authorities having
jurisdiction, or is, in the sole discretion of the Board acting in good faith
and in light of their fiduciary duties under federal and any applicable state
laws, necessary in the best interests of the shareholders of such Designated
Portfolio.
1.3 The Fund and the Underwriter agree that shares of the Fund will be
sold only to Participating Insurance Companies and their separate accounts. No
shares of any Designated
<PAGE>
- 3 -
Portfolios will be sold to the general public. The Fund and the Underwriter will
not sell Fund shares to any insurance company or separate account unless an
agreement containing provisions substantially the same as Articles I and VII of
this Agreement is in effect to govern such sales.
1.4 The Fund agrees to redeem, on the Company's request, any full or
fractional shares of the Designated Portfolios held by the Company, executing
such requests on a daily basis at the net asset value next computed after
receipt by the Fund or its designee of the request for redemption, except that
the Fund reserves the right to suspend the right of redemption or postpone the
date of payment or satisfaction upon redemption consistent with Section 22(e) of
the 1940 Act and any sales thereunder, and in accordance with the procedures and
policies of the Fund as described in the then current prospectus.
1.5 For purposes of Sections 1.1 and 1.4, the Company shall be the
designee of the Fund for receipt of purchase and redemption orders from the
Account, and receipt by such designee shall constitute receipt by the Fund;
provided that the Company receives the order by 4:00 p.m. Baltimore time and the
Fund receives notice of such order by 9:30 a.m. Baltimore time on the next
following Business Day. "Business Day" shall mean any day on which the New York
Stock Exchange is open for trading and on which the Fund calculates its net
asset value pursuant to the rules of the SEC.
1.6 The Company agrees to purchase and redeem the shares of each
Designated Portfolio offered by the then current prospectus of the Fund and in
accordance with the provisions of such prospectus.
1.7 The Company shall pay for Fund shares on the next Business Day after
receipt of an order to purchase Fund shares. Payment shall be in federal funds
transmitted by wire by 3:00 p.m. Baltimore time. If payment in Federal Funds for
any purchase is not received or is received by the Fund after 3:00 p.m.
Baltimore time on such Business Day, the Company shall promptly, upon the Fund's
request, reimburse the Fund for any charges, costs, fees, interest or other
expenses incurred by the Fund in connection with any advances to, or borrowings
or overdrafts by, the Fund, or any similar expenses incurred by the Fund, as a
result of portfolio transactions effected by the Fund based upon such purchase
request. For purposes of Section 2.8 and 2.9 hereof, upon receipt by the Fund of
the federal funds so wired, such funds shall cease to be the responsibility of
the Company and shall become the responsibility of the Fund.
1.8 Issuance and transfer of the Fund's shares will be by book entry only.
Stock certificates will not be issued to the Company or any Account. Shares
ordered from the Fund will be recorded in an appropriate title for each Account
or the appropriate subaccount of each Account.
1.9 The Fund shall furnish same day notice (by wire or telephone, followed
by written confirmation) to the Company of any income, dividends or capital gain
distributions payable on the Designated Portfolios' shares. The Company hereby
elects to receive all such income, dividends, and capital gain distributions as
are payable on Designated Portfolio shares in additional shares of that
Portfolio. The Company reserves the right to revoke this election and to receive
all such income dividends and capital gain distributions in cash. The Fund shall
notify the Company of the number of shares so issued as payment of such
dividends and distributions. The Fund shall use its best efforts to furnish
advance notice of the day such dividends and distributions are expected to be
paid.
<PAGE>
- 4 -
1.10 The Fund shall make the net asset value per share for each Designated
Portfolio available to the Company on a daily basis as soon as reasonably
practical after the net asset value per share is calculated (normally by 6:30
p.m. Baltimore time) and shall use its best efforts to make such net asset value
per share available by 7 p.m. Baltimore time.
1.11 The Parties hereto acknowledge that the arrangement contemplated by
this Agreement is not exclusive; the Fund's shares may be sold to other
insurance companies (subject to Section 1.3 and Article VI hereof) and the cash
value of the Contracts may be invested in other investment companies, provided,
however, that (a) such other investment company, or series thereof, has
investment objectives or policies that are substantially different from the
investment objectives and policies of the Fund; or (b) the Company gives the
Fund and the Underwriter 45 days written notice of its intention to make such
other investment company available as a funding vehicle for the Contracts; or
(c) such other investment company was available as a funding vehicle for the
Contracts prior to the date of this Agreement and the Company so informs the
Fund and Underwriter prior to their signing this Agreement; or (d) the Fund or
Underwriter consents to the use of such other investment company, such consent
not to be unreasonably withheld.
ARTICLE II. Representations and Warranties
2.1 The Company represents and warrants that the Contracts are or will be
registered under the 1933 Act; that the Contracts will be issued and sold in
compliance in all material respects with all applicable federal and state laws
and that the sale of the Contracts shall comply in all material respects with
state insurance suitability requirements. The Company further represents and
warrants that it is an insurance company duly organized and in good standing
under applicable law and that it has legally and validly established the Account
prior to any issuance or sale thereof as a segregated asset account under the
Delaware insurance laws and has registered or, prior to any issuance or sale of
the Contracts, will register the Account as a unit investment trust in
accordance with the provisions of the 1940 Act to serve as a segregated
investment account for the Contracts.
2.2 The Fund represents and warrants that Fund shares sold pursuant to
this Agreement shall be registered under the 1933 Act, duly authorized for
issuance and sold in compliance with the laws of the State of Delaware and all
applicable federal and state securities laws and that the Fund is and shall
remain registered under the 1940 Act. The Fund shall amend the Registration
Statement for its shares under the 1933 Act and the 1940 Act from time to time
as required in order to effect the continuous offering of its shares. The Fund
shall register and qualify the shares for sale in accordance with the laws of
the various states only if and to the extent deemed advisable by the Fund or the
Underwriter.
2.3 The Fund currently does not intend to make any payments to finance
distribution expenses pursuant to Rule 12b-1 under the 1940 Act, although it may
make such payments in the future. To the extent that it decides to finance
distribution expenses pursuant to Rule 12b-1, the Fund will undertake to have a
Board, a majority of whom are not interested persons of the Fund, formulate and
approve any plan pursuant to Rule 12b-1 under the 1940 Act to finance
distribution expenses.
2.4 The Fund makes no representations as to whether any aspect of its
operations, including but not limited to, investment policies, fees and
expenses, complies with the insurance and other applicable laws of the various
states, except that the Fund represents that the Fund's investment policies,
fees and expenses are and shall at all times remain in compliance with the laws
of the State of Delaware to the extent required to perform this Agreement.
<PAGE>
- 5 -
2.5 The Fund represents that it is lawfully organized and validly existing
under the laws of the State of Maryland and that it does and will comply in all
material respects with the 1940 Act.
2.6 The Underwriter represents and warrants that it is a member in good
standing of the NASD and is registered as a broker-dealer with the SEC. The
Underwriter further represents that it will sell and distribute the Fund shares
in accordance with the laws of the State of Delaware and any applicable state
and federal securities laws.
2.7 The Underwriter represents and warrants that the Adviser is and shall
remain duly registered under all applicable federal and state securities laws
and that the Adviser shall perform its obligations for the Fund in compliance in
all material respects with the laws of the State of Delaware and any applicable
state and federal securities laws.
2.8 The Fund and the Underwriter represent and warrant that all of their
directors, officers, employees, investment advisers, and other individuals or
entities dealing with the money and/or securities of the Fund are and shall
continue to be at all times covered by a blanket fidelity bond or similar
coverage for the benefit of the Fund in an amount not less than the minimum
coverage as required currently by Rule 17g-1 of the 1940 Act or related
provisions as may be promulgated from time to time. The aforesaid bond shall
include coverage for larceny and embezzlement and shall be issued by a reputable
bonding company.
2.9 The Company represents and warrants that all of its directors,
officers, employees, investment advisers, and other individuals/entities
employed or controlled by the Company dealing with the money and/or securities
of the Fund are covered by a blanket fidelity bond or similar coverage for the
benefit of the Fund, in an amount not less than $5 million. The aforesaid bond
includes coverage for larceny and embezzlement and is issued by a reputable
bonding company. The Company agrees to make all reasonable efforts to see that
this bond or another bond containing these provisions is always in effect, and
agrees to notify the Fund and the Underwriter in the event that such coverage no
longer applies.
ARTICLE III. Prospectuses, Statements of Additional Information, and Proxy
Statements; Voting
3.1 The Underwriter shall provide the Company with as many copies of the
Fund's current prospectus as the Company may reasonably request. If requested by
the Company in lieu thereof, the Fund shall provide such documentation
(including a final copy of the new prospectus as set in type at the Fund's
expense) and other assistance as is reasonably necessary in order for the
Company once each year (or more frequently if the prospectus for the Fund is
amended) to have the prospectus for the Contracts and the Fund's prospectus
printed together in one document.
The Underwriter shall bear the expense of printing copies of its
current prospectus that will be distributed to existing Contract owners and the
Company shall bear the expense of printing copies of the Fund's prospectus that
are used in connection with offering the Contracts issued by the Company.
3.2 The Fund's prospectus shall state that the current Statement of
Additional Information ("SAI") for the Fund is available from the Company (or,
in the Fund's discretion, from the Fund), and the Underwriter (or the Fund), at
its expense, shall print, or otherwise reproduce, and provide a copy of such SAI
free of charge to the Company for itself and for any owner of a Contract who
requests such SAI.
<PAGE>
- 6 -
3.3 The Fund, at its expense, shall provide the Company with copies of its
proxy material, reports to shareholders, and other communications to
shareholders in such quantity as the Company shall reasonably require for
distributing to Contract owners. The Underwriter, at the Company's expense,
shall provide the Company with copies of the Fund's annual and semi-annual
reports to shareholders in such quantity as the Company shall reasonably request
for use in connection with offering the Variable Contracts issued by the
Company. If requested by the Company in lieu thereof, the Underwriter shall
provide such documentation (which may include a final copy of the Fund's annual
and semi-annual reports as set in type or in camera-ready copy) and other
assistance as is reasonably necessary in order for the Company (at the Company's
expense) to print such shareholder communications for distribution to Contract
owners.
3.4 The Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the Fund shares in accordance with instructions received
from Contract owners; and
(iii) vote Fund shares for which no instructions have been received
in the same proportion as Fund shares of such Designated
Portfolio for which instructions have been received,
so long as and to the extent that the SEC continues to interpret the 1940 Act to
require pass-through voting privileges for variable contract owners or to the
extent otherwise required by law. The Company reserves the right to vote Fund
shares held in any segregated asset account in its own right, to the extent
permitted by law.
3.5 Participating Insurance Companies shall be responsible for assuring
that each of their separate accounts participating in a Designated Portfolio
calculates voting privileges as required by the Shared Funding Exemptive Order
and consistent with any reasonable standards that the Fund may adopt.
3.6 The Fund will comply with all provisions of the 1940 Act requiring
voting by shareholders, and in particular the Fund will either provide for
annual meetings or comply with Section 16(c) of the 1940 Act (although the Fund
is not one of the trusts described in Section 16(c) of that Act) as well as with
Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in
accordance with the SEC's interpretation of the requirements of Section 16(a)
with respect to periodic elections of directors or trustees and with whatever
rules the SEC may promulgate with respect thereto.
ARTICLE IV. Sales Material and Information
4.1 The Company shall furnish, or shall cause to be furnished, to the Fund
or its designee, each piece of sales literature or other promotional material
that the Company develops or uses and in which the Fund (or a Portfolio thereof)
or the Adviser or the Underwriter is named, at least fifteen calendar days prior
to its use. No such material shall be used if the Fund or its designee
reasonably object to such use within fifteen calendar days after receipt of such
material. The Fund or its designee reserves the right to reasonably object to
the continued use of such material, and no such material shall be used if the
Fund or its designee so object.
<PAGE>
- 7 -
4.2 The Company shall not give any information or make any representations
or statements on behalf of the Fund or concerning the Fund in connection with
the sale of the Contracts other than the information or representations
contained in the registration statement or prospectus or SAI for the Fund
shares, as such registration statement and prospectus or SAI may be amended or
supplemented from time to time, or in reports or proxy statements for the Fund,
or in sales literature or other promotional material approved by the Fund or its
designee or by the Underwriter, except with the permission of the Fund or the
Underwriter or the designee of either.
4.3 The Fund, Underwriter, or its designee shall furnish, or shall cause
to be furnished, to the Company, each piece of sales literature or other
promotional material in which the Company, and/or its Account, is named at least
fifteen calendar days prior to its use. No such material shall be used if the
Company reasonably objects to such use within fifteen calendar days after
receipt of such material. The Company reserves the right to reasonably object to
the continued use of such material and no such material shall be used if the
Company so objects.
4.4. The Fund and the Underwriter shall not give any information or make
any representations on behalf of the Company or concerning the Company, the
Account, or the Contracts other than the information or representations
contained in a registration statement, prospectus, or SAI for the Contracts, as
such registration statement, prospectus or SAI may be amended or supplemented
from time to time, or in published reports for the Account which are in the
public domain or approved by the Company for distribution to Contract owners, or
in sales literature or other promotional material approved by the Company or its
designee, except with the permission of the Company.
4.5 The Fund will provide to the Company at least one complete copy of all
registration statements, prospectuses, SAIs, reports, proxy statements, sales
literature and other promotional materials, applications for exemptions,
requests for no-action letters, and all amendments to any of the above, that
relate to the Fund or its shares, contemporaneously with the filing of such
document(s) with the SEC or other regulatory authorities.
4.6 The Company will provide to the Fund at least one complete copy of all
registration statements, prospectuses, SAIs, reports, solicitations for voting
instructions, sales literature and other promotional materials, applications for
exemptions, requests for no-action letters, and all amendments to any of the
above, that relate to the Contracts or the Account, contemporaneously with the
filing of such document(s) with the SEC or other regulatory authorities.
4.7 For purposes of this Article IV, the phrase "sales literature and
other promotional materials" includes, but is not limited to, any of the
following that refer to the Fund or any affiliate of the Fund: advertisements
(such as material published, or designed for use in, a newspaper, magazine, or
other periodical, radio, television, telephone or tape recording, videotape
display, signs or billboards, motion pictures, or other public media), sales
literature (i.e., any written communication distributed or made generally
available to customers or the public, including brochures, circulars, reports,
market letters, form letters, seminar texts, reprints or excerpts of any other
advertisement, sales literature, or published article), educational or training
materials or other communications distributed or made generally available to
some or all agents or employees, and registration statements, prospectuses,
SAIs, shareholder reports, proxy materials, and any other communications
distributed or made generally available with regard to the Funds.
<PAGE>
- 8 -
ARTICLE V. Fees and Expenses
5.1 The Fund and the Underwriter shall pay no fee or other compensation to
the Company under this Agreement, except that if the Fund or any Portfolio
adopts and implements a plan pursuant to Rule 12b-1 to finance distribution
expenses, then the Underwriter may make payments to the Company or to the
underwriter for the Contracts if and in amounts agreed to by the Underwriter in
writing, and such payments will be made out of existing fees otherwise payable
to the Underwriter, past profits of the Underwriter, or other resources
available to the Underwriter. No such payments shall be made directly by the
Fund. Currently, no such payments are contemplated.
5.2 All expenses incident to performance by the Fund under this Agreement
shall be paid by the Fund, except as otherwise provided herein. The Fund shall
see to it that all its shares are registered and authorized for issuance in
accordance with applicable federal law and, if and to the extent deemed
advisable by the Fund, in accordance with applicable state laws prior to their
sale. The Fund shall bear the expenses for the cost of registration and
qualification of the Fund's shares, preparation and filing of the Fund's
prospectus and registration statement, proxy materials and reports, setting the
prospectus in type, setting in type and printing the proxy materials and reports
to shareholders (including the costs of printing a prospectus that constitutes
an annual report), the preparation of all statements and notices required by any
federal or state law, and all taxes on the issuance or transfer of the Fund's
shares.
5.3 The Company shall bear the expenses of printing (in accordance with
Section 3.1) and distributing the Fund's prospectus to owners of Contracts
issued by the Company and of distributing the Fund's proxy materials and reports
to such Contract owners.
ARTICLE VI. Diversification and Qualification
6.1 The Fund will invest its assets in such a manner as to ensure that the
Contracts will be treated as annuity or life insurance contracts, whichever is
appropriate, under the Internal Revenue Code of 1986, as amended (the "Code")
and the regulations issued thereunder (or any successor provisions). Without
limiting the scope of the foregoing, the Fund will comply with Section 817(h) of
the Code and Treasury Regulation ss.1.817-5, and any Treasury interpretations
thereof, relating to the diversification requirements for variable annuity,
endowment, or life insurance contracts, and any amendments or other
modifications or successor provisions to such Section or Regulations. In the
event of a breach of this Article VI by the Fund, it will take all reasonable
steps (a) to notify the Company of such breach and (b) to adequately diversify
the Fund so as to achieve compliance within the grace period afforded by
Regulation 817.5.
6.2 The Fund represents that it is or will be qualified as a Regulated
Investment Company under Subchapter M of the Code, and that it will make every
effort to maintain such qualification (under Subchapter M or any successor or
similar provisions) and that it will notify the Company immediately upon having
a reasonable basis for believing that it has ceased to so qualify or that it
might not so qualify in the future.
6.3 The Company represents that the Contracts are currently, and at the
time of issuance shall be, treated as life insurance or annuity insurance
contracts, under applicable provisions of the Code, and that it will make every
effort to maintain such treatment, and that it will notify the Fund and the
Underwriter immediately upon having a reasonable basis for believing the
Contracts have ceased to be so treated or that they might not be so treated in
the future. The Company agrees
<PAGE>
- 9 -
that any prospectus offering a contract that is a "modified endowment contract"
as that term is defined in Section 7702A of the Code (or any successor or
similar provision), shall identify such contract as a modified endowment
contract.
ARTICLE VII. Potential Conflicts. The following provisions apply effective upon
(a) the issuance of the Shared Funding Exemptive Order, and (b) investment in
the Fund by a separate account of a Participating Insurance Company supporting
variable life insurance contracts.
7.1 The Board will monitor the Fund for the existence of any material
irreconcilable conflict between the interests of the contract owners of all
separate accounts investing in the Fund. An irreconcilable material conflict may
arise for a variety of reasons, including: (a) an action by any state insurance
regulatory authority; (b) a change in applicable federal or state insurance,
tax, or securities laws or regulations, or a public ruling, private letter
ruling, no-action or interpretative letter, or any similar action by insurance,
tax, or securities regulatory authorities; (c) an administrative or judicial
decision in any relevant proceeding; (d) the manner in which the investments of
any Portfolio are being managed; (e) a difference in voting instructions given
by variable annuity contract and variable life insurance contract owners; or (f)
a decision by an insurer to disregard the voting instructions of contract
owners. The Board shall promptly inform the Company if it determines that an
irreconcilable material conflict exists and the implications thereof.
7.2. The Company will report any potential or existing conflicts of which
it is aware to the Board. The Company will assist the Board in carrying out its
responsibilities under the Shared Funding Exemptive Order, by providing the
Board with all information reasonably necessary for the Board to consider any
issues raised. This includes, but is not limited to, an obligation by the
Company to inform the Board whenever Contract owner voting instructions are
disregarded.
7.3 If it is determined by a majority of the Board, or a majority of its
disinterested members, that a material irreconcilable conflict exists, the
Company and other Participating Insurance Companies shall, at their expense and
to the extent reasonably practicable (as determined by a majority of the
disinterested Board members), take whatever steps are necessary to remedy or
eliminate the irreconcilable material conflict, up to and including: (1),
withdrawing the assets allocable to some or all of the separate accounts from
the Fund or any Portfolio and reinvesting such assets in a different investment
medium, including (but not limited to) another Portfolio of the Fund, or
submitting the question whether such segregation should be implemented to a vote
of all affected contract owners and, as appropriate, segregating the assets of
any appropriate group (i.e., annuity contract owners, life insurance contract
owners, or variable contract owners of one or more Participating Insurance
Companies) that votes in favor of such segregation, or offering to the affected
contract owners the option of making such a change; and (2), establishing a new
registered management investment company or managed separate account.
7.4 If a material irreconcilable conflict arises because of a decision by
the Company to disregard contract owner voting instructions and that decision
represents a minority position or would preclude a majority vote, the Company
may be required, at the Fund's election, to withdraw the affected Account's
investment in the Fund and terminate this Agreement with respect to such Account
provided, however, that such withdrawal and termination shall be limited to the
extent required by the foregoing material irreconcilable conflict as determined
by a majority of the disinterested members of the Board. Any such withdrawal and
termination must take place within six (6) months after the Fund gives written
notice that this provision is being implemented, and until the end of that six
month period the Fund shall continue to accept and implement orders by the
Company for the purchase (and redemption) of shares of the Fund.
<PAGE>
- 10 -
7.5 If a material irreconcilable conflict arises because a particular
state insurance regulator's decision applicable to the Company conflicts with
the majority of other state regulators, then the Company will withdraw the
affected Account's investment in the Fund and terminate this Agreement with
respect to such Account within six months after the Board informs the Company in
writing that it has determined that such decision has created an irreconcilable
material conflict; provided, however, that such withdrawal and termination shall
be limited to the extent required by the foregoing material irreconcilable
conflict as determined by a majority of the disinterested members of the Board.
Until the end of the foregoing six month period, the Fund shall continue to
accept and implement orders by the company for the purchase (and redemption) of
shares of the Fund.
7.6 For purposes of Section 7.3 through 7.6 of this Agreement, a majority
of the disinterested members of the Board shall determine whether any proposed
action adequately remedies any irreconcilable material conflict, but in no event
will the Fund be required to establish a new funding medium for the Contracts.
The Company shall not be required by Section 7.3 to establish a new funding
medium for the Contract if an offer to do so has been declined by vote of a
majority of Contract owners materially adversely affected by the irreconcilable
material conflict. In the event that the Board determines that any proposed
action does not adequately remedy any irreconcilable material conflict, then the
Company will withdraw the Account's investment in the Fund and terminate this
Agreement within six (6) months after the Board informs the Company in writing
of the foregoing determination; provided, however, that such withdrawal and
termination shall be limited to the extent required by any such material
irreconcilable conflict as determined by a majority of the disinterested members
of the Board.
7.7 If and to the extent the Shared Funding Order contains terms and
conditions different from Sections 3.4, 3.5, 3.6, 7.1, 7.2, 7.3, 7.4 and 7.5 of
this Agreement, then the Fund and/or the Participating Insurance Companies, as
appropriate, shall take such steps as may be necessary to comply with the Shared
Funding Exemptive Order, and Sections 3.4, 3.5, 3.6, 7.1, 7.2, 7.3, 7.4 and 7.5
of the Agreement shall continue in effect only to the extent that terms and
conditions substantially identical to such Sections are contained in the Shared
Funding Exemptive Order or any amendment thereto. If and to the extent that Rule
6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive
relief from any provision of the 1940 Act or the rules promulgated thereunder
with respect to mixed or shared funding (as defined in the Shared Funding
Exemptive Order) on terms and conditions materially different from those
contained in the Shared Funding Exemptive Order, then (a) the Fund and/or the
Participating Insurance Companies, as appropriate, shall take such steps as may
be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3,
as adopted, to the extent such rules are applicable; and (b) Sections 3.4, 3.5,
3.6, 7.1., 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect
only to the extent that terms and conditions substantially identical to such
Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. Indemnification
8.1 Indemnification By the Company
8.1(a). The Company agrees to indemnify and hold harmless the Fund
and the Underwriter and each of their officers and directors and each person, if
any, who controls the Fund or the Underwriter within the meaning of Section 15
of the 1933 Act (collectively, the "Indemnified Parties" for purposes of this
Section 8.1) against any and all losses, claims, damages, liabilities (including
amounts paid in settlement with the written consent of the Company) or
litigation
<PAGE>
- 11 -
(including legal and other expenses), to which the Indemnified Parties may
become subject under any statute or regulation, at common law or otherwise,
insofar as such losses, claims, damages, liabilities or expenses (or actions in
respect thereof) or settlements are related to the sale or acquisition of the
Fund's shares or the Contracts and:
(i) arise out of or are based upon any untrue statements or
alleged untrue statements of any material fact contained in
the Registration Statement, prospectus, or statement of
additional information for the Contracts or contained in the
Contracts or sales literature for the Contracts (or any
amendment or supplement to any of the foregoing), or arise out
of or are based upon the omission or the alleged omission to
state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading,
provided that this agreement to indemnify shall not apply as
to any Indemnified Party if such statement or omission or such
alleged statement or omission was made in reliance upon and in
conformity with information furnished to the Company by or on
behalf of the Fund for use in the Registration Statement,
prospectus or statement of additional information for the
Contracts or in the Contracts or sales literature (or any
amendment or supplement) or otherwise for use in connection
with the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations
(other than statements or representations contained in the
Registration Statement, prospectus or sales literature of the
Fund not supplied by the Company or persons under its control)
or wrongful conduct of the Company or persons under its
authorization or control, with respect to the sale or
distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue statement
of a material fact contained in a Registration Statement,
prospectus, or sales literature of the Fund or any amendment
thereof or supplement thereto or the omission or alleged
omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not
misleading if such a statement or omission was made in
reliance upon information furnished to the Fund by or on
behalf of the Company; or
(iv) arise as a result of any material failure by the Company to
provide the services and furnish the materials under the terms
of this Agreement (including a failure, whether unintentional
or in good faith or otherwise, to comply with the
qualification requirements specified in Article VI of this
Agreement); or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Company in this
Agreement or arise out of or result from any other material
breach of this Agreement by the Company,
as limited by and in accordance with the provisions of Sections 8.1(b) and
8.1(c) hereof.
8.1(b). The Company shall not be liable under this indemnification
provision with respect to any losses, claims, damages, liabilities or litigation
to which an Indemnified Party would
<PAGE>
- 12 -
otherwise be subject by reason of such Indemnified Party's willful misfeasance,
bad faith, or gross negligence in the performance of such Indemnified Party's
duties or by reason of such Indemnified Party's reckless disregard of its
obligations or duties under this Agreement.
8.1(c). The Company shall not be liable under this indemnification
provision with respect to any claim made against an Indemnified Party unless
such Indemnified Party shall have notified the Company in writing within a
reasonable time after the summons or other first legal process giving
information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Company of any
such claim shall not relieve the Company from any liability which it may have to
the Indemnified Party against whom such action is brought otherwise than on
account of this indemnification provision. In case any such action is brought
against an Indemnified Party, the Company shall be entitled to participate, at
its own expense, in the defense of such action. The Company also shall be
entitled to assume the defense thereof, with counsel satisfactory to the party
named in the action and to settle the claim at its own expense; provided,
however, that no such settlement shall, without the Indemnified Parties' written
consent, include any factual stipulation referring to the Indemnified Parties or
their conduct. After notice from the Company to such party of the Company's
election to assume the defense thereof, the Indemnified Party shall bear the
fees and expenses of any additional counsel retained by it, and the Company will
not be liable to such party under this Agreement for any legal or other expenses
subsequently incurred by such party independently in connection with the defense
thereof other than reasonable costs of investigation.
8.1(d). The Indemnified Parties will promptly notify the Company of
the commencement of any litigation or proceedings against them in connection
with the issuance or sale of the Fund Shares or the Contracts or the operation
of the Fund.
8.2 Indemnification by the Underwriter
8.2(a). The Underwriter agrees to indemnify and hold harmless the
Company and each of it directors and officers and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act
(collectively, the "Indemnified Parties" for purposes of this Section 8.2)
against any and all losses, claims, damages, liabilities (including amounts paid
in settlement with the written consent of the Underwriter) or litigation
(including legal and other expenses) to which the Indemnified Parties may become
subject under any statute or regulation, at common law or otherwise, insofar as
such losses, claims, damages, liabilities or expenses (or actions in respect
thereof) or settlements are related to the sale or acquisition of the Fund's
shares or the Contracts; and
(i) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained
in the Registration Statement or prospectus or SAI or
sales literature of the Fund (or any amendment or
supplement to any of the foregoing), or arise out of or
are based upon the omission or the alleged omission to
state therein a material fact required to be stated
therein or necessary to make the statements therein not
misleading, provided that this agreement to indemnify
shall not apply as to any Indemnified Party if such
statement or omission or such alleged statement or
omission was made in reliance upon and in conformity
with information furnished to the Underwriter or Fund by
or on behalf of the
<PAGE>
- 13 -
Company for use in the Registration Statement or
prospectus for the Fund or in sales literature (or any
amendment or supplement) or otherwise for use in
connection with the sale of the Contracts or Fund
shares; or
(ii) arise out of or as a result of statements or
representations (other than statements or
representations contained in the Registration Statement,
prospectus or sales literature for the Contracts not
supplied by the Underwriter or persons under its
control) or wrongful conduct of the Fund or Underwriter
or persons under their control, with respect to the sale
or distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue
statement of a material fact contained in a Registration
Statement, prospectus or sales literature covering the
Contracts, or any amendment thereof or supplement
thereto, or the omission or alleged omission to state
therein a material fact required to be stated therein or
necessary to make the statement or statements therein
not misleading, if such statement or omission was made
in reliance upon information furnished to the Company by
or on behalf of the Fund; or
(iv) arise as a result of any failure by the Fund to provide
the services and furnish the materials under the terms
of this Agreement (including a failure, whether
unintentional or in good faith or otherwise, to comply
with the diversification and other qualification
requirements specified in Article VI of this Agreement);
or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Underwriter
in this Agreement or arise out of or result from any
other material breach of this Agreement by the
Underwriter;
as limited by and in accordance with the provisions of Sections 8.2(b) and
8.2(c) hereof.
8.2(b). The Underwriter shall not be liable under this
indemnification provision with respect to any losses, claims, damages,
liabilities or litigation to which an Indemnified Party would otherwise be
subject by reason of such Indemnified Party's willful misfeasance, bad faith, or
gross negligence in the performance or such Indemnified Party's duties or by
reason of such Indemnified Party's reckless disregard of obligations and duties
under this Agreement or to the Company or the Account, whichever is applicable.
8.2(c). The Underwriter shall not be liable under this
indemnification provision with respect to any claim made against an Indemnified
Party unless such Indemnified Party shall have notified the Underwriter in
writing within a reasonable time after the summons or other first legal process
giving information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Underwriter of
any such claim shall not relieve the Underwriter from any liability which it may
have to the Indemnified Party against whom such action is brought otherwise than
on account of this indemnification provision. In case any such action is brought
<PAGE>
- 14 -
against the Indemnified Party, the Underwriter will be entitled to participate,
at its own expense, in the defense thereof. The Underwriter also shall be
entitled to assume the defense thereof, with counsel satisfactory to the party
named in the action and to settle the claim at its own expense; provided,
however, that no such settlement shall, without the Indemnified Parties' written
consent, include any factual stipulation referring to the Indemnified Parties or
their conduct. After notice from the Underwriter to such party of the
Underwriter's election to assume the defense thereof, the Indemnified Party
shall bear the fees and expenses of any additional counsel retained by it, and
the Underwriter will not be liable to such party under this Agreement for any
legal or other expenses subsequently incurred by such party independently in
connection with the defense thereof other than reasonable costs of
investigation.
8.2(d). The Company agrees promptly to notify the Underwriter of
the commencement of any litigation or proceedings against it or any of its
officers or directors in connection with the issuance or sale of the Contracts
or the operation of the Account.
8.3 Indemnification By the Fund
8.3(a). The Fund agrees to indemnify and hold harmless the Company
and each of its directors and officers and each person, if any, who controls the
Company within the meaning of Section 15 of the 1933 Act (collectively, the
"Indemnified Parties" for purposes of this Section 8.3) against any and all
losses, claims, expenses, damages, liabilities (including amounts paid in
settlement with the written consent of the Fund) or litigation (including legal
and other expenses) to which the Indemnified Parties may be required to pay or
may become subject under any statute or regulation, at common law or otherwise,
insofar as such losses, claims, expenses, damages, liabilities or expenses (or
actions in respect thereof) or settlements, are related to the operations of the
Fund and:
(i) arise as a result of any failure by the Fund to provide
the services and furnish the materials under the terms
of this Agreement (including a failure, whether
unintentional or in good faith or otherwise, to comply
with the diversification and other qualification
requirements specified in Article VI of this Agreement);
or
(ii) arise out of or result from any material breach of any
representation and/or warranty made by the Fund in this
Agreement or arise out of or result from any other
material breach of this Agreement by the Fund;
as limited by and in accordance with the provisions of Sections 8.3(b) and
8.3(c) hereof.
8.3(b). The Fund shall not be liable under this indemnification
provision with respect to any losses, claims, damages, liabilities or litigation
to which an Indemnified Party would otherwise be subject by reason of such
Indemnified Party's willful misfeasance, bad faith, or gross negligence in the
performance of such Indemnified Party's duties or by reason of such Indemnified
Party's reckless disregard of obligations and duties under this Agreement or to
the Company, the Fund, the Underwriter or the Account, whichever is applicable.
8.3(c). The Fund shall not be liable under this indemnification
provision with respect to any claim made against an Indemnified Party unless
such Indemnified Party shall have notified the Fund in writing within a
reasonable time after the summons or other first legal process giving
<PAGE>
- 15 -
information of the nature of the claim shall have been served upon such
Indemnified Party (or after such indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Fund of any
such claim shall not relieve the Fund from any liability which it may have to
the Indemnified Party against whom such action is brought otherwise than on
account of this indemnification provision. In case any such action is brought
against the Indemnified Parties, the Fund will be entitled to participate, at
its own expense, in the defense thereof. The Fund also shall be entitled to
assume the expense thereof, with counsel satisfactory to the party named in the
action and to settle the claim at its own expense; provided, however, that no
such settlement shall, without the Indemnified Parties' written consent, include
any factual stipulation referring to the Indemnified Parties or their conduct.
After notice from the Fund to such party of the Fund's election to assume the
defense thereof, the Indemnified Party shall bear the fees and expenses of any
additional counsel retained by it, and the Fund will not be liable to such party
under this Agreement for any legal or other expenses subsequently incurred by
such party independently in connection with the defense thereof other than
reasonable costs of investigation.
8.3(d). The Company and the Underwriter agree promptly to notify
the Fund of the commencement of any litigation or proceeding against it or any
of its respective officers or directors in connection with the Agreement, the
issuance or sale of the Contracts, the operation of the Account, or the sale or
acquisition of shares of the Fund.
ARTICLE IX. Applicable Law
9.1 This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of the State of Maryland.
9.2 This Agreement shall be subject to the provisions of the 1933, 1934
and 1940 Acts, and the rules and regulations and rulings thereunder, including
such exemptions from those statutes, rules and regulations as the SEC may grant
(including, but not limited to, any Shared Funding Exemptive Order) and the
terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE X. Termination
10.1 This Agreement shall continue in full force and effect until the
first to occur of:
(a) termination by any party, for any reason with respect to some
or all Designated Portfolios, by six (6) months' advance
written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Designated Portfolio based
upon the Company's determination that shares of the Fund are
not reasonably available to meet the requirements of the
Contracts; provided that such termination shall apply only to
the Designated Portfolio not reasonably available; or
(c) termination by the Company by written notice to the Fund and
the Underwriter in the event any of the Designated Portfolio's
shares are not registered, issued or sold in accordance with
applicable state and/or federal law or such law precludes the
use of such shares as the underlying
<PAGE>
- 16 -
investment media of the Contracts issued or to be issued by
the Company; or
(d) termination by the Fund or Underwriter in the event that
formal administrative proceedings are instituted against the
Company by the NASD, the SEC, the Insurance Commissioner or
like official of any state or any other regulatory body
regarding the Company's duties under this Agreement or related
to the sale of the Contracts, the operation of any Account, or
the purchase of the Fund shares, provided, however, that the
Fund or Underwriter determines in its sole judgment exercised
in good faith, that any such administrative proceedings will
have a material adverse effect upon the ability of the Company
to perform its obligations under this Agreement; or
(e) termination by the Company in the event that formal
administrative proceedings are instituted against the Fund or
Underwriter by the NASD, the SEC, or any state securities or
insurance department or any other regulatory body, provided,
however, that the Company determines in its sole judgment
exercised in good faith, that any such administrative
proceedings will have a material adverse effect upon the
ability of the Fund or Underwriter to perform its obligations
under this Agreement; or
(f) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Designated Portfolio in
the event that such Designated Portfolio ceases to qualify as
a Regulated Investment Company under Subchapter M or fails to
comply with the Section 817(h) diversification requirements
specified in Article VI hereof, or if the Company reasonably
believes that such Designated Portfolio may fail to so qualify
or comply; or
(g) termination by the Fund or Underwriter by written notice to
the Company in the event that the Contracts fail to meet the
qualifications specified in Article VI hereof; or
(h) termination by either the Fund or the Underwriter by written
notice to the Company, if either one or both of the Fund or
the Underwriter respectively, shall determine, in their sole
judgment exercised in good faith, that the Company has
suffered a material adverse change in its business,
operations, financial condition, or prospects since the date
of this Agreement or is the subject of material adverse
publicity; or
(i) termination by the Company by written notice to the Fund and
the Underwriter, if the Company shall determine, in its sole
judgment exercised in good faith, that the Fund or the
Underwriter has suffered a material adverse change in its
business, operations, financial condition or prospects since
the date of this Agreement or is the subject of material
adverse publicity; or
(j) termination by the Fund or the Underwriter by written notice
to the Company, if the Company gives the Fund and the
Underwriter the written notice specified in Section 1.11
hereof and at the time such notice was given
<PAGE>
- 17 -
there was no notice of termination outstanding under any other
provision of this Agreement; provided, however, any
termination under this Section 10.1(j) shall be effective
forty-five days after the notice specified in Section 1.11 was
given.
10.2 Effect of Termination. Notwithstanding any termination of this
Agreement, the Fund and the Underwriter shall, at the option of the Company,
continue to make available additional shares of the Fund pursuant to the terms
and conditions of this Agreement, for all Contracts in effect on the effective
date of termination of this Agreement (hereinafter referred to as "Existing
Contracts"). Specifically, the owners of the Existing Contracts may be permitted
to reallocate investments in the Fund, redeem investments in the Fund and/or
invest in the Fund upon the making of additional purchase payments under the
Existing Contracts. The parties agree that this Section 10.2 shall not apply to
any termination under Article VII and the effect of such Article VII termination
shall be governed by Article VII of this Agreement. The parties further agree
that this Section 10.2 shall not apply to any termination under Section 10.1(g)
of this Agreement.
10.3 The Company shall not redeem Fund shares attributable to the
Contracts (as opposed to Fund shares attributable to the Company's assets held
in the Account) except (i) as necessary to implement Contract Owner initiated or
approved transactions, (ii) as required by state and/or federal laws or
regulations or judicial or other legal precedent of general application
(hereinafter referred to as a "Legally Required Redemption"), or (iii) as
permitted by an order of the SEC pursuant to Section 26(b) of the 1940 Act. Upon
request, the Company will promptly furnish to the Fund and the Underwriter the
opinion of counsel for the Company (which counsel shall be reasonably
satisfactory to the Fund and the Underwriter) to the effect that any redemption
pursuant to clause (ii) above is a Legally Required Redemption. Furthermore,
except in cases where permitted under the terms of the Contracts, the Company
shall not prevent Contract Owners from allocating payments to a Portfolio that
was otherwise available under the Contracts without first giving the Fund or the
Underwriter 90 days notice of its intention to do so.
10.4 Notwithstanding any termination of this Agreement, each party's
obligation under Article VIII to indemnify the other parties shall survive.
ARTICLE XI. Notices
Any notice shall be sufficiently given when sent by registered or
certified mail to the other party at the address of such party set forth below
or at such other address as such party may from time to time specify in writing
to the other party.
If to the Fund:
T. Rowe Price International Series, Inc.
100 East Pratt Street
Baltimore, Maryland 21202
Attention: Henry H. Hopkins, Esq.
If to the Company:
SMA Life Assurance Company
440 Lincoln Street
Worcester, Massachusetts 01653
Attention: Eric S. Levy
<PAGE>
- 18 -
If to Underwriter:
T. Rowe Price Investment Services
100 East Pratt Street
Baltimore, Maryland 21202
Attention: Terrie Westren
Copy to: Henry H. Hopkins, Esq.
ARTICLE XII. Miscellaneous
12.1 All persons dealing with the Fund must look solely to the property of
such Fund, and in the case of a series company, the respective Designated
Portfolio listed on Schedule A hereto as though such Designated Portfolio had
separately contracted with the Company and the Underwriter for the enforcement
of any claims against the Fund. The parties agree that neither the Board,
officers, agents or shareholders assume any personal liability or responsibility
for obligations entered into by or on behalf of the Fund.
12.2 Subject to the requirements of legal process and regulatory
authority, each party hereto shall treat as confidential the names and addresses
of the owners of the Contracts and all information reasonably identified as
confidential in writing by any other party hereto and, except as permitted by
this Agreement, shall not disclose, disseminate or utilize such names and
addresses and other confidential information without the express written consent
of the affected party until such time as such information may come into the
public domain.
12.3 The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
12.4 This Agreement may be executed simultaneously in two or more
counterparts, each of which taken together shall constitute one and the same
instrument.
12.5 If any provision of this Agreement shall be held or made invalid by a
court decision, statute, rule or otherwise, the remainder of the Agreement shall
not be affected thereby.
12.6 Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the SEC, the
NASD, and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation
or inquiry relating to this Agreement or the transactions contemplated hereby.
Notwithstanding the generality of the foregoing, each party hereto further
agrees to furnish the Delaware Insurance Commissioner with any information or
reports in connection with services provided under this Agreement which such
Commissioner may request in order to ascertain whether the variable annuity
operations of the Company are being conducted in a manner consistent with the
Delaware variable annuity laws and regulations and any other applicable law or
regulations.
12.7 The rights, remedies and obligations contained in this Agreement are
cumulative and are in addition to any and all rights, remedies, and obligations,
at law or in equity, which the parties hereto are entitled to under state and
federal laws.
<PAGE>
- 19 -
12.8 This Agreement or any of the rights and obligations hereunder may not
be assigned by any party without the prior written consent of all parties
hereto.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement
to be executed in its name and on its behalf by its duly authorized
representative and its seal to be hereunder affixed hereto as of the date
specified below.
COMPANY: SMA LIFE ASSURANCE COMPANY
By its authorized officer
By: /s Ruben P. Moreno
------------------------------------
Title: VP Finance
---------------------------------
Date: 5/2/95
----------------------------------
FUND: T. ROWE PRICE INTERNATIONAL SERIES, INC.
By its authorized officer
By: /s/ [Illegible]
------------------------------------
Title: Vice President
---------------------------------
Date: April 26, 1995
----------------------------------
UNDERWRITER: T. ROWE PRICE INVESTMENT SERVICES, INC.
By its authorized officer
By: /s/ [Illegible]
------------------------------------
Title: Vice President
---------------------------------
Date: April 26, 1995
----------------------------------
<PAGE>
SCHEDULE A
Pending issuance of the Shared Funding Order, the Underwriter shall not
sell to the Company, and the Fund shall not make available for purchase to the
Company, shares of the Designated Portfolio for variable life insurance
Contracts supported wholly or partially by the Accounts.
<TABLE>
<CAPTION>
Name of Separate Account and Contracts Funded by
Date Established by Board of Directors Separate Account Designated Portfolios
-------------------------------------- ---------------- ---------------------
<S> <C> <C>
Separate Account VA-K of SMA Life Assurance ExecAnnuity Plus T. Rowe Price International Series, Inc.
Company, November 1, 1990 33-39702 o T. Rowe Price International
811-6293 Stock Portfolio
Allmerica Select Separate Account of SMA Life Allmerica Select T. Rowe Price international Series, Inc.
Assurance Company, March 5, 1992 33-47216 o T. Rowe Price International Stock
811-6632 Portfolio
VEL Account of SMA Life Assurance Company, April VEL '87 T. Rowe Price international Series, Inc.
27, 1987 33-14672 o T. Rowe Price International
811-5183 Stock Portfolio
VEL Account of SMA Life Assurance Company, April VEL '91 T. Rowe Price international Series, Inc.
27, 1987 33-90320 o T. Rowe Price International
811-5183 Stock Portfolio
VEL Account of SMA Life Assurance Company, April VEL Plus T. Rowe Price international Series, Inc.
27, 1987 33-42687 o T. Rowe Price International
811-5183 Stock Portfolio
VEL II Account of SMA Life Assurance Company, VEL '93 T. Rowe Price international Series, Inc.
January 21, 1993 33-57792 o T. Rowe Price International
811-7466 Stock Portfolio
Inheiritage Account of SMA Life Assurance Company, Variable Inheiritage T. Rowe Price international Series, Inc.
September 15, 1993 33-70948 o T. Rowe Price International
811-8120 Stock Portfolio
Group VEL Account of SMA Life Assurance Company, Group VEL T. Rowe Price international Series, Inc.
November 22, 1993 33-82658 o T. Rowe Price International
811- Stock Portfolio
Allmerica Select Separate Account II of SMA Life Select VEL T. Rowe Price international Series, Inc.
Assurance Company, October 12, 1993 33-83604 o T. Rowe Price International Stock
811- Portfolio
</TABLE>
<PAGE>
LETTER AGREEMENT
June 4, 1997
Allmerica Financial Life Insurance and Annuity Company
First Allmerica Financial Life Insurance Company
Ladies and Gentlemen:
Effective as of October 1, 1996, this letter sets forth the agreement
("Agreement") between Allmerica Financial Life Insurance and Annuity Company
(formerly known as SMA Life Assurance Company) ("Company A") and First Allmerica
Financial Life Insurance Company (formerly known as State Mutual Life Assurance
Company of America) ("Company B") (each a "Company" and collectively "you,"
"your" or the "Companies"), on the one hand, and Rowe Price-Fleming
International, Inc. ("RPFI") (referred to as "we," or "RPFI") on the other ,
concerning certain administrative services to be provided by each of you, with
respect to the T. Rowe Price International Series, Inc. (the "Fund").
1. THE FUND. The Fund is a Maryland Corporation registered with the
Securities and Exchange Commission (the "SEC") under the Investment Company
Act of 1940, as amended (the "Act") as an open-end diversified management
investment company. The Fund serves as a funding vehicle for variable
annuity contracts and variable life insurance contracts and, as such,
sells its shares to insurance companies and their separate accounts. With
respect to various provisions of the Act, the SEC requires that owners of
variable annuity contracts and variable life insurance contracts be
provided with materials and rights afforded to shareholders of a
publicly-available SEC-registered mutual fund.
2. THE COMPANIES. Company A is a Delaware life insurance company, and Company
B is a Massachusetts life insurance company. Each Company issues
variable annuity contracts (the "Contracts") supported by one or more
separate accounts (individually a "Separate Account" and collectively the
"Separate Accounts") which are registered with the SEC as unit investment
trusts, or which are properly exempt from registration. Each of the
Companies has entered into a participation agreement with the Fund
(individually a "Participation Agreement" and collectively the
"Participation Agreements") pursuant to which each Company purchases shares
of the T. Rowe Price International Stock Portfolio of the Fund for the
Separate Accounts supporting the Company's Contracts.
<PAGE>
Allmerica Financial Life Insurance and Annuity Company
First Allmerica Financial Life Insurance Company
June 4, 1997
Page 2
3. RPFI. RPFI serves as the investment adviser to the T. Rowe Price
International Series, Inc. RPFI supervises and assists in the overall
management of the Fund's affairs under an investment management agreement
with the Fund (the "Management Agreement"), subject to the overall
authority of the Fund's Board of Directors in accordance with Maryland law.
Under the Management Agreement, RPFI is compensated for providing
investment advisory and certain administrative services (either directly or
through affiliates).
4. ADMINISTRATIVE SERVICES. You have agreed to assist us, as we may request
from time to time, with the provision of administrative services to the
Fund, as they may relate to the investment in a Fund by the Separate
Accounts. It is anticipated that such services may include (but shall not
be limited to): the mailing of Fund reports, notices, proxies and proxy
statements and other informational materials to holder of the Contracts
supported by the Separate Accounts; the maintenance of separate records for
each holder of the Contracts reflecting shares purchased and redeemed and
share balances; the preparation of various reports for submission to Fund
directors; the provision of advice and recommendations concerning the
operation of the series of the Funds as funding vehicles for the Contracts;
the provision of shareholder support services with respect to the Separate
Account portfolios serving as funding vehicles for the Contracts; telephone
support for holders of Contracts with respect to inquiries about the Fund;
and the provision of other administrative services as shall be mutually
agreed upon from time to time.
5. PAYMENT FOR ADMINISTRATIVE SERVICES. In consideration of the
administrative services to be provided by each of the Companies, we
shall make payments to each of the Companies on a quarterly basis
("Payments") from our assets, including our bona fide profits as investment
adviser to the Fund, an amount equal to 15 basis points (0.15%) per annum
of the average aggregate net asset value of shares of the Fund held by
the Separate Accounts under the Participation Agreements, PROVIDED,
HOWEVER, that such payments shall only be payable with respect to the Fund
for each calendar quarter during which the aggregate dollar value of shares
of the Fund purchased pursuant to a Participation Agreement by the
insurance companies in the aggregate exceeds $50,000,000. Subject to the
terms of paragraph 6 hereof, RPFI shall be responsible for payments due
pursuant to this Paragraph 5 with respect to the purchase of shares of the
Fund managed by RPFI. For purposes of computing the payment to each
Company contemplated under this Paragraph 5, the average aggregate net
asset value of shares of the Fund held by the Separate Accounts over a
quarterly period shall be computed by totaling each Separate Account's
aggregate investment (share net asset value multiplied by total number of
shares held by the Separate Account) on each business day during the
calendar quarter, and dividing by the total number of business days during
such quarter. The Payments contemplated by this Paragraph 5 shall be
calculated by RPFI at the end of each calendar quarter and will be paid to
each Company within 30 business days thereafter.
<PAGE>
Allmerica Financial Life Insurance and Annuity Company
First Allmerica Financial Life Insurance Company
June 4, 1997
Page 3
6. UNIFIED PAYMENT PROCEDURE. You have agreed that in order to simplify the
procedure by which Payments required to be made by RPFI pursuant to
Paragraph 5 hereof are made to the Companies, the obligations of RPFI to
make such Payments to each Company can be fulfilled by the remittance of a
single, unified Payment (the "Unified Payment"). The Unified Payment shall
be made by RPFI to Company A, accompanied by a written statement setting
forth the respective amounts due to each of the Companies. Company A in
turn, agrees that it will remit Company B's portion of each Unified Payment
to Company B as soon as practicable after Company A's receipt of such
Unified Payment, unless a different arrangement is agreed to between
Company A and Company B. Company B agrees that the obligation of RPFI to
make payments to it pursuant to paragraph 5 hereof shall be satisfied upon
receipt of the applicable Unified Payment by Company A.
7. NATURE OF PAYMENTS. The parties to this Agreement recognize and agree that
RPFI's payments to the Companies relate to administrative services only and
do not constitute payment in any manner for investment advisory services or
for costs of distribution of the Contracts or of Fund shares; and further,
that these payments are not otherwise related to investment advisory or
distribution services or expenses, or administrative services which RPFI is
required to provide to owners of the Contracts pursuant to the terms
thereof. You represent that you may legally receive the payments
contemplated by the Agreement.
8. TERM. This Agreement shall remain in full force and effect for an initial
term of two years, and shall automatically renew for successive one-year
periods unless any party informs each of the other parties upon 60-days
written notice of its intent not to continue this Agreement. This
Agreement and all obligations hereunder shall terminate automatically with
respect to a Company and its relationship with a Fund upon the redemption
of the Company's and its Separate Accounts investment in the Fund, or upon
termination of the Company's Participation Agreement with the Fund.
9. AMENDMENT. This Agreement may be amended only upon mutual agreement
of all of the parties hereto in writing.
10. COUNTERPARTS. This Agreement may be executed in counterparts, each of
which shall be deemed an original but all of which shall together
constitute one and the same instrument.
<PAGE>
Allmerica Financial Life Insurance and Annuity Company
First Allmerica Financial Life Insurance Company
June 4, 1997
Page 4
If this Agreement is consistent with your understanding of the matters we
discussed concerning your administrative services, kindly sign below and return
a signed copy to us.
Very truly yours,
ROWE PRICE-FLEMING
INTERNATIONAL, INC.
By: /s/ Nancy M. Morris
------------------------------------------
Name: Nancy M. Morris
----------------------------------------
Title: Vice President
----------------------------------------
Acknowledged and Agreed to:
ALL MERICA FINANCIAL LIFE INSURANCE
AND ANNUITY COMPANY
By: /s/ Richard M. Reilly
------------------------------
Name: Richard M. Reilly
------------------------------
Title: President
------------------------------
FIRST ALLMERICA FINANCIAL LIFE
INSURANCE COMPANY
By: /s/ Richard M. Reilly
------------------------------
Name: Richard M. Reilly
------------------------------
Title: Vice President
------------------------------
<PAGE>
AGREEMENT FOR LOCKBOX SERVICES
This Agreement is entered into as of July 1, 1997, by and between Boston
Financial Data Services Inc. ("BFDS") and First Allmerica Financial Life
Insurance Company, its subsidiaries and affiliates ("Customer") for the
lockbox services provided in the Exhibit(s) attached hereto and hereby made a
part of this Agreement.
WHEREFORE the parties hereto in consideration of the mutual covenants
contained herein and intending to be legally bound, agree as follows:
A. SERVICES:
Upon Customer's authorization of the postmaster in Boston to permit employees
of BFDS to access the P.O. Box specified and subject to the terms and
conditions of this Agreement, BFDS hereby agrees to provide Customer with the
services described in the Exhibit(s) attached hereto.
B. INVOICES:
As compensation for services hereunder, Customer shall pay BFDS mutually
agreed upon fees and expenses as specified in Exhibit _A_. These fees will
remain in effect for a period of three years with an allowable increase in
year two and three no greater than the calculated Northeast CPI for the
previous period. In addition, BFDS will charge such account for all
reasonable out-of-pocket expenses, such as courier fees, incurred by BFDS in
connection with any rent paid by BFDS for the P.O. Box. Payment on all
invoices submitted by BFDS shall be due net thirty (30) days from receipt of
invoice.
C. TERMINATION:
This Agreement may be terminated by either party with material cause at any
time by 30 days prior written notice to the other, and without cause at any
time by 90 days prior written notice to the other. Either party may
terminate this Agreement at any time on notice to the other in the event of
dissolution or insolvency or the commencement of any proceedings under any
bankruptcy or insolvency law by or against the other.
D. LIABILITY AND INDEMNIFICATION:
Notwithstanding anything to the contrary contained herein, neither party, in
performing its duties under this Agreement, shall be liable to the other
except for gross negligence or willful misconduct. Neither party shall be
liable for special or consequential damages. BFDS shall maintain fidelity
bonding of at least $1,000,000.00 for claims arising from fraudulent or
dishonest acts on the part of any BFDS employee, which shall be underwritten
by reputable insurer(s) licensed to do business in the Commonwealth of
Massachusetts and having an A. M. Best rating of "A" or better. Within ten
(10) days from Customer's request therefor, BFDS shall provide to Customer
either (a) copies of all relevant insurance policies, or (b) Certificates of
Insurance reasonably specifying the policies required hereunder.
E. FORCE MAJEURE:
Neither party shall be responsible for delays or failure in performance
resulting from causes beyond its control, including, without limitation, acts
of God, riots, acts of war, governmental regulations, fire, communication
line failures, power failures, earthquakes, or other disasters.
F. NO ADVERTISEMENT:
BFDS shall not (a) make any mention of this Agreement in any advertisement or
promotional material; or (b) issue or release any publicity statement or
release concerning this Agreement or the services provided, or to be
provided,
<PAGE>
hereunder, without the written consent of Customer being first obtained.
G. SOLICITATION:
BFDS shall not solicit any of Customer's employees while said employees are
employed by Customer, and for one (1) year following the date that Customer's
employee has terminated employment with Customer, unless otherwise expressly
agreed in writing by Customer.
H. CONFIDENTIALITY:
As used herein, the term "confidential information" shall mean non-public
information that either party designates as confidential, or which, under the
circumstances, ought to be treated as confidential. Confidential information
may be in any tangible form, including without limitation written or printed
text or documents, audio or video tapes, CD's or disks and computer disks or
tapes, whether in machine readable or user readable form. Confidential
information shall include without limitation information relating directly or
indirectly to the marketing or promotion of either party's products, released
or unreleased software or other programs, trade secrets, business policies
and/or practices, and any information received by or about third parties,
including claimants, that either party is obligated to treat as confidential.
Customer and BFDS hereby acknowledge and agree that, in providing sufficient
information or access to BFDS to allow BFDS to perform in accordance with
this Agreement, or otherwise allowing BFDS to perform as required hereunder,
Customer and/or its agents, servants, customers or employees may disclose to
BFDS, or BFDS may otherwise obtain, certain information that is confidential
and/or proprietary to Customer and/or its agents, servants, employees,
customers or the dependents thereof. Customer and BFDS hereby also
acknowledge and agree that, in providing sufficient information or access to
Customer to allow Customer to perform in accordance with this Agreement, or
otherwise allowing Customer to perform as required hereunder, BFDS and/or its
agents, servants, customers or employees may disclose to Customer, or
Customer may otherwise obtain, certain information that is confidential
and/or proprietary to BFDS and/or its agents, servants, employees, customers
or the dependents thereof. Accordingly, the parties hereby agree to keep
such information confidential and prevent its unauthorized disclosure. Each
party shall: (a) not make any copies of the other's (and/or its agents'
servants' or employees', or customers') confidential information without
first obtaining the written consent of such other and/or the appropriate
individual(s) therefor; (b) not utilize any confidential information of the
other (and/or any confidential information of its agents, servants,
employees, or customers) except in the furtherance of the obligations and
responsibilities specified hereunder, and for no other purpose(s) whatsoever;
and (c) return any such confidential information in its possession to the
other immediately upon (i) the other's demand therefor, (ii) the
accomplishment of the purpose for which such confidential information is or
was held or obtained, or (iii) the expiration or other termination of this
Agreement. In the event of any breach or threatened breach by either party
(or any of either party's agents, servants, vendors, principles, owners,
affiliated persons or employees) of the covenants, agreements and/or
conditions contained in this section, the other party and/or the appropriate
agents, servants, employees, claimants, or customers shall be entitled to an
injunction prohibiting such breach in addition to any other legal and/or
equitable remedies available to them and/or the appropriate individual(s) in
connection with such breach. The parties acknowledge that any confidential
information disclosed to it is valuable, proprietary and unique and that any
disclosure thereof in breach of this Agreement shall result in irreparable
harm. The agreements, covenants and conditions contained in this section
shall survive the expiration or any earlier termination of this Agreement.
I. ASSIGNMENT:
II.
Notwithstanding the foregoing, Customer may, without the consent of BFDS,
assign or transfer this Agreement to any present or future affiliate or
<PAGE>
subsidiary of First Allmerica Financial Life Insurance Company. BFDS agrees
to release Customer from all obligations under this Agreement in the event
that such obligations are assumed under the preceding sentence by a
corporation or entity whose financial responsibility is equivalent to or
greater than that of Customer. As used herein, the term "Customer" shall
include First Allmerica Financial Life Insurance Company and all of its
present or future affiliates or subsidiaries, including without limitation
all corporate successors of any of the foregoing that may result from merger,
consolidation, reorganization, demutualization or conversion. As used
herein, the term "affiliate" shall include any entity controlling, controlled
by or under common control with, First Allmerica Financial Life Insurance
Company, or which following a merger, consolidation, demutualization or
reorganization involving First Allmerica Financial Life Insurance Company is
controlled by an entity that controlled First Allmerica Financial Life
Insurance Company or that First Allmerica Financial Life Insurance Company
controlled or that was under common control with First Allmerica Financial
Life Insurance Company, in each case, prior to such merger, consolidation,
demutualization or reorganization. BFDS may not, without the consent of
Customer, assign or transfer this Agreement to any present or future
affiliate or subsidiary of Boston Financial Data Services, Inc.
J. NOTICE:
Any notice under this Agreement shall be deemed to have been given if sent by
mail, postage prepaid, to the following addresses: if to Customer - First
Allmerica Financial Life Insurance Company, 440 Lincoln Street, Worcester, MA
01653, Attn: Manager, Cash Management, N479; or such other address as
Customer may designate by written notice to BFDS; if to BFDS - Boston
Financial Data Service, Inc., 2 Heritage Drive, No. Quincy, MA 02171,
Attention: Cash Management Services, 1st Floor.
K. SEVERABILITY:
Each and every covenant, provision, term and clause contained in this
Agreement is severable from the others, and each such covenant, provision,
term and clause shall be valid and effective notwithstanding the invalidity
or unenforceability of any other such covenant, provision, term or clause.
L. ENTIRE AGREEMENT:
This Agreement constitutes the entire Agreement between the parties hereto
and supersedes any prior agreement with respect to the subject matter hereof,
whether written or oral, and may not be changed or otherwise terminated,
orally or otherwise, except as expressly provided herein or by an instrument
in writing signed by a duly authorized representative of Customer and BFDS.
M. GOVERNING LAW:
This Agreement shall be governed by the laws of the Commonwealth of
Massachusetts.
The Exhibits attached hereto are hereby made a part of this Agreement.
Additional Exhibits may be added to this Agreement if set forth in a writing
signed by a duly authorized representative of both parties. If any terms are
inconsistent between this Agreement and any Exhibits attached hereto, the
terms of this Agreement shall prevail.
IN WITNESS WHEREOF, the parties hereto by their duly authorized
representatives have executed this Agreement effective as of the date first
written above.
BOSTON FINANCIAL DATA SERVICES, INC.
BY: /s/ STEPHEN HILL
<PAGE>
TITLE: VICE PRESIDENT
DATE:
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
BY: /s/ EDWARD A. OSTROUT
TITLE: ASSISTANT TREASURER
DATE: JULY 24, 1997
<PAGE>
EXHIBIT A
(ALLMERICA FINANCIAL FEE PROPOSAL BOSTON FINANCIAL DATA SERVICES MAY 1997)
(REV. 7-14-97)
<PAGE>
Allmerica Financial
440 Lincoln Street
Worcester, MA 01653
Re: Retail Lockbox Agreement (Page 1 of 3)
Boston Financial Data Services Inc, ("BFDS") is pleased to establish a
lockbox service for your organization. The lockbox will be operated in
conjunction with Post Office Box No (the "P.O. Box") (See Attached) Boston,
MA, our unique zip code of 02266, and your deposit account(s) at Bank of
Boston entitled (the "Account").
We understand that you have authorized the postmaster in Boston to
permit employees of BFDS to access the P.O. Box. Subject to the terms of
this Agreement, BFDS hereby agrees to provide the following services:
1. BFDS will collect all mail received at the P.O. Box at
various times each day.
2. All checks removed by BFDS from the P.O. Box will be deposited
into the Account as instructed within the client's operating
procedures.
3. BFDS shall not have any responsibilities to read any letter
or other communication received in the P.O. Box, although
checks received with any letter or other communication will
be deposited in the Account. Likewise, any post-dated check
which BFDS determines will be received by the drawee bank by
the date of such check will be deposited in the Account.
BFDS is authorized to endorse checks deposited in the Account
with the endorsement "absence of endorsement guaranteed" or
other similar endorsements and you agree to indemnify BFDS
against any loss, cost or expense resulting from such
endorsement.
4. All processing, depositing and collection of checks shall be
subject to the established procedures followed from time to
time by BFDS in connection with any regular deposit received
by BFDS.
5. Checks returned unpaid because of insufficient funds will be
automatically forwarded for collection a second time; if
unpaid after the second presentation, such checks, together
with advice of debit, will be sent to you.
6. As compensation for services hereunder, you shall pay BFDS mutually
agreed upon fees and expenses.
These fees are to be applied to your account and will remain in effect
for a period of three years with an allowable increase in year two and
three no greater than the calculated Northeast CPI for the previous
period. In addition, BFDS will charge the Account for all out-of-pocket
expenses, such as courier fees, incurred by BFDS in connection with any
rent paid by BFDS for the P.O. Box.
7. This Agreement may be terminated by either party at any time by 90- days
prior written notice to the other, provided that BFDS may terminate this
Agreement at any time on notice to you in the event of your dissolution
or
<PAGE>
insolvency or the commencement of any proceedings under any bankruptcy or
insolvency law or by or against you.
8. BFDS, in performing its duties under this Agreement, shall not be liable
to you except for gross negligence or willful misconduct. BFDS shall
not be responsible for delays or failure in performance resulting from
causes beyond its control including, without limitation, acts of God,
strikes, lockouts, riots, acts of war, governmental regulations, fire,
communication line failures, power failures, earthquakes or other
disasters. BFDS shall also not be liable for special or consequential
damages.
9. Any notice under this Agreement shall be deemed to have been given if
sent by mail, postage prepaid, to the following addresses: If to you,
the address set forth on page one hereof, or to such other address as
you may designate by written notice to BFDS; if to BFDS, Boston
Financial Data Service, Inc., 2 Heritage Drive, No. Quincy, MA 02171,
Attention: Cash Management Services, 1st Floor.
10. This Agreement constitutes the entire Agreement between the parties
hereto and supersedes any prior agreement with respect to the subject
matter hereof, whether written or oral.
11. BFDS hereby agrees that all records which it maintains on behalf of
Allmerica are property of Allmerica, and further agrees to surrender
promptly to Allmerica such records upon Allmerica's request. However,
BFDS has the right to make copies of such records, in its discretion.
To the extent that any records maintained on behalf of Allmerica are
subject to section 31a-1 under the Investment Company Act of 1940 ("1940
Act"), BFDS agrees to preserve such records for the periods prescribed
by rule 31a-2 under the 1940 Act.
12. Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the
SEC, the NASD, and state insurance regulators) and shall permit such
authorities reasonable access to its books and records in conjunction
with any investigation or inquiry relating to the services to be
provided by BFDS. Notwithstanding the generality of the foregoing, each
party hereto further agrees to furnish the Insurance Commissioner of any
state with any information or reports in connection with services
provided under this Agreement which such Commissioner may reasonably
request in order to ascertain whether the variable contracts operations
of Allmerica are being conducted in a manner consistent with the state's
regulations concerning variable contracts and any other applicable law
or regulation.
13. This Agreement shall be governed by the laws of the Commonwealth of
Massachusetts.
BOSTON FINANCIAL DATA SERVICES INC.
BY: /s/ Stephen Hill
TITLE: Vice President
DATE: 11/4/97
ALLMERICA FINANCIAL
BY: /s/ Edward A. Ostrout
TITLE: Assistant Treasurer
DATE: 11/5/97
<PAGE>
Service Level Agreement
Boston Financial Data Services
First Allmerica Financial Life Insurance Company
and
Allmerica Financial Life Insurance and Annuity Company
THIS AGREEMENT is entered into as of this _____ day of January, 1998 by and
among First Allmerica Financial Life Company and Allmerica Financial Life
Insurance and Annuity Company (collectively, "Allmerica") and Boston Financial
Data Services, Inc., ("BFDS").
WHEREAS, Allmerica and BFDS have entered into a Retail Lockbox Agreement and
Allmerica wishes to obtain from BFDS additional mailroom services in connection
with said Retail Lockbox Agreement,
NOW, THEREFORE, in consideration of their mutual promises, Allmerica and BFDS
hereby agree as follows:
1. SERVICES
BFDS hereby agrees to provide Customer with Services ("Services")
according to the specifications ("Service Levels") described in the
following Exhibits(s), which are attached hereto and made a part of this
Agreement:
1. Exhibit B "Boston Financial Data Services--Operations Support Services--
Service
Level Agreement--Allmerica Financial"
2. Exhibit C "Allmerica Financial--Notes for BFDS on Allmerica's intended
Procedures"
Additional Exhibits may be added to this Agreement if set forth in a writing
signed by duly authorized representatives of both parties. If any terms are
inconsistent between this Agreement and any exhibits attached hereto, the
terms of this Agreement shall prevail.
Material failure to provide the Services and Service Levels set forth in the
Exhibits shall be considered a Default for the purposes of section 4.
TERMINATION.
2. COMPENSATION
As compensation for services hereunder, Customer shall pay BFDS mutually
agreed upon fees and expenses as specified in Exhibit A.
<PAGE>
3. LIMITATION OF LIABILITY
Notwithstanding anything to the contrary contained herein, neither party, in
performing its duties under this Agreement, shall be liable to the other
except for gross negligence or willful misconduct. Neither party shall be
liable for special or consequential damages. BFDS shall maintain fidelity
bonding of at least $1,000,000 for claims arising from fraudulent or
dishonest acts on the part of any BFDS employee, which shall be underwritten
by reputable insurers(s) licensed to do business in the Commonwealth of
Massachusetts and having an A.M. Best rating of "A" or better. Within ten
(10) days from Customer's request therefor, BFDS shall provide to Customer
either (a) copies of all relevant insurance Policies, or (b) Certificates of
Insurance reasonably specifying the policies required hereunder.
Neither party shall not responsible for delays or failure in performance
resulting from causes beyond its control including, without limitation,
acts, of God, strikes, lockouts, rots, acts of war, governmental
regulations, fire, communication line failures, power failures, earthquakes
or other disasters.
4. TERMINATION
This Agreement may be terminated: (a) by either party at any time by 90 days
prior written notice to the other; (b) at any time by mutual written consent
of the parties; or (c) by either party immediately, upon notice to the other
party that the other party is in Default. The occurrence of any one or more
of the following events shall constitute a Default under the Agreement by
the party to whom the event relates:
(a) Any failure or refusal by a party to substantially perform or satisfy
any material term or condition of the Agreement, if such failure or
refusal continues for more than 30 days after the earlier of (i) notice
thereof to such defaulting party by the other party, or (ii) actual
knowledge by the failing party that it is failing to perform or satisfy a
material term or condition of the Agreement.
(b) The voluntary or involuntary bankruptcy or insolvency of a party, the
voluntary or involuntary dissolution or liquidation of a party, the
admission in writing by a party of its inability to pay its debts as
they mature, or the assignment by a party for the benefit of creditors.
- 2 -
<PAGE>
5. NOTICES
Any notice shall be sufficiently given when sent by registered or certified
mail to the other party at the address of such party set forth below or at
such other address as such party may from time to time specify in writing to
the other party.
If to the Fund:
Boston Financial Data Services, Inc.
2 Heritage Drive
North Quincy, MA 02171
If to Allmerica:
First Allmerica Financial Life Insurance Company
440 Lincoln Street
Worcester, MA 01653
Attention: William Hayward, Vice President
Allmerica Financial Life Insurance and Annuity Company
440 Lincoln Street
Worcester, MA 01653
Attention: William Hayward, Vice President
6. RECORDS
BFDS hereby agrees that all records which it maintains on behalf of
Allmerica are the property of Allmerica, and further agrees to surrender
promptly to Allmerica such records upon Allmerica's request. However, BFDS
has the right to make copies of such records, in its discretion. To the
extent that any records maintained on behalf of Allmerica are subject to
section 312a-1 under the Investment Company Act of 1940 ("1940 Act") BFDS
agrees to preserve such records for the periods prescribed by Rule 31a-2
under the 1940 Act.
7. COUNTERPARTS
This Agreement may be executed simultaneously in two or more counterparts,
each of which taken together shall constitute one and the same instrument.
8. SEVERABILITY
Each and every covenant, profession, term and clause contained in this
Agreement is severable from the others, and each such covenant, provision,
term and clause shall be valid and effective notwithstanding the invalidity
or unenforceability of any other such covenant, provision, term, or clause.
If any provision of the Agreement shall be held or made invalid by a court
decision, statute, rule or otherwise, the remainder of the Agreement shall
not be affected thereby.
- 3 -
<PAGE>
9. ASSIGNMENT
Customer may, without the consent of BFDS, assign or transfer this Agreement
to any present or future affiliate or subsidiary of First Allmerica
Financial Life Insurance Company. As used herein, the term "affiliate"
shall include any entity controlling, controlled by or under common control
with, First Allmerica Financial Life Insurance Company. BFDS may not,
without the consent of Customer, assign or transfer this Agreement to any
present or future affiliate or subsidiary of BFDS. This Agreement or any of
the rights and obligations hereunder may not be assigned by any party
without the prior written consent of all parties hereto.
10. REGULATORY AUTHORITIES
Each party hereto shall cooperate with each other party and all appropriate
governmental authorities (including without limitation the SEC, the NASD,
and state insurance regulators) and shall permit such authorities reasonable
access to its books and records in connection with any investigation or
inquiry relating to this Agreement or the transactions contemplated hereby.
Notwithstanding the generality of the foregoing, each party hereto further
agrees to furnish the Insurance Commissioner of any state with any
information or reports in connection with services provided under this
Agreement which such Commissioner may request in order to ascertain whether
the insurance operations of the Company are being conducted in a manner
consistent with applicable laws and regulations.
11. CAPTIONS
The captions in this Agreement are included for convenience of reference
only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
12. CONTROLLING LAW
This Agreement shall be governed by and its provisions shall be construed in
accordance with the laws of the Commonwealth of Massachusetts.
- 4 -
<PAGE>
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to
be executed in its name and on behalf by its duly authorized representative
and its seal to be hereunder affixed hereto as of the date specified below.
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
By: /s/ William Hayward
-----------------------------------------------------
Title: Vice President & Managing Director
-----------------------------------------------------
Date: 2/6/98
-----------------------------------------------------
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
By: /s/ William Hayward
-----------------------------------------------------
Title: Vice President & Managing Director
-----------------------------------------------------
Date: 2/6/98
-----------------------------------------------------
BOSTON FINANCIAL DATA SERVICES, INC.
By: /s/ John E. Ciardi
-----------------------------------------------------
Title: Vice President - Operations Support Services
-----------------------------------------------------
Date: 2/4/98
-----------------------------------------------------
- 5 -
<PAGE>
[LOGO] ALLMERICA
FINANCIAL(R)
Allmerica Financial Life
Insurance and Annuity Company
440 Lincoln Street
Worcester, MA 01653
Conditional Receipt for Advance
Payment of Premium
================================================================================
Conditional Insurance Agreement
There is no insurance under this agreement until all the conditions have been
met.
- --------------------------------------------------------------------------------
RECEIPT
- --------------------------------------------------------------------------------
A payment of $____________________ has been received on _________________ with
the application for insurance on the life of
_______________________________________________________________________________.
the proposed insured (for survivorship contracts, please list both proposed
insureds).
ALL PREMIUM CHECKS MUST BE MADE PAYABLE TO THE COMPANY.
DO NOT MAKE CHECKS PAYABLE TO THE AGENT OR LEAVE THE PAYEE BLANK.
Received for the Company by _________________________
- --------------------------------------------------------------------------------
DEFINITIONS
- --------------------------------------------------------------------------------
"Proposed Insured" means the person (or both persons in the case of an
application for a survivorship contract) whose life will be insured if the
application is approved.
"We", "our", and "us" refer to the Company.
"Underwriting Date" means the date of the application, medical questionnaire, or
the Conditional Receipt, whichever date is later. If an Other Insured Rider is
applied for, the "Underwriting Date" for coverage on the Other Insured is the
later of the date of Conditional Receipt, the Supplemental Application for the
Other Insured, or the Medical Exam if required.
"Standard Underwriting Class" means the acceptable under the Company's
underwriting rules for the plan and amount of insurance applied for without any
additional premium change or restrictive rider.
"Non-standard Underwriting Class" means acceptable for the type of insurance
applied for under the Company's underwriting rules but subject to higher charges
or a restrictive rider.
- --------------------------------------------------------------------------------
CONDITIONS TO BE MET
- --------------------------------------------------------------------------------
The following conditions must be met before we have any liability under this
agreement, other than the return of the premium received.
1. The application must be completed and signed by the proposed insured(s)
and the owner, if not the insured.
2. The proposed insured(s) must be in a standard or non-standard
underwriting class on the underwriting date.
3. The proposed insured(s) must be under the age of 71.
4. The proposed insured(s) must have undergone a medical exam if required
by us.
5. If the date of the Conditional Receipt is later than the date of the
medical questionnaire and the Supplemental Application for Other Insured
(if applicable), the proposed insured must not have consulted or been
treated by any physician or practitioner of any healing art nor had any
tests listed in the application since their completion.
If all of the above conditions have been met, some insurance will be provided
under this agreement. However, the insurance will be subject to all of the
further provisions of this agreement.
- --------------------------------------------------------------------------------
LIFE INSURANCE NOT IN EFFECT
- --------------------------------------------------------------------------------
If a person proposed for life insurance is not insurable on either a standard
or a non-standard basis, no life insurance will be in effect.
1CR-97 PAGE 1
<PAGE>
- --------------------------------------------------------------------------------
BENEFITS
- --------------------------------------------------------------------------------
Amount of Insurance
If a proposed insured is in a standard underwriting class, the death benefit
provided under this agreement will be the lesser of the amount applied for or
the limit indicated in the Maximum Death Benefit Table below.
If a proposed insured is in a non-standard underwriting class that requires
higher insurance charges to apply, the amount of the death benefit will be
reduced. The reduced benefit is determined by using the same factor or
percentage that applies to the non-standard insurance charges. In no event will
the death benefit exceed the maximum limits indicated in the Maximum Death
Benefit Table below. If a proposed insured is in a non-standard underwriting
class which requires a restrictive rider, the death benefit provided under this
agreement will be the lesser of the following:
(a) the amount applied for;
(b) the maximum limit applicable to the proposed insured; and
(c) the premium paid if the proposed insured's death comes within the terms
of the restrictive rider which would have been attached to the policy
when issued.
Maximum Limit
The maximum limit under this agreement for life insurance is an amount which,
when added to any death benefit provided under any life insurance policy or
conditional insurance agreement having a date of issue or underwriting date,
respectively, within 90 days prior to the underwriting date of this agreement,
does not exceed the amounts listed in the Maximum Death Benefit Table below. The
maximum limit will not be increased because payment has been made to the Company
which is larger than the premium required for such reduced insurance. Upon
receipt of due proof of the death of the proposed insured, that portion of the
premium paid for any excess insurance shall be paid to the beneficiary named in
the application.
<TABLE>
<CAPTION>
Maximum Death Benefit Table
- ------------------------------------------------------------------------------------------
Standard Underwriting Class Non-Standard Underwriting Class
Age* Range Maximum Death Benefit Maximum Death Benefit
- ------------------------------------------------------------------------------------------
<S> <C> <C>
0-15 years old $50,000 $25,000
- ------------------------------------------------------------------------------------------
16-60 years old $500,000 $250,000
- ------------------------------------------------------------------------------------------
61-65 years old $250,000 $125,000
- ------------------------------------------------------------------------------------------
66-70 years old $100,000 $50,000
- ------------------------------------------------------------------------------------------
71 years of age and older no benefit no benefit
- ------------------------------------------------------------------------------------------
</TABLE>
*'Age' means how old the Proposed Insured is on his/her nearest birthday. If a
survivorship contract is being applied for, the age of the younger Proposed
Insured is used.
Suicide Exclusion
If a proposed insured commits suicide while this agreement is in effect, the
Company's liability will be limited to the return of the premium paid.
- --------------------------------------------------------------------------------
TERMINATION
- --------------------------------------------------------------------------------
This agreement may be terminated at any time prior to incurrence of a claim.
The Company's sole liability shall be limited to the refund of the premium
paid. Such termination will occur on the earliest of the following:
1. The delivery of the insurance issued on this application.
2. The date the Company mails a termination notice with a refund of your
payment to you.
3. Ninety days after the underwriting date.
- --------------------------------------------------------------------------------
GENERAL
- --------------------------------------------------------------------------------
Any check or draft is accepted subject to collection. No agent or broker is
authorized to amend, alter, or modify the terms of this agreement. All
statements in the application are representations, not warranties. If you do
not hear from us within 60 days of the date of this agreement, please write to
us without delay, stating the facts concerning this application. Our address
is 440 Lincoln Street, Worcester, MA 01653.
1CR-97 PAGE 2
<PAGE>
[LOGO] ALLMERICA
FINANCIAL(R)
Allmerica Financial Life
Insurance and Annuity Company
440 Lincoln Street
Worcester, MA 01653
Supplementary Application for
the Other Insured & Child
Insurance Rider
================================================================================
Name of Basic Insured: _____________________________________________
This application is for: |_| Other Insured Rider
|_| Child Insurance Rider
- --------------------------------------------------------------------------------
1. INSURED(S) The person(s) upon whose life this insurance coverage is proposed.
- --------------------------------------------------------------------------------
Insured A
_________________________________________
Insured Name
________-______-______ |_| M |_| F
Social Security Number Sex
M/____D/____Y/____ ______________
Date of Birth State of Birth
$_____________________________
Existing Life Insurance
$_____________________________
Amount of Insurance Requested
Insured B
_________________________________________
Insured Name
________-______-______ |_| M |_| F
Social Security Number Sex
M/____D/____Y/____ ______________
Date of Birth State of Birth
$_____________________________
Existing Life Insurance
$_____________________________
Amount of Insurance Requested
Insured C
_________________________________________
Insured Name
________-______-______ |_| M |_| F
Social Security Number Sex
M/____D/____Y/____ ______________
Date of Birth State of Birth
$_____________________________
Existing Life Insurance
$_____________________________
Amount of Insurance Requested
- --------------------------------------------------------------------------------
2. INFORMATION ABOUT THE INSURED(S) Please complete the following information.
- --------------------------------------------------------------------------------
Current height and weight
Height _____________ Weight _______________
Weight change during the past 12 months if any: __________________
Name, address, and telephone number of Personal Physician:
__________________________________________________________
__________________________________________________________
__________________________________________________________
(__________)______________________________________________
Date and Reason last consulted:
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
Will the proposed rider replace any existing annuity or life insurance
contract(s)?
|_| Yes |_| No
If yes, please complete appropriate Transfer of Assets and/or 1035 Exchange Form
included with this application package. If required, the appropriate state
replacement form must accompany the Transfer of Assets or 1035 Exchange Form.
Current height and weight
Height _____________ Weight _______________
Weight change during the past 12 months if any: __________________
Name, address, and telephone number of Personal Physician:
__________________________________________________________
__________________________________________________________
__________________________________________________________
(__________)______________________________________________
Date and Reason last consulted:
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
Will the proposed rider replace any existing annuity or life insurance
contract(s)?
|_| Yes |_| No
If yes, please complete appropriate Transfer of Assets and/or 1035 Exchange Form
included with this application package. If required, the appropriate state
replacement form must accompany the Transfer of Assets or 1035 Exchange Form.
Current height and weight
Height _____________ Weight _______________
Weight change during the past 12 months if any: __________________
Name, address, and telephone number of Personal Physician:
__________________________________________________________
__________________________________________________________
__________________________________________________________
(__________)______________________________________________
Date and Reason last consulted:
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
Will the proposed rider replace any existing annuity or life insurance
contract(s)?
|_| Yes |_| No
If yes, please complete appropriate Transfer of Assets and/or 1035 Exchange Form
included with this application package. If required, the appropriate state
replacement form must accompany the Transfer of Assets or 1035 Exchange Form.
- --------------------------------------------------------------------------------
3. BENEFICIARY The person or entity to whom policy proceeds are payable.
- --------------------------------------------------------------------------------
The beneficiary shall be the owner, if living, otherwise the owner's estate,
unless this right is expressly released. The owner may name another as
beneficiary (attach "Nomination of Beneficiary and Request" form, if
applicable).
1SCR-97 PAGE 1
<PAGE>
- --------------------------------------------------------------------------------
4. MEDICAL HISTORY The medical history of the person(s) upon whose life this
insurance coverage is proposed.
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Has any person listed in Section 1 of this application: Insured A Insured B Insured C
<S> <C> <C> <C>
4a. Had an illness or injury during the past 6
months that has prevented him/her from
working five consecutive days? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4b. During the past 3 years had their motor
vehicle license suspended or revoked, been
convicted of driving while intoxicated, or
been convicted of more than one moving
violation? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4c. During the past 3 years participated in or
intended to participate in scuba diving,
parachuting, motor racing, hang gliding or
similar flying activity? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4d. During the past 3 years flown, or intended
to fly, as a trainee, pilot or crew member? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4e. During the past 12 months, smoked one or
more cigarettes? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4f. Currently been using cigars, pipes, chewing
tobacco or other tobacco products? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4g. Made plans to travel outside the United
States or Canada? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4h. Ever had a life or health insurance
application declined, postponed, modified,
or rated? |_| Y |_| N |_| Y |_| N |_| Y |_| N
During the past 10 years, has any person listed in
Section 1 of this application had, been told
he/she had, or been treated for:
4i. Disorder of the eyes, ears, nose or throat? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4j. High blood pressure, chest pain, heart
attack, heart murmur, stroke, or other
cardiac disorder? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4k. Disorder of the kidneys, prostate,
genito-urinary tract, or reproductive
system, or any sexually transmitted disease
(other than AIDS, ARC)? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4l. Any immune system disorder, including
Acquired Immune Deficiency Syndrome (AIDS),
or AIDS-related complex (ARC)? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4m. Diabetes, thyroid disorder, or other
endocrine gland disorder? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4n. Ulcers, hepatitis, colon polyp, colitis,
disorder of the pancreas, liver, or
intestines? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4o. Asthma, shortness of breath, disorder of
the blood, lymph glands, or respiratory
system? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4p. Cancer, tumors, arthritis, disorder of the
skin, muscles, bones, joints, or connective
tissue disease? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4q. Mental, nervous, or brain disorder,
depression, suicide attempt, seizures,
headaches, dizziness, or fainting? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4r. Alcoholism, or have you been advised to
reduce or discontinue the use of alcohol
for health reasons? |_| Y |_| N |_| Y |_| N |_| Y |_| N
During the past 5 years, has any person listed in
Section 1 of this application:
4s. Used or received treatment or counseling
for marijuana, cocaine, barbiturates,
narcotics, excitants, or hallucinogens,
except as prescribed medication? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4t. Been a patient in a hospital, clinic,
sanitarium, or other medical facility or
been advised to have a test or surgery that
was not done? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4u. Consulted for any reason other than any
listed above, a physician or other physical
or mental health advisor? |_| Y |_| N |_| Y |_| N |_| Y |_| N
4v. Is any person listed in Section 1 currently
taking any medication? |_| Y |_| N |_| Y |_| N |_| Y |_| N
</TABLE>
1SCR-97 PAGE 2
<PAGE>
Please explain any "yes" answers to 4a-4v here. Please indicate the insured
being described. You may continue on a separate sheet of paper if necessary.
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------
Insured Question Condition/Diagnosis Medication/Treatment Date Still Being Physician/Address
A,B,C # Treated?
- ------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
</TABLE>
- --------------------------------------------------------------------------------
5. ACKNOWLEDGEMENTS AND SIGNATURES
- --------------------------------------------------------------------------------
IT IS UNDERSTOOD AND AGREED: (1) That the representations above recorded are
true and complete to the best of my knowledge and belief; (2) That no
liability exists until this rider is delivered and the first premium paid
during the lifetime of the proposed Insured(s) and then only if the proposed
Insured(s) has (have) not consulted or been treated by any physician or
practitioner of any healing art nor had any special tests since the date of
this application; but, if the premium is paid prior to the delivery of the
rider and a conditional receipt is delivered by a registered representative,
insurance shall be effective subject to the terms of the conditional receipt;
(3) No registered representative or broker is authorized to amend, alter, or
modify the terms of this agreement.
This application is made at the request of the undersigned who hereby agrees
to be bound by each statement, representation, and agreement herein, and
further agrees that any policy of insurance issued in connection with this
application shall be issued on the condition that each statement,
representation, and agreement shall be binding upon the owner(s) to the same
extent and degree as if made by the owner(s).
X_____________________________________________________ _______________________
Full signature of Insured under the rider or Date
applicant for Child Rider
X_____________________________________________________ _______________________
Full signature(s) of Owner(s) of the policy Date
under the rider or applicant for Child Rider
______________________________________________________
Official Title/Capacity (cannot be Insured)
______________________________________________________ _______________________
Signed at City State
1SCR-97 PAGE 3
<PAGE>
- --------------------------------------------------------------------------------
6. INFORMATION ABOUT THE INSURED(S) TO BE COMPLETED BY THE AGENT
- --------------------------------------------------------------------------------
Please complete the Questions 6a - 6d if this application is for the Other
Insured Rider (OIR):
6a. The need for the proposed insurance is: ____________________________________
6b. The supporting spouse or parent is insured for the benefit of the family.
The amount of insurance is: $ ______________________________________________
6c. The supporting spouse or parent is not insured because: ____________________
____________________________________________________________________________
6d. Supporting spouse's/parent's Name, Date of Birth, and Income: ______________
____________________________________________________________________________
Please complete Questions 6e - 6f if this application is for the Child
Insurance Rider (CIR):
6e. Are all children who have not reached their 18th birthday included in this
application? |_| Yes |_| No
If no, please explain: ________________________________________________
_______________________________________________________________________
6f. How long have you known the parent/person with whom the children
are living? ________________________________________________________________
If children are living with a person other than the proposed Insured,
please explain: ________________________________________________________
________________________________________________________________________
- --------------------------------------------------------------------------------
7. AGENT'S SIGNATURE
- --------------------------------------------------------------------------------
Agent/Registered Representative Statement
As Registered Representative, I certify witnessing the signature of the
applicant and that all information, statements, and answers in this
application are correct, complete, and true and have been accurately recorded,
to the best of my knowledge and belief. Based on the information furnished by
the Owner or Insured in this application, I certify that I have reasonable
grounds for believing the purchase of the policy applied for is suitable for
the Owner. I further certify that the Prospectuses were delivered and that no
written sales materials other than those furnished or approved by the Company
were used.
It is hereby stated that I/we personally solicited this application and except
as specified below, no other agent or broker has any commission interest in
this sale. (If more than one agent indicate split, otherwise the Company
assumes that any division of commission is in equal shares.)
Signature of Licensed Agent: ___________________________________________________
Underwriting Approval: ___________________________________________________
1SCR-97 PAGE 4
<PAGE>
[LOGO] ALLMERICA
FINANCIAL(R)
Allmerica Financial Life
Insurance and Annuity Company
440 Lincoln Street
Worcester, MA 01653
Variable Life Application
(Part II)
================================================================================
Insured: _________________________________________ D.O.B.:___/___/___
Social Security Number:___________________
2nd Insured:______________________________________ D.O.B.:___/___/___
Social Security Number:___________________
- --------------------------------------------------------------------------------
1. MEDICAL HISTORY Medical history of the person(s) upon whose life insurance
coverage is proposed.
- --------------------------------------------------------------------------------
Insured 2nd Insured
1a. Have you ever had a life or health insurance
application declined, postponed, modified, or
rated? |_| Y |_| N |_| Y |_| N
During the past 10 years, have you had, been told you
had, or been treated for:
1b. Disorder of the eyes, ears, nose or throat? |_| Y |_| N |_| Y |_| N
1c. High blood pressure, chest pain, heart attack,
heart murmur, stroke, or other cardiac disorder? |_| Y |_| N |_| Y |_| N
1d. Disorder of the kidneys, prostate, genito-urinary
tract, or reproductive system, or any sexually
transmitted disease (other than AIDS, ARC)? |_| Y |_| N |_| Y |_| N
1e. Any immune system disorder including Acquired
Immune Deficiency Syndrome (AIDS), or AIDS-related
complex (ARC)? |_| Y |_| N |_| Y |_| N
1f. Diabetes, thyroid disorder, or other endocrine
gland disorder? |_| Y |_| N |_| Y |_| N
1g. Ulcers, hepatitis, colon polyp, colitis, disorder
of the pancreas, liver, or intestines? |_| Y |_| N |_| Y |_| N
1h. Asthma, shortness of breath, disorder of the
blood, lymph glands, or respiratory system? |_| Y |_| N |_| Y |_| N
1i. Cancer, tumors, arthritis, disorder of the skin,
muscles, bones, joints, or connective tissue
disease? |_| Y |_| N |_| Y |_| N
1j. Mental, nervous, or brain disorder, depression,
suicide attempt, seizures, headaches, dizziness,
or fainting? |_| Y |_| N |_| Y |_| N
1k. Alcoholism, or have you been advised to reduce or
discontinue the use of alcohol for health reasons? |_| Y |_| N |_| Y |_| N
During the past 5 years, have you:
1l. Used or received treatment or counseling for
marijuana, cocaine, barbiturates, narcotics,
excitants, or hallucinogens, except as prescribed
medication? |_| Y |_| N |_| Y |_| N
1m. Been a patient in a hospital, clinic, sanitarium,
or other medical facility or been advised to have
a test or surgery that was not done? |_| Y |_| N |_| Y |_| N
1n. Are you currently taking any medication? |_| Y |_| N |_| Y |_| N
1o. Have you consulted for any reason other than any
listed above, a physician or other physical or
mental health advisor? |_| Y |_| N |_| Y |_| N
Please provide additional information for any "yes" answers in Section 4.
- --------------------------------------------------------------------------------
2. FAMILY HISTORY Please complete the following Family Record.
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------
Family Record Age if Living Present State of Health or Cause of Death Age at Death
1st Insured 2nd Insured 1st Insured 2nd Insured 1st Insured 2nd Insured
- -----------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Father
- -----------------------------------------------------------------------------------------------------------
Mother
- -----------------------------------------------------------------------------------------------------------
Siblings
- -----------------------------------------------------------------------------------------------------------
</TABLE>
1AM-97 PAGE 1
<PAGE>
- --------------------------------------------------------------------------------
3. PHYSICAL CONDITION Physical condition of the person(s) upon whose life
insurance coverage is proposed.
- --------------------------------------------------------------------------------
Insured
3a. Name, address and telephone number of personal physician
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
Date and Reason Last Consulted: _____________________________
_____________________________________________________________
- --------------------------------------------------------------------------------
3b. Do you engage in a scheduled exercise program?
|_| Yes |_| No If yes, please give details (duration, type, frequency):
_____________________________________________________________
_____________________________________________________________
- --------------------------------------------------------------------------------
3c. Are you currently pregnant? |_| Yes |_| No
If yes, please give expected delivery date: _____________
- --------------------------------------------------------------------------------
3d. Please provide your current height and weight.
Height:_______________ Weight: __________________
Weight change during the past 12 months, if any:_________
2nd Insured
Name, address and telephone number of personal physician
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
Date and Reason Last Consulted: _____________________________
_____________________________________________________________
- --------------------------------------------------------------------------------
Do you engage in a scheduled exercise program?
|_| Yes |_| No If yes, please give details (duration, type, frequency):
_____________________________________________________________
_____________________________________________________________
- --------------------------------------------------------------------------------
Are you currently pregnant? |_| Yes |_| No
If yes, please give expected delivery date: _____________
- --------------------------------------------------------------------------------
Please provide your current height and weight.
Height:_______________ Weight: __________________
Weight change during the past 12 months, if any:_________
- --------------------------------------------------------------------------------
4. ADDITIONAL MEDICAL INFORMATION Complete for appropriate items in Section
1a-1o. Please specify 1st or 2nd Insured. Continue on a separate sheet of
paper if necessary.
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------
1st/2nd Question Condition/Diagnosis Medication/Treatment Date Still Being Physician/Address
Insured # Treated?
- --------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------
</TABLE>
- --------------------------------------------------------------------------------
ACKNOWLEDGEMENTS & SIGNATURES
- --------------------------------------------------------------------------------
I understand and agree that the foregoing statements and answers are correct,
complete and true and have been accurately recorded to the best of my knowledge
and belief, and that they shall be part of the policy if issued.
X______________________________________ X__________________________________
Signature of Proposed Insured Signature of Proposed 2nd Insured
(if applicable)
X______________________________________ ___________________________________
Signature of Examiner/Agent Date
1AM-97 PAGE 2
<PAGE>
[LOGO] ALLMERICA
FINANCIAL(R)
Allmerica Financial Life
Insurance and Annuity Company
440 Lincoln Street
Worcester, MA 01653
Variable Life Application
(Part I)
================================================================================
- --------------------------------------------------------------------------------
1. INSURED The person upon whose life this insurance coverage is proposed.
- --------------------------------------------------------------------------------
_________________________________________________________
First Name Middle Last
_________________________________________________________
Street Address Years at this Address
_________________________________________________________
City State Zip
M/____D/____ Y/____ ______________ |_| M |_| F
Date of Birth State of Birth Sex
______________________________
Social Security Number
______________________________ ___________
Driver's License Number State
_________________________________________________________
Employer/Occupation
$___________________ $__________________
Annual Income Net Worth
(______)____________ (______)___________
Home Phone Business Phone
Allmerica or its representatives may contact you to discuss this application.
The best time for us to call is ____________________ at your
|_| Home |_| Business
- --------------------------------------------------------------------------------
2. SECOND INSURED If completed, survivorship insurance coverage will be issued.
- --------------------------------------------------------------------------------
_________________________________________________________
First Name Middle Last
_________________________________________________________
Street Address Years at this Address
_________________________________________________________
City State Zip
M/____D/____ Y/____ ______________ |_| M |_| F
Date of Birth State of Birth Sex
______________________________
Social Security Number
______________________________ ___________
Driver's License Number State
_________________________________________________________
Employer/Occupation
$___________________ $__________________
Annual Income Net Worth
(______)____________ (______)___________
Home Phone Business Phone
Allmerica or its representatives may contact you to discuss this application.
The best time for us to call is ____________________ at your
|_| Home |_| Business
- --------------------------------------------------------------------------------
3. INSURANCE How much life insurance coverage I would like.
- --------------------------------------------------------------------------------
3a. Life Insurance amount applied for $ _________________
3b. Life Insurance plan applied for _____________________
3c. I would like insurance coverage to be: (Choose one)
|_| Level (Option 1) |_| Adjustable (Option 2)
3d. I want the following additional insurance benefits:
|_| Accidental Death Benefit $_______________________
|_| Waiver Premium upon disability |_| Living Benefits Rider
|_| Waiver Charges upon disability |_| Exchange Option Rider
|_| Guaranteed Insurability Rider $__________________
|_| Child Insurance Rider (Complete Supplementary Application)
|_| Other Insured Rider (Complete Supplementary Application)
|_| 4 Year Term (Survivorship Coverage Only)
|_| Split Option (Survivorship Coverage Only)
|_| _________________________________________________
- --------------------------------------------------------------------------------
4. BENEFICIARY The person or entity to whom policy proceeds are payable.
- --------------------------------------------------------------------------------
_________________________________________________________
Name of Primary Beneficiary Relationship to Insured
_________________________________________________________
Social Security/Tax I.D. Number
_________________________________________________________
Name of Contingent Beneficiary Relationship to Insured
_________________________________________________________
Social Security/Tax I.D. Number
|_| 10-day Common Disaster Clause*
|_| _____-day Common Disaster Clause*
* A Common Disaster Clause requires that the Beneficiary survive the Insured for
a specified length of time before becoming entitled to the policy proceeds. The
Contingent Beneficiary will receive the policy proceeds rather than the estate
of the Primary Beneficiary.
- --------------------------------------------------------------------------------
5. POLICYOWNER The person or entity exercising the rights under this contract.
- --------------------------------------------------------------------------------
The policyowner will be the insured unless specified here.
_________________________________________________________
Name
_________________________________________________________
Social Security/Tax I.D. Number
_________________________________________________________
Street Address
_________________________________________________________
City State Zip
______/_____/_________
Date of Trust (if applicable)
1A-97 PAGE 1
<PAGE>
- --------------------------------------------------------------------------------
6. PAYMENT The monetary contribution to the policy.
- --------------------------------------------------------------------------------
Initial Payment (Check one):
|_| I have enclosed a check for my initial payment of $ _______ and have
received a Conditional Receipt.
(Please make check payable to Allmerica Financial)
|_| My initial payment will be transferred from another company.
Approximate amount $ _____________
Future payments:
Amount $_________________
|_| Monthly |_| Quarterly |_| Semi-Annually |_| Annually
(If monthly, include a voided check & "Bank Drafting Application" form). Premium
Notices will be mailed to the Owner's home address unless otherwise specified in
the "Remarks" section of this application.
- --------------------------------------------------------------------------------
7. ALLOCATION How I want my payments invested.
- --------------------------------------------------------------------------------
7a. Allocate payment as follows: Use whole percentages. You may allocate your
payments to no more than 20 of the variable accounts listed below.
_______ % Allmerica Select Aggressive Growth Fund
_______ % Allmerica Select Capital Appreciation Fund
_______ % Allmerica Select Value Opportunity Fund
_______ % Allmerica Select Emerging Markets Fund
_______ % T. Rowe Price International Stock Portfolio
_______ % Fidelity VIP Overseas Portfolio
_______ % Allmerica Select International Equity Fund
_______ % Delaware International Equity Series
_______ % Fidelity VIP Growth Portfolio
_______ % Allmerica Select Growth Fund
_______ % Allmerica Select Strategic Growth Fund
_______ % Allmerica Growth Fund
_______ % Allmerica Equity Index Fund
_______ % Fidelity VIP Equity-Income Portfolio
_______ % Allmerica Select Growth and Income Fund
_______ % Fidelity VIP II Asset Manager Portfolio
_______ % Fidelity VIP High Income Portfolio
_______ % Allmerica Investment Grade Income Fund
_______ % Allmerica Government Bond Fund
_______ % Allmerica Money Market Fund
_______ % General Account
_______ %
_______ %
_______ %
_______ % Total
7b. Deductions of all charges will be made pro rata according to the value of
each account and the General Account, unless specified below:
|_| Deduct all charges from ________________________
(Enter any single account except the General Account)
- --------------------------------------------------------------------------------
8. AUTOMATIC ACCOUNT REBALANCING
- --------------------------------------------------------------------------------
|_| I elect Automatic Account Rebalancing among the variable accounts to the
allocation specified in Section 7:
|_| Monthly |_| Quarterly |_| Semi-Annually |_| Annually
NOTE: Automatic Account Rebalancing and Dollar Cost Averaging cannot be in
effect simultaneously.
- --------------------------------------------------------------------------------
9. DOLLAR COST AVERAGING
- --------------------------------------------------------------------------------
Transfer $ _______________ ($100 minimum)
Select one account from which to transfer money.
From:
|_| Government Bond |_| Allmerica Money Market Fund
Every:
|_| Monthly |_| Quarterly |_| 6 Months |_| 12 Months
To
$ _______ Allmerica Select Aggressive Growth Fund
$ _______ Allmerica Select Capital Appreciation Fund
$ _______ Allmerica Select Value Opportunity Fund
$ _______ Allmerica Select Emerging Markets Fund
$ _______ T. Rowe Price International Stock Portfolio
$ _______ Fidelity VIP Overseas Portfolio
$ _______ Allmerica Select International Equity Fund
$ _______ Delaware International Equity Series
$ _______ Fidelity VIP Growth Portfolio
$ _______ Allmerica Select Growth Fund
$ _______ Allmerica Select Strategic Growth Fund
$ _______ Allmerica Growth Fund
$ _______ Allmerica Equity Index Fund
$ _______ Fidelity VIP Equity-Income Portfolio
$ _______ Allmerica Select Growth and Income Fund
$ _______ Fidelity VIP II Asset Manager Portfolio
$ _______ Fidelity VIP High Income Portfolio
$ _______ Allmerica Investment Grade Income Fund
$ _______ Allmerica Government Bond Fund
$ _______ Allmerica Money Market Fund
$ _______ General Account
$ _______
$ _______
- --------------------------------------------------------------------------------
10. TELEPHONE TRANSFER
- --------------------------------------------------------------------------------
Unless I check the box below I will automatically be able to transfer account
values and change the allocation of future investments by telephone or fax.
I understand that the Company is authorized to honor telephone requests by me or
by individuals authorized by me, to transfer account values among sub-accounts
and to change the allocation of my future payments.
|_| I do not accept this telephone transfer privilege.
- --------------------------------------------------------------------------------
11. REPLACING OTHER CONTRACTS
- --------------------------------------------------------------------------------
Will the proposed policy replace any existing annuity or life insurance
contract(s):
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
If yes, please complete the appropriate Transfer of Assets or 1035 Exchange Form
included with this application package.
1A-97 PAGE 2
<PAGE>
- --------------------------------------------------------------------------------
12. INFORMATION ABOUT INSURED(S)
- --------------------------------------------------------------------------------
12a. Have you had an illness or injury during the past 6 months that has
prevented you from working five consecutive days?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
12b. During the past 3 years have you had your motor vehicle license suspended
or revoked, been convicted or driving while intoxicated, or been convicted
of more than one moving violation?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
12c. During the past 3 years, have you participated in or do you intend to
participate in scuba diving, parachuting, motor racing, hang gliding or
similar flying activity?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
12d. During the past 3 years have you flown, or do you intend to fly as a
trainee, pilot or crew member?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
12e. During the past 12 months, have you smoked one or more cigarettes?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
12f. Do you currently use cigars, pipes, chewing tobacco or other tobacco
products?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
12g. Will you be travelling outside the U.S. or Canada?
Insured: |_| Yes |_| No
2nd Insured: |_| Yes |_| No
Name, address and telephone number of personal
physician, and the date/reason last consulted:
Insured:_________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
2nd Insured:_____________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
Please explain any "yes" answers to 12a-12g. Specify 1st or 2nd Insured.
Continue on separate sheet if necessary.
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
- --------------------------------------------------------------------------------
13. SUITABILITY Insureds, Owners, and Agents MUST review and complete this
section.
- --------------------------------------------------------------------------------
13a. Reason for Insurance:
|_| Estate Taxes |_| Family Income |_| Death Benefit
|_| Retirement Income |_| Cash Accumulation
|_| Business Insurance |_| Fund Business Agreement
|_| Gift |_| Other
13b. Owner's estimated financial data:
Securities: $_________ Savings: $_________
Liquid Net Worth: $___________ Tax Bracket: _______%
Gross Annual Income: $_____________________________
13c. Risk profile:
|_| Conservative |_| Moderate |_| Aggressive
Source of Funds: ___________________________________
13d. Investment objective:
|_| Emphasize Growth |_| Emphasize Stability
|_| Balances Growth and Stability
13e. Are any |_| life insurance, |_| annuities, |_| mutual funds, |_|
securities, or |_| unmatured CD's being liquidated to purchase this
variable life insurance policy?
If yes, a switching letter signed by the policyowner is attached:
|_| Yes |_| No
If yes, has the agent explained the potential advantages and disadvantages
of this transaction?
|_| Yes |_| No
13f. Are you an associated person of another broker or dealer?
|_| Yes |_| No
13g. Have you received a current prospectus describing the variable life
insurance policy, including the underlying funds, and do you believe that a
flexible-premium variable life insurance policy is consistent with your
investment objectives and financial needs?
|_| Yes |_| No
Authorization:
____________________________________________________ ___________________
(Completed by a Home Office Registered Principal) Date
1A-97 PAGE 3
<PAGE>
- --------------------------------------------------------------------------------
14. ACKNOWLEDGEMENTS & AUTHORIZATIONS
- --------------------------------------------------------------------------------
Authorization to Obtain Information
To all physicians, medical professionals, hospitals, clinics, other health care
providers, employers, Medical Information Bureau, Inc. (MIB), consumer reporting
agencies, other insurance support organizations, the united States Internal
Revenue Service, the Puerto Rice Bureau of Income Tax, and other persons who
have the types of information described about the proposed insured:
I authorize you to give the Company, its reinsurers, or its agent (a) all
information you have as to illness, injury, medical history, diagnosis,
treatment, and prognosis (including any drug or alcohol abuse condition or
treatment) with respect to any physical or mental condition of the proposed
Insured; and (b) any non-medical information including, but not limited to, an
investigative consumer reports and copies of my tax returns filed with the
United States Internal Revenue Service and/or the Puerto Rico Bureau of Income
Tax, that the Company believes it needs to perform the business functions
described below. I also authorize the Company to give the MIB health or
non-medical information it has about me and that of any minor member of my
family applying for insurance.
The information obtained will be used to determine if the proposed insured is
eligible for: (a) the insurance requested; or (b) benefits under a policy which
is in force. It will also be used for any other business purpose which relates
to the insurance requested or the policy which is in force.
This authorization will be valid for 30 months. I know that under federal
Regulations I may revoke this authorization as it applies to drug and alcohol
abuse treatment information at any time, but my revocation will not affect any
information that has been released prior thereto. I know that I may request a
copy of this form. I agree that a photocopy is as valid as the original. I have
received the Insurance Information Practices notice.
- --------------------------------------------------------------------------------
I understand that any death benefit in excess of the face amount, the policy
value allocated to the variable account, and/or the duration of coverage for the
flexible premium variable life insurance policy applied for, may increase or
decrease to reflect the investment experience of the sub-accounts and are not
guaranteed as to dollar amount. The policy value allocated to the General
Account will accumulate interest at a rate set by the Company which shall not be
less than the minimum guaranteed rate of 4% annually. There is no guaranteed
minimum policy value. The policy value may decrease to the point where the
policy will lapse and provide no further death benefit without additional
premium payments.
IT IS UNDERSTOOD AND AGREED THAT: (1) The application consists of this
application form and the medical questionnaire; (2) The representations are true
and complete to the best of my knowledge and belief; (3) No liability exists and
the insurance applied for will not take effect until the policy is delivered and
the payment is made during the lifetime of the proposed Insured(s) and then only
if the proposed Insured(s) has (have) not consulted or been treated by any
physician or practitioner of any healing art or had any tests listed in the
application since its completion; but if the payment is paid prior to delivery
of the policy and a conditional receipt is delivered by the registered
representative, insurance will be effective subject to the terms of the
conditional receipt; and (4) No registered representative or broker is
authorized to amend, alter, or modify the terms of this agreement.
X_____________________________________ X______________________________________
Signature of Insured Date Signature of Spouse Date
(if application is for Other
Insured Rider)
______________________________________ _______________________________________
Print Name of Insured Print Name of Spouse
X_____________________________________ _______________________________________
Signature of 2nd Insured Date Signed at City State
______________________________________
Print Name of 2nd Insured
X_____________________________________
Signature of Owner Date
(if other than Insured)
______________________________________
Print Name of Owner
1A-97 PAGE 4
<PAGE>
Agent's Report
- --------------------------------------------------------------------------------
15. REPLACEMENT Agents are required to complete this section.
- --------------------------------------------------------------------------------
Is the insurance being applied for considered a replacement according to its
definition in the replacement regulations (if any) of the state in which the
business was written? (send Replacement and/or 1035 Exchange forms where
applicable)
|_| Yes |_| No
Indicate any replacement in the chart below.
- --------------------------------------------------------------------------------
16. LIFE INSURANCE IN EFFECT Agents are required to complete this section.
- --------------------------------------------------------------------------------
Please list all life insurance currently in effect; indicate if insurance being
applied for will replace any of the listed policies:
<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------
Company/Policy # Year Amount Accidental Waiver Replacing Other
Personal Business Death Benefit Policies?*
- ---------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
$ $ $ |_| Yes |_| No |_| Yes |_| No
- ---------------------------------------------------------------------------------------------
|_| Yes |_| No |_| Yes |_| No
- ---------------------------------------------------------------------------------------------
|_| Yes |_| No |_| Yes |_| No
- ---------------------------------------------------------------------------------------------
|_| Yes |_| No |_| Yes |_| No
- ---------------------------------------------------------------------------------------------
|_| Yes |_| No |_| Yes |_| No
- ---------------------------------------------------------------------------------------------
Total $ $ $
--------------------------------------------------------------------
*If life insurance applied for is replacing existing policy
</TABLE>
- --------------------------------------------------------------------------------
17. BUSINESS INSURANCE Please complete this section if business insurance is
applied for.
- --------------------------------------------------------------------------------
17a. Social Security or Tax I.D. Number: _______________________________________
17b. Business Address: _________________________________________________________
_________________________________________________________
_________________________________________________________
17c. Type of Business: |_| Corporation |_| S-Corporation |_| Partnership
|_| Sole Proprietorship
17d. Date Incorporated/Organized: _________________ State Incorporated: ________
Number of Employees: ___________
17e. Have directors authorized this application? |_| Yes |_| No
17f. How long has the Insured been employed by or worked
with the owner? _____________________
Salary: $ ________________ $ _____________________
(Last Year) (Previous Year)
17g. Net Earnings for Business for: $ ____________________ $ ___________________
(Last Year) (Previous Year)
17h. Percentage of Business owned by Insured:________________%
1A-97 PAGE 5
<PAGE>
17i. Purpose for Insurance: |_| Stock Purchase |_| Split Dollar
|_| Stock Redemption |_| Executive Bonus |_| Deferred Compensation
|_| Business Keyperson |_| Executive Income Plan |_| Other
17j. Aggregate Business Insurance Authorized on this in all companies: $________
17k. Please list all other partners or associates. If any are insured or
proposed for business coverage, please include titles, amounts, and
companies:
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
- --------------------------------------------------------------------------------
18. AGENT'S SIGNATURE
- --------------------------------------------------------------------------------
As Registered Representative, I certify witnessing the signature of the
applicant and that all information, statements, and answers in this application
are correct, complete, and true and have been accurately recorded, to the best
of my knowledge and belief. Based on the information furnished by the Owner or
Insured in this application, I certify that I have reasonable grounds for
believing the purchase of the policy applied for is suitable for the Owner. I
further certify that the Prospectuses were delivered and that no written sales
materials other than those furnished or approved by the Company were used.
It is hereby stated that I/we personally solicited this application and, except
as specified below, no other agent or broker has any commission interest in this
sale. (If more than one agent indicate split, otherwise the Company assumes that
any division of commission is in equal in shares.)
<PAGE>
X__________________________________________ _____________
Signature of Registered Representative %
___________________________________________ _____________
Print Name of Registered Representative Date
__________________________________________________________
Agency Name/Code
X__________________________________________ _____________
Signature of Registered Representative %
___________________________________________ _____________
Print Name of Registered Representative Date
__________________________________________________________
Agency Name/Code
X__________________________________________ _____________
Signature of Registered Representative %
___________________________________________ _____________
Print Name of Registered Representative Date
__________________________________________________________
Agency Name/Code
X__________________________________________ _____________
Signature of Registered Representative %
___________________________________________ _____________
Print Name of Registered Representative Date
__________________________________________________________
Agency Name/Code
- --------------------------------------------------------------------------------
REMARKS
- --------------------------------------------------------------------------------
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
- --------------------------------------------------------------------------------
FOR HOME OFFICE USE ONLY
- --------------------------------------------------------------------------------
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
1A-97 PAGE 6
================================================================================
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
WORCESTER, MASSACHUSETTS 01653
APPLICATION FOR
INDIVIDUAL ADULT LIFE BASIC PACKAGE
AND/OR HEALTH INSURANCE
INSURANCE INFORMATION PRACTICES
Name of Proposed Insured________________________________________________________
Personal information about you may be obtained from persons other than you. You
have a right of access and correction with respect to personal information
obtained about you. The Company may in some cases also disclose personal or
privileged information it has about you to other third parties without your
authorization. A detailed description of the Company's information practices
will be furnished on your request.
Any request for information should be directed to Individual Insurance
Underwriting at the Home Office.
Medical Information Bureau Pre-Notice
Information regarding your insurability and/or any past or future claims will be
treated as confidential. The Company, or its reinsurers, may, however, make a
brief report thereon to the Medical Information Bureau, a nonprofit membership
organization of life insurance companies which operates an information exchange
on behalf of its members. If you apply to another Bureau member company for life
or health insurance coverage, or a claim for benefits is submitted to such a
company, the Bureau, upon request, will supply such company with the information
in its file.
Upon receipt of your request, the Medical Information Bureau, will arrange for
disclosure of the information about you contained in its file. If you question
the accuracy of the information in the Bureau's file, you may contact the Bureau
to seek a correction in accordance with the procedure established in the Federal
Fair Credit Reporting Act. The address of the Bureau's Information office is
P.O. Box 105, Essex Station, Boston, Massachusetts 02112: the Bureau's telephone
number is (617) 426-3660.
The Company, or its reinsurers, may also release information in its file to
other life insurance companies to whom you may apply for life or health
insurance, or to whom a claim for benefits may be submitted.
Fair Credit Reporting Act Pre-Notice
In making this application for insurance it is understood that an investigative
consumer report may be made. Information will be obtained through personal
interviews with third parties such as family members, business associates,
financial sources, friends, neighbors or others with whom you are acquainted.
This inquiry includes information as to your character, general reputation,
personal characteristics and mode of living, whichever may be applicable. Upon
written request, you will be told if an investigative consumer report has been
ordered. If so, you may ask to be interviewed in connection with its
preparation. You have the right to make a written request within a reasonable
period of time for a complete and accurate disclosure of additional information
concerning the nature and scope of the investigative consumer report. You also
have the right to inspect and obtain a copy of the investigative consumer report
from the investigating consumer reporting agency.
Personal Information Telephone Interview
Thank you for your application for insurance. While an underwriter is evaluating
your application, we may ask one of our Home Office Interviewers to contact you
for additional information. Whenever possible, calls will be made at your
convenience and to the telephone number you have provided. Your agent will
review with you the information we need to initiate the call and will record it
on a separate form.
FORM 05207-90 (9/95) ADULT
<PAGE>
CONDITIONAL RECEIPT FOR
ADVANCE PAYMENT OF PREMIUM Worcester, Massachusetts 01653
No. 315076
|_| FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY (THE "COMPANY")
|_| ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY (THE "COMPANY")
(check one)
- --------------------------------------------------------------------------------
Advance payment of $ _______(Life) $ _______ (Health) on _______ (date) with the
application for insurance has been received on the life of ____________________,
the proposed insured. This receipt bears the same serial numbers as the
application.
Received for the Company by ___________________
CONDITIONAL INSURANCE AGREEMENT
THERE IS NO INSURANCE UNDER THIS AGREEMENT UNTIL ALL THE CONDITIONS
HAVE BEEN MET.
GENERAL
Definitions
"Underwriting Date" means the date of Part I, Part II, the Conditional Receipt
or the Medical Exam, whichever date is later. If an Other Insured Rider is
applied for, the "Underwriting Date" for coverage on the Other Insured is the
later of the date of the Conditional Receipt, the Part IA or the Medical Exam if
required.
"Insurable on a standard basis" means acceptable under the Company's
underwriting rules for the plan and amount of insurance applied for without any
additional premium charge or restrictive rider.
"Insurable on a non-standard basis" means acceptable for the type of insurance
applied for under the Company's underwriting rules but not on a standard basis.
General
Any check or draft is accepted subject to collection. No agent or broker is
authorized to amend, alter, or modify the terms of this agreement. All
statements in the application are representations, not warranties. If you do not
hear from us within 60 days of the date of this agreement, please write to us
without delay, stating the facts concerning the application. Our address is 440
Lincoln Street, Worcester, MA 01653.
CONDITIONS TO BE MET
Conditions Precedent
The following conditions precedent must be met before we have any liability
under this agreement other than the return of the premium received:
1. The application must be completed and signed by the proposed
insured(s) and the owner, if not the insured.
2. The proposed insured(s) must be insurable on either a standard or
non-standard basis on the underwriting date if life insurance only
is applied for. The proposed insured(s) must be insurable on a
standard basis on the underwriting date for any health insurance.
3. The proposed insured(s) must be under the age of 71 for life
insurance and under the age of 61 for health insurance.
4. The proposed insured(s) must have undergone a medical exam if
required by us.
5. If the date of the Conditional Receipt is later than the date of
Part II and Part IA (if applicable), the proposed insured must not
have consulted or been treated by any physician or practitioner of
any healing art nor had any tests listed in the application since
the completion of Part II and Part IA.
If all of the conditions have been met, some insurance will be provided under
this agreement. However, the insurance will be subject to all of the further
provisions of this agreement.
Insurance Not in Force. If application is made for both health and life
insurance, no health insurance will be in force on any proposed insured who is
insurable on a non-standard basis.
If a person proposed for life insurance is not insurable on either a standard or
a non-standard basis, no life or health insurance will be in force.
- --------------------------------------------------------------------------------
Form 1CR-87 Rev. 9/95
<PAGE>
- --------------------------------------------------------------------------------
BENEFITS
Amount of Insurance - Life. If a proposed insured is insurable on a standard
basis, the death benefit provided under this agreement will be the lesser of the
amount applied for or the limit described below.
If a proposed insured is insurable on a non-standard basis which requires a
higher premium than the premium on the policy applied for, the amount of the
death benefit will be reduced. The reduced benefit will be in the same ratio to
the amount applied for as the premium paid with this receipt is to the total
premium that would be required on the plan the Company is willing to issue; but
in no event more than the maximum limit set forth below.
If the proposed insured is insurable on a non-standard basis which does not
require a higher premium, the death benefit provided under this agreement will
be the lesser of the following:
(a) the amount applied for;
(b) the maximum limit applicable to the proposed insured; and
(c) the premium paid if the proposed insured's death comes within the
terms of the restrictive rider which would have been attached to the
policy when used.
Maximum Limit - Life Insurance. The maximum limit under this agreement for life
insurance, including accidental death benefit, is an amount which when added to
any death benefit provided under any life insurance policy or conditional
insurance agreement having a date of issue or underwriting date respectively
within 90 days prior to the underwriting date of this agreement does not exceed
the following applicable amounts:
(a) If insurable on a standard basis, for issue ages 0 through 15,
$50,000; 16 through 60, $500,000; 61 through 65, $250,000; 66
through 70, $100,000; 71 and over, none.
(b) If insurable on a non-standard basis, for issue ages 0 through 15,
$25,000; 16 through 60, $250,000; 61 through 65, $125,000; 66
through 70, $50,000; 71 and over, none.
The maximum limit will not be increased because payment has been made to the
Company which is larger than the premium required for such reduced insurance.
Upon due proof of the death of the proposed insured that portion of the premium
paid for any excess insurance shall be paid to the beneficiary named in this
application.
Suicide Exclusion. If the proposed insured commits suicide while this agreement
is in force, the Company's liability will be limited to the return of the
premium paid.
Amount of Insurance - Health. If the proposed insured becomes totally disabled
as defined in the policy, the maximum monthly benefit will be the lesser of the
amount applied for and the maximum limit set forth below.
Maximum Limit - Health Insurance. The maximum limit under this agreement for
monthly indemnity is an amount which, when added to any monthly indemnity
provided by the Company under any health insurance policy or conditional
insurance agreement having a date of issue or underwriting date respectively
within 90 days prior to this agreement, does not exceed the lesser of:
(a) $2,000; and
(b) the published limit of the Company in effect on the underwriting
date.
Such health insurance will be subject to the elimination period elected in the
application, if any. Benefits will be payable for no more than 24 months or the
benefit period applied for, if less. Any such insurance in excess of the maximum
limit shall be void and all premiums paid for such excess shall be returned.
The maximum limit under this agreement for any health insurance other than
monthly indemnity will be the lesser of the amount applied for and the
applicable published limit of the Company in effect on the underwriting date of
this agreement.
TERMINATION
Termination - This agreement may be terminated at any time prior to incurrence
of a claim. The Company's sole liability shall be limited to the refund of the
premium paid. Such termination will occur on the earliest of the following:
1. The delivery of the insurance issued on this application.
2. The date the Company mails a termination notice with a refund of
your payment to you.
3. Ninety days after the underwriting date.
- --------------------------------------------------------------------------------
Form 1CR-87 Rev. 9/95
<PAGE>
First Allmerica Financial Life Insurance Company (The "Company")
Allmerica Financial Life Insurance and Annuity Company (The "Company")
Name of Proposed Insured _______________________________________________________
AUTHORIZATION TO OBTAIN INFORMATION
- --------------------------------------------------------------------------------
To all physicians; medical professionals; hospitals; clinics; other health care
providers; employers; Medical Information Bureau, Inc. (MIB); consumer reporting
agencies; other insurance support organizations; and other persons who
have the types of information described below about the proposed insured:
I authorize you to give the Company, its reinsurers, or its agent: (a) all
information you have as to illness, injury, medical history, diagnosis,
treatment, and prognosis (including any drug or alcohol abuse condition or
treatment) with respect to any physical or mental condition of the proposed
insured; and (b) any non-medical information, including an investigative
consumer report, which the Company believes it needs to perform the business
functions described below. I also authorize the Company to give MIB health or
non-medical information it has about me and that of any minor member of my
family applying for insurance.
The information obtained will be used to determine if the proposed insured is
eligible for: (a) the insurance requested; or (b) benefits under a policy which
is in force. It will also be used for any other business purpose which relates
to the insurance requested or the policy which is in force.
This authorization will be valid for 30 months. I know that under Federal
Regulations, I may revoke this authorization as it applies to drug and alcohol
abuse treatment information at any time; but my revocation will not affect any
information that has been released prior thereto. I know that I may request a
copy of this form. I agree that a photocopy is as valid as the original. I have
received the Insurance Information Practices notice.
_________________ _______________________________________________________
Date Signature of proposed insured (if proposed insured is a
minor, signature of legal guardian)
_______________________________________________________
Signature of spouse (if proposed for insurance)
Form 4826-90 Rev. 3/95
- --------------------------------------------------------------------------------
|_| First Allmerica Financial Life Insurance Company
|_| Allmerica Financial Life Insurance And Annuity Company
PERSONAL HISTORY INTERVIEW INFORMATION
- --------------------------------------------------------------------------------
Proposed Insured's Name (Professional Title)
|_| Adult Application for
|_| Life - Amount $_______
|_| Juvenile |_| Disability - Amount $_______
- --------------------------------------------------------------------------------
Home Telephone No. (Area Code) and No.
Business Telephone No. (Area Code) and No.
( ) ( )
- --------------------------------------------------------------------------------
Driver's License Information
No. State
- --------------------------------------------------------------------------------
The best time for us to call you is 1st Choice ____________ Eastern
at |_| Home |_| Business 2nd Choice ____________ Time
- --------------------------------------------------------------------------------
Agency Agent Date Received in P.H.I. Unit
- --------------------------------------------------------------------------------
Attempts to Call Attempts to Call
Date/Time ________________________ Date/Time ________________________
Date/Time ________________________ Date/Time ________________________
Date/Time ________________________ Date/Time ________________________
- --------------------------------------------------------------------------------
Date call completed Time ____________ Remarks
|_|AM |_|PM
- --------------------------------------------------------------------------------
No. 315076
APPLICATION FOR INDIVIDUAL
ADULT LIFE AND/OR HEALTH
INSURANCE - PART I |_| First Allmerica Financial Life
Insurance Company
|_| Allmerica Financial Life
Insurance and Annuity Company
|_| Life |_| Disability
Check applicable box(es)
All Answers Must Be Handwritten Worcester, Massachusetts 01653
- --------------------------------------------------------------------------------
COMPLETE FOR ALL APPLICATIONS
- --------------------------------------------------------------------------------
1.a) PROPOSED INSURED First - Middle Initial - Last
|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|
|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|_|
b) Sex c) BIRTH d) Owner's Soc. Sec. or I.D.
-----------------------
|_| M |_| F Mo. Day Yr. State
|____|____|____||___|___| - -
- --------------------------------------------------------------------------------
2. a) RESIDENCE
No. Street Apt. Yrs.
- --------------------------------------------------------------------------------
City State Zip
|___|___||___|___|___|___|___|
- --------------------------------------------------------------------------------
b) BUSINESS ADDRESS
No. Street Apt. Yrs.
- --------------------------------------------------------------------------------
City State Zip
|___|___||___|___|___|___|___|
- --------------------------------------------------------------------------------
3. PREMIUM PAYABLE
|_| Annual |_| Semi-Annual |_| Quarterly
|_| M.A.P. |_| Other ___________________________________________________
Existing M.A.P. or List Bill No._____________________________________________
- --------------------------------------------------------------------------------
4. Periodic Premium (Exceptional Life Only)
$
- --------------------------------------------------------------------------------
5. a) Premium Notices To
|_| Insured |_| Owner at |_| Residence |_| Business
|_| Other (Name)_____________________________________________________________
b) No._____ Str.___________________________________ Apt._____________________
__________________________________|___|___||___|___|___|___|___|
City State Zip
- --------------------------------------------------------------------------------
6. Has the initial premium been paid and the Yes No
Company's Conditional Receipt been given? |_| |_|
Life $______________ Disability $______________________
- --------------------------------------------------------------------------------
7. a) Have you smoked one or more Yes No
cigarettes in the last 12 months? |_| |_|
b) Do you currently use any other form of tobacco? |_| |_|
|_| Cigars |_| Pipe |_| Chew |_| Other________________________________
- --------------------------------------------------------------------------------
8. a) Employer, Occupation and Duties b) Yrs.________________________________
Yes No
c) Any change contemplated? |_| |_|
d) During the past 6 months has an illness or injury
prevented you from engaging in the usual duties
of your occupation for more than 7 days? |_| |_|
- --------------------------------------------------------------------------------
9. Will the insurance applied for replace or change
any existing insurance or annuities in any company? |_| |_|
- --------------------------------------------------------------------------------
10. Have you applied for any life or disability insurance
with another company in the last six months? |_| |_|
- --------------------------------------------------------------------------------
11. Do you intend to travel outside the United States
and Canada? |_| |_|
- --------------------------------------------------------------------------------
12. In the last 3 years have you
a) Had your motor vehicle license suspended
or revoked or have you been convicted
of driving under the influence of drugs
or alcohol or been convicted of more
than one moving violation? |_| |_|
b) Participated in or do you intend to
participate in |_| |_|
|_| Motor Racing |_| Scuba Diving
|_| Hang Gliding or |_| Parachuting
similar flying activities
c) Flown or intend to fly as a trainee,
pilot or crewmember? |_| |_|
If 12b or c "yes" - Complete Appropriate Questionnaire
================================================================================
Explain "yes" answers 8-12
- --------------------------------------------------------------------------------
COMPLETE FOR LIFE INSURANCE
- --------------------------------------------------------------------------------
13. LIFE INSURANCE APPLIED FOR
Amount Plan
$______________________________________|___________________________________
- --------------------------------------------------------------------------------
14. Flex Term Plans |_| Decreasing Term
|_| Level term Int. Rate ____________________%
|_| Level Prem. Red. Term. No. of Yrs. __________________
- --------------------------------------------------------------------------------
15. Death Benefit Option (Exceptional Life only)
|_| Option 1 |_| Option 2
- --------------------------------------------------------------------------------
16. RIDERS |_| Exchange Option Rider
|_| GIR $_________________ |_| Flex Term Rider $______________
|_| OIR (Complete Part 1a) |_| Level Term
|_| CIR (Complete Part 1a) |_| Level Prem. Red. Term
|_| AIR __________________ |_| Decreasing Term
|_| Paid up Additions Rider Int. Rate ___________________%
|_| Annual Premium $___________________ No. of Yrs.__________________
|_| Single Premium $___________________ |_| LBR
- --------------------------------------------------------------------------------
17. OPTIONAL BENEFITS
a) |_| Waiver of Premium c) |_| ADB $__________________________________
b) |_| Waiver of Charges d) |_| APL
================================================================================
18. DIVIDEND OPTION (First Allmerica Financial Only)
a) |_| Paid in Cash d) |_| Paid up Adds
b) |_| Reduced Prem. e) |_| Accumulate at Interest
c) |_| Other ______________________________________________________________
================================================================================
19. a) PRIMARY BENEFICIARY Relationship
|_| _________________ day Common Disaster Clause
----------------------------------------------------------------------------
b) CONTINGENT BENEFICIARY
================================================================================
20. OWNER (if other than insured)
- --------------------------------------------------------------------------------
Form 1A-90 Page 1 Rev. 9/95
<PAGE>
- --------------------------------------------------------------------------------
COMPLETE FOR DISABILITY INSURANCE
- --------------------------------------------------------------------------------
21. DISABILITY INSURANCE APPLIED FOR
a) |_| INCOME REPLACEMENT Elim. Ben.
Mo. Ben. $ __________ Per. __________ Per. ____________
RIDERS
|_| Regular Occupation |_| Residual Disability
|_| Lifetime Accident |_| Partial Disability
|_| Life Sick/Acc |_| Hosp. Conf. $__________________________
Elim. Ben.
|_| AIB: Mo. Ben. $ __________ Per. __________ Per. __________
Elim. Ben.
|_| SIS: Mo. Ben. $ __________ Per. __________ Per. __________
|_| AIO PLUS ______
|_| COLA
|_| Key Person $________________________________________________________
|_| Other________________________________________________________________
b) |_| DISABILITY BUY-OUT Amt. $_____________ Elim. Per.________________
|_| Additional Ins. Option $_________________________________________
c) |_| OVERHEAD EXPENSE
Elim. Ben.
Amt. $_________________ Per. __________ Per. __________
|_| Residual Rider
|_| Additional Insurance Benefit _______________________________%
|_| Additional Insurance Option Rider $__________________________
- --------------------------------------------------------------------------------
22. OVERHEAD EXPENSE DATA
a) Your share of the average monthly overhead expenses
for the last six months.
Rent $____________________ Laundry $____________________
Electricity $____________________ Janitorial Svs. $____________________
Telephone $____________________ Depreciation $____________________
Heat & Water $____________________ (office furniture & equipment only)
Taxes $____________________ ____________________
Salaries $____________________ ____________________
Mortgage Int. $____________________ TOTAL $____________________
b) Are you sole owner of the business? |_| Yes |_| No
c) If not, your share ___________________________________%
How many other owners _____________________________________
- --------------------------------------------------------------------------------
23. ANNUAL EARNED INCOME*
a) Last Tax Year $_________________________________________________
Prior Tax Year $_________________________________________________
Two Years Ago $_________________________________________________
b) Unearned Income (indicate source) $____________________________________
c) Net Worth Personal $________________________________________________
Business $________________________________________________
*Earned income is the total of your annual salaries, wages, bonuses,
commissions and fees less ordinary business expenses.
- --------------------------------------------------------------------------------
24. Record all disability income and overhead expense coverage in force
(include fringe, individual, group, salary continuation, association, union
benefits or state disability benefits). If none, write "NONE".
<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------------------
Company or Source Year Disability Overhead Monthly Elim. Benefit Offset By
Issued Income Expense Indemnity Period Period Social Security
- ---------------------------------------------------------------------------------------------------------
<S> <C> <C>
$ $
- ---------------------------------------------------------------------------------------------------------
$ $
- ---------------------------------------------------------------------------------------------------------
$ $
- ---------------------------------------------------------------------------------------------------------
</TABLE>
- --------------------------------------------------------------------------------
COMPLETE FOR ALL APPLICATIONS
- --------------------------------------------------------------------------------
Special Request Home Office Amendments and Corrections/Administrative Purpose
- --------------------------------------------------------------------------------
It is agreed that: (1) The application consists of Parts I, II and IA, if IA
applies. (2) The representations are true and complete to the best of my
knowledge and belief, (3) No liability exists and the insurance applied for will
not take effect unless the policy is delivered and the premium is paid during
the lifetime of the proposed insured(s) and then only if the proposed insured(s)
has (have) not consulted or been treated by any physician or practitioner of any
healing art nor had any tests listed in the application since its completion;
but, if the premium is paid prior to delivery of the policy and a conditional
receipt is delivered by the agent, insurance shall be effective subject to terms
of the conditional receipt. (4) No agent or broker is authorized to amend,
alter, or modify the terms of this agreement.
- --------------------------------------------------------------------------------
Signed at (City and State) Date Full signature of proposed insured
- --------------------------------------------------------------------------------
This application is made at the request of the undersigned who hereby ratifies
each statement, representation and agreement herein and agrees that any contract
of insurance issued in connection with this application shall be issued on the
condition that each statement, representation and agreement shall be binding
upon the above named owner(s) to the same extent and degree as if made by the
owner(s).
- --------------------------------------------------------------------------------
Signed at (City and State) Date Full signature(s) of owner(s)
(other than insured)
- --------------------------------------------------------------------------------
Soliciting Agent's Signature Date If Business, name of establishment
and title/capacity
- --------------------------------------------------------------------------------
Form 1A-90 Page 2 Rev. 9/95
<PAGE>
First Allmerica Financial Life Insurance Company
Allmerica Financial Life Insurance
AGENT'S REPORT and Annuity Company
- --------------------------------------------------------------------------------
SECTION A COMPLETE FOR ALL APPLICATIONS
- --------------------------------------------------------------------------------
1. Name First - Middle Initial - Last
- --------------------------------------------------------------------------------
2. Proposed Insured
a) Years Known ______________ b) Marital Status _______________
c) |_| Relative |_| Friend |_| Client |_| Stranger
- --------------------------------------------------------------------------------
3. Home Telephone No. (Area Code) and No.
( )
- --------------------------------------------------------------------------------
4. Driver's License Number and State
|
- --------------------------------------------------------------------------------
5. What is the proposed insured's annual
income? (Life only)
Earned $ _____________________________ Unearned $_____________________________
Financial Worth $
- --------------------------------------------------------------------------------
6. Quick Pay years (NOT GUARANTEED)
- --------------------------------------------------------------------------------
7. Occupational Class (Disability only)
|_|4AS |_|4A |_|3A |_|2A |_|A
- --------------------------------------------------------------------------------
8. a) Is the insurance being applied for considered a
replacement according to its definition in the
replacement regulations (if any) in the state the
business was written? |_| Yes |_| No
(Send Replacement forms or 1035 Exchange where applicable)
b) If the answer to a above is "yes", list below
all existing life, disability or annuity contracts
proposed to be replaced.
Policy Number Name of Issuing Company
------------- -----------------------
- --------------------------------------------------------------------------------
9. List all life insurance in force
- --------------------------------------------------------------------------------
Company Year Insurance Amount ADB Waiver
------------------------------
Personal Business
- --------------------------------------------------------------------------------
$ $ $ |_| Yes |_| No
- --------------------------------------------------------------------------------
|_| Yes |_| No
- --------------------------------------------------------------------------------
|_| Yes |_| No
- --------------------------------------------------------------------------------
|_| Yes |_| No
- --------------------------------------------------------------------------------
TOTAL $ $ $
- --------------------------------------------------------------------------------
SECTION B COMPLETE FOR ALL APPLICATIONS WHEN BUSINESS INSURANCE APPLIED FOR
- --------------------------------------------------------------------------------
10. a) Type of Business
|_| Corporation |_| S-Corporation
|_| Partnership |_| Sole Proprietorship
b) Date Incorporated or organized __________________________________
c) Number of employees______________________________________________
d) If Corporation, State of incorporation___________________________
Have directors authorized this application? |_| Yes |_| No
- --------------------------------------------------------------------------------
11. a) How long has proposed
insured been with owner?________________________________________
b) Percentage of business
owned by proposed insured?______________________________________%
- --------------------------------------------------------------------------------
12. Net Earnings (after tax) of business for
Last Year $ Previous Year $
- --------------------------------------------------------------------------------
13. Purpose of Insurance
|_| Stock Purchase |_| Business Keyperson
|_| Split Dollar |_| Executive Bonus
|_| Stock Redemption |_| Executive Income Plan
|_| Deferred Compensation
|_| Other_______________________________
- --------------------------------------------------------------------------------
14. Salary of proposed insured for
Last year $ Previous year $
- --------------------------------------------------------------------------------
15. a) What is aggregate business insurance (existing and
new) authorized on this life in all companies?
Existing $______________________ New $__________________________________
b) Are any other partners or associates insured or
proposed for business coverage? |_| Yes |_| No
Give names, titles, amounts and companies.
c) If partnership, give full name of all partners.
- --------------------------------------------------------------------------------
16. Home Office Assistance
|_| B.I. Handbook |_| Financial Topics
|_| Sales Proposals |_| Technical Release
|_| Inquiry |_| Other ______________________________
|_| What's New
Was this case a result of any previous assistance either
direct or indirect? |_| Yes |_| No
- --------------------------------------------------------------------------------
SECTION C COMPLETE WHEN OIR AND/OR CIR IS APPLIED FOR
- --------------------------------------------------------------------------------
17. For CIR
Are all children who have not reached their
18th birthday included? |_| Yes |_| No
If "no", explain
- --------------------------------------------------------------------------------
18. For CIR and OIR (child) How long have you
known the parent or person with whom the
child (children) is (are) living? (If other than the
applicant, give name and explain)
- --------------------------------------------------------------------------------
19. For CIR and OIR
a) To the best of your knowledge, will the life
insurance being applied for replace life
insurance or annuities in any company? |_| Yes |_| No
(Send replacement forms where applicable.)
b) If the answer to a above is "yes", list all existing life
insurance or annuity contracts proposed to be replaced.
Policy Number Name of Issuing Company
- --------------------------------------------------------------------------------
Form 1AR-90 Page 1 Rev. 3/95
<PAGE>
- --------------------------------------------------------------------------------
SECTION D COMPLETE FOR LIFE APPLICATION WHEN APPLICANT IS DEPENDENT SPOUSE OR
DEPENDENT CHILD
- --------------------------------------------------------------------------------
20. a) What is the need for proposed insurance?
b) If supporting spouse or parent is insured for benefit
of family, give amount. If not insured, give reasons.
c) Regarding supporting spouse or parent
Full Name____________________________________
Birthdate____________________________________
Income_______________________________________
- --------------------------------------------------------------------------------
SECTION E COMPLETE FOR LIFE APPLICATION WHEN INSURANCE IS FOR ESTATE PLANNING
PURPOSES
- --------------------------------------------------------------------------------
21. a) Home Office Assistance
|_| What's New |_| Inquiry
|_| Technical Release
|_| Financial Topics |_| Other_______________________
b) Was this case a result of any previous assistance
either direct or indirect? |_| Yes |_| No
- --------------------------------------------------------------------------------
22. a) Was an Estate Analysis prepared? |_| Yes |_| No
b) Was a Liquidity Analysis prepared? |_| Yes |_| No
- --------------------------------------------------------------------------------
SECTION F COMPLETE FOR LIFE APPLICATION WHEN INSURANCE IS FOR FINANCIAL
PLANNING PURPOSES
- --------------------------------------------------------------------------------
23. a) Home Office Assistance
|_| Financial Topics |_| Plan Prep./Review
|_| Inquiry |_| Other__________________________
b) Was this case a result of any previous assistance
either direct or indirect? |_| Yes |_| No
- --------------------------------------------------------------------------------
24. a) Was a financial plan prepared? |_| Yes |_| No
b) If "yes", type of plan |_| Basic
|_| Comprehensive
|_| Focus
c) Was a fee charged? |_| Yes |_| No
- --------------------------------------------------------------------------------
SECTION G COMPLETE FOR ALL APPLICATIONS FOR MARKET RESEARCH
- --------------------------------------------------------------------------------
25. Need
|_| Personal |_| Business |_| Estate
- --------------------------------------------------------------------------------
26. Occupation
|_| Business owner |_| Manager/Exec.
|_| Professional |_| Self-Employed
|_| Other white collar |_| Blue collar
- --------------------------------------------------------------------------------
27. Industry
|_| Medical |_| Retail Trade
|_| Construction |_| Finances, Ins., Real Estate
|_| Manufacturing |_| Professional Service
|_| Trans./Public Util. |_| Public Administration
|_| Wholesale Trade |_| Education
|_| Agriculture, Forestry |_| Other
- --------------------------------------------------------------------------------
28. a) Was this a competitive situation? |_| Yes |_| No
b) Competing Company_____________________________________________________
c) Home Office Assistance |_| Yes |_| No
- --------------------------------------------------------------------------------
29. Reason for Insurance
|_| Death Taxes |_| Family Income
|_| Gift |_| Retirement Income
|_| Estate Protection |_| Fund Bus. Agreement
|_| Cash Accumulation |_| Other
- --------------------------------------------------------------------------------
30. Source |_| Observation
|_| Personal |_| Seminar
|_| Direct Mail |_| Referred Lead
|_| Cold Call |_| Policyholder
|_| Orphan |_| Telemarketing Lead
- --------------------------------------------------------------------------------
31. Other Investments |_| Money Market
|_| Stocks & Bonds |_| Commodities
|_| Investment Property |_| Savings Account
|_| Group Benefit Plan |_| Pension Plan
- --------------------------------------------------------------------------------
32. Planning Tools Used |_| Ledger Proposal
|_| FSA |_| Next $
|_| Ins Mark |_| Other
- --------------------------------------------------------------------------------
It is hereby stated that (we) (I) personally solicited this application and,
except as specified below, no other agent or broker has any commission interest
in this sale. It is certified that the information supplied by the proposed
insured has been truly and accurately recorded. (If more than one agent indicate
split otherwise the Company assumes that any division of commission is in equal
shares.)
- --------------------------------------------------------------------------------
Signature of Agent Print Full Name Code Agency
%
- --------------------------------------------------------------------------------
Signature of Agent Print Full Name Code Agency
%
- --------------------------------------------------------------------------------
Signature of Agent Print Full Name Code Agency
%
- --------------------------------------------------------------------------------
Signature of Agent Print Full Name Code Agency
%
- --------------------------------------------------------------------------------
Form 1AR-90, Page 2 Rev. 3/95
<PAGE>
APPLICATION FOR INDIVIDUAL
ADULT LIFE AND/OR DISABILITY
INSURANCE - PART II |_| First Allmerica Financial Life
Insurance Company
|_| Allmerica Financial Life
Insurance and Annuity Company
|_| Life |_| Disability
Check applicable box(es)
All Answers Must Be Handwritten Worcester, Massachusetts 01653
- --------------------------------------------------------------------------------
1. Proposed Insured Birth Date
First M.I. Last Mo. Day Yr.
| |
- --------------------------------------------------------------------------------
2. Personal Physician
a) |_| Name and Address b) |_| None
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
Reason Last Consulted Date
c) |_| Routine Exam Were all findings normal? |_| Yes |_| No
d) |_| As indicated in #27 on page 2
e) |_| Other - Give Details
Date Reason Result
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
- --------------------------------------------------------------------------------
3. In the past 10 years have you been told you had or been
treated for immune system disorder including acquired
immune deficiency syndrome (AIDS) or AIDS related
complex (ARC)? |_| Yes |_| No
- --------------------------------------------------------------------------------
4. During the past 5 years have you used marijuana, cocaine,
barbiturates, narcotics, excitants, or hallucinogens, except
as prescribed medication? |_| Yes |_| No
- --------------------------------------------------------------------------------
5. Do you engage in a scheduled exercise program?
(If "yes", give details = type, duration, frequency)
|_| Yes |_| No
- --------------------------------------------------------------------------------
6. Are you now pregnant? |_| Yes |_| No
If yes, expected date of delivery
- --------------------------------------------------------------------------------
Explain "yes" answers to #3-5.
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
During the Past 10 years have you had, been told you had, or been treated for
<TABLE>
<S> <C> <C> <C> <C> <C>
7. a) |_| Chest pain or Angina c) |_| Heart Murmur e) |_| Heart Attack g) |_| Palpitations i) |_| None of These
b) |_| Rheumatic fever d) |_| High Blood Pressure f) |_| Blood Vessel h) |_| Heart
Disorder Disorder
8. a) |_| Pneumonia d) |_| Persistent Cough g) |_| Coughing of j) |_| Asthma m) |_| None of These
b) |_| Bronchitis e) |_| Persistent Hoarseness Blood k) |_| Pleurisy
c) |_| Tuberculosis f) |_| Allergies h) |_| Emphysema l) |_| Chronic
i) |_| Respiratory Shortness
Disorder of Breath
9. a) |_| Recurrent Headache c) |_| Dizziness or Fainting e) |_| Brain Disorder g) |_| Seizures i) |_| None of These
b) |_| Paralysis d) |_| Stroke f) |_| Speech Loss h) |_| Memory Loss
10. a) |_| Nervous Disorder b) |_| Mental Disorder c) |_| Depression d) |_| Suicide e) |_| None of These
Attempt
11. a) |_| Ulcer b) |_| Recurring Indigestion c) |_| Vomiting Blood d) |_| Difficulty e) |_| None of These
Swallowing
12. a) |_| Colon Polyp b) |_| Ileitis or Colitis c) |_| Persistent d) |_| Bloody Stools e) |_| None of These
Diarrhea
13. a) |_| Hepatitis c) |_| Cirrhosis e) |_| Jaundice g) |_| Gall Bladder i) |_| None of These
b) |_| Stomach Disorder d) |_| Liver Disorder f) |_| Intestinal Disorder
Disorder h) |_| Pancreas
Disorder
14. a) |_| Cancer c) |_| Skin Cancer e) |_| Tumor g) |_| Cyst h) |_| None of These
b) |_| Fibroids d) |_| Skin Disorder f) |_| Lymph Gland
Disorder
15. a) |_| Diabetes b) |_| Thyroid Disorder c) |_| Disease of d) |_| Glandular e) |_| None of These
Breast Disorder
16. a) |_| Sugar in Urine d) |_| Pus in Urine g) |_| Kidney Disorder i) |_| Urinary k) |_| None of These
b) |_| Albumin in Urine e) |_| Prostate Disorder h) |_| Reproductive Disorder
c) |_| Blood in Urine f) |_| Bladder Disorder System Disorder j) |_| Sexually
Transmitted
Disease
17. a) |_| Anemia b) |_| Leukemia c) |_| Blood Disorder d) |_| Recurrent e) |_| None of These
Infections
18. a) |_| Hernia b) |_| Hemorrhoids c) |_| Varicose Veins d) |_| Rectal e) |_| None of These
Disorder
19. a) |_| Deformity c) |_| Back Pain e) |_| Amputation g) |_| Arthritis i) |_| None of These
b) |_| Rheumatism d) |_| Gout f) |_| Bone or Muscle h) |_| Back, Spine,
Disorder Joint
Disorders
20. a) |_| Eye Disorder b) |_| Ear Disorder c) |_| Nose Disorder d) |_| Throat e) |_| None of These
Disorder
</TABLE>
Form 1AM-90 Page 1 Rev. 9/95
<PAGE>
All Answers Must Be Handwritten
- --------------------------------------------------------------------------------
21. Height in shoes __________________ Weight in clothing ______________________
Have you had any change in weight in the past year?
|_| Yes |_| No |_| Gain |_| Loss Amount_______________________________
Reason
- --------------------------------------------------------------------------------
22. Other than as indicated in 7-20, during the
past 5 years have you
a) Been or are you now under observation,
treatment, therapy, counseling, or medi- Yes No
cations or have you had any check up,
illness or surgery? |_| |_|
b) Had electrocardiogram, x-ray or blood studies? |_| |_|
c) Been advised to have a test or surgery
which was not done? |_| |_|
d) Been treated or received counseling for
alcohol or drug use? |_| |_|
e) Been a patient in a hospital, clinic,
sanitarium or other medical facility? |_| |_|
f) Consulted any other physician or chiropractor? |_| |_|
- --------------------------------------------------------------------------------
23. Have you ever requested or received a pension Yes No
benefit or payments because of an injury,
sickness or disability? |_| |_|
- --------------------------------------------------------------------------------
24. Have you ever changed occupation or residence
because of health? |_| |_|
- --------------------------------------------------------------------------------
25. Has any member of your family ever had high
blood pressure, diabetes, cancer, mental illness
or hereditary disease? |_| |_|
- --------------------------------------------------------------------------------
26. Family Age if Present State of Health Age at
Record Living or Cause of Death Death
----------------------------------------------------------------------------
Father
----------------------------------------------------------------------------
Mother
----------------------------------------------------------------------------
Brothers
& Sisters
- --------------------------------------------------------------------------------
27. COMPLETE FOR EACH APPROPRIATE ITEM CHECKED IN 7-25
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------------
No. Diagnosis Medication/Treatment Date Still Under Physician/Medical Facility Name
Treatment? (Include Address if not in 2 above)
- --------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------
</TABLE>
I understand and agree that the foregoing statements and answers are
complete, true and correctly recorded to the best of my knowledge and
belief, and that they shall be part of the contract if issued.
Date ______________ Witness _______________________ __________________________
Examiner or Agent Signature
of Proposed Insured
Form 1AM-90 Page 2 Rev. 9/95
SUPPLEMENT TO APPLICATION FOR FLEXIBLE PREMIUM
VARIABLE LIFE INSURANCE
ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
PRINCIPAL OFFICE: WORCESTER, MASSACHUSETTS 01653
INSURED______________________________ APPLICATION NUMBER______________________
1. Allocation of Net Premium. Please indicate below how the net payments (as
described in the Prospectuses) will be allocated to the General Account
and appropriate sub-accounts of the Variable Account. You may deposit
funds into up to seven sub-accounts. Whole percentages must total 100%.
All net payments will be allocated to the General Account unless otherwise
specified. You may request a change in the allocation at any time.
Investment Options Investment Objective
------------------ --------------------
---------
________% Allmerica Select International Equity Fund
________% Delaware International Equity Series International
________% Fidelity VIP Overseas Portfolio
________% T. Rowe Price International Stock Portfolio
---------
________% Allmerica Select Value Opportunity
________% Allmerica Select Aggressive Growth Fund Aggressive Growth
________% Allmerica Select Capital Appreciation Fund
---------
________% Allmerica Growth Fund
________% Allmerica Select Growth Fund Growth
________% Fidelity VIP Growth Portfolio
---------
________% Allmerica Select Growth & Income Fund
________% Allmerica Equity Index Fund Growth/Income
________% Fidelity VIP Equity-Income Portfolio
---------
________% Fidelity VIPII Asset Manager Portfolio Asset Allocation
---------
________% Allmerica Government Bond Fund
________% Allmerica Investment Grade Income Fund Income
________% Fidelity VIP High Income Portfolio
---------
________% Allmerica Money Market Fund Capital Preservation
________% General Account
---------
________%
________%
100 % Total
2. Monthly Insurance and Administrative Charges. Deduct all monthly insurance
charges and administrative charges from ______________(any single
sub-account, except the General Account, may be elected). If no
sub-account is specified, all monthly insurance charges and administrative
charges will be deducted pro rata according to the value of each
sub-account and the General Account. At any time the Policy Owner can
change the sub-account(s) from which monthly insurance charges and
administrative charges are deducted.
3. Reason(s) for Insurance: Death Taxes______ Fund Business Agreement_______
Gift______ Family Income______ Retirement Income______
Cash Accumulation______
Other (please specify) ___________________________________________________
(Continued on back. The Agent's Report on the back of this form must be
completed for NASD required information)
Form SML-1287-96 Rev. 12/97
<PAGE>
4. Owner's Estimated Financial Data: $___________ __________%
Gross Annual Income Tax Bracket
$___________ $___________ $___________
Securities Savings Liquid Net Worth
(exclusive of home,
furnishings, auto)
5. Investment Objective: How would you characterize your cash value
investment objective? Emphasize growth_______ A balance between growth and
stability________ Emphasize stability_______
6. Are any variable annuities, mutual funds, or any other securities being
liquidated to purchase this variable life insurance product?
Yes___ No___ If yes, has the agent explained the potential advantages
and disadvantages of this transaction? Yes___No___
7. The Owner |_| is |_| is not an associated person of another broker/dealer.
Have you received and understand the current prospectus describing the variable
life insurance policy, including the underlying funds, and do you believe that a
flexible premium variable life insurance policy is consistent with your
investment objectives and financial needs? |_| Yes |_| No
I UNDERSTAND THAT THE POLICY VALUE, DEATH BENEFIT, AND DURATION OF
COVERAGE FOR THE FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE POLICY APPLIED
FOR MAY INCREASE OR DECREASE TO REFLECT THE INVESTMENT EXPERIENCE OF THE
SUB-ACCOUNTS OF THE ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
VARIABLE LIFE ACCOUNT. THERE IS NO GUARANTEED MINIMUM POLICY VALUE. THE
POLICY VALUE IS NOT GUARANTEED AS TO DOLLAR AMOUNT.
I understand and agree that the foregoing statements and answers are complete,
true, and correctly recorded to the best of my knowledge and belief, and that
they shall be a part of the contract if issued.
_______________________________ ____________________________________________
Signature of Insured Signature of Owner (if other than Insured)
Signed at ____________________________________________ Date _____________
AGENT'S/REGISTERED REPRESENTATIVE'S REPORT
Based on the information furnished by the Owner and the Insured in this
application, I certify that I have reasonable grounds for believing the purchase
of the policy applied for is suitable for the Owner. I further certify that the
Prospectuses were delivered and that no written sales materials were used other
than those furnished and/or approved by the Principal Office.
Signature of Licensed Agent: -----------------------------------------
Registered Representative
Underwriting Approval: -----------------------------------------
Completed in Principal Office
Form SML-1287-96 Rev. 12/97
<PAGE>
April 15, 1998
Allmerica Financial Life Insurance and Annuity Company
440 Lincoln Street
Worcester MA 01653
RE: VEL II ACCOUNT OF ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY COMPANY
FILE NO.'S: 33-57792 AND 811-7466
Gentlemen:
In my capacity as Counsel of Allmerica Financial Life Insurance and Annuity
Company (the "Company"), I have participated in the preparation of this
Post-Effective Amendment to the Registration Statement for the VEL II Account on
Form S-6 under the Securities Act of 1933 with respect to the Company's
individual flexible premium variable life insurance policies.
I am of the following opinion:
1. The VEL II Account is a separate account of the Company validly existing
pursuant to the Delaware Insurance Code and the regulations issued
thereunder.
2. The assets held in the VEL II Account equal to the reserves and other
Policy liabilities of the Policies which are supported by the VEL II
Account are not chargeable with liabilities arising out of any other
business the Company may conduct.
3. The individual flexible premium variable life insurance policies, when
issued in accordance with the Prospectus contained in the Registration
Statement and upon compliance with applicable local law, will be legal and
binding obligations of the Company in accordance with their terms and when
sold will be legally issued, fully paid and non-assessable.
In arriving at the foregoing opinion, I have made such examination of law and
examined such records and other documents as in my judgment are necessary or
appropriate.
I hereby consent to the filing of this opinion as an exhibit to this
Post-Effective Amendment to the Registration Statement of the VEL II Account on
Form S-6 filed under the Securities Act of 1933.
Very truly yours,
/s/ Sheila B. St. Hilaire
Sheila B. St. Hilaire
Assistant Vice President and Counsel
<PAGE>
April 15, 1998
Allmerica Financial Life Insurance and Annuity Company
440 Lincoln Street
Worcester, MA 01653
RE: VEL II ACCOUNT OF ALLMERICA FINANCIAL LIFE INSURANCE AND ANNUITY
COMPANY FILE NO.'S: 33-57792 AND 811-7466
Gentlemen:
This opinion is furnished in connection with the filing by Allmerica Financial
Life Insurance and Annuity Company of a post-effective amendment to the
Registration Statement on Form S-6 of its flexible premium variable life
insurance policies ("Policies") allocated to the VEL II Account under the
Securities Act of 1933. The prospectus included in the post-effective amendment
to the Registration Statement describes the Policies. I am familiar with and
have provided actuarial advice concerning the preparation of the post-effective
amendment to the Registration Statement, including exhibits.
In my professional opinion, the illustration of death benefits and cash values
included in Appendix C of the prospectus, based on the assumptions stated in the
illustrations, are consistent with the provisions of the Policy. The rate
structure of the Policies has not been designed so as to make the relationship
between premiums and benefits, as shown in the illustrations, appear more
favorable to a prospective purchaser of a Policy for a person age 30 or a person
age 45 than to prospective purchasers of Policies for people at other ages or
underwriting classes.
I am also of the opinion that the aggregate fees and charges under the Policy
are reasonable in relation to the services rendered, the expenses expected to be
incurred, and the risks assumed by the Company
I hereby consent to the use of this opinion as an exhibit to the post-effective
amendment of the Registration Statement.
Sincerely,
/s/ William M. Mawdsley
William M. Mawdsley, FSA, MAAA
Vice President and Actuary
<PAGE>
Description of Issuance, Transfer
and Redemption Procedures for Policies
Offered by the VEL II Account of State Mutual Life Assurance Company of America
Pursuant to Rule 6e-3(T)(b)(12)(ii)
under the Investment Company Act of 1940
The VEL II Account of State Mutual Life Assurance Company of America
("Company") is registered under the Investment Company Act of 1940 ('1940 Act')
as a unit investment trust. Within the VEL II Account are 14 Sub-Accounts.
Procedures apply equally to each subaccount and for purposes of this description
are defined in terms of the VEL II Account, except where a discussion of both
the VEL II Account and the individual Sub-Accounts is necessary. Each
Sub-Account invests in shares of a corresponding investment division of the
Allmerica Investment Trust ("Trust"), Variable Insurance Products Fund ("VIPF"),
or Delaware Group Premium Fund, Inc. ("DGPF"), each of which is a "series" type
of mutual fund registered under the 1940 Act. The investment experience of a
Sub-Account of the VEL II Account depends on the market performance of its
corresponding investment division of the Trust, VIPF or DGPF. Although flexible
premium variable life insurance policies funded through the VEL II Account may
also provide for fixed benefits supported by the Company's General Account, this
description assumes that net premiums are allocated exclusively to the VEL II
Account and that all transactions involve only the Sub-Accounts of the VEL II
Account, except as otherwise explicitly stated herein.
I. "PUBLIC OFFERING PRICE": PURCHASE AND RELATED TRANSACTIONS -- SECTION
22(d) AND RULE 22c-l
This section outlines Policy provisions and administrative procedures
which might be deemed to constitute, either directly or indirectly, a
"purchase" transaction. Because of the insurance nature of the
policies, the procedures involved necessarily differ in certain
significant respects from the purchase procedures for mutual funds and
annuity plans. The chief differences revolve around the structure of
the cost of insurance charges and the insurance underwriting process.
Certain Policy provisions, such as reinstatement and loan repayment,
do not result in the issuance of a Policy but require certain payments
by the Policyowner and involve a transfer of assets supporting Policy
reserve into the VEL II Account.
a. INSURANCE CHARGES AND UNDERWRITING STANDARDS
Premium payments are not limited as to frequency and number, but
there are limitations as to amount. No premium payment may be
less than $100 without the Company's consent, and the total of
all premiums paid can never exceed the then current maximum
premiums determined by Internal Revenue Service rules. If at any
time a premium is paid which would result in total premiums
exceeding the current maximum premium limitations, the Company
will return the amount in excess of such maximums to the
Policyowner.
The Policy will remain in force so long as the Policy value less
any outstanding debt is sufficient to pay certain monthly charges
imposed in connection with the Policy. Cost of insurance charges
for the policies will not be the same for all Policyowners. The
insurance principle of pooling and distribution of mortality
risks is based upon the assumption that each Policyowner pays a
cost of insurance charge commensurate with the Insured's
mortality risk, which is actuarially determined based upon
factors
1
<PAGE>
such as age, health and occupation. In the context of life
insurance, a uniform mortality charge (the "cost of insurance
charge") for all Insured's would discriminate unfairly in favor
of those Insured's representing greater mortality risks to the
disadvantage of those representing lesser risks. Accordingly,
there will be a different "price" for each actuarial category of
Policyowners because different cost of insurance rates will
apply. Accordingly, while not all Policyowners will be subject
to the same cost of insurance rate, there will be a single "rate"
for all Policyowners in a given actuarial category. The policies
will be offered and sold pursuant to the Company's underwriting
standards and in accordance with state insurance laws. Such laws
prohibit unfair discrimination among Insureds, but recognize that
premiums must be based upon factors such as age, health and
occupation. Tables showing the maximum cost of insurance charges
will be delivered as part of the Policy.
b. APPLICATION AND INITIAL PREMIUM PROCESSING
Upon receipt of a completed application from a prospective
Policyowner, the Company will follow certain insurance
underwriting procedures designed to determine whether the
proposed Insured is insurable. This process may involve such
verification procedures as medical examinations and may require
that further information be provided by the proposed Policyowner
before a determination can be made. A Policy cannot be issued
until this underwriting procedure has been completed.
If at the time of Application a prospective Policyowner makes a
payment equal to at least one monthly deduction for the Policy as
applied for, the Company will provide fixed conditional insurance
in the amount of insurance applied for, up to a maximum of
$500,000, pending underwriting approval. If the application is
approved, the Policy will be issued as of the date the terms of
the Conditional Insurance Agreement were met. If the prospective
Policyowner does not wish to make any payment until the Policy is
issued, upon delivery of the Policy the Company will require
payment of sufficient premium to place the insurance in-force.
Pending completion of insurance underwriting and Policy issuance
procedures, the initial premium will be held in the Company's
General Account. If the application is approved and the Policy
is issued and accepted, the initial premium held in the General
Account will be credited with interest not later than the date of
receipt of the premium at the Company's Principal Office. Not
later than three days of underwriting approval of the Policy, the
amounts held in the Company's General Account will be allocated
to the Sub-Accounts according to Policyowner's instructions, for
that part of the total amount allocated to the VEL II Account
which is less than $10,000. If the amount allocated to the VEL
II Account exceeds $10,000 or if the Policy provides for planned
premium payments during the first year of $5,000 semi-annually,
$2,500 quarterly or $1,000 monthly, the entire amount will remain
in the General Account until expiration of the Free Look Period,
as evidenced by a delivery receipt. Amounts remaining in the
General Account will continue to be credited interest from date
of receipt of the premium at the Principal Office.
If a Policy is not issued, the premiums will be returned to the
Applicant without interest.
2
<PAGE>
These processing procedures are designed to provide insurance,
starting with the date of the application, to the proposed
Policyowner in connection with payment of the initial premium and
will not dilute any benefit it payable to any existing
Policyowner. Although a Policy cannot be issued until the
underwriting process has been completed, the proposed Policyowner
will receive immediate insurance coverage, if he has paid an
initial premium and proves to be insurable. If the initial
premium is not paid with the application, variability of benefits
will commence within three days of underwriting approval, subject
to the restrictions indicated above.
The Company will require that the Policy be delivered within a
specific delivery period to protect itself against anti-selection
by the prospective Policyowner resulting from a deterioration of
the health of the proposed Insured. Generally, the period will
not exceed the shorter of 30 days from the date the Policy is
issued and 75 days from the date of Part 2 of the Application.
c. PREMIUM ALLOCATION
"Net premiums" are credited to the Policy as of the date the
premium payments are received by the Company, with the possible
exception of the first net premium. Net premiums are equal to
the gross premiums minus the tax expense charge. The tax expense
charge compensates the Company for applicable state and local
taxes on premiums paid for the Policy and for federal taxes
imposed for deferred acquisition costs ("DAC taxes"). It will be
adjusted to reflect any increase or decrease in the applicable
state or local premium tax rate.
The Policyowner may allocate net premiums among the Company's
General Account and up to seven Sub-Accounts of the VEL II
Account. The Policyowner may change the allocation of net
premiums without charge at any time by providing written notice
to the Principal Office. The change will be effective as of the
date of receipt of the notice at the Principal Office. The
Policyowner may transfer amounts among all of the Sub-Accounts
and the General Account, subject to certain restrictions, but at
no time may have allocations in more than seven Subaccounts.
d. REPAYMENT OF LOAN
A loan made under this Policy may be repaid with an amount equal
to the original loan plus loan interest.
When a loan is made, the Company will transfer from each
Sub-Account of the VEL II Account to the General Account an
amount of that Sub-Account's Policy value equal to the loan
amount allocated to the Sub-Account. Since the Company
will-credit such assets with interest at 6%, which is below the
8% interest rate charged on the loan, the Company will retain the
difference between these rates in order to cover certain expenses
and contingencies. Upon repayment of debt, the Company will
reduce the Policy value in the general account attributable to
the loan and transfer assets supporting corresponding reserves to
the Sub-Accounts according to either Policyowner's instruction
or, if none, the premium payment allocation percentages then in
effect. Loan repayments allocated to the VEL II Account cannot
exceed Policy value previously transferred from the VEL II
Account to secure the debt.
3
<PAGE>
e. POLICY REINSTATEMENT
If the surrender value is insufficient to cover the next monthly
deduction plus loan interest accrued, or if Policy debt exceeds
the Policy value less surrender charges, the Company will notify
the Policyowner and any assignee of record. The Policyowner will
then have a grace period of 62 days, measured from the date the
notice is mailed, to make sufficient payments to prevent
termination.
Failure to make a sufficient payment within the grace period will
result in termination of the Policy without any Policy value.
The death benefit payable during the grace period will be reduced
by any overdue charges. If the Insured dies during the grace
period, the death proceeds will still be payable, but any monthly
deductions due and unpaid through the Policy month in which the
Insured dies will be deducted from the death proceeds.
If the Policy has not been surrendered and the Insured is alive,
the terminated Policy may be reinstated anytime within three
years after the date of default by submitting the following to
the Company: (1) a written application for reinstatement; (2)
evidence of insurability satisfactory to the Company; and (3) a
premium that, after the deduction of the premium expense charges,
is large enough to cover the minimum amount payable, as described
below.
If reinstatement is requested less than 48 months after the date
of issue or an increase in the face amount, the Policyowner must
pay the lesser of the amount shown in 1 or 2:
1. The minimum amount payable is the minimum monthly factor for
the three-month period beginning on the date of reinstatement.
2. The minimum amount payable is the sum of the amount by which
the surrender charge as of the date of the reinstatement exceeds
the Policy value on the date of default, plus mortality
deductions for the three-month period beginning on the date of
reinstatement.
If reinstatement is requested 48 months or more after the date of
issue or an increase in the face amount, the Policyowner must pay
the amount shown in 2 above. The surrender charge on the date of
reinstatement is the surrender charge which would have been in
effect had the Policy remained in force from the date of issue.
The Policy value less debt on the date of default will be
restored to the Policy to the extent it does not exceed the
surrender charge on the date of reinstatement. Any policy value
less debt as of the date of default which exceeds the surrender
charge on the date of reinstatement will be forfeited to the
Company.
Policy Value on Reinstatement - The Policy value on the date of
reinstatement is:
(a) the net premium paid to reinstate the Policy increased by
interest from the date the payment was received at the
Company's Principal Office; plus
(b) an amount equal to the Policy value less debt on the date of
default to the extent it does not exceed the surrender
charge on the date of reinstatement; minus
4
<PAGE>
(c) the monthly deduction due on the date of reinstatement.
The Policyowner may not repay or reinstate any debt outstanding
on the date of default or foreclosure.
f. CORRECTION OF MISSTATEMENT OF AGE
If the Company discovers that the age of the Insured has been
misstated, the death benefit and any rider benefits will be those
which would be purchased by the most recent deduction for the
cost of insurance and the cost of rider benefits at the correct
age.
g. CONTESTABILITY
A Policy is contestable for two years, measured from the issue
date, for material misrepresentations made in the initial
application for the Policy. Policy changes may be contested for
two years after the effective date of a change, and a
reinstatement may be contested for two years after the effective
date of reinstatement. No statement will be used to contest a
Policy unless it is contained in an application.
h. REDUCTION IN COST OF INSURANCE RATE CLASSIFICATION
By administrative practice, the Company will reduce the cost of
insurance rate classification for an outstanding Policy if new
evidence of insurability demonstrates that the Policyowner
qualifies for a lower classification. After the reduced rating is
determined, the Policyowner will pay a lower monthly cost of
insurance charge each month. If new evidence of insurability
provided in connection with an increase in face amount
demonstrates that the Policyowner is in a higher risk
classification, the higher cost of insurance rate will apply only
to the increase in face amount.
II. "REDEMPTION PROCEDURE"': SURRENDER AND RELATED TRANSACTIONS
The policies provide for the payment of monies to a Policyowner or
beneficiary upon presentation of a Policy. Generally except for the
payments of death proceeds, the imposition of cost of insurance and
administrative charges, and the possible effect of a contingent
surrender charge, the payee will receive a pro rata or proportionate
share of the VEL II Account's assets, within the meaning of the 1940
Act, in any transaction involving "redemption procedures". The amount
received by the payee will depend-upon the particular benefit for
which the Policy is presented, including, for example, the cash
surrender value or death benefit. There are also certain Policy
provisions (e.g., partial withdrawals or the loan privilege) under
which the Policy will not be presented to the Company but which will
affect the Policyowner's benefits and may involve a transfer of the
assets supporting the Policy reserve out of the VEL II Account. Any
combined transactions on the same day which counteract the effect of
each other will be allowed. The Company will assume the Policyowner
is aware of the possible conflicting nature of the transactions and
desires their combined result. If a transaction is requested which
the Company will not allow (e.g., a request for a decrease in face
amount which lowers the face amount below the stated minimum) the
Company will reject the whole transaction and not just the portion
which causes the disallowance. The Policyowner will be informed of
the rejection and will have an opportunity to give new instructions.
5
<PAGE>
a. SURRENDER FOR CASH VALUES
The Company will pay the net cash surrender value within seven
days after receipt, at its Principal Office, of the Policy and a
signed request for surrender. Computations with respect to the
investment experience of each Sub-Account will be made at the
close of trading of the New York Stock Exchange on each day in
which the degree of trading in the corresponding portfolio might
materially affect the net return of the Sub-Account and on which
the Company is open. This will enable the Company to pay a net
cash value on surrender based on the next computed value after
the surrender request is received. For valuation purposes, the
surrender is effective on the date the Company receives the
request at its Principal Office (although insurance coverage ends
the day the request is mailed).
The Policy value (equal to the value of all accumulations in the
VEL II Account) may increase or decrease from day to day
depending on the investment experience of the VEL II Account.
Calculation of the Policy value for any given day will reflect
the actual premiums paid, expenses charged and deductions taken.
The Company will deduct a charge for premium taxes and DAC taxes
from each premium payment. The balance (net premium) is
allocated to the VEL II Account according to Policyowner's
instructions. The Company will also make monthly deductions from
a Policy to cover the cost of insurance and administrative
expenses for the following month. The monthly administration
charge is only $5 and is designed to compensate the Company for
administering and maintaining a Policy. Other possible
deductions from the Policy (which will occur on a Policy-specific
basis) include a charge for partial withdrawals, a charge for
increases in face amount and a charge for certain transfers.
In calculating the cash surrender value, a surrender charge
comprised of a contingent deferred sales load and a contingent
deferred administrative charge will be deducted from the Policy.
The duration of the surrender charge is 15 years for issue ages 0
through 50, grading down to ten years for issue ages 55 and
above.
The Company will make the payment of net cash surrender value out
of its General Account and, at the same time, transfer assets
from the VEL II Account to the General Account in an amount equal
to the Policy reserves in the VEL II Account. If the Policy is
surrendered in the first Policy year, any unpaid first year
monthly administrative charges will be deducted at surrender, in
addition to any contingent surrender charges which may be
applicable.
The maximum surrender charge calculated upon issuance of the
Policy is equal to the sum of $8.50 per thousand dollars of the
initial face amount plus 49% of premiums received up to a maximum
number of the Guideline Annual Premiums subject to the deferred
sales charge that varies by issue age from 1.660714 (for ages 0
through 55) to 0.948980 (for age 80); provided, however, that in
accordance with limitations under state insurance regulations,
the amount of the Surrender Charge will not exceed a specified
amount per one thousand dollars of initial face amount, as
indicated on the Policy in the prospectus. The maximum Surrender
Charge remains level for the first 40 Policy months and reduces
by 0.5% or more per month (depending on usage) thereafter.
During the first two Policy years following the date of issue,
the actual Surrender Charge will be the sum of $8.50 per thousand
dollars of initial face amount plus an amount not to exceed 29%
of premiums received, up to one Guideline Annual Premium, plus 9%
of premiums receive in excess of one Guideline Annual Premium,
but less than the maximum number of Guideline Annual Premiums
subject to the deferred sales charge.
6
<PAGE>
A separate Surrender Charge is imposed for each increase in face
amount. The maximum Surrender Charge for the increase is $8.50
per thousand dollars of increase plus 49% of premiums associated
with the increase, up to a maximum number of Guideline Annual
Premiums (for the increase) subject to the deferred sales charge
that varies by age (at the time of increase) from 1.660714 (for
ages 0 through 55) to 0.948980 (for age 80); provided, however,
that the amount of the Surrender Charge will not exceed a
specified amount per one thousand dollars of increase, as
indicated in the Policy and prospectus. This maximum Surrender
Charge remains level for the first 40 Policy months following the
increase and reduces by 0.5% or more (depending on age at
increase) thereafter. During the first two Policy years
following an increase in Face Amount, the actual Surrender Charge
is the sum of $8.50 per thousand dollars of increase, plus an
amount not to exceed 29% of premiums associated with the
increase, up to one Guideline Annual Premium (for the increase),
plus 9% of premiums associated with the increase in excess of one
Guideline Annual Premium, but less than the maximum number of
Guideline Annual Premiums (for the increase) subject to the
deferred sales charge. For purposes of calculating actual
Surrender Charges, premium and Policy value will be allocated to
the initial face amount and subsequent increases in face amount
according to the ratio of the respective Guideline Annual
Premiums.
A Surrender Charge also will be made on a decrease in the face
amount. In the event of a decrease, the Surrender Charge imposed
is proportional to the charge that would apply to a full
surrender of the Policy. If more than one Surrender Charge is in
effect, (i.e., pursuant to one or more increases in the face
amount of a Policy), partial surrenders will deemed attributable
to that portion of the face amount governed by the most recent
Surrender Charge. Such charges will be the Surrender Charge
applicable to any increased face amount plus a pro rata share of
the Surrender Charge applicable to a partial reduction in the
initial face amount.
b. CHARGES ON PARTIAL WITHDRAWAL
After the first Policy year, partial withdrawals of surrender
value may be made. The minimum withdrawal is $500. Under Option
1, the face amount is reduced by the amount of the partial
withdrawal, and a partial withdrawal will not be allowed if it
would reduce the face amount below $40,000. A transaction charge
which is the smaller of 2% of the amount withdrawn or $25 will be
assessed on each partial withdrawal.
A Partial Withdrawal Charge will also be deducted from Policy
value when more than 10% of the Policy value is withdrawn in a
Policy year ("excess withdrawal"). Thus, for each partial
withdrawal the Policyowner may withdraw an amount equal to 10% of
the Policy value at that time less the total of any prior
withdrawals in that Policy year which were not subject to the
Partial Withdrawal Charge without incurring a Partial Withdrawal
Charge. Any excess withdrawal will be subject to the Partial
Withdrawal Charge. The Partial Withdrawal Charge is equal to 5
percent of the excess withdrawal up to the amount of the
surrender charge(s) on the date of withdrawal. There will be no
Partial Withdrawal Charge if there is no surrender charge on the
date of withdrawal.
This amount is not cumulative from Policy year to Policy year.
In other words, if only 8% of Policy value were withdrawn in
Policy year two, the amount the Policyowner could withdraw in
subsequent Policy years would not be increased by the amount the
Policyowner did not withdraw in the second Policy year.
7
<PAGE>
The Policy's outstanding surrender charge will be reduced by the
amount of the Partial Withdrawal Charge deducted. The Partial
Withdrawal Charge deducted will decrease existing surrender
charges in the following order:
. first, the surrender charge for the most recent increase in
Face Amount;
. second, the surrender charges for the next most recent increase
successively;
. last, the surrender charge for the initial face amount.
c. DEATH BENEFIT
The Company will pay a death benefit to the beneficiary within
seven days after receipt, at its Principal Office, of the Policy,
due proof of death of the Insured, and all other requirements
necessary to make payment.
The death proceeds payable will depend on the option in effect at
the time of death. Under Option 1, the death benefit is the
greater of either the face amount of insurance or the guideline
minimum sum Insured. Under Option 2, the death benefit is the
greater of either the face amount of insurance PLUS Policy value
or the guideline minimum sum Insured. The guideline minimum sum
Insured is calculated by multiplying the applicable percentage
from the following table for the Insured person's age (nearest
birthday) at the beginning of the Policy year of determination to
the-policy value.
GUIDELINE MINIMUM SUM INSURED
TABLE
<TABLE>
<CAPTION>
Age of
Insured on Percentage of
Date of Death Policy Value
------------- -------------
<S> <C>
40 and less 250%
45: . . . . . . . . . . . . . . . . . . . . . . 215%
50: . . . . . . . . . . . . . . . . . . . . . . 185%
55: . . . . . . . . . . . . . . . . . . . . . . 150%
60: . . . . . . . . . . . . . . . . . . . . . . 130%
65: . . . . . . . . . . . . . . . . . . . . . . 120%
70: . . . . . . . . . . . . . . . . . . . . . . 115%
75: . . . . . . . . . . . . . . . . . . . . . . 105%
80: . . . . . . . . . . . . . . . . . . . . . . 105%
85: . . . . . . . . . . . . . . . . . . . . . . 105%
90: . . . . . . . . . . . . . . . . . . . . . . 105%
95: . . . . . . . . . . . . . . . . . . . . . . 100%
</TABLE>
For the ages not listed, the progression between the listed ages is
linear.
The Company will make payment of the death proceeds out of its general
account, and will transfer assets from the VEL II Account to the
general account in an amount equal to the reserve in the VEL II
Account attributable to the Policy. The excess, if any, of the death
proceeds over the amount transferred will be paid
8
<PAGE>
out of the general account reserve maintained for that purpose.
d. DEFAULT AND OPTIONS ON LAPSE
The duration of insurance coverage depends upon the Policy value being
sufficient to cover the monthly deductions plus loan interest accrued.
If the surrender value at the beginning of a month is less than the
deductions for that month plus loan interest accrued, a grace period
of 62 days will begin. Written notice will be sent to the Policyowner
and any assignee on the Company's records stating that such a grace
period has begun and giving the amount of premium payment necessary to
prevent termination.
If sufficient payment is not received during the grace period, the
Policy will terminate without value. Notice of such termination will
be sent to the owner and any assignee. If the Insured should die
during the grace period, an amount sufficient to cover the overdue
monthly deductions and other charges will be deducted from the death
proceeds.
e. POLICY LOAN
The policies provide that in the first Policy year, a Policyowner may
take a loan of up to 75% of "a minus b", where "a" is Policy value
less surrender charges and "b" is monthly deductions plus interest on
loans accrued to the end of the Policy year. Thereafter, 90% of an
amount equal to Policy value less surrender charges may be borrowed.
The Policy value for this purpose will be that next computed after
receipt, at the Principal Office, of a loan request. Payment of the
loan amount will be made to the Policyowner within seven days after
such receipt.
The amount of any outstanding loan plus accrued interest is called
"debt". When a loan is made, the portion of the assets in the VEL II
Account (which is a portion of the surrender value and which also
constitutes a portion of the reserves for the death benefit) equal to
the debt created thereby is transferred by the Company from the VEL II
Account to the general account. Allocation of the loan among
Sub-Accounts will be according to the Policyowner's request. If this
allocation is not specified or not possible, the loan will be
allocated based on the proportion the Policy value in the General
Account, less debt, and the Policy value in each Sub-Account bears to
the total Policy value, less debt. Policy value in each Sub-Account
equal to the Policy loan allocated to such Subaccount will be
transferred to the General Account, and the number of Accumulation
Units equal to the Policy value so transferred will be cancelled.
Because of the transfer, a portion of the Policy is not variable
during the loan period and, therefore, the death benefit and the
surrender value are permanently affected by any debt, whether or not
repaid in whole or in part. The Company credits the Policy value in
the General Account attributable to the loan with a rate of return
equal to an effective annual yield of 6%, which is 2% lower than the
fixed interest rate charged on the loan.
Interest is payable in arrears at the annual rate of 8%. Interest is
payable at the end of each Policy year or on a pro rata basis for such
shorter period as the loan may exist. Loan interest is due on each
Policy anniversary. If not paid when due,
9
<PAGE>
it is added to the loan principal and bears interest at the same rate
of interest. If the resulting loan principal exceeds the Policy value
in the General Account the Company will transfer Policy value equal to
the excess debt from the Policy value in each Sub-Account to the
General Account; as security for the excess debt. The Company will
allocate the amount transferred among the Sub-Accounts in the same
proportion that the Policy value in each Sub-Account bears to the
total Policy values in all Sub-Accounts.
Failure to repay a loan will not necessarily terminate the Policy. If
the surrender value is not sufficient to cover the monthly deductions
for the cost of insurance and administrative expenses, the Policy will
go into a 62 day grace period as described above.
f. TRANSFERS AMONG SUBACCOUNTS
Amounts may be transferred, upon request, at any time from any
Sub-Account of the VEL II Account to one or more other Sub-Accounts.
Transfers from a Sub-Account of the VEL II Account will take effect as
of the receipt of a written request at the Principal Office. The
minimum amount allowed for a transfer is the lesser of $500 or the
total value in the Sub-Account. The first six transfers are free of
charge; however, the Company will make an administrative charge not to
exceed $25 for additional transfers in a Policy year. Transfers
resulting from Policy loans, the exercise of conversion rights, and
reallocation of Policy value within 20 days of issue, will not be
subject to a transfer charge, and will not be counted for purposes of
the limitation on the number of 'free' transfers allowed in each
Policy year. ff a Policyowner elects to have automatic transfers made
each month, the first automatic transfer counts as one transfer
towards the six free transfers allowed in each Policy year; each
subsequent automatic transfer does not reduce the remaining number of
transfers which may be made without charge.
Transfer charges, if any, are allocated by Policyowner request to one
Sub-Account. If an allocation is not specified or not possible the
allocations will be based on the proportion that the values in each of
the Sub-Accounts of the VEL II Account bears to the total unloaded
Policy value.
g. RIGHT OF WITHDRAWAL PROCEDURES
The Policy provides that the Policyowner may cancel it by returning
the Policy along with a written request for cancellation to the
Principal Office by the latest of 1) 45 days after Part I of the
application was signed, 2) 10 days after the Policyowner receives the
Policy, or 3) 10 days after the Company mails or personally delivers a
written Notice of Withdrawal Right. Upon returning the Policy, the
Policyowner will receive within seven days a refund equal to the sum
of (1) the difference between the premium, including fees, paid and
any amount allocated to the VEL II Account, and (2) the value of the
amounts allocated to the VEL II Account, and (3) any fees or charges
imposed on the amounts allocated to the VEL II Account. Where
required by State law, the Policyowner will receive a refund equal to
the sum of the premium payments made under the Policy. The postmark
date on the envelope containing the Policy will determine whether the
Policy has been surrendered within the Company's withdrawal period.
10
<PAGE>
A free look privilege also applies after a requested increase in Face
Amount. After an increase, the Company will mail or deliver notice of
the "Free Look" with respect to the increase. The Policyowner will
have the right to cancel the increase within 10 days, and receive a
credit for charges which would not have been deducted but for the
increase. Such charges with respect to the increase will be added to
Policy value, unless the Policyowner requests a refund of such
charges.
11
<PAGE>
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in the Prospectus constituting part of this
Post-Effective Amendment No. 12 to the Registration Statement of the VEL II
Account of Allmerica Financial Life Insurance and Annuity Company on Form S-6
of our report dated February 3, 1998, relating to the financial statements of
Allmerica Financial Life Insurance and Annuity Company, and our report dated
March 25, 1998, relating to the financial statements of the VEL II Account of
Allmerica Financial Life Insurance and Annuity Company, both of which appear
in such Prospectus. We also consent to the reference to us under the heading
"Independent Accountants" in such Prospectus.
/s/ Price Waterhouse LLP
Price Waterhouse LLP
Boston, Massachusetts
April 15, 1998
